{"meta":{"query_hash":"274f257c934d","filters":{"topic":"Lung Cancer Research Studies"},"cohort_total":587,"direct_labels_cover":0,"predictions_cover":587,"exported":587,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/274f257c934d","api":"https://metacan.xera.ac/api/v1/cohort?topic=Lung+Cancer+Research+Studies"},"results":[{"id":"W1109143382","doi":"10.7759/cureus.296","title":"Small Cell Cancer of the Bladder and Prostate: A Retrospective Review from a Tertiary Cancer Center","year":2015,"lang":"en","type":"review","venue":"Cureus","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Boniface Hospital; University of Manitoba; Manitoba Health; CancerCare Manitoba","funders":"","keywords":"Medicine; Malignancy; Stage (stratigraphy); Cancer; Radiation therapy; Prostate cancer; Retrospective cohort study; Prostate; Bladder cancer; Genitourinary system; Surgery; Internal medicine","score_opus":0.08220793046755934,"score_gpt":0.4057025673212575,"score_spread":0.32349463685369817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1109143382","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003502518,0.99179596,3.0539263e-7,0.000793663,0.00039173212,0.0038701987,0.0015488011,0.00002134293,0.0015429755],"genre_scores_gemma":[0.000013464884,0.9943438,0.000028640025,0.0005436272,0.00041439102,0.0014058194,0.000048849033,0.00007282757,0.00312857],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99778885,0.00019279521,0.00053569087,0.000572136,0.00054054137,0.00036996862],"domain_scores_gemma":[0.9981038,0.00006699139,0.00044568596,0.00076499983,0.0004420619,0.00017647068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002686434,0.00043707044,0.0022228227,0.000042477554,0.000054661356,0.000012289586,0.00030540134,0.00016653068,0.00031941518],"category_scores_gemma":[0.00016291687,0.00022715343,0.0003596873,0.00029448688,0.00033234095,0.0000432705,0.0004998515,0.00068028545,0.000009176742],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005514753,0.00023767493,0.0119120125,0.2556637,0.0033275094,0.000044185264,0.0011096983,3.711426e-8,0.0000048471215,0.000004280092,0.31150323,0.4161377],"study_design_scores_gemma":[0.0005320053,0.00006256817,0.0008350003,0.139011,0.0033085407,0.000008485008,0.000019648427,3.2732015e-7,0.000006480359,0.000016260663,0.85600954,0.00019016746],"about_ca_topic_score_codex":0.002874194,"about_ca_topic_score_gemma":0.0009027896,"teacher_disagreement_score":0.5445063,"about_ca_system_score_codex":0.00089739665,"about_ca_system_score_gemma":0.0016196121,"threshold_uncertainty_score":0.9263048},"labels":[],"label_agreement":null},{"id":"W1138370978","doi":"10.1097/jto.0000000000000652","title":"Refining Prognosis in Lung Cancer","year":2015,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Institutes of Health","keywords":"Medicine; Lung cancer; Population; Disease; Cancer; Oncology; Identification (biology); Medical physics; Intensive care medicine; Personalized medicine; Internal medicine; Bioinformatics","score_opus":0.09822665380393408,"score_gpt":0.5511675105923424,"score_spread":0.4529408567884083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1138370978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9420449,0.012039216,0.000026016469,0.03313338,0.00081700704,0.00016552465,0.000001473713,0.00001149778,0.011760969],"genre_scores_gemma":[0.9941265,0.00052114157,0.0032248963,0.00045902608,0.00067222514,0.000027966818,4.010442e-7,0.000013985953,0.0009538617],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986475,0.0001589647,0.0004265236,0.00010161695,0.00040192858,0.00026342986],"domain_scores_gemma":[0.99879193,0.00012654404,0.00027421457,0.00008225703,0.000500055,0.00022502038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001505988,0.000083299936,0.0005052605,0.0002970194,0.00002141729,0.000007501453,0.00011282043,0.000088774206,0.00005306939],"category_scores_gemma":[0.0008257452,0.00005957822,0.00007258367,0.00029255723,0.00007663041,0.00011103856,0.00007274744,0.00055778073,0.000005262048],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031634402,0.0003116351,0.7814902,0.00022159136,0.0002770908,0.002117709,0.0019709545,0.000062258085,0.0006967177,0.000014353737,0.045482177,0.16419187],"study_design_scores_gemma":[0.01068011,0.014442503,0.4992847,0.0037855508,0.0012337612,0.0048956326,0.0046076514,0.00094187405,0.0058600362,0.00041740024,0.453361,0.0004897803],"about_ca_topic_score_codex":0.00011100304,"about_ca_topic_score_gemma":0.00023300655,"teacher_disagreement_score":0.40787882,"about_ca_system_score_codex":0.0016512019,"about_ca_system_score_gemma":0.0017218232,"threshold_uncertainty_score":0.43178353},"labels":[],"label_agreement":null},{"id":"W129944274","doi":"10.1200/jco.2007.25.18_suppl.7627","title":"Phase II study of the efficacy and safety of intravenous (IV) AVE0005 (VEGF Trap) given every 2 weeks in patients (Pts) with platinum- and erlotinib- resistant adenocarcinoma of the lung (NSCLA)","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Febrile neutropenia; Performance status; Adverse effect; Progressive disease; Nausea; Oncology; Neutropenia; Lung cancer; Carboplatin; Sunitinib; Surgery; Cancer; Chemotherapy","score_opus":0.05390957801326977,"score_gpt":0.43178274645929626,"score_spread":0.3778731684460265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W129944274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961967,0.00077085185,0.0000044374556,0.0014252394,0.00017040301,0.0010786754,0.000011912919,0.0000016546503,0.00034014453],"genre_scores_gemma":[0.9993706,0.0002138775,0.00012682374,0.00010492657,0.00012814542,0.0000022384907,3.1634565e-7,0.000013391433,0.0000397134],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955526,0.00067771564,0.0025121698,0.00019970161,0.0008003181,0.0002574692],"domain_scores_gemma":[0.9936022,0.0032985667,0.002123981,0.00029847247,0.0005113011,0.00016543671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043809703,0.00015033515,0.0015381915,0.00013944149,0.00008180087,0.0000024114677,0.0002557302,0.00016752808,0.000010872331],"category_scores_gemma":[0.0030516782,0.00007328335,0.00015434388,0.00029572882,0.0009000172,0.000055263783,0.00024465704,0.00103334,4.9954096e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08134987,0.013965804,0.87045217,0.00017730227,0.00080294244,0.00008394774,0.005834037,0.000009338568,0.00029004493,0.000012634088,0.0002588997,0.026763005],"study_design_scores_gemma":[0.05595072,0.092208706,0.84879386,0.0004883771,0.00040834583,0.000026871963,0.0017364346,0.000011722539,0.00010152253,0.000019737086,0.00019992597,0.000053790154],"about_ca_topic_score_codex":0.00008526882,"about_ca_topic_score_gemma":0.0005379378,"teacher_disagreement_score":0.078242905,"about_ca_system_score_codex":0.00014045298,"about_ca_system_score_gemma":0.00081045413,"threshold_uncertainty_score":0.44894058},"labels":[],"label_agreement":null},{"id":"W1481967818","doi":"10.1002/cncr.10841","title":"Twenty‐five years of clinical research for patients with limited‐stage small cell lung carcinoma in North America","year":2002,"lang":"en","type":"article","venue":"Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":172,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Clinical trial; Stage (stratigraphy); Internal medicine; Epidemiology; Radiation therapy; Surgery; Confidence interval; Survival analysis; Carcinoma; Small-cell carcinoma","score_opus":0.12748944845242452,"score_gpt":0.4271477782755311,"score_spread":0.2996583298231066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1481967818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993956,0.002131304,0.0000065089575,0.00034764537,0.000108170774,0.0014913375,0.0001481084,0.000012699534,0.0017981799],"genre_scores_gemma":[0.9935759,0.0012471187,0.00030714966,0.00014933427,0.0001748163,0.00039199047,0.000022673341,0.00003484312,0.0040962133],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99799675,0.000111024856,0.00038937994,0.0003956712,0.00057573465,0.0005314493],"domain_scores_gemma":[0.9982336,0.0005000047,0.00011439789,0.00036400385,0.0006107024,0.00017730118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031918904,0.00011898387,0.00046959374,0.0002097414,0.00004604761,0.000007795394,0.00016500964,0.00006262776,0.00016620847],"category_scores_gemma":[0.00043205032,0.00009725419,0.0000880227,0.00064777816,0.00035357903,0.000046541903,0.00011197428,0.0004504785,0.000011892945],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008656777,0.00042971232,0.96829957,0.00043668124,0.00007126585,0.000025773685,0.0015458739,0.00003465312,0.000007743431,0.0000020256018,0.014100661,0.014180374],"study_design_scores_gemma":[0.005868518,0.0016545767,0.9602761,0.00015511985,0.000042983134,1.2959586e-7,0.00036416424,0.000876425,0.00006238181,0.0000013504169,0.030585367,0.000112850474],"about_ca_topic_score_codex":0.00089834887,"about_ca_topic_score_gemma":0.0011274689,"teacher_disagreement_score":0.016484708,"about_ca_system_score_codex":0.00031236128,"about_ca_system_score_gemma":0.00024199572,"threshold_uncertainty_score":0.3965911},"labels":[],"label_agreement":null},{"id":"W1491079171","doi":"10.1186/1471-2407-7-31","title":"Disease-specific survival for limited-stage small-cell lung cancer affected by statistical method of assessment","year":2007,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Queen's University; University of Saskatchewan","funders":"Saskatchewan Cancer Agency","keywords":"Surgical oncology; Medicine; Lung cancer; Disease; Stage (stratigraphy); Oncology; Internal medicine; Biology","score_opus":0.07400920070106777,"score_gpt":0.45228970089932247,"score_spread":0.3782805001982547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1491079171","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.064423956,0.023871683,0.89830923,0.0007890725,0.0009841378,0.0037915204,0.005212385,0.00012723506,0.0024907573],"genre_scores_gemma":[0.7425321,0.011948333,0.2001565,0.000851459,0.0028710626,0.0055285348,0.0009367545,0.0004403624,0.034734912],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99742395,0.00013027448,0.0004432534,0.00054691825,0.0007360944,0.0007195037],"domain_scores_gemma":[0.9972819,0.001269914,0.00016206998,0.00039829602,0.00044351167,0.00044430688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096047757,0.00027085387,0.00061652955,0.00013160707,0.000105702165,0.000020748537,0.00015747015,0.00008374416,0.00080268853],"category_scores_gemma":[0.00019398825,0.00022899291,0.00016215375,0.0003331471,0.0001527294,0.00004831251,0.00009815042,0.0002654947,0.0000018300683],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008704853,0.0021653436,0.52309877,0.013279892,0.0014720446,0.0001039016,0.0006491803,0.00047390972,0.09196327,0.0032881468,0.3258894,0.028911324],"study_design_scores_gemma":[0.012250633,0.0006890471,0.7907166,0.00077136606,0.0011707889,0.000001759973,0.0005662553,0.0080543915,0.02056031,0.0000627996,0.16437574,0.0007803443],"about_ca_topic_score_codex":0.0009623317,"about_ca_topic_score_gemma":0.0016890186,"teacher_disagreement_score":0.6981528,"about_ca_system_score_codex":0.0010789265,"about_ca_system_score_gemma":0.0010861442,"threshold_uncertainty_score":0.933806},"labels":[],"label_agreement":null},{"id":"W1491400775","doi":"10.20381/ruor-7451","title":"A comparative study of high-dose chemotherapy with autologous hematopoietic progenitor cell transplantation versus conventional chemotherapy as treatment for metastatic breast cancer.","year":2000,"lang":"en","type":"dissertation","venue":"Library and Archives Canada (Government of Canada)","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Chemotherapy; Medicine; Oncology; Breast cancer; Hematopoietic stem cell transplantation; Transplantation; Cancer; Internal medicine; Metastatic breast cancer; Progenitor cell; Stem cell; Biology","score_opus":0.010383982507922256,"score_gpt":0.2590640237222782,"score_spread":0.24868004121435597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1491400775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98874927,0.0007089704,0.0000032084317,0.00089563424,0.00012897127,0.0027820177,0.0014694603,0.000009981883,0.005252476],"genre_scores_gemma":[0.9905016,0.0012937301,0.00035048474,0.00008232505,0.00005037095,0.0005718931,0.00032836534,0.000045181674,0.006776046],"study_design_codex":"randomized_trial","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99736047,0.00005803477,0.0003844882,0.0003715939,0.0015506337,0.00027476507],"domain_scores_gemma":[0.99908066,0.0002444857,0.00032463687,0.00016772136,0.0000067814694,0.000175737],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000009053199,0.00036068022,0.0008673338,0.000051307983,0.00013229426,0.000010751659,0.00010815951,0.00003278958,0.0001130042],"category_scores_gemma":[4.9319624e-7,0.00028124946,0.00006455058,0.000096736505,0.00008465133,0.000097911674,0.0000058589435,0.00011194171,3.1475138e-9],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8617263,0.006752107,0.015287292,0.016680561,0.020591341,0.0006634928,0.023830699,0.0004275182,0.018219503,0.0023614177,0.0011708288,0.03228898],"study_design_scores_gemma":[0.08203466,0.019901592,0.3310743,0.0020036811,0.0035572918,0.00008826814,0.081585556,0.00043445296,0.47635108,0.0002584905,0.001553621,0.0011569978],"about_ca_topic_score_codex":0.010921833,"about_ca_topic_score_gemma":0.0808046,"teacher_disagreement_score":0.7796916,"about_ca_system_score_codex":0.00006624126,"about_ca_system_score_gemma":0.004964364,"threshold_uncertainty_score":0.99996394},"labels":[],"label_agreement":null},{"id":"W1524781181","doi":"10.1038/bjc.2015.171","title":"Serum LAMC2 enhances the prognostic value of a multi-parametric panel in non-small cell lung cancer","year":2015,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto; University Health Network","funders":"","keywords":"Lung cancer; Medicine; Value (mathematics); Parametric statistics; Lung; Pathology; Internal medicine; Oncology; Statistics; Mathematics","score_opus":0.04659178315381654,"score_gpt":0.36188258368458565,"score_spread":0.3152908005307691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1524781181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84710646,0.150255,0.00008329895,0.0010458843,0.00046876675,0.0006509917,0.000036132224,0.0000065961067,0.00034686935],"genre_scores_gemma":[0.9721926,0.025698107,0.0005282967,0.00021500932,0.00046556012,0.00012003035,6.358122e-7,0.00003053829,0.000749258],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997673,0.0001373834,0.00066552236,0.00020007278,0.000872071,0.0004520032],"domain_scores_gemma":[0.9979193,0.00023285547,0.00046380275,0.00016182596,0.000987138,0.00023504347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010126177,0.00016523495,0.00062835694,0.00025177037,0.000056385437,0.000044884007,0.00032951366,0.00007663666,0.000065536144],"category_scores_gemma":[0.00078787433,0.00012679334,0.00015671185,0.00085029606,0.0001944113,0.00015034327,0.000097811666,0.0006760524,0.0000018694295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058410363,0.00059866335,0.92274517,0.001319417,0.00058373914,0.001049505,0.0026918894,0.0022838807,0.0023542738,0.00000362059,0.009655303,0.056130454],"study_design_scores_gemma":[0.007884442,0.0005491443,0.97024286,0.005417834,0.00044037047,0.00041743982,0.0012922236,0.0020233104,0.0089812465,0.00003345937,0.0024898578,0.00022781164],"about_ca_topic_score_codex":0.00800566,"about_ca_topic_score_gemma":0.006629873,"teacher_disagreement_score":0.1250861,"about_ca_system_score_codex":0.0005515741,"about_ca_system_score_gemma":0.0016350375,"threshold_uncertainty_score":0.9986001},"labels":[],"label_agreement":null},{"id":"W1597090878","doi":"10.1046/j.0306-5251.2001.01468.x","title":"Population pharmacokinetics and pharmacodynamics of oral etoposide","year":2001,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Etoposide; Pharmacokinetics; Pharmacodynamics; Medicine; Population; Pharmacology; Bioavailability; Cmax; Neutropenia; Creatinine; Internal medicine; Chemotherapy; Gastroenterology","score_opus":0.07223844834311155,"score_gpt":0.5034119110384546,"score_spread":0.43117346269534307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1597090878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98992234,0.004882195,0.00014396061,0.0027187255,0.0014848592,0.00025672876,0.000012490982,0.000012321565,0.00056639494],"genre_scores_gemma":[0.945016,0.05082483,0.0012513222,0.0015591824,0.0011297336,0.0000027860508,0.0000042730558,0.000019941417,0.00019188816],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99729663,0.00033725356,0.0014975058,0.00017762107,0.00041504682,0.0002759167],"domain_scores_gemma":[0.99777055,0.0005403568,0.0006615025,0.00006294573,0.0006163788,0.00034829657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016950013,0.00011906549,0.000909611,0.00013161673,0.0000552276,0.000012252751,0.00013823868,0.00010848158,0.00036368065],"category_scores_gemma":[0.0006900104,0.000120171695,0.00022893785,0.0001924603,0.00036524134,0.00014035155,0.000100590056,0.00087824644,0.000002186922],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057185222,0.0014055002,0.45537695,0.00030567375,0.0017116786,0.005078703,0.00006130614,0.00014484333,0.018656809,0.000021826745,0.057037808,0.45448038],"study_design_scores_gemma":[0.024655936,0.002401523,0.90859324,0.00033604505,0.0016858848,0.013450594,0.000052287665,0.0028609717,0.0017360431,0.00039693058,0.04360805,0.00022247793],"about_ca_topic_score_codex":0.00009709969,"about_ca_topic_score_gemma":0.000018540499,"teacher_disagreement_score":0.4542579,"about_ca_system_score_codex":0.000054327633,"about_ca_system_score_gemma":0.00016373406,"threshold_uncertainty_score":0.49004593},"labels":[],"label_agreement":null},{"id":"W167503670","doi":"10.1007/978-3-642-18832-9_23","title":"The Treated Thorax in Patients with Hematological Malignancies","year":2004,"lang":"en","type":"book-chapter","venue":"Medical radiology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Autopsy; Thorax (insect anatomy); Chemotherapy; Radiation therapy; Disease; Natural history; Intensive care medicine; Internal medicine; Surgery","score_opus":0.016007417969919075,"score_gpt":0.2923789079195005,"score_spread":0.27637148994958144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W167503670","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12096387,0.024523582,0.00005322668,0.046354543,0.00093166746,0.005557867,0.00008439629,0.00040003203,0.80113083],"genre_scores_gemma":[0.6787009,0.012493919,0.00021114622,0.0043805656,0.001113403,0.00051883614,0.0004986354,0.00025140555,0.30183116],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99743503,0.000074094976,0.00043666692,0.00046927712,0.0009908382,0.00059407053],"domain_scores_gemma":[0.9984714,0.0005749129,0.000109402165,0.0004026097,0.0001468825,0.0002948052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041782847,0.00033846864,0.001015147,0.000118535216,0.0001100697,0.000007408296,0.00028387396,0.00068217056,0.000890033],"category_scores_gemma":[0.0011188464,0.00015463463,0.00010465613,0.00006190169,0.0020366705,0.000014135813,0.00015147147,0.0012251362,0.00008883059],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010926922,0.0007070356,0.49385104,0.00091318716,0.0028356796,0.014799289,0.00051344343,0.0000030196104,0.0000036042056,0.37813553,0.058014512,0.039296735],"study_design_scores_gemma":[0.027289277,0.01189322,0.3981498,0.005854074,0.00055102346,0.0012142897,0.00007050352,0.000014145675,0.000021876329,0.032053854,0.52160186,0.0012860807],"about_ca_topic_score_codex":0.000034635388,"about_ca_topic_score_gemma":0.00014058838,"teacher_disagreement_score":0.55773705,"about_ca_system_score_codex":0.0004716421,"about_ca_system_score_gemma":0.00065587246,"threshold_uncertainty_score":0.9745238},"labels":[],"label_agreement":null},{"id":"W1733892693","doi":"10.1016/j.ebiom.2015.09.031","title":"Associated Links Among Smoking, Chronic Obstructive Pulmonary Disease, and Small Cell Lung Cancer: A Pooled Analysis in the International Lung Cancer Consortium","year":2015,"lang":"en","type":"article","venue":"EBioMedicine","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Princess Margaret Cancer Centre; University of Toronto; University Health Network; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; Canadian Cancer Society Research Institute; National Institutes of Health; Natural Science Foundation of Jiangsu Province; Ministry of Health, Labour and Welfare; National Natural Science Foundation of China; Roy Castle Lung Cancer Foundation; National Institute on Drug Abuse; Bundesamt für Strahlenschutz; Ministry of Education, Culture, Sports, Science and Technology; National Cancer Center; Mayo Clinic","keywords":"Medicine; COPD; Lung cancer; Internal medicine; Logistic regression; Smoking cessation; Oncology; Physical therapy; Pathology","score_opus":0.017790462779392426,"score_gpt":0.32884565884980616,"score_spread":0.3110551960704137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1733892693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93476295,0.049029514,0.000028889313,0.01259657,0.0004594598,0.0009566398,0.0001522237,0.000052526437,0.00196123],"genre_scores_gemma":[0.99405766,0.0022483917,0.000012417354,0.0007712987,0.0007602759,0.00043534974,0.00020556043,0.000026505597,0.0014825335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974128,0.00014250143,0.0004184336,0.00051223335,0.0010092781,0.00050477305],"domain_scores_gemma":[0.9984857,0.00020605925,0.00021832551,0.00032611328,0.00039090932,0.00037290802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078470644,0.0002663766,0.0005933347,0.0005851749,0.00010038864,0.00003650384,0.00029948662,0.00013696283,0.00017909172],"category_scores_gemma":[0.00041756596,0.00017968759,0.00011445359,0.0014331624,0.00047250907,0.000102809965,0.00019228486,0.00073919253,8.5373597e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027585673,0.00013342849,0.98623747,0.00019515125,0.003044698,0.00038945468,0.0023426064,0.00009669653,0.00023366217,0.0000076171314,0.0061297757,0.0009136104],"study_design_scores_gemma":[0.0034465732,0.00009573528,0.96324456,0.00046803892,0.00474333,0.0000048888633,0.0009913851,0.0257587,0.00005100114,0.00002705415,0.0009862124,0.00018251604],"about_ca_topic_score_codex":0.0082498435,"about_ca_topic_score_gemma":0.00461409,"teacher_disagreement_score":0.059294723,"about_ca_system_score_codex":0.0021725602,"about_ca_system_score_gemma":0.0009146692,"threshold_uncertainty_score":0.9983543},"labels":[],"label_agreement":null},{"id":"W1824988371","doi":"10.1200/jco.2015.64.0888","title":"Limited-Stage Small-Cell Lung Cancer: An Age Limit for Combined Modality Therapy?","year":2015,"lang":"en","type":"letter","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Stage (stratigraphy); Lung cancer; Oncology; Internal medicine; Radiology","score_opus":0.3601170311879099,"score_gpt":0.5497337496686522,"score_spread":0.1896167184807423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1824988371","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.054645088,0.009399097,0.00012555359,0.9237748,0.005230745,0.0022676855,0.00020354266,0.00004888681,0.004304594],"genre_scores_gemma":[0.006801546,0.026372071,0.0041209366,0.8848051,0.04993912,0.00025890087,0.00019508392,0.00023850733,0.027268758],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99195176,0.0015627326,0.0037370203,0.00061685266,0.001246788,0.0008848378],"domain_scores_gemma":[0.9853779,0.0062125446,0.00382359,0.00075860624,0.0029712268,0.0008561001],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0085365595,0.00051924225,0.004888955,0.00031290026,0.00010551104,0.000043328568,0.00086337293,0.0025272742,0.00018180997],"category_scores_gemma":[0.0052367016,0.00035707155,0.0015175614,0.00019698219,0.0004965388,0.00014681401,0.00020309047,0.008177607,0.000007195985],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011595182,0.0017040645,0.0074755955,0.000811945,0.00242495,0.004689662,0.00019355798,0.0000118193875,0.000032460586,0.000007509072,0.95075285,0.020300424],"study_design_scores_gemma":[0.022745304,0.035303105,0.0042718635,0.0002989977,0.0012353456,0.000056477344,0.00006276952,0.00022020625,0.000024318486,0.0003694821,0.93509686,0.00031527266],"about_ca_topic_score_codex":0.000212132,"about_ca_topic_score_gemma":0.00021229354,"teacher_disagreement_score":0.047843542,"about_ca_system_score_codex":0.0013772884,"about_ca_system_score_gemma":0.0106935175,"threshold_uncertainty_score":0.9998881},"labels":[],"label_agreement":null},{"id":"W1861909078","doi":"10.1111/neup.12172","title":"Metastatic ovarian carcinoma to the brain: An approach to identification and classification for neuropathologists","year":2014,"lang":"en","type":"article","venue":"Neuropathology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Ovarian carcinoma; Brain metastasis; Metastatic carcinoma; Serous carcinoma; Pathology; Carcinoma; Serous fluid; Malignancy; Metastasis; Stage (stratigraphy); Carcinosarcoma; Ovarian carcinomas; Oncology; Internal medicine; Ovarian cancer; Cancer; Biology","score_opus":0.08332343353206814,"score_gpt":0.36709460151055273,"score_spread":0.28377116797848456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1861909078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.850272,0.000053854288,0.10565462,0.039850067,0.00029264382,0.002547381,0.000024267752,0.000097687094,0.0012074823],"genre_scores_gemma":[0.9864555,0.000006670398,0.0039378176,0.008139446,0.00022805542,0.00074539636,0.000030592597,0.00003612435,0.00042041473],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99795014,0.00060282496,0.00026020018,0.0006531499,0.00020145993,0.000332224],"domain_scores_gemma":[0.9985162,0.00028899888,0.000070047696,0.00072160596,0.00019961991,0.00020354192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012811574,0.00015104702,0.00026404575,0.00016752176,0.00020548044,0.00004969489,0.00021240053,0.0000369407,0.0000017081322],"category_scores_gemma":[0.0030460018,0.000106774416,0.00003900233,0.00027048934,0.00014932039,0.00006339037,0.00011869088,0.00016439382,0.000038078728],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001859074,0.00081996305,0.055705767,0.0006608476,0.000053891265,0.000121631776,0.008432168,0.00018975663,0.738131,0.027104203,0.022808926,0.14411277],"study_design_scores_gemma":[0.00071901036,0.0014801718,0.97714156,0.000005811787,0.000073655974,0.00041588195,0.00014490608,0.0034138712,0.00056394545,0.00018379687,0.015742194,0.00011520974],"about_ca_topic_score_codex":0.000009646259,"about_ca_topic_score_gemma":0.000010264547,"teacher_disagreement_score":0.9214358,"about_ca_system_score_codex":0.000035748413,"about_ca_system_score_gemma":0.000037718244,"threshold_uncertainty_score":0.43541342},"labels":[],"label_agreement":null},{"id":"W1903523058","doi":"10.1038/nature14664","title":"Comprehensive genomic profiles of small cell lung cancer","year":2015,"lang":"en","type":"article","venue":"Nature","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2386,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; Vancouver General Hospital","funders":"National Cancer Institute; National Institutes of Health; Stand Up To Cancer; Deutschen Konsortium für Translationale Krebsforschung; Associazione Italiana per la Ricerca sul Cancro; Bundesministerium für Bildung und Forschung; Deutsches Zentrum für Lungenforschung; European Regional Development Fund; Roy Castle Lung Cancer Foundation; European Commission; Universität zu Köln; Ministero della Salute; Deutsche Forschungsgemeinschaft; Genentech; Deutsche Krebshilfe","keywords":"Biology; Cancer research; Somatic cell; Gene; Chromothripsis; Cancer; Cyclin D1; Mutation; Suppressor; Mutant; Genetics; Tumor suppressor gene; Lung cancer; SMARCA4; Carcinogenesis; Genome instability; Gene expression; Cell cycle; Medicine; Pathology; DNA damage; DNA","score_opus":0.03260873819400115,"score_gpt":0.36216059487962293,"score_spread":0.3295518566856218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1903523058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9014273,0.08774244,0.0000043651094,0.0021494755,0.00029155498,0.00059747434,0.00004896688,0.000033421165,0.0077049807],"genre_scores_gemma":[0.9945033,0.00054340257,0.0008226721,0.0007241124,0.000322946,0.000046678313,0.000013052141,0.000019442423,0.003004358],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99920607,0.000023184133,0.00011011459,0.00016550726,0.00029908714,0.00019601706],"domain_scores_gemma":[0.9990682,0.000037661535,0.00005234913,0.00019617022,0.00052513054,0.000120503086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000675098,0.00009813132,0.0002482269,0.00006315692,0.000022475146,0.000004180368,0.00009864918,0.0003040969,0.000045732544],"category_scores_gemma":[0.00006367027,0.00007219856,0.000051130988,0.00013477688,0.000072558265,0.000021549402,0.00009585346,0.001043974,0.0000088013885],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095875515,0.00020030612,0.30553475,0.0034884333,0.00055714324,0.00010658179,0.004088082,0.000090199595,0.12545262,0.00016601112,0.5574926,0.0018645081],"study_design_scores_gemma":[0.010841779,0.0008916987,0.3684863,0.0009053388,0.00056499214,0.000034219862,0.0025752583,0.0009367337,0.21706717,0.00017941458,0.3969644,0.0005527221],"about_ca_topic_score_codex":0.00014732049,"about_ca_topic_score_gemma":0.000032228632,"teacher_disagreement_score":0.16052818,"about_ca_system_score_codex":0.00021447938,"about_ca_system_score_gemma":0.00041449125,"threshold_uncertainty_score":0.45356053},"labels":[],"label_agreement":null},{"id":"W1940768002","doi":"10.1186/s12935-015-0231-z","title":"Etoposide induces cell death via mitochondrial-dependent actions of p53","year":2015,"lang":"en","type":"article","venue":"Cancer Cell International","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver Coastal Health","funders":"Canadian Institutes of Health Research","keywords":"Etoposide; Programmed cell death; Mitochondrion; Cancer research; Apoptosis; Cell; Medicine; Cell biology; Biology; Neuroscience; Genetics; Chemotherapy; Internal medicine","score_opus":0.08949637099171534,"score_gpt":0.3952874771036114,"score_spread":0.3057911061118961,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1940768002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7000944,0.0039419094,0.001087783,0.0037503408,0.0051260833,0.0007030457,0.0001580514,0.000080685924,0.28505772],"genre_scores_gemma":[0.97817725,0.00068468205,0.00090197247,0.00021439261,0.0009683279,0.00013687788,0.00002986066,0.000021186243,0.018865447],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99851143,0.000026178945,0.00025516833,0.00024764342,0.0007602096,0.00019938232],"domain_scores_gemma":[0.9987955,0.000053073956,0.0001270592,0.0002010016,0.0006383706,0.00018500056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000099667486,0.00012768405,0.00021203766,0.00010032188,0.00003914989,0.000017257637,0.00021006007,0.00006285753,0.0008477692],"category_scores_gemma":[0.00006862891,0.00011068506,0.00008698575,0.00008779115,0.00007403598,0.00014804183,0.00012020533,0.00019941072,0.000051828385],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001139187,0.0009949128,0.043311734,0.00028795277,0.00080953137,0.000072033945,0.0032137262,0.00041494894,0.8380778,0.00048696264,0.10745284,0.0037383735],"study_design_scores_gemma":[0.0056152456,0.00043982035,0.009689273,0.00018138654,0.0001973319,0.000026674585,0.0012891124,0.00041249258,0.89277184,0.00048739897,0.08859583,0.00029359097],"about_ca_topic_score_codex":0.0023627565,"about_ca_topic_score_gemma":0.00031578582,"teacher_disagreement_score":0.27808288,"about_ca_system_score_codex":0.0009388618,"about_ca_system_score_gemma":0.00052658207,"threshold_uncertainty_score":0.9282478},"labels":[],"label_agreement":null},{"id":"W1946837456","doi":"10.1186/s12014-015-9090-9","title":"Blood-based lung cancer biomarkers identified through proteomic discovery in cancer tissues, cell lines and conditioned medium","year":2015,"lang":"en","type":"article","venue":"Clinical Proteomics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"School of Medicine, New York University; York University; George Washington University; National Cancer Institute; University of Pennsylvania","keywords":"Medicine; Lung cancer; National Lung Screening Trial; Biomarker; Biomarker discovery; Lung cancer screening; Oncology; Cancer; Population; Internal medicine; Proteomics; Pathology; Biology","score_opus":0.09832630586585482,"score_gpt":0.45723278813987484,"score_spread":0.35890648227402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1946837456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9754358,0.0079878345,0.00033478858,0.010567532,0.00094944367,0.0042161164,0.0001416724,0.0000792949,0.00028751395],"genre_scores_gemma":[0.98117816,0.0038137683,0.004376111,0.0014726822,0.0013845634,0.0035789947,0.00008768046,0.00009818454,0.00400984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970232,0.00022249843,0.00092702435,0.0007422637,0.00053932297,0.0005456878],"domain_scores_gemma":[0.99834764,0.0002680184,0.00027106263,0.00044563675,0.00030630257,0.00036131655],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011631264,0.00030255457,0.0007899674,0.00012462189,0.00009059258,0.00007933565,0.00019980296,0.00026685453,0.00009206505],"category_scores_gemma":[0.0011360154,0.0002483905,0.00013080669,0.00035011387,0.0007464999,0.00034454977,0.00020110287,0.00065111293,0.000011088534],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005167967,0.0014370292,0.9270473,0.0021070207,0.00093113346,0.00031532117,0.0009688182,0.00011150193,0.0153519,0.00005363554,0.04581584,0.0006925154],"study_design_scores_gemma":[0.1099135,0.0044147307,0.50241023,0.006891539,0.0033393458,0.000041517553,0.0016038006,0.00989141,0.34814355,0.002686826,0.007735587,0.002927973],"about_ca_topic_score_codex":0.003273926,"about_ca_topic_score_gemma":0.0007321879,"teacher_disagreement_score":0.42463708,"about_ca_system_score_codex":0.00037560807,"about_ca_system_score_gemma":0.0017348998,"threshold_uncertainty_score":0.99999684},"labels":[],"label_agreement":null},{"id":"W1964109435","doi":"10.1016/j.lungcan.2008.06.017","title":"Phase II study of weekly plitidepsin as second-line therapy for small cell lung cancer","year":2008,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cégep de Lévis; Jewish General Hospital","funders":"","keywords":"Medicine; Oncology; Internal medicine; Phase (matter); Lung cancer","score_opus":0.05241453114756632,"score_gpt":0.41515913076825106,"score_spread":0.3627445996206847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964109435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9537352,0.0372139,0.000054788903,0.0016290533,0.0005189994,0.004508893,0.00029914046,0.000087128996,0.0019529496],"genre_scores_gemma":[0.9586671,0.006373022,0.00016895647,0.0009095723,0.00088194193,0.0030658694,0.000023972936,0.00009649511,0.029813044],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974651,0.000063065614,0.0005445996,0.000627747,0.00060895295,0.0006905656],"domain_scores_gemma":[0.99822813,0.00016253797,0.00022224561,0.0005738962,0.0005730034,0.00024016213],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025593967,0.00036023944,0.0008291137,0.00018653102,0.0003639745,0.000011583382,0.00025539423,0.00010289132,0.0015527942],"category_scores_gemma":[0.00006166672,0.0002932863,0.0002017655,0.00038270548,0.00016517047,0.00010506746,0.00012981771,0.00033775406,0.000003029482],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027405024,0.0261126,0.2835897,0.006710022,0.008038104,0.0004390685,0.063553505,0.00041313746,0.097286426,0.00008519739,0.45539126,0.030975966],"study_design_scores_gemma":[0.29751587,0.07927776,0.05875899,0.0024275263,0.0031667056,0.00008314291,0.008247995,0.0074808914,0.3048629,0.00013012708,0.23522817,0.0028199463],"about_ca_topic_score_codex":0.0042956495,"about_ca_topic_score_gemma":0.0021496466,"teacher_disagreement_score":0.27011085,"about_ca_system_score_codex":0.000636255,"about_ca_system_score_gemma":0.0011432853,"threshold_uncertainty_score":0.9999519},"labels":[],"label_agreement":null},{"id":"W1965202985","doi":"10.1016/j.ijrobp.2010.01.056","title":"Temporal Lung Tumor Volume Changes in Small-Cell Lung Cancer Patients Undergoing Chemoradiotherapy","year":2010,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Medicine; Chemoradiotherapy; Lung cancer; Radiation therapy; Nuclear medicine; Lung; Radiology; Stage (stratigraphy); Pathology; Internal medicine","score_opus":0.016928184786724264,"score_gpt":0.3557150194412565,"score_spread":0.33878683465453224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965202985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98652196,0.0011939883,0.000547344,0.0074063176,0.003341011,0.0004345159,0.00004712837,0.000029297593,0.00047845684],"genre_scores_gemma":[0.9916884,0.0015043853,0.0016799604,0.0014746485,0.0033129214,0.000048117698,0.000051465115,0.00004208081,0.00019802744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982845,0.00013232054,0.00060614944,0.00026858834,0.00035230143,0.00035609512],"domain_scores_gemma":[0.99761695,0.00029574503,0.0008457079,0.00014565841,0.0009389423,0.00015698148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054272724,0.00022427185,0.00057508284,0.00030117307,0.00007167383,0.00003149023,0.00039825786,0.00018139769,0.00018690851],"category_scores_gemma":[0.00036913765,0.00019634073,0.0001541525,0.00022614395,0.00018200578,0.00021178169,0.00008447649,0.0009577902,0.000007728764],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040119982,0.0005242798,0.9687141,0.00004899343,0.00040635047,0.000048866652,0.00065407576,0.000082080405,0.007619075,0.00025285617,0.002960256,0.018287871],"study_design_scores_gemma":[0.04481373,0.0036863743,0.8562059,0.0005602338,0.00036354578,0.00017249625,0.00029649344,0.018031972,0.017435562,0.0021845333,0.055410422,0.00083873776],"about_ca_topic_score_codex":0.00015512921,"about_ca_topic_score_gemma":0.00057393004,"teacher_disagreement_score":0.11250819,"about_ca_system_score_codex":0.0016709897,"about_ca_system_score_gemma":0.0012402565,"threshold_uncertainty_score":0.80065423},"labels":[],"label_agreement":null},{"id":"W1966470979","doi":"10.1016/j.radonc.2011.08.042","title":"Clinical trial of post-chemotherapy consolidation thoracic radiotherapy for extensive-stage small cell lung cancer","year":2011,"lang":"en","type":"article","venue":"Radiotherapy and Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saint John Regional Hospital","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Chemotherapy; Radiation therapy; Conventional PCI; Esophagitis; Lung cancer; Stage (stratigraphy); Progressive disease; Surgery; Internal medicine; Disease; Myocardial infarction; Reflux","score_opus":0.10003562707364677,"score_gpt":0.46711241006866594,"score_spread":0.36707678299501917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966470979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96078265,0.023400633,0.006762812,0.0027618154,0.00083781284,0.004198067,0.000067312154,0.00005853008,0.0011303871],"genre_scores_gemma":[0.5231118,0.32732683,0.11229212,0.020628909,0.005106995,0.0022125323,0.00007273547,0.00033698283,0.008911071],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9980263,0.00028330833,0.00065323757,0.00046459044,0.00017072396,0.0004018449],"domain_scores_gemma":[0.998052,0.0006998511,0.00034278023,0.00032929465,0.00039626198,0.00017979801],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000992591,0.00023609537,0.0010237751,0.00015826545,0.00010149955,0.000008537962,0.00013461197,0.00030865232,0.0004697593],"category_scores_gemma":[0.00011295739,0.0001892443,0.00024923834,0.00013201487,0.0005023946,0.000064049746,0.000017491986,0.0002641637,5.789634e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.46582088,0.0026280875,0.05041298,0.0011093465,0.0024599668,0.000051028288,0.010312248,0.000003615163,0.045563065,0.00046076105,0.005819002,0.41535902],"study_design_scores_gemma":[0.44473454,0.07107034,0.05321226,0.0003063545,0.0008180516,0.000076024044,0.0012880743,0.0029238933,0.03182793,0.00020720277,0.3925748,0.0009605237],"about_ca_topic_score_codex":0.0002266778,"about_ca_topic_score_gemma":0.00011235636,"teacher_disagreement_score":0.4376708,"about_ca_system_score_codex":0.00039363,"about_ca_system_score_gemma":0.00071527704,"threshold_uncertainty_score":0.7717159},"labels":[],"label_agreement":null},{"id":"W1967004095","doi":"10.3857/roj.2013.31.3.175","title":"Timing of thoracic irradiation in limited stage small-cell lung cancer: is it still a star on the rise?","year":2013,"lang":"en","type":"article","venue":"Radiation Oncology Journal","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Stage (stratigraphy); Lung cancer; Irradiation; Star (game theory); Lung; Cancer; Oncology; Internal medicine; Biology; Astrophysics","score_opus":0.05834887739361485,"score_gpt":0.41637091521042524,"score_spread":0.3580220378168104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967004095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9504493,0.002983779,0.00005679146,0.042692937,0.00022165032,0.00089607143,0.00001724556,0.000012121432,0.0026701293],"genre_scores_gemma":[0.9897378,0.0060737077,0.00033873596,0.0019358128,0.00032340625,0.00013106516,0.0000042369825,0.000020741072,0.0014344878],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981942,0.00037627376,0.0004973932,0.00017814779,0.00040936918,0.0003446147],"domain_scores_gemma":[0.99828845,0.0005956419,0.00045664445,0.00018622578,0.0003317807,0.00014125128],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009895047,0.00013943805,0.00034063254,0.00039010702,0.00013995453,0.000028739201,0.00014620605,0.0001248999,0.0019460848],"category_scores_gemma":[0.0004288265,0.0000966617,0.00008365217,0.00037966028,0.00008593793,0.00015102822,0.000033774664,0.00075668347,0.000034713223],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014956652,0.0010930599,0.6087232,0.0005758048,0.0008333951,0.00013769361,0.036195725,0.003208276,0.010862579,0.000121224184,0.2233601,0.113393255],"study_design_scores_gemma":[0.0049955887,0.0019373626,0.8462694,0.0005612186,0.00026630724,0.000052090138,0.0044324007,0.08631773,0.0035811071,0.000118014934,0.051191516,0.00027720982],"about_ca_topic_score_codex":0.00041990605,"about_ca_topic_score_gemma":0.00013876552,"teacher_disagreement_score":0.23754624,"about_ca_system_score_codex":0.0016930468,"about_ca_system_score_gemma":0.00087169,"threshold_uncertainty_score":0.9989663},"labels":[],"label_agreement":null},{"id":"W1968673033","doi":"10.1016/s0169-5002(99)00132-4","title":"An estimate of the cost of conducting phase II trials in lung cancer","year":2000,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"","keywords":"Medicine; Gemcitabine; Docetaxel; Clinical trial; Lung cancer; Pharmacy; Oncology; Cancer; Internal medicine; Intensive care medicine; Family medicine","score_opus":0.10718475209156585,"score_gpt":0.5220729525916058,"score_spread":0.41488820050003994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968673033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9791249,0.014703635,0.0000071089066,0.0024792352,0.00041191105,0.0015681944,0.00019768445,0.000023403018,0.0014839313],"genre_scores_gemma":[0.9949632,0.0026744932,0.00010161882,0.00020322857,0.00044411176,0.0004257397,0.000005493361,0.00002935489,0.0011527304],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978974,0.00024401449,0.00071129855,0.00028287046,0.0004899166,0.00037451787],"domain_scores_gemma":[0.99879956,0.00018969028,0.0002813551,0.0004482797,0.0001843015,0.000096806056],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012057057,0.00016989809,0.0008937479,0.00009966815,0.00010567443,0.0000077915065,0.00021389121,0.00006722829,0.0024953724],"category_scores_gemma":[0.00034113444,0.000110485234,0.00014541498,0.00050193636,0.00022464394,0.00013160208,0.000062970474,0.00026862507,6.574489e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064169113,0.0017100835,0.44628015,0.0049841283,0.0019663605,0.00005768683,0.016042922,0.008005714,0.19631018,0.00020621771,0.027884614,0.29013503],"study_design_scores_gemma":[0.084720545,0.0029184544,0.13541134,0.018153828,0.0042461758,0.0000421555,0.0028163732,0.07794104,0.6310063,0.00015190516,0.041021388,0.0015705284],"about_ca_topic_score_codex":0.0064614443,"about_ca_topic_score_gemma":0.0015891549,"teacher_disagreement_score":0.4346961,"about_ca_system_score_codex":0.0004913081,"about_ca_system_score_gemma":0.00065230456,"threshold_uncertainty_score":0.9984165},"labels":[],"label_agreement":null},{"id":"W1970574485","doi":"10.1016/j.lungcan.2015.04.006","title":"Prophylactic cranial irradiation (PCI). Still a no-brainer?","year":2015,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Princess Margaret Cancer Centre; Sunnybrook Health Science Centre","funders":"Sunnybrook Foundation","keywords":"Prophylactic cranial irradiation; Conventional PCI; Medicine; Intensive care medicine; Medical physics; Surgery; Radiology; Internal medicine","score_opus":0.03641837392901453,"score_gpt":0.38552492142454425,"score_spread":0.3491065474955297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970574485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7937963,0.029358333,0.00045435206,0.049794815,0.006551763,0.0054781823,0.00012608079,0.0008686143,0.11357156],"genre_scores_gemma":[0.9840754,0.0001390916,0.00035045092,0.0010095858,0.002128055,0.00034069223,0.000011953959,0.000039985916,0.011904733],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99841124,0.000045415163,0.00018395497,0.00030515817,0.0006651751,0.00038907118],"domain_scores_gemma":[0.99879897,0.00004305568,0.00006733704,0.0002876048,0.00050266995,0.00030033695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022227771,0.00015960465,0.00027191767,0.00009812434,0.000055611094,0.000029661092,0.00009468497,0.00006707441,0.00028542455],"category_scores_gemma":[0.00057934446,0.00012521325,0.00006350357,0.0002732752,0.00008654573,0.0001512647,0.00006300572,0.00024531203,0.00018265207],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006557249,0.00055640156,0.25552,0.003582067,0.001154835,0.00041374215,0.01181047,0.0003735742,0.012103548,0.00069381774,0.6711272,0.036107115],"study_design_scores_gemma":[0.024918143,0.0030472085,0.18358815,0.00079801166,0.0011906942,0.00012249187,0.00066998386,0.023962138,0.00154175,0.0005141214,0.7583519,0.0012953934],"about_ca_topic_score_codex":0.00090102333,"about_ca_topic_score_gemma":0.0001489465,"teacher_disagreement_score":0.19027916,"about_ca_system_score_codex":0.0010637802,"about_ca_system_score_gemma":0.00089168345,"threshold_uncertainty_score":0.5106048},"labels":[],"label_agreement":null},{"id":"W1973891678","doi":"10.1016/j.hoc.2003.12.010","title":"Treatment of recurrent small cell lung cancer","year":2004,"lang":"en","type":"review","venue":"Hematology/Oncology Clinics of North America","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Canada Research Chairs; McMaster University; University of Toronto; Cancer Care Ontario","funders":"","keywords":"Topotecan; Irinotecan; Medicine; Oncology; Etoposide; Internal medicine; Chemotherapy; Lung cancer; Cancer","score_opus":0.09102166533395653,"score_gpt":0.47604534604582516,"score_spread":0.38502368071186865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973891678","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005764528,0.993663,0.00002315638,0.00030112025,0.0007922144,0.0031187707,0.00038239543,0.00005194019,0.0010909414],"genre_scores_gemma":[0.00012823578,0.9957502,0.0019336868,0.000067569155,0.00017165246,0.0012652131,0.0002590938,0.00009316476,0.0003311932],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949966,0.00041090333,0.0024998356,0.0009221219,0.00036791092,0.0008026457],"domain_scores_gemma":[0.99343234,0.0018640424,0.0028344363,0.0010361009,0.0005081637,0.0003249174],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018667373,0.00078022986,0.009031194,0.00048175614,0.00007252297,0.0000025107556,0.0004363279,0.0006836625,0.0001377881],"category_scores_gemma":[0.0003570737,0.0005706636,0.0015486002,0.00072903704,0.0013795678,0.000023037888,0.00025389434,0.0007791846,0.000044982524],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029685083,0.0025000514,0.013476035,0.07715059,0.0026651034,0.00038911012,0.00028252357,0.0000034109469,6.759421e-8,0.000019672621,0.0011892454,0.9020273],"study_design_scores_gemma":[0.0027795832,0.007626633,0.00018421143,0.009699796,0.0075260103,0.00021202936,0.00004661887,0.0000075777593,0.000004384893,0.000008943439,0.97154284,0.00036137732],"about_ca_topic_score_codex":0.00029350835,"about_ca_topic_score_gemma":0.00032444368,"teacher_disagreement_score":0.9703536,"about_ca_system_score_codex":0.0016698594,"about_ca_system_score_gemma":0.008979621,"threshold_uncertainty_score":0.9996745},"labels":[],"label_agreement":null},{"id":"W1974953539","doi":"10.5863/1551-6776-17.4.395","title":"Cisplatin-Induced Ototoxicity and the Role of Pharmacogenetic Testing","year":2012,"lang":"en","type":"article","venue":"The Journal of Pediatric Pharmacology and Therapeutics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Ototoxicity; Thiopurine methyltransferase; Cisplatin; Nephrotoxicity; Body surface area; Surgery; Urology; Chemotherapy; Internal medicine; Toxicity; Inflammatory bowel disease","score_opus":0.05196197375354968,"score_gpt":0.3743509210687343,"score_spread":0.32238894731518464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974953539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93627465,0.0615339,0.000014289342,0.0013783622,0.00020751776,0.00028159685,0.0000017387231,0.0000041214334,0.00030381206],"genre_scores_gemma":[0.97985214,0.017888434,0.00008996107,0.00081755227,0.0013248223,0.00000389726,6.8349514e-8,0.000009300527,0.000013841808],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988104,0.00035146988,0.00031632732,0.000050080227,0.00022928475,0.00024245377],"domain_scores_gemma":[0.9977001,0.0016011854,0.00033228588,0.00006966307,0.00019348015,0.00010328994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019281807,0.00010565229,0.0002899176,0.000077329445,0.00015941504,0.000004107179,0.000121088044,0.000043345983,0.00002120683],"category_scores_gemma":[0.00008315592,0.000050416806,0.000046990273,0.0001958579,0.0003297783,0.000059542173,0.00008987057,0.00047520205,7.528917e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049116504,0.00034108214,0.41146874,0.000177275,0.001925063,0.0000094248735,0.0068805837,0.000010447611,0.5408786,0.00009375239,0.00041635902,0.032886993],"study_design_scores_gemma":[0.053455044,0.0042074,0.41541052,0.000082613755,0.03688735,0.004129367,0.0040164683,0.004119292,0.4637413,0.004850337,0.008482757,0.0006175503],"about_ca_topic_score_codex":0.000006216422,"about_ca_topic_score_gemma":2.8223252e-7,"teacher_disagreement_score":0.077137314,"about_ca_system_score_codex":0.000022362226,"about_ca_system_score_gemma":0.0001097682,"threshold_uncertainty_score":0.20645429},"labels":[],"label_agreement":null},{"id":"W1977262321","doi":"10.1016/j.ijrobp.2010.07.1158","title":"Treatment of Cranial Metastases Following Prophylactic Cranial Irradiation (PCI) for Small Cell Lung Cancer (SCLC)","year":2010,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Conventional PCI; Prophylactic cranial irradiation; Retrospective cohort study; Brain metastasis; Radiation therapy; Surgery; Population; Internal medicine; Cancer; Nuclear medicine; Metastasis; Myocardial infarction","score_opus":0.029857473229881006,"score_gpt":0.391150800310649,"score_spread":0.361293327080768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977262321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9818854,0.0015412568,0.005807048,0.0036085437,0.005590451,0.001024903,0.00024529846,0.00002817047,0.00026893904],"genre_scores_gemma":[0.9876157,0.00075339375,0.0064004688,0.00017111267,0.0047193756,0.00012071392,0.00007902242,0.000037313508,0.00010287535],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99813336,0.00013987794,0.0007889242,0.00025972677,0.0003805188,0.0002976133],"domain_scores_gemma":[0.99671346,0.00070532376,0.0010946329,0.00015992965,0.0011797064,0.00014692472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043551813,0.00023897461,0.0007047704,0.00023443223,0.000105953244,0.000025190813,0.00026689548,0.00019374439,0.00005977262],"category_scores_gemma":[0.00053797977,0.00018910217,0.0005253488,0.00015303656,0.00015456212,0.00023292401,0.000035753565,0.00034484253,0.0000035905696],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005008955,0.0027591363,0.5045585,0.00019068051,0.0049652713,0.00010369961,0.0024479658,0.00062514486,0.24817817,0.0026635162,0.0011525222,0.22734642],"study_design_scores_gemma":[0.19107763,0.04997427,0.23727314,0.00053692504,0.012179173,0.0008326229,0.00097086036,0.035852518,0.24340539,0.015127775,0.21060252,0.0021671588],"about_ca_topic_score_codex":0.00014278338,"about_ca_topic_score_gemma":0.00006437064,"teacher_disagreement_score":0.26728538,"about_ca_system_score_codex":0.0011723338,"about_ca_system_score_gemma":0.0015908952,"threshold_uncertainty_score":0.7711363},"labels":[],"label_agreement":null},{"id":"W1979699724","doi":"10.1097/jto.0b013e3181c8cbf5","title":"Surgery for Limited Stage Small Cell Lung Cancer: Time to Fish or Cut Bait","year":2010,"lang":"en","type":"letter","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Fish <Actinopterygii>; Stage (stratigraphy); Lung cancer; Surgery; Oncology; Fishery; Biology","score_opus":0.05446420084354163,"score_gpt":0.4431004005296949,"score_spread":0.38863619968615326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979699724","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012865949,0.001488969,0.00012615454,0.9773979,0.0034306115,0.0018806315,0.0005335929,0.000042432504,0.0022337297],"genre_scores_gemma":[0.00013493471,0.001767147,0.004952203,0.68008333,0.027176198,0.0003420924,0.00012478176,0.00023351827,0.28518578],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99603295,0.00034739132,0.001273576,0.00047479387,0.00081652956,0.0010547575],"domain_scores_gemma":[0.9920591,0.0038463299,0.0014407822,0.0005174006,0.001679557,0.000456793],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0019018304,0.0004949775,0.00261021,0.0011050052,0.0001380959,0.000052153602,0.00056214863,0.0019025801,0.0028928649],"category_scores_gemma":[0.002057996,0.0003506684,0.00076295825,0.00038933457,0.00015791734,0.00009752421,0.00023213144,0.006622655,0.000066267654],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00558004,0.00016048572,0.00045527818,0.003201133,0.0009643948,0.00576494,0.00018263822,0.000004585839,0.00089404854,6.163097e-8,0.9618732,0.020919211],"study_design_scores_gemma":[0.00091934466,0.0025501458,0.0002524496,0.0010388545,0.0014466803,0.0005649663,0.00003481774,0.000044947352,0.0010779903,0.000005010633,0.9917262,0.00033860237],"about_ca_topic_score_codex":0.000070397036,"about_ca_topic_score_gemma":0.00033119452,"teacher_disagreement_score":0.2973146,"about_ca_system_score_codex":0.0020345633,"about_ca_system_score_gemma":0.006273783,"threshold_uncertainty_score":0.99989456},"labels":[],"label_agreement":null},{"id":"W1981402488","doi":"10.1016/j.cllc.2014.11.008","title":"Correlation of Dosimetric and Clinical Factors With the Development of Esophagitis and Radiation Pneumonitis in Patients With Limited-Stage Small-Cell Lung Carcinoma","year":2014,"lang":"en","type":"article","venue":"Clinical Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Esophagitis; Pneumonitis; Esophagus; Radiation therapy; Chemoradiotherapy; Nuclear medicine; Internal medicine; Gastroenterology; Lung; Cumulative incidence; Stage (stratigraphy); Lung cancer; Incidence (geometry); Radiology; Reflux; Disease","score_opus":0.026204664064820776,"score_gpt":0.3468570903380057,"score_spread":0.3206524262731849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981402488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99653864,0.0018686368,0.0001920344,0.00017775447,0.00009566559,0.00093025214,0.000018089971,0.000009429863,0.0001694938],"genre_scores_gemma":[0.9988374,0.0005576037,0.0002936287,0.00006771795,0.000054917655,0.000035909437,0.000019598723,0.000020359108,0.00011283052],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99809414,0.0002002006,0.0007665309,0.00034457014,0.0003851473,0.00020943901],"domain_scores_gemma":[0.99746054,0.0015530108,0.00038713563,0.00021608235,0.00024673078,0.00013648212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008046034,0.00015746034,0.00055261503,0.00014541543,0.000065010994,0.0000100150655,0.00007620559,0.00011134642,0.000011797442],"category_scores_gemma":[0.00046118483,0.000091878435,0.00004477462,0.00039022224,0.00038540113,0.00006685725,0.00008269341,0.00036153983,2.4466183e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000677028,0.00019000802,0.9787518,0.0003146252,0.00015342195,0.0000012560432,0.0005132642,0.000013830352,0.0000022468553,0.0000060858874,0.00009195835,0.019284522],"study_design_scores_gemma":[0.005935157,0.0012327161,0.9903173,0.00026320718,0.00022038819,2.4018303e-7,0.000088492474,0.0016252308,0.0000819959,0.0000010400847,0.00012981289,0.000104441795],"about_ca_topic_score_codex":0.00015244237,"about_ca_topic_score_gemma":0.00036957033,"teacher_disagreement_score":0.01918008,"about_ca_system_score_codex":0.0001282832,"about_ca_system_score_gemma":0.00028671732,"threshold_uncertainty_score":0.37466937},"labels":[],"label_agreement":null},{"id":"W1986783484","doi":"10.1016/s0169-5002(00)00240-3","title":"Using treatment interruptions to palliate the toxicity from concurrent chemoradiation for limited small cell lung cancer decreases survival and disease control","year":2001,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Western University","funders":"","keywords":"Medicine; Etoposide; Internal medicine; Epirubicin; Toxicity; Population; Gastroenterology; Cyclophosphamide; Radiation therapy; Chemotherapy; Mucositis; Vincristine; Progressive disease; Cancer; Oncology; Surgery; Urology","score_opus":0.08057751619949674,"score_gpt":0.4081317458969609,"score_spread":0.32755422969746417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986783484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95284116,0.027967753,0.005533316,0.008754552,0.000556647,0.0030498158,0.0011711781,0.000057422818,0.00006815026],"genre_scores_gemma":[0.98983735,0.005423707,0.00015107343,0.0010120204,0.0008551147,0.0021428782,0.000066737986,0.000036814956,0.00047432072],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859184,0.000070591435,0.00023889479,0.00042511418,0.00024874305,0.00042481258],"domain_scores_gemma":[0.9986025,0.00032396778,0.00009618022,0.00026887056,0.00021412437,0.0004943639],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010550518,0.00024960877,0.00038803226,0.00006840308,0.0002596977,0.000059517413,0.000092717455,0.000043764067,0.00011166955],"category_scores_gemma":[0.00017894186,0.00016969121,0.00012495084,0.00017917316,0.000080987375,0.000064610154,0.00005320015,0.000101810685,0.0000011239925],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039650532,0.00044197537,0.9620095,0.00044014095,0.001512478,0.000026877535,0.0018475283,0.0024036698,0.0077629904,0.000054907305,0.0043964135,0.015138451],"study_design_scores_gemma":[0.025837505,0.00080949574,0.5778208,0.0018458173,0.0075121955,0.0000031928746,0.00080527586,0.35199225,0.004577672,0.00007835261,0.02777395,0.0009434783],"about_ca_topic_score_codex":0.008988618,"about_ca_topic_score_gemma":0.0061976076,"teacher_disagreement_score":0.3841887,"about_ca_system_score_codex":0.0015971143,"about_ca_system_score_gemma":0.00054094865,"threshold_uncertainty_score":0.9976106},"labels":[],"label_agreement":null},{"id":"W1988586595","doi":"10.1053/sonc.2003.50017","title":"Thoracic radiotherapy for limited-stage small cell lung cancer: Issues of timing, volumes, dose, and fractionation","year":2003,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Radiation therapy; Medicine; Chemotherapy; Dose fractionation; Randomized controlled trial; Oncology; Lung cancer; Stage (stratigraphy); Internal medicine; Surgery","score_opus":0.08208530181503791,"score_gpt":0.4927384745917523,"score_spread":0.41065317277671437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988586595","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015951955,0.9938997,0.00006298019,0.00034725608,0.00041143634,0.003112685,0.00010980541,0.000022446817,0.0018741839],"genre_scores_gemma":[0.000003963595,0.97481865,0.0062608793,0.00010583522,0.0002628799,0.0012948908,0.000101950485,0.0000716998,0.017079243],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99793583,0.00027794717,0.0006472966,0.00051060144,0.0002271045,0.00040121382],"domain_scores_gemma":[0.9978862,0.001003414,0.0005227724,0.00029457486,0.00020185768,0.000091219146],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00078760897,0.00034144614,0.0021244958,0.00052794267,0.00006639176,0.000009222139,0.00014654594,0.00054930645,0.0001206163],"category_scores_gemma":[0.0002754319,0.00029561188,0.00020161679,0.0003848796,0.00020581386,0.000047544596,0.000057994133,0.0005554517,0.0000011697748],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015619071,0.00019265398,0.0010970702,0.04467922,0.00033318315,0.000034553465,0.00049208757,0.0000029213252,0.0000127876065,0.000025691576,0.023904575,0.92906904],"study_design_scores_gemma":[0.0010105087,0.00090607983,0.000049291055,0.009595905,0.00067773345,0.00003534765,0.000119698234,0.00013620823,0.00001968838,0.000011973319,0.9872271,0.00021049159],"about_ca_topic_score_codex":0.00022209251,"about_ca_topic_score_gemma":0.00022133117,"teacher_disagreement_score":0.9633225,"about_ca_system_score_codex":0.0020014462,"about_ca_system_score_gemma":0.0013436488,"threshold_uncertainty_score":0.9999496},"labels":[],"label_agreement":null},{"id":"W1989020905","doi":"10.1111/j.1440-1843.2006.00850.x","title":"Small cell lung cancer: Treatment review","year":2006,"lang":"en","type":"review","venue":"Respirology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Contraindication; Lung cancer; Radiation therapy; Cancer; Quarter (Canadian coin); Intensive care medicine; Oncology; Surgery; Internal medicine; Pathology; Alternative medicine","score_opus":0.11090579267032195,"score_gpt":0.46033283413422255,"score_spread":0.3494270414639006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989020905","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000016680475,0.98000884,0.0000022036365,0.0012551901,0.00024950222,0.004110404,0.00010612853,0.00009040031,0.0141756805],"genre_scores_gemma":[1.1607993e-7,0.97309023,0.000058559028,0.00080343615,0.0009062986,0.003113425,0.00018737745,0.00010142905,0.021739146],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99695146,0.00039122297,0.00080193224,0.00078255235,0.00028228943,0.0007905594],"domain_scores_gemma":[0.99811435,0.0002988067,0.00036392367,0.00089896756,0.0001147751,0.00020917869],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028446212,0.00064871134,0.0044314074,0.00025659314,0.00008461888,0.000008725421,0.00025771945,0.00039419692,0.00042618805],"category_scores_gemma":[0.00008898227,0.00041609147,0.00094851287,0.00038069114,0.00014842795,0.000014218951,0.00016369746,0.00054494524,0.00020483774],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001586888,0.00010800609,0.0000819001,0.22296529,0.000560923,0.00028835316,0.0000056958525,1.2319107e-7,2.3964543e-7,0.000008478303,0.08152534,0.69443977],"study_design_scores_gemma":[0.0006529466,0.00061074586,0.00001482571,0.049179092,0.0073547107,0.00010566279,4.412851e-7,8.598e-7,9.474279e-7,0.0000025635782,0.9418206,0.00025658382],"about_ca_topic_score_codex":0.00071697956,"about_ca_topic_score_gemma":0.00023009407,"teacher_disagreement_score":0.8602953,"about_ca_system_score_codex":0.001773736,"about_ca_system_score_gemma":0.0017891717,"threshold_uncertainty_score":0.9998291},"labels":[],"label_agreement":null},{"id":"W1996846809","doi":"10.1080/1042819021000002901","title":"Phase II Study of Sequential Topotecan and Etoposide in Patients with Intermediate Grade Non-Hodgkin's Lymphoma: A National Cancer Institute of Canada Clinical Trials Group Study","year":2002,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research; Queen Elizabeth II Health Sciences Centre; Saskatoon Medical Imaging; Humber River Regional Hospital; Hamilton Health Sciences; BC Cancer Agency; Princess Margaret Cancer Centre","funders":"","keywords":"Topotecan; Medicine; Etoposide; Neutropenia; Internal medicine; Gastroenterology; Lymphoma; Regimen; Febrile neutropenia; Phases of clinical research; Chemotherapy; Surgery","score_opus":0.05278015313966829,"score_gpt":0.37454118198458514,"score_spread":0.32176102884491686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996846809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994687,0.0007418654,0.000005260985,0.00012160865,0.00058623846,0.0033504963,0.00018575921,0.00003523538,0.00028652177],"genre_scores_gemma":[0.99819815,0.0004335859,0.00006768126,0.00026565508,0.00030484697,0.0004069483,0.000040088744,0.00006792046,0.00021509531],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9930708,0.00066916144,0.0023478793,0.0011064385,0.0020088176,0.00079691905],"domain_scores_gemma":[0.9968378,0.00057802384,0.0009246776,0.00057974923,0.00054647063,0.0005333072],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020154596,0.0006535876,0.0024129213,0.0005216268,0.00030932334,0.000042581498,0.00035422205,0.00023567575,0.000043735523],"category_scores_gemma":[0.00085816486,0.00052210863,0.00016401506,0.0007998241,0.00073994184,0.00035873827,0.000492354,0.0002128091,6.844211e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.011795773,0.020395622,0.79055417,0.0005923296,0.0029432354,0.0006940863,0.0094098495,0.000066495544,0.00025913434,0.000035592293,0.0037538907,0.15949984],"study_design_scores_gemma":[0.19994652,0.015636552,0.7781211,0.00049501436,0.00062743074,0.00003569196,0.002170387,0.0014114858,0.00026497256,0.000020877369,0.00076171674,0.0005082396],"about_ca_topic_score_codex":0.27825043,"about_ca_topic_score_gemma":0.25662085,"teacher_disagreement_score":0.18815075,"about_ca_system_score_codex":0.0076643,"about_ca_system_score_gemma":0.00653291,"threshold_uncertainty_score":0.9997231},"labels":[],"label_agreement":null},{"id":"W1997036848","doi":"10.1097/jto.0b013e31820d782d","title":"Selecting Patients with Extensive-Stage Small Cell Lung Cancer for Prophylactic Cranial Irradiation by Predicting Brain Metastases","year":2011,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Stage (stratigraphy); Lung cancer; Radiology; Lung; Oncology; Brain metastasis; Cancer; Internal medicine; Metastasis","score_opus":0.03521243200563374,"score_gpt":0.4076535004350479,"score_spread":0.37244106842941416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997036848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935594,0.0013644184,0.0017265729,0.0012152141,0.0004202165,0.0011568759,0.000057921057,0.000019413563,0.00047994833],"genre_scores_gemma":[0.9877897,0.000055560824,0.010533812,0.00043170518,0.0004808456,0.00007542271,0.00000903332,0.000041365816,0.00058255595],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99826956,0.00021837177,0.00050621765,0.000214603,0.00038278487,0.00040849292],"domain_scores_gemma":[0.99686664,0.0004801618,0.0009359613,0.0001164282,0.0014128741,0.00018792797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089271605,0.00017557378,0.0005751144,0.00020114385,0.00016981953,0.000015775751,0.00011899523,0.00009319988,0.000065141954],"category_scores_gemma":[0.0010706369,0.000122017715,0.00010999121,0.00020819079,0.00007925538,0.00020586458,0.00003930945,0.00047178112,7.589098e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038531844,0.002559235,0.8055092,0.0035853875,0.0022467112,0.00036057227,0.010276657,0.000109268214,0.018069156,0.000007476567,0.0220943,0.0966502],"study_design_scores_gemma":[0.044726554,0.10753964,0.6993203,0.002369396,0.012433001,0.00065442314,0.0086216545,0.0047280174,0.07616723,0.0001675232,0.04160187,0.0016703599],"about_ca_topic_score_codex":0.00014263764,"about_ca_topic_score_gemma":0.00010994654,"teacher_disagreement_score":0.10618887,"about_ca_system_score_codex":0.0008182323,"about_ca_system_score_gemma":0.0010088622,"threshold_uncertainty_score":0.4975738},"labels":[],"label_agreement":null},{"id":"W1998967593","doi":"10.1016/j.clinbiochem.2014.06.039","title":"Closing the gaps in pediatric population reference values for cancer biomarkers: A CALIPER study of healthy community children","year":2014,"lang":"en","type":"article","venue":"Clinical Biochemistry","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Carcinoembryonic antigen; Oncology; Internal medicine; Cancer; Metastatic breast cancer; Cancer antigen; CA15-3; Metastasis; Pathological; Tumor marker; Gastroenterology; Antigen; Pathology; Immunology","score_opus":0.11114169739447531,"score_gpt":0.4922531227846824,"score_spread":0.3811114253902071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998967593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99691355,0.0009539839,0.000004318407,0.0010471857,0.00007197142,0.0008268135,0.000025435655,0.000018511877,0.00013819868],"genre_scores_gemma":[0.99859655,0.00047247703,0.0000819052,0.00022331493,0.00042627376,0.00011621221,0.00004275387,0.000012078728,0.000028413042],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982404,0.00039940287,0.0006211482,0.00025436337,0.000261363,0.00022329649],"domain_scores_gemma":[0.9976501,0.0013450562,0.00019174405,0.00056162244,0.00015941737,0.000092084214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002362339,0.00011569696,0.00039123057,0.00003728124,0.00015362477,0.000008507414,0.00021409008,0.000119602824,0.000007072683],"category_scores_gemma":[0.0032026046,0.00007756285,0.000084046944,0.00022942011,0.00015756514,0.00002120667,0.0001423843,0.0005608361,7.224846e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057167397,0.00084012694,0.993899,0.00037237693,0.00008554918,2.3509561e-7,0.0002087272,0.0000015161187,0.00016771225,0.0000014311769,0.00083238975,0.0030192703],"study_design_scores_gemma":[0.0027830983,0.000861923,0.99476856,0.00011614045,0.00013170422,0.0000010245855,0.00053388666,0.00006357769,0.000548715,0.00008425961,0.00002668208,0.00008040848],"about_ca_topic_score_codex":0.0031270485,"about_ca_topic_score_gemma":0.00036720803,"teacher_disagreement_score":0.0029388617,"about_ca_system_score_codex":0.000111980684,"about_ca_system_score_gemma":0.00013284909,"threshold_uncertainty_score":0.47271827},"labels":[],"label_agreement":null},{"id":"W1999139776","doi":"10.1016/s0093-7754(01)90077-6","title":"The importance of drug diversity in the treatment of small cell lung cancer","year":2001,"lang":"en","type":"article","venue":"Seminars in Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Etoposide; Cisplatin; Oncology; Lung cancer; Drug; Chemotherapy; Population; Internal medicine; Combination chemotherapy; Pharmacology","score_opus":0.03271828028642188,"score_gpt":0.3800493503969207,"score_spread":0.34733107011049885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999139776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9622897,0.023990385,6.1441426e-7,0.004473622,0.00009862714,0.0005777409,0.0000062292447,0.000003212986,0.0085598985],"genre_scores_gemma":[0.93098736,0.0671287,0.00006311841,0.0001406767,0.000044392607,0.00009887599,0.0000014213475,0.0000047333665,0.0015307349],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908656,0.00013060361,0.00022039415,0.00013954661,0.00017698093,0.00024592024],"domain_scores_gemma":[0.9988679,0.00069429213,0.000107813124,0.00024988325,0.000055075943,0.000025008929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048131178,0.000081342834,0.00030067813,0.00006050091,0.0000704583,0.0000011599095,0.00019050953,0.000046888814,0.000029035633],"category_scores_gemma":[0.00006162815,0.000043705546,0.00005342431,0.00026116436,0.00027541126,0.000012880342,0.00010887763,0.00012936679,5.791288e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047741598,0.00052430044,0.96883696,0.00005645409,0.00004259294,0.00019701071,0.016425531,0.00001571894,0.0001568512,0.000030756426,0.0036963846,0.009539999],"study_design_scores_gemma":[0.006559342,0.0030702478,0.8875811,0.00029586905,0.00018893916,0.000027581236,0.017043784,0.00020646668,0.002940427,0.00032047974,0.08163454,0.00013122089],"about_ca_topic_score_codex":0.002729933,"about_ca_topic_score_gemma":0.026379898,"teacher_disagreement_score":0.081255876,"about_ca_system_score_codex":0.00089835504,"about_ca_system_score_gemma":0.00023133888,"threshold_uncertainty_score":0.9913861},"labels":[],"label_agreement":null},{"id":"W2000232364","doi":"10.1053/s1043-0679(03)00098-4","title":"Small-cell lung cancer: a review of clinical trials","year":2003,"lang":"en","type":"review","venue":"Seminars in Thoracic and Cardiovascular Surgery","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto; National Comprehensive Cancer Network","keywords":"Medicine; Prophylactic cranial irradiation; Clinical trial; Disease; Lung cancer; Radiation therapy; Oncology; Cancer; Chemotherapy; Modalities; Stage (stratigraphy); Intensive care medicine; Internal medicine; Surgery","score_opus":0.2576794840656253,"score_gpt":0.5220665338572965,"score_spread":0.2643870497916712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000232364","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000017879078,0.99387175,0.000021242806,0.000036585883,0.00078155374,0.0034083675,0.000078110024,0.000025417023,0.0017591113],"genre_scores_gemma":[0.000001682126,0.9974566,0.00015793885,0.00013243832,0.00044535781,0.0009801271,0.000068900175,0.0000995575,0.0006574107],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98519194,0.00797,0.004110601,0.0010356994,0.0010829399,0.000608813],"domain_scores_gemma":[0.9917739,0.0051170588,0.0010612266,0.0014537107,0.00027823148,0.00031585718],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":["metaresearch","metaepi_broad"],"category_scores_codex":[0.059950877,0.00066895917,0.019655475,0.00048462374,0.00005255373,0.000015010178,0.00020188928,0.00060036656,0.0001006567],"category_scores_gemma":[0.00886802,0.0004827424,0.010878745,0.001128873,0.00029610493,0.00004608853,0.00021172567,0.001237657,0.0000053541266],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026651815,0.00005394028,0.00082900556,0.3923685,0.0040512127,0.00029360875,0.000009418113,7.79213e-8,1.2705718e-8,6.9006495e-7,0.009805377,0.59256154],"study_design_scores_gemma":[0.00020427708,0.000022226974,0.000010181871,0.38150954,0.013465774,0.00011961255,0.000016894477,5.459774e-7,0.0000011562612,0.0000014591922,0.60440034,0.00024797584],"about_ca_topic_score_codex":0.00006699739,"about_ca_topic_score_gemma":0.000002054321,"teacher_disagreement_score":0.59459496,"about_ca_system_score_codex":0.00019953559,"about_ca_system_score_gemma":0.002791478,"threshold_uncertainty_score":0.9997624},"labels":[],"label_agreement":null},{"id":"W2001238669","doi":"10.1016/s0360-3016(03)00070-1","title":"Twenty-year follow-up study of long-term survival of limited-stage small-cell lung cancer and overview of prognostic and treatment factors","year":2003,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Saskatchewan; Saskatchewan Cancer Agency","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Lung cancer; Stage (stratigraphy); Radiation therapy; Survival analysis; Internal medicine; Cohort; Multivariate analysis; Incidence (geometry); Oncology; Cancer; Survival rate; Surgery","score_opus":0.06544769733230364,"score_gpt":0.39486723071124424,"score_spread":0.3294195333789406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001238669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932156,0.00505118,0.000118535114,0.00015786078,0.0006516116,0.00058485026,0.00009030934,0.0000054066572,0.00012461109],"genre_scores_gemma":[0.99062586,0.008916569,0.00013496031,0.000021918184,0.00016126955,0.000016206252,0.000015440897,0.000016399812,0.00009135197],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983943,0.00025370927,0.0006850926,0.00018688983,0.0003170316,0.00016296789],"domain_scores_gemma":[0.9973364,0.00059702614,0.0010508493,0.00011711531,0.0008004307,0.00009817366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037244085,0.00017734918,0.0007310832,0.00017713157,0.00003329119,0.0000067364995,0.0001338924,0.00009480642,0.00003163555],"category_scores_gemma":[0.00032025477,0.00013411298,0.00012779869,0.00013884713,0.00020070419,0.00009503593,0.000060007213,0.00018790408,2.3201628e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004989646,0.0013010919,0.98374516,0.00014303999,0.001958206,0.000018211696,0.0020706328,0.00005761292,0.0020023722,0.00046071594,0.000022738133,0.0077212304],"study_design_scores_gemma":[0.016273875,0.0064919656,0.9687661,0.00023012588,0.00077550765,0.00001645651,0.00094157417,0.00009144939,0.0059047374,0.00010588493,0.0002788822,0.00012343489],"about_ca_topic_score_codex":0.00013996632,"about_ca_topic_score_gemma":0.00012923252,"teacher_disagreement_score":0.015774911,"about_ca_system_score_codex":0.00043385712,"about_ca_system_score_gemma":0.00049450825,"threshold_uncertainty_score":0.5468969},"labels":[],"label_agreement":null},{"id":"W2003901423","doi":"10.1097/01.jto.0000283006.34791.31","title":"E05-06: Clinical staging of small cell lung cancer: report of the International Association for the Study of Lung Cancer Staging Initiative, Small Cell Lung Cancer Subcommittee","year":2007,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; TNM staging system; Lung cancer; Stage (stratigraphy); Oncology; Internal medicine; Lung cancer staging; Pleural effusion; Cancer; Radiology; Neoplasm staging; Mediastinoscopy","score_opus":0.07672109753829616,"score_gpt":0.5107732582045514,"score_spread":0.4340521606662553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003901423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9775502,0.007365985,0.0009345444,0.007836018,0.0030188665,0.0018633779,0.00009801618,0.000009402302,0.0013236107],"genre_scores_gemma":[0.9927139,0.0032267673,0.0007369764,0.00040281765,0.0012557639,0.00011546008,0.0000035451772,0.00004386836,0.0015008601],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99470234,0.00057263346,0.002591894,0.00033370944,0.0012629365,0.00053646654],"domain_scores_gemma":[0.98608726,0.0038186233,0.005920211,0.00041354203,0.003617873,0.00014248755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009323629,0.000261948,0.0012969862,0.0003241042,0.00018320842,0.00001703529,0.0007582377,0.00020567767,0.000081125116],"category_scores_gemma":[0.0017074795,0.00016776474,0.000453438,0.00049200567,0.0002117316,0.00014104573,0.00038116556,0.0012705579,1.1208324e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021838346,0.0011519669,0.96832514,0.00093571504,0.0028600597,0.00010148001,0.0055127623,0.0008786487,0.0019098661,0.000004806671,0.010172703,0.005963044],"study_design_scores_gemma":[0.007477462,0.0018469443,0.9447403,0.0015150572,0.005374431,0.000040436877,0.011155444,0.0040606023,0.016216537,0.00002900458,0.007259143,0.00028465214],"about_ca_topic_score_codex":0.0019331431,"about_ca_topic_score_gemma":0.004260346,"teacher_disagreement_score":0.023584828,"about_ca_system_score_codex":0.0034116604,"about_ca_system_score_gemma":0.0035693836,"threshold_uncertainty_score":0.89213735},"labels":[],"label_agreement":null},{"id":"W2004731110","doi":"10.1053/sonc.2003.50016","title":"Surgical treatment of small cell lung cancer","year":2003,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Chemoradiotherapy; Radiation therapy; Lung cancer; Chemotherapy; Surgery; Clinical trial; Oncology; Internal medicine","score_opus":0.07881713051370332,"score_gpt":0.48020935050552593,"score_spread":0.4013922199918226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004731110","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011887575,0.9671338,3.8165106e-7,0.0001084705,0.00041502024,0.0018415748,0.000048616363,0.000013843992,0.030319402],"genre_scores_gemma":[0.00000345566,0.9856022,0.0003218879,0.000020587086,0.00021555745,0.0011999541,0.000037611768,0.00004937508,0.012549399],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99769485,0.00037111656,0.00070052553,0.00048210294,0.00022166809,0.0005297647],"domain_scores_gemma":[0.9983022,0.00078824174,0.0002857781,0.00040047534,0.00008159232,0.00014169594],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029668235,0.00038819865,0.0035428382,0.00033594354,0.000025716805,0.0000024291585,0.00014796795,0.00053106115,0.00037452744],"category_scores_gemma":[0.000056254856,0.00026988055,0.0004491916,0.0004280073,0.00023035302,0.0000097674565,0.00008113637,0.0004055747,0.000014616171],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008514854,0.0008175832,0.0009993039,0.022714641,0.00039116733,0.0020907577,0.0003003054,6.469653e-7,4.565563e-7,0.000016286764,0.005565053,0.96701866],"study_design_scores_gemma":[0.0018828901,0.001973087,0.0000073650713,0.011936329,0.0013850876,0.00022946786,0.00004368176,0.0000021520414,0.000008696665,0.000003501934,0.982355,0.00017275767],"about_ca_topic_score_codex":0.00027807153,"about_ca_topic_score_gemma":0.00022785598,"teacher_disagreement_score":0.97678995,"about_ca_system_score_codex":0.005175904,"about_ca_system_score_gemma":0.0031190333,"threshold_uncertainty_score":0.9999753},"labels":[],"label_agreement":null},{"id":"W2005412601","doi":"10.1016/s0360-3016(01)01448-1","title":"Practice guideline on prophylactic cranial irradiation in small-cell lung cancer","year":2001,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Cancer Care Ontario; Ottawa Regional Cancer Foundation; Lakehead University","funders":"","keywords":"Prophylactic cranial irradiation; Medicine; Guideline; Conventional PCI; Radiation therapy; Regimen; Oncology; Randomized controlled trial; Quality of life (healthcare); Chemoradiotherapy; Lung cancer; Internal medicine; Adverse effect; Clinical trial; Surgery; Pathology","score_opus":0.03023396410218973,"score_gpt":0.41367273148740846,"score_spread":0.38343876738521876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005412601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88547695,0.0042873514,0.008939071,0.083941706,0.0059145717,0.0013095494,0.000060064856,0.00007671455,0.0099940235],"genre_scores_gemma":[0.98110604,0.0045991843,0.003518536,0.0051868674,0.0052524125,0.0000512727,0.000047524452,0.000038444294,0.00019972262],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99758714,0.00033931166,0.0009848948,0.00028512094,0.00047887053,0.00032466996],"domain_scores_gemma":[0.9961194,0.00070477475,0.0011445541,0.00016455802,0.001720829,0.00014590501],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001065011,0.00021832518,0.00049425213,0.00035615623,0.00007054354,0.00003157187,0.0003239702,0.00020468571,0.0001226854],"category_scores_gemma":[0.0017297998,0.00018692661,0.0001653154,0.0003461077,0.000114845425,0.00039135286,0.000061993334,0.0008506147,0.000029198633],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008649057,0.0030892568,0.67836136,0.000074428484,0.0013753735,0.0008667021,0.0018634856,0.008181731,0.009671381,0.003740617,0.014451431,0.2696752],"study_design_scores_gemma":[0.06069144,0.011000196,0.18994685,0.0006445739,0.0012537477,0.0014103773,0.00092356483,0.04180445,0.004710361,0.007983525,0.6785101,0.0011207788],"about_ca_topic_score_codex":0.00021861303,"about_ca_topic_score_gemma":0.00005091488,"teacher_disagreement_score":0.6640587,"about_ca_system_score_codex":0.0030040748,"about_ca_system_score_gemma":0.0014333135,"threshold_uncertainty_score":0.78555506},"labels":[],"label_agreement":null},{"id":"W2006230590","doi":"10.1093/jnci/djg013","title":"An Advance in Small-Cell Lung Cancer Treatment--More or Less","year":2003,"lang":"en","type":"review","venue":"JNCI Journal of the National Cancer Institute","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Topotecan; Irinotecan; Carboplatin; Etoposide; Regimen; Internal medicine; Oncology; Chemotherapy; Anthracycline; Disease; Radiation therapy; Lung cancer; Cancer; Surgery; Cisplatin; Colorectal cancer; Breast cancer","score_opus":0.20230522890686956,"score_gpt":0.5144856095733713,"score_spread":0.3121803806665018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006230590","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00049519975,0.99327964,0.000009114303,0.0009617981,0.0025925485,0.0012896636,0.00029781158,0.00000930499,0.0010649238],"genre_scores_gemma":[0.00011704225,0.9923501,0.000344233,0.0005076617,0.0022277765,0.00041799972,0.000014291831,0.000060007358,0.0039608623],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966635,0.00020704983,0.001069837,0.00036941934,0.0012630884,0.0004271178],"domain_scores_gemma":[0.99714315,0.00016835013,0.0011299471,0.00029903097,0.0010357786,0.00022372368],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00052251463,0.00050142297,0.0018215611,0.0004867649,0.00017461083,0.000043846932,0.00064249535,0.00021135791,0.0001266688],"category_scores_gemma":[0.0002780514,0.0002587331,0.0006368528,0.0009656441,0.00022011473,0.0004265688,0.000072075236,0.0010124657,0.0000027101125],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0011258036,0.0012792686,0.003935379,0.029080415,0.003628353,0.0006828454,0.00075399206,0.0031191204,0.000021293168,0.0002870825,0.016661076,0.93942535],"study_design_scores_gemma":[0.0024870732,0.00020556105,0.00022457764,0.019252665,0.0013986003,0.00034732136,0.0000334548,0.000021690703,0.000023384462,0.000019540981,0.97572273,0.00026341868],"about_ca_topic_score_codex":0.00043881917,"about_ca_topic_score_gemma":0.003689684,"teacher_disagreement_score":0.9590616,"about_ca_system_score_codex":0.009685068,"about_ca_system_score_gemma":0.015559687,"threshold_uncertainty_score":0.99998647},"labels":[],"label_agreement":null},{"id":"W2011868684","doi":"10.1016/j.ijrobp.2004.01.055","title":"Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer","year":2004,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":168,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency","funders":"National Cancer Institute","keywords":"Medicine; Etoposide; Radiation therapy; Randomization; Internal medicine; Esophagitis; Prophylactic cranial irradiation; Lung cancer; Cisplatin; Gastroenterology; Randomized controlled trial; Chemotherapy; Surgery; Urology; Conventional PCI","score_opus":0.04023676340957497,"score_gpt":0.40169895818336204,"score_spread":0.36146219477378705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011868684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.978239,0.0053996164,0.009871451,0.003692701,0.0012450549,0.0010501086,0.00009091994,0.000034841523,0.00037630563],"genre_scores_gemma":[0.98528314,0.0077134715,0.00306317,0.00071791455,0.0028772978,0.00006561392,0.00007123871,0.000056869867,0.00015128315],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99682534,0.00028332087,0.0014236879,0.00040364466,0.00062081293,0.00044316764],"domain_scores_gemma":[0.9962337,0.00049806555,0.001851446,0.00026638407,0.00095299486,0.00019739495],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009369629,0.00034356225,0.0011944127,0.00049230707,0.0000747338,0.000034725963,0.0005561313,0.00024152848,0.000045637502],"category_scores_gemma":[0.00017778703,0.00027803233,0.0002753717,0.00043658903,0.00039940362,0.00030904834,0.000055905755,0.00089386175,0.0000016008628],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3250103,0.0057385415,0.5423337,0.00015128324,0.004880851,0.00058431225,0.007863861,0.016552756,0.039906483,0.0007314964,0.00088168256,0.05536474],"study_design_scores_gemma":[0.9109098,0.017885633,0.04392885,0.0011154751,0.0004121183,0.00019311,0.0002830726,0.0049042953,0.0133337965,0.00021794853,0.006227367,0.0005885652],"about_ca_topic_score_codex":0.0004291589,"about_ca_topic_score_gemma":0.00025619782,"teacher_disagreement_score":0.5858995,"about_ca_system_score_codex":0.0036389807,"about_ca_system_score_gemma":0.0022360464,"threshold_uncertainty_score":0.99996716},"labels":[],"label_agreement":null},{"id":"W2011961706","doi":"10.1016/j.path.2013.10.005","title":"Ancillary Studies, Including Immunohistochemistry and Molecular Studies, in Lung Cytology","year":2013,"lang":"en","type":"review","venue":"Surgical pathology clinics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Cytology; Lung cancer; Pathology; Lung; Molecular diagnostics; Immunocytochemistry; Immunohistochemistry; Internal medicine; Bioinformatics","score_opus":0.2108921984330582,"score_gpt":0.5501329081952359,"score_spread":0.3392407097621777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011961706","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003819421,0.9925112,0.0000014421215,0.00032130847,0.0007349927,0.0017505651,0.000031013387,0.00007947128,0.00075055944],"genre_scores_gemma":[0.00016577532,0.99741554,0.00031484576,0.00023669531,0.0003014605,0.00081415806,0.000089569374,0.00009637618,0.0005655783],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99441063,0.0009085178,0.0019198487,0.0013384327,0.0004204706,0.0010021096],"domain_scores_gemma":[0.99457055,0.00330292,0.00055913406,0.00089389,0.00042326894,0.00025023334],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0021900842,0.000828287,0.0067364583,0.00035547212,0.00015910166,0.000010825784,0.00031333923,0.0012364843,0.00002802568],"category_scores_gemma":[0.004944502,0.00062200695,0.00055891805,0.00056480255,0.0022621055,0.000052515275,0.0018162217,0.002641033,0.00004474056],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025604595,0.00044830746,0.0017081301,0.18003629,0.0071220123,0.105230324,0.00097131706,6.0683755e-7,0.00002303138,0.0003542222,0.00922948,0.69462025],"study_design_scores_gemma":[0.0025134042,0.0004088161,0.000020566973,0.017743185,0.0018682816,0.0061191893,0.00043374803,0.000005544742,0.0000020286936,0.00036199708,0.9698252,0.0006980086],"about_ca_topic_score_codex":0.000006584349,"about_ca_topic_score_gemma":0.000003140723,"teacher_disagreement_score":0.9605957,"about_ca_system_score_codex":0.0013230257,"about_ca_system_score_gemma":0.0007562948,"threshold_uncertainty_score":0.9996599},"labels":[],"label_agreement":null},{"id":"W2012290550","doi":"10.1016/s0169-5002(00)80349-9","title":"Concurrent chemo- (cisplatin and etoposide) radiation for stage III non-small cell lung cancer: Lack of correlation of p53 expression to treatment response","year":2000,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Etoposide; Oncology; Cisplatin; Lung cancer; Internal medicine; Stage (stratigraphy); Radiation therapy; Correlation; Cancer research; Chemotherapy; Biology","score_opus":0.028126937392692876,"score_gpt":0.391023161995535,"score_spread":0.3628962246028421,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012290550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98476636,0.010089015,0.0006272333,0.0007167703,0.00019811039,0.002821632,0.00032281803,0.000020600497,0.00043743517],"genre_scores_gemma":[0.9833872,0.005122955,0.00043235393,0.00009050326,0.00015216279,0.00094679126,0.00003574146,0.000032406002,0.009799899],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986259,0.000052835403,0.0003968265,0.00034084934,0.0003019648,0.00028167453],"domain_scores_gemma":[0.99896437,0.0002602982,0.00019095684,0.00024018,0.00019354103,0.00015067816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023865614,0.00019675674,0.00047796627,0.00012023239,0.00007846465,0.0000087453045,0.00006248686,0.00008425851,0.00035605297],"category_scores_gemma":[0.00005020893,0.0001618974,0.00008486008,0.00018272492,0.00006242026,0.000072915056,0.000033029064,0.00009164835,0.0000010569335],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025478937,0.0005902769,0.21398717,0.005639911,0.0006919138,0.000010648405,0.031263493,0.012872325,0.5179862,0.00002962491,0.021762732,0.16968682],"study_design_scores_gemma":[0.02005637,0.0025144017,0.1189368,0.0027216384,0.0008155599,0.0000016927835,0.0005263044,0.05043338,0.77917296,0.000004193222,0.024390446,0.00042624798],"about_ca_topic_score_codex":0.002128898,"about_ca_topic_score_gemma":0.00029215644,"teacher_disagreement_score":0.2611868,"about_ca_system_score_codex":0.0011914107,"about_ca_system_score_gemma":0.00050122297,"threshold_uncertainty_score":0.66019845},"labels":[],"label_agreement":null},{"id":"W2012372031","doi":"10.3892/ijo.23.6.1607","title":"Surrogate end-point biomarker analysis in a retinol chemoprevention trial in current and former smokers with bronchial dysplasia","year":2003,"lang":"en","type":"article","venue":"International Journal of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; U.S. Public Health Service","keywords":"Dysplasia; Medicine; Retinol; Internal medicine; Gastroenterology; Lung cancer; Bronchopulmonary dysplasia; Pathology; Cancer; Vitamin; Biology","score_opus":0.03372050695342879,"score_gpt":0.40900700009038976,"score_spread":0.37528649313696094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012372031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942634,0.00048647603,0.00016774307,0.002456505,0.0005047297,0.00027066615,0.0000033794042,0.0000024639498,0.0018446052],"genre_scores_gemma":[0.99866825,0.00059226836,0.00047598354,0.00005801437,0.00012509333,0.000016106706,0.000004996963,0.000006527748,0.000052741627],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998433,0.0001742862,0.00054315757,0.00014819573,0.0005166489,0.00018472441],"domain_scores_gemma":[0.9990899,0.00016758901,0.0002960627,0.00006141036,0.00030306965,0.0000819428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011252083,0.00009936564,0.0004251296,0.000947288,0.000013997594,0.000013634515,0.00009253868,0.00005849415,0.00017720326],"category_scores_gemma":[0.00044561154,0.00007298067,0.000114121045,0.000343719,0.00011419159,0.00012834408,0.000033333792,0.00034660572,0.0000012702618],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11453904,0.0017117676,0.7820155,0.00005175966,0.004164774,0.0015282116,0.0013145544,0.000081015074,0.0011313467,0.00038811847,0.0007359048,0.09233802],"study_design_scores_gemma":[0.18478179,0.005295003,0.7833553,0.0004472562,0.00077527,0.0012453626,0.00073374494,0.00033494382,0.000864909,0.0006423258,0.02131124,0.00021284536],"about_ca_topic_score_codex":0.00008237373,"about_ca_topic_score_gemma":0.0010504713,"teacher_disagreement_score":0.09212518,"about_ca_system_score_codex":0.00095430855,"about_ca_system_score_gemma":0.00048323188,"threshold_uncertainty_score":0.29760653},"labels":[],"label_agreement":null},{"id":"W2015102817","doi":"10.3816/clc.2009.n.044","title":"Cooperative Group Research Endeavors in Small-Cell Lung Cancer: Current and Future Directions","year":2009,"lang":"en","type":"article","venue":"Clinical Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Lung cancer; Etoposide; Clinical trial; Oncology; Radiation therapy; Internal medicine; Clinical Oncology; Chemotherapy; Intensive care medicine; Cancer; Family medicine","score_opus":0.09840935802406386,"score_gpt":0.519429932824909,"score_spread":0.42102057480084515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015102817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.59204054,0.3658638,0.000018139073,0.03126798,0.0022808681,0.0027923812,0.000088361965,0.00012327878,0.005524659],"genre_scores_gemma":[0.57088095,0.4190046,0.00014713945,0.0010746268,0.0052532633,0.0010325838,0.000019521198,0.000047839098,0.0025394878],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99654996,0.00050384365,0.0006750258,0.00086656463,0.00056844595,0.0008361836],"domain_scores_gemma":[0.9977667,0.0007308642,0.00008950057,0.00041674866,0.0005246168,0.00047161913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016571716,0.00027054566,0.000711962,0.00027201665,0.00031975453,0.000054630535,0.00019883984,0.00021140967,0.0002561687],"category_scores_gemma":[0.00043449836,0.00021436672,0.0001425379,0.0010213341,0.00045846056,0.00011905181,0.00017891121,0.002288332,0.000007053382],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009328255,0.001017924,0.63426095,0.0006691248,0.00025779617,0.000080965685,0.0016996363,0.000013076008,0.00018935185,0.0005545582,0.079352684,0.2809711],"study_design_scores_gemma":[0.0052959756,0.00088067766,0.6517183,0.0013120775,0.00019765916,0.0000052433024,0.0004977786,0.0015882917,0.00012430229,0.00012488611,0.33786157,0.00039325978],"about_ca_topic_score_codex":0.0008711052,"about_ca_topic_score_gemma":0.0037060422,"teacher_disagreement_score":0.28057787,"about_ca_system_score_codex":0.001052441,"about_ca_system_score_gemma":0.000900543,"threshold_uncertainty_score":0.9941791},"labels":[],"label_agreement":null},{"id":"W2015179401","doi":"10.1158/1055-9965.epi-06-0923","title":"The Association between the Anti-inflammatory Protein CC10 and Smoking Status among Participants in a Chemoprevention Trial","year":2007,"lang":"en","type":"article","venue":"Cancer Epidemiology Biomarkers & Prevention","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Medicine; Bronchoalveolar lavage; Internal medicine; Gastroenterology; Lung cancer; Cigarette smoking; Smoking cessation; Lung; Pathology","score_opus":0.07211029146092054,"score_gpt":0.42442204531863315,"score_spread":0.35231175385771263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015179401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98416877,0.007299294,0.00023963409,0.004746989,0.0003877943,0.002959887,0.000005375218,0.00003404872,0.00015819298],"genre_scores_gemma":[0.9961938,0.0017964421,0.00007139921,0.00007300897,0.00046632107,0.0007549649,0.000022149652,0.000019850637,0.0006020666],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958089,0.0013830361,0.00097299303,0.00043413948,0.00032785727,0.0010730542],"domain_scores_gemma":[0.99658567,0.0021861724,0.0006546435,0.00029699385,0.00012064735,0.0001558795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018676497,0.0001978556,0.00051945064,0.0001287483,0.00038466734,0.000020531172,0.00012578405,0.00025918888,0.000016849202],"category_scores_gemma":[0.004898201,0.00012552564,0.00016011682,0.00031282176,0.00041341103,0.00015217368,0.00011492167,0.0004909512,0.0000032858031],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003277527,0.00003402231,0.9483637,0.00006480606,0.0007603259,0.000003741785,0.00017440552,0.0000014181744,0.00041555995,0.000062530155,0.00051376194,0.046328194],"study_design_scores_gemma":[0.0106934095,0.00020262612,0.9830368,0.00042120504,0.00025660527,6.7218775e-7,0.00023353616,0.0000781949,0.00053506636,0.0021354377,0.0022860956,0.000120358265],"about_ca_topic_score_codex":0.00070554164,"about_ca_topic_score_gemma":0.0028016928,"teacher_disagreement_score":0.046207834,"about_ca_system_score_codex":0.0013873662,"about_ca_system_score_gemma":0.00021986871,"threshold_uncertainty_score":0.6472938},"labels":[],"label_agreement":null},{"id":"W2018754160","doi":"10.1097/jto.0b013e3181b27799","title":"The IASLC Lung Cancer Staging Project: Proposals Regarding the Relevance of TNM in the Pathologic Staging of Small Cell Lung Cancer in the Forthcoming (Seventh) Edition of the TNM Classification for Lung Cancer","year":2009,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":492,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"University of Texas MD Anderson Cancer Center; Barbara Ann Karmanos Cancer Institute; Wayne State University; Institut Gustave-Roussy; International Association for the Study of Lung Cancer; Eli Lilly and Company","keywords":"Medicine; Lung cancer staging; Lung cancer; Stage (stratigraphy); TNM staging system; Oncology; Internal medicine; Population; Malignancy; Cancer; Survival analysis; Radiology; Neoplasm staging; Mediastinoscopy","score_opus":0.04987874132873191,"score_gpt":0.4713034335580689,"score_spread":0.421424692229337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018754160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90516055,0.027191343,0.0009109547,0.060297925,0.0009523501,0.0048053428,0.000064543245,0.000009088015,0.0006079361],"genre_scores_gemma":[0.9894455,0.008239009,0.00044649252,0.0005676538,0.00059576303,0.0005577613,0.000001855445,0.000024383535,0.00012156563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954409,0.00138431,0.0013997513,0.00028552246,0.00090410456,0.0005854],"domain_scores_gemma":[0.9938818,0.0023056942,0.0023881155,0.0005459217,0.0008412851,0.00003715084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007843881,0.00025246973,0.00078166946,0.00024580976,0.0003864239,0.00003293295,0.0009893158,0.00014294473,0.000007377295],"category_scores_gemma":[0.0011579609,0.00010462873,0.00029734737,0.0009005648,0.00041702847,0.00020757603,0.00011608383,0.0012164849,3.1434258e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009629119,0.0014434526,0.47568712,0.0069005624,0.0011204178,0.0001383616,0.10716237,0.010941934,0.07475107,0.0011143603,0.01894431,0.29216692],"study_design_scores_gemma":[0.010475121,0.0040911823,0.7007277,0.019528614,0.0048216344,0.00032704338,0.12421092,0.07518847,0.046360783,0.0029855433,0.010335271,0.00094771275],"about_ca_topic_score_codex":0.0006801299,"about_ca_topic_score_gemma":0.0022156588,"teacher_disagreement_score":0.2912192,"about_ca_system_score_codex":0.0014777427,"about_ca_system_score_gemma":0.0018246684,"threshold_uncertainty_score":0.5285089},"labels":[],"label_agreement":null},{"id":"W2020966893","doi":"10.1371/journal.pone.0071670","title":"Genomic Deregulation of the E2F/Rb Pathway Leads to Activation of the Oncogene EZH2 in Small Cell Lung Cancer","year":2013,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Princess Margaret Cancer Centre","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"EZH2; Cancer research; PRC2; Oncogene; Biology; Gene knockdown; E2F; DNA methylation; Carcinogenesis; Methylation; Cell cycle; Cancer; Cell culture; Gene; Genetics; Gene expression","score_opus":0.04963951948847328,"score_gpt":0.2844435283209572,"score_spread":0.23480400883248392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020966893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99288905,0.0003865636,0.000008274923,0.0042174687,0.000029939962,0.0015224793,0.000008224549,0.0000070155384,0.00093097094],"genre_scores_gemma":[0.99789596,0.000070206355,0.00021965495,0.00018799756,0.00007879916,0.00020095722,0.0000016427936,0.0000147715255,0.0013299983],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990956,0.00006142709,0.00021411192,0.00013506146,0.00032976156,0.00016400036],"domain_scores_gemma":[0.9992413,0.00006649809,0.00011347142,0.00032904663,0.00021433651,0.00003537926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013118515,0.00007963764,0.00021126747,0.000061781524,0.00003808897,0.0000041439807,0.00014562458,0.000040503022,0.00009929024],"category_scores_gemma":[0.00013803244,0.000046846966,0.00004503317,0.00028928687,0.00005681241,0.000041022617,0.00013167021,0.00012827267,0.000004982143],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003762647,0.00020715539,0.2666985,0.00031963224,0.00006054497,6.9068236e-8,0.0009121613,0.00011362326,0.7308152,0.000007986949,0.0001811212,0.0006463882],"study_design_scores_gemma":[0.0003651709,0.000040831885,0.43131286,0.0003838736,0.000038579008,5.48402e-8,0.00004700475,0.00029424508,0.5674518,0.000021390131,0.000014757204,0.000029450908],"about_ca_topic_score_codex":0.0018937244,"about_ca_topic_score_gemma":0.00063177,"teacher_disagreement_score":0.16461436,"about_ca_system_score_codex":0.00035855203,"about_ca_system_score_gemma":0.00021443363,"threshold_uncertainty_score":0.28627574},"labels":[],"label_agreement":null},{"id":"W2026867617","doi":"10.1016/j.ijrobp.2005.12.013","title":"Phase I study of hypofractionated dose-escalated thoracic radiotherapy for limited-stage small-cell lung cancer","year":2006,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Interior Health; Alberta Cancer Foundation","funders":"","keywords":"Medicine; Radiation therapy; Chemotherapy; Esophagitis; Lung cancer; Prophylactic cranial irradiation; Etoposide; Stage (stratigraphy); Acute toxicity; Induction chemotherapy; Toxicity; Surgery; Radiology; Oncology; Internal medicine; Conventional PCI; Disease","score_opus":0.03901653506255092,"score_gpt":0.4343916082421459,"score_spread":0.39537507317959497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026867617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821649,0.0028651813,0.009379392,0.002345548,0.0015204091,0.0012056098,0.0001876083,0.00004409753,0.0002872425],"genre_scores_gemma":[0.9931526,0.0013969775,0.0018810278,0.00037935344,0.0024483164,0.00010757629,0.00012443548,0.000048016573,0.00046167563],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9977273,0.00024652726,0.0010149127,0.00028316554,0.0004336659,0.00029447215],"domain_scores_gemma":[0.9954212,0.0006928918,0.0014638813,0.00017479398,0.0021396535,0.00010761528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006367602,0.00024038613,0.0007075468,0.00034830955,0.00010172174,0.00002205116,0.00034015923,0.00019805446,0.00008760282],"category_scores_gemma":[0.00021915942,0.00020396229,0.0002627011,0.00032431603,0.00015469572,0.0002613774,0.000044578723,0.0004908467,0.0000020278821],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012868399,0.02019013,0.621669,0.00018244082,0.0071265115,0.00012580359,0.0018352814,0.009234243,0.120101206,0.0012333139,0.011329373,0.19410431],"study_design_scores_gemma":[0.28531268,0.054001793,0.25336483,0.00067563046,0.003728803,0.00031343507,0.0025198548,0.11432287,0.08641165,0.0038700765,0.19381495,0.0016634152],"about_ca_topic_score_codex":0.00025638175,"about_ca_topic_score_gemma":0.00003379199,"teacher_disagreement_score":0.36830413,"about_ca_system_score_codex":0.0015130804,"about_ca_system_score_gemma":0.00084979157,"threshold_uncertainty_score":0.83173406},"labels":[],"label_agreement":null},{"id":"W2029712223","doi":"10.1038/bjc.2012.21","title":"A phase I trial of pan-Bcl-2 antagonist obatoclax administered as a 3-h or a 24-h infusion in combination with carboplatin and etoposide in patients with extensive-stage small cell lung cancer","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Medical Association","funders":"National Cancer Institute; Moffitt Cancer Center","keywords":"Carboplatin; Medicine; Etoposide; Adverse effect; Clinical endpoint; Internal medicine; Chemotherapy; Anesthesia; Clinical trial; Cisplatin","score_opus":0.02277835739252881,"score_gpt":0.3474266205460649,"score_spread":0.32464826315353607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029712223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98808295,0.0097984625,0.000006825564,0.00023575871,0.00017054685,0.00147335,0.00006903321,0.000004671061,0.00015840615],"genre_scores_gemma":[0.99517673,0.0039269044,0.0001823694,0.00012927376,0.00014784207,0.00011288551,0.00000671373,0.00003099684,0.00028627692],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980013,0.00011869527,0.0006289557,0.0001876244,0.00069022324,0.00037321032],"domain_scores_gemma":[0.9984204,0.00009778581,0.0005710302,0.000112265276,0.00059725525,0.00020124545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038945035,0.00017924553,0.00067752367,0.00025205986,0.00005401245,0.000035855493,0.00008102573,0.00007344389,0.00005958423],"category_scores_gemma":[0.00017160478,0.00013788517,0.00004567183,0.00035998403,0.00014843691,0.00027451784,0.000049690574,0.0004312037,1.3375993e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19942747,0.0029216763,0.7541454,0.00085952424,0.00021888268,0.0008216755,0.002436029,0.000014110283,0.00094725424,0.0000031666857,0.00031041153,0.0378944],"study_design_scores_gemma":[0.37683472,0.012757273,0.5977963,0.0077351015,0.0002943644,0.00017915705,0.0007822277,0.00007367639,0.002498544,0.000003696428,0.00077026634,0.00027465352],"about_ca_topic_score_codex":0.007174488,"about_ca_topic_score_gemma":0.019239435,"teacher_disagreement_score":0.17740725,"about_ca_system_score_codex":0.0005911192,"about_ca_system_score_gemma":0.0011663099,"threshold_uncertainty_score":0.9994368},"labels":[],"label_agreement":null},{"id":"W2030500811","doi":"10.1097/jto.0b013e318160c0cb","title":"Outcomes of Second-Line Chemotherapy in Patients with Relapsed Extensive Small Cell Lung Cancer","year":2008,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Chemotherapy; Internal medicine; Oncology; Lung cancer; Multivariate analysis; Disease; Cancer","score_opus":0.02656031899069337,"score_gpt":0.41168510553714527,"score_spread":0.3851247865464519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030500811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99375266,0.0015924269,0.000021385196,0.0032368482,0.0002342454,0.00039341106,0.000008310467,0.0000048666407,0.0007558181],"genre_scores_gemma":[0.99459827,0.00087164843,0.0020699608,0.00090564,0.000120477926,0.000010315478,0.0000015467342,0.000023739658,0.0013984053],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984709,0.000116172385,0.0005962917,0.0001429717,0.00040111374,0.0002725542],"domain_scores_gemma":[0.9978772,0.00020560574,0.0006522955,0.00016900062,0.0009700301,0.00012586982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003462127,0.00014917625,0.00097162393,0.00030172852,0.00003515607,0.000001857858,0.00013359726,0.00010648955,0.00021052256],"category_scores_gemma":[0.0001442384,0.00009456389,0.00011523049,0.0002374433,0.00018151735,0.000075715645,0.000038839473,0.00052917405,0.0000013111119],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0084219435,0.00086968456,0.978605,0.00022671014,0.00042260104,0.00041354823,0.0016066044,0.000038060647,0.0007410927,7.6034155e-7,0.0029783677,0.0056756353],"study_design_scores_gemma":[0.008060859,0.0045846784,0.9813336,0.00021470009,0.00014605296,0.000075889955,0.00020208512,0.0000144024225,0.0034934941,0.0000099151,0.0017733605,0.00009096904],"about_ca_topic_score_codex":0.000053281427,"about_ca_topic_score_gemma":0.00019068256,"teacher_disagreement_score":0.005584666,"about_ca_system_score_codex":0.00064053753,"about_ca_system_score_gemma":0.0009269307,"threshold_uncertainty_score":0.38562036},"labels":[],"label_agreement":null},{"id":"W2032700254","doi":"","title":"Metallothionein expression in patients with small cell carcinoma of the lung: correlation with other molecular markers and clinical outcome.","year":2001,"lang":"en","type":"article","venue":"PubMed","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Internal medicine; Oncology; Proliferating cell nuclear antigen; Exact test; Logistic regression; Chemotherapy; Gastroenterology; Immunohistochemistry","score_opus":0.026496780706113693,"score_gpt":0.2775490660371601,"score_spread":0.2510522853310464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032700254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958567,0.000241931,0.00015543144,0.00032422965,0.00003742195,0.0015673047,0.0000025190132,0.000007644325,0.0018068422],"genre_scores_gemma":[0.99877286,0.000012197866,0.00026591265,0.00013167298,0.000010771006,0.00020088136,0.000002306923,0.000017829287,0.0005855656],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989024,0.0001123762,0.00023439869,0.00019763262,0.0003421027,0.0002111134],"domain_scores_gemma":[0.9994246,0.00007317257,0.00010608068,0.00023560924,0.00007662416,0.000083955376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035030724,0.000098277014,0.000230537,0.00006155846,0.000025761306,0.0000053205426,0.000065970955,0.000046850713,0.0000074718237],"category_scores_gemma":[0.00012279623,0.000049747192,0.000036717036,0.00018360552,0.00013415025,0.000040045623,0.000066219276,0.0001824701,3.3471954e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001516082,0.0001662666,0.99588555,0.000059912254,0.000043449058,0.000006826921,0.00007234267,0.000009668052,0.000012171712,0.0000025366105,0.00007108008,0.0021541403],"study_design_scores_gemma":[0.0050309813,0.00017076697,0.99403715,0.000049754097,0.00009064664,0.0000010521318,0.000048810234,0.000044173634,0.000223076,0.0000024520366,0.00024010592,0.00006103798],"about_ca_topic_score_codex":0.000076606826,"about_ca_topic_score_gemma":0.000054576278,"teacher_disagreement_score":0.0035148992,"about_ca_system_score_codex":0.00006861983,"about_ca_system_score_gemma":0.000031449068,"threshold_uncertainty_score":0.20286316},"labels":[],"label_agreement":null},{"id":"W2033893059","doi":"10.1053/j.seminoncol.2003.12.021","title":"Targeted molecules in small cell lung cancer","year":2004,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Lung cancer; Imatinib mesylate; Cancer research; Tyrosine kinase; Targeted therapy; Cancer; Immunoconjugate; Clinical trial; Imatinib; Immunology; Oncology; Antibody; Pathology; Internal medicine; Receptor; Monoclonal antibody","score_opus":0.04207325589161267,"score_gpt":0.44114568123938175,"score_spread":0.3990724253477691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033893059","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001410728,0.9866596,0.000002906118,0.00036868168,0.0004677715,0.0022758015,0.00004105857,0.00003699674,0.010006103],"genre_scores_gemma":[0.000020377465,0.9944539,0.0010351911,0.00016266068,0.00020904867,0.0017167822,0.000078927216,0.00008706549,0.0022360387],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970811,0.00032987326,0.0007959485,0.0007036683,0.00023847498,0.00085095415],"domain_scores_gemma":[0.99863774,0.00045130044,0.0002544792,0.0004256674,0.0000759834,0.00015481061],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005304706,0.00048088995,0.0029577708,0.00080629444,0.000033496653,0.0000071539407,0.00034528956,0.0007490836,0.00026145586],"category_scores_gemma":[0.0003170177,0.00039950237,0.000281371,0.0009193579,0.00022241934,0.000024068038,0.00031601766,0.0016357523,0.000036339978],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00008117441,0.0004182464,0.0012754085,0.069575444,0.00019798074,0.004250924,0.0007481587,0.000016553424,0.000005067376,0.000029121347,0.006095,0.9173069],"study_design_scores_gemma":[0.0016102891,0.00042262234,0.00009123334,0.05159339,0.0004756425,0.00008314015,0.0000972541,0.000008772173,0.000010933518,0.00004256006,0.94524515,0.0003190142],"about_ca_topic_score_codex":0.001304476,"about_ca_topic_score_gemma":0.0028077099,"teacher_disagreement_score":0.93915015,"about_ca_system_score_codex":0.008765458,"about_ca_system_score_gemma":0.005685846,"threshold_uncertainty_score":0.999951},"labels":[],"label_agreement":null},{"id":"W2034304549","doi":"10.1097/jto.0b013e3182572ead","title":"Effect of Chemotherapy in Patients With Resected Small-Cell or Large-Cell Neuroendocrine Carcinoma","year":2012,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"Medicine; Chemotherapy; Perioperative; Surgery; Hazard ratio; Radiation therapy; Lung cancer; Small-cell carcinoma; Retrospective cohort study; Carcinoma; Internal medicine; Confidence interval","score_opus":0.0170289900780441,"score_gpt":0.3991541811091218,"score_spread":0.3821251910310777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034304549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99643564,0.0008716733,0.000009667265,0.0007516078,0.0002447566,0.00056966406,0.000004738046,0.0000065369586,0.0011057054],"genre_scores_gemma":[0.9982842,0.00014414033,0.00052592135,0.00018873537,0.00023365986,0.00001010795,0.0000025753848,0.000031071748,0.0005795609],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99781096,0.00055880053,0.0005161172,0.00012987187,0.00045178496,0.00053247693],"domain_scores_gemma":[0.9981715,0.00053352385,0.0004932377,0.00021586586,0.00036329636,0.00022255219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009822701,0.00017551267,0.0008730231,0.0003644805,0.000030202133,0.000003838077,0.00016797309,0.000059192524,0.00012229464],"category_scores_gemma":[0.000328149,0.00009845918,0.00010063687,0.00039276184,0.00009129693,0.000105198225,0.0000767269,0.0006250488,0.0000049858368],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.059091523,0.0026245697,0.92231256,0.0008354127,0.000114697286,0.00048084173,0.0004528429,0.0000018709911,0.0024355818,4.594713e-7,0.0019189025,0.009730732],"study_design_scores_gemma":[0.026006378,0.057874564,0.82833725,0.00021699347,0.00030080084,0.00028026119,0.00012789223,0.0000108406675,0.07882449,0.0000016669558,0.007889443,0.00012939719],"about_ca_topic_score_codex":0.00002368143,"about_ca_topic_score_gemma":0.00002519834,"teacher_disagreement_score":0.09397529,"about_ca_system_score_codex":0.00040287687,"about_ca_system_score_gemma":0.00035696905,"threshold_uncertainty_score":0.4015049},"labels":[],"label_agreement":null},{"id":"W2035885090","doi":"10.1093/annonc/mdv104","title":"Tecemotide in unresectable stage III non-small-cell lung cancer in the phase III START study: updated overall survival and biomarker analyses","year":2015,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Chemoradiotherapy; Internal medicine; Placebo; Clinical endpoint; Oncology; Subgroup analysis; Biomarker; Lung cancer; Surrogate endpoint; Stage (stratigraphy); Phases of clinical research; Cancer; Gastroenterology; Clinical trial; Pathology; Confidence interval","score_opus":0.22608756890889636,"score_gpt":0.5120381683515557,"score_spread":0.2859505994426593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035885090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98164433,0.0033427877,0.000009330102,0.004498216,0.00011249991,0.0014311755,0.00004462785,0.000012305522,0.008904734],"genre_scores_gemma":[0.9970121,0.0012172428,0.000028648405,0.0005346722,0.00005687463,0.00014336812,0.00001930046,0.000017778453,0.0009700112],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975846,0.0005257555,0.00051612273,0.00036837067,0.00045346338,0.00055172073],"domain_scores_gemma":[0.9986161,0.00035132776,0.00016154659,0.00035658025,0.00035769073,0.00015675972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002456047,0.00020138903,0.00083484384,0.00039503982,0.0000553901,0.000015452551,0.00022446773,0.000095143114,0.00011613266],"category_scores_gemma":[0.00023089041,0.00013744152,0.000053562733,0.0006822832,0.00022857437,0.000112149515,0.00023134827,0.00035133166,0.0000016747844],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01586887,0.008767365,0.8534012,0.00041444413,0.0014529416,0.0018193561,0.018677527,0.00029847556,0.01696622,0.00003170039,0.07443731,0.007864619],"study_design_scores_gemma":[0.15923198,0.020090314,0.7156545,0.00038016,0.0005853918,0.000022096161,0.059473768,0.0058032824,0.009031785,0.00013049821,0.028850906,0.0007453162],"about_ca_topic_score_codex":0.030896997,"about_ca_topic_score_gemma":0.030711412,"teacher_disagreement_score":0.1433631,"about_ca_system_score_codex":0.00020364558,"about_ca_system_score_gemma":0.00087179826,"threshold_uncertainty_score":0.98697555},"labels":[],"label_agreement":null},{"id":"W2035891246","doi":"10.1016/j.cllc.2013.11.003","title":"Third-Line Chemotherapy in Small-Cell Lung Cancer: An International Analysis","year":2013,"lang":"en","type":"article","venue":"Clinical Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; University of British Columbia; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Chemotherapy; Regimen; Internal medicine; Lung cancer; Chemotherapy regimen; Oncology; Multivariate analysis; Surgery","score_opus":0.055800522048560286,"score_gpt":0.47713408424617715,"score_spread":0.42133356219761686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035891246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.969398,0.006431904,0.00015615416,0.017126188,0.000905522,0.0012754407,0.000052221432,0.0001043966,0.0045501376],"genre_scores_gemma":[0.9577634,0.024078896,0.00075203885,0.005912779,0.002082508,0.0011127065,0.00006187791,0.000060235223,0.008175582],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971186,0.00014205863,0.0009072121,0.00077298924,0.00050217443,0.00055694504],"domain_scores_gemma":[0.997992,0.0003092255,0.00020622993,0.00062380556,0.00047607624,0.0003926854],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000741625,0.00026878854,0.00088659395,0.0003212287,0.00006728342,0.00006242675,0.00044539667,0.00020450578,0.0048415517],"category_scores_gemma":[0.00023865695,0.00021588316,0.00038725336,0.0008939971,0.00021346087,0.00024048312,0.00015130144,0.0007570311,0.00003306089],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036915185,0.00048782767,0.9646021,0.00013228045,0.0020914339,0.000019099109,0.0002568806,0.00030041303,0.00021405591,0.000020788035,0.015654335,0.015851598],"study_design_scores_gemma":[0.005227463,0.00024604288,0.9201068,0.00022437135,0.00095686316,9.801987e-7,0.00008733952,0.065446764,0.00030202483,0.000049618295,0.007041137,0.00031055257],"about_ca_topic_score_codex":0.0064559868,"about_ca_topic_score_gemma":0.004746887,"teacher_disagreement_score":0.06514635,"about_ca_system_score_codex":0.00080821436,"about_ca_system_score_gemma":0.00053050346,"threshold_uncertainty_score":0.9960682},"labels":[],"label_agreement":null},{"id":"W2036318642","doi":"10.1016/j.ijrobp.2014.05.1783","title":"Is Prophylactic Cranial Irradiation (PCI) With Hippocampal Avoidance (HA) Justified in Limited-Stage Small Cell Lung Cancer (LS-SCLC)?","year":2014,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario","funders":"","keywords":"Medicine; Conventional PCI; Prophylactic cranial irradiation; Neurocognitive; Oncology; Internal medicine; Lung cancer; Radiation therapy; Cognition","score_opus":0.027017089394324977,"score_gpt":0.3565873919246701,"score_spread":0.32957030253034514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036318642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768987,0.0012975454,0.006947729,0.010576393,0.0019542284,0.0007059455,0.00008455493,0.00004895358,0.0014859278],"genre_scores_gemma":[0.99145895,0.001050872,0.002058869,0.0017415844,0.0031630273,0.00006979221,0.00004746777,0.000048907765,0.0003605561],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973774,0.00036300594,0.0008247356,0.0004010645,0.00059382315,0.0004399847],"domain_scores_gemma":[0.99664813,0.00056462747,0.0011663451,0.00022556003,0.0011976165,0.0001977059],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008548032,0.00030254264,0.00067458395,0.00036179405,0.00010579577,0.000047986094,0.00042391286,0.00022163277,0.00009368559],"category_scores_gemma":[0.00051878387,0.00024766478,0.00017651895,0.0003655755,0.0002467405,0.00034255913,0.00007519992,0.0010014909,0.000020747208],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031686153,0.0007498484,0.92871964,0.00019697836,0.00070217194,0.00011443501,0.002224194,0.0031131248,0.0083138915,0.0015675273,0.001694584,0.049434982],"study_design_scores_gemma":[0.06096036,0.010246324,0.73367107,0.001088908,0.0012194685,0.00043273182,0.0007535816,0.08065463,0.011893977,0.0038875258,0.09371933,0.0014721181],"about_ca_topic_score_codex":0.00014533912,"about_ca_topic_score_gemma":0.00014755772,"teacher_disagreement_score":0.1950486,"about_ca_system_score_codex":0.0021765856,"about_ca_system_score_gemma":0.0014353058,"threshold_uncertainty_score":0.99999756},"labels":[],"label_agreement":null},{"id":"W2036953209","doi":"10.1016/s1547-4127(04)00004-0","title":"Should aggressive surgery ever be part of the management of small cell lung cancer?","year":2004,"lang":"en","type":"review","venue":"Thoracic surgery clinics/Thorac. surg. clin.","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital; University of Toronto","funders":"","keywords":"Medicine; Mediastinoscopy; Stage (stratigraphy); Chemotherapy; Thoracotomy; Mediastinum; Surgery; Lung cancer; Mediastinal lymph node; Radiation therapy; Disease; Cancer; Radiology; Metastasis; Oncology; Internal medicine","score_opus":0.2358553025352921,"score_gpt":0.4828800507153279,"score_spread":0.2470247481800358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036953209","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030322643,0.98322177,0.00001693849,0.00056097546,0.0054918285,0.0047359387,0.0010377631,0.00017185933,0.0017306808],"genre_scores_gemma":[0.00079539634,0.9907788,0.00025602142,0.00025875063,0.0011017852,0.0011616452,0.00033671124,0.00045230024,0.0048586144],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9837726,0.0024759711,0.006959518,0.0020347193,0.0028407509,0.0019164552],"domain_scores_gemma":[0.96891594,0.016366392,0.008896521,0.0038118227,0.0013630458,0.0006462483],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.01138467,0.0018268919,0.011373962,0.0011941832,0.0003225151,0.000057375117,0.0013229261,0.0013199131,0.00058396865],"category_scores_gemma":[0.0023162223,0.0012755961,0.0071873087,0.0033391693,0.001281887,0.00019336987,0.0015289014,0.0027620187,0.000047051246],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061186234,0.000880706,0.013594677,0.24474874,0.0054252595,0.0008357164,0.00012614104,0.0000205501,4.789829e-7,0.000014999694,0.022505695,0.71123517],"study_design_scores_gemma":[0.00043944124,0.000085857646,0.00058906863,0.25465122,0.013863576,0.0000534103,0.00017498621,0.000010010119,0.00017891229,0.000052594623,0.72864777,0.0012531738],"about_ca_topic_score_codex":0.00036744602,"about_ca_topic_score_gemma":0.00006437737,"teacher_disagreement_score":0.709982,"about_ca_system_score_codex":0.0012312602,"about_ca_system_score_gemma":0.007829618,"threshold_uncertainty_score":0.9999766},"labels":[],"label_agreement":null},{"id":"W2040800229","doi":"10.1016/j.ijrobp.2008.06.705","title":"Differential Regional Brain Atrophy Following Prophylactic Cranial Irradiation in Small Cell Lung Cancer Patients","year":2008,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital; McGill University Health Centre","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Conventional PCI; Atrophy; Radiology; Radiation therapy; Nuclear medicine; Internal medicine; Myocardial infarction","score_opus":0.024810192212339925,"score_gpt":0.349156272627218,"score_spread":0.32434608041487806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040800229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98987025,0.00070682156,0.0014153204,0.0044205487,0.0028367087,0.00048091152,0.000031315365,0.00002525848,0.0002128702],"genre_scores_gemma":[0.99427176,0.00077094586,0.00069224177,0.00086806196,0.0031325947,0.00004526165,0.00008875259,0.00003628463,0.00009408316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99768424,0.00027269206,0.00082175183,0.00030441955,0.0005596472,0.0003572629],"domain_scores_gemma":[0.9976678,0.00038821765,0.0008460731,0.00012587398,0.0008131215,0.0001589411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027339288,0.00024206804,0.0005719344,0.00035068076,0.0001279307,0.000020843845,0.00033155974,0.00021391478,0.000067080495],"category_scores_gemma":[0.0004271027,0.00021400751,0.00034588162,0.00026103485,0.00016817683,0.0003144303,0.00008183664,0.00071260706,0.000010720566],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011803167,0.0009602092,0.97373796,0.0000349408,0.0005587664,0.00017153953,0.0012834824,0.00034147606,0.0050121783,0.00025331197,0.0021743164,0.014291513],"study_design_scores_gemma":[0.025629846,0.002322055,0.95902514,0.00016568023,0.0002591894,0.00010856825,0.000066566405,0.0037359789,0.0012952731,0.0013298779,0.005683736,0.00037806437],"about_ca_topic_score_codex":0.00016434725,"about_ca_topic_score_gemma":0.000035216188,"teacher_disagreement_score":0.02444953,"about_ca_system_score_codex":0.0024569156,"about_ca_system_score_gemma":0.0012814553,"threshold_uncertainty_score":0.8726973},"labels":[],"label_agreement":null},{"id":"W2043428486","doi":"10.1097/jto.0b013e3181952678","title":"Defining Genomic Alteration Boundaries for a Combined Small Cell and Non-small Cell Lung Carcinoma","year":2009,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Small Cell Lung Carcinoma; Lung; Small-cell carcinoma; Cell; Carcinoma; Cancer research; Pathology; Internal medicine; Genetics; Biology","score_opus":0.023514930183573268,"score_gpt":0.38241518063877733,"score_spread":0.3589002504552041,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043428486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827439,0.0061968053,0.0023578228,0.0057570143,0.00041133576,0.0005955864,0.0000067933906,0.000010768699,0.0019199806],"genre_scores_gemma":[0.9797622,0.00026125443,0.018131336,0.0007909224,0.00041253775,0.000014312836,0.0000061336737,0.000018854265,0.0006024333],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99863136,0.00010333323,0.0005365228,0.00018834134,0.00017421583,0.0003662138],"domain_scores_gemma":[0.9984977,0.0003028139,0.00044509524,0.00014037936,0.00041718953,0.00019681841],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008608386,0.00016712518,0.0006511301,0.0002394191,0.00026546678,0.0000862358,0.00012172633,0.00012725715,0.000011206759],"category_scores_gemma":[0.00016725763,0.00013621399,0.00013312556,0.00009480799,0.00013910477,0.00009504828,0.00005613785,0.00041085543,0.0000030662206],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0507211,0.0031958614,0.24544965,0.0062700287,0.0011018746,0.0026842125,0.033347458,0.00022169811,0.37785637,0.0007396914,0.06785225,0.2105598],"study_design_scores_gemma":[0.035504393,0.10032382,0.60354394,0.001081409,0.0044739675,0.0032726733,0.0058008796,0.008703868,0.12252232,0.0041533657,0.109356016,0.0012633562],"about_ca_topic_score_codex":0.000019408142,"about_ca_topic_score_gemma":0.000040354036,"teacher_disagreement_score":0.35809427,"about_ca_system_score_codex":0.0005625993,"about_ca_system_score_gemma":0.0013062248,"threshold_uncertainty_score":0.5554645},"labels":[],"label_agreement":null},{"id":"W2044016668","doi":"10.1200/jco.2014.57.9235","title":"Reply to P. Niravath et al","year":2014,"lang":"fr","type":"letter","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Internal medicine","score_opus":0.24465761939170472,"score_gpt":0.5869392432318591,"score_spread":0.34228162384015437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044016668","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002465773,0.0051858,0.00056587375,0.943619,0.02110915,0.0005930195,0.00001728726,0.00001499589,0.026429089],"genre_scores_gemma":[0.0015205286,0.009945345,0.0051683066,0.9120736,0.052912783,0.000016461021,0.000008278936,0.00009157717,0.018263109],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98393613,0.004689706,0.0071693314,0.00073665724,0.0021618316,0.0013063716],"domain_scores_gemma":[0.9663125,0.02380052,0.0048774057,0.0008675633,0.0024522168,0.0016897741],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.028275907,0.00055377977,0.0065038525,0.0004759184,0.00009940023,0.000039012462,0.0010330693,0.0016491391,0.0013569501],"category_scores_gemma":[0.07307661,0.0003924057,0.0019045058,0.00032387726,0.0010530701,0.00014253758,0.00058432715,0.015242163,0.0015805756],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003856055,0.00078619894,0.008999998,0.0002436764,0.0023609486,0.011130746,0.00018986814,0.00001481224,0.000024997855,0.000116589785,0.88859975,0.083676375],"study_design_scores_gemma":[0.0070540477,0.048880864,0.020958291,0.0018047772,0.0009740059,0.0015130449,0.000059819675,0.000017540026,0.0000077386985,0.00025842118,0.91816586,0.00030558053],"about_ca_topic_score_codex":0.00021393826,"about_ca_topic_score_gemma":0.00006425432,"teacher_disagreement_score":0.0833708,"about_ca_system_score_codex":0.0015362828,"about_ca_system_score_gemma":0.010122517,"threshold_uncertainty_score":0.9998528},"labels":[],"label_agreement":null},{"id":"W2045359677","doi":"10.1016/s0360-3016(03)00635-7","title":"Shifting from hypofractionated to “conventionally” fractionated thoracic radiotherapy: A single institution's 10-year experience in the management of limited-stage small-cell lung cancer using concurrent chemoradiation","year":2003,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; BC Cancer Agency","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Etoposide; Regimen; Radiation therapy; Lung cancer; Vincristine; Conventional PCI; Cyclophosphamide; Chemotherapy; Oncology; Surgery; Internal medicine","score_opus":0.0662570391408563,"score_gpt":0.42014297887011887,"score_spread":0.3538859397292626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045359677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9726856,0.002189376,0.020368747,0.0017841514,0.0014991681,0.00063347793,0.00007894561,0.00002043203,0.0007401278],"genre_scores_gemma":[0.99041677,0.0012624222,0.00690643,0.00060796394,0.00057506334,0.00006471647,0.0000728715,0.000021936912,0.0000718505],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977683,0.00034345425,0.0008035301,0.00028221324,0.0005621488,0.00024039611],"domain_scores_gemma":[0.99743265,0.00036638137,0.0010010528,0.00015683121,0.0009517038,0.00009135915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007281414,0.0001980204,0.0004031069,0.00026047527,0.00010786591,0.000034869056,0.00032720153,0.00013631102,0.00030102313],"category_scores_gemma":[0.00026609193,0.00016745682,0.0001602044,0.0005593948,0.00014327638,0.000378798,0.00004518405,0.0004234838,0.000004981941],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002262877,0.003648596,0.7653229,0.00021786633,0.0039180573,0.0001722891,0.0074180737,0.04294862,0.067354396,0.014435632,0.00094117504,0.09135952],"study_design_scores_gemma":[0.048732586,0.003474362,0.54993606,0.0030114648,0.0017507966,0.0002708024,0.011689964,0.07190006,0.08990662,0.0035117643,0.21403569,0.0017798075],"about_ca_topic_score_codex":0.00014906288,"about_ca_topic_score_gemma":0.000013421681,"teacher_disagreement_score":0.21538682,"about_ca_system_score_codex":0.002437239,"about_ca_system_score_gemma":0.00062850467,"threshold_uncertainty_score":0.6828691},"labels":[],"label_agreement":null},{"id":"W2045410673","doi":"10.1200/jco.2003.10.089","title":"Continued Cigarette Smoking by Patients Receiving Concurrent Chemoradiotherapy for Limited-Stage Small-Cell Lung Cancer Is Associated With Decreased Survival","year":2003,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":249,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Medicine; Internal medicine; Lung cancer; Toxicity; Etoposide; Chemotherapy; Cyclophosphamide; Vincristine; Chemoradiotherapy; Radiation therapy; Stage (stratigraphy); Surgery; Gastroenterology","score_opus":0.10128393816825154,"score_gpt":0.4610338190641434,"score_spread":0.3597498808958919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045410673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883922,0.0037013162,0.00052721397,0.0032322565,0.0015335046,0.00089557096,0.00007419566,0.000018315548,0.0016254534],"genre_scores_gemma":[0.99047333,0.002645269,0.00050988694,0.0041563855,0.0005235873,0.0000552625,0.000018268913,0.000063773165,0.0015542277],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99600637,0.0006684084,0.0017405638,0.0003245445,0.00070962176,0.00055047683],"domain_scores_gemma":[0.99028385,0.004929038,0.0022843343,0.00018197054,0.0018018387,0.00051897665],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0040897313,0.00024677458,0.0020766582,0.00010063353,0.00010737867,0.00002319798,0.00019289124,0.00034838094,0.00015454015],"category_scores_gemma":[0.010297829,0.00017328325,0.00043208752,0.00022100781,0.00022663016,0.00008530592,0.000027157044,0.0011251016,3.7355798e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003435765,0.001954574,0.91396487,0.00011861768,0.0032548758,0.0000794204,0.0002811224,0.0000043915566,0.00015738694,0.0000072001703,0.055276763,0.021465005],"study_design_scores_gemma":[0.14307211,0.025984885,0.48287886,0.0017220123,0.0032409136,0.00001887611,0.00034662202,0.00054446247,0.0033664762,0.000021027083,0.33814797,0.00065580197],"about_ca_topic_score_codex":0.000038319595,"about_ca_topic_score_gemma":0.00012631419,"teacher_disagreement_score":0.43108603,"about_ca_system_score_codex":0.0009896177,"about_ca_system_score_gemma":0.0023614503,"threshold_uncertainty_score":0.9980388},"labels":[],"label_agreement":null},{"id":"W2048869426","doi":"10.1002/cncr.24833","title":"Treatment of small‐cell lung cancer in elderly patients","year":2010,"lang":"en","type":"review","venue":"Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Lung cancer; Radiation therapy; Disease; Stage (stratigraphy); Population; Chemotherapy; Retrospective cohort study; Cancer; Internal medicine; Oncology; Intensive care medicine; Surgery","score_opus":0.05950808557390528,"score_gpt":0.4324454076823065,"score_spread":0.3729373221084012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048869426","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010524166,0.99306947,5.0507674e-7,0.00006443702,0.00068152125,0.0027437317,0.00039191078,0.000018973968,0.0019770325],"genre_scores_gemma":[0.00008729085,0.9915823,0.000035872537,0.000017130984,0.00041655614,0.003225958,0.000056330537,0.00007768817,0.00450092],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980558,0.00005953571,0.0005739496,0.0004881788,0.00035504848,0.00046749244],"domain_scores_gemma":[0.99873346,0.00009831932,0.00030312384,0.0004962079,0.00021263688,0.00015627414],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00005994741,0.0004405893,0.0022010496,0.00027112893,0.000032055254,0.000008469814,0.00017127061,0.00029911823,0.00048737726],"category_scores_gemma":[0.00003595281,0.000295679,0.00040119994,0.000380598,0.00011103051,0.000029090073,0.00006432367,0.0004397194,0.000011428149],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003667866,0.00028940648,0.012645156,0.030028407,0.00033189575,0.000022454667,0.0002433593,5.4208994e-7,0.0000015566534,0.0000017858721,0.00095872296,0.95544004],"study_design_scores_gemma":[0.0020570853,0.0004800616,0.0009947745,0.01615065,0.001419387,0.000001260678,0.000007887517,0.0000034857246,0.000023292769,0.0000010790151,0.9786283,0.00023273141],"about_ca_topic_score_codex":0.0021771435,"about_ca_topic_score_gemma":0.001976391,"teacher_disagreement_score":0.9776696,"about_ca_system_score_codex":0.0023122928,"about_ca_system_score_gemma":0.0021328756,"threshold_uncertainty_score":0.9999495},"labels":[],"label_agreement":null},{"id":"W2049426090","doi":"10.1016/j.radonc.2011.12.009","title":"Locoregional failures following thoracic irradiation in patients with limited-stage small cell lung carcinoma","year":2012,"lang":"en","type":"article","venue":"Radiotherapy and Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Stage (stratigraphy); Radiation therapy; Carcinoma; Lung; Retrospective cohort study; Surgery; Radiology; Nuclear medicine; Internal medicine","score_opus":0.0204053157260985,"score_gpt":0.3263769555936294,"score_spread":0.3059716398675309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049426090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900415,0.0073213717,0.0001353622,0.00091024133,0.000118743585,0.00063701614,0.0000036236056,0.000021831158,0.0008103316],"genre_scores_gemma":[0.9969933,0.00029444057,0.0013999391,0.000601097,0.00021126974,0.00006279903,0.0000196108,0.00002243733,0.00039508258],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99897593,0.00010968837,0.00015012777,0.00019334185,0.0001809725,0.00038991796],"domain_scores_gemma":[0.9994974,0.00014205494,0.00005985607,0.00012484545,0.00003692105,0.00013889262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023993244,0.00013536184,0.0003124963,0.0001670872,0.00007509107,0.000008887376,0.000047579106,0.000104188606,0.000036590962],"category_scores_gemma":[0.000019173018,0.00010069812,0.000042837688,0.0001607878,0.00007988203,0.00011634253,0.000017606491,0.00020526971,0.00000165281],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001067841,0.00030040694,0.98873305,0.000108315166,0.00008814919,0.000026373105,0.002280253,0.000007020343,0.0002349205,0.00005648603,0.00044585633,0.006651342],"study_design_scores_gemma":[0.0050349417,0.0012201448,0.96998763,0.00003554393,0.000040948966,0.000005491301,0.00017342712,0.00016012798,0.00008599836,0.0000031728268,0.02313829,0.00011427203],"about_ca_topic_score_codex":0.00012234184,"about_ca_topic_score_gemma":0.00015359341,"teacher_disagreement_score":0.022692434,"about_ca_system_score_codex":0.00076367287,"about_ca_system_score_gemma":0.00014179538,"threshold_uncertainty_score":0.41063502},"labels":[],"label_agreement":null},{"id":"W2049657582","doi":"10.1158/0008-5472.sabcs13-p6-11-05","title":"Abstract P6-11-05: ANG4043, a brain-penetrant anti-HER2 mAb increases survival in mice bearing intracranial BT-474 breast tumor cells","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Angiochem (Canada)","funders":"","keywords":"Transcytosis; Brain tumor; In vivo; Cancer research; Receptor; Medicine; Monoclonal antibody; Pharmacology; Internal medicine; Biology; Antibody; Pathology; Immunology","score_opus":0.0437908769327742,"score_gpt":0.3827641558444934,"score_spread":0.33897327891171924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049657582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852233,0.0017425203,0.0000031374948,0.008565669,0.00032015282,0.002302538,0.00020864909,0.00010697487,0.0015270506],"genre_scores_gemma":[0.9951762,0.0010915541,0.00011726672,0.00035817892,0.0011930338,0.00078275485,0.0000289569,0.00012120753,0.0011308494],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9933351,0.0004304805,0.0006710581,0.0010465422,0.002350193,0.0021666083],"domain_scores_gemma":[0.99629235,0.001139943,0.00010288584,0.0007191953,0.0009898726,0.0007557768],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024988723,0.00043580946,0.0008960103,0.00081196224,0.0003364215,0.00025500858,0.0007047802,0.0001637579,0.0038610783],"category_scores_gemma":[0.00072174816,0.00037839118,0.0001754104,0.0013426705,0.00063315977,0.0004601421,0.0005661116,0.0018468967,0.0005151066],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016691041,0.0012512489,0.250767,0.0021533123,0.0004007877,0.0029714713,0.0014201044,0.00005256614,0.67911303,0.00010215916,0.04612546,0.0139737725],"study_design_scores_gemma":[0.005106328,0.00034371778,0.9640355,0.0012851871,0.00003286631,0.00020099629,0.00115352,0.0001412923,0.02361423,0.00012126829,0.003472756,0.00049234775],"about_ca_topic_score_codex":0.18541662,"about_ca_topic_score_gemma":0.014560121,"teacher_disagreement_score":0.7132685,"about_ca_system_score_codex":0.0014969176,"about_ca_system_score_gemma":0.0016132868,"threshold_uncertainty_score":0.9998668},"labels":[],"label_agreement":null},{"id":"W2049906715","doi":"10.3389/fonc.2014.00271","title":"A Multicenter Pilot Study Examining the Role of Circulating Tumor Cells as a Blood-Based Tumor Marker in Patients with Extensive Small-Cell Lung Cancer","year":2014,"lang":"en","type":"article","venue":"Frontiers in Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Center for Advancing Translational Sciences; LUNGevity Foundation","keywords":"Medicine; Circulating tumor cell; Internal medicine; Oncology; Etoposide; Lung cancer; Prostate cancer; Biomarker; Chemotherapy; Cancer; Lung; Gastroenterology; Metastasis","score_opus":0.013040215679648309,"score_gpt":0.2908344038407549,"score_spread":0.27779418816110657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049906715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947261,0.00069544953,0.00004390586,0.00012141637,0.00030382286,0.002646546,0.0000075564026,0.000015590384,0.0014396015],"genre_scores_gemma":[0.9966021,0.000006385901,0.0020491069,0.0006378835,0.000061201325,0.0005359256,0.0000037863117,0.00004005019,0.000063564396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976393,0.0005406346,0.00045198807,0.0004451689,0.00039218483,0.0005307037],"domain_scores_gemma":[0.9985753,0.00043264774,0.00027309224,0.00036011232,0.0002694027,0.000089443805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007199189,0.00022372422,0.0007143863,0.00027406256,0.00006635278,0.000008467313,0.00020420976,0.000037494392,0.00003308866],"category_scores_gemma":[0.00040514563,0.000153068,0.00003386692,0.00033372396,0.00021887867,0.00004037313,0.00013240147,0.00046069096,0.0000015274973],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003325501,0.0025624977,0.9873514,0.00016912217,0.00019006376,0.00013280413,0.0030680918,0.00044407998,0.001058881,6.8554175e-7,0.00031865778,0.001378179],"study_design_scores_gemma":[0.021820026,0.009575591,0.9503962,0.0003513202,0.0003125911,0.00000202381,0.0066140085,0.009422759,0.0010626358,0.000007763045,0.00025316767,0.00018192858],"about_ca_topic_score_codex":0.0018095765,"about_ca_topic_score_gemma":0.0010488901,"teacher_disagreement_score":0.03695525,"about_ca_system_score_codex":0.0006121851,"about_ca_system_score_gemma":0.00044103738,"threshold_uncertainty_score":0.6241932},"labels":[],"label_agreement":null},{"id":"W2051653983","doi":"10.1007/s11864-002-0045-9","title":"Elderly patients with lung cancer: Biases and evidence","year":2002,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto","keywords":"Medicine; Lung cancer; Internal medicine; Radiation therapy; Neutropenia; Chemotherapy; Clinical trial; Performance status; Oncology; Cancer; Surgery","score_opus":0.26352508198025576,"score_gpt":0.5318729844685911,"score_spread":0.26834790248833534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051653983","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000768429,0.9947879,0.0000019338431,0.00023603976,0.00038423546,0.0034998446,0.00011621573,0.000041510757,0.0001639055],"genre_scores_gemma":[0.00010768673,0.9944043,0.0001507544,0.000007323314,0.00016437302,0.004625592,0.00013288045,0.00003736322,0.00036971914],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979572,0.00022342739,0.00046100625,0.000645393,0.00027370497,0.00043921702],"domain_scores_gemma":[0.99826604,0.00083925395,0.00021327773,0.0003749773,0.00013833262,0.0001681432],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000090580004,0.0004636941,0.0018150833,0.00047761004,0.000116769996,0.00001945859,0.00010605568,0.00017120472,0.00013300762],"category_scores_gemma":[0.0001839229,0.00028498558,0.00015868442,0.00048743552,0.00027070325,0.000092374954,0.000095372736,0.00039447477,0.000019947955],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047185153,0.0013535554,0.01613366,0.0076824534,0.0005142258,0.000047269918,0.00011769991,0.0000014229312,4.948198e-9,0.0000148689705,0.001190309,0.97289735],"study_design_scores_gemma":[0.0023406935,0.003669889,0.0018706009,0.061821904,0.0028804329,0.000026209264,0.0000119156175,0.000013077586,2.9838283e-8,0.0000013250296,0.9271356,0.00022834168],"about_ca_topic_score_codex":0.000113722715,"about_ca_topic_score_gemma":0.00030335062,"teacher_disagreement_score":0.972669,"about_ca_system_score_codex":0.0050693606,"about_ca_system_score_gemma":0.0010445311,"threshold_uncertainty_score":0.99996024},"labels":[],"label_agreement":null},{"id":"W2052267217","doi":"10.1097/jto.0b013e31820c2f2e","title":"Characteristics and Outcomes of Small Cell Lung Cancer Patients Diagnosed During Two Lung Cancer Computed Tomographic Screening Programs in Heavy Smokers","year":2011,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Stage (stratigraphy); Lung cancer screening; Retrospective cohort study; Lung cancer; Radiation therapy; Cancer; Computed tomographic; Interim; Computed tomography; Disease; Interim analysis; Radiology; Clinical trial; Internal medicine","score_opus":0.04729657512002468,"score_gpt":0.40958893375337474,"score_spread":0.3622923586333501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052267217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946595,0.0035142393,0.000050526578,0.0004907654,0.00048530014,0.0006929678,0.00001595726,0.000013187129,0.000077585144],"genre_scores_gemma":[0.99469894,0.00226336,0.002645427,0.00011571634,0.00014950946,0.000058919417,0.0000035825244,0.000029504132,0.000035023095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978408,0.00019907209,0.0008810671,0.00022437,0.00038846157,0.000466204],"domain_scores_gemma":[0.9979695,0.00018393392,0.00087973615,0.0001494912,0.0005782444,0.0002391125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005574096,0.000221827,0.0010847346,0.0005390174,0.000070821785,0.000011962585,0.0001819747,0.00012231943,0.000036295165],"category_scores_gemma":[0.0001398047,0.00017314001,0.00014981501,0.0003884302,0.00021691683,0.0001246291,0.00016471402,0.0006464188,1.3094743e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002153968,0.00076123665,0.9616409,0.0010242813,0.00056637096,0.00035123256,0.0029356102,0.0000104542105,0.00029591675,9.1885215e-7,0.000065049615,0.030194089],"study_design_scores_gemma":[0.0039750035,0.0011031843,0.99125236,0.0012190901,0.0005108319,0.000023804896,0.0002841943,0.000406012,0.0010175405,0.0000042890633,0.000058888472,0.00014477271],"about_ca_topic_score_codex":0.0012847832,"about_ca_topic_score_gemma":0.0007885345,"teacher_disagreement_score":0.030049317,"about_ca_system_score_codex":0.0005045865,"about_ca_system_score_gemma":0.0003627501,"threshold_uncertainty_score":0.7060445},"labels":[],"label_agreement":null},{"id":"W2054724578","doi":"10.1097/jto.0b013e318200e509","title":"Phase II Multicenter Trial of Voreloxin as Second-Line Therapy in Chemotherapy-Sensitive or Refractory Small Cell Lung Cancer","year":2011,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saint John Regional Hospital","funders":"Sunesis","keywords":"Medicine; Refractory (planetary science); Chemotherapy; Lung cancer; Oncology; Internal medicine; Multicenter study; Randomized controlled trial","score_opus":0.07526664195801742,"score_gpt":0.48279497794253895,"score_spread":0.40752833598452154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054724578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915674,0.0023297423,0.00003258494,0.0017439799,0.00080334477,0.00095227675,0.000014187301,0.0000080478,0.0025484394],"genre_scores_gemma":[0.987945,0.005871072,0.001841032,0.001130844,0.0007968421,0.0000315496,0.0000015739108,0.00003694982,0.0023451203],"study_design_codex":"randomized_trial","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977077,0.0003856151,0.0009567382,0.00021476983,0.00036182956,0.00037331478],"domain_scores_gemma":[0.9976763,0.00032998784,0.0009435184,0.00022047765,0.00063981453,0.00018986319],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013033594,0.00021308669,0.0010818515,0.00040406839,0.000047241418,0.0000039642596,0.00019429982,0.00020702569,0.0016221892],"category_scores_gemma":[0.00028239176,0.00013875897,0.00022467757,0.00023592942,0.00020742408,0.00011579014,0.00007162611,0.00082687545,0.0000032805608],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.74399966,0.011525019,0.0012789508,0.00025869874,0.00085554435,0.0014570705,0.014833481,0.0000015653659,0.06006774,0.0000016914888,0.0024802084,0.16324034],"study_design_scores_gemma":[0.36232018,0.17043795,0.005788382,0.00092764007,0.00053493143,0.00032588057,0.0031013435,0.000186604,0.4207559,0.000061158586,0.035186272,0.0003737687],"about_ca_topic_score_codex":0.00021143956,"about_ca_topic_score_gemma":0.00041309395,"teacher_disagreement_score":0.3816795,"about_ca_system_score_codex":0.0007514933,"about_ca_system_score_gemma":0.0015932441,"threshold_uncertainty_score":0.99929047},"labels":[],"label_agreement":null},{"id":"W2054807753","doi":"10.1097/mph.0b013e31821f0eaf","title":"Survival and Long-term Outcomes in Children With Hepatoblastoma Treated With Continuous Infusion of Cisplatin and Doxorubicin","year":2011,"lang":"en","type":"article","venue":"Journal of Pediatric Hematology/Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Hepatoblastoma; Ototoxicity; Audiogram; Chemotherapy; Cohort; Cisplatin; Dosing; Retrospective cohort study; Cardiomyopathy; Surgery; Internal medicine; Hearing loss; Heart failure","score_opus":0.025338809194596888,"score_gpt":0.32289955981027596,"score_spread":0.29756075061567905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054807753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970431,0.0017581754,0.000023633782,0.00032467104,0.00004080157,0.0004523769,0.0000043531604,0.000010095743,0.00034282613],"genre_scores_gemma":[0.9972791,0.0016200533,0.00092389004,0.00003586379,0.0000801696,0.000008887671,0.0000014340751,0.000019721992,0.00003087846],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99823606,0.00019538094,0.00070675195,0.00021653861,0.00030720088,0.00033808628],"domain_scores_gemma":[0.99827516,0.00037563173,0.0006973586,0.00014277975,0.00030641575,0.00020265904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005792183,0.00021623711,0.0014901673,0.0006079785,0.000039639537,0.00000430534,0.00009885734,0.00019504737,0.000026396829],"category_scores_gemma":[0.00021210723,0.00012656434,0.00004979384,0.00032183545,0.0003940357,0.00010240273,0.00009927811,0.00048145922,8.999889e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031673461,0.00046355158,0.9919524,0.00013867937,0.00044702925,0.001423075,0.00088459556,2.0666472e-7,0.00011396944,0.00003856784,0.00007107885,0.0012994717],"study_design_scores_gemma":[0.010324658,0.010877445,0.96986914,0.00008132571,0.00053460896,0.007407546,0.0003099983,0.0000028092047,0.00045669172,0.00001556211,0.000005515075,0.00011468914],"about_ca_topic_score_codex":0.00018438592,"about_ca_topic_score_gemma":0.0005479095,"teacher_disagreement_score":0.022083277,"about_ca_system_score_codex":0.00011138869,"about_ca_system_score_gemma":0.00041650864,"threshold_uncertainty_score":0.51611435},"labels":[],"label_agreement":null},{"id":"W2056504493","doi":"10.1097/coc.0b013e31828aab2a","title":"Outcomes of Small Cell Lung Cancer Patients Treated With Cisplatin-Etoposide Versus Carboplatin-Etoposide","year":2013,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Etoposide; Carboplatin; Internal medicine; Population; Gastroenterology; Cisplatin; Retrospective cohort study; Chemotherapy; Surgery","score_opus":0.05152157600792551,"score_gpt":0.4453391437418046,"score_spread":0.3938175677338791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056504493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900039,0.00030258147,0.00002193032,0.0032243861,0.00047635013,0.0005625466,0.000010004165,0.000013522159,0.005384815],"genre_scores_gemma":[0.99400973,0.0006165898,0.0038685242,0.00075527147,0.00028143602,0.000035129204,0.0000032331097,0.00003787756,0.0003922158],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961617,0.0004289626,0.0019857124,0.0002864067,0.0006593048,0.00047791],"domain_scores_gemma":[0.99123013,0.003809376,0.0025463027,0.00029813978,0.0015732382,0.00054280227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006657493,0.00026470487,0.002419539,0.00019325457,0.000051856063,0.000009280794,0.00027083195,0.00012741532,0.00022010114],"category_scores_gemma":[0.0014828267,0.00016212021,0.00039481104,0.0003697676,0.0010814487,0.00010857906,0.0001041227,0.00090038136,0.000009812659],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005467705,0.0009051577,0.94094026,0.000052905107,0.0015551095,0.000099554374,0.00022857892,0.000028367871,0.0001443561,0.0000048909505,0.001888281,0.048684802],"study_design_scores_gemma":[0.016003102,0.03433858,0.94618297,0.00015813927,0.0010108647,0.000016718406,0.00042115356,0.00008947235,0.00050934695,0.000007185166,0.0010969682,0.00016552699],"about_ca_topic_score_codex":0.0026107677,"about_ca_topic_score_gemma":0.0003252227,"teacher_disagreement_score":0.048519276,"about_ca_system_score_codex":0.00038535835,"about_ca_system_score_gemma":0.0014931157,"threshold_uncertainty_score":0.661107},"labels":[],"label_agreement":null},{"id":"W2057138654","doi":"10.1016/s0360-3016(01)01748-5","title":"Prophylactic cranial irradiation revisited: cost-effectiveness and quality of life in small-cell lung cancer","year":2002,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; University of Saskatchewan; Saskatchewan Cancer Agency","funders":"","keywords":"Conventional PCI; Medicine; Prophylactic cranial irradiation; Quality of life (healthcare); Surgery; Internal medicine; Lung cancer; Cost effectiveness; Toxicity; Retrospective cohort study; Myocardial infarction","score_opus":0.0632273612866845,"score_gpt":0.4132628435005799,"score_spread":0.3500354822138954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057138654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98803496,0.0065340186,0.0013387135,0.0021611645,0.00072320906,0.00072635396,0.000052361713,0.000013215363,0.00041602884],"genre_scores_gemma":[0.9943756,0.0037462593,0.0003962937,0.00033523855,0.0010405337,0.00004991276,0.000012996915,0.00001787436,0.000025286048],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99786085,0.00058300333,0.0008250167,0.00022037172,0.00030598493,0.00020475272],"domain_scores_gemma":[0.99695396,0.0008063532,0.0010457851,0.00011412635,0.00095214474,0.00012760944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011073047,0.000160895,0.0006672264,0.00024476246,0.000043858057,0.000015494166,0.0001883026,0.00016377243,0.00007148932],"category_scores_gemma":[0.0011663622,0.00014002489,0.0001267882,0.00024255882,0.0001849101,0.00022177603,0.00006011134,0.0004890261,0.000003432381],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011067017,0.00050550426,0.9314643,0.00027924828,0.00038310097,0.00001516719,0.00065567053,0.0003620559,0.008519358,0.0010623761,0.00018110422,0.055465393],"study_design_scores_gemma":[0.015476628,0.0011551647,0.97260666,0.00023611735,0.00017779757,0.000029625966,0.00009047016,0.0059131947,0.001628923,0.0010003151,0.0014843806,0.00020071467],"about_ca_topic_score_codex":0.0002143823,"about_ca_topic_score_gemma":0.00003392157,"teacher_disagreement_score":0.055264678,"about_ca_system_score_codex":0.001258872,"about_ca_system_score_gemma":0.0004556019,"threshold_uncertainty_score":0.57100487},"labels":[],"label_agreement":null},{"id":"W2058732484","doi":"10.3816/clc.2000.n.001","title":"Small-Cell Lung Cancer at the Millennium: Radiotherapy Innovations Improve Survival While New Chemotherapy Treatments Remain Unproven","year":2000,"lang":"en","type":"article","venue":"Clinical Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Radiation therapy; Lung cancer; Etoposide; Oncology; Chemotherapy; Regimen; Vincristine; Internal medicine; Cyclophosphamide; Surgery","score_opus":0.05962236724209133,"score_gpt":0.42511883145126506,"score_spread":0.3654964642091737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058732484","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8102472,0.10744637,0.00009769383,0.0582335,0.0027848484,0.0055266614,0.00033907147,0.00026675683,0.015057891],"genre_scores_gemma":[0.052712128,0.28256354,0.0011225296,0.022290342,0.010415389,0.002899168,0.00013725864,0.00040147893,0.62745816],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99625945,0.00022317332,0.0009797582,0.00096962525,0.0006780193,0.00088995864],"domain_scores_gemma":[0.9972907,0.0006517833,0.00025556504,0.0010915459,0.00028785996,0.00042258686],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007917754,0.00048165032,0.0009420161,0.00008090822,0.00042253666,0.000058220052,0.00042806115,0.0002806029,0.010150002],"category_scores_gemma":[0.00010247083,0.00031584373,0.0004183634,0.0007605679,0.00043807307,0.000105282255,0.00010761802,0.0007713468,0.00005092491],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002833733,0.0005606356,0.29653978,0.00023097736,0.0028868157,0.00002342936,0.00082633214,0.00008354761,0.0016549686,0.000021556802,0.47720522,0.217133],"study_design_scores_gemma":[0.023516392,0.0011760006,0.1425774,0.0005594062,0.0011690013,0.000006015019,0.000109624954,0.0020096437,0.0018947705,0.000054869604,0.82612586,0.00080104603],"about_ca_topic_score_codex":0.0032588413,"about_ca_topic_score_gemma":0.0019907702,"teacher_disagreement_score":0.7575351,"about_ca_system_score_codex":0.0021103406,"about_ca_system_score_gemma":0.0016593622,"threshold_uncertainty_score":0.99992937},"labels":[],"label_agreement":null},{"id":"W2059355012","doi":"10.1097/jto.0b013e318282707b","title":"A Phase I Study of Pomalidomide (CC-4047) in Combination with Cisplatin and Etoposide in Patients with Extensive-Stage Small-Cell Lung Cancer","year":2013,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Etoposide; Neutropenia; Pomalidomide; Internal medicine; Adverse effect; Regimen; Chemotherapy; Gastroenterology; Surgery; Thalidomide; Multiple myeloma","score_opus":0.022202202067033938,"score_gpt":0.42377374883985286,"score_spread":0.4015715467728189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059355012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967365,0.0004954403,0.000020315347,0.0009692841,0.000056132463,0.0015157051,0.0000033047604,0.0000031769794,0.00020008514],"genre_scores_gemma":[0.99884516,0.00008941745,0.00069943216,0.00011257564,0.00002812925,0.00006154047,0.000001386666,0.000017302527,0.00014505582],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983399,0.00026178907,0.0005703879,0.00017346234,0.00040815666,0.0002463256],"domain_scores_gemma":[0.9980951,0.00022041211,0.0005956513,0.00013172504,0.00083957013,0.00011753651],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005210539,0.00014595449,0.0007310202,0.000472659,0.00002989265,0.0000104907285,0.00008759453,0.000066767265,0.000029132945],"category_scores_gemma":[0.00013968501,0.00009403698,0.000024297811,0.0003221629,0.00011013524,0.00018065574,0.000060546503,0.00046670932,4.459706e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012486373,0.014326448,0.9549568,0.0003142588,0.00021948024,0.00046162304,0.00436922,0.000065178654,0.00068343966,0.0000018248485,0.00016212076,0.011953223],"study_design_scores_gemma":[0.07411508,0.033381093,0.8858215,0.00064279797,0.00025862345,0.000035762103,0.0046285875,0.00033532368,0.0006157806,0.000013622595,0.000038872662,0.00011294115],"about_ca_topic_score_codex":0.0011639864,"about_ca_topic_score_gemma":0.0025047683,"teacher_disagreement_score":0.0691353,"about_ca_system_score_codex":0.0005522358,"about_ca_system_score_gemma":0.0003957458,"threshold_uncertainty_score":0.38347167},"labels":[],"label_agreement":null},{"id":"W2059793948","doi":"10.1097/01.coc.0000195092.25516.19","title":"Examining Time Intervals Between Diagnosis and Treatment in the Management of Patients With Limited Stage Small Cell Lung Cancer","year":2006,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; BC Cancer Agency","funders":"","keywords":"Medicine; Lung cancer; Confidence interval; Odds ratio; Stage (stratigraphy); Internal medicine; Radiation therapy; Proportional hazards model; Chemotherapy; Cancer; Logistic regression; Oncology","score_opus":0.09451095105498074,"score_gpt":0.44607742118003774,"score_spread":0.351566470125057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059793948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99590045,0.00052272173,0.000016251026,0.0018194687,0.000036975605,0.0004582725,0.000014725564,0.0000027076023,0.0012284343],"genre_scores_gemma":[0.99543446,0.0022581914,0.001620088,0.0002684284,0.00015821311,0.000046617428,0.0000032840492,0.0000117505615,0.00019894357],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99787146,0.0004575146,0.0009979488,0.00016086425,0.0002957303,0.00021647532],"domain_scores_gemma":[0.99633926,0.002283646,0.0009702433,0.0001424534,0.00016680581,0.00009757031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010552168,0.00012207926,0.0010646973,0.00011289849,0.000022565398,0.0000053616263,0.00013271984,0.000038316975,0.000030361025],"category_scores_gemma":[0.000078626465,0.00006376376,0.00009408568,0.00022778298,0.00047640447,0.000033414373,0.000063097745,0.00028196015,6.5228744e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094386755,0.0008904032,0.8278975,0.000047626207,0.0005762308,0.00014023035,0.00030626345,0.000011471238,0.0000013516067,0.0000015312175,0.00026541806,0.16891812],"study_design_scores_gemma":[0.006001768,0.021812364,0.9654805,0.00026601914,0.0006409341,0.0000017763974,0.0007418382,0.000009752815,0.000015861177,0.0000030383233,0.0049692653,0.000056846304],"about_ca_topic_score_codex":0.0005298852,"about_ca_topic_score_gemma":0.00013008034,"teacher_disagreement_score":0.16886128,"about_ca_system_score_codex":0.00024442555,"about_ca_system_score_gemma":0.00019449291,"threshold_uncertainty_score":0.26002106},"labels":[],"label_agreement":null},{"id":"W2062668422","doi":"10.1002/1097-0142(20001101)89:9<1953::aid-cncr11>3.3.co;2-y","title":"Similar outcome of elderly patients in Intergroup Trial 0096","year":2000,"lang":"en","type":"article","venue":"Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":128,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Toxicity; Internal medicine; Etoposide; Retrospective cohort study; Survival rate; Performance status; Radiation therapy; Surgery; Chemotherapy","score_opus":0.038670754912903546,"score_gpt":0.4024898100377814,"score_spread":0.36381905512487783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062668422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99174994,0.0006466538,0.0000011163108,0.00075746846,0.00024310882,0.00058761716,0.000019456975,0.000014655638,0.0059799845],"genre_scores_gemma":[0.99562854,0.0005526107,0.00002796726,0.0003031694,0.00017426912,0.00012422241,0.0000052875525,0.000013304343,0.0031706465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990153,0.00002642616,0.0002882905,0.00016566039,0.00028784134,0.00021652454],"domain_scores_gemma":[0.9996023,0.000035276516,0.000038629056,0.00018480806,0.00007609,0.00006287882],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000103743434,0.000089884066,0.00031522484,0.00007870916,0.0000152091225,0.000003546481,0.000081624574,0.000042880733,0.00198942],"category_scores_gemma":[0.000101941,0.00007018428,0.00006907422,0.00017638739,0.00007487542,0.00004960617,0.000028079943,0.00015404222,0.000025361076],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019626861,0.0003276239,0.83723515,0.00020890479,0.00010630091,0.000015746831,0.0007633538,0.000011515361,0.000083634724,0.000010662171,0.009528922,0.13208131],"study_design_scores_gemma":[0.13225481,0.0035704009,0.78188217,0.0006110037,0.0000937524,7.6635723e-7,0.00012573886,0.000049613216,0.0011509988,0.00010877613,0.07989442,0.00025756497],"about_ca_topic_score_codex":0.00062275626,"about_ca_topic_score_gemma":0.0004165257,"teacher_disagreement_score":0.13182375,"about_ca_system_score_codex":0.00026133913,"about_ca_system_score_gemma":0.00007475894,"threshold_uncertainty_score":0.9989229},"labels":[],"label_agreement":null},{"id":"W2063405814","doi":"10.1155/2012/708936","title":"Uptake and Tolerance of Chemotherapy in Elderly Patients with Small Cell Lung Cancer and Impact on Survival","year":2012,"lang":"en","type":"article","venue":"Journal of Cancer Epidemiology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; University of Alberta","funders":"","keywords":"Medicine; Chemotherapy; Lung cancer; Internal medicine; Cancer; Cancer registry; Oncology; Surgery","score_opus":0.0412040762676599,"score_gpt":0.4009334681823219,"score_spread":0.359729391914662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063405814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9474899,0.049346145,0.000027513128,0.002532352,0.00022530586,0.0002561697,0.000015771493,0.000002362636,0.00010445121],"genre_scores_gemma":[0.98537546,0.01317347,0.0004471096,0.0005863146,0.00032830765,0.00001584212,7.039947e-7,0.000018029823,0.000054746477],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985251,0.0001677525,0.0005449773,0.00014602381,0.00019138183,0.0004248002],"domain_scores_gemma":[0.99833006,0.000594631,0.00050840434,0.00011529455,0.00023277022,0.00021887137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011503096,0.00017000076,0.0009907986,0.00015272902,0.00002388745,0.0000022162935,0.000066293425,0.00008252695,0.00004515125],"category_scores_gemma":[0.00019927887,0.00009896255,0.000067035166,0.00011370584,0.00017417783,0.00009361756,0.000021804886,0.0003901309,1.4137733e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034367186,0.0001360798,0.97841364,0.0002538137,0.00024478554,0.0000035559274,0.00053936767,0.00012471023,0.00015506716,0.00001110797,0.0009185139,0.01576263],"study_design_scores_gemma":[0.005533646,0.0018007165,0.99037975,0.00052454614,0.00007873296,0.0000067645456,0.00004820761,0.00004847748,0.00020806864,0.000025684058,0.0012592089,0.00008620763],"about_ca_topic_score_codex":0.0009362717,"about_ca_topic_score_gemma":0.00030184397,"teacher_disagreement_score":0.037885547,"about_ca_system_score_codex":0.0002699081,"about_ca_system_score_gemma":0.00022222807,"threshold_uncertainty_score":0.40355754},"labels":[],"label_agreement":null},{"id":"W2063481154","doi":"10.1016/j.lungcan.2003.08.026","title":"Impaired diffusion capacity predicts for decreased treatment tolerance and survival in limited stage small cell lung cancer patients treated with concurrent chemoradiation","year":2004,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Western University","funders":"","keywords":"Medicine; DLCO; Internal medicine; Pulmonary function testing; Pulmonary toxicity; Toxicity; Diffusing capacity; Etoposide; Vincristine; Cumulative incidence; Gastroenterology; Urology; Surgery; Cyclophosphamide; Lung; Chemotherapy; Cohort","score_opus":0.02322103713015736,"score_gpt":0.3031683424275841,"score_spread":0.27994730529742673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063481154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901687,0.0044615446,0.000100383884,0.0004199227,0.00019769323,0.0038765983,0.00059994,0.000079494916,0.000095758216],"genre_scores_gemma":[0.9939985,0.0025035394,0.00011105339,0.00010792605,0.00015845508,0.0023967535,0.00016552774,0.00005189579,0.00050631206],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99808925,0.000050816994,0.00031468703,0.00057889766,0.00039836374,0.00056797446],"domain_scores_gemma":[0.9989441,0.000088574525,0.00016177821,0.00022685355,0.00029101418,0.00028770397],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010024744,0.00035853143,0.00058395346,0.00014301753,0.0001368942,0.000029645798,0.00006997569,0.00010195198,0.000026900027],"category_scores_gemma":[0.0000491834,0.00026468435,0.00007110232,0.000327402,0.000108316555,0.00011292992,0.00003295617,0.00015198709,3.2666708e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021436696,0.00080272736,0.98885477,0.0010733808,0.00022452876,0.000013127215,0.0019418696,0.00064234476,0.0017034862,0.0000063984603,0.0001451833,0.0024485409],"study_design_scores_gemma":[0.047790643,0.0016745694,0.9211279,0.001298783,0.0004888544,9.0887096e-7,0.0000964521,0.012325028,0.014292238,0.0000023435914,0.0005244931,0.00037779126],"about_ca_topic_score_codex":0.01472032,"about_ca_topic_score_gemma":0.012408506,"teacher_disagreement_score":0.06772685,"about_ca_system_score_codex":0.0036743297,"about_ca_system_score_gemma":0.00058652495,"threshold_uncertainty_score":0.9999805},"labels":[],"label_agreement":null},{"id":"W2064508141","doi":"10.1097/jto.0000000000000058","title":"NCIC CTG IND.190 Phase I Trial of Dalotuzumab (MK-0646) in Combination with Cisplatin and Etoposide in Extensive-Stage Small-Cell Lung Cancer","year":2014,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Queen's University; McMaster University; University of Ottawa; Ottawa Hospital; Princess Margaret Cancer Centre; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Neutropenia; Leukopenia; Etoposide; Internal medicine; Gastroenterology; Cancer; Anemia; Surgery; Chemotherapy","score_opus":0.03256486841170175,"score_gpt":0.46006590205995973,"score_spread":0.427501033648258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064508141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99346125,0.0015213094,0.00024081497,0.0027231965,0.00025728784,0.00075907906,0.0000051449,0.000004723626,0.001027191],"genre_scores_gemma":[0.997427,0.00070039043,0.0011167392,0.0002088782,0.00019180101,0.00003179606,0.0000021897401,0.000019779298,0.0003014602],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9978322,0.0004581874,0.00078484026,0.00019949542,0.00042382945,0.00030148987],"domain_scores_gemma":[0.99794614,0.0005700963,0.0007063141,0.00016164001,0.0004771764,0.00013862122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001878797,0.00016231801,0.0009804992,0.0006139757,0.000035937243,0.0000100472125,0.00012268232,0.00014807971,0.000035822894],"category_scores_gemma":[0.0006704291,0.00012001388,0.00006311698,0.00035211953,0.00018624832,0.00013289726,0.00007246568,0.00072796334,5.789348e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5284383,0.007525648,0.15915217,0.0030522244,0.0006780461,0.0027854347,0.009799444,0.00062674674,0.03470246,0.0002364868,0.0016922825,0.25131074],"study_design_scores_gemma":[0.65447414,0.099341825,0.18342021,0.0049994504,0.0015706419,0.0009154162,0.004740201,0.01030837,0.030660871,0.00077629363,0.007995257,0.000797332],"about_ca_topic_score_codex":0.0003272572,"about_ca_topic_score_gemma":0.0014447146,"teacher_disagreement_score":0.2505134,"about_ca_system_score_codex":0.0008901423,"about_ca_system_score_gemma":0.0009813479,"threshold_uncertainty_score":0.48940238},"labels":[],"label_agreement":null},{"id":"W2065188377","doi":"10.1097/jto.0b013e31815bdc0d","title":"The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals Regarding the Clinical Staging of Small Cell Lung Cancer in the Forthcoming (Seventh) Edition of the Tumor, Node, Metastasis Classification for Lung Cancer","year":2007,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":547,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; TNM staging system; Lung cancer; Oncology; Stage (stratigraphy); Internal medicine; Lung cancer staging; Cancer; Radiology; Neoplasm staging; Mediastinoscopy","score_opus":0.08743869756397145,"score_gpt":0.5345343729513192,"score_spread":0.4470956753873478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065188377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9278429,0.01468297,0.00456825,0.03844688,0.0044858786,0.0094485795,0.0002976914,0.000011669545,0.0002151563],"genre_scores_gemma":[0.9916513,0.0039524985,0.00040704754,0.00036657232,0.001715688,0.0015750002,0.0000037853677,0.000045499666,0.00028260602],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.994358,0.0010207952,0.0022121214,0.0003473572,0.0014516247,0.00061010313],"domain_scores_gemma":[0.9856891,0.006765809,0.004591869,0.0004451213,0.002450157,0.000057937257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018128235,0.00027180483,0.0009175928,0.0002716052,0.0006018018,0.000055863136,0.0010565232,0.00013773711,0.000017323096],"category_scores_gemma":[0.002129544,0.00012359684,0.00049783714,0.0006764766,0.00026238943,0.00024094035,0.00022741749,0.0011092466,2.0859401e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047902223,0.0007581795,0.9167002,0.0013408045,0.0040609506,0.000006144891,0.013840146,0.0033722068,0.0023753154,0.000075370896,0.011988404,0.040692072],"study_design_scores_gemma":[0.013076812,0.0017739381,0.69148844,0.0053310515,0.014627916,0.000028471,0.08578396,0.16220851,0.01341223,0.00015253866,0.011545762,0.0005703658],"about_ca_topic_score_codex":0.0025226092,"about_ca_topic_score_gemma":0.012910472,"teacher_disagreement_score":0.22521174,"about_ca_system_score_codex":0.0038355954,"about_ca_system_score_gemma":0.002892151,"threshold_uncertainty_score":0.9999885},"labels":[],"label_agreement":null},{"id":"W2065276159","doi":"10.1097/01.jto.0000283329.83483.2b","title":"PD6-1-7: A phase II study of UCN-01 in combination with topotecan in patients (pts) with chemosensitive relapsed small cell lung cancer (SCLC): a study of the Princess Margaret Hospital phase II consortium (PMH-C).","year":2007,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Ottawa Hospital; Ottawa Regional Cancer Foundation; Princess Margaret Cancer Centre","funders":"","keywords":"Topotecan; Medicine; Oncology; Internal medicine; Apoptosis; Chemotherapy; Cell cycle checkpoint; Pharmacology; Cancer; Cell cycle","score_opus":0.016519547986206362,"score_gpt":0.4052030107723295,"score_spread":0.38868346278612315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065276159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948684,0.00015364285,0.000020497704,0.0007831941,0.00022202492,0.0036201803,0.000011570302,0.000006066559,0.00031439812],"genre_scores_gemma":[0.99955094,0.000029011322,0.00013133971,0.00005648315,0.000053260213,0.000049276638,0.000002090799,0.0000279101,0.00009968424],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966187,0.00048859627,0.001163398,0.00031166547,0.0009922052,0.00042546907],"domain_scores_gemma":[0.99642426,0.000248711,0.0016297689,0.0003156979,0.0012388059,0.00014277699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017892031,0.0002562434,0.0011538725,0.00052814104,0.00012362994,0.000006223133,0.00027707193,0.000111560585,0.000018481947],"category_scores_gemma":[0.00025409638,0.00015822977,0.000069805676,0.0009355714,0.00027988118,0.00014209464,0.00024021055,0.00093637157,9.4840395e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.054770976,0.115165204,0.758235,0.00027619113,0.00073599676,0.0010389219,0.055345852,0.0001009655,0.0008021466,0.0000017443248,0.00012242788,0.013404581],"study_design_scores_gemma":[0.10566846,0.26841226,0.5777964,0.000885186,0.0007078221,0.000036509267,0.040276356,0.00008583515,0.005867152,0.000006342032,0.000053902706,0.00020374515],"about_ca_topic_score_codex":0.0007330445,"about_ca_topic_score_gemma":0.008556366,"teacher_disagreement_score":0.18043858,"about_ca_system_score_codex":0.001445817,"about_ca_system_score_gemma":0.001034646,"threshold_uncertainty_score":0.6452423},"labels":[],"label_agreement":null},{"id":"W2066832802","doi":"10.1007/s00280-003-0711-z","title":"Pharmacokinetics of etoposide in cancer patients treated with high-dose etoposide and with dexrazoxane (ICRF-187) as a rescue agent","year":2003,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Etoposide; Pharmacokinetics; Dexrazoxane; Pharmacology; Medicine; Toxicity; Chemotherapy; Cancer; Internal medicine; Breast cancer; Anthracycline","score_opus":0.019167464852908944,"score_gpt":0.35378738882824584,"score_spread":0.3346199239753369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066832802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98786217,0.008597985,0.000003152842,0.0017701852,0.00010249469,0.0011609402,0.000038679198,0.000023353625,0.0004410527],"genre_scores_gemma":[0.96078306,0.03523724,0.00013904352,0.0027444805,0.00008206606,0.0004090372,0.000007854999,0.000047879348,0.00054930756],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984283,0.00011683112,0.0002806041,0.00045835963,0.00026210013,0.0004538201],"domain_scores_gemma":[0.9992427,0.000086197484,0.00011313406,0.00013366321,0.00020665475,0.00021761702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013052946,0.00029714234,0.0005866091,0.00016327293,0.00006944744,0.00000888321,0.0000731121,0.00009146854,0.00058841327],"category_scores_gemma":[0.000010177788,0.0002103466,0.000027731507,0.00038010962,0.00045992376,0.00006646536,0.000027662474,0.00031094035,7.0541324e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015460669,0.00079941534,0.76530516,0.00080567395,0.0014709978,0.00017309411,0.0022509708,0.00012366766,0.2015324,0.000048248843,0.0023953656,0.009634353],"study_design_scores_gemma":[0.041315366,0.0033733314,0.1729878,0.00039169766,0.0005362854,0.00004596435,0.00012052457,0.00006551742,0.76869863,0.000031978456,0.012055344,0.00037752886],"about_ca_topic_score_codex":0.0026237052,"about_ca_topic_score_gemma":0.0007247034,"teacher_disagreement_score":0.59231734,"about_ca_system_score_codex":0.0002646915,"about_ca_system_score_gemma":0.00034181672,"threshold_uncertainty_score":0.85776854},"labels":[],"label_agreement":null},{"id":"W2074044989","doi":"10.1016/j.radonc.2010.05.013","title":"Phase I dose escalation trial of hypofractionated limited-field external beam thoracic radiotherapy for limited-stage small cell carcinoma of the lung","year":2010,"lang":"en","type":"article","venue":"Radiotherapy and Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saint John Regional Hospital","funders":"Alberta Cancer Foundation","keywords":"Medicine; Radiation therapy; Lung cancer; Clinical endpoint; Chemotherapy; Stage (stratigraphy); Oncology; Nuclear medicine; Toxicity; Dose fractionation; Acute toxicity; Internal medicine; Radiology; Urology; Randomized controlled trial","score_opus":0.03476654564473217,"score_gpt":0.3886735354685558,"score_spread":0.3539069898238236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074044989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883357,0.0037331204,0.0025952233,0.0020786559,0.0007592188,0.0021551035,0.00003375122,0.000021203006,0.00028800181],"genre_scores_gemma":[0.99178076,0.0018872073,0.0038256356,0.0006802716,0.0007328583,0.00014565987,0.000009008397,0.00003429329,0.00090431893],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99864215,0.00013790543,0.00044134512,0.0002771411,0.00022975629,0.000271701],"domain_scores_gemma":[0.9979556,0.0010492632,0.0003370392,0.00034955802,0.000207346,0.00010115002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005553566,0.00017890088,0.0005614283,0.00016446953,0.00012462681,0.000009844078,0.000157885,0.00027450366,0.000120635406],"category_scores_gemma":[0.0001876119,0.00012444312,0.00019933889,0.00021252065,0.0002594581,0.00008239599,0.000023906498,0.0004389263,1.6391768e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11179903,0.0023252587,0.016678317,0.00038124662,0.00030826087,0.000009080534,0.0012329097,0.000015199655,0.78290087,0.00017848732,0.0014285663,0.08274279],"study_design_scores_gemma":[0.31660417,0.04149942,0.047721397,0.00013802253,0.0004578712,0.00010732456,0.00026970357,0.013225606,0.48869178,0.00013611729,0.09071127,0.0004373242],"about_ca_topic_score_codex":0.00012333292,"about_ca_topic_score_gemma":0.00006250085,"teacher_disagreement_score":0.2942091,"about_ca_system_score_codex":0.00021443103,"about_ca_system_score_gemma":0.0003627759,"threshold_uncertainty_score":0.5074643},"labels":[],"label_agreement":null},{"id":"W2074144195","doi":"10.1016/j.cllc.2011.03.013","title":"A Phase II Study of Carboplatin and Irinotecan in Extensive Stage Small-Cell Lung Cancer","year":2011,"lang":"en","type":"article","venue":"Clinical Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Pfizer","keywords":"Medicine; Carboplatin; Irinotecan; Lung cancer; Oncology; Internal medicine; Stage (stratigraphy); Cancer; Chemotherapy; Cisplatin; Colorectal cancer","score_opus":0.1242241102550383,"score_gpt":0.4814820898648671,"score_spread":0.35725797960982886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074144195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816473,0.013222438,0.0000061612022,0.00033081183,0.00037064054,0.0024705513,0.00007456598,0.00003847776,0.0018390449],"genre_scores_gemma":[0.9931305,0.00347334,0.00012743409,0.00036955604,0.00026204943,0.00059651706,0.0000027165033,0.00004674746,0.0019911153],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997142,0.00019846985,0.0009850296,0.00072316366,0.00042353375,0.0005277655],"domain_scores_gemma":[0.99814385,0.00033244066,0.00028749186,0.00054012885,0.0003718697,0.00032423402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007112246,0.00028275425,0.0010358456,0.00017801474,0.00009568674,0.000008106694,0.00018503006,0.00015122588,0.00044039896],"category_scores_gemma":[0.00041399166,0.00023154117,0.00012094919,0.00038492476,0.00034914917,0.00007200581,0.00040938373,0.000748437,0.0000010910663],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003313905,0.0071842126,0.95801234,0.0009873284,0.0006849814,0.00028846678,0.01198954,0.000011292119,0.0007678639,0.000013983723,0.0023513595,0.014394732],"study_design_scores_gemma":[0.060726836,0.019390522,0.90311617,0.0015979214,0.0015140971,0.0000043418954,0.0060477494,0.0035640032,0.0023540277,0.00002300625,0.00097146287,0.00068984815],"about_ca_topic_score_codex":0.010841834,"about_ca_topic_score_gemma":0.011097165,"teacher_disagreement_score":0.057412934,"about_ca_system_score_codex":0.00032123114,"about_ca_system_score_gemma":0.00063614425,"threshold_uncertainty_score":0.99574506},"labels":[],"label_agreement":null},{"id":"W2075136921","doi":"10.1016/j.cllc.2011.03.028","title":"Clinical Outcomes of Extensive Stage Small Cell Lung Carcinoma Patients Treated With Consolidative Thoracic Radiotherapy","year":2011,"lang":"en","type":"article","venue":"Clinical Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Radiation therapy; Stage (stratigraphy); Lung cancer; Lung; Radiology; Carcinoma; Oncology; Small Cell Lung Carcinoma; Internal medicine; Small-cell carcinoma","score_opus":0.09780638833724518,"score_gpt":0.4554487585161819,"score_spread":0.3576423701789367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075136921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99012274,0.0029917024,0.00010699224,0.00020728631,0.00041142732,0.0021414983,0.0002062542,0.00007542071,0.0037366678],"genre_scores_gemma":[0.9895973,0.002753293,0.0016948137,0.0011911975,0.00024817445,0.00020620177,0.000029857823,0.000087141205,0.004192021],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99600947,0.0005178978,0.0014421534,0.000851321,0.0005649801,0.0006141735],"domain_scores_gemma":[0.9953498,0.0013635156,0.0006632529,0.0008167458,0.0013205638,0.00048609692],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000806184,0.0004107059,0.0017620018,0.00012755292,0.000092229435,0.000011426587,0.0002901631,0.0002667388,0.0006296216],"category_scores_gemma":[0.0006665366,0.00026713786,0.00048066754,0.0003235614,0.0012168982,0.0000988873,0.00014209068,0.0008016597,0.000009970966],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054618237,0.0012418791,0.9827073,0.00039073313,0.0018042875,0.00009952801,0.00075947534,9.900923e-7,0.000015619667,0.000013861494,0.0038485373,0.0036559226],"study_design_scores_gemma":[0.008803625,0.003161622,0.9847345,0.00030769204,0.00085646793,0.0000012574255,0.00019858508,0.00015601679,0.0007549256,0.0000043354944,0.00072110776,0.0002998843],"about_ca_topic_score_codex":0.0007358324,"about_ca_topic_score_gemma":0.00014622667,"teacher_disagreement_score":0.0033560381,"about_ca_system_score_codex":0.00031173945,"about_ca_system_score_gemma":0.0007667902,"threshold_uncertainty_score":0.99997807},"labels":[],"label_agreement":null},{"id":"W2076643424","doi":"10.1016/s0360-3016(02)04576-5","title":"Do age and comorbidity impact treatment allocation and outcomes in limited stage small-cell lung cancer? a community-based population analysis","year":2003,"lang":"en","type":"review","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":145,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Comorbidity; Internal medicine; Population; Chemoradiotherapy; Lung cancer; Multivariate analysis; Cancer; Radiation therapy; Retrospective cohort study; Stage (stratigraphy); Cancer registry; Oncology","score_opus":0.09335179534133689,"score_gpt":0.46796316600748544,"score_spread":0.3746113706661486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076643424","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19516169,0.800897,0.0008312052,0.00057469285,0.0005299988,0.0013303038,0.00055066234,0.00002684305,0.00009758909],"genre_scores_gemma":[0.10149346,0.8963376,0.0005366385,0.0001697719,0.00026066453,0.0000895138,0.001015084,0.000035916597,0.000061300096],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965587,0.001471178,0.0010987774,0.0002980604,0.00030704535,0.00026620127],"domain_scores_gemma":[0.99614656,0.0012510582,0.001693335,0.0002582436,0.00047878563,0.00017203872],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010494195,0.00043234415,0.0022762062,0.0009705498,0.000120428434,0.000059388673,0.00024305502,0.00036166044,0.000022865726],"category_scores_gemma":[0.00025835278,0.00031840496,0.0005756792,0.00056018395,0.00016694756,0.00014240904,0.00007249854,0.0009435713,9.533412e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014716195,0.00069941033,0.6436006,0.00074102264,0.0061818254,0.00006753019,0.0003701459,0.00049627916,0.0000072721014,0.000101369355,0.000050398863,0.347537],"study_design_scores_gemma":[0.031087935,0.0068338304,0.64675003,0.005178966,0.02848356,0.00017211548,0.00030799076,0.007338076,0.000026367035,0.0007580174,0.27152136,0.0015417412],"about_ca_topic_score_codex":0.001976344,"about_ca_topic_score_gemma":0.00062999135,"teacher_disagreement_score":0.34599528,"about_ca_system_score_codex":0.0051576197,"about_ca_system_score_gemma":0.001163457,"threshold_uncertainty_score":0.9999268},"labels":[],"label_agreement":null},{"id":"W2080644517","doi":"10.4103/0970-2113.92345","title":"Surgery in limited-disease small-cell lung cancer","year":2012,"lang":"en","type":"article","venue":"Lung India","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Lung cancer; Disease; Surgery; Oncology; Internal medicine","score_opus":0.030971374175624126,"score_gpt":0.3396830649898023,"score_spread":0.30871169081417815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080644517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9443729,0.04634288,0.00000820263,0.0015562719,0.0006160628,0.0006686263,0.000027331977,0.00008444955,0.006323293],"genre_scores_gemma":[0.9931323,0.0019708078,0.000073640935,0.00087550806,0.0007320796,0.00031969763,0.000026398404,0.000041550404,0.0028280506],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982423,0.00007456821,0.00024701277,0.00024697714,0.00037064656,0.0008184547],"domain_scores_gemma":[0.99875164,0.0002696139,0.000060259666,0.00033572828,0.00007014712,0.00051263237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004300067,0.00018008813,0.0003466927,0.0002972853,0.000067654815,0.000016577225,0.00009524662,0.00007315381,0.00040095445],"category_scores_gemma":[0.00026898485,0.00015613715,0.00011454549,0.0004490222,0.00006546693,0.00013771822,0.000112002184,0.00033956376,0.000060404534],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017029938,0.0001984995,0.95100766,0.0008553529,0.00008463379,0.0001249583,0.000901701,0.000003541208,0.00018291037,0.000022615028,0.0454536,0.0009942087],"study_design_scores_gemma":[0.00077342946,0.000013693008,0.989314,0.0004171009,0.0001371038,0.000003327828,0.00007379907,0.00024176821,0.00048539744,0.0000051008883,0.008348842,0.00018644572],"about_ca_topic_score_codex":0.00047349816,"about_ca_topic_score_gemma":0.00009379103,"teacher_disagreement_score":0.048759386,"about_ca_system_score_codex":0.0005742425,"about_ca_system_score_gemma":0.0004893145,"threshold_uncertainty_score":0.6367088},"labels":[],"label_agreement":null},{"id":"W2089171902","doi":"10.1002/cncr.25341","title":"Utilization of prophylactic cranial irradiation in patients with limited stage small cell lung carcinoma","year":2010,"lang":"en","type":"article","venue":"Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Stage (stratigraphy); Lung; Small Cell Lung Carcinoma; Carcinoma; Oncology; Small-cell carcinoma; Pathology; Internal medicine","score_opus":0.021788731753863824,"score_gpt":0.2982805176712885,"score_spread":0.2764917859174247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089171902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997762,0.0002201869,0.00002055866,0.00011586622,0.0001522084,0.000841472,0.000021769423,0.000014434425,0.0008514799],"genre_scores_gemma":[0.999117,0.000024890867,0.00011681544,0.000046248282,0.00008283643,0.00008642309,0.0000235718,0.000018670024,0.00048351142],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992062,0.000021052756,0.00015053376,0.00017459072,0.00026979597,0.00017783105],"domain_scores_gemma":[0.9993658,0.00002324631,0.0000884705,0.00017830919,0.00028378822,0.000060378283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007108595,0.00009026315,0.00017183271,0.00012587567,0.00002685395,0.000006239951,0.000049420847,0.000050365077,0.000118583244],"category_scores_gemma":[0.00007475536,0.000068861285,0.000019198606,0.00028486276,0.00006108764,0.000070705864,0.000020457515,0.00020397575,0.0000017497835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070835,0.00014442936,0.99216205,0.00055923907,0.00001591712,0.0000034927893,0.0006753797,0.000024074892,0.0036391825,0.000010630178,0.00009191687,0.0019653256],"study_design_scores_gemma":[0.0036995478,0.00032932984,0.99004203,0.00005231812,0.00004172712,1.2146812e-7,0.000042617776,0.00061807,0.0047873203,0.000002045311,0.0003134124,0.00007144509],"about_ca_topic_score_codex":0.0005564842,"about_ca_topic_score_gemma":0.0008785327,"teacher_disagreement_score":0.0029911979,"about_ca_system_score_codex":0.0002032608,"about_ca_system_score_gemma":0.00030050802,"threshold_uncertainty_score":0.28080818},"labels":[],"label_agreement":null},{"id":"W2090674284","doi":"10.1007/s00262-011-1083-6","title":"Immunization with N-propionyl polysialic acid–KLH conjugate in patients with small cell lung cancer is safe and induces IgM antibodies reactive with SCLC cells and bactericidal against group B meningococci","year":2011,"lang":"en","type":"article","venue":"Cancer Immunology Immunotherapy","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada; Institute for Biological Sciences","funders":"National Cancer Institute; Memorial Sloan-Kettering Cancer Center","keywords":"Polysialic acid; Conjugate; Immunization; Antibody; Medicine; Group A; Immunology; Cancer research; Cell; Chemistry; Internal medicine","score_opus":0.014581903922429659,"score_gpt":0.25844688750645256,"score_spread":0.2438649835840229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090674284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96961766,0.027665196,0.00005401014,0.0003047874,0.00012321101,0.0017254076,0.0000615314,0.000059535694,0.00038868067],"genre_scores_gemma":[0.969163,0.028446525,0.00082426774,0.0006274943,0.000036665668,0.00055743585,0.00004161784,0.000110646,0.0001923454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997729,0.00015679556,0.00039482233,0.0007202192,0.00029274655,0.0007064053],"domain_scores_gemma":[0.9985925,0.000053904238,0.00037295854,0.00049736444,0.00039124952,0.000092039234],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015467845,0.000552296,0.0008518268,0.00035689512,0.0002896385,0.000053993383,0.00020347108,0.0001947869,0.00011154441],"category_scores_gemma":[0.000006668907,0.0003729423,0.00003617467,0.00050001114,0.0010961137,0.00038654596,0.000116547635,0.000600758,0.0000014053295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01612231,0.00030445895,0.72025603,0.0001992314,0.0020810792,0.00002764603,0.01693883,0.000001914802,0.23079495,0.000011989588,0.000026539448,0.013234996],"study_design_scores_gemma":[0.015483154,0.0030706488,0.8325691,0.00090688287,0.00019622782,0.000009509971,0.0014843482,0.000009113148,0.14530675,0.000005572355,0.00043152532,0.0005271323],"about_ca_topic_score_codex":0.0053543276,"about_ca_topic_score_gemma":0.0006645808,"teacher_disagreement_score":0.11231308,"about_ca_system_score_codex":0.00043188976,"about_ca_system_score_gemma":0.00036431188,"threshold_uncertainty_score":0.99987227},"labels":[],"label_agreement":null},{"id":"W2091163157","doi":"10.1007/s11864-001-0017-5","title":"Limited stage small cell lung cancer","year":2001,"lang":"en","type":"review","venue":"Current Treatment Options in Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Etoposide; Radiation therapy; Prophylactic cranial irradiation; Chemotherapy; Oncology; Stage (stratigraphy); Cisplatin; Lung cancer; Internal medicine; Surgery; Conventional PCI","score_opus":0.23981062934101902,"score_gpt":0.5337653040662865,"score_spread":0.2939546747252675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091163157","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000081219696,0.986709,0.000014143592,0.00025292445,0.0013767071,0.0044116164,0.0003284202,0.00009787705,0.0067280955],"genre_scores_gemma":[0.0000031714608,0.9762538,0.00027161866,0.000017760181,0.00055928365,0.00825985,0.0006847352,0.00007595111,0.013873835],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99700415,0.00037214247,0.00079145294,0.0008112096,0.00024441033,0.0007766587],"domain_scores_gemma":[0.9982161,0.00046147054,0.00029613517,0.00065193605,0.00013046658,0.00024392208],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018760723,0.0006613943,0.0026809932,0.00087040896,0.00012325251,0.000019266075,0.0002177417,0.00039400955,0.0006647631],"category_scores_gemma":[0.00006758837,0.00047562903,0.00059101934,0.0010113738,0.00017683535,0.000038546925,0.00017336328,0.0008145511,0.00013896539],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003668667,0.0027611197,0.001109627,0.012759492,0.0006373786,0.0003190185,0.00015672634,0.000008992099,1.5336077e-7,0.00005853427,0.0038267483,0.97832555],"study_design_scores_gemma":[0.0026563879,0.0009471934,0.000083959014,0.009337375,0.0031145453,0.00004038464,0.000044296707,0.000032029166,3.592343e-7,0.0000026396733,0.9834336,0.00030719923],"about_ca_topic_score_codex":0.00023917248,"about_ca_topic_score_gemma":0.00074225164,"teacher_disagreement_score":0.97960687,"about_ca_system_score_codex":0.014077319,"about_ca_system_score_gemma":0.0033892929,"threshold_uncertainty_score":0.99976957},"labels":[],"label_agreement":null},{"id":"W2091582167","doi":"10.3816/clc.2003.n.024","title":"A Phase I Study of Pegylated Liposomal Doxorubicin Hydrochloride (Caelyx™) in Combination with Cyclophosphamide and Vincristine as Second-Line Treatment of Patients with Small-Cell Lung Cancer","year":2003,"lang":"en","type":"article","venue":"Clinical Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Humber River Regional Hospital; Credit Valley Hospital; Mount Sinai Hospital; Toronto East General Hospital; University of Toronto; University Health Network; Essar Steel Algoma (Canada); Northeast Cancer Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Doxorubicin Hydrochloride; Lung cancer; Cyclophosphamide; Vincristine; Doxorubicin; Oncology; Internal medicine; Chemotherapy","score_opus":0.028322384938492345,"score_gpt":0.390273185052095,"score_spread":0.3619508001136027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091582167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99134034,0.004293891,0.0000092154305,0.00014282399,0.00013983261,0.0036014772,0.000086049135,0.0000267074,0.00035968964],"genre_scores_gemma":[0.9971901,0.0012312521,0.00010879499,0.00008193419,0.000060285525,0.0005699189,0.00003195665,0.00005411756,0.00067164603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99711436,0.0002596403,0.0010413697,0.00060462294,0.00055791775,0.00042207414],"domain_scores_gemma":[0.9978274,0.00046234106,0.0004856495,0.000413488,0.0005616394,0.00024944215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041059792,0.00036162316,0.0011980986,0.0001771797,0.00008241048,0.000009960253,0.000099259596,0.00011360865,0.00017400342],"category_scores_gemma":[0.00021984198,0.0002443314,0.00007643078,0.00056795776,0.00028451462,0.000086765336,0.00004970606,0.00038861195,5.516481e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013901843,0.01862331,0.961099,0.00075139373,0.0010007606,0.00006917252,0.0017513424,0.00010002672,0.00025281357,0.000008122697,0.000088985566,0.0023531846],"study_design_scores_gemma":[0.14248586,0.058073662,0.78575915,0.001124687,0.0017051158,0.0000036366825,0.0008219867,0.0006964252,0.008656423,0.000012966094,0.00026107777,0.0003990279],"about_ca_topic_score_codex":0.004280329,"about_ca_topic_score_gemma":0.00785005,"teacher_disagreement_score":0.1753399,"about_ca_system_score_codex":0.0006075745,"about_ca_system_score_gemma":0.0006872921,"threshold_uncertainty_score":0.99635446},"labels":[],"label_agreement":null},{"id":"W2092041185","doi":"10.1016/s0169-5002(01)00289-6","title":"Commentary on “Carboplatin–etoposide association in small cell lung cancer patients older than 70 years: a phase II trial”","year":2002,"lang":"en","type":"letter","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Carboplatin; Etoposide; Lung cancer; Oncology; Internal medicine; Clinical trial; Chemotherapy; Cisplatin","score_opus":0.020139594596299222,"score_gpt":0.34367419092856416,"score_spread":0.32353459633226495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092041185","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44447806,0.012397373,0.0000022689806,0.52418566,0.0045798062,0.00878329,0.0015491177,0.00018245913,0.0038419503],"genre_scores_gemma":[0.069129,0.008418793,0.000056220477,0.8459935,0.01930974,0.007380856,0.0018919056,0.0004921445,0.04732785],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947759,0.00032768038,0.00086825894,0.0010876781,0.0016087948,0.0013316697],"domain_scores_gemma":[0.99774635,0.00038831274,0.0006879361,0.0006952584,0.00029129468,0.00019082992],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00036688455,0.00075339293,0.0013465111,0.0005645815,0.00019182054,0.00007079991,0.0003714853,0.0009093035,0.0013339798],"category_scores_gemma":[0.00014112587,0.0007142926,0.00036745804,0.00054068,0.000072449875,0.00013244775,0.00026437576,0.003373634,0.000021606425],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026634915,0.0010879134,0.08840163,0.0011938119,0.00090834475,0.00026410812,0.0019222354,0.00001613118,0.000021594558,2.616717e-7,0.90208,0.0014404473],"study_design_scores_gemma":[0.1981027,0.0036274479,0.016754882,0.0077676363,0.0024590397,0.0000012496386,0.000060883816,0.0009435375,0.00049637933,0.000009917718,0.76812077,0.0016555465],"about_ca_topic_score_codex":0.009719005,"about_ca_topic_score_gemma":0.0022802593,"teacher_disagreement_score":0.37534907,"about_ca_system_score_codex":0.0115334885,"about_ca_system_score_gemma":0.00045856595,"threshold_uncertainty_score":0.99957895},"labels":[],"label_agreement":null},{"id":"W2092880963","doi":"10.1002/gcc.20260","title":"Gain of a region on 7p22.3, containing <i>MAD1L1</i>, is the most frequent event in small‐cell lung cancer cell lines","year":2005,"lang":"en","type":"article","venue":"Genes Chromosomes and Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Comparative genomic hybridization; Biology; Loss of heterozygosity; Gene dosage; Copy-number variation; Cancer research; Gene expression profiling; Gene; Genetics; Computational biology; Genome; Gene expression; Allele","score_opus":0.02566807577442347,"score_gpt":0.32627308882556183,"score_spread":0.30060501305113835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092880963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78747076,0.2025076,0.000014341506,0.007823554,0.00015653184,0.0007727115,0.000039053954,0.00001906292,0.0011964185],"genre_scores_gemma":[0.86725914,0.12723753,0.000055642893,0.0024295608,0.00060468126,0.00044804777,0.00000446976,0.000031995653,0.0019289315],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983558,0.000056506822,0.0003632276,0.00039210357,0.00039498153,0.00043739102],"domain_scores_gemma":[0.9991262,0.00009763824,0.00015099379,0.00032571124,0.00018706,0.00011237452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023179693,0.00024415948,0.00044056564,0.00007326951,0.00011329931,0.000018848727,0.0001431043,0.00008037278,0.00023387528],"category_scores_gemma":[0.000018814486,0.00016016178,0.00009669458,0.00023628195,0.00013771345,0.000062992855,0.00010862643,0.00021573788,0.0000023974658],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024224988,0.0010840249,0.41413975,0.0053923707,0.0009070628,0.00015493827,0.029423099,0.005306916,0.08910144,0.00021006427,0.047035214,0.40482262],"study_design_scores_gemma":[0.016843941,0.0023222514,0.055701025,0.0064792098,0.0008168276,0.000048391637,0.008643416,0.008026789,0.52811205,0.00009479663,0.371559,0.0013523172],"about_ca_topic_score_codex":0.0056983647,"about_ca_topic_score_gemma":0.006680231,"teacher_disagreement_score":0.4390106,"about_ca_system_score_codex":0.00069281633,"about_ca_system_score_gemma":0.00042704743,"threshold_uncertainty_score":0.8614261},"labels":[],"label_agreement":null},{"id":"W2093469730","doi":"10.1017/s0266462304001485","title":"Estimating the benefit and cost of radiotherapy for lung cancer","year":2004,"lang":"en","type":"article","venue":"International Journal of Technology Assessment in Health Care","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Queen's University; Sunnybrook Health Science Centre","funders":"","keywords":"Lung cancer; Radiation therapy; Medicine; Intensive care medicine; Oncology; General surgery; Internal medicine","score_opus":0.020547052937520793,"score_gpt":0.4871723609361508,"score_spread":0.46662530799863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093469730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5943343,0.049809013,0.014975905,0.33840397,0.0009770546,0.0013364451,0.000056785502,0.00001844153,0.000088123394],"genre_scores_gemma":[0.95960206,0.0027586136,0.036795806,0.0005938948,0.00015437142,0.000074137264,0.0000024640965,0.000008950903,0.000009680494],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99903554,0.000011144304,0.00042186087,0.00008320408,0.0003117066,0.0001365636],"domain_scores_gemma":[0.9987843,0.00009479039,0.00036875647,0.00007694426,0.0006426002,0.000032624277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003480874,0.00006358319,0.00024303408,0.00032387365,0.00005031727,0.0000070181,0.00019317972,0.000049014743,0.000006736348],"category_scores_gemma":[0.00012371383,0.000043026208,0.000044161694,0.00011514436,0.00011233106,0.000049806913,0.000044091972,0.00032111767,1.4716961e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007117152,0.0002111136,0.57098144,0.00125075,0.0012448378,0.00006740635,0.002832694,0.016115146,0.00083736435,0.015046256,0.000679657,0.39002162],"study_design_scores_gemma":[0.08014612,0.012879856,0.740034,0.031613998,0.00039651405,0.002966402,0.037336912,0.032938052,0.008036419,0.018783303,0.03404034,0.00082811917],"about_ca_topic_score_codex":0.0001613323,"about_ca_topic_score_gemma":0.00012929323,"teacher_disagreement_score":0.3891935,"about_ca_system_score_codex":0.001490468,"about_ca_system_score_gemma":0.000732612,"threshold_uncertainty_score":0.3897522},"labels":[],"label_agreement":null},{"id":"W2095839943","doi":"10.1634/theoncologist.2009-0298","title":"Limited-Stage Small Cell Lung Cancer: Current Chemoradiotherapy Treatment Paradigms","year":2010,"lang":"en","type":"review","venue":"The Oncologist","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Chemoradiotherapy; Stage (stratigraphy); Oncology; Current (fluid); Lung cancer; Internal medicine; Cancer; Intensive care medicine","score_opus":0.14461746522540633,"score_gpt":0.4771418083636698,"score_spread":0.3325243431382635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095839943","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005373179,0.98314786,0.000006941882,0.0011998623,0.0012467195,0.00499349,0.00025028057,0.00015971405,0.0089413775],"genre_scores_gemma":[0.000006687213,0.9726223,0.00010452428,0.00013773429,0.002009457,0.003428889,0.000120621386,0.000121118814,0.021448666],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99713236,0.00027247562,0.00062159466,0.00071664806,0.00043781224,0.0008191082],"domain_scores_gemma":[0.99716157,0.0006149225,0.00051294366,0.0013326787,0.000104144194,0.0002737207],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004812404,0.0008049084,0.0030600815,0.0001490854,0.0002967784,0.000066633496,0.00067138195,0.00038674215,0.0003372088],"category_scores_gemma":[0.000081053906,0.00039418004,0.0008650989,0.00040491816,0.0006401873,0.000025807261,0.00017014873,0.0015467497,0.00009808387],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005761911,0.00047905772,0.00015866227,0.013730279,0.0006233564,0.00009389944,0.00022026707,8.4489545e-7,0.0000027354577,0.000044972923,0.011712076,0.97287625],"study_design_scores_gemma":[0.0013637318,0.00064955745,0.000028328037,0.0041139373,0.0027415555,0.000034853634,0.000020540943,0.000016643387,0.00001657425,0.0000031960794,0.99064505,0.0003660548],"about_ca_topic_score_codex":0.00073967065,"about_ca_topic_score_gemma":0.00056183286,"teacher_disagreement_score":0.978933,"about_ca_system_score_codex":0.0042408803,"about_ca_system_score_gemma":0.0029219373,"threshold_uncertainty_score":0.999851},"labels":[],"label_agreement":null},{"id":"W2100319754","doi":"10.5430/jbgc.v4n1p21","title":"Prognostic value of FDG-PET scans at diagnosis in small cell lung cancer","year":2013,"lang":"en","type":"article","venue":"Journal of Biomedical Graphics and Computing","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Standardized uptake value; Positron emission tomography; Hazard ratio; Stage (stratigraphy); Lung cancer; PET-CT; Nuclear medicine; Imaging biomarker; Radiology; Biomarker; Predictive value; Prospective cohort study; Oncology; Internal medicine; Magnetic resonance imaging; Confidence interval","score_opus":0.014998057485935171,"score_gpt":0.309217830347643,"score_spread":0.2942197728617078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100319754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867869,0.008825316,0.00022899048,0.0036439332,0.00016681224,0.0002756276,0.0000037569605,0.0000050185567,0.00006363079],"genre_scores_gemma":[0.99485236,0.0039342786,0.00072939787,0.00022889268,0.0002157724,0.0000102014765,0.0000010135926,0.000011385499,0.000016691996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983807,0.000064303276,0.0005963655,0.00014426777,0.00050655927,0.00030780357],"domain_scores_gemma":[0.99857277,0.00046608335,0.0002998194,0.00008554893,0.00027668933,0.00029908962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006365542,0.00011970941,0.00046045086,0.00038869213,0.000068488735,0.000016589034,0.000119897144,0.000059134774,0.000040959858],"category_scores_gemma":[0.00027052552,0.00008364212,0.0001122821,0.00052595045,0.00030251598,0.000041072133,0.00017096047,0.00043189086,3.2422054e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004215356,0.0002610646,0.9883242,0.0008552077,0.00016173546,0.00014682111,0.00053551374,0.000016533568,0.0010690849,0.00006395405,0.0022523783,0.006271305],"study_design_scores_gemma":[0.003871265,0.0012625953,0.94227356,0.0045618806,0.0002803041,0.00023531982,0.00040403375,0.045017082,0.0007828175,0.00042531115,0.00068509846,0.000200734],"about_ca_topic_score_codex":0.0005496227,"about_ca_topic_score_gemma":0.00004899537,"teacher_disagreement_score":0.04605069,"about_ca_system_score_codex":0.00010084128,"about_ca_system_score_gemma":0.00019518117,"threshold_uncertainty_score":0.34108263},"labels":[],"label_agreement":null},{"id":"W2101599998","doi":"10.1158/1535-7163.mct-09-0243","title":"Drug ratio–dependent antitumor activity of irinotecan and cisplatin combinations <i>in vitro</i> and <i>in vivo</i>","year":2009,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celator Pharmaceuticals (Canada)","funders":"","keywords":"Irinotecan; Cisplatin; In vivo; Pharmacology; Drug; In vitro; Cytotoxicity; Chemistry; Medicine; Liposome; Chemotherapy; Cancer; Biology; Internal medicine; Biochemistry","score_opus":0.01875205029635636,"score_gpt":0.32668222912345213,"score_spread":0.3079301788270958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101599998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858716,0.0063883546,0.0002443351,0.0062010637,0.00003608386,0.000560583,0.00002769592,0.000014974226,0.0006553064],"genre_scores_gemma":[0.99626756,0.0022707738,0.00017503869,0.0010943186,0.000013213601,0.000035727608,0.0000018790715,0.000014673319,0.00012680035],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988867,0.000072806986,0.00020621136,0.00026153517,0.00031995683,0.0002528097],"domain_scores_gemma":[0.99954295,0.000046758385,0.0000680457,0.00020432186,0.00007173561,0.00006616513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019534142,0.0001508376,0.0003472312,0.00015895409,0.000041492465,0.000016261403,0.00006293927,0.000046826226,0.000006813242],"category_scores_gemma":[0.0000147732535,0.00014258026,0.000033937627,0.00026585435,0.00013469563,0.00006603387,0.000043978212,0.00023625923,2.2550739e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043873064,0.0003398665,0.0072522312,0.00011047504,0.00006645879,0.0000689388,0.00058561424,0.000038686772,0.97168046,0.00022379072,0.000022708833,0.019172018],"study_design_scores_gemma":[0.004234185,0.00024337108,0.0535774,0.00016061898,0.00008138512,0.000011986373,0.000087604945,0.0013166816,0.9391633,0.0004316868,0.0005179433,0.00017381427],"about_ca_topic_score_codex":0.00035456102,"about_ca_topic_score_gemma":0.00035714902,"teacher_disagreement_score":0.04632517,"about_ca_system_score_codex":0.00015247162,"about_ca_system_score_gemma":0.00012930244,"threshold_uncertainty_score":0.5814254},"labels":[],"label_agreement":null},{"id":"W2105518844","doi":"10.1016/j.lungcan.2010.05.022","title":"A phase I trial of sorafenib combined with cisplatin/etoposide or carboplatin/pemetrexed in refractory solid tumor patients","year":2010,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Research Resources; National Cancer Institute; Bayer Canada; Eli Lilly and Company","keywords":"Medicine; Sorafenib; Carboplatin; Pemetrexed; Internal medicine; Etoposide; Oncology; Refractory (planetary science); Lung cancer; Cisplatin; Urology; Chemotherapy; Hepatocellular carcinoma","score_opus":0.01762870376819342,"score_gpt":0.3877932423721357,"score_spread":0.3701645386039423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105518844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99484247,0.00021900132,0.000005265761,0.0003632604,0.0006019026,0.0023128358,0.000073072195,0.000045897767,0.0015362991],"genre_scores_gemma":[0.9979302,0.00007040761,0.00034048338,0.00015804278,0.00026221442,0.0005345667,0.000028328179,0.00005264842,0.00062310556],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.997753,0.0000515457,0.00052505283,0.00040045203,0.0007913173,0.00047858027],"domain_scores_gemma":[0.9985439,0.00017846462,0.0002727447,0.00046710935,0.00034832998,0.00018945982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024231087,0.00026176256,0.00074290746,0.00026534733,0.000058934304,0.000012596998,0.00015820852,0.00008992929,0.00037213688],"category_scores_gemma":[0.00053784496,0.0001758243,0.00008164778,0.00055978494,0.00022583695,0.00013014398,0.0000827443,0.0006426192,0.0000030240578],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7576725,0.008504229,0.15795746,0.001978034,0.0010921311,0.00044903927,0.0040079933,0.000039353545,0.052375164,0.00011672175,0.004104169,0.011703213],"study_design_scores_gemma":[0.86559093,0.026782263,0.060313985,0.002056078,0.0006023924,0.000011681988,0.00031383644,0.00086357363,0.04107364,0.000053391726,0.0016403152,0.00069792446],"about_ca_topic_score_codex":0.001454586,"about_ca_topic_score_gemma":0.0063590263,"teacher_disagreement_score":0.10791843,"about_ca_system_score_codex":0.00045648223,"about_ca_system_score_gemma":0.0012705597,"threshold_uncertainty_score":0.7169907},"labels":[],"label_agreement":null},{"id":"W2107266701","doi":"10.1016/j.ijrobp.2010.07.1159","title":"Patterns of Failure in Patients with Limited-Stage Small Cell Lung Carcinoma","year":2010,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Stage (stratigraphy); Lung; Radiation therapy; Survival analysis; Surgery; Internal medicine","score_opus":0.01384009817909699,"score_gpt":0.31110163759689613,"score_spread":0.29726153941779915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107266701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99605864,0.00008983725,0.000835604,0.0013612653,0.00082034303,0.00031420146,0.00010272764,0.0000114249615,0.0004059786],"genre_scores_gemma":[0.99716794,0.00008425953,0.0015334027,0.00026589897,0.00075295044,0.000010504671,0.000077156794,0.000024547837,0.000083363186],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844396,0.0001132537,0.0006141935,0.0001966178,0.0003897342,0.00024224744],"domain_scores_gemma":[0.9973,0.0002773566,0.00084306416,0.00017165615,0.0012903999,0.00011749271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036502944,0.00017281694,0.00047453932,0.00028288196,0.00003159291,0.0000120051145,0.00034362313,0.00017958046,0.000073096235],"category_scores_gemma":[0.00024219532,0.00013359248,0.00012845207,0.0001616881,0.00013169921,0.00017394198,0.000085847656,0.0008592777,0.00000471993],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007153831,0.00063875207,0.98682475,0.000041265957,0.0002693439,0.000039664188,0.00053738157,0.00008792097,0.002569613,0.00065291335,0.00033091177,0.007292089],"study_design_scores_gemma":[0.0110428305,0.0017760927,0.9778823,0.000080118676,0.00008078453,0.000017903374,0.00012275742,0.00031701295,0.0034391433,0.00017961992,0.0049316036,0.00012981983],"about_ca_topic_score_codex":0.0000749022,"about_ca_topic_score_gemma":0.00014442774,"teacher_disagreement_score":0.010327448,"about_ca_system_score_codex":0.00048873044,"about_ca_system_score_gemma":0.000599426,"threshold_uncertainty_score":0.5447743},"labels":[],"label_agreement":null},{"id":"W2112870137","doi":"10.1200/jco.2005.03.171","title":"Influence of Sex on Toxicity and Treatment Outcome in Small-Cell Lung Cancer","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":143,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Cancer Care Ontario; University of Toronto; BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Toxicity; Leukopenia; Gastroenterology; Vomiting; Vincristine; Etoposide; Chemotherapy; Stomatitis; Cyclophosphamide; Lung cancer; Surgery","score_opus":0.16985025298338588,"score_gpt":0.5546774789976718,"score_spread":0.384827226014286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112870137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98437184,0.0014556409,0.0000019529236,0.012450376,0.00009459187,0.00020872743,0.0000026802434,0.0000024848844,0.001411721],"genre_scores_gemma":[0.9911696,0.005768641,0.0005537426,0.0015809288,0.0004461383,0.0000073381752,1.0538898e-7,0.0000065078507,0.0004670178],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99777097,0.00020377352,0.001486713,0.00013337641,0.0002172108,0.00018795997],"domain_scores_gemma":[0.9971185,0.001713624,0.00065765786,0.00011527678,0.00018458485,0.00021036826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015200495,0.000097780656,0.0012029618,0.000117050804,0.000015615675,0.000002113451,0.00008236818,0.0001502983,0.000030114656],"category_scores_gemma":[0.0014374866,0.00006044688,0.00015523516,0.00008541668,0.00018147976,0.000047416677,0.00004715859,0.0005542374,0.0000018639769],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020010634,0.0018418917,0.9231246,0.000059815753,0.00018994413,0.00017319623,0.00030235347,0.0006866275,0.00033689803,0.000010124487,0.00031124617,0.07096223],"study_design_scores_gemma":[0.012061206,0.013867093,0.9616976,0.00016482966,0.0001629355,0.000027241438,0.00007441679,0.00017235885,0.0011106023,0.000019584224,0.010584681,0.000057485806],"about_ca_topic_score_codex":0.00017848455,"about_ca_topic_score_gemma":0.0008234879,"teacher_disagreement_score":0.07090475,"about_ca_system_score_codex":0.0006442981,"about_ca_system_score_gemma":0.0009463385,"threshold_uncertainty_score":0.24649522},"labels":[],"label_agreement":null},{"id":"W2113396130","doi":"10.1007/s13277-012-0379-2","title":"EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays","year":2012,"lang":"en","type":"article","venue":"Tumor Biology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":191,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"University of Nottingham","keywords":"Medicine; Lung cancer; Autoantibody; Internal medicine; Population; Cancer; Lung; Prospective cohort study; Oncology; Immunology; Gastroenterology; Pathology; Antibody","score_opus":0.068781475045296,"score_gpt":0.4493550002952464,"score_spread":0.38057352524995036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113396130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8742153,0.0077500874,0.00096295885,0.011543559,0.0038533614,0.0029177687,0.005964357,0.000896523,0.09189605],"genre_scores_gemma":[0.9932024,0.0001137455,0.0018028944,0.001421626,0.0019124313,0.000112822796,0.00057780615,0.000021781121,0.0008345203],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99798465,0.00021095033,0.00045366268,0.0003865537,0.00018577134,0.00077843876],"domain_scores_gemma":[0.9976115,0.0014432933,0.00011422997,0.00040903446,0.00017372593,0.00024819432],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009689506,0.00018881787,0.0005257065,0.000046953704,0.0001286042,0.0000074993904,0.0001497197,0.00013855528,0.006830124],"category_scores_gemma":[0.0040183533,0.00013887332,0.00017795157,0.00015310472,0.0007100079,0.00011970013,0.00022971851,0.00057195796,0.00040553755],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022486283,0.0005671934,0.84588426,0.00007069536,0.00019802002,0.00002112256,0.000084176834,8.094097e-9,0.0026224111,0.0010118342,0.14748658,0.0018288409],"study_design_scores_gemma":[0.001342869,0.0007225108,0.8263884,0.00003535955,0.00007386013,0.00009867734,0.000047078083,0.00016828811,0.00034798845,0.00046491745,0.17015412,0.00015592967],"about_ca_topic_score_codex":0.00011077149,"about_ca_topic_score_gemma":0.00001063459,"teacher_disagreement_score":0.11898704,"about_ca_system_score_codex":0.00011706849,"about_ca_system_score_gemma":0.00027895914,"threshold_uncertainty_score":0.99407774},"labels":[],"label_agreement":null},{"id":"W2116664839","doi":"10.1016/j.lungcan.2006.02.006","title":"Phase II study of pegylated liposomal doxorubicin HCl (Caelyx) in combination with cyclophosphamide and vincristine as second-line treatment of patients with small cell lung cancer","year":2006,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Humber River Regional Hospital; Ottawa Regional Cancer Foundation; Mount Sinai Hospital; Toronto East General Hospital; University of Toronto; Northeast Cancer Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Mucositis; Vincristine; Internal medicine; Cyclophosphamide; Gastroenterology; Chemotherapy; Oncology; Surgery","score_opus":0.009898937503427602,"score_gpt":0.31056079973476003,"score_spread":0.3006618622313324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116664839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902698,0.005892615,0.000006972434,0.0001553747,0.00006781155,0.0030011393,0.0001612582,0.000030010682,0.00041502184],"genre_scores_gemma":[0.9972947,0.00034484133,0.00007816165,0.000029597099,0.00005695436,0.00052956573,0.00008083131,0.000050574286,0.0015347664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99806386,0.00008219657,0.00050542085,0.00043081213,0.0005361625,0.00038156335],"domain_scores_gemma":[0.9987376,0.00007425647,0.0003156864,0.00029608206,0.00047194652,0.00010447507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010723135,0.00032833396,0.0007514094,0.00022625504,0.000115134535,0.000009166695,0.000079238715,0.00006412052,0.00013726555],"category_scores_gemma":[0.000013574069,0.00022681757,0.000036248428,0.0005219169,0.0001424619,0.00009137648,0.000060737482,0.00019335443,2.1549863e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008600943,0.014204766,0.9660872,0.0010009862,0.00054871413,0.000057864814,0.004181387,0.0004110042,0.0026164027,0.0000065630193,0.0001862934,0.0020978695],"study_design_scores_gemma":[0.09032704,0.04076136,0.83852535,0.0008219284,0.0009800983,0.0000024176366,0.0006696013,0.0007793014,0.026629914,0.000006485438,0.00018103224,0.00031548121],"about_ca_topic_score_codex":0.048942294,"about_ca_topic_score_gemma":0.040766057,"teacher_disagreement_score":0.12756187,"about_ca_system_score_codex":0.0008936807,"about_ca_system_score_gemma":0.00035299192,"threshold_uncertainty_score":0.97673744},"labels":[],"label_agreement":null},{"id":"W2118797321","doi":"10.1590/s0100-39842006000100009","title":"Tratamento do câncer de pequenas células de pulmão: doença limitada: resultados de uma única instituição","year":2006,"lang":"pt","type":"article","venue":"Radiologia Brasileira","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal General Hospital","funders":"","keywords":"Medicine; Conventional PCI; Surgery; Internal medicine","score_opus":0.03517528740010017,"score_gpt":0.33421031900655923,"score_spread":0.29903503160645906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118797321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9232879,0.044611048,0.0020759082,0.006542897,0.0011802295,0.0033296328,0.0004237034,0.00061800634,0.017930634],"genre_scores_gemma":[0.9772391,0.0029657297,0.0023487303,0.0018515432,0.0033093875,0.0006714564,0.00016579342,0.0001594987,0.011288808],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9913992,0.0010652001,0.0012914423,0.0015709349,0.0010899829,0.00358324],"domain_scores_gemma":[0.9953933,0.0012309013,0.00043702245,0.0015772246,0.00038342114,0.000978141],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0026688294,0.0010468502,0.0016000444,0.00042694042,0.00069531746,0.0002960963,0.0012226785,0.0009458019,0.0004002586],"category_scores_gemma":[0.0034916638,0.0009106381,0.0005460531,0.0010160056,0.0013929849,0.00038975553,0.00047042442,0.0020687361,0.00031976853],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002096573,0.00086664275,0.6066758,0.0008273396,0.0012336846,0.00318246,0.0029403334,0.0007010177,0.024231488,0.0027840915,0.34850776,0.005952842],"study_design_scores_gemma":[0.009019973,0.0025909573,0.931741,0.0018012652,0.0010128632,0.0010728231,0.002734447,0.0019434061,0.0067166327,0.0006989414,0.03908526,0.0015824126],"about_ca_topic_score_codex":0.0052875075,"about_ca_topic_score_gemma":0.0012190738,"teacher_disagreement_score":0.32506523,"about_ca_system_score_codex":0.0068381564,"about_ca_system_score_gemma":0.003975674,"threshold_uncertainty_score":0.9993344},"labels":[],"label_agreement":null},{"id":"W2119063943","doi":"10.1259/bjr.20130653","title":"Is pre-trial quality assurance necessary? Experiences of the CONVERT Phase III randomized trial for good performance status patients with limited-stage small-cell lung cancer","year":2014,"lang":"en","type":"article","venue":"British Journal of Radiology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba","funders":"Cancer Research UK; National Cancer Research Institute","keywords":"Medicine; Quality assurance; Context (archaeology); Protocol (science); Medical physics; Clinical trial; Randomized controlled trial; Radiation treatment planning; Radiation therapy; Randomization; Stage (stratigraphy); Physical therapy; Surgery; Alternative medicine; Internal medicine; Pathology","score_opus":0.021258187998997067,"score_gpt":0.34746975815077225,"score_spread":0.32621157015177515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119063943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98902816,0.004895038,0.00066493533,0.00027635667,0.0013726228,0.0035158405,0.00009762815,0.000008248507,0.00014115368],"genre_scores_gemma":[0.9942687,0.0037217652,0.00022272233,0.0002543435,0.00066548033,0.00042048257,0.000007760151,0.00002022341,0.0004184802],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9968178,0.0007908028,0.0011264092,0.0002623287,0.00052750314,0.00047514285],"domain_scores_gemma":[0.99608403,0.00130815,0.001358112,0.00023092341,0.000855544,0.00016320712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020794675,0.00019133763,0.0015958559,0.000077298624,0.0001853983,0.000025918931,0.0003267564,0.000109670626,0.00008520695],"category_scores_gemma":[0.0017449098,0.00012397296,0.00035193574,0.00016580833,0.0007171925,0.00016682234,0.00005642086,0.0003934369,1.3504693e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9668094,0.0005391679,0.020685934,0.00040242646,0.00063145155,0.0000061784012,0.0033852179,0.000028631668,0.00006493299,0.000006104138,0.004536829,0.0029037395],"study_design_scores_gemma":[0.9837241,0.005551243,0.0064929533,0.0005125508,0.00035152468,0.00008611688,0.00051228533,0.000498296,0.0009940019,0.0000062285835,0.0011229593,0.00014772105],"about_ca_topic_score_codex":0.00043498355,"about_ca_topic_score_gemma":0.00010131281,"teacher_disagreement_score":0.016914733,"about_ca_system_score_codex":0.00014197441,"about_ca_system_score_gemma":0.00071111566,"threshold_uncertainty_score":0.5055471},"labels":[],"label_agreement":null},{"id":"W2120616064","doi":"10.1016/j.lungcan.2003.07.004","title":"Population-based outcomes for small cell lung cancer: impact of standard management policies in British Columbia","year":2003,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Stage (stratigraphy); Radiation therapy; Population; Lung cancer; Chemotherapy; Cancer; Disease; Internal medicine; Surgery","score_opus":0.015905256602102007,"score_gpt":0.3731261203917312,"score_spread":0.3572208637896292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120616064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866957,0.007868933,0.00014779356,0.00042949631,0.00024185398,0.002524126,0.0007062903,0.00004281341,0.0013430042],"genre_scores_gemma":[0.9920158,0.001191547,0.0007666839,0.00025916335,0.00006365268,0.0012444468,0.000030394405,0.000049222166,0.0043790843],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982382,0.000047639347,0.00039747768,0.00033201926,0.00042476482,0.00055989006],"domain_scores_gemma":[0.9991168,0.000113935406,0.00013878282,0.0002823314,0.0002233485,0.00012484683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025564418,0.00016476691,0.0006293509,0.00013652525,0.00010172975,0.000064867425,0.000115193274,0.00006593017,0.0004570521],"category_scores_gemma":[0.000087685235,0.00019797367,0.00023646375,0.00036879454,0.000059418115,0.000057905214,0.000034521407,0.00013746317,2.894474e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001340296,0.000082936065,0.9754281,0.002108409,0.00040412846,0.0000132545065,0.00016543262,0.001509334,0.000045505727,0.000018154324,0.0187234,0.0013673072],"study_design_scores_gemma":[0.005265533,0.00017413293,0.99079245,0.0008328528,0.00026989254,8.039172e-7,0.00011725685,0.0006664418,0.00018026932,0.000043471948,0.0014538853,0.00020299763],"about_ca_topic_score_codex":0.3234169,"about_ca_topic_score_gemma":0.34695795,"teacher_disagreement_score":0.023541076,"about_ca_system_score_codex":0.002699871,"about_ca_system_score_gemma":0.0006592931,"threshold_uncertainty_score":0.8073132},"labels":[],"label_agreement":null},{"id":"W2121478471","doi":"10.1016/j.ijrobp.2010.07.1230","title":"Phase II Trial of Consolidation Chest Radiotherapy for Extensive Stage Small Cell Lung Cancer","year":2010,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saint John Regional Hospital","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Chemotherapy; Radiation therapy; Lung cancer; Esophagitis; Conventional PCI; Progressive disease; Surgery; Internal medicine; Disease; Myocardial infarction; Reflux","score_opus":0.0360691853938333,"score_gpt":0.4247224750977204,"score_spread":0.3886532897038871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121478471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97258466,0.0009780527,0.015001156,0.0050614085,0.004604897,0.0011576876,0.00030108757,0.000020131642,0.00029091557],"genre_scores_gemma":[0.9832917,0.002364095,0.0069380556,0.00073880405,0.0061050216,0.000111179324,0.00010473235,0.000036635625,0.00030980917],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983476,0.000113719994,0.0007793788,0.00021588436,0.0003061485,0.00023731746],"domain_scores_gemma":[0.99529344,0.00066152547,0.0013962196,0.00015958595,0.002362871,0.00012634892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007183244,0.00018093082,0.0006123022,0.00019909862,0.00009596237,0.000014919078,0.0003003751,0.0002118075,0.00011846316],"category_scores_gemma":[0.0007249915,0.00015362815,0.00028008394,0.00012150266,0.00028502053,0.00017498086,0.00004926655,0.0005383524,0.0000012648786],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0742009,0.006886875,0.040553793,0.0001813293,0.003963724,0.000039769697,0.0032377094,0.00039749703,0.58188826,0.007631676,0.010284662,0.2707338],"study_design_scores_gemma":[0.5216971,0.031881038,0.0038363135,0.00018318424,0.0008408779,0.00009305501,0.0003447802,0.011641349,0.17007689,0.0026162602,0.2562749,0.00051424693],"about_ca_topic_score_codex":0.0000406714,"about_ca_topic_score_gemma":0.000019228304,"teacher_disagreement_score":0.44749618,"about_ca_system_score_codex":0.00063978095,"about_ca_system_score_gemma":0.0015053126,"threshold_uncertainty_score":0.6264774},"labels":[],"label_agreement":null},{"id":"W2124177114","doi":"","title":"Expression and prognostic significance of kit, protein kinase B, and mitogen-activated protein kinase in patients with small cell lung cancer.","year":2003,"lang":"en","type":"article","venue":"PubMed","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Protein kinase B; MAPK/ERK pathway; Kinase; Cancer research; Protein kinase A; Biology; Medicine; Internal medicine; Pathology; Signal transduction; Cell biology","score_opus":0.01654411216181807,"score_gpt":0.24520256669132096,"score_spread":0.2286584545295029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124177114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858357,0.0025205037,0.000012076575,0.00012522943,0.000025736146,0.011203432,0.000022611986,0.000026167234,0.00022854753],"genre_scores_gemma":[0.98563325,0.000048223585,0.0005231513,0.00001746504,0.000017838602,0.013220689,0.000005838909,0.00003214136,0.0005013951],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99828464,0.00013753223,0.000255723,0.00043961583,0.000375701,0.0005068079],"domain_scores_gemma":[0.9991509,0.000055556193,0.00014341205,0.00022687702,0.0001857006,0.00023758771],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024672685,0.00021501232,0.00036988972,0.00014097005,0.000060875012,0.000017097525,0.00006232282,0.00006631103,0.000007860132],"category_scores_gemma":[0.0004943862,0.00015825957,0.000019168914,0.00033956504,0.00019050518,0.00010075942,0.000063162486,0.00022700806,1.6721988e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019226627,0.0005068416,0.87115794,0.00250893,0.000058976853,0.000034207464,0.00045323937,0.0000026271455,0.11529399,0.000006512976,0.00006839998,0.0079856515],"study_design_scores_gemma":[0.005094345,0.00024855425,0.57789415,0.0006310419,0.000035083372,5.017392e-7,0.000058210022,0.0000050183066,0.4157225,0.0000083581535,0.00015908504,0.00014314028],"about_ca_topic_score_codex":0.00034331073,"about_ca_topic_score_gemma":0.00007018683,"teacher_disagreement_score":0.30042848,"about_ca_system_score_codex":0.00017460392,"about_ca_system_score_gemma":0.00015554769,"threshold_uncertainty_score":0.6453638},"labels":[],"label_agreement":null},{"id":"W2125430981","doi":"10.1200/jco.2005.05.3181","title":"Early Compared With Late Radiotherapy in Combined Modality Treatment for Limited Disease Small-Cell Lung Cancer: A London Lung Cancer Group Multicenter Randomized Clinical Trial and Meta-Analysis","year":2006,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":184,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Etoposide; Radiation therapy; Chemotherapy; Vincristine; Lung cancer; Hazard ratio; Prophylactic cranial irradiation; Internal medicine; Cyclophosphamide; Surgery; Oncology; Confidence interval","score_opus":0.30821068473514257,"score_gpt":0.571832692282891,"score_spread":0.26362200754774845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125430981","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018337902,0.96371114,0.0005565095,0.0036688535,0.0006781653,0.012724538,0.00028826733,0.000016568742,0.00001803779],"genre_scores_gemma":[0.0016960398,0.99029505,0.002133314,0.000507145,0.0014867001,0.0030259038,0.00007938927,0.00008946298,0.0006869843],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.979696,0.008721171,0.009151192,0.00097315904,0.00076313503,0.0006953898],"domain_scores_gemma":[0.96484315,0.025519444,0.0072621573,0.0005788337,0.0007827793,0.0010136588],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.012802963,0.00087377825,0.035091307,0.00068126275,0.0000897203,0.00005583249,0.00037224285,0.0007951484,0.00010706867],"category_scores_gemma":[0.0023458293,0.00044546786,0.012503983,0.00063138996,0.0008073544,0.00010388035,0.000088864756,0.0018686774,3.217651e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.63973534,0.0050616385,0.009834375,0.0032076256,0.3008286,0.00039780236,0.00004883595,0.00006789031,3.710756e-8,0.000002257618,0.0005225494,0.040293053],"study_design_scores_gemma":[0.47650412,0.005889667,0.0014165613,0.00055377465,0.46969342,0.0000029857408,0.0000023673144,0.0032966926,2.3626953e-8,0.0000040390796,0.042401273,0.0002350799],"about_ca_topic_score_codex":0.0022507308,"about_ca_topic_score_gemma":0.003167203,"teacher_disagreement_score":0.1688648,"about_ca_system_score_codex":0.0018927875,"about_ca_system_score_gemma":0.0053390875,"threshold_uncertainty_score":0.9997997},"labels":[],"label_agreement":null},{"id":"W2125702108","doi":"10.1158/1078-0432.ccr-04-1036","title":"Antitumor Efficacy of Oblimersen Bcl-2 Antisense Oligonucleotide Alone and in Combination with Vinorelbine in Xenograft Models of Human Non–Small Cell Lung Cancer","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stemcell Technologies; University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency","keywords":"Vinorelbine; Lung cancer; Cancer research; Cancer; Pharmacology; Apoptosis; Paclitaxel; Medicine; Biology; Chemotherapy; Pathology; Internal medicine; Biochemistry; Cisplatin","score_opus":0.1256711117554593,"score_gpt":0.4880451359847064,"score_spread":0.3623740242292471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125702108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98970133,0.0055749216,0.000017407756,0.0018869862,0.000048471487,0.0019773247,0.000026440059,0.000015149252,0.00075194944],"genre_scores_gemma":[0.9859526,0.013198312,0.00028662756,0.000049154598,0.00008469957,0.00017730704,0.000009998631,0.000047001573,0.00019427773],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99618864,0.00030252838,0.0010436805,0.0006544892,0.0010724503,0.00073818257],"domain_scores_gemma":[0.99764526,0.00062796805,0.0002041929,0.00048807746,0.0007639272,0.0002705602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025807193,0.00022009322,0.0010620863,0.0007747754,0.00008468722,0.000017129887,0.0002479264,0.0001479195,0.000040774485],"category_scores_gemma":[0.00033464585,0.00017923958,0.00009709821,0.0014709719,0.0013803156,0.00014789216,0.00030712067,0.0011781744,0.0000017275731],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057219425,0.0031097084,0.9556516,0.0030022617,0.00022323559,0.00034278302,0.001571161,0.002084278,0.024979303,0.00018928245,0.00031109448,0.0028133795],"study_design_scores_gemma":[0.03413378,0.0029013737,0.93745625,0.0039473437,0.000101291655,0.0000044226485,0.00041822286,0.0017736102,0.018657366,0.00031400748,0.000037881895,0.00025442636],"about_ca_topic_score_codex":0.02399031,"about_ca_topic_score_gemma":0.013157922,"teacher_disagreement_score":0.028411837,"about_ca_system_score_codex":0.0005059302,"about_ca_system_score_gemma":0.0012268571,"threshold_uncertainty_score":0.982509},"labels":[],"label_agreement":null},{"id":"W2125817273","doi":"10.1016/j.ijrobp.2014.12.026","title":"Risk of Hippocampal Metastases in Small Cell Lung Cancer Patients at Presentation and After Cranial Irradiation: A Safety Profile Study for Hippocampal Sparing During Prophylactic or Therapeutic Cranial Irradiation","year":2015,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency; University of Saskatchewan","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Internal medicine; Confidence interval; Lung cancer; Radiation therapy; Logistic regression; Cancer; Neurocognitive; Oncology; Clinical trial; Hazard ratio; Incidence (geometry); Surgery; Conventional PCI","score_opus":0.030822629929344612,"score_gpt":0.36617453287702667,"score_spread":0.3353519029476821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125817273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944939,0.0008674047,0.0007417157,0.0004018888,0.0011286617,0.0020675722,0.00024321333,0.000016648206,0.000038971815],"genre_scores_gemma":[0.99671847,0.00043609366,0.0010440992,0.000076149176,0.0012751721,0.0002877602,0.00007791007,0.000036428457,0.000047907823],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973202,0.00052526343,0.0010206889,0.00033912988,0.0004877536,0.0003070176],"domain_scores_gemma":[0.9964381,0.0005733101,0.0013602576,0.00013380789,0.0013287114,0.00016582834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093106227,0.00025340682,0.00064664206,0.00032975612,0.000105177045,0.00003117648,0.0001983193,0.0001455506,0.00003615448],"category_scores_gemma":[0.00071220216,0.00020467694,0.00014225938,0.00024506176,0.00014195051,0.0003982908,0.00010462598,0.000377883,0.0000019705342],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017647495,0.0012465158,0.95907,0.00013718494,0.0008216328,0.000019850317,0.0047456636,0.0011130116,0.0008042962,0.000022963812,0.000059076123,0.014312256],"study_design_scores_gemma":[0.027477533,0.0038531306,0.9612011,0.000077128294,0.0006180696,0.000019842579,0.00052025844,0.0046128174,0.00080511876,0.0004446479,0.00017653636,0.00019382319],"about_ca_topic_score_codex":0.00020104644,"about_ca_topic_score_gemma":0.00030652253,"teacher_disagreement_score":0.014118433,"about_ca_system_score_codex":0.002273243,"about_ca_system_score_gemma":0.0010553955,"threshold_uncertainty_score":0.8346483},"labels":[],"label_agreement":null},{"id":"W2126286484","doi":"10.1097/cco.0b013e328011bec3","title":"Small cell lung cancer and targeted therapies","year":2007,"lang":"en","type":"review","venue":"Current Opinion in Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Lung cancer; Oncology; Cancer research","score_opus":0.23965804037608615,"score_gpt":0.5356286030227594,"score_spread":0.2959705626466732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126286484","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000016802815,0.99067205,0.000012708054,0.00031808455,0.0060136416,0.0020014658,0.000047548983,0.00004048342,0.00087720115],"genre_scores_gemma":[0.0000026260127,0.9971552,0.00010769422,0.00003382072,0.0013875668,0.00084930396,0.00012745021,0.00004853563,0.00028780903],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978183,0.0002158302,0.0006304034,0.00054666295,0.00023247772,0.00055632164],"domain_scores_gemma":[0.9986716,0.00052811624,0.00025496102,0.00026468153,0.00011114153,0.00016950359],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00052290334,0.00039159568,0.001975789,0.00053678214,0.000059232243,0.0000118523385,0.00016651374,0.000376921,0.00013199127],"category_scores_gemma":[0.0001042139,0.0002890018,0.00019041264,0.00041729675,0.00023096766,0.000027014687,0.00023187154,0.0011546494,0.000015147926],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036412916,0.0001656218,0.0012102372,0.07348177,0.00015161544,0.000009274982,0.0003499196,7.605253e-8,2.2674598e-7,0.000037514,0.01685547,0.90770185],"study_design_scores_gemma":[0.0011853296,0.00025121067,0.00028064905,0.021151261,0.00023213179,0.00002245713,0.000048253136,0.000005681353,3.7310386e-7,0.000009412203,0.97658217,0.00023107183],"about_ca_topic_score_codex":0.00007313416,"about_ca_topic_score_gemma":0.000043264226,"teacher_disagreement_score":0.9597267,"about_ca_system_score_codex":0.0013891684,"about_ca_system_score_gemma":0.0015741644,"threshold_uncertainty_score":0.9999562},"labels":[],"label_agreement":null},{"id":"W2126709547","doi":"10.1158/1078-0432.ccr-11-3090","title":"Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung Cancer","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":551,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"National Cancer Institute; U.S. Food and Drug Administration","keywords":"Medicine; Internal medicine; Oncology; Biomarker; Toxicity; Phases of clinical research; Clinical endpoint; Lung cancer; Clinical trial; Biology","score_opus":0.1977189728280281,"score_gpt":0.5160958239841599,"score_spread":0.3183768511561318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126709547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855751,0.009300147,0.0000021270364,0.00055850256,0.0003725081,0.0036219521,0.000042210228,0.000026240232,0.0005012303],"genre_scores_gemma":[0.99654746,0.0013309768,0.000050519815,0.000076688106,0.00024547265,0.00075874856,0.000012729965,0.000063572516,0.00091380713],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948379,0.00075512443,0.0009432678,0.000720286,0.0015726754,0.0011707458],"domain_scores_gemma":[0.99647343,0.0011312707,0.00019374317,0.00062530994,0.0009253419,0.0006508805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033145314,0.0002812326,0.0008747581,0.00039121913,0.00024025567,0.000024820822,0.000268043,0.00018959219,0.00024394532],"category_scores_gemma":[0.0008549059,0.0002003439,0.00008864985,0.0010499676,0.00081435783,0.0001666914,0.0007010311,0.0013860929,0.000006023385],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009951431,0.018455952,0.94969475,0.0005030707,0.00038305626,0.00002586403,0.0026167198,0.000003619044,0.00042389394,0.0000023353286,0.0035029398,0.014436337],"study_design_scores_gemma":[0.048077878,0.021722648,0.9253666,0.0009142729,0.00022315189,8.018309e-7,0.001252373,0.00012856118,0.00052746455,0.000005671146,0.0015105166,0.00027008425],"about_ca_topic_score_codex":0.0029419127,"about_ca_topic_score_gemma":0.0013261845,"teacher_disagreement_score":0.038126446,"about_ca_system_score_codex":0.00079376536,"about_ca_system_score_gemma":0.0006288863,"threshold_uncertainty_score":0.8169787},"labels":[],"label_agreement":null},{"id":"W2127363643","doi":"10.1093/annonc/mdp300","title":"The strength of female sex as a prognostic factor in small-cell lung cancer: a pooled analysis of chemotherapy trials from the Manchester Lung Group and Medical Research Council Clinical Trials Unit","year":2009,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Mucositis; Lung cancer; Chemotherapy; Confidence interval; Univariate analysis; Randomized controlled trial; Performance status; Gastroenterology; Surgery; Multivariate analysis","score_opus":0.46529234876494757,"score_gpt":0.5755875765724024,"score_spread":0.11029522780745488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127363643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9487624,0.022391321,0.000008382343,0.02616164,0.000070904636,0.001904947,0.00011825031,0.0000075403777,0.00057457085],"genre_scores_gemma":[0.95117533,0.047174,0.000048766466,0.0010266779,0.00026320215,0.00013477092,0.00001188751,0.000013920971,0.00015144347],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9866434,0.007873226,0.0025433036,0.00045552943,0.001927364,0.00055721897],"domain_scores_gemma":[0.942547,0.054207828,0.0009606545,0.0005689639,0.0014967138,0.00021884135],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.060274314,0.00020277705,0.0030688527,0.00025101178,0.000090952504,0.000015764623,0.0004733613,0.00034933782,0.00033325198],"category_scores_gemma":[0.05572494,0.000105556224,0.00048163236,0.0010618693,0.0010679939,0.000038215778,0.0001542208,0.0008001286,6.0866427e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011832467,0.0021114922,0.74209493,0.00026794817,0.012130445,0.000067239605,0.007385746,0.0000042396473,0.0020065114,0.000120298086,0.009294094,0.21268456],"study_design_scores_gemma":[0.019554738,0.009169717,0.94451255,0.00080448174,0.004139651,0.0000032692997,0.0037136131,0.0020592683,0.0040005087,0.0005251703,0.011302412,0.00021464171],"about_ca_topic_score_codex":0.0036597487,"about_ca_topic_score_gemma":0.0060878242,"teacher_disagreement_score":0.21246992,"about_ca_system_score_codex":0.00021488746,"about_ca_system_score_gemma":0.003635632,"threshold_uncertainty_score":0.96764535},"labels":[],"label_agreement":null},{"id":"W2128083415","doi":"10.1016/s1470-2045(13)70510-2","title":"Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial","year":2013,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":526,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Juravinski Cancer Centre; Institut universitaire de cardiologie et de pneumologie de Québec; Alberta Cancer Foundation","funders":"Merck KGaA","keywords":"Medicine; Placebo; Chemoradiotherapy; Clinical endpoint; Internal medicine; Population; Lung cancer; Surgery; Phases of clinical research; Hazard ratio; Cancer; Clinical trial; Oncology; Confidence interval; Pathology","score_opus":0.08993665752350942,"score_gpt":0.43539217495574034,"score_spread":0.3454555174322309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128083415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.945483,0.0031691666,0.0005948705,0.020048415,0.0016735637,0.020653915,0.00008144759,0.00011829083,0.008177314],"genre_scores_gemma":[0.8852832,0.005107578,0.0023926278,0.0064561935,0.013410655,0.06143029,0.00007886163,0.00020739631,0.025633221],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9973777,0.00018809059,0.0005021088,0.00051389117,0.00035318892,0.0010650455],"domain_scores_gemma":[0.99727285,0.0012379162,0.00023926151,0.0007342948,0.00027795127,0.0002377458],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012399283,0.00036299354,0.0014766181,0.00011806607,0.0002105619,0.000053975455,0.0004187261,0.00020792817,0.0016595522],"category_scores_gemma":[0.00012649687,0.00023148254,0.00027744196,0.00022721582,0.00032771955,0.000106006286,0.00012697259,0.00057313376,0.00005828293],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9244736,0.00049788255,0.0001767278,0.00038415077,0.0008568019,0.000037407874,0.0016455301,0.00001617181,0.0032074368,0.000018865281,0.065470144,0.0032153013],"study_design_scores_gemma":[0.89604825,0.00358879,0.000046522546,0.000059416358,0.00041500432,0.00000575931,0.00032057226,0.0009831968,0.004060821,0.000017762011,0.09421468,0.00023924715],"about_ca_topic_score_codex":0.0008858728,"about_ca_topic_score_gemma":0.0006373264,"teacher_disagreement_score":0.06019984,"about_ca_system_score_codex":0.0008988513,"about_ca_system_score_gemma":0.00094964035,"threshold_uncertainty_score":0.9992531},"labels":[],"label_agreement":null},{"id":"W2128284305","doi":"10.2174/157488708784223880","title":"Combined Modality Treatment of Limited Stage Small Cell Carcinoma of the Lung","year":2008,"lang":"en","type":"review","venue":"Reviews on Recent Clinical Trials","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Medicine; Radiation therapy; Etoposide; Lung cancer; Oncology; Chemotherapy; Chemoradiotherapy; Prophylactic cranial irradiation; Small-cell carcinoma; Small Cell Lung Carcinoma; Stage (stratigraphy); Regimen; Internal medicine","score_opus":0.695592279869349,"score_gpt":0.5919639224378469,"score_spread":0.10362835743150212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128284305","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022652444,0.9773303,0.0000017658004,0.00047993058,0.0008535813,0.019302953,0.00043681226,0.000020264302,0.0013478609],"genre_scores_gemma":[0.000018174587,0.99569494,0.0001108385,0.000116199175,0.00051005726,0.0006994485,0.00010888677,0.0000720314,0.0026694117],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97176623,0.01637741,0.009536433,0.0009193874,0.0008996469,0.00050088216],"domain_scores_gemma":[0.9763175,0.0136221945,0.006617196,0.0026627318,0.00042049444,0.00035983027],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.01128424,0.0008374748,0.01933991,0.00017415585,0.0000835896,0.000008616721,0.00061086315,0.00056159444,0.00023533148],"category_scores_gemma":[0.02626329,0.00037825565,0.007995556,0.0008665098,0.00045240295,0.000016518628,0.00022764676,0.0007880705,0.00004795177],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005825004,0.003079156,0.001189142,0.06554399,0.001118125,0.000016530188,0.000026381174,1.441991e-7,6.290758e-7,0.0000248099,0.00998027,0.9184383],"study_design_scores_gemma":[0.004985384,0.0029470134,0.00041981053,0.030210923,0.004980663,0.0000031055763,0.0000035435055,0.0000018158613,0.00003142786,0.0000040897717,0.9561714,0.00024083401],"about_ca_topic_score_codex":0.000059142883,"about_ca_topic_score_gemma":0.000004439059,"teacher_disagreement_score":0.94619113,"about_ca_system_score_codex":0.0007313084,"about_ca_system_score_gemma":0.0017133665,"threshold_uncertainty_score":0.99986696},"labels":[],"label_agreement":null},{"id":"W2129527916","doi":"10.1097/01.jto.0000263720.15062.51","title":"Chemotherapy for Relapsed Small Cell Lung Cancer: A Systematic Review and Practice Guideline","year":2007,"lang":"en","type":"review","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Princess Margaret Cancer Centre; Hamilton Health Sciences; Juravinski Cancer Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Topotecan; Carboplatin; Internal medicine; Randomized controlled trial; Vincristine; Oncology; Lung cancer; Guideline; Chemotherapy; Cyclophosphamide; Surgery; Cisplatin; Pathology","score_opus":0.10232241946579926,"score_gpt":0.576323181801895,"score_spread":0.4740007623360958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129527916","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[3.0434256e-7,0.9789378,0.00073633384,0.011595373,0.00048154488,0.007164213,0.000025952424,0.000014160058,0.0010443219],"genre_scores_gemma":[9.8034725e-8,0.96984667,0.020853622,0.0058874995,0.00095765805,0.00040196817,0.000009937261,0.000090882444,0.001951668],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99446815,0.0010198936,0.0031820214,0.00034007846,0.0005059899,0.0004838463],"domain_scores_gemma":[0.98759633,0.0044746706,0.005103148,0.0004266282,0.002070161,0.00032903036],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.010550305,0.0004766721,0.008196913,0.00044489995,0.000085291,0.000021998121,0.00035141406,0.00045204093,0.000049169463],"category_scores_gemma":[0.0070799333,0.0002943296,0.00088537496,0.00041543352,0.00011382481,0.00010330454,0.00009723024,0.0012410249,0.000003885267],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041937962,0.00013649091,4.198086e-7,0.6843728,0.0018835863,0.00023809074,0.000064551576,5.4039454e-8,7.756171e-7,0.0000019179233,0.054999802,0.25788215],"study_design_scores_gemma":[0.0006136263,0.001093159,8.7032404e-8,0.35914844,0.040667705,0.004102558,0.000053060336,0.0000022979305,9.169513e-7,0.0000032561134,0.59418166,0.00013322063],"about_ca_topic_score_codex":0.000013053214,"about_ca_topic_score_gemma":0.000009774541,"teacher_disagreement_score":0.5391819,"about_ca_system_score_codex":0.0020842922,"about_ca_system_score_gemma":0.0036568407,"threshold_uncertainty_score":0.9999509},"labels":[],"label_agreement":null},{"id":"W2129638180","doi":"10.1200/jco.2007.12.3083","title":"Phase II Study of Vandetanib or Placebo in Small-Cell Lung Cancer Patients After Complete or Partial Response to Induction Chemotherapy With or Without Radiation Therapy: National Cancer Institute of Canada Clinical Trials Group Study BR.20","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":196,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Vandetanib; Medicine; Internal medicine; Placebo; Gastroenterology; Oncology; Cancer; Phases of clinical research; Chemotherapy; Surgery; Pathology; Sorafenib","score_opus":0.2888795793822542,"score_gpt":0.5751775702922032,"score_spread":0.28629799090994895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129638180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916983,0.00019286993,0.00006169825,0.0021736003,0.0017370756,0.0040662424,0.00004566471,0.0000049902246,0.000019551244],"genre_scores_gemma":[0.9961205,0.0004947144,0.00033229537,0.0012335115,0.0013109974,0.00019119219,0.0000025693942,0.000029365967,0.00028481253],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9893242,0.0030901686,0.0053922096,0.00039862233,0.001411468,0.0003833211],"domain_scores_gemma":[0.988769,0.0057030264,0.0032400722,0.00021217066,0.0016422048,0.00043351497],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.02533067,0.00025731712,0.002976155,0.00035772385,0.00008141948,0.000007648467,0.0002267897,0.0002252886,0.0002631452],"category_scores_gemma":[0.010044691,0.00013846277,0.00018561613,0.00061725016,0.00020896502,0.0001645301,0.000071790164,0.0009513591,1.9612688e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.50277686,0.02059345,0.44300854,0.000030835214,0.0012282392,0.00017746871,0.0017128503,0.0000714317,0.00013955327,1.4249586e-7,0.0012085704,0.029052082],"study_design_scores_gemma":[0.18923001,0.18104297,0.6173336,0.0001913615,0.00039398923,0.000007609947,0.0011875748,0.00008715585,0.000100430356,0.0000011030448,0.010277772,0.00014643448],"about_ca_topic_score_codex":0.0197544,"about_ca_topic_score_gemma":0.6925155,"teacher_disagreement_score":0.6727611,"about_ca_system_score_codex":0.0014118936,"about_ca_system_score_gemma":0.016168335,"threshold_uncertainty_score":0.9982941},"labels":[],"label_agreement":null},{"id":"W2130774003","doi":"10.1002/cncy.21435","title":"Accuracy of bronchial brush and wash specimens prepared by the ThinPrep method in the diagnosis of pulmonary small cell carcinoma","year":2014,"lang":"en","type":"article","venue":"Cancer Cytopathology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Dalhousie University; Alberta Health Services","funders":"","keywords":"Medicine; Brush; Positive predicative value; Gastroenterology; Carcinoma; Internal medicine; Pathology; Predictive value","score_opus":0.028201559662309268,"score_gpt":0.34191097670112697,"score_spread":0.3137094170388177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130774003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97834295,0.013249249,0.00010576803,0.0036706156,0.00012979654,0.0008337209,0.00006848076,0.000010824794,0.0035886024],"genre_scores_gemma":[0.9964135,0.0017874393,0.000379594,0.0006281325,0.0001871044,0.00041362632,0.0000069477483,0.000018442868,0.00016515439],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979892,0.0007062809,0.00037259108,0.00035690327,0.00024107783,0.0003339668],"domain_scores_gemma":[0.9975578,0.0015077142,0.00021287269,0.00055454054,0.000112195616,0.00005488532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011741106,0.00016978373,0.00052481523,0.00007380167,0.000066323744,0.0000064451574,0.00032833146,0.000092016366,0.00005140677],"category_scores_gemma":[0.0005104296,0.000096907424,0.00008250452,0.000205083,0.0004946173,0.000038820683,0.00024037529,0.00031821177,0.0000011735881],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007106399,0.00030434027,0.878274,0.0006610144,0.000053689062,0.00006968739,0.014847421,0.0000143108155,0.06759381,0.00018777624,0.008877785,0.028405476],"study_design_scores_gemma":[0.0028671366,0.0008971815,0.89672625,0.0001356032,0.00028078965,0.0001894965,0.0020046039,0.00030563938,0.08619038,0.00051954674,0.009678903,0.0002044915],"about_ca_topic_score_codex":0.0015145635,"about_ca_topic_score_gemma":0.0003754566,"teacher_disagreement_score":0.028200986,"about_ca_system_score_codex":0.00008708056,"about_ca_system_score_gemma":0.00015240342,"threshold_uncertainty_score":0.395177},"labels":[],"label_agreement":null},{"id":"W2132247116","doi":"10.1016/j.lungcan.2003.09.002","title":"Practice guideline for the role of combination chemotherapy in the initial management of limited-stage small-cell lung cancer","year":2003,"lang":"en","type":"review","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"Cancer Care Ontario","keywords":"Medicine; Regimen; Etoposide; Guideline; Vincristine; Oncology; Randomized controlled trial; Chemotherapy; Internal medicine; Anthracycline; Chemotherapy regimen; Intensive care medicine; Cyclophosphamide; Cancer; Breast cancer; Pathology","score_opus":0.06482960285760901,"score_gpt":0.47039443093817324,"score_spread":0.4055648280805642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132247116","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000011253516,0.98059386,0.00023064771,0.0024601256,0.00032582373,0.0076644756,0.00021457604,0.000013268001,0.00848596],"genre_scores_gemma":[0.00007697751,0.9908258,0.00059252325,0.0011244789,0.0002646843,0.0050506224,0.00006664394,0.00007927988,0.0019190401],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99712276,0.0002755153,0.0010450769,0.00040713564,0.0007391865,0.00041034477],"domain_scores_gemma":[0.9968151,0.00092845055,0.00092805753,0.00069959194,0.00058446534,0.000044353754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015660485,0.0003807916,0.0012420089,0.00018184881,0.00009000231,0.000020701757,0.0005022328,0.00016549499,0.00015912179],"category_scores_gemma":[0.00012636164,0.00021564844,0.00037118202,0.0007351843,0.00013287687,0.00007317506,0.000097611955,0.00050644804,6.721541e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005045619,0.0006243104,0.00020082078,0.10260086,0.004114448,0.00001889369,0.0014687452,0.000056391644,0.0000059219265,0.0014807925,0.039140992,0.84978324],"study_design_scores_gemma":[0.0023996506,0.00012786937,0.00002467641,0.010392733,0.004256169,0.0000033709541,0.000835814,0.00052034884,0.000049739814,0.000014754946,0.9811877,0.00018715675],"about_ca_topic_score_codex":0.0013327867,"about_ca_topic_score_gemma":0.00022634948,"teacher_disagreement_score":0.9420467,"about_ca_system_score_codex":0.000862483,"about_ca_system_score_gemma":0.0008107439,"threshold_uncertainty_score":0.87938887},"labels":[],"label_agreement":null},{"id":"W2135547180","doi":"10.1586/17476348.2.1.37","title":"BLP-25 liposomal vaccine: a promising potential therapy in nonsmall-cell lung cancer","year":2008,"lang":"en","type":"article","venue":"Expert Review of Respiratory Medicine","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Regional Cancer Foundation","funders":"","keywords":"Medicine; Lung cancer; Immunotherapy; Oncology; MUC1; Immune system; Cancer vaccine; Clinical trial; Cancer; Vaccine therapy; Internal medicine; Immunology; Cancer research","score_opus":0.04224112573535768,"score_gpt":0.4048146357692714,"score_spread":0.3625735100339137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135547180","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14074607,0.8457253,0.00003099107,0.008131111,0.00032834153,0.0021307648,0.000003775964,0.000050835406,0.0028528105],"genre_scores_gemma":[0.13231948,0.85152954,0.00035918763,0.012866065,0.0017880469,0.00054928294,0.00000865676,0.0000689384,0.0005108307],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.996455,0.00025983204,0.001055406,0.0005406031,0.0011366144,0.000552516],"domain_scores_gemma":[0.9981661,0.00011509515,0.0003037807,0.0006800998,0.00045413288,0.00028081794],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00096140726,0.00038017886,0.0014990472,0.0003359402,0.00011573965,0.0000029958733,0.00028736645,0.00010572822,0.0010947621],"category_scores_gemma":[0.0005461527,0.00025154644,0.00020524587,0.0007914797,0.00029192108,0.0001210734,0.00010767477,0.00048763395,0.000008675192],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020372707,0.0012838263,0.13277398,0.041475814,0.0007504878,0.0025815011,0.0053552017,0.0000030161443,0.19988164,0.000031258256,0.5210801,0.0927459],"study_design_scores_gemma":[0.023181055,0.004121171,0.06028104,0.101439096,0.00026484876,0.00027049085,0.00027607498,0.000103771774,0.018144455,0.0000039463503,0.79116464,0.0007494399],"about_ca_topic_score_codex":0.0004464042,"about_ca_topic_score_gemma":0.000025053287,"teacher_disagreement_score":0.2700845,"about_ca_system_score_codex":0.00032673907,"about_ca_system_score_gemma":0.00081872434,"threshold_uncertainty_score":0.9999937},"labels":[],"label_agreement":null},{"id":"W2136962513","doi":"10.1016/j.oraloncology.2015.03.014","title":"Extra-pulmonary small cell carcinoma in the head and neck setting: The role of prophylactic cranial irradiation","year":2015,"lang":"en","type":"letter","venue":"Oral Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cape Breton University; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Prophylactic cranial irradiation; Conventional PCI; Medicine; Head and neck; Retrospective cohort study; Population; Carcinoma; Overall survival; Head and neck squamous-cell carcinoma; Surgery; Radiology; Head and neck cancer; Radiation therapy; Internal medicine","score_opus":0.0422524130871455,"score_gpt":0.33182169034737596,"score_spread":0.28956927726023046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136962513","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.36564618,0.0064228065,4.6390082e-7,0.6071749,0.00024061064,0.0017182094,0.000024127286,0.000013960524,0.01875878],"genre_scores_gemma":[0.9184216,0.00008283697,0.00013029312,0.07818986,0.0020825863,0.00019422744,0.00006685499,0.000034575507,0.0007971538],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979703,0.0006126188,0.00030982742,0.00030493393,0.00040952605,0.00039279493],"domain_scores_gemma":[0.9988034,0.00045939704,0.00020513762,0.00033803206,0.00014823477,0.000045805114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007454222,0.00020904004,0.0005475824,0.00012413978,0.000068042806,0.00001310479,0.0002481694,0.00042526878,0.00001965062],"category_scores_gemma":[0.00017758906,0.00011283061,0.00006814835,0.00017041118,0.00031596082,0.00003474974,0.000117268835,0.0017173069,0.000010747449],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017802098,0.00055612787,0.13200638,0.001997566,0.00012648766,0.0041985917,0.009542391,0.000004826488,0.0018581132,0.000024899988,0.8010184,0.046886],"study_design_scores_gemma":[0.0018515162,0.0029455454,0.11215363,0.00005391186,0.00021107831,0.00028601667,0.0007439313,0.00013912277,0.000054356788,0.0004955439,0.880914,0.00015138759],"about_ca_topic_score_codex":0.0013818985,"about_ca_topic_score_gemma":0.00038856204,"teacher_disagreement_score":0.55277544,"about_ca_system_score_codex":0.00042658934,"about_ca_system_score_gemma":0.0008994594,"threshold_uncertainty_score":0.7460939},"labels":[],"label_agreement":null},{"id":"W2137119609","doi":"10.1016/j.ijrobp.2013.02.033","title":"Decline in Tested and Self-Reported Cognitive Functioning After Prophylactic Cranial Irradiation for Lung Cancer: Pooled Secondary Analysis of Radiation Therapy Oncology Group Randomized Trials 0212 and 0214","year":2013,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":197,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Lung cancer; Randomized controlled trial; Prophylactic cranial irradiation; Radiation therapy; Radiation oncology; Internal medicine; Surgery; Oncology; Conventional PCI","score_opus":0.030814886788619655,"score_gpt":0.4027891035192069,"score_spread":0.3719742167305872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137119609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97706735,0.007844086,0.007588621,0.004047428,0.0008475912,0.0024215821,0.00010196721,0.000023487779,0.000057870882],"genre_scores_gemma":[0.9870308,0.008723648,0.0014689224,0.00087008707,0.0010571023,0.0006072152,0.00020486263,0.000024798332,0.000012571865],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9960455,0.0012173596,0.001818365,0.0003323668,0.00033811148,0.00024834773],"domain_scores_gemma":[0.98950505,0.0057887775,0.0026902326,0.0000940544,0.00179364,0.0001282296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003611898,0.00024282855,0.0019558812,0.00084165036,0.000075330376,0.000041810956,0.00010913477,0.00025518786,0.0001359058],"category_scores_gemma":[0.0043691755,0.00019244633,0.000381417,0.00049463136,0.00028263265,0.0004704359,0.000049509996,0.00042370128,5.9139774e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05413388,0.0007737661,0.45046273,0.0000716439,0.020430606,0.000017504208,0.0019556354,0.00022740758,0.003977833,0.00018033423,0.00013173385,0.4676369],"study_design_scores_gemma":[0.24284938,0.0030574873,0.6852872,0.0001284662,0.007845868,0.00006181963,0.0002739408,0.056446776,0.00072984584,0.0022561457,0.00078812084,0.00027495075],"about_ca_topic_score_codex":0.0003366657,"about_ca_topic_score_gemma":0.000104569444,"teacher_disagreement_score":0.46736196,"about_ca_system_score_codex":0.0009021777,"about_ca_system_score_gemma":0.00097307935,"threshold_uncertainty_score":0.78477335},"labels":[],"label_agreement":null},{"id":"W2138416295","doi":"10.1093/annonc/mdl353","title":"Randomised phase II study comparing topotecan/carboplatin administration for 5 versus 3 days in the treatment of extensive-stage small-cell lung cancer","year":2006,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Smiths Detection (Canada)","funders":"","keywords":"Topotecan; Carboplatin; Medicine; Regimen; Internal medicine; Lung cancer; Chemotherapy; Phases of clinical research; Progressive disease; Surgery; Cisplatin; Toxicity; Oncology","score_opus":0.19003189340734147,"score_gpt":0.49725881214030293,"score_spread":0.3072269187329615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138416295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98895335,0.001907427,0.000023322746,0.0019264041,0.000107763895,0.003402808,0.000034256776,0.0000074780237,0.003637215],"genre_scores_gemma":[0.9981631,0.00042335945,0.00009251742,0.00006849192,0.0001268509,0.0007939122,0.000023857083,0.00000935567,0.0002985432],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9988002,0.00013877841,0.00043550416,0.00019580462,0.0001849877,0.0002447074],"domain_scores_gemma":[0.99856216,0.00070839963,0.00021573945,0.0002097992,0.00026978547,0.00003410995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045465925,0.00012526746,0.00063302694,0.0001000466,0.000072409006,0.0000035615246,0.00008775631,0.00005227514,0.000019342058],"category_scores_gemma":[0.00010694451,0.000087009874,0.000112457616,0.00013351861,0.000096700904,0.000023962255,0.000021707214,0.00007395667,1.8692425e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5824407,0.10393249,0.09237206,0.0017540866,0.0035061238,0.0007357441,0.05753868,0.0022679316,0.050432365,0.0005825519,0.015525892,0.08891142],"study_design_scores_gemma":[0.6273245,0.21990839,0.03891647,0.00014221272,0.0011119014,0.0000047261224,0.012411842,0.0040526767,0.07731864,0.00006165847,0.018446779,0.0003001771],"about_ca_topic_score_codex":0.0023145357,"about_ca_topic_score_gemma":0.007856784,"teacher_disagreement_score":0.115975894,"about_ca_system_score_codex":0.00016178958,"about_ca_system_score_gemma":0.00040042296,"threshold_uncertainty_score":0.438427},"labels":[],"label_agreement":null},{"id":"W2140014443","doi":"10.1200/jco.2014.60.3845","title":"Cisplatin and Etoposide Versus Carboplatin and Paclitaxel With Concurrent Radiation for Stage III Non–Small-Cell Lung Cancer: Is There an Impact on Radiation Pneumonitis Rates?","year":2015,"lang":"en","type":"letter","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Medicine; Carboplatin; Internal medicine; Oncology; Etoposide; Chemoradiotherapy; Lung cancer; Radiation therapy; Veterans Affairs; Mucositis; Pneumonitis; Surgery; Cisplatin; Chemotherapy; Lung","score_opus":0.1505962876777015,"score_gpt":0.525359451233374,"score_spread":0.3747631635556725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140014443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79770976,0.014473512,0.00007732865,0.18269984,0.001764805,0.0021190455,0.00042063353,0.000013847381,0.00072118477],"genre_scores_gemma":[0.8591137,0.039044686,0.00077063736,0.0813073,0.017512081,0.0002164094,0.00025000842,0.00018967336,0.0015955442],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99616086,0.00058145536,0.0016041751,0.00046667753,0.0007102019,0.0004766108],"domain_scores_gemma":[0.99058,0.0050704777,0.0026768001,0.0002460163,0.0008880161,0.00053869036],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.002475898,0.00041411447,0.0022857953,0.00024299111,0.00010210813,0.000058104055,0.00014798611,0.00095513236,0.00005625218],"category_scores_gemma":[0.0011930758,0.00026440123,0.0002827659,0.000112394024,0.00028676755,0.00018668697,0.000053863314,0.0030478658,0.0000010200692],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028516233,0.00048680196,0.080550864,0.0011579435,0.003387826,0.0012636377,0.0014831184,0.0000778561,0.00006201543,0.0000053252693,0.7033712,0.17963713],"study_design_scores_gemma":[0.12339273,0.1721302,0.22527057,0.0017785984,0.0055423784,0.00021734703,0.00066277804,0.0058349934,0.00017392762,0.00006159452,0.4640148,0.0009200962],"about_ca_topic_score_codex":0.0004698599,"about_ca_topic_score_gemma":0.00022623395,"teacher_disagreement_score":0.23935644,"about_ca_system_score_codex":0.0012662169,"about_ca_system_score_gemma":0.004658927,"threshold_uncertainty_score":0.9999808},"labels":[],"label_agreement":null},{"id":"W2149519864","doi":"10.1002/cncr.22235","title":"Extrapulmonary small cell cancer","year":2006,"lang":"en","type":"article","venue":"Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Saskatchewan Cancer Agency; University of Alberta; University of Saskatchewan","funders":"","keywords":"Medicine; Confidence interval; Internal medicine; Odds ratio; Genitourinary system; Gastroenterology; Carcinoma; Cancer; Medical record; Survival analysis; Surgery","score_opus":0.030557794521675365,"score_gpt":0.3429949897304098,"score_spread":0.3124371952087345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149519864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75154746,0.10960723,0.00006693589,0.0074059907,0.0007470562,0.0007699526,0.000085351225,0.00019732885,0.1295727],"genre_scores_gemma":[0.92370707,0.0045598596,0.00023449959,0.0010246824,0.0017851642,0.0006372317,0.000012656771,0.000046552082,0.06799227],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988329,0.000016428348,0.00016057625,0.00029491493,0.00027923408,0.0004159897],"domain_scores_gemma":[0.99942636,0.000030364708,0.00004263756,0.00024776993,0.00013937807,0.00011347293],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000068879315,0.00014981374,0.00023981187,0.000069793954,0.00008595734,0.000013044806,0.00009657728,0.000058470556,0.0013831961],"category_scores_gemma":[0.000009365412,0.00012101112,0.00008745655,0.00021299723,0.00011412711,0.00004405887,0.000058031463,0.000203227,0.00006414887],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040265397,0.00029662787,0.4663519,0.0009450552,0.00017082522,0.00033183073,0.00027344262,0.0001899159,0.056131974,0.00021133348,0.43920088,0.035493556],"study_design_scores_gemma":[0.0022224674,0.00014119744,0.317052,0.00032741204,0.00017860837,0.000013529148,0.00010004974,0.0001436085,0.038173392,0.00028101838,0.64102376,0.0003429339],"about_ca_topic_score_codex":0.005100168,"about_ca_topic_score_gemma":0.0010049496,"teacher_disagreement_score":0.20182289,"about_ca_system_score_codex":0.0004375989,"about_ca_system_score_gemma":0.00036991524,"threshold_uncertainty_score":0.99952966},"labels":[],"label_agreement":null},{"id":"W2151968455","doi":"10.1016/j.ijrobp.2014.05.1902","title":"Dosimetry and Survival From an Adaptive Radiation Therapy Clinical Trial for Limited-Stage Small Cell Lung Cancer","year":2014,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Radiation therapy; Stage (stratigraphy); Radiation treatment planning; Dosimetry; Radiology; Nuclear medicine; Lung cancer; Oncology","score_opus":0.08063952840790334,"score_gpt":0.45077018271872277,"score_spread":0.37013065431081943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151968455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9703311,0.0025812178,0.018281497,0.002739036,0.0047056526,0.0008363967,0.00023723619,0.00003230424,0.00025556094],"genre_scores_gemma":[0.9751982,0.007325169,0.002509974,0.0015172177,0.013087707,0.00006816841,0.0001651182,0.000040064802,0.000088362096],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99753815,0.00064047583,0.0008825149,0.00035380735,0.00032733593,0.000257716],"domain_scores_gemma":[0.99521995,0.0023607775,0.0011130455,0.00016772954,0.00092196005,0.00021653935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016383176,0.00021386036,0.00070049905,0.00015651688,0.000100373676,0.000039475624,0.00030138655,0.00029155257,0.000043322085],"category_scores_gemma":[0.00087883795,0.00017612216,0.00026108755,0.00010902895,0.0002230778,0.0002590333,0.00005906056,0.000562111,0.000002652384],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050890423,0.0010314048,0.5212472,0.000016654789,0.00202429,0.000009003858,0.0006822238,0.00019974327,0.001798647,0.0025457265,0.0019287434,0.4176259],"study_design_scores_gemma":[0.41467294,0.03596548,0.31415585,0.00016627532,0.0009877669,0.000019479949,0.00042158065,0.0593886,0.0073994314,0.008342663,0.15767023,0.0008097215],"about_ca_topic_score_codex":0.00014073715,"about_ca_topic_score_gemma":0.00003239637,"teacher_disagreement_score":0.41681617,"about_ca_system_score_codex":0.00060199614,"about_ca_system_score_gemma":0.0008020054,"threshold_uncertainty_score":0.71820533},"labels":[],"label_agreement":null},{"id":"W2156739226","doi":"10.1111/j.1365-2354.2005.00638.x","title":"Comparing the predictive value of neural network models to logistic regression models on the risk of death for small-cell lung cancer patients","year":2005,"lang":"en","type":"article","venue":"European Journal of Cancer Care","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; University of Ontario Institute of Technology","funders":"","keywords":"Logistic regression; Medicine; Lung cancer; Artificial neural network; Regression; Cancer; Regression analysis; Predictive value; Predictive modelling; Intensive care medicine; Artificial intelligence; Statistics; Machine learning; Oncology; Internal medicine; Computer science","score_opus":0.08443507997770791,"score_gpt":0.35035932792913027,"score_spread":0.26592424795142233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156739226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97006917,0.020238644,0.0039562583,0.0010698909,0.0003842674,0.0012207719,0.00015883267,0.000009008399,0.002893141],"genre_scores_gemma":[0.99642646,0.0017491129,0.00042725707,0.00033552447,0.0009081268,0.000035262696,0.0000022893385,0.000045669578,0.00007029653],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9977878,0.00043954208,0.00058184494,0.00018706787,0.00067927415,0.00032449438],"domain_scores_gemma":[0.9972027,0.00032410957,0.00072568504,0.00029746458,0.0013125807,0.0001374779],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007198197,0.0001974856,0.00047576375,0.000074779404,0.00018676248,0.000014336162,0.00041456282,0.000020614114,0.000008025844],"category_scores_gemma":[0.000133589,0.00009668789,0.00023469634,0.00017004236,0.00010177258,0.00008662556,0.00016060825,0.0004613646,3.026947e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002262644,0.000057435303,0.05268376,0.00021203002,0.00036387108,0.0000049068576,0.006520095,0.92874515,0.00003850801,0.00007306176,0.005504649,0.0035338837],"study_design_scores_gemma":[0.01045046,0.0060211136,0.1905654,0.010852176,0.0029232388,0.000006651811,0.003780933,0.77003455,0.0030943328,0.00029457535,0.0015421323,0.00043445046],"about_ca_topic_score_codex":0.00017092278,"about_ca_topic_score_gemma":0.00008703244,"teacher_disagreement_score":0.15871063,"about_ca_system_score_codex":0.00044221844,"about_ca_system_score_gemma":0.00022275487,"threshold_uncertainty_score":0.39428177},"labels":[],"label_agreement":null},{"id":"W2160506158","doi":"10.1158/1078-0432.ccr-07-0437","title":"A Phase I and Pharmacokinetic Trial of Erlotinib in Combination with Weekly Docetaxel in Patients with Taxane-Naive Malignancies","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Center for Research Resources; Sanofi","keywords":"Docetaxel; Medicine; Erlotinib; Neutropenia; Taxane; Internal medicine; Pharmacokinetics; Gastroenterology; Oncology; Mucositis; Pharmacology; Chemotherapy; Cancer; Epidermal growth factor receptor; Breast cancer","score_opus":0.18398884871801144,"score_gpt":0.5254690886657982,"score_spread":0.34148023994778676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160506158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993986,0.00071597315,0.000002983912,0.001623445,0.000060635204,0.0031259917,0.00003340826,0.000012345945,0.00043917831],"genre_scores_gemma":[0.9966263,0.0021610775,0.000091424714,0.00007121467,0.00010657259,0.0005256159,0.000013906225,0.000026279342,0.00037757383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99626064,0.0005028633,0.00066893204,0.0005049594,0.0014989491,0.00056363444],"domain_scores_gemma":[0.9976006,0.00089347304,0.00013739955,0.00027844388,0.0008704506,0.00021962264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020013822,0.00016313711,0.00069406745,0.00044614117,0.00008061589,0.000010899979,0.00015727735,0.00008815844,0.00007210907],"category_scores_gemma":[0.0011554722,0.00011125904,0.000043899818,0.0010899099,0.0016103032,0.0001236197,0.0001385334,0.0009645357,0.0000031595034],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20781052,0.005276318,0.7762652,0.0002791257,0.00009743744,0.00014781393,0.0005991513,0.0000043783366,0.00006846455,0.000018015586,0.0009958212,0.008437728],"study_design_scores_gemma":[0.34188184,0.024551094,0.63165283,0.0006471326,0.000028116701,0.0000031354764,0.0001777472,0.000058381185,0.00029589402,0.000026521051,0.0005554267,0.00012187827],"about_ca_topic_score_codex":0.0010721756,"about_ca_topic_score_gemma":0.00048291203,"teacher_disagreement_score":0.14461239,"about_ca_system_score_codex":0.00024926043,"about_ca_system_score_gemma":0.0009286147,"threshold_uncertainty_score":0.59332293},"labels":[],"label_agreement":null},{"id":"W2164730570","doi":"10.1093/annonc/mdt009","title":"Multicentre phase II study of cisplatin–etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma: the GFPC 0302 study","year":2013,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":176,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Etoposide; Internal medicine; Lung cancer; Oncology; Chemotherapy; Cisplatin; Chemotherapy regimen; Small Cell Lung Carcinoma; Small-cell carcinoma; Gastroenterology","score_opus":0.05888404863705851,"score_gpt":0.45237937195816075,"score_spread":0.39349532332110226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164730570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98023033,0.0009257738,0.00000986996,0.009488409,0.00014677671,0.008202838,0.000026468755,0.00002407135,0.0009454321],"genre_scores_gemma":[0.996608,0.0002229074,0.00012756565,0.0010437239,0.00011566998,0.0008172492,0.000007247062,0.00003691467,0.0010206748],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9977834,0.00021982258,0.0006270614,0.00038344815,0.00040040456,0.0005858324],"domain_scores_gemma":[0.99739283,0.00070700655,0.00034681184,0.00059144036,0.00083582156,0.00012606353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039647127,0.0002302388,0.00086491724,0.00012680906,0.0001907495,0.0000058639807,0.00029147815,0.000035107543,0.000127799],"category_scores_gemma":[0.0003840832,0.00015261654,0.00014570491,0.00023778282,0.00013602985,0.000094954295,0.00023403781,0.00024984186,0.0000043927416],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021885535,0.21391393,0.36405352,0.0015534898,0.0036651818,0.00045457672,0.069240205,0.00009365495,0.063702084,0.000077184035,0.14461286,0.11674779],"study_design_scores_gemma":[0.27574596,0.3331288,0.20419285,0.00010131782,0.0010781372,0.000043001208,0.082794555,0.0024176436,0.062130827,0.00011448914,0.037695743,0.00055669853],"about_ca_topic_score_codex":0.0004638105,"about_ca_topic_score_gemma":0.0002973028,"teacher_disagreement_score":0.2538604,"about_ca_system_score_codex":0.000057671077,"about_ca_system_score_gemma":0.00017335055,"threshold_uncertainty_score":0.6223522},"labels":[],"label_agreement":null},{"id":"W2165132221","doi":"10.1200/jco.2002.02.108","title":"Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Marimastat After Response to First-Line Chemotherapy in Patients With Small-Cell Lung Cancer: A Trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer","year":2002,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":258,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Medicine; Internal medicine; Chemotherapy; Lung cancer; Clinical trial; Cancer; Placebo; Oncology; Surgery; Gastroenterology; Pathology","score_opus":0.178127568875417,"score_gpt":0.49852558092779165,"score_spread":0.3203980120523746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165132221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97067356,0.0011829471,0.00001806581,0.013673843,0.00063947204,0.013633878,0.00006289367,0.0000011561153,0.000114195675],"genre_scores_gemma":[0.9907297,0.0072169006,0.00018040017,0.0001558299,0.0007875434,0.00063082046,0.0000011887166,0.000022969109,0.00027468646],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98981786,0.004807645,0.003915358,0.00025342577,0.000977283,0.0002284244],"domain_scores_gemma":[0.97579134,0.01832875,0.0029234965,0.00016627541,0.0026319353,0.00015819707],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.029734695,0.00016734446,0.0036044004,0.00019818988,0.00006853603,0.0000071622826,0.00017823557,0.00013597928,0.000054264136],"category_scores_gemma":[0.020426136,0.000075353375,0.00033829702,0.00039236946,0.001091987,0.00005437798,0.00007774579,0.00040211738,2.4956018e-8],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93656266,0.0033355374,0.051255878,0.00009506011,0.0021000744,0.000003990027,0.0006396473,0.000094230265,0.000012287283,0.000013912172,0.00041213882,0.0054745874],"study_design_scores_gemma":[0.93505305,0.021736128,0.041039705,0.0002757648,0.0007529698,9.3447824e-7,0.00003163455,0.00008900388,0.00007727125,0.00002722772,0.00085814326,0.000058177447],"about_ca_topic_score_codex":0.010227991,"about_ca_topic_score_gemma":0.08033637,"teacher_disagreement_score":0.07010838,"about_ca_system_score_codex":0.00071293866,"about_ca_system_score_gemma":0.0040410515,"threshold_uncertainty_score":0.99909234},"labels":[],"label_agreement":null},{"id":"W2166536412","doi":"10.1200/jco.2011.38.6672","title":"Reply to P.G. Tsoutsou et al and A.H. Trainer et al","year":2011,"lang":"fr","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Gynecology","score_opus":0.320163013477212,"score_gpt":0.5827577782536111,"score_spread":0.2625947647763991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166536412","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08466159,0.013686916,0.00029810134,0.8622751,0.0072224736,0.00036083453,0.00001931439,0.000011637334,0.031464037],"genre_scores_gemma":[0.15962273,0.029314097,0.0120751625,0.78993046,0.0024687208,0.000010552696,0.000001179817,0.000051501214,0.0065256115],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9933534,0.0018932145,0.0028962407,0.0004076916,0.00075554074,0.0006939003],"domain_scores_gemma":[0.9908132,0.005383461,0.0011778583,0.00031917822,0.0008092204,0.0014970867],"candidate_categories":["metaresearch","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.017446138,0.00025252003,0.0021613855,0.00020234444,0.00005879112,0.00001791668,0.00029192638,0.00031296283,0.0010092511],"category_scores_gemma":[0.02390034,0.00018249587,0.0005160841,0.00020129666,0.0009752757,0.000229798,0.00033436192,0.003002527,0.0001461152],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006578634,0.0015203794,0.03063108,0.00004853283,0.0010961051,0.0030205257,0.0028929082,0.0000024571848,0.00006676375,0.0010656482,0.8271615,0.12591548],"study_design_scores_gemma":[0.0062869047,0.027925286,0.17866753,0.0003997529,0.00031948605,0.0008485297,0.00058047875,0.000018159519,0.00001586878,0.00048860785,0.78431576,0.00013362229],"about_ca_topic_score_codex":0.00031279578,"about_ca_topic_score_gemma":0.00022261255,"teacher_disagreement_score":0.14803645,"about_ca_system_score_codex":0.00029851604,"about_ca_system_score_gemma":0.003345225,"threshold_uncertainty_score":0.999904},"labels":[],"label_agreement":null},{"id":"W2168227366","doi":"10.1016/j.lungcan.2005.02.008","title":"A randomised phase II study of the efficacy and safety of intravenous topotecan in combination with either cisplatin or etoposide in patients with untreated extensive disease small-cell lung cancer","year":2005,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Humber River Regional Hospital","funders":"","keywords":"Medicine; Topotecan; Neutropenia; Etoposide; Internal medicine; Gastroenterology; Regimen; Surgery; Febrile neutropenia; Lung cancer; Chemotherapy","score_opus":0.00883246383519371,"score_gpt":0.30646718245021914,"score_spread":0.29763471861502544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168227366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918319,0.0013172983,0.00000892686,0.000637658,0.000030611438,0.006023855,0.00005176653,0.000011398305,0.00008658453],"genre_scores_gemma":[0.99880135,0.00020978371,0.000034742643,0.000098634584,0.000026407977,0.00048530614,0.00000741182,0.000032571945,0.0003037787],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983307,0.00014721738,0.00041225797,0.00033905153,0.00048053215,0.00029024205],"domain_scores_gemma":[0.9988547,0.00015040523,0.00023762762,0.00030946307,0.00033925087,0.00010853837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016462924,0.0002199168,0.00057466805,0.00015927498,0.000082743485,0.000006747396,0.000104034145,0.000041475698,0.00007024531],"category_scores_gemma":[0.00009231702,0.00012173667,0.000027691334,0.00057715777,0.0001587413,0.00006767282,0.000080937185,0.00023633319,6.378069e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15100962,0.0051193708,0.81784505,0.0005247026,0.0004294692,0.00002968492,0.014287461,0.0018043193,0.00023680563,0.0000031019722,0.00006253251,0.008647897],"study_design_scores_gemma":[0.23450367,0.0029345164,0.7573652,0.0015217727,0.0005353705,5.1517566e-7,0.0004701052,0.0018782844,0.00062913244,0.000001005074,0.000013975731,0.0001463943],"about_ca_topic_score_codex":0.0042402856,"about_ca_topic_score_gemma":0.019166445,"teacher_disagreement_score":0.08349405,"about_ca_system_score_codex":0.00060593366,"about_ca_system_score_gemma":0.00052763266,"threshold_uncertainty_score":0.9987312},"labels":[],"label_agreement":null},{"id":"W2171023584","doi":"10.1016/j.cllc.2012.04.005","title":"Prophylactic Cranial Irradiation for Patients With Limited-Stage Small-Cell Lung Cancer With Response to Chemoradiation","year":2012,"lang":"en","type":"article","venue":"Clinical Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Cancer Care Ontario; University of Alberta","funders":"Saskatchewan Cancer Agency","keywords":"Conventional PCI; Prophylactic cranial irradiation; Medicine; Chemotherapy; Radiation therapy; Lung cancer; Stage (stratigraphy); Internal medicine; Surgery; Oncology; Urology; Myocardial infarction","score_opus":0.038873565552808374,"score_gpt":0.408409128966218,"score_spread":0.36953556341340965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171023584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872115,0.0016856942,0.0004942245,0.004065009,0.00071964186,0.0052938634,0.00018168181,0.000094542294,0.00025382426],"genre_scores_gemma":[0.9877816,0.0001691781,0.0017092058,0.0016700879,0.0017155465,0.0028415706,0.00005203212,0.000102973456,0.0039578127],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99724936,0.00017663221,0.0005381743,0.00058756245,0.00065485656,0.00079338683],"domain_scores_gemma":[0.99707633,0.00078698056,0.0002878519,0.00045645758,0.0007609024,0.00063145545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094141363,0.00031189874,0.00058851164,0.00015051088,0.00019135242,0.00004220931,0.00014783068,0.00016502474,0.00013844299],"category_scores_gemma":[0.0009991229,0.00021744428,0.00012103586,0.00048483838,0.00013009444,0.0002584253,0.0000639479,0.00041034215,0.000011876652],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04475245,0.00072282413,0.9415266,0.0010355043,0.00032535018,0.000003854045,0.00068026397,0.00014027183,0.00020181871,0.000006644031,0.006391891,0.0042125597],"study_design_scores_gemma":[0.012549261,0.0030652091,0.9670151,0.00033066169,0.00087749073,6.872544e-7,0.000052084353,0.0012491008,0.0002803257,0.000001097146,0.01419603,0.00038295102],"about_ca_topic_score_codex":0.00018507618,"about_ca_topic_score_gemma":0.00021419351,"teacher_disagreement_score":0.032203186,"about_ca_system_score_codex":0.0013094731,"about_ca_system_score_gemma":0.0010881047,"threshold_uncertainty_score":0.8867121},"labels":[],"label_agreement":null},{"id":"W2171079592","doi":"10.1158/1078-0432.ccr-08-0810","title":"Retinoblastoma Tumor Suppressor Gene Expression Determines the Response to Sequential Flavopiridol and Doxorubicin Treatment in Small-Cell Lung Carcinoma","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Doxorubicin; Cancer research; Gene knockdown; Retinoblastoma protein; In vivo; Apoptosis; Cell cycle; Cell growth; Cell culture; Small interfering RNA; Biology; Cell cycle checkpoint; Retinoblastoma; Transfection; Chemotherapy; Gene; Biochemistry","score_opus":0.15630511695266835,"score_gpt":0.5023661816812044,"score_spread":0.34606106472853604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171079592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96964896,0.0033815484,0.000010632414,0.02340076,0.000172745,0.0030059232,0.000038338214,0.000043062668,0.00029802762],"genre_scores_gemma":[0.99322987,0.0009273378,0.00031489172,0.00093857327,0.00089154707,0.0008571466,0.0000048572942,0.000042308544,0.0027934816],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99396986,0.0020588185,0.00080401445,0.0010240364,0.0009674049,0.0011758676],"domain_scores_gemma":[0.9944614,0.0033900111,0.00008540738,0.0009666378,0.0004292592,0.0006672928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046198335,0.00031662174,0.00072869816,0.0003905202,0.000349336,0.00009611178,0.00043285405,0.00015433195,0.00011900585],"category_scores_gemma":[0.0028830713,0.00019569388,0.00017370224,0.0006922508,0.000579439,0.000077295925,0.00049813057,0.0010351107,0.00003089287],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06186019,0.0011213374,0.21526317,0.00027692784,0.0000883763,0.0019943293,0.0028896458,0.00004417495,0.68713015,0.000006372446,0.015212444,0.01411288],"study_design_scores_gemma":[0.009575005,0.009103899,0.51588786,0.0006212914,0.00007939461,0.000041272626,0.00050767104,0.0006807557,0.45419326,0.00006766618,0.008906683,0.00033524894],"about_ca_topic_score_codex":0.001208348,"about_ca_topic_score_gemma":0.000869807,"teacher_disagreement_score":0.30062467,"about_ca_system_score_codex":0.0009210795,"about_ca_system_score_gemma":0.0011380562,"threshold_uncertainty_score":0.7980165},"labels":[],"label_agreement":null},{"id":"W2189143821","doi":"10.1016/j.cllc.2015.09.007","title":"Thoracic Radiotherapy for Extensive Stage Small-Cell Lung Cancer: A Meta-Analysis","year":2015,"lang":"en","type":"review","venue":"Clinical Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Medicine; Radiation therapy; Stage (stratigraphy); Lung cancer; Meta-analysis; Oncology; Radiology; Internal medicine","score_opus":0.4089820723585534,"score_gpt":0.6118290681439336,"score_spread":0.20284699578538018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2189143821","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000066134526,0.98191863,0.0007987004,0.001476558,0.0011758615,0.01055252,0.0033458043,0.00016259737,0.00056272256],"genre_scores_gemma":[0.0000020665348,0.929442,0.0016976041,0.0015968243,0.0030135612,0.014876536,0.00031397337,0.00031569062,0.048741776],"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","domain_scores_codex":[0.9909355,0.001097238,0.0029501508,0.002358385,0.0012807935,0.0013779275],"domain_scores_gemma":[0.9896223,0.0032612707,0.0017416107,0.00214643,0.002132885,0.0010954846],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["metaepi_narrow","metaepi_broad"],"category_scores_codex":[0.0039287778,0.0013733391,0.016817637,0.0006601655,0.00022490753,0.00011278554,0.0009109352,0.0010074243,0.0022150874],"category_scores_gemma":[0.0010048059,0.0008971493,0.01379709,0.0019698043,0.00051097677,0.00010414264,0.00033469414,0.0019874296,0.000019726076],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049682724,0.00027260344,0.00061659823,0.05531236,0.5352566,0.00009063247,0.000109537745,0.00003472038,2.0736032e-7,0.000011842039,0.12823032,0.27956772],"study_design_scores_gemma":[0.0009835765,0.00022655558,0.00001037736,0.0012716445,0.44311044,0.0000023665684,0.000014671262,0.00039031554,5.944228e-7,0.0000035557978,0.55348766,0.0004982825],"about_ca_topic_score_codex":0.0006285594,"about_ca_topic_score_gemma":0.00063360867,"teacher_disagreement_score":0.42525733,"about_ca_system_score_codex":0.0030074345,"about_ca_system_score_gemma":0.0072137425,"threshold_uncertainty_score":0.9999017},"labels":[],"label_agreement":null},{"id":"W2189851308","doi":"10.7759/cureus.400","title":"SBRT Treatment of Metachronous Small-Cell and Non-Small-Cell Lung Carcinomas in a Patient with Severe COPD","year":2015,"lang":"en","type":"article","venue":"Cureus","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Radiation therapy; Etoposide; Lung cancer; Stage (stratigraphy); Prophylactic cranial irradiation; Chemoradiotherapy; Radiology; Chemotherapy; Lung; COPD; Oncology; Surgery; Internal medicine; Conventional PCI","score_opus":0.03317657058405306,"score_gpt":0.2874784316596297,"score_spread":0.2543018610755767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2189851308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9631841,0.023473084,0.000017861956,0.00018257827,0.000053764747,0.001217414,0.000016810227,0.000018467621,0.011835917],"genre_scores_gemma":[0.9969154,0.00074570207,0.0010254853,0.000043611763,0.000050676448,0.00015438165,0.000012315749,0.000028361415,0.0010240929],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877626,0.00004535486,0.00022634325,0.00032136744,0.00028414495,0.00034655124],"domain_scores_gemma":[0.9990782,0.000054573997,0.000083852865,0.00036171125,0.00017285251,0.00024878496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000100957805,0.00021918278,0.00050679274,0.00008727111,0.00003155546,0.000010085581,0.00007040316,0.000057977424,0.00001717644],"category_scores_gemma":[0.000021271917,0.00014800411,0.00004675539,0.00016380264,0.00009812503,0.000042275133,0.00008703113,0.00010406106,0.000007376111],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016554889,0.002721108,0.9521804,0.0013453986,0.0006276254,0.0014340592,0.031014271,0.00010143776,0.0025185852,0.000011490278,0.0034296692,0.0029605052],"study_design_scores_gemma":[0.14638582,0.09722325,0.48722628,0.0020618637,0.0049496237,0.0011720533,0.0420919,0.0037548116,0.17931102,0.00010887417,0.032880664,0.002833846],"about_ca_topic_score_codex":0.0026119305,"about_ca_topic_score_gemma":0.001593664,"teacher_disagreement_score":0.46495408,"about_ca_system_score_codex":0.000841898,"about_ca_system_score_gemma":0.00050150853,"threshold_uncertainty_score":0.6035433},"labels":[],"label_agreement":null},{"id":"W2200087787","doi":"10.1200/jco.2015.33.15_suppl.7504","title":"Results from a randomized study of carboplatin and etoposide (CE) with or without palifosfamide (Pa) in extensive stage small cell lung cancer (ES-SCLC): The MATISSE study.","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Regional Municipality of Durham; Lakeridge Health","funders":"","keywords":"Medicine; Etoposide; Carboplatin; Internal medicine; Ifosfamide; Clinical endpoint; Regimen; Oncology; Chemotherapy; Lung cancer; Cisplatin; Randomized controlled trial","score_opus":0.1812571299523963,"score_gpt":0.5058153914415326,"score_spread":0.32455826148913636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2200087787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906052,0.0021568409,0.000015723648,0.003177594,0.00030657297,0.0032006905,0.000022973496,0.0000068673507,0.00050755055],"genre_scores_gemma":[0.9966183,0.0010344005,0.00096511305,0.00045161886,0.00040759635,0.00007016496,9.511446e-7,0.000026867627,0.0004250228],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99175245,0.003394732,0.003263003,0.00036329657,0.00091571483,0.00031079035],"domain_scores_gemma":[0.98188937,0.013537667,0.002562641,0.00039323588,0.0012257423,0.00039131928],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.011270785,0.00024314951,0.0039042733,0.0001647651,0.000046050583,0.000016704822,0.0002477494,0.00016796832,0.000024455723],"category_scores_gemma":[0.014685104,0.000108833716,0.00016247295,0.0002614395,0.00050567754,0.00007957782,0.00021170934,0.0014428404,7.483053e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.46838787,0.0026808325,0.50448745,0.000042637632,0.0015591176,0.0019774325,0.01828588,0.00013299183,0.00003965542,0.0000014558957,0.00066549086,0.0017391678],"study_design_scores_gemma":[0.4936204,0.02557286,0.4461376,0.00038560625,0.0017295589,0.00004059407,0.031270728,0.00086451566,0.00002994796,0.000024140567,0.00020204032,0.000121982506],"about_ca_topic_score_codex":0.012075462,"about_ca_topic_score_gemma":0.04874004,"teacher_disagreement_score":0.058349855,"about_ca_system_score_codex":0.00027425526,"about_ca_system_score_gemma":0.0031503416,"threshold_uncertainty_score":0.9945032},"labels":[],"label_agreement":null},{"id":"W2212041110","doi":"10.1016/s1556-0864(15)31579-3","title":"A Review of First-Line Treatment for Small-cell Lung Cancer","year":2006,"lang":"en","type":"review","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":127,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Etoposide; Prophylactic cranial irradiation; Radiation therapy; Chemotherapy; Oncology; Regimen; Lung cancer; Cisplatin; Clinical trial; Internal medicine","score_opus":0.13951046375844217,"score_gpt":0.5695194519831677,"score_spread":0.4300089882247255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2212041110","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00000604434,0.9923308,0.00009200376,0.0025161393,0.00063057226,0.0031363824,0.00015441218,0.0000075219386,0.0011261208],"genre_scores_gemma":[9.797693e-7,0.9921924,0.0020976893,0.00024431612,0.0016619163,0.00053317787,0.000036494792,0.00006427842,0.0031687843],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99665546,0.00029934003,0.0019995472,0.00027229343,0.00035476172,0.00041862228],"domain_scores_gemma":[0.99443275,0.0009589219,0.0029840963,0.00035997518,0.0010641043,0.00020014464],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001221893,0.00043884656,0.006084387,0.00038985183,0.00005872221,0.0000055084333,0.0002940028,0.00032336713,0.0001316669],"category_scores_gemma":[0.0004078037,0.0002591662,0.001854806,0.00034763652,0.00011290219,0.000035090354,0.000084108004,0.0005550744,0.0000029808511],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021874205,0.00043388933,0.000018297436,0.36826625,0.0012198153,0.00012409853,0.000018301169,7.462153e-7,3.7967163e-7,7.662206e-7,0.047850586,0.58184814],"study_design_scores_gemma":[0.00086075475,0.0038343717,0.0000019721913,0.23398978,0.016122708,0.00043278476,0.000005293032,0.000003163156,0.000008310053,0.00000549399,0.74461114,0.00012421956],"about_ca_topic_score_codex":0.00008433912,"about_ca_topic_score_gemma":0.00017023203,"teacher_disagreement_score":0.6967606,"about_ca_system_score_codex":0.003819098,"about_ca_system_score_gemma":0.004654768,"threshold_uncertainty_score":0.99998605},"labels":[],"label_agreement":null},{"id":"W2229481660","doi":"10.1097/jto.0000000000000588","title":"Cabazitaxel Versus Topotecan in Patients with Small-Cell Lung Cancer with Progressive Disease During or After First-Line Platinum-Based Chemotherapy","year":2015,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"American Society of Clinical Oncology; Genentech; AstraZeneca; Celgene; Merck KGaA; Sanofi; Eli Lilly and Company","keywords":"Cabazitaxel; Topotecan; Taxane; Medicine; Hazard ratio; Internal medicine; Oncology; Chemotherapy; Lung cancer; Confidence interval; Surgery; Cancer; Prostate cancer; Breast cancer","score_opus":0.0301059198192701,"score_gpt":0.4078467590959927,"score_spread":0.37774083927672264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2229481660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99284464,0.0015985541,0.000043176853,0.0043445923,0.00020272727,0.00082552206,0.000016720802,0.000012657159,0.000111431546],"genre_scores_gemma":[0.99644697,0.00007231443,0.0024351003,0.00025987896,0.00032864715,0.00014027793,0.0000037153404,0.000041583353,0.0002714981],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982466,0.00010283436,0.0003884193,0.0002261496,0.00062218384,0.00041378767],"domain_scores_gemma":[0.9979564,0.00012825422,0.00044992013,0.00020526235,0.000770399,0.00048978935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026725436,0.0002187015,0.0005951359,0.0002566988,0.00005193142,0.000015958716,0.00014170093,0.00008282612,0.0001145393],"category_scores_gemma":[0.00016684626,0.00012533559,0.00006166164,0.00031135223,0.00016219488,0.0001231013,0.0000464015,0.0005107243,0.0000013634946],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.31774282,0.0009738254,0.67054015,0.0004971049,0.00026065548,0.0031051214,0.0008329707,0.0007443022,0.000009187271,9.416292e-8,0.00026651882,0.0050272187],"study_design_scores_gemma":[0.059179045,0.019204773,0.91561425,0.0021334963,0.0006735714,0.00004578558,0.0004402838,0.0002941474,0.0007626607,0.0000043066957,0.0013312647,0.0003164229],"about_ca_topic_score_codex":0.000045723697,"about_ca_topic_score_gemma":0.0011601496,"teacher_disagreement_score":0.2585638,"about_ca_system_score_codex":0.0018924375,"about_ca_system_score_gemma":0.0027046546,"threshold_uncertainty_score":0.5111037},"labels":[],"label_agreement":null},{"id":"W2242665894","doi":"10.1200/jco.2009.27.15_suppl.8108","title":"An open label phase II trial of the Plk1 inhibitor BI 2536, in patients with sensitive relapse small cell lung cancer (SCLC)","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Tolerability; Internal medicine; Progressive disease; Chemotherapy; Phases of clinical research; Gastroenterology; Oncology; Surgery; Adverse effect","score_opus":0.12108365241612293,"score_gpt":0.5261446769068916,"score_spread":0.40506102449076864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2242665894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98772794,0.00016074102,0.0000049200644,0.008598958,0.0008640344,0.0013633744,0.000016384944,0.0000034058546,0.0012602243],"genre_scores_gemma":[0.9956638,0.000321207,0.00072360237,0.0019843876,0.0010264524,0.000009507691,0.0000016892268,0.000014473119,0.0002548375],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99621147,0.00086822425,0.0017975521,0.00022971888,0.0005981203,0.0002949068],"domain_scores_gemma":[0.9959019,0.0009415755,0.00164477,0.0002874454,0.0009279962,0.00029633744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031012644,0.00015107065,0.0015080626,0.00012267295,0.00007423618,0.000010028924,0.0003907218,0.00023149373,0.000026475207],"category_scores_gemma":[0.0022746304,0.00007889233,0.00014896423,0.00029928723,0.00028555523,0.00017345212,0.00019754967,0.0013663856,7.490719e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7047566,0.053074945,0.15520573,0.00006569104,0.0006246476,0.00044867772,0.0015642644,0.000035365454,0.00090740516,0.00002277976,0.010892062,0.07240184],"study_design_scores_gemma":[0.4817266,0.23238184,0.280714,0.00055559416,0.0004706322,0.000009121798,0.00018988289,0.00007474868,0.0006431852,0.00004821795,0.0030623523,0.00012383344],"about_ca_topic_score_codex":0.00016219041,"about_ca_topic_score_gemma":0.00045110236,"teacher_disagreement_score":0.22303,"about_ca_system_score_codex":0.00040665088,"about_ca_system_score_gemma":0.0034483632,"threshold_uncertainty_score":0.61172485},"labels":[],"label_agreement":null},{"id":"W2247345771","doi":"10.1200/jco.2006.24.18_suppl.7092","title":"Compliance with oral topotecan in patients with non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC)","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Topotecan; Internal medicine; Lung cancer; Docetaxel; Tolerability; Etoposide; Chemotherapy; Population; Regimen; Performance status; Oncology; Surgery; Adverse effect","score_opus":0.06969167848800148,"score_gpt":0.4408552272446751,"score_spread":0.37116354875667357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2247345771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865457,0.0043488187,0.00014478131,0.0034631626,0.00044487833,0.0008169596,0.000016534788,0.000010585722,0.004208571],"genre_scores_gemma":[0.99147445,0.0017121568,0.0034719752,0.0012230551,0.0008480595,0.00004672708,0.0000031109712,0.000046418627,0.0011740245],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965314,0.00026387733,0.0015535323,0.00041959403,0.00059625175,0.00063531636],"domain_scores_gemma":[0.99642503,0.0007603278,0.0012586208,0.00023923932,0.0008895214,0.0004272311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012285364,0.00029422936,0.0017803459,0.00018303921,0.00008279862,0.000021960572,0.00024543997,0.00026898112,0.0000840209],"category_scores_gemma":[0.00015802383,0.00018667271,0.00014960892,0.000306718,0.0004588323,0.00012578676,0.00012510292,0.0016366458,0.0000017463227],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007686077,0.0013833039,0.97653073,0.00045299338,0.00024710584,0.0004293594,0.00017595348,0.00028329698,0.000042520704,0.0000034799625,0.0052096876,0.0075554973],"study_design_scores_gemma":[0.02798005,0.008169633,0.9559415,0.0011518553,0.0005268542,0.000017449955,0.00008894793,0.00044193896,0.00011051236,0.000011837036,0.005325822,0.00023357826],"about_ca_topic_score_codex":0.0031170156,"about_ca_topic_score_gemma":0.013504718,"teacher_disagreement_score":0.020589205,"about_ca_system_score_codex":0.00086850004,"about_ca_system_score_gemma":0.0034522132,"threshold_uncertainty_score":0.7612293},"labels":[],"label_agreement":null},{"id":"W2259828625","doi":"10.1200/jco.2005.23.16_suppl.7017","title":"Oral topotecan demonstrates clinical activity in relapsed non-small cell lung cancer. Results from an open-label, phase III study (387) comparing oral topotecan to intravenous docetaxel","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Topotecan; Docetaxel; Medicine; Maximum tolerated dose; Lung cancer; Oncology; Internal medicine; Phases of clinical research; Cancer; Pharmacology; Chemotherapy","score_opus":0.2571557998899412,"score_gpt":0.5700849347029274,"score_spread":0.31292913481298623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2259828625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.980897,0.00041548276,0.00014997719,0.0129539445,0.0014146412,0.0022618969,0.00004941836,0.000029581224,0.0018280612],"genre_scores_gemma":[0.9867579,0.0006655584,0.007659666,0.0018205809,0.0027263241,0.00005122763,0.0000074630825,0.000052386356,0.00025891504],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.98885226,0.0025135532,0.0057159644,0.0010012115,0.0008832502,0.0010337539],"domain_scores_gemma":[0.9902375,0.0040601613,0.0023823893,0.0007690283,0.00078856945,0.0017623634],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.015472764,0.00045086438,0.004713522,0.0003240842,0.00019475607,0.00010214974,0.0013156785,0.0006233588,0.000090634836],"category_scores_gemma":[0.0056306003,0.00036705876,0.0002916878,0.00056316727,0.00046894402,0.00042174855,0.0008221199,0.0046096477,0.000015148816],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11881702,0.060543418,0.35262313,0.000047470538,0.0013815892,0.0029319464,0.002338783,0.00049705856,0.0013144223,0.000005727129,0.0054334574,0.45406598],"study_design_scores_gemma":[0.2721773,0.11339304,0.5946032,0.0005486831,0.0012848096,0.0000680311,0.0017267122,0.008208861,0.00061657303,0.00009403558,0.006661496,0.000617254],"about_ca_topic_score_codex":0.008254884,"about_ca_topic_score_gemma":0.07156658,"teacher_disagreement_score":0.4534487,"about_ca_system_score_codex":0.0016686268,"about_ca_system_score_gemma":0.006848208,"threshold_uncertainty_score":0.9998781},"labels":[],"label_agreement":null},{"id":"W2275579275","doi":"10.1159/000416199","title":"Sequential Wide Field Irradiation and Systemic Chemotherapy as Part of the Induction Treatment of Small Cell Lung Cancer1","year":2015,"lang":"en","type":"article","venue":"Antibiotics and chemotherapy/Antibiotica et chemotherapia","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Lung; Chemotherapy; Medicine; Irradiation; Internal medicine; Physics","score_opus":0.026951768991937988,"score_gpt":0.30884052375384974,"score_spread":0.2818887547619118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2275579275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859069,0.0037131452,0.0001033891,0.0074318945,0.0002514532,0.00106783,0.000018521496,0.00003672722,0.0014701438],"genre_scores_gemma":[0.9785131,0.01843831,0.0005978558,0.0013713371,0.00017656609,0.000001086351,0.00000851662,0.000066183566,0.00082703965],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981026,0.00009891432,0.00052532274,0.00046538917,0.00044464535,0.00036313015],"domain_scores_gemma":[0.99849784,0.0001391912,0.00036357276,0.00053242827,0.0002752271,0.00019175086],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033693755,0.00036149126,0.0007183801,0.00012183691,0.00009367359,0.000037923463,0.00014044312,0.00024006209,0.000038151535],"category_scores_gemma":[0.000062938176,0.0002538831,0.000161254,0.0003084326,0.00037026312,0.000080690195,0.000048164264,0.00019279301,0.0000013263779],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023278578,0.0015528983,0.6047628,0.0026996778,0.00197797,0.000012609482,0.01473105,0.000029398172,0.3376559,0.0008889579,0.0031497625,0.030211145],"study_design_scores_gemma":[0.009316803,0.0022622785,0.0462887,0.0007627586,0.00031504597,0.00010203633,0.0010997064,0.0006270865,0.93413955,0.00024242565,0.0044643013,0.00037927966],"about_ca_topic_score_codex":0.00076221424,"about_ca_topic_score_gemma":0.00006352058,"teacher_disagreement_score":0.5964837,"about_ca_system_score_codex":0.00018228959,"about_ca_system_score_gemma":0.00039552557,"threshold_uncertainty_score":0.99999136},"labels":[],"label_agreement":null},{"id":"W2278015318","doi":"10.1016/j.jtho.2015.12.095","title":"Contrasting Management of Small Cell Lung Cancer and Non–Small Cell Lung Cancer: Emerging Data for Low-Dose Computed Tomography Screening","year":2016,"lang":"en","type":"letter","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Lung cancer; Computed tomography; Lung; Cancer; Lung cancer screening; Radiology; Oncology; Internal medicine","score_opus":0.04530686336755013,"score_gpt":0.422963664208508,"score_spread":0.3776568008409579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2278015318","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09222891,0.18554042,0.070272736,0.627729,0.0075775366,0.009951178,0.0033973926,0.00011515778,0.0031876985],"genre_scores_gemma":[0.104847886,0.11432704,0.434016,0.24215633,0.08330979,0.0018376389,0.0015996061,0.0016853627,0.016220357],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955976,0.00024657577,0.0015304693,0.000767482,0.00074945856,0.0011084],"domain_scores_gemma":[0.99424636,0.0009961234,0.0026622803,0.0007330308,0.0010838062,0.00027842043],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018945591,0.0005850532,0.0022370103,0.00090338785,0.00021257793,0.000045116594,0.0010353366,0.00055164745,0.00005349923],"category_scores_gemma":[0.00007778911,0.0004473006,0.00038840986,0.00036958823,0.00026787093,0.00017875023,0.0010290577,0.0020648162,3.9250295e-7],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032185032,0.00021077943,0.018754566,0.0414721,0.006897377,0.0031877293,0.00055253936,0.00011920994,0.0015319621,9.576339e-7,0.7599258,0.1641285],"study_design_scores_gemma":[0.021823527,0.0035963485,0.009715971,0.054141074,0.024543228,0.0004473326,0.0011996505,0.020893604,0.0027548806,0.00003931898,0.8591091,0.001735977],"about_ca_topic_score_codex":0.00022239248,"about_ca_topic_score_gemma":0.00009601765,"teacher_disagreement_score":0.38557264,"about_ca_system_score_codex":0.0007990999,"about_ca_system_score_gemma":0.0010532619,"threshold_uncertainty_score":0.9997979},"labels":[],"label_agreement":null},{"id":"W2299648334","doi":"10.1159/000416205","title":"Complications of Treatment of Small Cell Carcinoma of the Lung","year":2015,"lang":"en","type":"article","venue":"Antibiotics and chemotherapy/Antibiotica et chemotherapia","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Lung; Medicine; Oncology; Internal medicine","score_opus":0.03769688040493961,"score_gpt":0.3169588049791568,"score_spread":0.27926192457421717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2299648334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856902,0.0023873558,0.00016786445,0.004059477,0.00006527521,0.00076222717,0.000050844345,0.00001623488,0.0068005747],"genre_scores_gemma":[0.99447536,0.0021420924,0.002448729,0.00034509017,0.000035116627,3.2010715e-7,0.0000074080654,0.000046236186,0.000499666],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985709,0.000058293645,0.00048517322,0.00029695785,0.0003217687,0.0002669026],"domain_scores_gemma":[0.99830127,0.00010891821,0.00031618748,0.00072117755,0.00041367023,0.00013875746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002123677,0.00024974195,0.00067055854,0.000101067155,0.000048789443,0.000009285259,0.00019730268,0.00011656189,0.000015888652],"category_scores_gemma":[0.00003198876,0.0001639417,0.00020962983,0.00034223316,0.0006556498,0.000028671142,0.00006410794,0.00011021475,8.874392e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004359327,0.0021218355,0.7196793,0.0014059993,0.00064943807,0.0000021557819,0.005790122,0.000009752578,0.26355115,0.0019569753,0.0011711168,0.0032262173],"study_design_scores_gemma":[0.0046519237,0.0012616169,0.23526417,0.00019736864,0.00017299726,0.000013284692,0.0004910436,0.00057165255,0.7557012,0.0001466588,0.0013746684,0.00015340827],"about_ca_topic_score_codex":0.0002980537,"about_ca_topic_score_gemma":0.00001988529,"teacher_disagreement_score":0.49215007,"about_ca_system_score_codex":0.00008968086,"about_ca_system_score_gemma":0.0003412318,"threshold_uncertainty_score":0.6685349},"labels":[],"label_agreement":null},{"id":"W2308706242","doi":"10.1136/bmjopen-2015-009849","title":"Protocol for the CONVERT trial—Concurrent ONce-daily VErsus twice-daily RadioTherapy: an international 2-arm randomised controlled trial of concurrent chemoradiotherapy comparing twice-daily and once-daily radiotherapy schedules in patients with limited stage small cell lung cancer (LS-SCLC) and good performance status","year":2016,"lang":"en","type":"article","venue":"BMJ Open","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Cancer Research UK; National Cancer Research Institute","keywords":"Medicine; Radiation therapy; Activities of daily living; Physical therapy; Randomized controlled trial; Protocol (science); Chemoradiotherapy; Surgery; Alternative medicine; Pathology","score_opus":0.08849882217331131,"score_gpt":0.42856883699955367,"score_spread":0.34007001482624233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2308706242","genre_codex":"empirical","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.62846595,0.000820554,0.0004257381,0.00094476977,0.0006546721,0.36826277,0.00013949281,0.000043594744,0.00024243917],"genre_scores_gemma":[0.4898119,0.002844508,0.0011334969,0.00035485078,0.0008609935,0.5041406,0.00005132083,0.00017909314,0.0006232582],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99474126,0.0005666199,0.0015047332,0.0010558007,0.0011843613,0.0009472083],"domain_scores_gemma":[0.9950599,0.0018161505,0.0012416762,0.0007898925,0.00068884494,0.00040353945],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002266866,0.00075751316,0.0024392575,0.00030312146,0.00027204945,0.00029526348,0.0008783426,0.0001822506,0.00019868136],"category_scores_gemma":[0.00035439368,0.00043159677,0.00022409807,0.000311947,0.0006825213,0.0007442446,0.0002210151,0.00043955076,6.9426153e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.87133163,0.0015914377,0.09785619,0.00067476474,0.0019984792,0.0000037812167,0.0018977508,0.000037386217,0.00058503606,0.000060302198,0.00024603304,0.023717212],"study_design_scores_gemma":[0.938908,0.016614906,0.019243442,0.0013981678,0.00026207187,0.0000012567504,0.00030212867,0.01084911,0.0007964575,0.0000014818482,0.011019892,0.00060309627],"about_ca_topic_score_codex":0.00076399965,"about_ca_topic_score_gemma":0.0005048881,"teacher_disagreement_score":0.13865408,"about_ca_system_score_codex":0.0010971277,"about_ca_system_score_gemma":0.0014942401,"threshold_uncertainty_score":0.99981356},"labels":[],"label_agreement":null},{"id":"W2317710868","doi":"10.1097/00007890-200004271-00077","title":"ALLOPEPTIDE/MHC-TCR AFFINITY DETERMINES PHOSPHORYLATION KINETICS.","year":2000,"lang":"en","type":"article","venue":"Transplantation","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"T-cell receptor; Phosphorylation; Kinetics; Chemistry; Cell biology; Major histocompatibility complex; Biology; Biochemistry; Immunology; T cell; Immune system; Physics; Gene","score_opus":0.02132749771224245,"score_gpt":0.3126142987883511,"score_spread":0.29128680107610866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317710868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9805277,0.00028047356,0.00021040374,0.0006733922,0.000059037186,0.00039858444,0.000023109007,0.00011329876,0.01771399],"genre_scores_gemma":[0.9934535,0.0027683799,0.0007579871,0.00021016611,0.00011255209,0.0000406263,0.00014843879,0.000017205337,0.0024911398],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990802,0.000029663852,0.00018953445,0.00019268936,0.00030649774,0.00020142054],"domain_scores_gemma":[0.9996184,0.000059705097,0.000025750087,0.00014265119,0.00007358003,0.000079929945],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00009437032,0.00011491607,0.00015884488,0.000060943683,0.00007039635,0.00001615331,0.00005079891,0.000050114722,0.001123714],"category_scores_gemma":[0.000016216149,0.00010053006,0.000052775555,0.00014829816,0.00005897392,0.00011557846,0.0000028889215,0.00010405191,0.00022654343],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012245253,0.0012317606,0.17504084,0.0035605184,0.00065822894,0.00081133726,0.017576067,0.0009126165,0.2534947,0.00034866467,0.007601843,0.52651817],"study_design_scores_gemma":[0.004552127,0.0007003094,0.8834178,0.00029816106,0.00034245706,0.00012831247,0.00007839481,0.00047288008,0.10109529,0.0001909489,0.008435887,0.00028747122],"about_ca_topic_score_codex":0.00012065101,"about_ca_topic_score_gemma":0.00015722476,"teacher_disagreement_score":0.70837694,"about_ca_system_score_codex":0.00006193174,"about_ca_system_score_gemma":0.000035576857,"threshold_uncertainty_score":0.9997894},"labels":[],"label_agreement":null},{"id":"W2334091744","doi":"10.1016/j.ejca.2016.03.004","title":"Development of molecularly targeted agents and immunotherapies in small cell lung cancer","year":2016,"lang":"en","type":"review","venue":"European Journal of Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"British Lung Foundation; Medical Research Council; National Institute for Health and Care Research","keywords":"Medicine; Lung cancer; Malignancy; Immunotherapy; Targeted therapy; Clinical trial; Oncology; Biomarker; Disease; Cancer; Cancer research; Bioinformatics; Internal medicine; Biology","score_opus":0.05263321894245841,"score_gpt":0.3856924144383269,"score_spread":0.3330591954958685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334091744","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016530461,0.99642533,0.000064105065,0.0001272933,0.00028201743,0.00048741934,0.00002552913,0.000005158306,0.0009300727],"genre_scores_gemma":[0.00027477602,0.99691147,0.0011661972,0.0000647732,0.00025397033,0.000027220924,0.0000017373173,0.00009974732,0.0012001286],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99733305,0.0003879444,0.0012469143,0.00023222627,0.00047136928,0.00032847136],"domain_scores_gemma":[0.99813473,0.00006046892,0.0010805542,0.00020282376,0.00036979115,0.00015160682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009879514,0.0003433521,0.001607375,0.00044325402,0.000040722243,0.000019302723,0.00028854585,0.00005003669,0.0002215166],"category_scores_gemma":[0.00006417914,0.00021069814,0.000262599,0.00023620644,0.00011086804,0.000062183644,0.00015161165,0.0005186105,0.0000044432454],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012404396,0.00005093687,0.00060324575,0.015136407,0.0015054325,0.00037992492,0.0016994177,5.6037936e-7,0.00026295488,9.823476e-7,0.0011299935,0.9791061],"study_design_scores_gemma":[0.0018366358,0.00011240452,0.0021894171,0.07058959,0.00047762837,0.00002553131,0.000042802003,4.248438e-7,0.00014540069,6.634542e-7,0.9243778,0.00020171028],"about_ca_topic_score_codex":0.000026374868,"about_ca_topic_score_gemma":0.000030623236,"teacher_disagreement_score":0.97890437,"about_ca_system_score_codex":0.0006622271,"about_ca_system_score_gemma":0.0017832941,"threshold_uncertainty_score":0.8592021},"labels":[],"label_agreement":null},{"id":"W2335023411","doi":"10.1097/ftd.0000000000000298","title":"Clinical Practice Recommendations for the Management and Prevention of Cisplatin-Induced Hearing Loss Using Pharmacogenetic Markers","year":2016,"lang":"en","type":"review","venue":"Therapeutic Drug Monitoring","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Calgary; Child and Family Research Institute; University of Toronto; BC Children's Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Pharmacogenomics; Pharmacogenetics; Hearing loss; Medicine; Cisplatin; Context (archaeology); Intensive care medicine; Chemotherapy; Audiology; Pharmacology; Internal medicine","score_opus":0.3370780127387425,"score_gpt":0.5732328798191023,"score_spread":0.23615486708035982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335023411","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001957215,0.99354774,0.0009762378,0.0006335244,0.0011629289,0.0032441723,0.000009567992,0.000025274034,0.00020481386],"genre_scores_gemma":[0.0008042204,0.9905047,0.006862879,0.000023841445,0.00083204947,0.0003566893,0.0000035697988,0.000064266846,0.00054780155],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977949,0.00034851243,0.00080676476,0.0003779211,0.00035402813,0.00031784718],"domain_scores_gemma":[0.99632215,0.0025147093,0.00052090344,0.0004006816,0.0001598533,0.000081716236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021373143,0.00026774578,0.00088791345,0.00013444069,0.0002248805,0.000029789791,0.00017748824,0.00008295859,0.0000105203535],"category_scores_gemma":[0.00010773251,0.00016502803,0.00032658878,0.00018904894,0.00009988156,0.00009537959,0.00020590927,0.00033992124,0.0000026352689],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011477205,0.000050101553,0.0001502007,0.009425154,0.003757254,0.0000034223583,0.00008888065,2.9087386e-7,0.000011089343,0.000012623193,0.000042713888,0.9863435],"study_design_scores_gemma":[0.0016330929,0.00015790871,0.00031707666,0.03854557,0.010729823,0.000047747806,0.00041640192,0.00004497609,0.0000439586,0.0000589774,0.94776976,0.0002346853],"about_ca_topic_score_codex":0.000013353328,"about_ca_topic_score_gemma":2.8928935e-7,"teacher_disagreement_score":0.98610884,"about_ca_system_score_codex":0.00025898128,"about_ca_system_score_gemma":0.00018293758,"threshold_uncertainty_score":0.67296475},"labels":[],"label_agreement":null},{"id":"W2407143741","doi":"","title":"Latest advances and research in lung cancer.","year":2006,"lang":"en","type":"article","venue":"PubMed","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lung cancer; Quarter (Canadian coin); Medicine; Cancer; Cigarette smoking; Demography; Environmental health; Oncology; Internal medicine; Geography; Sociology","score_opus":0.05508771946178657,"score_gpt":0.4137895656211896,"score_spread":0.35870184615940304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407143741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8200902,0.12000912,0.0000010050628,0.016896637,0.0001033828,0.0017040928,0.0000087381295,0.000047926897,0.041138954],"genre_scores_gemma":[0.9870139,0.0062750136,0.00002951019,0.00005409065,0.00026272907,0.0032679576,0.0000023051982,0.000011275094,0.003083244],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986485,0.000049066555,0.000121731005,0.00022265846,0.00039957362,0.0005584577],"domain_scores_gemma":[0.999518,0.00015322302,0.000014662569,0.00012571174,0.00009512823,0.000093323746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006868775,0.000067043366,0.0001617366,0.00019915798,0.00006937804,0.000020851245,0.000055683904,0.00003094419,0.00001135694],"category_scores_gemma":[0.00014576662,0.000053556974,0.000014344587,0.00045203592,0.00019611105,0.00009840009,0.000089678855,0.00025725443,0.0000021418546],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011142983,0.0000501821,0.9117629,0.00043955422,0.000017477967,0.00007001257,0.00006960516,0.0000055061596,0.00003563117,0.00014483448,0.008947215,0.078345634],"study_design_scores_gemma":[0.0009140302,0.000018225519,0.9461894,0.00006130164,0.0000072638086,0.0000044631934,0.00004699293,0.000043688662,0.0003278449,0.00035460928,0.051978085,0.000054101434],"about_ca_topic_score_codex":0.0025411523,"about_ca_topic_score_gemma":0.0018927658,"teacher_disagreement_score":0.16692373,"about_ca_system_score_codex":0.00029542114,"about_ca_system_score_gemma":0.00005982427,"threshold_uncertainty_score":0.3841479},"labels":[],"label_agreement":null},{"id":"W2411638242","doi":"10.1007/s11060-016-2155-4","title":"Single-agent erlotinib versus oral etoposide in patients with recurrent or refractory pediatric ependymoma: a randomized open-label study","year":2016,"lang":"en","type":"article","venue":"Journal of Neuro-Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Astellas Pharma Global Development","keywords":"Medicine; Erlotinib; Etoposide; Internal medicine; Randomized controlled trial; Oncology; Surgery; Gastroenterology; Chemotherapy; Epidermal growth factor receptor; Cancer","score_opus":0.1056974383727223,"score_gpt":0.41323130484330145,"score_spread":0.3075338664705791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2411638242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914091,0.00034691702,0.000012773644,0.003275965,0.0016032751,0.0028645955,0.0000063779835,0.000012762274,0.00046820735],"genre_scores_gemma":[0.99772984,0.00056674884,0.00076692575,0.00027663406,0.000360894,0.0000949168,0.000001077344,0.000043949785,0.00015901992],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99564415,0.0014205186,0.0011446512,0.00035528393,0.0009312941,0.0005040981],"domain_scores_gemma":[0.99438894,0.0033024692,0.0009923611,0.00029727095,0.00069569895,0.00032328352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001877519,0.00027052074,0.001686739,0.0005172543,0.00007470966,0.00002974134,0.0004292711,0.00009560215,0.00010639554],"category_scores_gemma":[0.0052951775,0.00012891836,0.00010343287,0.00041764905,0.00018160859,0.00030585876,0.00037205694,0.00071334984,0.000016478292],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8812462,0.017339943,0.062012114,0.0000466485,0.0005419256,0.005189325,0.0008938416,8.0530106e-7,0.00045599943,0.000003515895,0.0047832355,0.02748642],"study_design_scores_gemma":[0.8368716,0.1060773,0.048038263,0.00014376066,0.00073346595,0.00018475963,0.00029857317,0.0000026784196,0.00004217542,0.000011705723,0.007419984,0.00017572833],"about_ca_topic_score_codex":0.000027896425,"about_ca_topic_score_gemma":0.00025659258,"teacher_disagreement_score":0.08873735,"about_ca_system_score_codex":0.0015153815,"about_ca_system_score_gemma":0.0014081546,"threshold_uncertainty_score":0.63392043},"labels":[],"label_agreement":null},{"id":"W2424105215","doi":"10.3747/co.23.3116","title":"Response to: “Small-Cell Carcinoma of the Genitourinary Tract: A Point of View”","year":2016,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Genitourinary system; Medicine; Reading (process); Carcinoma; Oncology; Pathology; Internal medicine; Philosophy; Linguistics","score_opus":0.11017347782939417,"score_gpt":0.42497434381398175,"score_spread":0.31480086598458756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2424105215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9789625,0.0031832652,0.000030383142,0.014983854,0.00059926586,0.0006995398,0.000027225351,0.0000096019585,0.0015043555],"genre_scores_gemma":[0.9984186,0.00022052405,0.00009719241,0.0001025646,0.00012745896,0.00007443685,5.0765584e-7,0.000012258324,0.0009464199],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986237,0.00033308868,0.00031995,0.00020055243,0.0002536357,0.00026905135],"domain_scores_gemma":[0.9984253,0.00062355417,0.00013575664,0.00044620142,0.000248867,0.000120288554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006329098,0.00010896978,0.0003963084,0.00011423669,0.0000334725,9.4783593e-7,0.00021993669,0.000057285062,0.000114495764],"category_scores_gemma":[0.0007993421,0.000054638665,0.00013745516,0.00019282904,0.00025695856,0.000019135825,0.00030126632,0.00016016171,0.000027518248],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01081384,0.0031819707,0.31148836,0.0010776464,0.00009874364,0.00010414437,0.0039388193,6.27119e-7,0.4827204,0.000079373865,0.04971674,0.13677932],"study_design_scores_gemma":[0.00422957,0.0048702797,0.6564322,0.00039008493,0.000110345536,0.0000685587,0.00028374244,0.0000024506935,0.083172604,0.00007388571,0.25026536,0.000100908466],"about_ca_topic_score_codex":0.000018843202,"about_ca_topic_score_gemma":0.000014643264,"teacher_disagreement_score":0.3995478,"about_ca_system_score_codex":0.00032847113,"about_ca_system_score_gemma":0.0006533965,"threshold_uncertainty_score":0.22281},"labels":[],"label_agreement":null},{"id":"W2437950242","doi":"10.3747/co.23.3023","title":"Management of Small-Cell Lung Cancer with Radiotherapy—A Pan-Canadian Survey of Radiation Oncologists","year":2016,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Institute of Health Economics; University of Alberta; McMaster University; Alberta Health Services; Hamilton Health Sciences; Juravinski Cancer Centre","funders":"Hamilton Health Sciences","keywords":"Medicine; Radiation therapy; Lung cancer; Cancer; Medical physics; Family medicine; Oncology; Internal medicine","score_opus":0.10165716570343747,"score_gpt":0.44068697077890456,"score_spread":0.3390298050754671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2437950242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9521354,0.03673035,0.0011497842,0.0025866863,0.0008567082,0.0019011046,0.00018836436,0.000027785753,0.0044238516],"genre_scores_gemma":[0.97479606,0.023829136,0.0004127353,0.000045779965,0.00008850936,0.00019850566,0.000019702338,0.00002033289,0.00058922643],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99864227,0.00018710896,0.00030295362,0.00026072052,0.00023735817,0.00036958963],"domain_scores_gemma":[0.9988101,0.00022989752,0.00021236467,0.00026866968,0.0003073605,0.0001716228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047006243,0.00013829437,0.00048628895,0.00020476418,0.000034663553,0.0000021796843,0.0001479326,0.00007722231,0.00021700519],"category_scores_gemma":[0.000045651108,0.000084601124,0.000047738078,0.0002884315,0.00027051242,0.000032703185,0.00004215578,0.0001139859,0.0000035844093],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005138802,0.0002500265,0.58325374,0.0006264393,0.00036570046,0.000022943525,0.00018889888,0.00000477038,0.0003340861,0.000053293814,0.0054518874,0.40893435],"study_design_scores_gemma":[0.0059577487,0.0014240268,0.9330769,0.00051813386,0.00018613214,0.0000036330468,0.000055778677,0.000076704244,0.0015984303,0.000004708048,0.05697556,0.00012223795],"about_ca_topic_score_codex":0.022898888,"about_ca_topic_score_gemma":0.07429583,"teacher_disagreement_score":0.4088121,"about_ca_system_score_codex":0.0019210628,"about_ca_system_score_gemma":0.0013182778,"threshold_uncertainty_score":0.9836077},"labels":[],"label_agreement":null},{"id":"W2464196345","doi":"10.1016/s1470-2045(16)30065-1","title":"Prophylactic cranial irradiation for patients with lung cancer","year":2016,"lang":"en","type":"review","venue":"The Lancet Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Neurocognitive; Brain metastasis; Lung cancer; Incidence (geometry); Oncology; Quality of life (healthcare); Internal medicine; Cancer; Lung; Radiation therapy; Surgery; Metastasis","score_opus":0.08109539761877588,"score_gpt":0.47817937414475764,"score_spread":0.39708397652598176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2464196345","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000320882,0.98865,0.00003206329,0.003422365,0.0005487899,0.0056441436,0.00022844141,0.000046384277,0.0013957267],"genre_scores_gemma":[0.000111631656,0.990256,0.00014976326,0.00029665505,0.0035985487,0.004272269,0.00006562179,0.0000610719,0.0011884201],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99837637,0.00022268386,0.00028485493,0.00032770418,0.0002870914,0.000501294],"domain_scores_gemma":[0.99823684,0.0006761601,0.00033973256,0.00041921227,0.00025554243,0.0000725365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038595067,0.00026422192,0.0018790425,0.00008016694,0.00013246087,0.000011258631,0.00024143598,0.00018848797,0.00009093814],"category_scores_gemma":[0.00027849988,0.00010669391,0.00015859221,0.0001543406,0.0001825128,0.00003947913,0.00007301673,0.000367112,0.000029507757],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010529242,0.000096937874,0.00058515935,0.028326754,0.00072980195,0.000006541716,0.000094378374,8.3457344e-8,1.4693552e-7,0.000092827126,0.016154418,0.95286006],"study_design_scores_gemma":[0.0037879236,0.0013347839,0.00083183096,0.0041433084,0.0017687636,0.000008150284,0.0000024175324,0.0000025021436,7.713381e-8,0.000027007163,0.9879487,0.00014453297],"about_ca_topic_score_codex":0.000030629468,"about_ca_topic_score_gemma":0.00005663801,"teacher_disagreement_score":0.9717943,"about_ca_system_score_codex":0.0016407883,"about_ca_system_score_gemma":0.0016715736,"threshold_uncertainty_score":0.43508512},"labels":[],"label_agreement":null},{"id":"W2505623435","doi":"10.1093/annonc/mdw263","title":"Impact of thoracic radiotherapy timing in limited-stage small-cell lung cancer: usefulness of the individual patient data meta-analysis","year":2016,"lang":"en","type":"review","venue":"Annals of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; BC Cancer Agency","funders":"Institut Gustave-Roussy; National Cancer Institute; Ligue Contre le Cancer; Sanofi; Eli Lilly and Company","keywords":"Medicine; Radiation therapy; Hazard ratio; Lung cancer; Randomized controlled trial; Meta-analysis; Stage (stratigraphy); Log-rank test; Clinical trial; Survival analysis; Surgery; Internal medicine; Oncology; Confidence interval","score_opus":0.5676325483529087,"score_gpt":0.5740618394205091,"score_spread":0.006429291067600484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2505623435","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0039952034,0.98970497,0.000015387726,0.00049674726,0.00007609683,0.0017225277,0.003749545,0.000009256634,0.00023029515],"genre_scores_gemma":[0.003452957,0.9956306,0.00012463552,0.00009206359,0.000064948836,0.0002443632,0.00012582232,0.0000618308,0.0002027803],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99515337,0.0013854485,0.0016163745,0.000614095,0.0007123475,0.00051834184],"domain_scores_gemma":[0.9935114,0.0015097416,0.0023485324,0.0020333016,0.00048370488,0.000113354836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020193786,0.00045889305,0.007466447,0.0009858978,0.000032094835,0.000005841755,0.0013673094,0.00035695932,0.00042175714],"category_scores_gemma":[0.00043936635,0.00021999818,0.0029183498,0.0016969958,0.0004085152,0.00007945398,0.0008849289,0.000543527,6.2965756e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020313388,0.0006690929,0.0039439364,0.016491748,0.31184614,0.000027834261,0.00068612996,0.00004444741,0.000008475054,0.0000036910008,0.0033965877,0.6626788],"study_design_scores_gemma":[0.0010628651,0.0029098524,0.0020518163,0.005251379,0.40214968,0.000011384009,0.00009878568,0.000053688116,0.00022139544,0.000004109353,0.58572596,0.00045907425],"about_ca_topic_score_codex":0.0016821536,"about_ca_topic_score_gemma":0.0006409544,"teacher_disagreement_score":0.6622197,"about_ca_system_score_codex":0.00034650118,"about_ca_system_score_gemma":0.003201362,"threshold_uncertainty_score":0.89712656},"labels":[],"label_agreement":null},{"id":"W2508952936","doi":"10.1016/j.exphem.2016.06.120","title":"G protein-coupled receptor 56 as a potential regulator of normal and leukemic stem cells","year":2016,"lang":"en","type":"article","venue":"Experimental Hematology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hospital for Sick Children; University Health Network; McGill University; McGill University Health Centre","funders":"","keywords":"Haematopoiesis; Biology; Stem cell; Progenitor cell; Myeloid leukemia; Myeloid; CD34; Leukemia; Flow cytometry; Cord blood; Cancer research; Molecular biology; Immunology; Cell biology","score_opus":0.011668539340448236,"score_gpt":0.3012452218477054,"score_spread":0.28957668250725715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2508952936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98969024,0.0080169225,0.000029211058,0.0007110987,0.00015986702,0.0007957923,0.000008815515,0.000044101165,0.000543964],"genre_scores_gemma":[0.9958129,0.000053664087,0.0004030896,0.000053390435,0.000088899505,0.00015652816,0.000001604697,0.000024241555,0.0034056997],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987253,0.000049875383,0.00029079235,0.00031570182,0.0002732323,0.00034510286],"domain_scores_gemma":[0.999394,0.000040475086,0.000098321965,0.00024938074,0.000064969994,0.00015282583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009839281,0.00016231074,0.00046775737,0.00008646053,0.00005966242,0.0000043020973,0.00008763205,0.00009937595,0.0006210691],"category_scores_gemma":[0.00001738311,0.00010745397,0.0000890578,0.00006933153,0.00046473567,0.000077512464,0.00019795637,0.00008266403,0.00010206615],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011300084,0.00013830072,0.0006754198,0.00015029745,0.00013930506,0.000057010664,0.0003828769,2.8767365e-8,0.991995,0.0034068022,0.0014242847,0.000500675],"study_design_scores_gemma":[0.0034820058,0.0010124496,0.00015040068,0.00020405249,0.00001897516,0.0003116062,0.0008001545,0.000011889106,0.99334806,0.000031674044,0.0005163861,0.000112317386],"about_ca_topic_score_codex":0.00006711064,"about_ca_topic_score_gemma":0.0000018703671,"teacher_disagreement_score":0.007963259,"about_ca_system_score_codex":0.00017986848,"about_ca_system_score_gemma":0.00013632022,"threshold_uncertainty_score":0.6800271},"labels":[],"label_agreement":null},{"id":"W2518871594","doi":"10.1097/01.jto.0000283046.50283.51","title":"MTP4-01: Small cell lung cancer","year":2007,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Lung cancer; Oncology","score_opus":0.040807048020115894,"score_gpt":0.498526565168928,"score_spread":0.4577195171488121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2518871594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92929745,0.01759718,0.0012153686,0.013157039,0.0017010508,0.00033575128,0.000003881055,0.00002150993,0.036670774],"genre_scores_gemma":[0.98145294,0.0022636077,0.0062364163,0.0015442737,0.0023951319,0.0000075640073,8.1046096e-7,0.00003056849,0.0060686865],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982948,0.00009941052,0.0005699269,0.00014076463,0.0004250878,0.00047002087],"domain_scores_gemma":[0.9982118,0.000332121,0.00043750595,0.00016768069,0.0005263011,0.00032456475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019233822,0.00013372634,0.0005908646,0.00030577776,0.00007334271,0.00000915196,0.00018774245,0.00014709977,0.00037132457],"category_scores_gemma":[0.00025776413,0.00009637413,0.00018360057,0.00025365778,0.00012543835,0.000073380725,0.00009018218,0.00077815884,0.000016282816],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0134989945,0.0014629532,0.21793753,0.0016673589,0.0014968449,0.010342039,0.003647222,0.00005867917,0.052509703,0.00005636848,0.19111039,0.50621194],"study_design_scores_gemma":[0.004995213,0.0069508287,0.19343497,0.00089657557,0.0018236814,0.0031133671,0.0022936456,0.00011748026,0.062255573,0.00023763315,0.72347224,0.0004087747],"about_ca_topic_score_codex":0.00006287563,"about_ca_topic_score_gemma":0.00021948921,"teacher_disagreement_score":0.53236187,"about_ca_system_score_codex":0.001321021,"about_ca_system_score_gemma":0.0011229956,"threshold_uncertainty_score":0.40657437},"labels":[],"label_agreement":null},{"id":"W2526309682","doi":"10.1186/s12943-016-0546-y","title":"Synthetic lethality in lung cancer and translation to clinical therapies","year":2016,"lang":"en","type":"review","venue":"Molecular Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Centre for Drug Research and Development; BC Cancer Agency; University of British Columbia Hospital","funders":"Canadian Institutes of Health Research; University of British Columbia; Michael Smith Health Research BC","keywords":"Synthetic lethality; Lung cancer; Context (archaeology); Lethality; Cancer; Biology; Translation (biology); Bioinformatics; Computational biology; Disease; Medicine; Oncology; Internal medicine; DNA repair; Genetics; Gene","score_opus":0.11742899543442857,"score_gpt":0.5218766134063233,"score_spread":0.4044476179718947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2526309682","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003160721,0.99258065,0.00015888846,0.00405996,0.00028959924,0.0021390663,0.00010641516,0.000030630625,0.00031868898],"genre_scores_gemma":[0.00039370306,0.9965066,0.000115116774,0.00043828815,0.00030341206,0.0018016461,0.0000067492797,0.00007433589,0.00036016383],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99747247,0.0003257104,0.0006369958,0.00071721425,0.00042757503,0.00042001114],"domain_scores_gemma":[0.99891347,0.00022518758,0.00012407528,0.00044116972,0.0000900436,0.00020606896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006586655,0.00036271426,0.0017312258,0.00021620495,0.000039575054,0.000021761332,0.00014059627,0.00025612616,0.00019055321],"category_scores_gemma":[0.00015275253,0.00023643192,0.00033478675,0.00031893185,0.00017391701,0.000041325147,0.00008659058,0.00047464235,0.000011456241],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005575296,0.000029082048,0.00101138,0.011893318,0.00058618403,0.0000696084,0.00016304324,3.4268697e-7,0.000012056454,0.000018677792,0.0005261491,0.9856344],"study_design_scores_gemma":[0.0007216834,0.000069284346,0.00059658696,0.038930934,0.00068665075,0.0000068166046,0.000006203009,0.000004114608,0.000009023094,0.000018546876,0.9586709,0.00027924246],"about_ca_topic_score_codex":0.000521985,"about_ca_topic_score_gemma":0.00038068203,"teacher_disagreement_score":0.98535514,"about_ca_system_score_codex":0.0006774979,"about_ca_system_score_gemma":0.0008494339,"threshold_uncertainty_score":0.9641414},"labels":[],"label_agreement":null},{"id":"W2529738115","doi":"10.1016/j.cllc.2016.09.002","title":"Phase 1/2 Study of the CD56-Targeting Antibody-Drug Conjugate Lorvotuzumab Mertansine (IMGN901) in Combination With Carboplatin/Etoposide in Small-Cell Lung Cancer Patients With Extensive-Stage Disease","year":2016,"lang":"en","type":"article","venue":"Clinical Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre","funders":"ImmunoGen","keywords":"Carboplatin; Medicine; Etoposide; Internal medicine; Adverse effect; Phases of clinical research; Lung cancer; Gastroenterology; Chemotherapy; Surgery; Cisplatin","score_opus":0.023026111291990812,"score_gpt":0.39652066178710005,"score_spread":0.3734945504951092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2529738115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902647,0.002475627,0.000027110862,0.002097404,0.00033391014,0.0045072143,0.00013546401,0.00003347002,0.00012509066],"genre_scores_gemma":[0.9975053,0.0006538969,0.00003771365,0.00037187786,0.00013023402,0.0005014447,0.000020194382,0.00007237266,0.00070695573],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99609756,0.00043422246,0.0011373189,0.00084447965,0.00085254834,0.0006338887],"domain_scores_gemma":[0.99687755,0.0007436826,0.00057710096,0.00064358866,0.0008656226,0.00029245848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070827716,0.00039206358,0.0009843373,0.00017249146,0.000120242265,0.000019041398,0.00028758624,0.00008296882,0.00007751091],"category_scores_gemma":[0.00069962215,0.00020162451,0.00011170338,0.0007249568,0.0004616627,0.0001843372,0.00021453876,0.0005972188,0.000001056108],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008318297,0.004881216,0.9822566,0.0005767235,0.00032465276,0.00011698734,0.0011887129,0.0002361587,0.00042436767,0.000012727487,0.0004483189,0.0012152767],"study_design_scores_gemma":[0.06630426,0.0020326956,0.9237058,0.0035197015,0.00057750754,2.9837196e-7,0.0005338217,0.0024347738,0.00044437934,0.000010578282,0.00008472146,0.00035146586],"about_ca_topic_score_codex":0.0037203794,"about_ca_topic_score_gemma":0.010729178,"teacher_disagreement_score":0.05855076,"about_ca_system_score_codex":0.00091106945,"about_ca_system_score_gemma":0.0011060124,"threshold_uncertainty_score":0.8222009},"labels":[],"label_agreement":null},{"id":"W2557836851","doi":"10.1016/j.heliyon.2016.e00204","title":"RBM5 reduces small cell lung cancer growth, increases cisplatin sensitivity and regulates key transformation-associated pathways","year":2016,"lang":"en","type":"article","venue":"Heliyon","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences North; Laurentian University","funders":"","keywords":"Cancer research; Cisplatin; Lung cancer; Cell cycle; Cell growth; Apoptosis; Biology; Transcriptome; Cell culture; Tumor suppressor gene; Cell; Angiogenesis; Cancer; Gene expression; Medicine; Oncology; Chemotherapy; Gene; Carcinogenesis; Genetics","score_opus":0.01810483696389525,"score_gpt":0.2784925029462149,"score_spread":0.26038766598231966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557836851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98705983,0.007575667,0.000040697018,0.003063996,0.0000695912,0.00051282684,0.00024182233,0.00012276096,0.0013128255],"genre_scores_gemma":[0.98604625,0.012619376,0.000076781995,0.00016219361,0.00013371589,0.000070844486,0.000016883694,0.00002546609,0.00084849366],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986108,0.00013609293,0.00024199879,0.0002872244,0.00033366177,0.00039022526],"domain_scores_gemma":[0.99890584,0.0003997533,0.00008846137,0.00015057159,0.00027726617,0.000178105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004003264,0.00019142311,0.0003390369,0.00010844787,0.00016912234,0.000020162865,0.00004322782,0.00009978994,0.00006588855],"category_scores_gemma":[0.00039248753,0.00012547306,0.0000646042,0.00017162853,0.00013799297,0.00018216022,0.000049553233,0.0001310684,0.000011144905],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066340034,0.0003028497,0.20738229,0.0030503436,0.00040220586,0.00011286895,0.0046024215,0.000002123096,0.7686209,0.00022080229,0.002832587,0.011807173],"study_design_scores_gemma":[0.0043681585,0.0002978289,0.40802145,0.0042080735,0.0002698271,0.000027889673,0.00038661135,0.00024049635,0.5813539,0.00007726872,0.00038397452,0.00036453345],"about_ca_topic_score_codex":0.0008300951,"about_ca_topic_score_gemma":0.0009969581,"teacher_disagreement_score":0.20063916,"about_ca_system_score_codex":0.00027788713,"about_ca_system_score_gemma":0.0001746115,"threshold_uncertainty_score":0.5116643},"labels":[],"label_agreement":null},{"id":"W2561485099","doi":"","title":"PET Imaging in Small Cell Lung Cancer","year":2009,"lang":"en","type":"article","venue":"","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Lung cancer; Cancer; Radiology; Pathology; Internal medicine","score_opus":0.016444101095777305,"score_gpt":0.3629799667283767,"score_spread":0.34653586563259936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561485099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6948161,0.008838157,0.000092136004,0.026871739,0.00010020697,0.00056172046,0.0000025786965,0.00010620278,0.26861116],"genre_scores_gemma":[0.9856201,0.0006230057,0.0005574175,0.002209339,0.00011192212,0.000024981635,0.0000014358808,0.0000075825037,0.010844249],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992941,0.0000120361865,0.00010564673,0.00016453316,0.00013593269,0.00028772152],"domain_scores_gemma":[0.9997015,0.000021998132,0.000013329379,0.00013993088,0.000048978196,0.000074291835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010914286,0.00007641445,0.00014439806,0.00009322732,0.00002522165,0.000009961691,0.000055385248,0.000009008524,0.00037394284],"category_scores_gemma":[0.00002989295,0.000057671707,0.000030165424,0.0001528711,0.0000221487,0.000039593786,0.00003034008,0.00014217672,0.000015343807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011507885,0.00016133109,0.9030511,0.00019331127,0.000020596302,0.00060158066,0.0007902393,0.000016966636,0.011675234,0.00019611395,0.06265446,0.020524025],"study_design_scores_gemma":[0.0049633933,0.00016816104,0.9618575,0.0004254937,0.00006940826,0.000036909896,0.0006898369,0.004692014,0.014041803,0.00026222927,0.01248692,0.00030634843],"about_ca_topic_score_codex":0.0011514463,"about_ca_topic_score_gemma":0.00053036265,"teacher_disagreement_score":0.29080397,"about_ca_system_score_codex":0.00024562204,"about_ca_system_score_gemma":0.00012090711,"threshold_uncertainty_score":0.40944117},"labels":[],"label_agreement":null},{"id":"W2562390400","doi":"10.1016/j.lungcan.2016.12.019","title":"An open-label, phase II study of the polo-like kinase-1 (Plk-1) inhibitor, BI 2536, in patients with relapsed small cell lung cancer (SCLC)","year":2016,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Nausea; Neutropenia; Internal medicine; Vomiting; Constipation; Phases of clinical research; Adverse effect; Lung cancer; Polo-like kinase; Gastroenterology; Oncology; Cancer; Surgery; Clinical trial; Chemotherapy; Cell cycle","score_opus":0.02410631831682526,"score_gpt":0.36205355458020266,"score_spread":0.3379472362633774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562390400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893896,0.0025502183,0.000005301273,0.0013897775,0.0007106164,0.0051079206,0.00020858773,0.000049939554,0.000588064],"genre_scores_gemma":[0.9940921,0.00036049308,0.000055835677,0.0004685615,0.00022531711,0.0013033256,0.000008231636,0.00009630265,0.0033898312],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966075,0.00024272889,0.0005636485,0.0008149015,0.001002184,0.00076906243],"domain_scores_gemma":[0.9976834,0.000092486196,0.00031925915,0.0011580498,0.0004899862,0.0002568207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036534911,0.00040953018,0.00073238794,0.00021567065,0.00028613387,0.00003637078,0.0007865151,0.00011400777,0.00027830852],"category_scores_gemma":[0.00006658796,0.00021417945,0.000046349956,0.0008735682,0.00025757783,0.0003343282,0.0006918794,0.00042241017,0.0000023376074],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005439741,0.008734931,0.95361423,0.00037783766,0.000442497,0.000027216476,0.004604442,0.000019909845,0.009478211,0.000007728713,0.012049122,0.005204123],"study_design_scores_gemma":[0.21119843,0.026263468,0.7331953,0.005587197,0.0012552302,0.0000015274566,0.0014352814,0.0002745415,0.0140724005,0.000011726491,0.0056139296,0.0010909701],"about_ca_topic_score_codex":0.011173712,"about_ca_topic_score_gemma":0.01550998,"teacher_disagreement_score":0.22041894,"about_ca_system_score_codex":0.001424909,"about_ca_system_score_gemma":0.0009668237,"threshold_uncertainty_score":0.995411},"labels":[],"label_agreement":null},{"id":"W2564674425","doi":"10.1016/j.jtho.2016.12.004","title":"The Use of Immunohistochemistry Improves the Diagnosis of Small Cell Lung Cancer and Its Differential Diagnosis. An International Reproducibility Study in a Demanding Set of Cases","year":2016,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":131,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; H&E stain; Pathology; Immunohistochemistry; Biopsy; Lung cancer; Differential diagnosis; Carcinoma; Medical diagnosis; Radiology","score_opus":0.09684801767149295,"score_gpt":0.481293159134783,"score_spread":0.38444514146329,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564674425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916368,0.004570368,0.000005034473,0.0029469174,0.00027736725,0.00050990516,0.000039582515,0.0000018168176,0.000012211079],"genre_scores_gemma":[0.99342275,0.0061569056,0.000060422608,0.0000140133725,0.0001735602,0.00009743024,4.6463487e-7,0.000008617818,0.000065863314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99810797,0.00034371484,0.0007992812,0.0002485564,0.00033543448,0.00016505811],"domain_scores_gemma":[0.99539244,0.0025993763,0.0009273829,0.000434896,0.00058722787,0.000058692483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019089243,0.000110194036,0.0005552282,0.000103879334,0.000056894893,0.00000810251,0.0002777609,0.00005985448,0.000026281787],"category_scores_gemma":[0.0043913275,0.00005086175,0.000097890545,0.000108126646,0.00030785246,0.00013213564,0.000234759,0.00025381782,3.730507e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003217495,0.0009689347,0.8963239,0.00030825316,0.00048086705,0.000060233044,0.0021035864,0.000005526054,0.069102496,0.00000223983,0.00023812518,0.027188348],"study_design_scores_gemma":[0.002035347,0.0029370547,0.8480885,0.00072054396,0.000549589,0.000089771915,0.0017423945,0.00006414278,0.1433513,0.000025550235,0.000316481,0.0000793396],"about_ca_topic_score_codex":0.00040012843,"about_ca_topic_score_gemma":0.00047125464,"teacher_disagreement_score":0.074248806,"about_ca_system_score_codex":0.000397531,"about_ca_system_score_gemma":0.00033918896,"threshold_uncertainty_score":0.52571464},"labels":[],"label_agreement":null},{"id":"W2567370351","doi":"10.1055/s-2006-933784","title":"Eine randomisierte Phase III Studie einer Kombinationstherapie Carboplatin/Paclitaxel mit oder ohne Bexarotene (Targretin®) bei nicht vortherapierten Patienten mit fortgeschrittenem oder metastasiertem Nicht-kleinzelligem Bronchialkarzinom (NSCLC)","year":2006,"lang":"de","type":"article","venue":"Pneumologie","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Bexarotene; Carboplatin; Gynecology; Retinoid X receptor; Medicine; Paclitaxel; Chemistry; Cisplatin; Chemotherapy; Internal medicine; Nuclear receptor","score_opus":0.026866498092176228,"score_gpt":0.318347715890344,"score_spread":0.29148121779816777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567370351","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25320607,0.696758,0.002185724,0.02416787,0.0047241445,0.010874358,0.0011860435,0.00094846287,0.005949334],"genre_scores_gemma":[0.9608403,0.019215344,0.0016131395,0.0019871648,0.0037519813,0.002130009,0.0015379771,0.0006099933,0.008314133],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9827553,0.0015682868,0.0041765086,0.0034610338,0.0035039724,0.004534906],"domain_scores_gemma":[0.98935014,0.0022359358,0.0017201937,0.0031060115,0.002441669,0.0011460793],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0033120024,0.0027861716,0.005056992,0.0012394434,0.0015990413,0.00036808828,0.0017205745,0.0010443471,0.0008900191],"category_scores_gemma":[0.0017490555,0.0023417282,0.0018410985,0.002060832,0.0019190884,0.00075076683,0.0009559389,0.0025272449,0.0006668578],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.061536264,0.036082562,0.10095516,0.0039779707,0.16603419,0.009796296,0.0088963825,0.0022806542,0.04116545,0.00265289,0.2081633,0.35845888],"study_design_scores_gemma":[0.4873864,0.022672338,0.039798006,0.0039006993,0.058302917,0.00027020142,0.002991033,0.012975887,0.019864885,0.0073072594,0.33280733,0.011723026],"about_ca_topic_score_codex":0.0035407224,"about_ca_topic_score_gemma":0.0006291081,"teacher_disagreement_score":0.7076342,"about_ca_system_score_codex":0.0018226115,"about_ca_system_score_gemma":0.0013669528,"threshold_uncertainty_score":0.999774},"labels":[],"label_agreement":null},{"id":"W2568140973","doi":"10.1016/j.jtho.2016.11.962","title":"P1.07-050 Patterns of Relapse in Small Cell Lung Cancer (SCLC): A Retrospective Analysis of Outcomes from a Single Canadian Center","year":2017,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Conventional PCI; Carboplatin; Etoposide; Retrospective cohort study; Chemotherapy; Internal medicine; Single Center; Lung cancer; Radiation therapy; Stage (stratigraphy); Oncology; Surgery; Cisplatin","score_opus":0.04123785998035705,"score_gpt":0.44019176793862125,"score_spread":0.3989539079582642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2568140973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907341,0.0010222895,0.000030966054,0.0051199137,0.00042302615,0.00023233617,0.0002778361,0.0000025119598,0.0021570006],"genre_scores_gemma":[0.99789625,0.0006523067,0.00062380766,0.0001907081,0.00014583267,0.000008356261,0.0000054875054,0.000017248492,0.00045998135],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804276,0.00018717397,0.0008091752,0.0002147349,0.0003673171,0.00037883324],"domain_scores_gemma":[0.99703836,0.00021506383,0.0013938296,0.00047388548,0.0005967984,0.00028208192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071362895,0.0001638912,0.0015685047,0.0010226911,0.00007598255,0.000015466057,0.00039512504,0.00016269326,0.00042789234],"category_scores_gemma":[0.00066204974,0.00012518291,0.0003943518,0.00024561622,0.00016474494,0.0001213688,0.0001307783,0.0005804607,0.0000013243796],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077573163,0.0004021869,0.9872435,0.0001300599,0.0030693256,0.00059455977,0.0021369874,0.000026057092,0.0015914548,0.0000024016404,0.0005282444,0.0034995133],"study_design_scores_gemma":[0.0017104285,0.00082594884,0.99163055,0.00043357056,0.0023962,0.00001059751,0.00060974853,0.00011700744,0.0016753401,0.00003416383,0.00046413695,0.00009229526],"about_ca_topic_score_codex":0.2197961,"about_ca_topic_score_gemma":0.68279874,"teacher_disagreement_score":0.46300265,"about_ca_system_score_codex":0.002784447,"about_ca_system_score_gemma":0.0012599793,"threshold_uncertainty_score":0.7853993},"labels":[],"label_agreement":null},{"id":"W2568171230","doi":"10.1016/j.jtho.2018.09.027","title":"Compliance and Outcome of Elderly Patients Treated in the Concurrent Once-Daily Versus Twice-Daily Radiotherapy (CONVERT) Trial","year":2018,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"Sirtex Medical; European Organisation for Research and Treatment of Cancer; Cancer Research UK; Ministère des Affaires Sociales et de la Santé; Canadian Cancer Society Research Institute; National Institute for Health and Care Research; National Cancer Research Institute; Cancer Research Institute","keywords":"Medicine; Outcome (game theory); Compliance (psychology); Radiation therapy; Patient compliance; Surgery; Emergency medicine","score_opus":0.13159369692412945,"score_gpt":0.5185113461987123,"score_spread":0.38691764927458283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2568171230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99111897,0.0017865822,0.000030357614,0.004082397,0.0013850493,0.00067291013,0.000008131306,0.000005665299,0.000909925],"genre_scores_gemma":[0.9979533,0.00059733656,0.00028971134,0.00039093016,0.00064178,0.000012321291,0.0000016800665,0.000013314631,0.00009963778],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9976902,0.0004941494,0.0008315271,0.00016907546,0.0005207679,0.0002943031],"domain_scores_gemma":[0.9976964,0.00075320515,0.000657738,0.00020502864,0.0005702155,0.00011741028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011425321,0.00016134341,0.0008707533,0.00020791504,0.000065216715,0.000013074462,0.0002592227,0.00011639939,0.00006812359],"category_scores_gemma":[0.0005572291,0.000096526324,0.00013184187,0.0002747041,0.0006010304,0.00010649578,0.000044673976,0.0005041809,0.0000046524356],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3351057,0.0018560988,0.29820833,0.00026829867,0.0008475768,0.00021697566,0.0053465716,9.123458e-7,0.0007178816,0.000035867863,0.009181209,0.3482146],"study_design_scores_gemma":[0.23532702,0.17005941,0.50076014,0.00068355876,0.0006950725,0.00021406102,0.0018399669,0.00015446648,0.00084108824,0.00007344783,0.08903209,0.00031968314],"about_ca_topic_score_codex":0.00010038929,"about_ca_topic_score_gemma":0.00017266968,"teacher_disagreement_score":0.3478949,"about_ca_system_score_codex":0.0005154329,"about_ca_system_score_gemma":0.00026077114,"threshold_uncertainty_score":0.39362293},"labels":[],"label_agreement":null},{"id":"W2568673175","doi":"10.1016/j.jtho.2016.11.1985","title":"PUB015 The Use of Immunohistochemistry Improves the Diagnosis of SCLC. An International Reproducibility Study in a Demanding Set of Cases","year":2017,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Immunohistochemistry; Pathology; Biopsy; Immunostaining; Lung cancer; Carcinoma; Not Otherwise Specified; Cancer; Kappa; Internal medicine","score_opus":0.21427963595774463,"score_gpt":0.5570368561241257,"score_spread":0.34275722016638105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2568673175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932124,0.0005347205,0.0000027414103,0.0052653244,0.00026396022,0.0005198019,0.000018114053,0.0000013226655,0.00018164041],"genre_scores_gemma":[0.99907607,0.0003067988,0.00030734824,0.00002956891,0.00017547785,0.000028497328,7.9968925e-7,0.000006841945,0.00006857208],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99798715,0.0003956481,0.0008278754,0.00022515738,0.00042912402,0.00013506624],"domain_scores_gemma":[0.9950245,0.0011167958,0.0017135465,0.0013253376,0.0007748826,0.000044953573],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0061130635,0.0000902338,0.00062120723,0.0001006347,0.000110518544,0.000025170852,0.000947629,0.000054477052,0.00002323179],"category_scores_gemma":[0.016819514,0.000047563342,0.0001139112,0.00008795594,0.00065175066,0.00031685256,0.00056790956,0.00040450273,9.9073105e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004905233,0.0016787789,0.9335998,0.00019259372,0.0006964776,0.00018829097,0.004632493,0.000017742685,0.021789724,0.0000068606982,0.000749685,0.031542297],"study_design_scores_gemma":[0.0012793457,0.0037306496,0.96339154,0.000346008,0.0002999823,0.0003065577,0.005548831,0.000035541052,0.02408613,0.00012933773,0.00079336803,0.000052684776],"about_ca_topic_score_codex":0.0011984614,"about_ca_topic_score_gemma":0.00037917003,"teacher_disagreement_score":0.03148961,"about_ca_system_score_codex":0.00034863967,"about_ca_system_score_gemma":0.00051401823,"threshold_uncertainty_score":0.99146223},"labels":[],"label_agreement":null},{"id":"W2569547003","doi":"10.1016/j.jtho.2016.11.058","title":"ED14.05 Immunotherapy of Small Cell Lung Cancer","year":2017,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Immunotherapy; Lung cancer; Cancer immunotherapy; Targeted therapy; Cancer research; Cancer; Clinical trial; Oncology; Immune system; Immunology; Internal medicine","score_opus":0.04548576438345652,"score_gpt":0.5014252161603496,"score_spread":0.4559394517768931,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2569547003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9488307,0.019142354,0.00020495307,0.016393231,0.001571305,0.00031209196,0.000008704321,0.000007594509,0.013529063],"genre_scores_gemma":[0.98197985,0.008795677,0.0036152257,0.00042475815,0.001005557,0.000012206068,4.0118383e-7,0.000025847417,0.004140481],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99862736,0.00012308561,0.0005139304,0.00011659987,0.00034251166,0.0002765011],"domain_scores_gemma":[0.9974617,0.00016606471,0.0011830025,0.00040822258,0.00064595026,0.00013510908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009819616,0.000121512836,0.0007480784,0.00016668299,0.00014693633,0.000017165014,0.00042235618,0.0001201937,0.00026205837],"category_scores_gemma":[0.00029432125,0.00008585776,0.00021794367,0.000056478897,0.00026932397,0.00011042245,0.00011739587,0.0005143512,0.0000037618413],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012580729,0.0012581438,0.22164723,0.0016406744,0.002404506,0.0015803053,0.0031185339,0.000041677118,0.15327695,0.000044114382,0.08590667,0.5165005],"study_design_scores_gemma":[0.010555654,0.011652662,0.47885147,0.0020154922,0.0015995515,0.0012873877,0.001112601,0.00026267563,0.12821601,0.0004993321,0.3635094,0.0004377726],"about_ca_topic_score_codex":0.00018813649,"about_ca_topic_score_gemma":0.00009220147,"teacher_disagreement_score":0.5160627,"about_ca_system_score_codex":0.0005252532,"about_ca_system_score_gemma":0.0011757041,"threshold_uncertainty_score":0.35011777},"labels":[],"label_agreement":null},{"id":"W2571308635","doi":"10.1016/j.jtho.2016.11.927","title":"P1.07-016 Trends, Practice Patterns and Underuse of Surgery in the Treatment of Early Stage Small Cell Lung Cancer","year":2017,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Stage (stratigraphy); Contraindication; Cancer; Logistic regression; Lung cancer; Medicaid; Pneumonectomy; Demographics; Surgery; Internal medicine; Pathology; Health care","score_opus":0.10757032847245042,"score_gpt":0.508546255502176,"score_spread":0.4009759270297256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571308635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98112464,0.0057342174,0.000013219098,0.0111767445,0.00023361937,0.00019149153,0.000026514468,0.0000017166005,0.0014978554],"genre_scores_gemma":[0.97806907,0.020486705,0.00022686324,0.00011534795,0.00021350992,0.000014048597,6.5458363e-7,0.000011425147,0.00086237356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984001,0.00037932844,0.00053789455,0.00012290975,0.00033280978,0.00022698582],"domain_scores_gemma":[0.9965473,0.0014536879,0.0013213649,0.0003280155,0.0002614507,0.00008820249],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012885482,0.000122024656,0.0007384607,0.0002543706,0.000074324766,0.000018295048,0.0001822607,0.00008367444,0.000061109335],"category_scores_gemma":[0.00038571842,0.00007008045,0.00014012241,0.00007629403,0.00019339575,0.00016608162,0.00005120174,0.00026778347,4.7186012e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004485733,0.0015983462,0.8586938,0.0005655252,0.0006370639,0.0013368417,0.0074411305,0.000006094395,0.00069590076,0.0000073772217,0.0013455284,0.12318666],"study_design_scores_gemma":[0.0020834936,0.004550343,0.9694652,0.00043838006,0.000842967,0.00018129512,0.0030854186,0.000015335007,0.0024011675,0.000014685945,0.016837757,0.00008397596],"about_ca_topic_score_codex":0.0032467558,"about_ca_topic_score_gemma":0.0018131267,"teacher_disagreement_score":0.12310269,"about_ca_system_score_codex":0.0004658715,"about_ca_system_score_gemma":0.0006862588,"threshold_uncertainty_score":0.4908145},"labels":[],"label_agreement":null},{"id":"W2574837766","doi":"10.1016/j.radonc.2017.01.005","title":"Cost-effectiveness of prophylactic cranial irradiation with hippocampal avoidance in limited stage small cell lung cancer","year":2017,"lang":"en","type":"article","venue":"Radiotherapy and Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Queen's University","funders":"","keywords":"Conventional PCI; Prophylactic cranial irradiation; Medicine; Neurocognitive; Lung cancer; Population; Oncology; Internal medicine; Surgery; Cognition","score_opus":0.04349840953210288,"score_gpt":0.39167082525683067,"score_spread":0.3481724157247278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2574837766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914955,0.004910634,0.00033026104,0.0007355076,0.00012321786,0.0016594925,0.000011642182,0.000012533676,0.0007212078],"genre_scores_gemma":[0.99562526,0.0030086627,0.00050504116,0.00010500858,0.00013173491,0.000330023,0.0000024245448,0.000019243837,0.00027259215],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989985,0.0002163363,0.00015168257,0.00024985042,0.00013581372,0.00024778227],"domain_scores_gemma":[0.99913824,0.00027404152,0.00017542188,0.00024374966,0.000094146664,0.00007440408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043806684,0.00012685219,0.00046779352,0.00010067525,0.00012790362,0.000015607122,0.00009492737,0.00010104204,0.000031989093],"category_scores_gemma":[0.00007184436,0.000095045914,0.000027557522,0.00007916607,0.00029667883,0.000087882705,0.000020132882,0.0002369504,2.7604037e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013582319,0.00038451457,0.90653646,0.0020875714,0.000193622,0.00014299534,0.002392092,0.0001460621,0.044458892,0.000059120815,0.00003248063,0.02998387],"study_design_scores_gemma":[0.012656741,0.0028497467,0.976475,0.00024587993,0.00005618235,0.000013346088,0.000086287124,0.0014879064,0.003867869,0.000013708851,0.0021237233,0.00012360813],"about_ca_topic_score_codex":0.001114797,"about_ca_topic_score_gemma":0.001906315,"teacher_disagreement_score":0.06993854,"about_ca_system_score_codex":0.0009470209,"about_ca_system_score_gemma":0.0005166298,"threshold_uncertainty_score":0.38758597},"labels":[],"label_agreement":null},{"id":"W2586885021","doi":"10.1016/j.jtho.2016.01.012","title":"Small Cell Lung Cancer: Can Recent Advances in Biology and Molecular Biology Be Translated into Improved Outcomes?","year":2016,"lang":"en","type":"review","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":182,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Cancer Institute; Cancer Research UK","keywords":"Cancer research; Targeted therapy; Aurora kinase; Medicine; Wnt signaling pathway; Receptor tyrosine kinase; Tyrosine kinase; Biology; Kinase; Bioinformatics; Cancer; Signal transduction; Cell cycle; Receptor; Internal medicine; Genetics","score_opus":0.047730748269638766,"score_gpt":0.530468196576259,"score_spread":0.48273744830662024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586885021","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00075899175,0.98551506,0.00018413052,0.010797636,0.0010779493,0.0012664475,0.00008162415,0.000015110734,0.00030306462],"genre_scores_gemma":[0.00018394912,0.9973048,0.0013550553,0.0005000396,0.00028998865,0.00014709237,0.000018987337,0.0000643403,0.00013573845],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956285,0.0011821734,0.0017095874,0.0005522681,0.0001755576,0.0007519611],"domain_scores_gemma":[0.99652684,0.00078844326,0.0015509662,0.0003315389,0.00044384788,0.00035835968],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013244773,0.0005776187,0.0048842244,0.0009841401,0.000060810256,0.00000998082,0.0004289555,0.00087559427,0.00008827462],"category_scores_gemma":[0.0004857642,0.00033782312,0.00048717827,0.00044587193,0.00044819008,0.000071299255,0.00017799174,0.0016034383,0.0000016406633],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046248897,0.00015119245,0.0013453823,0.010721236,0.0008608386,0.00044828648,0.00023010418,2.0373987e-7,0.0004262871,0.00001721265,0.0001383547,0.98519844],"study_design_scores_gemma":[0.001733014,0.0023120507,0.00003383023,0.0067738523,0.0017255427,0.00036425388,0.000038830938,0.000002678539,0.000067509434,0.0003167372,0.9863257,0.00030599974],"about_ca_topic_score_codex":0.00014626834,"about_ca_topic_score_gemma":0.0009951605,"teacher_disagreement_score":0.98618734,"about_ca_system_score_codex":0.002356047,"about_ca_system_score_gemma":0.0035819847,"threshold_uncertainty_score":0.9999074},"labels":[],"label_agreement":null},{"id":"W2588051892","doi":"10.1016/j.ijrobp.2015.07.1573","title":"Extrapulmonary Small Cell Cancer: Is There a Role for PCI?","year":2015,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Incidence (geometry); Cumulative incidence; Conventional PCI; Population; Brain metastasis; Internal medicine; Genitourinary system; Cancer registry; Retrospective cohort study; Disease; Cancer; Head and neck cancer; Cohort; Surgery; Oncology; Metastasis; Myocardial infarction","score_opus":0.052538293039701034,"score_gpt":0.39077511086858885,"score_spread":0.3382368178288878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588051892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88677126,0.031045036,0.01567864,0.046842996,0.006509787,0.0014385871,0.00055032724,0.00010621819,0.011057152],"genre_scores_gemma":[0.9835117,0.0034502859,0.004263933,0.0023715086,0.0054643797,0.00009044303,0.00005658447,0.0000439451,0.00074725365],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99846005,0.000117517964,0.0005489057,0.00022700909,0.00035674684,0.0002897448],"domain_scores_gemma":[0.9967417,0.0003517182,0.0006763071,0.00014274342,0.0018554049,0.0002321091],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006067236,0.00018570568,0.0004749242,0.00014330924,0.0000640841,0.000021861642,0.00039101037,0.00018384158,0.00006743709],"category_scores_gemma":[0.0002933033,0.00015166281,0.00026480434,0.0001265239,0.0001630983,0.00017556398,0.00008271339,0.00041427716,0.00002376378],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032740636,0.0010780529,0.5878582,0.0000664254,0.0019608117,0.00010329061,0.0031715182,0.00044023123,0.008466724,0.0031306983,0.053398307,0.3370517],"study_design_scores_gemma":[0.021629699,0.0053834827,0.018088313,0.00019396498,0.00045205696,0.00032819354,0.0011726599,0.005031412,0.015004294,0.037834898,0.8944607,0.00042032424],"about_ca_topic_score_codex":0.00007950107,"about_ca_topic_score_gemma":0.000013436374,"teacher_disagreement_score":0.84106237,"about_ca_system_score_codex":0.001292655,"about_ca_system_score_gemma":0.0017186439,"threshold_uncertainty_score":0.618463},"labels":[],"label_agreement":null},{"id":"W2593287697","doi":"10.1200/jco.2013.31.15_suppl.tps2622","title":"Phase II, multicenter, open-label, proof of concept study of tasquinimod in patients with advanced/metastatic hepatocellular (HCC), ovarian (OC), renal cell (RCC) and gastric (GC) carcinomas.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Oncology; Combination therapy; Progression-free survival; Clinical endpoint; Phases of clinical research; Clinical trial; Chemotherapy","score_opus":0.1109235187220886,"score_gpt":0.4580474076056311,"score_spread":0.3471238888835425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593287697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99526364,0.00087917666,0.000062876934,0.0004751132,0.00017850536,0.0029248404,0.000015284993,0.0000027874983,0.00019779059],"genre_scores_gemma":[0.994522,0.0001235328,0.0049684094,0.00013953152,0.00008047226,0.000048730144,0.0000040750956,0.000023897968,0.00008937348],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9947063,0.0007625587,0.0030081556,0.0003401832,0.00079709874,0.0003857182],"domain_scores_gemma":[0.9942255,0.0011409578,0.0025747612,0.00032043245,0.0013191148,0.00041925893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019802859,0.00023072935,0.0025259876,0.00028449117,0.000049568123,0.000010676233,0.00037643523,0.00011776902,0.000085663254],"category_scores_gemma":[0.001788994,0.0001505198,0.00009551054,0.0003555507,0.00051358907,0.00032439386,0.00040869287,0.0009395732,9.071982e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026000554,0.10366193,0.7899014,0.00027969183,0.00087545085,0.00041925145,0.001854201,0.00003360739,0.0005314604,0.0000032037658,0.0010663966,0.075372905],"study_design_scores_gemma":[0.26925063,0.38868752,0.33770546,0.00046849204,0.0006374455,0.000021647797,0.0015616661,0.00046219426,0.00056331273,0.000038322552,0.00044305215,0.00016027458],"about_ca_topic_score_codex":0.0002059678,"about_ca_topic_score_gemma":0.00006661654,"teacher_disagreement_score":0.45219588,"about_ca_system_score_codex":0.00017051294,"about_ca_system_score_gemma":0.0010862488,"threshold_uncertainty_score":0.6138019},"labels":[],"label_agreement":null},{"id":"W2593673147","doi":"10.1016/j.athoracsur.2016.11.039","title":"Indications for Adjuvant Mediastinal Radiotherapy in Surgically Resected Small Cell Lung Cancer","year":2017,"lang":"en","type":"article","venue":"The Annals of Thoracic Surgery","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Hazard ratio; Confidence interval; Proportional hazards model; Pneumonectomy; Lung cancer; Radiation therapy; Survival analysis; Stage (stratigraphy); Surgery; Internal medicine; Resection margin; Oncology; Resection","score_opus":0.19129051638917777,"score_gpt":0.4913777465979625,"score_spread":0.30008723020878475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593673147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9406253,0.017167984,0.00011654301,0.040067077,0.00021386142,0.00096631574,0.0000766504,0.000027132823,0.0007391435],"genre_scores_gemma":[0.98447025,0.013047441,0.00022103023,0.00041622433,0.00037135388,0.0004746471,0.000017532804,0.00003236567,0.00094917783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982882,0.00016849523,0.00042123333,0.00025110657,0.00040087407,0.0004700755],"domain_scores_gemma":[0.9961658,0.0020741597,0.00038754893,0.0008112847,0.00043393113,0.00012726447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026455086,0.00015275805,0.0005894606,0.00024278923,0.00028582712,0.000032970416,0.0003985396,0.00007031614,0.00011915786],"category_scores_gemma":[0.002097688,0.00010048237,0.00022965412,0.00020144627,0.0003541046,0.00008831019,0.00010186755,0.00024419202,0.0000018377399],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0080986945,0.0006330775,0.7542587,0.0022434813,0.0007805147,0.00009580604,0.0023887297,0.000038977407,0.0096005695,0.00007299243,0.09652319,0.12526524],"study_design_scores_gemma":[0.0011017104,0.00022664532,0.9166478,0.002028729,0.00017451354,0.000014884816,0.00024648252,0.0012659703,0.063920744,0.00040457226,0.013611797,0.00035618295],"about_ca_topic_score_codex":0.0008057835,"about_ca_topic_score_gemma":0.000408224,"teacher_disagreement_score":0.16238904,"about_ca_system_score_codex":0.000059851052,"about_ca_system_score_gemma":0.0006091343,"threshold_uncertainty_score":0.4097552},"labels":[],"label_agreement":null},{"id":"W2595416856","doi":"10.1200/jco.2007.25.18_suppl.7522","title":"Randomized phase II study of maintenance vandetanib (ZD6474) in small cell lung cancer (SCLC) patients who have a complete or partial response to induction therapy: NCIC CTG BR.20","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Juravinski Cancer Centre; Sunnybrook Health Science Centre; Niagara Health System; BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Vandetanib; Gastroenterology; Hazard ratio; Asymptomatic; Progressive disease; Rash; Maintenance therapy; Performance status; Progression-free survival; Surgery; Chemotherapy; Confidence interval; Sorafenib","score_opus":0.19794544748806914,"score_gpt":0.5368576189100606,"score_spread":0.3389121714219914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595416856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914394,0.0006650064,0.0002302262,0.0037827722,0.0010322223,0.002638422,0.000011307057,0.000007005143,0.00019362026],"genre_scores_gemma":[0.9956244,0.0011765044,0.00038832639,0.0012859447,0.00073840894,0.00006666078,0.0000011024638,0.00002699266,0.00069163117],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9918267,0.0026377498,0.0039029743,0.0003448027,0.0007506687,0.0005370955],"domain_scores_gemma":[0.98937863,0.006504321,0.0020327484,0.00027429595,0.0013321188,0.000477892],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.018176006,0.0002336838,0.0032404352,0.00042816778,0.00008407966,0.000007700549,0.00025923722,0.00024794563,0.00012607989],"category_scores_gemma":[0.012502202,0.00014148102,0.00042250942,0.00040303936,0.00032118562,0.000099522294,0.00015349254,0.0012954473,0.0000018557271],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8659206,0.011789318,0.07819413,0.00004319346,0.000717424,0.0006465126,0.004121094,0.00005616137,0.0008913939,0.000001183664,0.0023797173,0.035239276],"study_design_scores_gemma":[0.6857319,0.079696074,0.22057393,0.00034703492,0.0003736808,0.000020127025,0.001478733,0.0002486999,0.00029234224,0.000018678254,0.011066608,0.0001522082],"about_ca_topic_score_codex":0.0003336916,"about_ca_topic_score_gemma":0.0028903568,"teacher_disagreement_score":0.18018872,"about_ca_system_score_codex":0.00074451254,"about_ca_system_score_gemma":0.0018879906,"threshold_uncertainty_score":0.99581593},"labels":[],"label_agreement":null},{"id":"W2597133748","doi":"10.1016/j.canrad.2016.09.015","title":"Thoracic irradiation in 3 weeks for limited-stage small cell lung cancer: Is twice a day fractionation really needed?","year":2017,"lang":"en","type":"review","venue":"Cancer/Radiothérapie","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Lung cancer; Stage (stratigraphy); Fractionation; Irradiation; Lung; Dose fractionation; Medicine; Oncology; Nuclear medicine; Internal medicine; Biology; Chemistry; Radiation therapy; Chromatography; Physics","score_opus":0.12906043142095702,"score_gpt":0.47469009405384643,"score_spread":0.3456296626328894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597133748","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007067222,0.9822774,0.00028920302,0.002281098,0.0017558275,0.007334833,0.0016288729,0.00015365126,0.0042084656],"genre_scores_gemma":[0.00006367383,0.96900386,0.00055057503,0.0005419105,0.0029895168,0.009066429,0.0006445952,0.00027275732,0.01686669],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99500936,0.00025400837,0.0012573638,0.0014587382,0.00088967587,0.0011308652],"domain_scores_gemma":[0.9951588,0.0008049843,0.0015683686,0.0014039164,0.000658429,0.00040549386],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011703324,0.0009819472,0.0031350283,0.0011851382,0.0004947799,0.00022022973,0.0007644932,0.0008446873,0.00033294375],"category_scores_gemma":[0.0006866914,0.0009063634,0.0008583865,0.0008264109,0.00019485455,0.00042776464,0.00015353523,0.0014576593,0.000021734832],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025390298,0.00016511088,0.00041074152,0.07970508,0.0010910197,0.000050089817,0.0009759571,0.000031459927,0.000019323976,0.000042910433,0.05379284,0.86346155],"study_design_scores_gemma":[0.0019629602,0.00026376088,0.0004982941,0.021456541,0.0024141357,0.000011891055,0.00008213129,0.0011461128,0.000023361625,0.000015795124,0.9713417,0.0007833156],"about_ca_topic_score_codex":0.0047008526,"about_ca_topic_score_gemma":0.0018381999,"teacher_disagreement_score":0.91754884,"about_ca_system_score_codex":0.007918456,"about_ca_system_score_gemma":0.0055929516,"threshold_uncertainty_score":0.9993387},"labels":[],"label_agreement":null},{"id":"W2598968435","doi":"10.1200/jco.2017.35.5_suppl.225","title":"The impact of neurocognitive function on health utility scores (HUS) in Stage 4 (S4) lung cancer patients (pts) with and without brain metastases (BrM).","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Neurocognitive; Internal medicine; Quality of life (healthcare); Lung cancer; Asymptomatic; Cancer; Oncology; Stage (stratigraphy); Disease; Gastroenterology; Cognition","score_opus":0.16405613200716299,"score_gpt":0.5830119411110996,"score_spread":0.4189558091039366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2598968435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886842,0.0009030745,0.000016344158,0.008949679,0.0002602268,0.0005647513,0.000043515916,0.0000025450358,0.0005756783],"genre_scores_gemma":[0.9962468,0.0026606843,0.000038960738,0.0007368787,0.0002063778,0.000011294548,0.0000011906047,0.000009542438,0.00008825426],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99700356,0.0008726012,0.001139554,0.00019214557,0.00051429,0.00027782467],"domain_scores_gemma":[0.99364203,0.0028955017,0.0022551885,0.00023346084,0.0007018721,0.0002719417],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.004284138,0.00013163249,0.0011683141,0.00009226505,0.00019384094,0.00001959674,0.00014593652,0.000086846,0.000029552857],"category_scores_gemma":[0.01121269,0.00006181426,0.00017765247,0.00006550952,0.0008063226,0.00015151466,0.00008774118,0.0009931164,4.7254161e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024682282,0.0008146132,0.8472783,0.000060066515,0.0005992612,0.00002685662,0.00012338863,0.000007036456,0.0000048739685,0.000008991502,0.0036004316,0.12279388],"study_design_scores_gemma":[0.010649821,0.039845094,0.9471102,0.0003784192,0.0001245199,0.0000069215926,0.00011588673,0.000095913674,0.000010108411,0.00005047389,0.0015668562,0.00004582301],"about_ca_topic_score_codex":0.0019561995,"about_ca_topic_score_gemma":0.004385646,"teacher_disagreement_score":0.122748055,"about_ca_system_score_codex":0.00031435638,"about_ca_system_score_gemma":0.0026213382,"threshold_uncertainty_score":0.99711627},"labels":[],"label_agreement":null},{"id":"W2599647662","doi":"10.1200/jco.2004.22.90140.7041","title":"Influence of gender on treatment outcome and toxicity in small cell lung cancer (SCLC)","year":2004,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Cancer Care Ontario","funders":"","keywords":"Medicine; Internal medicine; Toxicity; Univariate analysis; Vincristine; Etoposide; Chemotherapy; Performance status; Cyclophosphamide; Oncology; Multivariate analysis","score_opus":0.22601284712966604,"score_gpt":0.5548682603600174,"score_spread":0.3288554132303513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2599647662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911433,0.0016392613,0.000008811922,0.0056363097,0.00016141329,0.00023439892,0.000003165663,0.0000026415105,0.0011707363],"genre_scores_gemma":[0.9925005,0.005215591,0.0006256101,0.0012899763,0.00024432165,0.000007435845,1.313519e-7,0.0000076130955,0.0001088552],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977936,0.0001574262,0.0014538121,0.00014972177,0.00023872257,0.00020667861],"domain_scores_gemma":[0.99762005,0.0011158114,0.00068131136,0.00012266455,0.00022900802,0.00023113514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012855602,0.000111476635,0.0012268102,0.00012709702,0.000017427,0.0000022902032,0.00008555158,0.00016635527,0.00001894771],"category_scores_gemma":[0.0014581849,0.00006654827,0.00018478438,0.00010043747,0.0002120206,0.000043455773,0.00004870862,0.0005785402,0.0000015626789],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002545789,0.0017819671,0.98404604,0.0001319925,0.00025215198,0.0005091241,0.00042876258,0.0021348211,0.0007738618,0.000042464515,0.000091166316,0.0072618416],"study_design_scores_gemma":[0.013213137,0.012367657,0.9714258,0.00017316495,0.00018240928,0.000031918808,0.00007037331,0.000014572616,0.0012670298,0.0001780895,0.0010195822,0.000056321507],"about_ca_topic_score_codex":0.00033953338,"about_ca_topic_score_gemma":0.00057620514,"teacher_disagreement_score":0.012620314,"about_ca_system_score_codex":0.00090728793,"about_ca_system_score_gemma":0.0017207762,"threshold_uncertainty_score":0.3052583},"labels":[],"label_agreement":null},{"id":"W2600973140","doi":"10.1200/jco.2014.32.15_suppl.e17661","title":"Do patients with small cell lung cancer (SCLC) who have chemotherapy initiated during a hospital admission benefit from therapy?","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Juravinski Cancer Centre; University of Manitoba","funders":"","keywords":"Medicine; Chemotherapy; Lung cancer; Retrospective cohort study; Cohort; Stage (stratigraphy); Internal medicine; Hospital admission; Cancer; Emergency medicine","score_opus":0.06996706244504795,"score_gpt":0.43963645638551596,"score_spread":0.369669393940468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2600973140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99030405,0.0018590249,0.000044870263,0.005329341,0.0005158342,0.00044933424,0.000010993181,0.000014683914,0.0014718765],"genre_scores_gemma":[0.9890838,0.005817768,0.0009987628,0.001950258,0.0017166449,0.000015428139,0.000004528792,0.000046112014,0.00036669927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99702156,0.0002710881,0.0013691266,0.00030952707,0.0006472086,0.00038146455],"domain_scores_gemma":[0.99560595,0.0011980216,0.0013726677,0.00025653144,0.0010049662,0.0005618552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010181236,0.00022488582,0.001487433,0.00011559361,0.000086081,0.000019838273,0.00023671839,0.0003101165,0.0003909393],"category_scores_gemma":[0.0010001872,0.00013251125,0.00030803448,0.00011685488,0.00015347789,0.0001172099,0.000077599936,0.0011801693,0.000004237974],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012625159,0.0018437649,0.91449785,0.000049862312,0.00084312644,0.00010058467,0.00064075703,0.000012551489,0.00012689253,0.0000017062252,0.0021086792,0.06714908],"study_design_scores_gemma":[0.03454045,0.016043589,0.93165714,0.00058006187,0.0001898731,0.0000045121305,0.00008354461,0.000084588355,0.0006823244,0.00006386184,0.015910732,0.00015931639],"about_ca_topic_score_codex":0.00014323212,"about_ca_topic_score_gemma":0.00007550076,"teacher_disagreement_score":0.066989765,"about_ca_system_score_codex":0.00034487425,"about_ca_system_score_gemma":0.0009652275,"threshold_uncertainty_score":0.5403652},"labels":[],"label_agreement":null},{"id":"W2606202551","doi":"10.1016/j.ijrobp.2015.07.1621","title":"Small Cell Lung Cancer Limited Disease (LSCLC): Are Long Treatments With Higher Doses Really Needed?","year":2015,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Conventional PCI; Etoposide; Radiation therapy; Surgery; Lung cancer; Chemotherapy; Pleural effusion; Internal medicine","score_opus":0.04657598275778986,"score_gpt":0.37380477584635663,"score_spread":0.3272287930885668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606202551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9729519,0.0057404335,0.0013487788,0.015348858,0.0021551505,0.0005507957,0.00014817085,0.0000676666,0.0016882853],"genre_scores_gemma":[0.9905963,0.0022248903,0.0009946334,0.0016051949,0.0031747534,0.0000637155,0.00010240579,0.0000490472,0.0011890532],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99810237,0.0002004901,0.0005286939,0.000284068,0.00055310735,0.00033126428],"domain_scores_gemma":[0.9962128,0.00025132822,0.0009574208,0.00019419311,0.0019054521,0.00047882862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003027472,0.00026462262,0.0005430175,0.00021193732,0.00007545315,0.00003876315,0.0003420339,0.00013859301,0.00006246485],"category_scores_gemma":[0.000235362,0.00019122714,0.00017117735,0.0002253315,0.0002134143,0.00026466034,0.00009190873,0.0004459988,0.00001615738],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034151564,0.00076984835,0.9703141,0.000036534886,0.0019783454,0.00046883355,0.00055002223,0.0008614153,0.00035251144,0.00025086937,0.009635999,0.01136636],"study_design_scores_gemma":[0.033641722,0.0038068474,0.91868067,0.0006197586,0.0017315351,0.00014432057,0.00052667834,0.0014405526,0.0019360068,0.0014103116,0.03554367,0.0005179194],"about_ca_topic_score_codex":0.00018024685,"about_ca_topic_score_gemma":0.00005060539,"teacher_disagreement_score":0.05163342,"about_ca_system_score_codex":0.002427782,"about_ca_system_score_gemma":0.0018692008,"threshold_uncertainty_score":0.77980167},"labels":[],"label_agreement":null},{"id":"W2611025812","doi":"10.1016/j.lungcan.2017.04.021","title":"Surgery Versus Chemotherapy and Radiotherapy For Early and Locally Advanced Small Cell Lung Cancer: A Propensity-Matched Analysis of Survival","year":2017,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Medicine; Propensity score matching; Radiation therapy; Chemotherapy; Lung cancer; Oncology; Surgery; Internal medicine","score_opus":0.03873701686102035,"score_gpt":0.3714446377825013,"score_spread":0.332707620921481,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2611025812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96201754,0.032614615,0.00045746553,0.0025623848,0.0003986331,0.0015546381,0.0001206262,0.00003519883,0.00023892774],"genre_scores_gemma":[0.9559302,0.040611364,0.00088532915,0.00023904913,0.00027536557,0.0005899028,0.000012272084,0.00006948604,0.0013870568],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982465,0.000045462395,0.0003278307,0.0005507239,0.00035344344,0.00047607833],"domain_scores_gemma":[0.9981231,0.00037423027,0.0003314937,0.0005977793,0.00037590598,0.00019745603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004310796,0.00027555795,0.0013288521,0.00022069993,0.00028557362,0.000078240155,0.00017170473,0.00010262874,0.00006267977],"category_scores_gemma":[0.00012161362,0.00022943068,0.00021723504,0.00024972856,0.000341837,0.0001511647,0.00008375029,0.00016756136,9.8804826e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009662268,0.00008443223,0.9354464,0.0018228621,0.007933772,0.000012123701,0.0016793777,0.00006405559,0.011800385,0.00001683448,0.0010815035,0.030396022],"study_design_scores_gemma":[0.014954527,0.00045488143,0.9589415,0.0006043954,0.0039441753,0.0000010965924,0.00012728885,0.009382363,0.007465178,0.000007514525,0.003623781,0.00049325405],"about_ca_topic_score_codex":0.0043239985,"about_ca_topic_score_gemma":0.0035647927,"teacher_disagreement_score":0.029902767,"about_ca_system_score_codex":0.0003431333,"about_ca_system_score_gemma":0.0004543796,"threshold_uncertainty_score":0.93559116},"labels":[],"label_agreement":null},{"id":"W2612146719","doi":"10.1093/annonc/mdx195.001","title":"Use of G-CSF and prophylactic antibiotics with concurrent chemo-radiotherapy in limited-stage small cell lung cancer: Results from the Phase III CONVERT trial","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Etoposide; Internal medicine; Antibiotics; Gastroenterology; Chemotherapy; Context (archaeology); Granulocyte colony-stimulating factor; Surgery; Leukocytopenia","score_opus":0.194582472380949,"score_gpt":0.46416702038981633,"score_spread":0.26958454800886733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2612146719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840685,0.0031412365,0.000012273667,0.010297921,0.00020457098,0.0015125176,0.0002627329,0.000007393496,0.0004928398],"genre_scores_gemma":[0.9868546,0.011951629,0.0001467248,0.00047608503,0.00019533433,0.000012524703,0.000014839903,0.000016421622,0.0003318154],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998601,0.00013568994,0.00044228917,0.00029574317,0.00023701512,0.00028825755],"domain_scores_gemma":[0.99764574,0.00078847416,0.00060617476,0.00054193824,0.00032368762,0.000094018505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004774591,0.00015770474,0.0007402907,0.000067400426,0.00009108001,0.000022306172,0.00020574122,0.00010874328,0.000018386827],"category_scores_gemma":[0.0006406122,0.00009666687,0.00005673767,0.000076216274,0.00082721136,0.00009759002,0.0000998639,0.0002947846,2.5630584e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6578245,0.006377709,0.1323849,0.0015218498,0.002307457,0.0005886362,0.016818238,0.0000388393,0.04078872,0.00014650011,0.0173135,0.123889156],"study_design_scores_gemma":[0.65757,0.044170987,0.07434127,0.0012688759,0.0006075063,0.00001260851,0.0009933773,0.0040506353,0.14388275,0.000021799277,0.07257154,0.0005086575],"about_ca_topic_score_codex":0.006680098,"about_ca_topic_score_gemma":0.0017891513,"teacher_disagreement_score":0.1233805,"about_ca_system_score_codex":0.00008916518,"about_ca_system_score_gemma":0.00070328196,"threshold_uncertainty_score":0.9999345},"labels":[],"label_agreement":null},{"id":"W2613503690","doi":"10.1093/annonc/mdx088.001","title":"Early limited-stage small cell lung cancer: Sub-group analysis of the concurrent once-daily versus twice-daily radiotherapy (CONVERT) trial","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Radiation therapy; Etoposide; Stage (stratigraphy); Conventional PCI; Chemotherapy; Lung cancer; Randomized controlled trial; Internal medicine; Surgery","score_opus":0.14425836304562678,"score_gpt":0.45388087881650246,"score_spread":0.3096225157708757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613503690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9759047,0.008401786,0.000029402714,0.0076353904,0.0016397986,0.0012673251,0.0001597741,0.000024045148,0.004937764],"genre_scores_gemma":[0.9835775,0.013874898,0.000047490357,0.000599788,0.00046222412,0.00014561934,0.000012182571,0.000031412746,0.0012488804],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972852,0.00033737763,0.0006959656,0.0004730417,0.0006063548,0.0006020715],"domain_scores_gemma":[0.9961594,0.00072040525,0.0010762447,0.0012235963,0.0006189612,0.00020144435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086595817,0.00027795177,0.0014694248,0.00031389578,0.00026205517,0.000029118173,0.00085251086,0.00023235097,0.00021299205],"category_scores_gemma":[0.00053910766,0.00019821912,0.0007571557,0.0004657129,0.0009779005,0.0001137116,0.00028015915,0.0004624928,0.0000032581895],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2453979,0.0040888535,0.4519805,0.0014655424,0.043531477,0.00019393048,0.010073328,0.00020998079,0.043206025,0.00082923885,0.06556385,0.13345939],"study_design_scores_gemma":[0.18851385,0.029221928,0.5401752,0.00034798912,0.0077185514,0.0000022352303,0.0006201246,0.002314822,0.029774673,0.000015723239,0.2006337,0.00066119304],"about_ca_topic_score_codex":0.0057054367,"about_ca_topic_score_gemma":0.0036831663,"teacher_disagreement_score":0.13506985,"about_ca_system_score_codex":0.0003332144,"about_ca_system_score_gemma":0.0009266775,"threshold_uncertainty_score":0.8624952},"labels":[],"label_agreement":null},{"id":"W2613700593","doi":"10.1016/j.lungcan.2017.05.004","title":"Trends, practice patterns and underuse of surgery in the treatment of early stage small cell lung cancer","year":2017,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Contraindication; Stage (stratigraphy); Lung cancer; Cancer; Logistic regression; Pneumonectomy; Medicaid; Surgical oncology; Surgery; General surgery; Internal medicine; Health care; Pathology","score_opus":0.07380272844780107,"score_gpt":0.41596516259941896,"score_spread":0.3421624341516179,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613700593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97068995,0.021995535,0.0000063789325,0.0042130803,0.00018353302,0.0005106532,0.00018829205,0.0000088146835,0.0022037586],"genre_scores_gemma":[0.95326483,0.0432652,0.0000299421,0.00014003422,0.00015247532,0.00029006228,0.0000041711432,0.000022207094,0.0028310583],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986566,0.000100041085,0.00028497743,0.00027030316,0.00037356597,0.00031454442],"domain_scores_gemma":[0.9983077,0.0005140793,0.0003403065,0.00063137285,0.0001337243,0.0000727934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030721087,0.00017313226,0.0004799285,0.00014084202,0.000109939465,0.000033637476,0.00015470531,0.000056020905,0.00011318856],"category_scores_gemma":[0.0000979033,0.00011102534,0.000099609955,0.000114429124,0.00016766813,0.00014904953,0.00005647919,0.00013996015,2.9398493e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004992398,0.00030902008,0.97941947,0.0009328022,0.00036634845,0.00007246294,0.006730468,0.000008883682,0.00025638036,0.000017553126,0.0013534933,0.010033873],"study_design_scores_gemma":[0.0020913926,0.00027469662,0.98616314,0.0005621169,0.00047389412,0.0000023862522,0.0008474548,0.00010852984,0.002586817,0.0000023570226,0.006764764,0.00012242633],"about_ca_topic_score_codex":0.0899809,"about_ca_topic_score_gemma":0.017450009,"teacher_disagreement_score":0.07253089,"about_ca_system_score_codex":0.0004086155,"about_ca_system_score_gemma":0.0003481058,"threshold_uncertainty_score":0.9737514},"labels":[],"label_agreement":null},{"id":"W2624841205","doi":"10.1200/jco.2016.71.7454","title":"Carboplatin and Etoposide With or Without Palifosfamide in Untreated Extensive-Stage Small-Cell Lung Cancer: A Multicenter, Adaptive, Randomized Phase III Study (MATISSE)","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lakeridge Health","funders":"","keywords":"Medicine; Carboplatin; Etoposide; Clinical endpoint; Lung cancer; Phases of clinical research; Internal medicine; Adverse effect; Chemotherapy; Randomized controlled trial; Gastroenterology; Surgery; Cisplatin","score_opus":0.13933934224863498,"score_gpt":0.5256645909311786,"score_spread":0.3863252486825436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2624841205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911659,0.0019653381,0.000104421415,0.0028226143,0.00030805316,0.0027233243,0.000009181391,0.000011310954,0.0008898659],"genre_scores_gemma":[0.991867,0.003938229,0.0020980875,0.0004960791,0.00033215428,0.00009785191,8.104454e-7,0.00003117225,0.001138599],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99494976,0.001300462,0.0023981691,0.00038115782,0.0005566059,0.00041383103],"domain_scores_gemma":[0.9908943,0.0044461796,0.0028652125,0.00040375764,0.0008969125,0.0004936039],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052198907,0.00028580343,0.004246681,0.00020618935,0.00024031251,0.00004000775,0.00028646793,0.00020803757,0.00006339632],"category_scores_gemma":[0.008165558,0.00015461593,0.0002269233,0.0001012823,0.0008001339,0.00016623891,0.00034853283,0.0013747785,0.0000010107999],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5527285,0.0031097303,0.42521936,0.000104578954,0.0015878149,0.0061460864,0.0020598548,0.000016183372,0.0001364851,0.000002689722,0.00017585569,0.008712919],"study_design_scores_gemma":[0.83721054,0.018620118,0.13084218,0.00093106664,0.0020838701,0.0001224087,0.0029805775,0.006606842,0.00010640171,0.000008171192,0.00030088308,0.00018695994],"about_ca_topic_score_codex":0.0040670307,"about_ca_topic_score_gemma":0.016358599,"teacher_disagreement_score":0.29437718,"about_ca_system_score_codex":0.00031071837,"about_ca_system_score_gemma":0.002172532,"threshold_uncertainty_score":0.9775526},"labels":[],"label_agreement":null},{"id":"W2642802273","doi":"10.1016/j.jtho.2017.06.015","title":"Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone to Prophylactic Cranial Irradiation and Consolidative Extracranial Irradiation for Extensive-Disease Small Cell Lung Cancer (ED SCLC): NRG Oncology RTOG 0937","year":2017,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":168,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute","keywords":"Prophylactic cranial irradiation; Medicine; Oncology; Randomized controlled trial; Radiation therapy; Internal medicine; Nuclear medicine; Conventional PCI","score_opus":0.05793151531993769,"score_gpt":0.4838327757027396,"score_spread":0.4259012603828019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2642802273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97203547,0.0018602235,0.001967847,0.011480494,0.0022651742,0.010034691,0.000056496745,0.000038259343,0.00026136724],"genre_scores_gemma":[0.9916867,0.0003536665,0.0034207036,0.00045232542,0.002834677,0.0009122318,0.000017470802,0.00007533093,0.00024691733],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.994627,0.0014554575,0.0016188741,0.00071415317,0.00081827684,0.000766253],"domain_scores_gemma":[0.99190074,0.0014167789,0.0029691833,0.0005164054,0.002311837,0.0008850375],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0037109908,0.0005155262,0.0026680976,0.00070652895,0.0013622475,0.00019088414,0.00040238397,0.00027950713,0.00006623503],"category_scores_gemma":[0.0063319704,0.00042853292,0.00036729284,0.0002125227,0.000502468,0.00070427574,0.00022406258,0.00093870907,0.00000694397],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.85995203,0.006858086,0.008399964,0.0013662182,0.0016644954,0.0011108022,0.012332632,0.0003678324,0.017842872,0.000020491765,0.0012952476,0.08878932],"study_design_scores_gemma":[0.6848668,0.050603308,0.20997904,0.0005204172,0.012976655,0.00043322975,0.0023480156,0.033848763,0.0007175225,0.000422633,0.002236765,0.001046875],"about_ca_topic_score_codex":0.00037020523,"about_ca_topic_score_gemma":0.0004279298,"teacher_disagreement_score":0.20157908,"about_ca_system_score_codex":0.002548647,"about_ca_system_score_gemma":0.0035759448,"threshold_uncertainty_score":0.99993783},"labels":[],"label_agreement":null},{"id":"W2687777185","doi":"10.1016/j.radonc.2017.06.005","title":"The incidence of symptomatic brain metastases from extra-pulmonary small cell carcinoma: Is there a role for prophylactic cranial irradiation in a clinically relevant population cohort?","year":2017,"lang":"en","type":"article","venue":"Radiotherapy and Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Incidence (geometry); Cohort; Oncology; Internal medicine; Population; Radiology","score_opus":0.027319765760346695,"score_gpt":0.3618371475955857,"score_spread":0.33451738183523905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2687777185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819153,0.01012699,0.00015466179,0.0059638955,0.00010143607,0.0015497218,0.000033274442,0.000009782096,0.00014494461],"genre_scores_gemma":[0.9953533,0.0017985238,0.0019999489,0.00031277357,0.00017831147,0.00021315333,0.00001119591,0.000017705914,0.000115094794],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986538,0.00024224169,0.00044338824,0.0002729209,0.00016673018,0.00022087213],"domain_scores_gemma":[0.9973102,0.0018077226,0.00038685574,0.00035412467,0.00007944419,0.000061648985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096515234,0.00012492198,0.00047845734,0.000055214314,0.00026663838,0.000028449575,0.00016371746,0.00011718126,0.0000154839],"category_scores_gemma":[0.00065937557,0.00008305949,0.000080004145,0.000044058936,0.00023272412,0.000086943706,0.000032165022,0.00016692486,5.6526426e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038484975,0.00027820643,0.90834045,0.00026477315,0.00014217022,0.00003789545,0.0019316738,0.000004673391,0.011943527,0.00007462217,0.00012792554,0.07300559],"study_design_scores_gemma":[0.0034649055,0.0021174925,0.98543733,0.00006375742,0.0001027605,0.00001335285,0.0001926308,0.0055995276,0.00028285108,0.0015974856,0.0010405924,0.00008729158],"about_ca_topic_score_codex":0.0027766307,"about_ca_topic_score_gemma":0.0016433725,"teacher_disagreement_score":0.0770969,"about_ca_system_score_codex":0.00032231864,"about_ca_system_score_gemma":0.00025505098,"threshold_uncertainty_score":0.41974536},"labels":[],"label_agreement":null},{"id":"W2699278758","doi":"10.1016/s1470-2045(17)30318-2","title":"Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial","year":2017,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":570,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa","funders":"Cancer Research UK","keywords":"Medicine; Chemoradiotherapy; Regimen; Lung cancer; Radiation therapy; Etoposide; Chemotherapy regimen; Internal medicine; Clinical endpoint; Performance status; Surgery; Randomized controlled trial; Chemotherapy; Oncology","score_opus":0.15045437894064043,"score_gpt":0.4667886956623838,"score_spread":0.3163343167217434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2699278758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9807629,0.001177687,0.000013062536,0.005767933,0.0016097073,0.0063020294,0.00013645043,0.000060053248,0.004170154],"genre_scores_gemma":[0.99137837,0.0025605266,0.00019735772,0.0014506269,0.0017439899,0.0014886457,0.00006559295,0.00007466504,0.0010401994],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9968519,0.0005788234,0.00048076053,0.000675016,0.00049031945,0.00092317665],"domain_scores_gemma":[0.99710894,0.0004804021,0.00042628107,0.0014255613,0.00028063337,0.00027818832],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013909034,0.00039148054,0.0017439977,0.00008958431,0.0005141053,0.00017724882,0.0014839284,0.0001913051,0.00029497093],"category_scores_gemma":[0.00036522374,0.00024864209,0.000062160834,0.00015849095,0.00074971543,0.00033992765,0.00041788907,0.0008797793,0.000011911797],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.89005584,0.0045053526,0.07243042,0.00022919542,0.00061051943,0.00013513256,0.002352051,0.0000041831045,0.0006390958,0.00003632375,0.0045136255,0.024488276],"study_design_scores_gemma":[0.9205495,0.018314356,0.01795355,0.00013041719,0.00027997146,0.0000018998685,0.00017710461,0.00050433143,0.00040653624,0.0000035078426,0.041352227,0.00032660583],"about_ca_topic_score_codex":0.0031041836,"about_ca_topic_score_gemma":0.0049625635,"teacher_disagreement_score":0.05447687,"about_ca_system_score_codex":0.0013145186,"about_ca_system_score_gemma":0.0013289542,"threshold_uncertainty_score":0.9999966},"labels":[],"label_agreement":null},{"id":"W2724508033","doi":"10.1371/journal.pone.0180258","title":"RBM10 promotes transformation-associated processes in small cell lung cancer and is directly regulated by RBM5","year":2017,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences North; Laurentian University","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Lung cancer; Transformation (genetics); Cancer research; Biology; Medicine; Oncology; Genetics; Gene","score_opus":0.040349274366560405,"score_gpt":0.3078051572573502,"score_spread":0.2674558828907898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2724508033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98089117,0.0067053386,9.913008e-7,0.008253519,0.000012510144,0.0010641227,0.000086657004,0.000064682885,0.00292102],"genre_scores_gemma":[0.9909657,0.0047260597,0.00007303536,0.00012758997,0.000036102407,0.0002496215,0.000025872523,0.00002450241,0.0037714771],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998877,0.00002195727,0.00020704941,0.00024297634,0.00032654827,0.0003244818],"domain_scores_gemma":[0.9991991,0.000060124905,0.0001092041,0.00023109872,0.00029728777,0.00010318477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017977359,0.00014519482,0.00036912443,0.00007472612,0.00022511628,0.00006929132,0.00012411883,0.000083687984,0.000053747466],"category_scores_gemma":[0.0004940791,0.00012312751,0.000020770052,0.00014597796,0.00011112296,0.00020292425,0.000045562327,0.00020977411,0.000003563954],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004013283,0.0029842323,0.79692924,0.011675577,0.0013629888,0.0000254751,0.019136703,4.341464e-7,0.16009763,0.0000037146904,0.005293532,0.002089146],"study_design_scores_gemma":[0.0060254885,0.00035604453,0.1745773,0.0047037937,0.00057825027,0.0000010890219,0.00019069058,0.0013999587,0.81140876,0.000072356204,0.0003252302,0.00036103735],"about_ca_topic_score_codex":0.0015284681,"about_ca_topic_score_gemma":0.0018881841,"teacher_disagreement_score":0.65131116,"about_ca_system_score_codex":0.00018874784,"about_ca_system_score_gemma":0.00021117319,"threshold_uncertainty_score":0.5020994},"labels":[],"label_agreement":null},{"id":"W2739368227","doi":"10.1200/jco.2017.35.15_suppl.2073","title":"Neurocognitive function testing and health related quality of life in stage IV lung cancer patients with and without brain metastases.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Neurocognitive; Lung cancer; Internal medicine; Quality of life (healthcare); Stage (stratigraphy); Oncology; Cancer; Gastroenterology; Cognition","score_opus":0.3114774786996251,"score_gpt":0.5797852137703787,"score_spread":0.2683077350707536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739368227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875245,0.0010772136,0.000018350998,0.010546596,0.00015776661,0.00038119446,0.00001527384,0.000002940442,0.00027614651],"genre_scores_gemma":[0.99755156,0.00054161175,0.00052354217,0.001209245,0.00010516879,0.0000050394874,8.5585026e-7,0.000009297235,0.000053674485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969671,0.0007066583,0.0016266434,0.00017414377,0.0003438155,0.00018168408],"domain_scores_gemma":[0.99305105,0.0025782865,0.0032367017,0.00012018302,0.0007055797,0.0003082152],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00628349,0.00009324335,0.001408227,0.00009148589,0.00009465016,0.000009412223,0.000060869355,0.000090896276,0.000011105925],"category_scores_gemma":[0.03133062,0.00005968053,0.000052286003,0.000072280665,0.00047454785,0.00016517281,0.00009280552,0.00080577,1.0824584e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006650407,0.0003904117,0.95831484,0.00021729522,0.00036740748,0.00002236379,0.00013937383,0.00000304364,0.000010793742,0.000008723331,0.00027044,0.033604912],"study_design_scores_gemma":[0.017265208,0.010845168,0.9708858,0.00041876134,0.00012583149,0.0000064620963,0.000108084474,0.000084776235,0.000001544248,0.00003983652,0.00017061426,0.000047929818],"about_ca_topic_score_codex":0.0017628933,"about_ca_topic_score_gemma":0.0015604472,"teacher_disagreement_score":0.033556983,"about_ca_system_score_codex":0.00012642278,"about_ca_system_score_gemma":0.0017464968,"threshold_uncertainty_score":0.9768289},"labels":[],"label_agreement":null},{"id":"W2739590162","doi":"10.1158/1538-7445.am2017-2248","title":"Abstract 2248: Common <i>TDP1</i> polymorphisms in relation to survival among small cell lung cancer patients in a multicenter study from the International Lung Cancer Consortium","year":2017,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Sinai Health System; Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Internal medicine; Hazard ratio; Lung cancer; Genotype; Oncology; Medicine; Topotecan; Topoisomerase; Irinotecan; Cancer; Confidence interval; Biology; Genetics; Chemotherapy; Gene; DNA; Colorectal cancer","score_opus":0.07079258910405739,"score_gpt":0.43121373376579725,"score_spread":0.36042114466173986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739590162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820564,0.002222962,0.0000018270816,0.00771022,0.001242825,0.0044898638,0.00031751048,0.000026232916,0.0019321641],"genre_scores_gemma":[0.99328923,0.0014731141,0.000011188383,0.0003017893,0.00061948295,0.0031183516,0.0000387416,0.00006882701,0.0010792913],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99500287,0.00036360516,0.0006639274,0.0008902994,0.002039657,0.0010396477],"domain_scores_gemma":[0.99703556,0.0006575401,0.0002356455,0.0010202801,0.00074657734,0.00030439434],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001863487,0.00031676696,0.00055357936,0.00041346057,0.00053807895,0.00028795624,0.0012866146,0.00013724333,0.0007251578],"category_scores_gemma":[0.00071893295,0.00024545527,0.00009381767,0.00042391173,0.0003830025,0.00036823834,0.0010802463,0.0016630609,0.000019537521],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016476248,0.0007547576,0.9809944,0.000085012696,0.00025774696,0.000094401235,0.006097305,0.00020363998,0.0019757678,0.0000029075054,0.0061983885,0.0016880302],"study_design_scores_gemma":[0.0070146862,0.000115557224,0.9878211,0.0011365104,0.000055070745,7.899271e-8,0.00097211223,0.0009199972,0.0011969499,0.0000071812465,0.0005250783,0.00023565673],"about_ca_topic_score_codex":0.4126386,"about_ca_topic_score_gemma":0.42314604,"teacher_disagreement_score":0.0112328185,"about_ca_system_score_codex":0.0036438962,"about_ca_system_score_gemma":0.00088577473,"threshold_uncertainty_score":0.99999976},"labels":[],"label_agreement":null},{"id":"W2748804458","doi":"10.1016/j.ijrobp.2014.08.288","title":"Evaluation of Prognostic Variables in Patients With Small Cell Lung Cancer: The Role of Volumetric Response to Initial Therapy in Determining the Benefit of Prophylactic Cranial Irradiation","year":2014,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; American Society of Clinical Oncology; York University; Teva Pharmaceutical Industries; Genentech; National Aeronautics and Space Administration; U.S. Department of Defense","keywords":"Medicine; Prophylactic cranial irradiation; Conventional PCI; Lung cancer; Proportional hazards model; Radiation therapy; Stage (stratigraphy); Hazard ratio; Internal medicine; Retrospective cohort study; Nuclear medicine; Chemotherapy; Cancer; Oncology; Surgery; Radiology; Confidence interval; Myocardial infarction","score_opus":0.02379437390616405,"score_gpt":0.35432225058366723,"score_spread":0.33052787667750316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2748804458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99719113,0.00043881588,0.00035251703,0.0006176416,0.00029149943,0.0009992633,0.000025548678,0.0000028972195,0.000080675134],"genre_scores_gemma":[0.9990035,0.00010064565,0.00042320706,0.000090056375,0.00028616312,0.00006879617,0.000010966502,0.000014569168,0.0000020425095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99725384,0.0009066446,0.0007443361,0.00014743354,0.0007857589,0.00016199442],"domain_scores_gemma":[0.9941777,0.0015975927,0.0012107806,0.00013736308,0.0028376002,0.00003895411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033404627,0.00012500024,0.0003969195,0.0004138439,0.000035171823,0.000008265209,0.00031000306,0.00008964177,0.000011167118],"category_scores_gemma":[0.002753311,0.000077317934,0.00007215953,0.0005377471,0.00014280065,0.0001261235,0.000045505873,0.0002928056,3.7618165e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004349589,0.0004893417,0.8255921,0.000017474582,0.00018851386,5.2709765e-7,0.0015540217,0.0068981363,0.0017057678,0.00009230664,0.00000534184,0.15910688],"study_design_scores_gemma":[0.0101323305,0.0039389622,0.9700266,0.00013368706,0.00016997253,0.0000018359686,0.000101891885,0.012488115,0.0019633279,0.0008844964,0.00009150169,0.00006727409],"about_ca_topic_score_codex":0.00017906303,"about_ca_topic_score_gemma":0.00008071046,"teacher_disagreement_score":0.1590396,"about_ca_system_score_codex":0.00085957116,"about_ca_system_score_gemma":0.0011835257,"threshold_uncertainty_score":0.32961693},"labels":[],"label_agreement":null},{"id":"W2754680561","doi":"10.1016/j.clon.2017.09.002","title":"The CONVERT Trial: Interpretation, Journey and Lessons Learnt","year":2017,"lang":"en","type":"editorial","venue":"Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Cancer Society Research Institute; National Institute for Health and Care Research; Cancer Research UK","keywords":"Medicine; Radiation therapy; Chemoradiotherapy; Lung cancer; Clinical trial; Randomized controlled trial; Chemotherapy; Oncology; Internal medicine","score_opus":0.18343334459035662,"score_gpt":0.5933799124866903,"score_spread":0.40994656789633366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754680561","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024602027,0.0043690456,0.000012470163,0.055138335,0.9265666,0.0010839553,0.000026343792,0.000041527022,0.012515702],"genre_scores_gemma":[0.0020654981,0.05325553,0.000050002545,0.00048333377,0.9130875,0.0001977958,0.0000509369,0.000047537,0.030761864],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99644476,0.00084874174,0.001079092,0.00056656596,0.0006331971,0.00042762145],"domain_scores_gemma":[0.9670489,0.029882312,0.0009013107,0.00090499665,0.00088627427,0.00037619655],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0054330095,0.00024123043,0.001543262,0.00005469102,0.00054240966,0.000100563666,0.00048830465,0.0014268712,0.000042483272],"category_scores_gemma":[0.118305944,0.00014024986,0.00031989533,0.0000365209,0.0024801427,0.000046993024,0.0005471989,0.0035969687,0.00010372025],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0297255,0.00013869582,0.00013054618,0.000069672074,0.00063959305,0.000090783724,0.00009776991,1.9153704e-8,3.3853078e-7,0.000046883335,0.87513316,0.09392707],"study_design_scores_gemma":[0.035796665,0.006978595,0.0008211352,0.00021196408,0.00044709133,0.000007074138,0.00007952749,0.000017823066,4.3440699e-7,0.0004010172,0.9551149,0.00012378983],"about_ca_topic_score_codex":0.00007576252,"about_ca_topic_score_gemma":0.00046518192,"teacher_disagreement_score":0.112872936,"about_ca_system_score_codex":0.00037466388,"about_ca_system_score_gemma":0.0051612067,"threshold_uncertainty_score":0.99986947},"labels":[],"label_agreement":null},{"id":"W2758484518","doi":"10.1016/j.ijrobp.2017.06.1669","title":"Treatment, Technology, and Time Trends in the Management of Limited-Stage Small Cell Lung Cancer","year":2017,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Radiation therapy; Chemoradiotherapy; Conventional PCI; Stage (stratigraphy); Lung cancer; Logistic regression; Statistical significance; Retrospective cohort study; Internal medicine; Oncology","score_opus":0.03237294400331394,"score_gpt":0.3926802650978611,"score_spread":0.36030732109454716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2758484518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9671686,0.0031812273,0.00020982863,0.019342244,0.0005143198,0.0003361585,0.00008363237,0.000014958248,0.009149027],"genre_scores_gemma":[0.9909983,0.00643292,0.00083517464,0.00016321379,0.00044245267,0.00003761391,0.000016543501,0.000012619097,0.0010611494],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989823,0.000083747305,0.00039808772,0.0001648406,0.00019017176,0.00018083202],"domain_scores_gemma":[0.99850756,0.00013619612,0.0007948754,0.00023345243,0.00028293813,0.000044952816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034900603,0.000138494,0.0003753864,0.00035599663,0.00009679418,0.000023534978,0.0004685239,0.00012195849,0.00003879269],"category_scores_gemma":[0.000051509756,0.00009248294,0.00010785971,0.00015164689,0.00035195056,0.00012173908,0.000119762306,0.00027712947,0.0000028166637],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000374399,0.00048741171,0.7097691,0.000037666407,0.001328326,0.00016283314,0.0006866796,0.000060338934,0.0016219409,0.006301312,0.00074516993,0.27842477],"study_design_scores_gemma":[0.030122247,0.00498312,0.85329974,0.0004656427,0.0011256301,0.00022943372,0.0009775291,0.0047726207,0.0063412185,0.005032042,0.09226905,0.0003817122],"about_ca_topic_score_codex":0.00007069902,"about_ca_topic_score_gemma":0.000019767014,"teacher_disagreement_score":0.27804306,"about_ca_system_score_codex":0.0006403548,"about_ca_system_score_gemma":0.0001636697,"threshold_uncertainty_score":0.37713447},"labels":[],"label_agreement":null},{"id":"W2767096845","doi":"10.1016/j.athoracsur.2017.07.009","title":"Surgical Treatment for Early Small Cell Lung Cancer: Variability in Practice and Impact on Survival","year":2017,"lang":"en","type":"article","venue":"The Annals of Thoracic Surgery","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Quartile; Hazard ratio; Confidence interval; Odds ratio; Lung cancer; Proportional hazards model; Comorbidity; Logistic regression; Surgery; Cancer; Internal medicine","score_opus":0.1798770833228253,"score_gpt":0.5124172341637343,"score_spread":0.33254015084090904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767096845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9796121,0.0024861768,0.0000044109624,0.014457008,0.0001487943,0.00085934176,0.00007941096,0.000013092827,0.0023396371],"genre_scores_gemma":[0.9929104,0.0062394557,0.000030666903,0.000078779114,0.00020285153,0.00016549263,0.000004322195,0.000018447883,0.00034962475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982407,0.0004756338,0.00029241244,0.00028632465,0.0002983735,0.00040653924],"domain_scores_gemma":[0.98994535,0.008632089,0.0002682347,0.00074804435,0.0002729441,0.00013333277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055789077,0.0001840314,0.00064744544,0.000091084345,0.0001998379,0.000047224225,0.0001424038,0.000062790095,0.000020241714],"category_scores_gemma":[0.0030804242,0.000102324164,0.00024409968,0.0000807454,0.00021888594,0.00013197414,0.00009308547,0.00016018443,0.0000012811565],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020292426,0.0008335306,0.88814175,0.0006171835,0.00072774664,0.000112573696,0.000811919,0.000018076738,0.00011111398,0.00004110066,0.0018899157,0.08640268],"study_design_scores_gemma":[0.0013991629,0.0012803049,0.9716109,0.00076745223,0.00046379014,0.000019699552,0.00025145916,0.00049912435,0.017679656,0.00031273163,0.005412455,0.0003032756],"about_ca_topic_score_codex":0.0060213883,"about_ca_topic_score_gemma":0.00013210191,"teacher_disagreement_score":0.0860994,"about_ca_system_score_codex":0.00013161951,"about_ca_system_score_gemma":0.00036488086,"threshold_uncertainty_score":0.91025776},"labels":[],"label_agreement":null},{"id":"W2767853540","doi":"10.1016/j.jtho.2016.11.929","title":"P1.07-017 Indications for Adjuvant Mediastinal Radiation in Surgically Resected Small Cell Lung Cancer","year":2017,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Proportional hazards model; Pneumonectomy; Resection margin; Hazard ratio; Radiation therapy; Lung cancer; Comorbidity; Survival analysis; Cancer; Stage (stratigraphy); Oncology; Internal medicine; Surgery; Resection; Confidence interval","score_opus":0.05568723844528266,"score_gpt":0.5043517592412755,"score_spread":0.44866452079599284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767853540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95635444,0.005570194,0.00061043026,0.03257706,0.0009976821,0.0009231168,0.00003334282,0.000011966174,0.0029217813],"genre_scores_gemma":[0.9915765,0.002771493,0.0031839197,0.00019105124,0.001180209,0.00012815358,0.000007966402,0.000021168064,0.00093955576],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982472,0.00018157226,0.0006352879,0.00018587486,0.00037374656,0.00037632298],"domain_scores_gemma":[0.99706066,0.0006446165,0.0011128476,0.00029462698,0.00065532234,0.00023194287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016660432,0.00012909537,0.00063781923,0.00037647277,0.00025670437,0.00003501668,0.00037534756,0.00016419015,0.00013010102],"category_scores_gemma":[0.002597822,0.00010010359,0.00014449356,0.00011484724,0.00020074804,0.00016658065,0.00010239577,0.0006371361,0.00000476906],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013828091,0.0013870317,0.4947798,0.0013296728,0.0007051833,0.0014414807,0.0035953382,0.00012547147,0.012162916,0.00008788963,0.044630498,0.42592663],"study_design_scores_gemma":[0.0060279574,0.0026725866,0.94439834,0.0006516972,0.00056138524,0.00026701562,0.0003180507,0.0009822015,0.003077893,0.0002949715,0.040567394,0.00018052303],"about_ca_topic_score_codex":0.00015211814,"about_ca_topic_score_gemma":0.00088221993,"teacher_disagreement_score":0.44961852,"about_ca_system_score_codex":0.0011531332,"about_ca_system_score_gemma":0.0022710874,"threshold_uncertainty_score":0.4082106},"labels":[],"label_agreement":null},{"id":"W2769343437","doi":"10.21037/jtd.2017.11.23","title":"Surgery for small cell lung cancer in the modern era: opportunities and challenges","year":2017,"lang":"en","type":"letter","venue":"Journal of Thoracic Disease","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Medicine; Lung cancer; Lung; Surgery; General surgery; Oncology; Internal medicine","score_opus":0.1825703947129138,"score_gpt":0.412831140887854,"score_spread":0.2302607461749402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769343437","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004479595,0.2538037,0.000011926464,0.74009246,0.0003715749,0.0005888733,0.00020196449,0.0000055513974,0.00044433502],"genre_scores_gemma":[0.07094935,0.700326,0.00015394077,0.19684955,0.019305982,0.0006554799,0.00006770007,0.00020108881,0.011490885],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99793214,0.00020660438,0.00047060015,0.00023670561,0.00072448025,0.00042949477],"domain_scores_gemma":[0.9973326,0.00090188364,0.00066739036,0.0004594551,0.00040211697,0.00023658849],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013050538,0.00028842903,0.00085030834,0.00037355706,0.00015050198,0.00011360359,0.0003669887,0.00017103164,0.000018972352],"category_scores_gemma":[0.0005397832,0.00017481706,0.00038673522,0.0000319114,0.00019172736,0.00015878782,0.00009174154,0.0013240159,3.3840718e-7],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011224404,0.00010251597,0.0025533487,0.024104819,0.00044033493,0.009198262,0.00089410227,0.000003515708,0.0000018325675,0.0000022731674,0.9237051,0.037871435],"study_design_scores_gemma":[0.0015438251,0.00029980726,0.023420498,0.016108068,0.00418242,0.00025885832,0.0009637787,0.000358446,0.0000125240485,0.0013973411,0.9507862,0.0006682811],"about_ca_topic_score_codex":0.000027464725,"about_ca_topic_score_gemma":0.000023355073,"teacher_disagreement_score":0.54324293,"about_ca_system_score_codex":0.00018439369,"about_ca_system_score_gemma":0.0016768513,"threshold_uncertainty_score":0.7128833},"labels":[],"label_agreement":null},{"id":"W2769943794","doi":"10.1200/jco.2017.76.0645","title":"Reply to D.T.W. Jones et al","year":2017,"lang":"en","type":"letter","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Humanities","score_opus":0.31410172871791164,"score_gpt":0.6230269659975991,"score_spread":0.30892523727968746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769943794","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013367714,0.000877831,0.000024198776,0.9707858,0.0055921385,0.00034565246,0.000012461072,0.0000127053145,0.021012438],"genre_scores_gemma":[0.00042175388,0.0028427055,0.0024249963,0.9556075,0.024020717,0.000010561294,0.0000062173717,0.000049803693,0.014615783],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9941082,0.0008363473,0.0028564106,0.00039703783,0.0012935916,0.00050843356],"domain_scores_gemma":[0.9888683,0.005037038,0.0033275587,0.00080950797,0.0014276569,0.00052994175],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.008088472,0.00026953197,0.0036742538,0.0002896489,0.00008669062,0.00003557649,0.00072417303,0.0010052469,0.00022436705],"category_scores_gemma":[0.04131779,0.00017493375,0.0011407564,0.00006909332,0.0004687654,0.00010631064,0.00037870256,0.009980374,0.00021212468],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019430659,0.00021837572,0.0027812668,0.000085247484,0.0011988238,0.023552623,0.000048136324,3.9712103e-7,0.000005783713,0.0000042964148,0.946318,0.023844017],"study_design_scores_gemma":[0.0034835362,0.015712913,0.017626079,0.0005700108,0.0004176051,0.0013263418,0.0000121270905,7.777892e-7,0.000004146448,0.00015934519,0.96054053,0.00014656373],"about_ca_topic_score_codex":0.000092261864,"about_ca_topic_score_gemma":0.000024650813,"teacher_disagreement_score":0.03322932,"about_ca_system_score_codex":0.00041262337,"about_ca_system_score_gemma":0.006194397,"threshold_uncertainty_score":0.99943954},"labels":[],"label_agreement":null},{"id":"W2789846220","doi":"10.1002/prca.201700084","title":"An MRM‐Based Cytokeratin Marker Assay as a Tool for Cancer Studies: Application to Lung Cancer Pleural Effusions","year":2018,"lang":"en","type":"article","venue":"PROTEOMICS - CLINICAL APPLICATIONS","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Genome British Columbia; Jewish General Hospital; University of Victoria","funders":"Narodowe Centrum Nauki","keywords":"Cytokeratin; Lung cancer; Medicine; Pleural fluid; Pathology; Pleural effusion; Oncology; Tumor marker; Cancer research; Cancer; Internal medicine; Immunohistochemistry","score_opus":0.08450941785232464,"score_gpt":0.5404492689821476,"score_spread":0.455939851129823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789846220","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30149338,0.0013303242,0.5784329,0.07519187,0.00043873896,0.040824596,0.00113965,0.0005298643,0.00061864563],"genre_scores_gemma":[0.61478096,0.0010480877,0.118503764,0.013922202,0.004805786,0.24510297,0.00021886655,0.00015563896,0.0014617135],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.996651,0.00015749951,0.0010093652,0.001081351,0.00047833036,0.00062248716],"domain_scores_gemma":[0.9952439,0.0010766484,0.00027044694,0.0011496777,0.001751889,0.00050745247],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016650517,0.00032481688,0.00069295184,0.000137245,0.0007392152,0.00006124638,0.0004306514,0.00019677599,0.0001633092],"category_scores_gemma":[0.0015207934,0.00027478873,0.00023718872,0.0006576501,0.00050495664,0.0001180041,0.00019450679,0.00043249616,0.00013187241],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009812942,0.0058558867,0.36150327,0.002796865,0.0041152854,0.0000054388165,0.0027961163,0.0005042052,0.16950446,0.009959539,0.13535029,0.29779568],"study_design_scores_gemma":[0.0143383145,0.004828158,0.12526882,0.0010068129,0.0023429217,0.000009368131,0.0006214358,0.14971124,0.033025905,0.004791371,0.66183335,0.0022223091],"about_ca_topic_score_codex":0.0003631163,"about_ca_topic_score_gemma":0.0008798395,"teacher_disagreement_score":0.52648306,"about_ca_system_score_codex":0.0006371765,"about_ca_system_score_gemma":0.0010578334,"threshold_uncertainty_score":0.99997044},"labels":[],"label_agreement":null},{"id":"W2795047916","doi":"10.1016/j.ijrobp.2018.01.108","title":"A Small Window of Opportunity When Disease Is Limited in Extensive-Stage Small Cell Lung Cancer?","year":2018,"lang":"en","type":"letter","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Radiology; Pulmonary function testing; Radiation therapy; Lung cancer; Stage (stratigraphy); Vital capacity; Small Cell Lung Carcinoma; Small-cell carcinoma; Lung; Thorax (insect anatomy); Diffusing capacity; Biopsy; Conventional PCI; Internal medicine; Myocardial infarction; Lung function; Anatomy","score_opus":0.06398726882915338,"score_gpt":0.37173532529853914,"score_spread":0.30774805646938574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2795047916","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2991228,0.007512672,0.0014440356,0.68047285,0.005751071,0.001740638,0.0024096544,0.00006207935,0.0014841888],"genre_scores_gemma":[0.17078109,0.021404238,0.0042746826,0.7471157,0.048058707,0.00026907615,0.0020761408,0.00034611867,0.005674256],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961859,0.00053940277,0.0014675349,0.0005218486,0.00073369103,0.0005516375],"domain_scores_gemma":[0.99202365,0.00084718736,0.0027438516,0.0004115278,0.0036367944,0.00033700748],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00076905126,0.00048478428,0.0013979013,0.0007198698,0.00006724373,0.000029262752,0.00089774805,0.0007570797,0.00037736562],"category_scores_gemma":[0.0011687333,0.00043176932,0.0005465077,0.0002583344,0.0005848628,0.00017964703,0.00027485142,0.0026521247,0.000012760655],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001966875,0.0007083345,0.37169036,0.0005803635,0.0026305527,0.0019673277,0.0016985446,0.00010500983,0.000931277,0.00009203053,0.6049118,0.012717499],"study_design_scores_gemma":[0.016526183,0.0026572759,0.05765287,0.0019012538,0.0015036846,0.000112712994,0.000181302,0.0025366216,0.002054022,0.003475632,0.91054463,0.00085381634],"about_ca_topic_score_codex":0.00032152288,"about_ca_topic_score_gemma":0.000054251595,"teacher_disagreement_score":0.3140375,"about_ca_system_score_codex":0.0027431566,"about_ca_system_score_gemma":0.005059221,"threshold_uncertainty_score":0.99981344},"labels":[],"label_agreement":null},{"id":"W2800252028","doi":"10.1016/j.ijrobp.2018.04.058","title":"Prophylactic Cranial Irradiation in Extensive Stage Small Cell Lung Cancer: Outcomes at a Comprehensive Cancer Centre","year":2018,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Conventional PCI; Brain metastasis; Internal medicine; Lung cancer; Multivariate analysis; Oncology; Univariate analysis; Cancer; Radiation therapy; Stage (stratigraphy); Randomized controlled trial; Metastasis; Surgery","score_opus":0.03143533037194826,"score_gpt":0.3892543607506191,"score_spread":0.3578190303786708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800252028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.981711,0.002504866,0.0003870799,0.010510703,0.0035058756,0.00070898444,0.00016687567,0.000031856176,0.0004727714],"genre_scores_gemma":[0.99105716,0.002068402,0.0007013112,0.0020238995,0.003406901,0.000050189716,0.00004122458,0.000040104613,0.0006108051],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976522,0.00028353266,0.0007998447,0.0003532828,0.00048791707,0.0004232237],"domain_scores_gemma":[0.9954107,0.00045603764,0.0011423968,0.00017359544,0.0026381698,0.00017913867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002947805,0.00027943557,0.0007265412,0.00030612972,0.00012320573,0.000027311984,0.00033484038,0.00021174517,0.0002755935],"category_scores_gemma":[0.00035374542,0.00023350464,0.00022073508,0.00026344828,0.00033973504,0.0002485624,0.00014845429,0.00060654833,0.000030113297],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001633506,0.00039791295,0.95913,0.000080623046,0.0007499179,0.00013302744,0.002560143,0.0005722044,0.011358182,0.000343364,0.0020413226,0.020999791],"study_design_scores_gemma":[0.02207535,0.0020259542,0.92164236,0.00025339832,0.0004624926,0.0000812694,0.0006298251,0.0075395443,0.0075524515,0.0008269534,0.036417626,0.00049277593],"about_ca_topic_score_codex":0.0005885032,"about_ca_topic_score_gemma":0.00058015285,"teacher_disagreement_score":0.03748765,"about_ca_system_score_codex":0.004887731,"about_ca_system_score_gemma":0.0014868479,"threshold_uncertainty_score":0.9989323},"labels":[],"label_agreement":null},{"id":"W2802321489","doi":"10.21037/jtd.2018.03.121","title":"A lower level of forced expiratory volume in one second predicts the poor prognosis of small cell lung cancer","year":2018,"lang":"en","type":"article","venue":"Journal of Thoracic Disease","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital","funders":"","keywords":"Medicine; COPD; Internal medicine; Lung cancer; Hazard ratio; Proportional hazards model; Pulmonary function testing; Multivariate analysis; Vital capacity; Retrospective cohort study; Log-rank test; Oncology; Lung; Confidence interval; Lung function; Diffusing capacity","score_opus":0.0791309594943882,"score_gpt":0.38271467388917485,"score_spread":0.30358371439478665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802321489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883337,0.008358592,0.00009032143,0.0017013233,0.0002209586,0.00062843575,0.00015018928,0.0000050471817,0.00051140774],"genre_scores_gemma":[0.99692726,0.00025603292,0.00030128416,0.0002620709,0.00044259845,0.00004377126,0.000001044975,0.000023170254,0.0017427738],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980877,0.00012012817,0.0006426113,0.00014997426,0.00071322214,0.0002863544],"domain_scores_gemma":[0.99788386,0.000089803194,0.0005524615,0.00025106192,0.00091051724,0.00031230773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071361585,0.00014257975,0.00048365857,0.00022473527,0.000045144378,0.00001072759,0.00026793723,0.000046484187,0.00050695013],"category_scores_gemma":[0.00041835007,0.00009237027,0.00021095596,0.0003121462,0.00033035016,0.00013915228,0.00011700168,0.00029475294,0.000002186424],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012619695,0.002415701,0.90005475,0.009725837,0.0011766304,0.00030052304,0.0033241203,0.00004804302,0.023262184,0.000008354766,0.040059242,0.0070049],"study_design_scores_gemma":[0.003822624,0.0021564385,0.92698234,0.0063442565,0.0015080777,0.00001057961,0.00089991785,0.0011898123,0.054856315,0.00007792724,0.0019179843,0.0002337164],"about_ca_topic_score_codex":0.00006800408,"about_ca_topic_score_gemma":0.00015035296,"teacher_disagreement_score":0.038141258,"about_ca_system_score_codex":0.00020180857,"about_ca_system_score_gemma":0.0011793108,"threshold_uncertainty_score":0.5550749},"labels":[],"label_agreement":null},{"id":"W2810830875","doi":"10.1016/j.jval.2018.04.094","title":"Approaches for Estimating the Comparative Efficacy of Treatments for Patients with Recurrent Small Cell Lung Cancer (SCLC) within Connected and Disconnected Networks of Evidence","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"Topotecan; Medicine; Nivolumab; Internal medicine; Oncology; Ipilimumab; Randomized controlled trial; Hazard ratio; Chemotherapy; Cancer; Confidence interval; Immunotherapy","score_opus":0.2681648071868797,"score_gpt":0.4290487568621788,"score_spread":0.16088394967529912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810830875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859668,0.004103715,0.0033762243,0.00041898846,0.00010235241,0.0059545515,0.000059902115,0.00001021565,0.0000072627577],"genre_scores_gemma":[0.9852339,0.0001523935,0.013876281,0.000025710873,0.00008474069,0.0005806041,0.000019990883,0.000015600112,0.000010746749],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99862814,0.00016362226,0.000444362,0.00027560344,0.00019196016,0.00029632924],"domain_scores_gemma":[0.9971464,0.0018436813,0.00042280057,0.00018565703,0.0003225792,0.00007883014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005258445,0.00014609746,0.0004999672,0.00006123987,0.00013195767,0.000006328255,0.000082278966,0.00003046821,0.0000012157083],"category_scores_gemma":[0.0004586821,0.0000762995,0.000032205375,0.00024264316,0.00024429825,0.00004257649,0.000040590898,0.00010755242,3.143583e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0109109115,0.00131494,0.90229136,0.00864381,0.0006250746,3.6970854e-7,0.041188676,0.026797367,0.00003004982,0.00019308462,0.00028807163,0.0077162655],"study_design_scores_gemma":[0.007958301,0.0067016697,0.32025337,0.005071002,0.0002090411,3.632652e-7,0.0005699639,0.6587668,0.00032607155,0.000032922835,0.0000034363354,0.00010703443],"about_ca_topic_score_codex":0.0016165795,"about_ca_topic_score_gemma":0.0004025942,"teacher_disagreement_score":0.63196945,"about_ca_system_score_codex":0.00021364674,"about_ca_system_score_gemma":0.00038676837,"threshold_uncertainty_score":0.31114033},"labels":[],"label_agreement":null},{"id":"W2815764189","doi":"10.1016/j.clon.2018.06.008","title":"Guideline for the Initial Management of Small Cell Lung Cancer (Limited and Extensive Stage) and the Role of Thoracic Radiotherapy and First-line Chemotherapy","year":2018,"lang":"en","type":"review","venue":"Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Sunnybrook Health Science Centre; Juravinski Cancer Centre; McMaster University; Thunder Bay Regional Health Sciences Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Radiation therapy; Regimen; Irinotecan; Guideline; Etoposide; Oncology; Chemotherapy; Carboplatin; Lung cancer; Stage (stratigraphy); Internal medicine; Surgery; Cancer; Cisplatin; Colorectal cancer; Pathology","score_opus":0.1655876035082247,"score_gpt":0.5609793436833594,"score_spread":0.39539174017513473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2815764189","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00049591047,0.98895705,0.00037519448,0.0045255814,0.00022452783,0.0050613154,0.00010608629,0.000009622877,0.0002447217],"genre_scores_gemma":[0.00009234701,0.9940662,0.0025463256,0.0012331209,0.00085287174,0.0005876024,0.000016447177,0.00004980888,0.00055528694],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970201,0.00043225367,0.0015677914,0.0005005921,0.00019180306,0.0002874352],"domain_scores_gemma":[0.9910586,0.006887922,0.0009805806,0.00047473237,0.00048609273,0.00011205763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002896521,0.00031574926,0.0029003324,0.00007641108,0.00010944174,0.0000089812065,0.00022536317,0.00034835035,0.000045690933],"category_scores_gemma":[0.00044661056,0.00014995525,0.00033996222,0.00015174385,0.0024695005,0.000015980106,0.0002635072,0.00045128065,2.3860414e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031715874,0.00016371513,0.0001918855,0.016345244,0.00295167,0.000009249264,0.00023107696,4.962906e-7,5.3317393e-7,0.00007536333,0.0027728868,0.9740863],"study_design_scores_gemma":[0.0072498075,0.0021958286,0.00020319258,0.0032409532,0.0038328227,0.000012524322,0.00018147468,0.000761712,0.0000052159007,0.00008846047,0.9820942,0.00013376166],"about_ca_topic_score_codex":0.000107568376,"about_ca_topic_score_gemma":0.000102725244,"teacher_disagreement_score":0.97932136,"about_ca_system_score_codex":0.00011360877,"about_ca_system_score_gemma":0.0004162943,"threshold_uncertainty_score":0.90989774},"labels":[],"label_agreement":null},{"id":"W2883045134","doi":"","title":"From Targeted to Pinpoint: The Implementation of Pharmacogenomics in Clinical Oncology","year":2017,"lang":"en","type":"article","venue":"UBC Faculty of Medicine medical journal","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pharmacogenomics; Medicine; Tolerability; Pace; Oncology; Imatinib; Cancer; Internal medicine; Intensive care medicine; Bioinformatics; Pharmacology; Biology; Adverse effect","score_opus":0.13131760824608513,"score_gpt":0.5617596773999427,"score_spread":0.4304420691538576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883045134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7509985,0.0005674232,0.00019929593,0.24633583,0.00078144914,0.0003996601,0.00003623011,0.000005284951,0.0006763439],"genre_scores_gemma":[0.9917529,0.0017156908,0.0007639652,0.0030140334,0.0026345924,0.000011762233,0.000026928095,0.000014270717,0.00006580937],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99579436,0.00030613015,0.0015781323,0.00022242391,0.0017507905,0.0003481479],"domain_scores_gemma":[0.9971587,0.0005865221,0.0007968052,0.00038337416,0.00041490572,0.0006596587],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0056751072,0.00014947381,0.00096821354,0.00015473804,0.0001705802,0.000008148217,0.00072415743,0.00013441472,0.0019268604],"category_scores_gemma":[0.00868329,0.00008076374,0.0001603232,0.00011385576,0.0013709966,0.000069446935,0.0002900729,0.0011529325,0.000010410222],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016709954,0.00036458738,0.19480276,0.0000830266,0.0007812607,0.0005150214,0.007788829,0.0000020155758,0.0054327706,0.000038925005,0.14606282,0.642457],"study_design_scores_gemma":[0.024708359,0.0033616738,0.89982164,0.0009662554,0.00031409354,0.00017851664,0.008984583,0.00013253828,0.0024447092,0.00044923247,0.058524214,0.00011420192],"about_ca_topic_score_codex":0.0031292792,"about_ca_topic_score_gemma":0.0006617893,"teacher_disagreement_score":0.7050189,"about_ca_system_score_codex":0.00022165566,"about_ca_system_score_gemma":0.001274417,"threshold_uncertainty_score":0.999667},"labels":[],"label_agreement":null},{"id":"W2883956485","doi":"10.1093/icvts/ivy223","title":"Is lobectomy superior to sublobar resection for early-stage small-cell lung cancer discovered intraoperatively?","year":2018,"lang":"en","type":"review","venue":"Interactive Cardiovascular and Thoracic Surgery","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Stage (stratigraphy); Lung cancer; Surgery; Pneumonectomy; Oncology","score_opus":0.09074264587629223,"score_gpt":0.4284799213802781,"score_spread":0.33773727550398586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883956485","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009398588,0.98130214,0.00097422284,0.00010435542,0.0013413591,0.005196396,0.0011776502,0.00006265436,0.00044261885],"genre_scores_gemma":[0.0030328103,0.98773974,0.00011348711,0.0001489633,0.0017431892,0.004217734,0.00017122985,0.00019998943,0.0026328638],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954602,0.00066375744,0.0007882348,0.0015112692,0.00073410757,0.0008424199],"domain_scores_gemma":[0.99607384,0.0012522775,0.00021775864,0.00096032827,0.0010591715,0.00043663237],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015910661,0.0008703017,0.004274154,0.0007229286,0.00030655545,0.00023245337,0.00019950366,0.00035551822,0.00018700259],"category_scores_gemma":[0.00094508624,0.000669069,0.0041295444,0.00072426815,0.00020788657,0.00031949478,0.00032689574,0.0007519831,0.00004787644],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002691996,0.00016875508,0.0014830263,0.07875554,0.04094529,0.00030785866,0.0019767755,0.000001935006,0.0000125959505,0.0000016943945,0.01550937,0.8581452],"study_design_scores_gemma":[0.00044091805,0.00028073366,0.000220288,0.024335934,0.0073404093,0.000093459625,0.00020848938,0.000011784107,0.0010347994,0.0000017169481,0.9653021,0.00072933425],"about_ca_topic_score_codex":0.0009947085,"about_ca_topic_score_gemma":0.000085749634,"teacher_disagreement_score":0.94979274,"about_ca_system_score_codex":0.0011938716,"about_ca_system_score_gemma":0.0011033689,"threshold_uncertainty_score":0.99957603},"labels":[],"label_agreement":null},{"id":"W2885149505","doi":"10.21037/jtd.2018.06.98","title":"The evolving role of radiotherapy in the management of small cell lung cancer","year":2018,"lang":"en","type":"review","venue":"Journal of Thoracic Disease","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Medicine; Radiation therapy; Lung cancer; Oncology; Intensive care medicine; Medical physics; Pathology; Bioinformatics; Radiology; Biology","score_opus":0.03796293180624902,"score_gpt":0.44578805279646483,"score_spread":0.40782512099021584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885149505","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033009902,0.99714303,0.000015531696,0.00036361045,0.00018661158,0.0011057671,0.00002884343,0.000002423636,0.00082410476],"genre_scores_gemma":[0.00060974754,0.9980113,0.00027106234,0.000036751288,0.000453181,0.00007562715,0.0000016107623,0.000034214754,0.0005064938],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972818,0.0003884438,0.0009772186,0.00015788012,0.0009108605,0.00028378158],"domain_scores_gemma":[0.99739397,0.00031518255,0.0012512436,0.0005442029,0.00033681485,0.00015856717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018331468,0.00024097541,0.0011890763,0.00022590128,0.00007166187,0.00002801206,0.000759156,0.000053614927,0.000055244902],"category_scores_gemma":[0.00009243306,0.000108091364,0.0007277765,0.0004266993,0.00019313174,0.000055481953,0.00011513707,0.00046783066,9.896753e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007742157,0.00040231162,0.0012407582,0.15575203,0.002956248,0.00029907454,0.0006334316,0.000007755337,0.0000021620363,0.000024735606,0.007126888,0.8307804],"study_design_scores_gemma":[0.00075090455,0.00030744198,0.0020087902,0.14187168,0.0084464615,0.000025962516,0.0008246458,0.00007764869,0.000007632551,0.00008515168,0.84539306,0.00020064165],"about_ca_topic_score_codex":0.00002413803,"about_ca_topic_score_gemma":0.0000075614976,"teacher_disagreement_score":0.83826613,"about_ca_system_score_codex":0.0004199674,"about_ca_system_score_gemma":0.00088205485,"threshold_uncertainty_score":0.4407838},"labels":[],"label_agreement":null},{"id":"W2886015068","doi":"10.1111/crj.12950","title":"Impact of baseline characteristics on extensive‐stage SCLC patients treated with etoposide/carboplatin: A secondary analysis of a phase III study","year":2018,"lang":"en","type":"article","venue":"The Clinical Respiratory Journal","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; University of Calgary","funders":"","keywords":"Medicine; Internal medicine; Univariate analysis; Multivariate analysis; Oncology; Carboplatin; Proportional hazards model; Etoposide; Performance status; Univariate; Stage (stratigraphy); Multivariate statistics; Chemotherapy; Cisplatin","score_opus":0.09689549558880146,"score_gpt":0.48052804002598554,"score_spread":0.3836325444371841,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886015068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998528,0.00008103465,0.00003392074,0.00007497936,0.00006930738,0.00072553847,0.0001741295,0.000012113615,0.00030098518],"genre_scores_gemma":[0.9988894,0.000050664697,0.000028361395,0.00047271376,0.00040570312,0.0000087495,0.000010210936,0.000027252576,0.00010695842],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99571556,0.00097465364,0.001633927,0.00031419052,0.0010194507,0.0003422086],"domain_scores_gemma":[0.99359244,0.0014212532,0.0012180873,0.0007377036,0.0026644573,0.00036605314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036163582,0.0002545798,0.0014347135,0.00037099601,0.00019412553,0.000022361439,0.00026064453,0.000082340746,0.0005519397],"category_scores_gemma":[0.00416139,0.00012505995,0.0005743347,0.000994793,0.00084520155,0.00007576703,0.00010429155,0.0009660896,0.0000058873193],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02879705,0.005112427,0.9355937,0.000023450555,0.0105350865,0.00015405672,0.00065921043,0.000006225825,0.0006181333,0.0000012892505,0.000791158,0.017708179],"study_design_scores_gemma":[0.019536104,0.05839708,0.91752124,0.00018741086,0.0033196965,0.0000048191014,0.00025530637,0.00030581464,0.00018487129,0.0000019786585,0.0001741265,0.00011157238],"about_ca_topic_score_codex":0.000055324963,"about_ca_topic_score_gemma":0.00004209809,"teacher_disagreement_score":0.053284656,"about_ca_system_score_codex":0.00016576744,"about_ca_system_score_gemma":0.0008387402,"threshold_uncertainty_score":0.6043353},"labels":[],"label_agreement":null},{"id":"W2888508386","doi":"10.21037/apm.2018.07.10","title":"Immunotherapy and radiotherapy for metastatic cancers","year":2018,"lang":"en","type":"review","venue":"Annals of Palliative Medicine","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Immunotherapy; Radiation therapy; Oncology; Internal medicine; Intensive care medicine; Medical physics; Cancer","score_opus":0.33581688569249024,"score_gpt":0.5592838748085075,"score_spread":0.22346698911601726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888508386","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000008523132,0.99272656,0.00051629194,0.0027192472,0.00019890192,0.0032222844,0.00015977529,0.000023026436,0.0004254137],"genre_scores_gemma":[0.000004371661,0.99450904,0.0013184805,0.00088946905,0.00086568895,0.0006053784,0.00008937488,0.000090944566,0.0016272357],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99748677,0.000155254,0.00085085386,0.0005073493,0.0005417686,0.0004580165],"domain_scores_gemma":[0.9968281,0.0011432533,0.00065998523,0.00044307503,0.0007339151,0.00019168638],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001027504,0.0005094156,0.003916346,0.00038328776,0.00008200513,0.0000059214162,0.00019546335,0.00011298735,0.000196142],"category_scores_gemma":[0.0007668754,0.0003031962,0.00041886335,0.00041294846,0.0012724092,0.000039761097,0.00003734203,0.00026314872,0.0000030044441],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041726322,0.000055804383,0.000039577444,0.05576826,0.007977063,0.000011717805,0.0012796606,4.533273e-8,0.000010212095,0.00019354248,0.08063536,0.85361147],"study_design_scores_gemma":[0.0024167795,0.0040985346,0.000072775176,0.03694297,0.0011163094,0.000006506591,0.00011346285,0.0000074733052,0.000018023598,0.0002770205,0.9547121,0.00021802708],"about_ca_topic_score_codex":0.00016159975,"about_ca_topic_score_gemma":0.000018245959,"teacher_disagreement_score":0.8740768,"about_ca_system_score_codex":0.00020805623,"about_ca_system_score_gemma":0.00068617205,"threshold_uncertainty_score":0.999942},"labels":[],"label_agreement":null},{"id":"W2890544386","doi":"10.1200/jco.2017.35.15_suppl.e20019","title":"A meta-analysis of trials of etoposide plus platinum agent versus irinotecan/topotecan plus platinum agent in first-line therapy of extensive stage small cell lung cancer (ES SCLC).","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network; Thunder Bay Regional Health Sciences Centre; Health Sciences Centre; Princess Margaret Cancer Centre; Juravinski Cancer Centre; Sunnybrook Health Science Centre; Cancer Care Ontario","funders":"","keywords":"Medicine; Irinotecan; Topotecan; Internal medicine; Etoposide; Neutropenia; Randomized controlled trial; Oncology; Meta-analysis; Chemotherapy; Cancer; Colorectal cancer","score_opus":0.5605280711602462,"score_gpt":0.570289572427092,"score_spread":0.009761501266845829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890544386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97405064,0.015879417,0.00017504874,0.0065829176,0.0010750953,0.0011659454,0.00022855419,0.0000057092793,0.000836698],"genre_scores_gemma":[0.9761796,0.020886037,0.0015194279,0.00029746493,0.0005100687,0.000043904063,0.0000055252094,0.000032812426,0.000525159],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.98870456,0.0015625282,0.0074953814,0.00045412924,0.0012760346,0.00050736446],"domain_scores_gemma":[0.97084457,0.012005051,0.013754067,0.00095793064,0.0020356083,0.0004027721],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0131067075,0.000372236,0.011181032,0.000764411,0.00010193987,0.000015094806,0.00075724756,0.00047313818,0.0009107659],"category_scores_gemma":[0.017574186,0.000244162,0.004219298,0.00041160377,0.00088273006,0.00012007139,0.00034781703,0.0013139481,0.0000010448163],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1869717,0.006526657,0.10191512,0.0016180468,0.6077089,0.0026421088,0.007794857,0.044339646,0.006887479,0.00014691667,0.0038697477,0.02957885],"study_design_scores_gemma":[0.1515025,0.051557057,0.45478913,0.0007821711,0.29597887,0.000022862378,0.0022984056,0.007268703,0.022468382,0.00020383198,0.012303235,0.000824837],"about_ca_topic_score_codex":0.004200682,"about_ca_topic_score_gemma":0.011296416,"teacher_disagreement_score":0.352874,"about_ca_system_score_codex":0.00088294974,"about_ca_system_score_gemma":0.004638332,"threshold_uncertainty_score":0.9972248},"labels":[],"label_agreement":null},{"id":"W2895657963","doi":"10.1016/j.jtho.2018.09.019","title":"Prophylactic Cranial Irradiation for Limited-Stage Small-Cell Lung Cancer Patients: Secondary Findings From the Prospective Randomized Phase 3 CONVERT Trial","year":2018,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Canadian Cancer Society Research Institute; European Organisation for Research and Treatment of Cancer; Ministère des Affaires Sociales et de la Santé; Cancer Research UK","keywords":"Prophylactic cranial irradiation; Medicine; Conventional PCI; Univariate analysis; Chemoradiotherapy; Radiation therapy; Brain metastasis; Lung cancer; Internal medicine; Stage (stratigraphy); Nuclear medicine; Surgery; Multivariate analysis; Oncology; Radiology; Cancer; Metastasis; Myocardial infarction","score_opus":0.02859961238320336,"score_gpt":0.4390860858578507,"score_spread":0.41048647347464734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2895657963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98266983,0.0013047929,0.00062057015,0.0059481016,0.0030525785,0.005552627,0.00012642218,0.000015486154,0.0007095644],"genre_scores_gemma":[0.9918488,0.00020714788,0.0009906018,0.0010311863,0.004479875,0.00042370826,0.000017630024,0.000033526245,0.00096748234],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99759144,0.0005474378,0.0008209287,0.0002489235,0.00044263114,0.00034866153],"domain_scores_gemma":[0.9950441,0.0021155952,0.0009543696,0.00017872501,0.0015521323,0.00015503728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018533164,0.00020189844,0.0010996547,0.00015902925,0.0002540295,0.000040735704,0.00021856697,0.00016617092,0.00042454386],"category_scores_gemma":[0.0029150124,0.000117334865,0.00035926778,0.00019131986,0.0004264944,0.00019457166,0.00006387784,0.00066929916,0.0000063301527],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96736205,0.0012091062,0.002620468,0.00020127448,0.0010029768,0.000031093416,0.004063384,9.3251134e-7,0.001409392,0.000009170007,0.009444093,0.012646079],"study_design_scores_gemma":[0.9545202,0.019306293,0.0044416366,0.00015189596,0.0026734802,0.000014794433,0.00050199946,0.0008379486,0.0039934083,0.00025839533,0.013118612,0.0001812842],"about_ca_topic_score_codex":0.00012260619,"about_ca_topic_score_gemma":0.00010217114,"teacher_disagreement_score":0.018097186,"about_ca_system_score_codex":0.0013494686,"about_ca_system_score_gemma":0.0019598939,"threshold_uncertainty_score":0.4784777},"labels":[],"label_agreement":null},{"id":"W2896512435","doi":"10.1016/j.ijrobp.2018.07.1939","title":"A Novel and Practical Prognostic Model for Limited-Stage Small-Cell Lung Cancer","year":2018,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Medicine; Proportional hazards model; Internal medicine; Clinical endpoint; Recursive partitioning; Oncology; Stage (stratigraphy); Retrospective cohort study; Radiation therapy; Lung cancer; Pleural effusion; Progression-free survival; Hazard ratio; Prophylactic cranial irradiation; Prognostic variable; Population; Chemotherapy; Cancer; Clinical trial; Confidence interval; Conventional PCI","score_opus":0.06688022832148097,"score_gpt":0.43082721582544914,"score_spread":0.36394698750396814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896512435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5294837,0.0018965487,0.43719125,0.026263976,0.002490298,0.0012596755,0.00029704455,0.000055018154,0.0010625091],"genre_scores_gemma":[0.9579606,0.0015163888,0.033120412,0.0019430432,0.004699224,0.00010663604,0.000033762568,0.00003925179,0.0005806753],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99866533,0.000063761436,0.00048510224,0.00023835318,0.0002707798,0.0002766719],"domain_scores_gemma":[0.9964603,0.00079028367,0.00060689973,0.000104898514,0.0018745558,0.00016304146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005302025,0.00016542965,0.0003995586,0.00013751433,0.00010068617,0.000029856483,0.00015796408,0.00016533457,0.000024968404],"category_scores_gemma":[0.0012635103,0.00013590849,0.00012924375,0.0001046824,0.0003293944,0.00020340155,0.0000986511,0.00040335977,0.0000037381587],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006326732,0.0028740896,0.793024,0.0003404633,0.00488178,0.00010494017,0.004521419,0.0018839154,0.056953833,0.029468862,0.023027943,0.07659201],"study_design_scores_gemma":[0.025851939,0.005566096,0.024310717,0.00032454086,0.0011384487,0.00042326303,0.00029045498,0.8738504,0.0051802564,0.0051369285,0.057443105,0.0004838616],"about_ca_topic_score_codex":0.000018178895,"about_ca_topic_score_gemma":0.000020578547,"teacher_disagreement_score":0.8719665,"about_ca_system_score_codex":0.0007315162,"about_ca_system_score_gemma":0.0014380052,"threshold_uncertainty_score":0.5542187},"labels":[],"label_agreement":null},{"id":"W2897369942","doi":"10.1158/1078-0432.ccr-18-2014","title":"A Phase I Dose-Escalation Study of Veliparib Combined with Carboplatin and Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer and Other Solid Tumors","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"AbbVie","keywords":"Veliparib; Carboplatin; Medicine; Etoposide; Internal medicine; Tolerability; Oncology; Pharmacokinetics; Chemotherapy; Pharmacology; Adverse effect; Surgery; Cisplatin","score_opus":0.12093273205170117,"score_gpt":0.5074382325365686,"score_spread":0.3865055004848674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897369942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949991,0.00077095896,0.0000042031593,0.00039571256,0.000046053603,0.0033555909,0.00004892122,0.000017398255,0.00036203623],"genre_scores_gemma":[0.99851286,0.00021084277,0.00008135827,0.00013853246,0.00015406693,0.0004355146,0.0000046794908,0.00005155732,0.00041060237],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965677,0.0004035649,0.00063846924,0.0007225983,0.0010594663,0.00060817297],"domain_scores_gemma":[0.9971013,0.0006285072,0.00017721932,0.00042937114,0.0013362318,0.00032738587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015210904,0.00022496148,0.0007819926,0.00027739326,0.00016019709,0.00003331428,0.00013691791,0.00009813926,0.00007630039],"category_scores_gemma":[0.00039900123,0.00015097651,0.000028157696,0.0006655385,0.0012978069,0.000084734056,0.00025427405,0.0008364676,0.000001200919],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02353952,0.0028395515,0.9665294,0.0004083154,0.00021628178,0.000039212373,0.0028191134,0.000009755403,0.00017435144,0.0000052141127,0.00023049585,0.003188761],"study_design_scores_gemma":[0.04678887,0.029869737,0.91928273,0.00079933397,0.00010808019,6.1260056e-7,0.0013281689,0.00094971014,0.0005812052,0.0000069802068,0.00010469617,0.0001798986],"about_ca_topic_score_codex":0.0079716705,"about_ca_topic_score_gemma":0.015852226,"teacher_disagreement_score":0.04724672,"about_ca_system_score_codex":0.00024148668,"about_ca_system_score_gemma":0.00068736664,"threshold_uncertainty_score":0.99863434},"labels":[],"label_agreement":null},{"id":"W2897371223","doi":"10.1016/j.jgo.2018.10.001","title":"The effect of age on referral to an oncologist and receipt of chemotherapy among small cell lung cancer patients in Ontario, Canada","year":2018,"lang":"en","type":"article","venue":"Journal of Geriatric Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Juravinski Cancer Centre; University of Manitoba; CancerCare Manitoba; McMaster University","funders":"Ontario Ministry of Health and Long-Term Care; National Comprehensive Cancer Network; Ontario Institute for Cancer Research; Cancer Care Ontario; McMaster University; Institute for Clinical Evaluative Sciences","keywords":"Medicine; Receipt; Referral; Lung cancer; Chemotherapy; Family medicine; Internal medicine; Oncology","score_opus":0.014602637008806471,"score_gpt":0.3403001184491374,"score_spread":0.3256974814403309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897371223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996047,0.00032837834,9.467954e-7,0.00086160394,0.0005950085,0.00054403156,0.00000401089,0.0000015497949,0.0016174638],"genre_scores_gemma":[0.9985693,0.00043234965,0.00012518224,0.00018657802,0.00023883038,0.00001550582,7.494912e-7,0.000011802312,0.0004197189],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984356,0.00026574888,0.0005507663,0.00013977391,0.0003360487,0.00027205714],"domain_scores_gemma":[0.9983577,0.0004945322,0.00051057135,0.00015205513,0.0003228693,0.00016222923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009478095,0.00012498362,0.0006709244,0.0001734309,0.00005771969,0.000005047616,0.00017301353,0.00009131465,0.00004927471],"category_scores_gemma":[0.00028590893,0.00007341036,0.00005169916,0.00022440708,0.00019921912,0.000035073142,0.000055142293,0.00039270686,1.4252294e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073059206,0.00018824129,0.966991,0.000094748684,0.0001244097,0.000071220435,0.0011875321,0.000010195166,0.0008928163,0.000001109644,0.012538868,0.010593939],"study_design_scores_gemma":[0.0052838386,0.031704724,0.95118827,0.00009463508,0.00008881098,0.0000062932627,0.00009941152,0.00000777302,0.00330696,0.0000031831773,0.008154825,0.00006128114],"about_ca_topic_score_codex":0.77031,"about_ca_topic_score_gemma":0.9860135,"teacher_disagreement_score":0.21570352,"about_ca_system_score_codex":0.0028558637,"about_ca_system_score_gemma":0.0022483957,"threshold_uncertainty_score":0.7467984},"labels":[],"label_agreement":null},{"id":"W2898354241","doi":"10.1016/j.jtho.2018.08.1767","title":"P3.08-16 Prognostic Value of PDL-1 Expression and Correlation Between Primary Tissue and Brain Metastases in Oligometastatic NSCLC","year":2018,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Internal medicine; Oncology; Primary tumor; Biopsy; Lung cancer; Incidence (geometry); Cohort; Immunohistochemistry; Cancer; Pathology; Metastasis","score_opus":0.0320720943749037,"score_gpt":0.44708829714619647,"score_spread":0.41501620277129275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898354241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899955,0.003893663,0.0015199808,0.0033747356,0.0001554402,0.0004314769,0.000014396871,0.0000054354746,0.00060940784],"genre_scores_gemma":[0.9895914,0.0003447752,0.009427574,0.00015291134,0.00031260072,0.0000071852296,0.000006667941,0.000013898749,0.00014296],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99812734,0.0004953243,0.000626174,0.00016050816,0.0003684166,0.00022223123],"domain_scores_gemma":[0.997463,0.0014748703,0.0005014146,0.000114912385,0.00029035818,0.00015543275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017758445,0.00012597084,0.0007734885,0.00044681,0.000051960367,0.000009129508,0.00006641851,0.0000941656,0.00004176554],"category_scores_gemma":[0.0017435205,0.00009107017,0.000040028306,0.00024950967,0.0004127815,0.00018092645,0.00012555068,0.00034228904,0.000002552825],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052318457,0.00058046635,0.35249397,0.0018581403,0.0005767587,0.0005393606,0.0038887137,0.000009452528,0.07580515,0.00005777396,0.0073944177,0.5515639],"study_design_scores_gemma":[0.005060487,0.020612594,0.9275934,0.0028679548,0.0011446846,0.0014765266,0.0012080742,0.00011953972,0.025869833,0.0019892477,0.011823354,0.00023430273],"about_ca_topic_score_codex":0.00003115623,"about_ca_topic_score_gemma":0.000025257714,"teacher_disagreement_score":0.5750994,"about_ca_system_score_codex":0.0002642455,"about_ca_system_score_gemma":0.0003547349,"threshold_uncertainty_score":0.3713734},"labels":[],"label_agreement":null},{"id":"W2898447721","doi":"10.1016/j.jtho.2018.08.846","title":"P1.12-11 2010 – 2015 Extensive Stage SCLC Diagnoses in a Canadian Institution: Baseline Characteristics That Impact on the Overall Survival","year":2018,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Radiation therapy; Lung cancer; Statistical significance; Confidence interval; Internal medicine; Cancer; Survival analysis; Stage (stratigraphy); Oncology; Conventional PCI","score_opus":0.06932617902037251,"score_gpt":0.46729817399630774,"score_spread":0.3979719949759352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898447721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9336731,0.00045883143,0.000031608386,0.060662933,0.0024108335,0.00042579824,0.00010626475,0.000008432697,0.0022222064],"genre_scores_gemma":[0.99249274,0.0009097238,0.00015806343,0.0028873659,0.002103585,0.0000114069335,0.000007855673,0.00002031705,0.0014089494],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975747,0.00052310573,0.000512814,0.00019371994,0.0005632308,0.0006324182],"domain_scores_gemma":[0.9967982,0.0009940257,0.00042753058,0.0003270239,0.0009008472,0.0005523802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028158294,0.00022053912,0.0007514727,0.00039558872,0.00017596655,0.000036267524,0.00026731275,0.00016522262,0.00072828494],"category_scores_gemma":[0.003779931,0.00012516795,0.00016245586,0.0002228837,0.0005034281,0.00017851716,0.00008078448,0.0008860552,0.000052984222],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011562597,0.0009747173,0.5733985,0.00016699368,0.00085387815,0.012563912,0.0025453186,0.000037958915,0.0009385836,0.0004678665,0.3603196,0.036170088],"study_design_scores_gemma":[0.0011777931,0.0039071054,0.7569411,0.0004191083,0.00012647909,0.0005172252,0.0005248855,0.00014875724,0.00034256533,0.000072403454,0.23566969,0.00015289636],"about_ca_topic_score_codex":0.036100328,"about_ca_topic_score_gemma":0.26449886,"teacher_disagreement_score":0.22839853,"about_ca_system_score_codex":0.0028390628,"about_ca_system_score_gemma":0.0045945127,"threshold_uncertainty_score":0.9703184},"labels":[],"label_agreement":null},{"id":"W2898452066","doi":"10.1016/j.jtho.2018.08.845","title":"P1.12-10 Patterns of Curative Chemo-Radiotherapy Regimen and Impacts on the Outcome of Limited Stage SCLC in a Canadian Institution: 2010 – 2015 Diagnoses","year":2018,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Conventional PCI; Radiation therapy; Statistical significance; Internal medicine; Exact test; Regimen; Stage (stratigraphy); Lung cancer; Confidence interval; Surgery","score_opus":0.07010327992927107,"score_gpt":0.4832179830159742,"score_spread":0.4131147030867031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898452066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9542594,0.00093223836,0.000010079166,0.042209808,0.00029340983,0.00035087392,0.00003488398,0.000002568056,0.0019067486],"genre_scores_gemma":[0.99641937,0.0013458065,0.00018510256,0.00081288756,0.00026513005,0.000007281357,0.000001130687,0.000010461911,0.0009528416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984964,0.00023611638,0.00053498836,0.00011782434,0.00031566442,0.0002989708],"domain_scores_gemma":[0.9980702,0.00051143824,0.0005233977,0.00020899877,0.00043136624,0.0002546053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012121948,0.00012853449,0.00064412056,0.00035690988,0.00005829668,0.000007382436,0.00016230003,0.000113716786,0.0002636118],"category_scores_gemma":[0.0012366403,0.00007607164,0.00007181978,0.00021244543,0.000500224,0.00011753686,0.000037873506,0.0004265629,0.0000020070777],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006882198,0.00059538876,0.91793185,0.00031952455,0.00089314784,0.0007350016,0.009269911,0.000009296704,0.004471833,0.00036792448,0.042772777,0.015751155],"study_design_scores_gemma":[0.002990741,0.012389086,0.8932701,0.0010578786,0.00013227476,0.00026725692,0.00270355,0.00005947341,0.009308081,0.00006934513,0.07760072,0.00015149181],"about_ca_topic_score_codex":0.01982815,"about_ca_topic_score_gemma":0.14020003,"teacher_disagreement_score":0.120371886,"about_ca_system_score_codex":0.0010487507,"about_ca_system_score_gemma":0.0014537353,"threshold_uncertainty_score":0.9866989},"labels":[],"label_agreement":null},{"id":"W2898568148","doi":"10.1016/j.jtho.2018.08.844","title":"P1.12-09 The Effect of Site of First Chemotherapy on Small Cell Lung Cancer Patient Outcomes","year":2018,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Cohort; Internal medicine; Neutropenia; Lung cancer; Febrile neutropenia; Chemotherapy; Retrospective cohort study; Cancer; Surgery","score_opus":0.02011478323117746,"score_gpt":0.43761888045381286,"score_spread":0.41750409722263543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898568148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831155,0.0017534283,0.00001885809,0.011010276,0.000638012,0.00050364825,0.0000115333105,0.0000049727314,0.0029437502],"genre_scores_gemma":[0.9974853,0.0007548263,0.00025364713,0.0006211579,0.0003870487,0.000016042048,3.793854e-7,0.000020028487,0.00046161472],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998272,0.0002809415,0.00057970703,0.00012785566,0.00047867405,0.00026079535],"domain_scores_gemma":[0.9974065,0.0010030402,0.00084001425,0.0002739568,0.00037618243,0.000100298865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009896059,0.00016064777,0.00089089986,0.00016901898,0.00007399275,0.0000041710096,0.0002000881,0.00010110088,0.00021216656],"category_scores_gemma":[0.00029936054,0.00007994799,0.00026681746,0.0001552576,0.0003400584,0.000030073892,0.0000752742,0.00040820325,0.0000043119794],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016460648,0.00060389086,0.7910395,0.0012439402,0.0014524888,0.000106551015,0.0067940964,0.000051297604,0.009627599,0.0000045983593,0.024059549,0.14855583],"study_design_scores_gemma":[0.00792851,0.0818759,0.39307502,0.0016743735,0.0014643288,0.00014381738,0.0006447629,0.00022767334,0.41556376,0.000034206987,0.097112015,0.00025563315],"about_ca_topic_score_codex":0.000116477895,"about_ca_topic_score_gemma":0.0002720787,"teacher_disagreement_score":0.40593618,"about_ca_system_score_codex":0.0004699092,"about_ca_system_score_gemma":0.00027117188,"threshold_uncertainty_score":0.32601842},"labels":[],"label_agreement":null},{"id":"W2900369182","doi":"10.1097/coc.0000000000000489","title":"Role of Stereotactic Body Radiation Therapy in Early Stage Small Cell Lung Cancer in the Era of Lung Cancer Screening","year":2018,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Lung cancer; Stage (stratigraphy); Radiation therapy; Cancer; Lung cancer screening; Oncology; Chemotherapy; Radiology; Metastasis; Internal medicine","score_opus":0.10745501994803246,"score_gpt":0.5305652655606843,"score_spread":0.4231102456126518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900369182","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13198417,0.86551017,0.000008845194,0.0007550994,0.0003124678,0.0010813011,0.00003697092,0.0000028180339,0.00030814484],"genre_scores_gemma":[0.053550765,0.9447125,0.00023526602,0.0003217123,0.0009794876,0.00010010775,0.0000026607013,0.000044634933,0.000052847055],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9918645,0.0029082706,0.0037376727,0.00034057756,0.0006819451,0.00046701264],"domain_scores_gemma":[0.98702353,0.0054513495,0.0064132824,0.00039326044,0.0005382434,0.00018035035],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.005212133,0.00033139583,0.0052818554,0.00043172584,0.000029624614,0.000009574352,0.00063917553,0.00027099432,0.000115143834],"category_scores_gemma":[0.0010946399,0.00019833111,0.00083988777,0.00090863067,0.000903732,0.00009513643,0.00010080214,0.0029068412,7.431593e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012884225,0.0004618837,0.18344975,0.0017681775,0.0011055423,0.0000822809,0.0011606291,0.000005837839,0.0000033262515,0.0000022865563,0.00020234828,0.8104695],"study_design_scores_gemma":[0.0097979205,0.024248125,0.34658945,0.026253179,0.003006727,0.000060565064,0.0009756565,0.00017324316,0.000009980302,0.000008911241,0.5884339,0.00044235121],"about_ca_topic_score_codex":0.0052071707,"about_ca_topic_score_gemma":0.0009929748,"teacher_disagreement_score":0.8100272,"about_ca_system_score_codex":0.00070030324,"about_ca_system_score_gemma":0.0057129385,"threshold_uncertainty_score":0.99992377},"labels":[],"label_agreement":null},{"id":"W2900598696","doi":"10.1186/s12935-018-0683-z","title":"Mifepristone inhibits non-small cell lung carcinoma cellular escape from DNA damaging cisplatin","year":2018,"lang":"en","type":"article","venue":"Cancer Cell International","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; McGill University","keywords":"Cisplatin; Clonogenic assay; Medicine; Lung cancer; Cancer research; Chemotherapy; Cancer cell; Cancer; Bleomycin; Oncology; Immunology; Cell; Internal medicine; Biology","score_opus":0.017717238548344345,"score_gpt":0.30611312166329285,"score_spread":0.2883958831149485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900598696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9066663,0.0040204683,0.0010656602,0.0014703965,0.0017368804,0.00046280885,0.00013146852,0.000069857524,0.08437615],"genre_scores_gemma":[0.9818792,0.00032959343,0.0012549649,0.00078709796,0.0032113346,0.00012126699,0.00016800176,0.0000634377,0.012185153],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99765736,0.0000375067,0.00039667415,0.0006571565,0.000762965,0.0004883336],"domain_scores_gemma":[0.9984163,0.000098801145,0.00017015285,0.0004371903,0.0006293931,0.00024816112],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018610842,0.0002933229,0.00035936674,0.00014933622,0.00016567943,0.000065723725,0.0004083296,0.00010222428,0.004431932],"category_scores_gemma":[0.000045783956,0.00028272954,0.00014112242,0.00017929565,0.00023647396,0.00017235099,0.0003557117,0.0003592192,0.00025810208],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042542623,0.00026382718,0.2606684,0.0002602135,0.00033693368,0.00018145004,0.0039721634,0.000018274983,0.64925194,0.000032691212,0.08282729,0.0017614026],"study_design_scores_gemma":[0.004264519,0.00017573882,0.050538324,0.00036970622,0.00019197733,0.0000065697623,0.0005877661,0.010141789,0.8995367,0.00006899484,0.033681467,0.000436417],"about_ca_topic_score_codex":0.0035385678,"about_ca_topic_score_gemma":0.0004782389,"teacher_disagreement_score":0.2502848,"about_ca_system_score_codex":0.0011441825,"about_ca_system_score_gemma":0.00040764423,"threshold_uncertainty_score":0.9999625},"labels":[],"label_agreement":null},{"id":"W2900603576","doi":"10.14740/wjon1163","title":"Serum Carcinoembryonic Antigen Level Predicts Cancer-Specific Outcomes of Resected Non-Small Cell Lung Cancer With Interstitial Pneumonia","year":2018,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Carcinoembryonic antigen; Internal medicine; Lung cancer; Oncology; Stage (stratigraphy); Univariate analysis; Proportional hazards model; Cancer; Gastroenterology; Multivariate analysis","score_opus":0.04819863471184301,"score_gpt":0.372640469793328,"score_spread":0.324441835081485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900603576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98209786,0.0055054002,0.00014878392,0.0056409533,0.0014509463,0.0005510872,0.00007359931,0.000016099666,0.004515256],"genre_scores_gemma":[0.9906836,0.0032942095,0.00084598665,0.0003179949,0.0013988625,0.000031280335,0.0000017654178,0.000045784294,0.0033805238],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99747723,0.00014634535,0.0007875686,0.0002941676,0.00066417,0.00063052436],"domain_scores_gemma":[0.99684435,0.00022768602,0.0007563888,0.00031525435,0.0015535376,0.0003028071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005160384,0.00027027488,0.0011832288,0.0006385511,0.00013602599,0.000013961522,0.00038896603,0.00010865009,0.00050130364],"category_scores_gemma":[0.00007036762,0.0001844048,0.00017689544,0.00061864726,0.0006595932,0.000114509705,0.00017590595,0.00081274734,0.0000049308273],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038062679,0.0003024891,0.92922914,0.00033715318,0.0012557628,0.0005647687,0.0022871895,0.000037571306,0.02973091,0.00000961464,0.027393362,0.005045745],"study_design_scores_gemma":[0.007221653,0.0055063646,0.94974047,0.00089013187,0.0003787419,0.00015040472,0.00038209,0.00007263776,0.013189448,0.000006178689,0.022289492,0.0001723807],"about_ca_topic_score_codex":0.0010415699,"about_ca_topic_score_gemma":0.017078597,"teacher_disagreement_score":0.02051131,"about_ca_system_score_codex":0.0014507509,"about_ca_system_score_gemma":0.0030537574,"threshold_uncertainty_score":0.95302576},"labels":[],"label_agreement":null},{"id":"W2902933008","doi":"10.1016/j.cllc.2018.11.012","title":"Phase 1b/2 Randomized Study of MEDI-575 in Combination With Carboplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel Alone in Adult Patients With Previously Untreated Advanced Non–Small-Cell Lung Cancer","year":2018,"lang":"en","type":"article","venue":"Clinical Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Eli Lilly Japan; Pfizer Japan; Genentech; MSD K.K.; Ono Pharmaceutical; Stiftelsen för Kunskaps- och Kompetensutveckling; Exelixis; Taiho Pharmaceutical; North Carolina GlaxoSmithKline Foundation; Novartis; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Bayer Corporation; Takeda Pharmaceutical Company; AbbVie; MedImmune; Merck; GlaxoSmithKline; Celgene; Bayer","keywords":"Carboplatin; Paclitaxel; Medicine; Lung cancer; Oncology; Internal medicine; Chemotherapy; Cisplatin","score_opus":0.02561469216365942,"score_gpt":0.4055740958390569,"score_spread":0.3799594036753975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902933008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817011,0.00252698,0.000044531233,0.0004454444,0.0006946835,0.013575544,0.000118780285,0.00008143064,0.00081151497],"genre_scores_gemma":[0.993487,0.0012885879,0.00036185057,0.0001834594,0.00027857735,0.003790555,0.000106629705,0.00013241169,0.00037093312],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99276215,0.0009190505,0.0023084076,0.0013745646,0.0015253146,0.0011105316],"domain_scores_gemma":[0.9933907,0.002208231,0.0010757411,0.00093694124,0.0019181697,0.00047025262],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017165487,0.00074863835,0.0032964326,0.00045639937,0.00013691805,0.00003155514,0.00037561328,0.00031772017,0.000117147865],"category_scores_gemma":[0.0019719566,0.0005306622,0.00021197855,0.0015169469,0.0009945256,0.0002569531,0.0002181926,0.0011513504,0.0000033963709],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4407849,0.007770297,0.5360853,0.00093382364,0.001522618,0.00010958427,0.008718594,0.00042197036,0.000042051215,0.000007130697,0.00042801816,0.0031756964],"study_design_scores_gemma":[0.8716496,0.015179989,0.08720984,0.0034428772,0.0017757359,8.154077e-7,0.0018411571,0.018031945,0.00022322718,0.0000054814,0.000018181758,0.0006211232],"about_ca_topic_score_codex":0.014611245,"about_ca_topic_score_gemma":0.07450001,"teacher_disagreement_score":0.4488755,"about_ca_system_score_codex":0.0025828641,"about_ca_system_score_gemma":0.0021305694,"threshold_uncertainty_score":0.9997145},"labels":[],"label_agreement":null},{"id":"W2905529840","doi":"10.1200/jco.18.01585","title":"<i>EGFR</i> -Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":471,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Centre hospitalier universitaire de Québec","funders":"National Cancer Institute; Foundation Medicine; Pharmacyclics; Genentech; Incyte; Five Prime Therapeutics; Syndax Pharmaceuticals; Clovis Oncology; Exelixis; Alexion Pharmaceuticals; Amgen; Ariad Pharmaceuticals; Gilead Sciences; Jounce Therapeutics; Celgene; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Pfizer; Stop Cancer","keywords":"Medicine; T790M; Internal medicine; Oncology; Epidermal growth factor receptor; Lung cancer; Adenocarcinoma; Cancer; Cancer research; Gefitinib","score_opus":0.18107480095245018,"score_gpt":0.5113336326705391,"score_spread":0.3302588317180889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905529840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9171441,0.0026880642,0.00008458042,0.07166685,0.0025681204,0.0007512537,0.000018153303,0.000022885206,0.005055993],"genre_scores_gemma":[0.9626956,0.0032701304,0.0012612521,0.027112726,0.0037142728,0.000023941077,4.3237117e-7,0.000056304154,0.0018653275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99476814,0.00050171744,0.0028758927,0.00049300416,0.0006821204,0.00067914085],"domain_scores_gemma":[0.9935991,0.003147676,0.0009527082,0.0003777224,0.00065288454,0.0012698767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032720002,0.00030888658,0.0026425,0.00021100817,0.00010963763,0.000023057775,0.000371719,0.00022633538,0.00023250844],"category_scores_gemma":[0.0027201865,0.00017970189,0.00075621356,0.00021713295,0.0008194145,0.00011110608,0.00022305067,0.0016744965,0.000024768866],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004857719,0.0007756505,0.9334382,0.00011642088,0.0007612116,0.0011915094,0.00029617615,7.07167e-7,0.000105216,0.000019824214,0.01597982,0.04245757],"study_design_scores_gemma":[0.011645173,0.016503695,0.7178852,0.00014180652,0.00087612885,0.00045481583,0.00020866771,0.0000429232,0.0004584961,0.000053066662,0.25155148,0.00017855612],"about_ca_topic_score_codex":0.00025217116,"about_ca_topic_score_gemma":0.0009147424,"teacher_disagreement_score":0.23557167,"about_ca_system_score_codex":0.0002802634,"about_ca_system_score_gemma":0.0020137664,"threshold_uncertainty_score":0.73280305},"labels":[],"label_agreement":null},{"id":"W2906110772","doi":"10.1016/j.jval.2018.09.103","title":"PCN21 - COMPARATIVE EFFICACY OF NIVOLUMAB±IPILIMUMAB VERSUS STANDARD OF CARE (SOC) FOR THIRD-LINE (3L) PATIENTS WITH RECURRENT SMALL CELL LUNG CANCER (SCLC) USING POPULATION-ADJUSTED INDIRECT COMPARISON","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"Nivolumab; Ipilimumab; Medicine; Oncology; Population; Internal medicine; Lung cancer; Hazard ratio; Regimen; Cancer; Immunotherapy; Confidence interval","score_opus":0.146381492280194,"score_gpt":0.4403910053062912,"score_spread":0.29400951302609724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906110772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98903227,0.0063464404,0.00015158755,0.00009897136,0.00045744475,0.0033875955,0.00041322573,0.00002639164,0.00008609857],"genre_scores_gemma":[0.9954286,0.00020684263,0.0039526513,0.00001743719,0.0001543348,0.000060020102,0.00014061932,0.00003131657,0.000008143073],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99737585,0.00023558951,0.00084081024,0.0003919611,0.0006716358,0.0004841499],"domain_scores_gemma":[0.99726486,0.00041997706,0.000657114,0.00031278416,0.0011902592,0.00015499567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038867228,0.00023171138,0.0011750079,0.00026561393,0.00015945811,0.000006853971,0.0001261497,0.00007416299,0.000011403789],"category_scores_gemma":[0.0001672756,0.00019124353,0.00007984455,0.0005480672,0.00017334134,0.000056084253,0.00006740109,0.00026162856,3.8464643e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041099038,0.000664835,0.91400033,0.0073853796,0.00024274818,7.3962644e-7,0.024964113,0.008948583,0.000024036108,0.000021090813,0.00060354546,0.0020455685],"study_design_scores_gemma":[0.064114645,0.038828805,0.8259701,0.008364224,0.0005531576,4.4317972e-7,0.0049500894,0.051845197,0.004460738,0.000010804112,0.00037724507,0.0005245207],"about_ca_topic_score_codex":0.011695526,"about_ca_topic_score_gemma":0.0062102443,"teacher_disagreement_score":0.08803019,"about_ca_system_score_codex":0.0020577991,"about_ca_system_score_gemma":0.0012516206,"threshold_uncertainty_score":0.9948857},"labels":[],"label_agreement":null},{"id":"W2911458603","doi":"","title":"Proceedings of the NAACL HLT 2010 Student Research Workshop","year":2010,"lang":"en","type":"article","venue":"","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Presentation (obstetrics); Work (physics); Computer science; Medical education; Engineering ethics; Library science; Mathematics education; Psychology; Engineering; Medicine","score_opus":0.1440169142521091,"score_gpt":0.4975021724441452,"score_spread":0.3534852581920361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911458603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.866606,0.000115742325,5.9243183e-7,0.017420862,0.0002936069,0.0007816047,0.0000010831893,0.00003057282,0.11474994],"genre_scores_gemma":[0.91980034,0.000070607326,0.00029101074,0.000135992,0.00028381788,0.0000761202,2.4007136e-7,0.000014896274,0.07932695],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9977706,0.000013448238,0.00017850062,0.00022110423,0.0014210201,0.0003953051],"domain_scores_gemma":[0.9982995,0.00017167606,0.00003424345,0.00031027495,0.0010657507,0.0001185744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012728588,0.00008572255,0.00019069995,0.00011112621,0.00016033016,0.000028096309,0.00038851725,0.000073000214,0.0005130635],"category_scores_gemma":[0.0010747563,0.000043901673,0.00007294672,0.00058300473,0.000569168,0.000060016187,0.0005983146,0.0011507337,0.00005299022],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014240804,0.0003174577,0.323303,0.00020921773,0.00015461701,0.000003460802,0.002081118,5.8648833e-8,0.29338336,0.008203192,0.37002563,0.0021764429],"study_design_scores_gemma":[0.0014340127,0.00029397005,0.78829527,0.00022116056,0.000041697767,0.000021095213,0.004915011,0.000010964783,0.13237932,0.0007204384,0.0715472,0.000119885255],"about_ca_topic_score_codex":0.00013623427,"about_ca_topic_score_gemma":0.00018521407,"teacher_disagreement_score":0.46499223,"about_ca_system_score_codex":0.00006767686,"about_ca_system_score_gemma":0.00016576066,"threshold_uncertainty_score":0.56176853},"labels":[],"label_agreement":null},{"id":"W2916875443","doi":"10.1016/j.ejca.2019.01.003","title":"Role of thoracic consolidation radiation in extensive stage small cell lung cancer: A systematic review and meta-analysis of randomised controlled trials","year":2019,"lang":"en","type":"review","venue":"European Journal of Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Manitoba; University of Toronto; CancerCare Manitoba","funders":"","keywords":"Medicine; Meta-analysis; Hazard ratio; Randomized controlled trial; Confidence interval; Lung cancer; Internal medicine; Relative risk; Systematic review; Radiation therapy; Oncology; Surgery; MEDLINE","score_opus":0.13143423963807155,"score_gpt":0.46120397986925177,"score_spread":0.3297697402311802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2916875443","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003902527,0.98918796,0.000034523964,0.00014599408,0.000066375665,0.009942964,0.00026722107,0.000003133456,0.00031280698],"genre_scores_gemma":[0.00055441476,0.9979437,0.000042532192,0.0001026882,0.00007957372,0.000340684,0.000015295713,0.000052223968,0.0008688688],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98142827,0.011516377,0.0057403054,0.00029090667,0.0008040887,0.00022004126],"domain_scores_gemma":[0.98144644,0.0032664211,0.01307751,0.0004276927,0.0016524785,0.00012945292],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.01989334,0.0004388674,0.031462055,0.0012219993,0.000019173869,0.000022197546,0.00024460017,0.00006186527,0.00034596206],"category_scores_gemma":[0.006477892,0.00023564225,0.004788103,0.0009070372,0.00008092468,0.0000885542,0.000056981953,0.0004628066,0.000001347655],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015296334,0.00004184313,0.000010785483,0.72256875,0.26604158,0.000028049266,0.00029292656,0.00006142994,0.000020581121,0.000001404495,0.00013417848,0.009268817],"study_design_scores_gemma":[0.012292794,0.00013768749,0.000011058556,0.12248885,0.86065704,0.0000069269795,0.00006764997,0.000045383098,0.000019147761,3.1221663e-7,0.004127554,0.00014557823],"about_ca_topic_score_codex":0.000055040728,"about_ca_topic_score_gemma":0.000021859754,"teacher_disagreement_score":0.60007995,"about_ca_system_score_codex":0.00036819535,"about_ca_system_score_gemma":0.0011449574,"threshold_uncertainty_score":0.9829169},"labels":[],"label_agreement":null},{"id":"W2939133296","doi":"10.1016/j.jtho.2019.03.023","title":"18F-Fludeoxyglucose PET/CT in SCLC: Analysis of the CONVERT Randomized Controlled Trial","year":2019,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Cancer Society Research Institute; NIHR Maudsley Biomedical Research Centre; Manchester Biomedical Research Centre; European Organisation for Research and Treatment of Cancer; National Institute for Health and Care Research; Ministère des Affaires Sociales et de la Santé; Cancer Research UK; Cancer Research UK Manchester Centre; Elekta; University of Manchester; Engineering and Physical Sciences Research Council; National Cancer Research Institute; AstraZeneca; Cancer Research Institute","keywords":"Medicine; Nuclear medicine; Confidence interval; Hazard ratio; Positron emission tomography; Bone scintigraphy; Scintigraphy; Radiology; Internal medicine","score_opus":0.020019066259394966,"score_gpt":0.4464594834922874,"score_spread":0.42644041723289244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2939133296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835664,0.0015589457,0.000011732441,0.0065365247,0.0011858657,0.0028010148,0.0000029811506,0.0000041434528,0.004332409],"genre_scores_gemma":[0.996747,0.0005735462,0.00016334592,0.00037465582,0.00019709089,0.000051130435,9.2102675e-7,0.000011072302,0.0018812311],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9953395,0.0018832954,0.0015747377,0.00015763266,0.0007645274,0.00028028834],"domain_scores_gemma":[0.9942909,0.0032172112,0.0014797626,0.0003406184,0.00056167087,0.00010983048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007116244,0.0001581217,0.004812764,0.00087997323,0.000031985248,0.000008914631,0.00031078924,0.000029993353,0.00055366853],"category_scores_gemma":[0.004361599,0.000078147015,0.001742109,0.00095391826,0.0003197923,0.00007640583,0.00011248656,0.0006799981,0.000010715385],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.980459,0.0005122647,0.006822284,0.000067736095,0.008590573,0.0005373402,0.00022352592,0.00011513905,0.0008562742,0.000037263653,0.0006207864,0.0011578199],"study_design_scores_gemma":[0.9807165,0.00184831,0.004792031,0.00016621401,0.00837792,0.0003934262,0.00036570185,0.0012452923,0.0004742364,0.00010642716,0.00143626,0.00007765659],"about_ca_topic_score_codex":0.00006840318,"about_ca_topic_score_gemma":0.00010519426,"teacher_disagreement_score":0.013180624,"about_ca_system_score_codex":0.000554034,"about_ca_system_score_gemma":0.0012325568,"threshold_uncertainty_score":0.60622823},"labels":[],"label_agreement":null},{"id":"W2941467697","doi":"10.1093/annonc/mdz122","title":"Prognostic value of circulating tumour cells in limited-stage small-cell lung cancer: analysis of the concurrent once-daily versus twice-daily radiotherapy (CONVERT) randomised controlled trial","year":2019,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Cancer Society Research Institute; Cancer Research UK","keywords":"Medicine; Radiation therapy; Oncology; Lung cancer; Stage (stratigraphy); Randomized controlled trial; Internal medicine","score_opus":0.06480225364933935,"score_gpt":0.4011862293424574,"score_spread":0.33638397569311806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941467697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831913,0.0058981376,0.00002336791,0.0012647898,0.0008406485,0.0068728933,0.000055217795,0.0000132768455,0.0018403525],"genre_scores_gemma":[0.99630284,0.0025168646,0.000050011615,0.00025522677,0.00011539194,0.00037485478,0.000008677103,0.000026703132,0.00034940202],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9961686,0.00092851144,0.0013595532,0.0004159623,0.00061157753,0.0005158003],"domain_scores_gemma":[0.99333185,0.004146953,0.0012928434,0.00047603488,0.00063836674,0.000113972186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016839247,0.0002722076,0.0028319391,0.00051836146,0.000039940413,0.0000061850865,0.00036512848,0.0001849711,0.0002278592],"category_scores_gemma":[0.0010998799,0.00018954575,0.00089937355,0.0011493723,0.00032489863,0.000051355713,0.00010716936,0.00039449683,0.0000013001402],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7213031,0.0018770202,0.12347515,0.0013153668,0.013398767,0.000032913427,0.004104749,0.008337076,0.122136936,0.00009269993,0.0007133724,0.0032128652],"study_design_scores_gemma":[0.9137161,0.0068243206,0.019896952,0.00036571926,0.0035601244,7.204574e-7,0.0006200887,0.035676844,0.018474886,0.0000033759607,0.0006465744,0.00021429674],"about_ca_topic_score_codex":0.0015786121,"about_ca_topic_score_gemma":0.00043505867,"teacher_disagreement_score":0.19241302,"about_ca_system_score_codex":0.00031511203,"about_ca_system_score_gemma":0.0014921839,"threshold_uncertainty_score":0.77294517},"labels":[],"label_agreement":null},{"id":"W2947719708","doi":"10.1200/jco.2019.37.15_suppl.9069","title":"Clinical outcomes of EGFR+ NSCLC pts treated with immune checkpoint inhibitors (ICI).","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec","funders":"","keywords":"Medicine; Pemetrexed; Nivolumab; Pembrolizumab; Ipilimumab; Erlotinib; Internal medicine; Oncology; Carboplatin; Atezolizumab; Lung cancer; Cancer; Chemotherapy; Immunotherapy; Epidermal growth factor receptor; Cisplatin","score_opus":0.1224058409726355,"score_gpt":0.5188490254552658,"score_spread":0.3964431844826303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947719708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9797047,0.00070747733,0.000013872284,0.010111031,0.0012953131,0.0004883531,0.0000034211494,0.000015278818,0.007660564],"genre_scores_gemma":[0.9931769,0.0013473955,0.0016286487,0.0008618379,0.0009582112,0.0000044462045,0.000001823098,0.00003170043,0.0019890605],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9922588,0.0007138268,0.005402692,0.0003007611,0.00092100294,0.00040290126],"domain_scores_gemma":[0.98903906,0.0054401834,0.0033068953,0.0004623933,0.0012511028,0.0005003685],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0077733295,0.0002304864,0.0040462585,0.00020758882,0.000031022097,0.0000064243795,0.00029953188,0.00048182614,0.00029262624],"category_scores_gemma":[0.008587902,0.00012617192,0.0013325869,0.00026978666,0.00078871474,0.00012748758,0.00017041697,0.0019875807,0.000076925884],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011075904,0.0022795484,0.950718,0.00008567076,0.0024736645,0.00043842543,0.00007430218,0.000004448322,0.00042273916,0.00003126887,0.0023776002,0.030018464],"study_design_scores_gemma":[0.021073414,0.040155683,0.9165014,0.00039487737,0.0005973766,0.0001531656,0.00024243096,0.000014591793,0.0005357002,0.000049813854,0.020159468,0.0001221014],"about_ca_topic_score_codex":0.00010655476,"about_ca_topic_score_gemma":0.000043180487,"teacher_disagreement_score":0.037876137,"about_ca_system_score_codex":0.0002579966,"about_ca_system_score_gemma":0.002416255,"threshold_uncertainty_score":0.9997632},"labels":[],"label_agreement":null},{"id":"W2954144408","doi":"10.3747/co.26.4481","title":"Initial Management of Small-Cell Lung Cancer (limited- and Extensive-Stage) and the Role of Thoracic Radiotherapy and First-Line Chemotherapy: A Systematic Review","year":2019,"lang":"en","type":"review","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Sunnybrook Health Science Centre; Juravinski Cancer Centre; McMaster University; Thunder Bay Regional Health Sciences Centre; Princess Margaret Cancer Centre","funders":"Ontario Ministry of Health and Long-Term Care; Cancer Care Ontario","keywords":"Medicine; Etoposide; Chemotherapy; Radiation therapy; Cisplatin; Oncology; Stage (stratigraphy); Carboplatin; Lung cancer; Internal medicine","score_opus":0.12077251376841378,"score_gpt":0.49878108717061626,"score_spread":0.3780085734022025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954144408","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010023736,0.9883673,0.00002625681,0.00046568885,0.0001865135,0.01054334,0.000061243125,0.000011390454,0.00023801473],"genre_scores_gemma":[0.000040455794,0.99805564,0.00008776333,0.00014466944,0.000104641826,0.001260574,0.000017246528,0.00004704491,0.00024196696],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9974224,0.00055305474,0.0009910053,0.0004584814,0.00029099625,0.0002840844],"domain_scores_gemma":[0.99742115,0.00077029166,0.00096815283,0.00050901674,0.00023707353,0.00009433018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010208051,0.00041654077,0.004919356,0.00016238373,0.00005455321,0.0000095536,0.00018373119,0.00014971917,0.00003487117],"category_scores_gemma":[0.000088008215,0.00023068179,0.000247431,0.0002431457,0.0005539238,0.000024782417,0.00023762854,0.00041533797,7.734598e-7],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012996484,0.000081639795,0.000042835327,0.64161354,0.0012700587,0.0000070312553,0.00024934433,7.2595576e-8,2.4975262e-7,0.000041511263,0.00012510698,0.35643864],"study_design_scores_gemma":[0.0027772817,0.00038551458,0.000013488667,0.6205679,0.012487784,0.000057656933,0.00012172497,0.00013722845,0.0000017405226,0.00000894549,0.363253,0.00018772235],"about_ca_topic_score_codex":0.000028288287,"about_ca_topic_score_gemma":0.000011913804,"teacher_disagreement_score":0.3631279,"about_ca_system_score_codex":0.00026697648,"about_ca_system_score_gemma":0.00027229977,"threshold_uncertainty_score":0.940693},"labels":[],"label_agreement":null},{"id":"W2955554680","doi":"10.1158/1538-7445.am2019-3925","title":"Abstract 3925: A screen for epigenetic radiosensitizers in small cell lung cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Epigenetics; Epigenetic therapy; Cancer research; Lung cancer; Cancer; Malignancy; Cell culture; Cell; Medicine; Chemistry; Biology; Oncology; Genetics; Internal medicine; DNA methylation; Gene expression","score_opus":0.08063073401355869,"score_gpt":0.44443369437175356,"score_spread":0.36380296035819487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955554680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96241885,0.021736009,0.000016681586,0.003849053,0.00026645738,0.004732596,0.00013065281,0.000046512614,0.0068031885],"genre_scores_gemma":[0.9804613,0.0053655882,0.00023880367,0.0002796713,0.0005472887,0.0021028358,0.000020409117,0.00009470965,0.010889369],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963199,0.00012262198,0.00036520904,0.0007704448,0.00091392244,0.0015079078],"domain_scores_gemma":[0.9976226,0.0006195933,0.000059168524,0.0006186796,0.00071550166,0.00036445883],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015936234,0.0002442922,0.0005776298,0.0005857229,0.00014849563,0.000054520646,0.00033800304,0.0001503983,0.0011164512],"category_scores_gemma":[0.0002360521,0.00021587459,0.00015486193,0.0008365075,0.00025139563,0.000083376704,0.00020201057,0.0009552189,0.00009660878],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047873417,0.00039277851,0.49905595,0.008816345,0.00056742853,0.00027315205,0.0028634842,0.0007837763,0.37331063,0.00012738987,0.0853721,0.02364962],"study_design_scores_gemma":[0.02748403,0.0017559725,0.68338346,0.005255982,0.00016745753,0.000015340145,0.00274088,0.002949864,0.21053341,0.00038247617,0.0640018,0.0013292942],"about_ca_topic_score_codex":0.009888574,"about_ca_topic_score_gemma":0.0041617057,"teacher_disagreement_score":0.18432754,"about_ca_system_score_codex":0.0020041554,"about_ca_system_score_gemma":0.0019929504,"threshold_uncertainty_score":0.9997967},"labels":[],"label_agreement":null},{"id":"W2955954677","doi":"10.1158/1538-7445.am2019-2699","title":"Abstract 2699: Targeting an ubiquitin-activating enzyme in small-cell lung cancer (SCLC)","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Etoposide; Cancer research; Cancer; Lung cancer; Cisplatin; Medicine; Viability assay; Cell culture; Cancer cell; Chemotherapy; Cell; Biology; Oncology; Internal medicine; Genetics","score_opus":0.08719973509604924,"score_gpt":0.4541016868402734,"score_spread":0.3669019517442242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955954677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96835095,0.012722924,0.000005020603,0.0022376005,0.0002955553,0.0020443953,0.000034009332,0.00009690826,0.014212661],"genre_scores_gemma":[0.9907132,0.0024172284,0.00019379,0.0002423281,0.0009848471,0.0011085866,0.000023926732,0.00011956234,0.0041965484],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9948934,0.00029291722,0.00053612,0.0009968253,0.0014135991,0.0018671732],"domain_scores_gemma":[0.9973603,0.0005460588,0.00011869426,0.00069477956,0.00080338476,0.0004768045],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0027701592,0.00032154206,0.00061836565,0.00061624835,0.0002859591,0.00012198564,0.0005085537,0.000182614,0.003187613],"category_scores_gemma":[0.00049236073,0.0002862703,0.00010715726,0.0012313765,0.00023092155,0.00037137727,0.00044365483,0.0022090357,0.00011873905],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009940413,0.00034808295,0.3062997,0.003269775,0.00016996132,0.0002974849,0.0044615585,0.0005085869,0.66078806,0.000081819686,0.009165671,0.013615259],"study_design_scores_gemma":[0.0126047,0.0013347726,0.28640422,0.007374966,0.00006850157,0.000018091927,0.012444657,0.0047524404,0.6401257,0.00015144891,0.03314614,0.0015743502],"about_ca_topic_score_codex":0.015801862,"about_ca_topic_score_gemma":0.0020885153,"teacher_disagreement_score":0.023980467,"about_ca_system_score_codex":0.0024894406,"about_ca_system_score_gemma":0.0020451979,"threshold_uncertainty_score":0.99995893},"labels":[],"label_agreement":null},{"id":"W2956067738","doi":"10.1158/1538-7445.am2019-ct073","title":"Abstract CT073: Pembrolizumab after two or more lines of prior therapy in patients with advanced small-cell lung cancer (SCLC): Results from the KEYNOTE-028 and KEYNOTE-158 studies","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Pembrolizumab; Medicine; Internal medicine; Response Evaluation Criteria in Solid Tumors; Clinical endpoint; Oncology; Progression-free survival; Lung cancer; Cancer; Phases of clinical research; Surrogate endpoint; Immunotherapy; Clinical trial; Surgery; Chemotherapy","score_opus":0.057755507929358435,"score_gpt":0.43304730403021957,"score_spread":0.37529179610086116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2956067738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.944636,0.047117822,4.866672e-7,0.003547478,0.00017515416,0.0038114572,0.000458996,0.000028642311,0.00022400207],"genre_scores_gemma":[0.96233153,0.03433079,0.0001164759,0.00025343496,0.00029009065,0.0010352356,0.000026413054,0.00008472751,0.0015313089],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955078,0.00022106418,0.00062996,0.0009566743,0.0016747983,0.001009729],"domain_scores_gemma":[0.99551016,0.0014681655,0.0002026647,0.00096999545,0.0016437249,0.00020530318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089140516,0.0004084299,0.0008817537,0.00028428,0.0001705095,0.000051253348,0.00044340896,0.00011505966,0.00027824155],"category_scores_gemma":[0.00052251446,0.00021691472,0.00008407814,0.0008652536,0.00081352744,0.0002115829,0.0004342882,0.0010758449,0.000010002102],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11654747,0.0004143734,0.8357564,0.001126599,0.000879927,0.000069864145,0.0121865375,0.00019503663,0.0036525298,0.0000020119876,0.002274923,0.026894284],"study_design_scores_gemma":[0.03541546,0.001452706,0.94986856,0.002973914,0.00006162435,6.879661e-7,0.0022507068,0.000060566726,0.0060638404,0.00001758828,0.0015257152,0.00030861498],"about_ca_topic_score_codex":0.0077842707,"about_ca_topic_score_gemma":0.0065268157,"teacher_disagreement_score":0.11411214,"about_ca_system_score_codex":0.0006625132,"about_ca_system_score_gemma":0.001196712,"threshold_uncertainty_score":0.998823},"labels":[],"label_agreement":null},{"id":"W2966439920","doi":"10.1200/jco.2013.31.15_suppl.tps7609","title":"Cabazitaxel (Cbz) versus topotecan in patients (pts) with small cell lung cancer (SCLC) that has progressed during or after first-line treatment with platinum-based chemotherapy: A randomized phase II study.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Regional Municipality of Durham; Lakeridge Health; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Taxane; Topotecan; Internal medicine; Oncology; Chemotherapy; Regimen; Chemotherapy regimen; Gemcitabine; Refractory (planetary science); Surgery; Cancer; Breast cancer","score_opus":0.10857136224346695,"score_gpt":0.44816974150394057,"score_spread":0.33959837926047365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966439920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871073,0.00059104024,0.00003083067,0.0069749183,0.00028419943,0.0048667337,0.0000084861995,0.000017531342,0.00011897344],"genre_scores_gemma":[0.9954906,0.0005332196,0.0016628639,0.00035997047,0.00041623146,0.0010426467,0.0000030166257,0.00005279174,0.00043863425],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9960588,0.0005442726,0.0017063064,0.00040722894,0.00073943794,0.0005439396],"domain_scores_gemma":[0.9948818,0.002241728,0.0014320463,0.00030728383,0.0006842022,0.0004529368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012714602,0.00037373384,0.0028479137,0.00023408054,0.00012827315,0.000032219064,0.0001808781,0.00019985967,0.00050179067],"category_scores_gemma":[0.0006465898,0.00018035715,0.00032557343,0.0002423488,0.0004745952,0.00014237792,0.00006345502,0.0008080662,0.0000027239064],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6313841,0.016966427,0.32887724,0.00011836119,0.0015017841,0.00089556276,0.0012776718,0.000070190195,0.0000058798078,4.6279492e-8,0.00011556153,0.018787192],"study_design_scores_gemma":[0.71648544,0.15770817,0.12271114,0.00048339792,0.0009436562,0.0000082905035,0.0002661052,0.0003656844,0.00014672522,0.0000012064135,0.0007023205,0.00017788546],"about_ca_topic_score_codex":0.00071170577,"about_ca_topic_score_gemma":0.008634385,"teacher_disagreement_score":0.2061661,"about_ca_system_score_codex":0.0013049112,"about_ca_system_score_gemma":0.002841747,"threshold_uncertainty_score":0.7354751},"labels":[],"label_agreement":null},{"id":"W2968747111","doi":"10.1200/jco.2012.30.15_suppl.7093","title":"NCIC IND.190: A phase I trial of MK-0646 in combination with cisplatin and etoposide in extensive-stage small cell lung cancer (ES SCLC).","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Ottawa Hospital; Princess Margaret Cancer Centre; University of Toronto; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Etoposide; Internal medicine; Cisplatin; Chemotherapy; Oncology; Cancer","score_opus":0.15381927137870718,"score_gpt":0.5391692761335148,"score_spread":0.38535000475480763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2968747111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99165267,0.0032736112,0.00004217538,0.0031780212,0.00046505054,0.0006711295,0.0000042792362,0.0000028607258,0.00071023416],"genre_scores_gemma":[0.9953871,0.0025275561,0.0009228749,0.00046170707,0.00051201,0.00002218943,0.0000010709292,0.000013946997,0.00015158611],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967724,0.00055333576,0.0017741537,0.00015650137,0.00041658978,0.00032700234],"domain_scores_gemma":[0.9953115,0.0025544467,0.0012769597,0.00012232213,0.0004647299,0.00027001544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045431624,0.00013149783,0.0014476196,0.00031816625,0.000021432257,0.000004992461,0.000095909636,0.00022918919,0.000046853293],"category_scores_gemma":[0.0035061715,0.00008875845,0.00011795854,0.00024411018,0.00029575982,0.0001591791,0.00007204422,0.0011321527,7.19905e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1671258,0.007075992,0.7895759,0.0003470813,0.00025650844,0.00054227817,0.0016277342,0.000025626843,0.0009675989,0.00010726013,0.00068039657,0.03166784],"study_design_scores_gemma":[0.3700261,0.035342462,0.5881613,0.0008068272,0.00037703634,0.000065218075,0.0008376878,0.00036759966,0.000809457,0.00008385236,0.0029717626,0.00015068041],"about_ca_topic_score_codex":0.00026549186,"about_ca_topic_score_gemma":0.0010464992,"teacher_disagreement_score":0.2029003,"about_ca_system_score_codex":0.0003410506,"about_ca_system_score_gemma":0.0016482545,"threshold_uncertainty_score":0.4918703},"labels":[],"label_agreement":null},{"id":"W2978687871","doi":"10.1093/annonc/mdz260.097","title":"Preliminary results from phase Ib study of spartalizumab plus chemotherapy for advanced non-small cell lung cancer (NSCLC)","year":2019,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pemetrexed; Internal medicine; Carboplatin; Lung cancer; Nausea; Chemotherapy; Discontinuation; Oncology; Gastroenterology; Cisplatin","score_opus":0.07776748119648753,"score_gpt":0.4609315789499341,"score_spread":0.38316409775344656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978687871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98567903,0.002849748,0.000035286044,0.0028082374,0.00029048524,0.00398848,0.0003793528,0.000020167454,0.0039492208],"genre_scores_gemma":[0.99517703,0.0015856788,0.0005173354,0.0005227088,0.00018011758,0.00040071495,0.000057785786,0.000038215385,0.0015203953],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99811625,0.0000754106,0.0006158346,0.00046824894,0.00030138172,0.00042289463],"domain_scores_gemma":[0.997701,0.00062197604,0.00042881732,0.0005416745,0.0005895276,0.00011704167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037025943,0.00020340756,0.0010131849,0.00012910408,0.00003897357,0.0000029309076,0.00022339437,0.00012729084,0.00011494571],"category_scores_gemma":[0.00015132022,0.00017245903,0.00014649234,0.00016395481,0.0001039373,0.00006387142,0.00010600324,0.00017694401,0.0000049880387],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4432263,0.02464546,0.029465355,0.0033096948,0.0050040446,0.00018020731,0.068995975,0.0011314492,0.13584772,0.000019002284,0.12405603,0.16411875],"study_design_scores_gemma":[0.34076777,0.24390727,0.043770712,0.0011975749,0.0008319829,0.000006044339,0.011528361,0.0036738252,0.2928795,0.00010119797,0.060654394,0.0006813725],"about_ca_topic_score_codex":0.0014336769,"about_ca_topic_score_gemma":0.00032896572,"teacher_disagreement_score":0.21926181,"about_ca_system_score_codex":0.00015339447,"about_ca_system_score_gemma":0.00079353416,"threshold_uncertainty_score":0.7032675},"labels":[],"label_agreement":null},{"id":"W2979808837","doi":"10.1093/neuros/nyz428","title":"Role of Gamma Knife Radiosurgery in Small Cell Lung Cancer: A Multi-Institutional Retrospective Study of the International Radiosurgery Research Foundation (IRRF)","year":2019,"lang":"en","type":"article","venue":"Neurosurgery","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"National Center for Advancing Translational Sciences; National Institute of General Medical Sciences; National Institutes of Health","keywords":"Radiosurgery; Medicine; Prophylactic cranial irradiation; Hazard ratio; Proportional hazards model; Lung cancer; Recursive partitioning; Retrospective cohort study; Cumulative incidence; Institutional review board; Radiation therapy; Brain metastasis; Salvage therapy; Logistic regression; Oncology; Nuclear medicine; Internal medicine; Confidence interval; Cancer; Surgery; Chemotherapy; Cohort; Metastasis","score_opus":0.04831715106326516,"score_gpt":0.3555535540802199,"score_spread":0.3072364030169547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979808837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99377674,0.00088059914,0.0000047284907,0.00062484824,0.0014030461,0.0019010813,0.000035121888,0.000026750227,0.0013471047],"genre_scores_gemma":[0.9978514,0.0005208486,0.000033381777,0.00007503869,0.0002061613,0.0002410552,0.000010442588,0.000037625497,0.0010240814],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995805,0.0004806401,0.0008635463,0.0006208876,0.0017052585,0.0005246142],"domain_scores_gemma":[0.99705076,0.00093954155,0.00034741685,0.00067333796,0.0008830861,0.00010583523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022370578,0.00023991244,0.00075895054,0.00087926624,0.00013175854,0.000029168925,0.00038016966,0.00009668781,0.00023034484],"category_scores_gemma":[0.0014714105,0.00018180364,0.00026495795,0.0013537299,0.00033832146,0.00019501422,0.0003805159,0.0008122886,0.0000109023385],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000634495,0.0014762498,0.92577225,0.00025875185,0.00015140184,0.000041113482,0.000991645,0.00036496276,0.06860193,0.000050644627,0.0009758211,0.00068073545],"study_design_scores_gemma":[0.002490836,0.00018515813,0.98373914,0.00041625294,0.000037971196,0.000015649113,0.000704261,0.0024384516,0.009053577,0.000021340762,0.00075768033,0.00013966864],"about_ca_topic_score_codex":0.0018321626,"about_ca_topic_score_gemma":0.00045647472,"teacher_disagreement_score":0.059548352,"about_ca_system_score_codex":0.0009483749,"about_ca_system_score_gemma":0.0013604057,"threshold_uncertainty_score":0.7413737},"labels":[],"label_agreement":null},{"id":"W2981560305","doi":"10.1016/j.jtho.2019.08.2247","title":"EP1.12-02 SCLC Treatment Uptake and Survival Outcomes: A 2-Year Comparison Between 2 Tertiary Referral Centers in Alberta, Canada","year":2019,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Hazard ratio; Internal medicine; Radiation therapy; Referral; Guideline; Proportional hazards model; Lung cancer; Retrospective cohort study; Cancer; Oncology; Conventional PCI; Family medicine; Confidence interval; Pathology","score_opus":0.05230667235199401,"score_gpt":0.4400525911824128,"score_spread":0.3877459188304188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981560305","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9785807,0.00039008228,0.00000239835,0.017354056,0.0006662594,0.0003613787,0.000010872971,0.000004204116,0.0026300354],"genre_scores_gemma":[0.9970906,0.00018497894,0.00028627727,0.00034117515,0.00020723756,0.0000060060192,0.00000610705,0.000018488274,0.0018591501],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99795896,0.0002513149,0.0007047795,0.00020377315,0.00045993074,0.0004212379],"domain_scores_gemma":[0.9985306,0.00055774744,0.00032401353,0.00019580165,0.00011017124,0.00028161742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053626206,0.0001965004,0.0012558928,0.0002191893,0.000040308812,0.000011767725,0.000136214,0.00010710713,0.000086622895],"category_scores_gemma":[0.0001680112,0.00013341675,0.00011066526,0.00010554214,0.00008114447,0.000091147645,0.00008390911,0.00048798058,0.0000095523255],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012075513,0.0001947172,0.97320807,0.00008593195,0.0005327921,0.00030704134,0.00069640763,0.000006907074,0.00007759279,0.000004013114,0.0026071698,0.02107181],"study_design_scores_gemma":[0.003252256,0.0028033818,0.95773315,0.00016535258,0.00021260817,0.00009864569,0.0015993724,0.000022120284,0.00009187025,0.000014294025,0.03390075,0.000106197054],"about_ca_topic_score_codex":0.18415625,"about_ca_topic_score_gemma":0.5897492,"teacher_disagreement_score":0.40559295,"about_ca_system_score_codex":0.0027156114,"about_ca_system_score_gemma":0.0015029226,"threshold_uncertainty_score":0.82127655},"labels":[],"label_agreement":null},{"id":"W2981636558","doi":"10.1016/j.jtho.2019.10.013","title":"Randomized Phase II Study of Paclitaxel plus Alisertib versus Paclitaxel plus Placebo as Second-Line Therapy for SCLC: Primary and Correlative Biomarker Analyses","year":2019,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":147,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Charles-Le Moyne; Université de Sherbrooke; University of Alberta","funders":"Takeda Oncology; EMD Serono; National Institutes of Health; PharmaMar; Daiichi-Sankyo; G1 Therapeutics; Clovis Oncology; University of Texas Southwestern Medical Center; Merck Sharp and Dohme; Genzyme; Takeda Pharmaceuticals U.S.A.; Foundation Medicine; United Therapeutics Corporation; F. Hoffmann-La Roche; Ipsen Biopharmaceuticals; Novartis; Celgene; Merck; Spectrum Pharmaceuticals; Purdue University; MedImmune; Sanofi; GlaxoSmithKline; Roche; AbbVie; Genentech; Aeglea BioTherapeutics; Amgen; Daiichi Sankyo Europe; National Cancer Institute; Intuitive Surgical; Moderna; Pfizer; AstraZeneca; Purdue Pharma; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Paclitaxel; Hazard ratio; Internal medicine; Oncology; Placebo; Clinical endpoint; Population; Gastroenterology; Confidence interval; Randomized controlled trial; Chemotherapy; Pathology","score_opus":0.12534256394026563,"score_gpt":0.5412142173577857,"score_spread":0.4158716534175201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981636558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98016304,0.009803067,0.00019778097,0.002209798,0.001006075,0.0041337903,0.000044821056,0.000014369809,0.002427277],"genre_scores_gemma":[0.9945428,0.0013000838,0.000888397,0.00032307184,0.00025650702,0.00011662317,0.000013921911,0.000039852282,0.0025187875],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99609345,0.001083913,0.0013478388,0.000358822,0.0006875956,0.0004283924],"domain_scores_gemma":[0.9918698,0.0049761045,0.0014444939,0.0003452272,0.0010847688,0.00027957893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003841329,0.0003317407,0.0029701635,0.0005660837,0.00017008395,0.000017869892,0.00022278269,0.0002006233,0.000323972],"category_scores_gemma":[0.0019610017,0.00021589463,0.0004751708,0.00032892026,0.0005048514,0.00024892544,0.00018125448,0.0005559537,0.000004472546],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94544506,0.0025612612,0.00035358893,0.00030666706,0.0074998685,0.00015875888,0.006320353,0.000031406442,0.007330481,0.000015215113,0.002481973,0.02749536],"study_design_scores_gemma":[0.87784195,0.09849394,0.0016755813,0.0002832824,0.0025177072,0.00021178038,0.012393415,0.0011014157,0.0015380144,0.00021644562,0.0034657225,0.0002607692],"about_ca_topic_score_codex":0.000074801326,"about_ca_topic_score_gemma":0.000053040825,"teacher_disagreement_score":0.09593268,"about_ca_system_score_codex":0.0008884407,"about_ca_system_score_gemma":0.0015097333,"threshold_uncertainty_score":0.88039273},"labels":[],"label_agreement":null},{"id":"W2982042823","doi":"10.1016/j.jtho.2019.08.2257","title":"EP1.12-12 Factors Associated with Survival Outcomes Among Relapsed SCLC Diagnosed at a Canadian Cancer Centre","year":2019,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Etoposide; Internal medicine; Proportional hazards model; Hazard ratio; Lung cancer; Stage (stratigraphy); Multivariate analysis; Oncology; Survival analysis; Chemotherapy; Retrospective cohort study; Cancer; Confidence interval","score_opus":0.0420348322713473,"score_gpt":0.41250479156459924,"score_spread":0.37046995929325194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982042823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98436654,0.00037504462,0.0000014107117,0.008743283,0.0013487703,0.00054647005,0.000049473078,0.000021325779,0.0045476947],"genre_scores_gemma":[0.9878702,0.0002057966,0.00005394204,0.00046984246,0.00019566121,0.000010023643,0.000013724687,0.000046436784,0.011134362],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971799,0.00038897587,0.0005566314,0.00026002043,0.0008195784,0.0007948873],"domain_scores_gemma":[0.996713,0.0009519753,0.0006996091,0.00026193872,0.00057808403,0.00079538266],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008715805,0.00027520105,0.0013024596,0.0004211289,0.00015506742,0.000021574606,0.00025090118,0.00026197807,0.00107844],"category_scores_gemma":[0.0012379792,0.00017560029,0.0002363139,0.00027032418,0.00021316676,0.00017287627,0.00008687573,0.00087655935,0.000027226375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010452758,0.00016389647,0.984342,0.00006093493,0.0015319211,0.001401198,0.001343103,0.000038623686,0.00016687735,0.0000027141512,0.007907388,0.0019960655],"study_design_scores_gemma":[0.003365275,0.0014712064,0.9801669,0.0004411179,0.00048206843,0.00003825457,0.0011965748,0.000016778627,0.00020795806,0.000008377969,0.01241864,0.00018684698],"about_ca_topic_score_codex":0.033180024,"about_ca_topic_score_gemma":0.6732214,"teacher_disagreement_score":0.6400414,"about_ca_system_score_codex":0.006982632,"about_ca_system_score_gemma":0.0030779713,"threshold_uncertainty_score":0.9998347},"labels":[],"label_agreement":null},{"id":"W2991104201","doi":"10.1016/j.jmir.2019.10.001","title":"Should Stereotactic Radiosurgery Be Considered for Salvage of Intracranial Recurrence after Prophylactic Cranial Irradiation or Whole Brain Radiotherapy in Small Cell Lung Cancer? A Population-Based Analysis and Literature Review","year":2019,"lang":"en","type":"review","venue":"Journal of medical imaging and radiation sciences","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Conventional PCI; Radiosurgery; Univariate analysis; Hazard ratio; Lung cancer; Proportional hazards model; Salvage therapy; Population; Cohort; Radiation therapy; Surgery; Multivariate analysis; Internal medicine; Oncology; Chemotherapy; Confidence interval","score_opus":0.05551280026917967,"score_gpt":0.4364040362062346,"score_spread":0.38089123593705493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991104201","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021103777,0.97818106,0.000392729,0.01768985,0.00038011937,0.0011769491,0.00006235007,0.000004785276,0.0000017696451],"genre_scores_gemma":[0.005267186,0.9923226,0.00077777955,0.0010888015,0.00041642328,0.00006923888,0.000021926453,0.000015869227,0.000020155288],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9963658,0.0005035983,0.0013055252,0.00038706334,0.0011637503,0.00027428212],"domain_scores_gemma":[0.99511164,0.0028302486,0.0013854012,0.00014461474,0.00028759698,0.00024051838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004135548,0.00027065483,0.0021157146,0.001258674,0.00008682196,0.00012766744,0.00018234857,0.00016467692,0.00005158475],"category_scores_gemma":[0.0035812566,0.00016220185,0.00035373025,0.0017327901,0.00026202766,0.00030372234,0.00002143615,0.00062910974,6.216426e-8],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003118388,0.00011220288,0.03676158,0.10362562,0.00049922516,0.00017945857,0.000556773,0.000010150891,0.0000039435513,0.0000016553125,0.0017788613,0.8561587],"study_design_scores_gemma":[0.017100828,0.0023034883,0.07190209,0.5966471,0.027796272,0.0020295547,0.0004969727,0.08701591,0.0000051053594,0.000048645852,0.192827,0.0018270741],"about_ca_topic_score_codex":0.00008208476,"about_ca_topic_score_gemma":0.00005125641,"teacher_disagreement_score":0.8543316,"about_ca_system_score_codex":0.00024163468,"about_ca_system_score_gemma":0.0027509895,"threshold_uncertainty_score":0.66143996},"labels":[],"label_agreement":null},{"id":"W2995682899","doi":"10.1200/jco.19.02748","title":"Lung Cancer Surveillance After Definitive Curative-Intent Therapy: ASCO Guideline","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":193,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Guideline; Lung cancer; Stage (stratigraphy); Positron emission tomography; Magnetic resonance imaging; Radiology; Randomized controlled trial; Medical physics; Internal medicine; Pathology","score_opus":0.14893239327123653,"score_gpt":0.5650323579464293,"score_spread":0.4160999646751927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995682899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9016781,0.018780204,0.00016311515,0.06574206,0.0034517585,0.0006227694,0.000019094474,0.000014669233,0.009528265],"genre_scores_gemma":[0.96419376,0.019611996,0.0011836074,0.0114954375,0.0019788577,0.000028896771,0.0000019851047,0.000025290366,0.00148015],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99584085,0.00060465187,0.0022769866,0.00025390423,0.0006642333,0.00035935378],"domain_scores_gemma":[0.9935605,0.0024385415,0.001255586,0.00023293888,0.0021788669,0.00033355286],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00419608,0.00017613043,0.0017808615,0.00011136922,0.00002968564,0.0000098775945,0.00018764431,0.00025011334,0.0016834709],"category_scores_gemma":[0.0039878627,0.00010632324,0.00056068995,0.00016539727,0.00027078096,0.00012717886,0.00010830263,0.0013661055,0.00006490022],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014959411,0.0006860932,0.8467899,0.000046457666,0.0015976202,0.0005160897,0.0002468149,0.000013715899,0.00013610937,0.000046822126,0.069977224,0.06498377],"study_design_scores_gemma":[0.0102551095,0.009152634,0.6217261,0.00024070583,0.000097096345,0.000094735406,0.00019027133,0.00017636591,0.00006847803,0.000103750644,0.35777,0.0001247762],"about_ca_topic_score_codex":0.00008119062,"about_ca_topic_score_gemma":0.0001459798,"teacher_disagreement_score":0.28779277,"about_ca_system_score_codex":0.00045642394,"about_ca_system_score_gemma":0.0027167585,"threshold_uncertainty_score":0.99922913},"labels":[],"label_agreement":null},{"id":"W2995889981","doi":"10.1016/j.jtho.2019.12.109","title":"Pembrolizumab After Two or More Lines of Previous Therapy in Patients With Recurrent or Metastatic SCLC: Results From the KEYNOTE-028 and KEYNOTE-158 Studies","year":2019,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":438,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Merck Sharp and Dohme; EMD Serono; Genentech; National Institutes of Health; Eli Lilly and Company; Ono Pharmaceutical; National Cancer Institute; Servier; Daiichi-Sankyo; Puma Biotechnology; AbbVie; Aminex Therapeutics; Roche; Celgene; Novartis; Meso Scale Diagnostics; Sanofi; MedImmune; Merck; GlaxoSmithKline; Boehringer Ingelheim; Amgen; Novartis Pharmaceuticals Corporation; Pfizer; PharmaMar; AstraZeneca; Bristol-Myers Squibb","keywords":"Medicine; Pembrolizumab; Oncology; Internal medicine; Cancer; Immunotherapy","score_opus":0.059163210304026236,"score_gpt":0.4761060156971092,"score_spread":0.416942805393083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995889981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97932595,0.013174916,0.0000038134315,0.005980822,0.00034175275,0.0010635002,0.000057623205,0.0000054341485,0.000046178102],"genre_scores_gemma":[0.9892213,0.008209273,0.0015754156,0.00043277798,0.00021518851,0.000026534315,0.000004715879,0.000024299547,0.0002905317],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9973777,0.00047716743,0.0009159373,0.00026105915,0.000661843,0.0003062979],"domain_scores_gemma":[0.99612486,0.0017559122,0.0008028324,0.00033126475,0.0008797534,0.000105354346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009996665,0.00023585594,0.0012188507,0.00019997443,0.000041008352,0.00001304516,0.00020586938,0.00006152418,0.000064563406],"category_scores_gemma":[0.0013510259,0.000096139804,0.000093518254,0.0003036593,0.00035347018,0.00014376295,0.00014912774,0.0005562214,0.0000035633914],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.51616615,0.0013252513,0.26882708,0.00043115608,0.0028220534,0.0005481734,0.015525577,0.00004368871,0.000089324414,0.0000012159401,0.0025922495,0.19162807],"study_design_scores_gemma":[0.03753588,0.04060886,0.9068954,0.0031642818,0.00083806395,0.000166499,0.004564982,0.00005816817,0.0002884336,0.00012787804,0.0055072526,0.0002443253],"about_ca_topic_score_codex":0.00008047243,"about_ca_topic_score_gemma":0.0005026085,"teacher_disagreement_score":0.6380683,"about_ca_system_score_codex":0.0002783923,"about_ca_system_score_gemma":0.00062674616,"threshold_uncertainty_score":0.39204672},"labels":[],"label_agreement":null},{"id":"W2996673269","doi":"10.1097/coc.0000000000000657","title":"Real-World Adherence to Guideline-Recommended Treatment for Small Cell Lung Cancer","year":2019,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; University of Calgary","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Lung cancer; Guideline; Chemotherapy; Radiation therapy; Proportional hazards model; Stage (stratigraphy); Cancer; Oncology; Surgery; Confidence interval","score_opus":0.1688143842316305,"score_gpt":0.5700223225478211,"score_spread":0.4012079383161906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996673269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9370202,0.00047746146,0.00048296145,0.048417065,0.0019334377,0.0015641849,0.000028453593,0.000020474265,0.010055757],"genre_scores_gemma":[0.892201,0.006449659,0.070357285,0.013344007,0.0032207286,0.0002316724,0.0000067210367,0.00006824324,0.014120685],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966374,0.0002895615,0.0019759564,0.00032626945,0.0002904388,0.00048037752],"domain_scores_gemma":[0.9938794,0.003006053,0.0012723567,0.0003066537,0.00088509446,0.0006504561],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017285855,0.0002002299,0.0019875115,0.0001923656,0.000040753413,0.000008384152,0.00025776046,0.000072571325,0.00038343182],"category_scores_gemma":[0.0008572827,0.00013441581,0.000557119,0.0003179991,0.00017999011,0.0000413561,0.00008449283,0.00043501408,0.000034812543],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007990696,0.0010096517,0.3437327,0.00006213103,0.00097427727,0.00009117906,0.0003268438,0.00007382536,0.00045007467,0.000027293449,0.08902679,0.55623454],"study_design_scores_gemma":[0.015549591,0.12124424,0.04802488,0.00025708496,0.00080854795,0.000034402914,0.0008056799,0.00031069125,0.0005424504,0.000046739195,0.81211984,0.00025583693],"about_ca_topic_score_codex":0.0014887744,"about_ca_topic_score_gemma":0.0013879479,"teacher_disagreement_score":0.7230931,"about_ca_system_score_codex":0.0010689411,"about_ca_system_score_gemma":0.0031159145,"threshold_uncertainty_score":0.5527499},"labels":[],"label_agreement":null},{"id":"W3003747453","doi":"10.1016/j.jtho.2020.01.016","title":"New Approaches to SCLC Therapy: From the Laboratory to the Clinic","year":2020,"lang":"en","type":"review","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":176,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Janssen Pharmaceuticals; National Cancer Institute; National Health and Medical Research Council; Daiichi Sankyo Europe; Agios Pharmaceuticals; Karolinska Institutet; Takeda Oncology; EMD Serono; Ipsen; PharmaMar; Astellas Pharma; Merck; Kyowa Hakko Kirin; Daiichi-Sankyo; Syndax Pharmaceuticals; Cancer Research UK; AstraZeneca; International Association for the Study of Lung Cancer; Genentech; ANGLE; Bayer Fund; Meso Scale Diagnostics; Astex Pharmaceuticals; TG Therapeutics; Aeglea BioTherapeutics; Pfizer Pharmaceuticals; Marshfield Clinic Research Foundation; Memorial Sloan-Kettering Cancer Center; Merck KGaA; National Institutes of Health; Regeneron Pharmaceuticals; Victorian Cancer Agency; Incyte; Medical Research Council; University of Texas Southwestern Medical Center; AbbVie; Celgene; Novartis; Foundation Medicine; GlaxoSmithKline; Eli Lilly and Company; Bristol-Myers Squibb; G1 Therapeutics; Lung Cancer Research Foundation; Cold Spring Harbor Laboratory; Roche; Astellas Pharma US; Amgen; Ariad Pharmaceuticals; Boehringer Ingelheim; Pfizer","keywords":"Medicine; Intensive care medicine; Lung cancer; Clinical trial; Immunotherapy; Disease; Oncology; Cancer; Internal medicine","score_opus":0.36389056416098625,"score_gpt":0.5524615542292449,"score_spread":0.18857099006825867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3003747453","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000018196803,0.8442825,0.0001175665,0.15194842,0.0011582715,0.0015516689,0.000051101426,0.000013490629,0.0008587934],"genre_scores_gemma":[0.000011532372,0.97876924,0.0028187952,0.008061919,0.009065961,0.00007930039,0.0000052460023,0.00006748082,0.0011205341],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956785,0.0015758207,0.001195244,0.0003633481,0.0007776457,0.0004094752],"domain_scores_gemma":[0.99493426,0.002553273,0.00095261395,0.000696155,0.00023640058,0.0006272874],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0026551618,0.0003958338,0.0030205832,0.0001777617,0.00014925157,0.00005547711,0.0012942306,0.00031069454,0.0003385707],"category_scores_gemma":[0.0017496084,0.00016309139,0.00076866295,0.0009952128,0.00011856311,0.00005181916,0.00044027047,0.0023912378,0.000613154],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056386297,0.000049286708,0.000011630572,0.00042216622,0.001297344,0.00017641485,0.00085870514,4.1181866e-7,6.024265e-7,0.00000514197,0.28768876,0.70892566],"study_design_scores_gemma":[0.00030554796,0.0025318237,0.000104126986,0.0039305254,0.0016791504,0.00015860827,0.00037480003,2.800623e-7,0.0000025899296,0.000049312195,0.99071866,0.00014457187],"about_ca_topic_score_codex":0.00003964009,"about_ca_topic_score_gemma":0.000065983186,"teacher_disagreement_score":0.7087811,"about_ca_system_score_codex":0.0009235625,"about_ca_system_score_gemma":0.00798034,"threshold_uncertainty_score":0.9999103},"labels":[],"label_agreement":null},{"id":"W3006923011","doi":"10.1016/j.cllc.2020.02.013","title":"Effect of Hospitalization During First Chemotherapy and Performance Status on Small-cell Lung Cancer Outcomes","year":2020,"lang":"en","type":"article","venue":"Clinical Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Institute in Oncology and Hematology; University of Manitoba; CancerCare Manitoba","funders":"Fondation de l’Hôpital Saint-Boniface; University of Manitoba; Manitoba Medical Service Foundation","keywords":"Medicine; Internal medicine; Lung cancer; Cohort; Performance status; Neutropenia; Chemotherapy; Retrospective cohort study; Cancer; Febrile neutropenia; Oncology","score_opus":0.024733776137534275,"score_gpt":0.40715397650250174,"score_spread":0.3824202003649675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006923011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98470294,0.007985022,0.00001195565,0.005172181,0.00031660625,0.0012588114,0.00004422489,0.00006759818,0.0004406606],"genre_scores_gemma":[0.96481556,0.03264705,0.000034725184,0.0013225286,0.00042397078,0.00022936673,0.0000054261814,0.000049911905,0.00047144978],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980746,0.00008638384,0.00052757614,0.0005027364,0.00039054395,0.0004181477],"domain_scores_gemma":[0.99858445,0.00050467724,0.00019505696,0.00026116456,0.00013103135,0.00032363596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031611466,0.00025614045,0.0007916942,0.000051953903,0.00011291865,0.000016240949,0.00011603333,0.0001207319,0.00020929641],"category_scores_gemma":[0.00040372583,0.00018559153,0.00016192129,0.00023475738,0.00019853195,0.000074940304,0.00010466581,0.00038532008,0.0000032953205],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002521136,0.00007283368,0.9809183,0.0052686264,0.00039099398,0.0000065738677,0.00050082826,0.00010522081,0.00015392531,0.00000237882,0.0019032778,0.0081559075],"study_design_scores_gemma":[0.007904558,0.0024509893,0.9738136,0.0008777279,0.00033557139,4.061793e-7,0.000017174241,0.0056225765,0.0077952323,4.7523378e-7,0.0009734884,0.00020819546],"about_ca_topic_score_codex":0.00012876221,"about_ca_topic_score_gemma":0.000041685067,"teacher_disagreement_score":0.02466203,"about_ca_system_score_codex":0.00027164395,"about_ca_system_score_gemma":0.00018437585,"threshold_uncertainty_score":0.7568203},"labels":[],"label_agreement":null},{"id":"W3011743004","doi":"10.1200/jco.2012.30.15_suppl.e17518","title":"Prognostic factors and trends in outcome for small cell lung cancer over 20 years.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Proportional hazards model; Cancer registry; Internal medicine; Lung cancer; Incidence (geometry); Hazard ratio; Population; Cancer; Radiation therapy; Clinical trial; Oncology; Relative survival; Confidence interval","score_opus":0.25374892070157656,"score_gpt":0.5750290758065449,"score_spread":0.3212801551049684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011743004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99070805,0.004152981,0.000017234503,0.0031709261,0.0009961274,0.00023060462,0.0000081903145,0.0000039077904,0.00071197463],"genre_scores_gemma":[0.99570686,0.0007395265,0.0007239106,0.00060383725,0.0012589145,0.000016202344,0.0000012489307,0.000014387014,0.00093508925],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980415,0.0001369857,0.0011475405,0.00011400723,0.00021146472,0.0003484892],"domain_scores_gemma":[0.9962898,0.0026217713,0.0005086627,0.00008035778,0.00013678626,0.00036263897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002097097,0.00010049573,0.0010377773,0.00018688303,0.000018005425,0.0000048392885,0.00008030065,0.00019685391,0.000119740405],"category_scores_gemma":[0.0027697627,0.00006403796,0.00023796875,0.00011614469,0.00012434571,0.000087106906,0.00006189234,0.00068947574,9.76984e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008197912,0.00052945426,0.9658768,0.00008105211,0.00017683224,0.000043031654,0.0002786836,0.0000010198119,0.000030510915,0.000009055975,0.007043646,0.025110086],"study_design_scores_gemma":[0.0059192525,0.0024615054,0.94790584,0.0000519192,0.0003089104,0.0000125462775,0.00007000707,0.000033468576,0.00001548142,0.000014719849,0.04314661,0.00005971863],"about_ca_topic_score_codex":0.00006301718,"about_ca_topic_score_gemma":0.00027894267,"teacher_disagreement_score":0.036102965,"about_ca_system_score_codex":0.00024879945,"about_ca_system_score_gemma":0.0003885513,"threshold_uncertainty_score":0.33158648},"labels":[],"label_agreement":null},{"id":"W3014319679","doi":"10.21037/jtd.2020.03.89","title":"PARP inhibitors for small cell lung cancer and their potential for integration into current treatment approaches","year":2020,"lang":"en","type":"review","venue":"Journal of Thoracic Disease","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Center for Advancing Translational Sciences; Ontario Institute for Cancer Research; American Society of Clinical Oncology; International Association for the Study of Lung Cancer; Conquer Cancer Foundation","keywords":"Medicine; Lung cancer; Immunotherapy; Oncology; Radiation therapy; Chemotherapy; Clinical trial; Biomarker; Cancer; Disease; Internal medicine; Cancer research; Biology","score_opus":0.12099512687709159,"score_gpt":0.44977142235243156,"score_spread":0.32877629547534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014319679","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016524355,0.99035513,0.0036936468,0.001001552,0.00060956745,0.003733007,0.00042285974,0.00001197843,0.000006984798],"genre_scores_gemma":[0.0006150914,0.9944141,0.00086139713,0.000019863503,0.0025724552,0.001188141,0.00012216106,0.00006524531,0.00014153635],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99827445,0.00010210198,0.00073851715,0.00033836742,0.00027131478,0.00027526423],"domain_scores_gemma":[0.9979438,0.00019179002,0.00075199304,0.00017464418,0.0002959975,0.00064176804],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030756093,0.00045075009,0.0016940607,0.00023234249,0.00011864855,0.000073398674,0.00014007017,0.000088312445,0.000004548294],"category_scores_gemma":[0.0002278295,0.0002477901,0.0012056421,0.00013852322,0.0000731151,0.00009534921,0.00007092165,0.00031422195,4.914806e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010648951,0.0002828256,0.000024936513,0.08913362,0.0008794061,0.000023585448,0.0003939462,0.0000028978845,0.0000014822491,0.0000036964216,0.002290836,0.90589786],"study_design_scores_gemma":[0.0015118804,0.0011721655,0.000010808669,0.03754819,0.015512375,0.000020797737,0.0003024092,0.0008424866,0.000054741588,0.00014129227,0.94254684,0.00033599624],"about_ca_topic_score_codex":0.000007929168,"about_ca_topic_score_gemma":0.000006566988,"teacher_disagreement_score":0.940256,"about_ca_system_score_codex":0.0009803292,"about_ca_system_score_gemma":0.001999197,"threshold_uncertainty_score":0.99999744},"labels":[],"label_agreement":null},{"id":"W3017187232","doi":"10.3747/co.27.5183","title":"Immuno-Oncology—The New Paradigm of Lung Cancer Treatment","year":2020,"lang":"en","type":"review","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; University of Manitoba; CancerCare Manitoba","funders":"Manitoba Medical Service Foundation","keywords":"Medicine; Lung cancer; Oncology; Internal medicine; Immunotherapy; Treatment of lung cancer; Chemoradiotherapy; Pembrolizumab; Cancer; Intensive care medicine","score_opus":0.2838468422970253,"score_gpt":0.5795696855701663,"score_spread":0.295722843273141,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3017187232","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000002377114,0.9850553,0.000011642722,0.0059880246,0.0025894998,0.0034669586,0.00012102934,0.000050096674,0.002715031],"genre_scores_gemma":[0.000004098923,0.99490565,0.00003793845,0.00007606755,0.0020925575,0.0016565748,0.0001079427,0.00006154072,0.0010576411],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969709,0.000497814,0.00095310214,0.00060642045,0.00037470573,0.00059703895],"domain_scores_gemma":[0.99736154,0.0008595438,0.0006867275,0.000648684,0.00011423536,0.00032925353],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025259858,0.00056900986,0.004357376,0.00017390295,0.00010420352,0.000008720864,0.00045689632,0.00036726292,0.0005121264],"category_scores_gemma":[0.00022879831,0.00031255343,0.00091357576,0.00051546865,0.0004570408,0.000027280876,0.00032219253,0.00088825513,0.00007447426],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00010672153,0.00034681224,0.000073490715,0.012015464,0.002339191,0.00008095729,0.0006237713,1.4863305e-7,5.022519e-7,0.00010166152,0.10382354,0.88048774],"study_design_scores_gemma":[0.0017721431,0.002136737,0.000016899789,0.0068627233,0.00688723,0.000108137894,0.00003417085,0.0000070129886,0.000001996511,0.00001946509,0.9819458,0.00020767929],"about_ca_topic_score_codex":0.0002452513,"about_ca_topic_score_gemma":0.00015837958,"teacher_disagreement_score":0.8802801,"about_ca_system_score_codex":0.007004059,"about_ca_system_score_gemma":0.014305517,"threshold_uncertainty_score":0.99993265},"labels":[],"label_agreement":null},{"id":"W3019010871","doi":"10.1111/joim.13053","title":"Tumour biomarkers: association with heart failure outcomes","year":2020,"lang":"en","type":"article","venue":"Journal of Internal Medicine","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"European Research Council; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; National Institute for Health and Care Research; China Scholarship Council; Fondation Leducq; European Commission","keywords":"Medicine; Internal medicine; Hazard ratio; Quartile; Heart failure; Gastroenterology; Cohort; Proportional hazards model; Area under the curve; Confidence interval","score_opus":0.022859536971567132,"score_gpt":0.34498561655028953,"score_spread":0.3221260795787224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3019010871","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47367856,0.0010213278,0.00056171033,0.5226577,0.00032174742,0.0001934613,0.000002833176,0.00002319618,0.0015394661],"genre_scores_gemma":[0.98737586,0.00007985699,0.0013256076,0.009220538,0.0015959702,0.0000021707585,7.60762e-7,0.000019713816,0.00037953365],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99775165,0.000058785015,0.0005229429,0.00012307726,0.0013154192,0.00022814189],"domain_scores_gemma":[0.9980818,0.00024652862,0.00046731054,0.00008522297,0.000735506,0.00038360897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006023655,0.00014866733,0.0006945904,0.00016266576,0.00003276184,0.000013458496,0.00014554802,0.000046657107,0.00030703252],"category_scores_gemma":[0.0030020468,0.00007688167,0.00013094679,0.00023899447,0.000085885076,0.00013661804,0.00004129654,0.0005817725,0.000020753649],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013468398,0.000041943695,0.7057843,0.00010122747,0.0011607407,0.00032820684,0.0006229503,0.0000012786955,0.017422073,0.000006180436,0.27293578,0.00024843137],"study_design_scores_gemma":[0.019764537,0.01960156,0.7781682,0.0047934633,0.0010644259,0.001882693,0.0047781877,0.00008731544,0.014227847,0.00006265118,0.15529309,0.00027603377],"about_ca_topic_score_codex":0.000058600515,"about_ca_topic_score_gemma":0.000012556932,"teacher_disagreement_score":0.5136973,"about_ca_system_score_codex":0.00038783264,"about_ca_system_score_gemma":0.00015900772,"threshold_uncertainty_score":0.35939473},"labels":[],"label_agreement":null},{"id":"W3021245509","doi":"10.1016/s0923-7534(20)34093-x","title":"Third-Line Chemotherapy in Small Cell Lung Cancer: An International Analysis","year":2012,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Ottawa Hospital","funders":"","keywords":"Medicine; Chemotherapy; Oncology; Lung cancer; Internal medicine; Chemotherapy regimen","score_opus":0.11391382267285063,"score_gpt":0.4960946420736674,"score_spread":0.3821808194008167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021245509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9708619,0.00322636,0.000045209435,0.014105052,0.00017637412,0.00021555093,0.000014538402,0.00002472027,0.011330295],"genre_scores_gemma":[0.9892017,0.0069462718,0.00048519977,0.0023430742,0.00038217337,0.000051607825,0.000019529343,0.000014764384,0.0005556692],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99897426,0.00007547726,0.0002699996,0.00016523834,0.00017908438,0.00033594572],"domain_scores_gemma":[0.9992127,0.00009198962,0.00011513719,0.00020190072,0.00024630752,0.00013200312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005997621,0.00009441218,0.00045571977,0.0003700407,0.000014762744,0.0000030719393,0.00015514353,0.0000873244,0.0003015066],"category_scores_gemma":[0.00007254409,0.00007934637,0.00011447821,0.00042526127,0.000086193926,0.00010930649,0.00005619343,0.0001740657,0.0000031416778],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056979264,0.00106043,0.9677783,0.000065599124,0.0011600086,0.000013512371,0.0018845896,0.00008088041,0.0021887098,0.00010454157,0.0037152003,0.021378413],"study_design_scores_gemma":[0.003149821,0.0014110436,0.89974153,0.000039012626,0.00033227736,0.0000044374515,0.0003328624,0.0015477724,0.01708407,0.000052394113,0.07615939,0.00014539446],"about_ca_topic_score_codex":0.0012981776,"about_ca_topic_score_gemma":0.0013192677,"teacher_disagreement_score":0.072444186,"about_ca_system_score_codex":0.0001547059,"about_ca_system_score_gemma":0.00019811404,"threshold_uncertainty_score":0.33012858},"labels":[],"label_agreement":null},{"id":"W3029908290","doi":"10.1200/jco.2020.38.15_suppl.e19306","title":"Predictors of and longitudinal assessment of health utility scores in patients with small cell lung cancer using real-world data.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Stage (stratigraphy); Lung cancer; Disease; Cohort; Internal medicine; Clinical trial; Medical record; Cancer; Performance status; Surgery","score_opus":0.3681568588088141,"score_gpt":0.5781826114878956,"score_spread":0.21002575267908152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3029908290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99493724,0.0008016729,0.00014304537,0.0033966303,0.00015804182,0.000363459,0.00004261948,0.000002180431,0.00015510361],"genre_scores_gemma":[0.99253136,0.0017787275,0.005197553,0.00026269833,0.00021074626,0.0000013910325,0.0000039385022,0.00000903795,0.0000045403326],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964881,0.0005040648,0.0020409017,0.0002303966,0.0005254449,0.00021111088],"domain_scores_gemma":[0.9958445,0.00095822534,0.0022232984,0.00019891019,0.00047574763,0.00029932972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032159528,0.00010215589,0.0017299925,0.00011415147,0.000021985983,0.0000026066273,0.00017832694,0.000061106504,0.000017865968],"category_scores_gemma":[0.0010381262,0.00006646976,0.000074240794,0.00025743272,0.0004425251,0.00009172174,0.00024439135,0.0007224027,3.0451254e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034716206,0.0009351971,0.9859802,0.0006413982,0.00035858556,0.00002912308,0.00015149389,0.00004695596,0.0000054723846,0.000003289444,0.0006521883,0.0077244677],"study_design_scores_gemma":[0.0071659135,0.010382552,0.9798041,0.00047336172,0.00024027286,0.000001361905,0.00006658127,0.0015271724,0.0000078030225,0.0000034246611,0.0002852288,0.000042233893],"about_ca_topic_score_codex":0.0016111966,"about_ca_topic_score_gemma":0.0026779226,"teacher_disagreement_score":0.009447354,"about_ca_system_score_codex":0.00028078476,"about_ca_system_score_gemma":0.0047693825,"threshold_uncertainty_score":0.846068},"labels":[],"label_agreement":null},{"id":"W3030178583","doi":"10.1200/jco.20.00793","title":"Pembrolizumab or Placebo Plus Etoposide and Platinum as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer: Randomized, Double-Blind, Phase III KEYNOTE-604 Study","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":759,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"William Osler Health System; University of Toronto","funders":"National Cancer Institute","keywords":"Pembrolizumab; Medicine; Placebo; Internal medicine; Lung cancer; Hazard ratio; Clinical endpoint; Etoposide; Population; Gastroenterology; Progression-free survival; Oncology; Randomized controlled trial; Surgery; Confidence interval; Cancer; Chemotherapy; Immunotherapy; Pathology","score_opus":0.24579924696283775,"score_gpt":0.5415262119285564,"score_spread":0.2957269649657187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3030178583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93631536,0.007962205,0.0011867029,0.044551212,0.000930682,0.008206927,0.000026719827,0.000033002336,0.000787209],"genre_scores_gemma":[0.9619196,0.023626411,0.0009992059,0.0073733577,0.0035605747,0.00048133748,0.000005579063,0.000069885726,0.001964027],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9939471,0.0007725986,0.003413784,0.0005643825,0.00072662067,0.0005755172],"domain_scores_gemma":[0.9821501,0.012960614,0.00224054,0.0002803896,0.0013622643,0.0010061256],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.005244841,0.00039810172,0.004814168,0.00016882403,0.00021227001,0.000041575022,0.00033860226,0.00037675578,0.00033577436],"category_scores_gemma":[0.008400469,0.0002399045,0.00079381256,0.0002404395,0.0005051063,0.00014434774,0.0002151027,0.0017043373,0.0000048758284],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9657739,0.0029187873,0.0020638783,0.00030123728,0.0032083467,0.0017953165,0.002831375,0.00023818301,0.00009315171,0.000016076481,0.0061242976,0.014635446],"study_design_scores_gemma":[0.91138786,0.05873763,0.0002772695,0.00015107777,0.0017269112,0.00012953833,0.0012054541,0.0040579103,0.00023985434,0.000038178892,0.021820042,0.00022826766],"about_ca_topic_score_codex":0.00024064841,"about_ca_topic_score_gemma":0.00040383128,"teacher_disagreement_score":0.05581884,"about_ca_system_score_codex":0.0003914437,"about_ca_system_score_gemma":0.004925498,"threshold_uncertainty_score":0.9999522},"labels":[],"label_agreement":null},{"id":"W3030792017","doi":"10.1200/jco.2020.38.15_suppl.9065","title":"Preliminary efficacy data of platinum-pretreated small cell lung cancer (SCLC) cohort of NCI 9881 study: A phase II study of cediranib in combination with olaparib in advanced solid tumors.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Institutes of Health","keywords":"Olaparib; Medicine; PARP inhibitor; Internal medicine; Oncology; Response Evaluation Criteria in Solid Tumors; Clinical endpoint; Adverse effect; Phases of clinical research; Chemotherapy; Gastroenterology; Clinical trial; Poly ADP ribose polymerase","score_opus":0.16719664029712927,"score_gpt":0.5222723428559617,"score_spread":0.3550757025588324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3030792017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952224,0.00069932395,0.000018663108,0.0009863736,0.00013603813,0.0026609919,0.000034068464,0.000006641197,0.0002355155],"genre_scores_gemma":[0.99886066,0.00041444748,0.00041916023,0.00010233702,0.00011532606,0.000031933174,0.0000113904025,0.000025772802,0.000018968885],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9934601,0.00088845217,0.0040362165,0.00042895335,0.0008900718,0.0002961834],"domain_scores_gemma":[0.99288255,0.002360071,0.0031093468,0.00047382535,0.0009248321,0.00024936753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035748165,0.00021762119,0.0032880716,0.00030155276,0.000028278635,0.0000025822378,0.0005612142,0.00015797137,0.000035581583],"category_scores_gemma":[0.005585971,0.0001571736,0.000121103185,0.0007530461,0.00026283585,0.00016879867,0.0004948626,0.0012919537,2.4599706e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07046048,0.054299593,0.8534852,0.00045033803,0.001008587,0.00093391904,0.007449586,0.00082586677,0.0011955304,9.612979e-7,0.0003116164,0.009578321],"study_design_scores_gemma":[0.10289354,0.20832528,0.68019366,0.00067736895,0.0008237516,0.000009933495,0.0041793934,0.0022597404,0.00049966434,0.0000028670772,0.00003633717,0.000098453995],"about_ca_topic_score_codex":0.0005448892,"about_ca_topic_score_gemma":0.0013846459,"teacher_disagreement_score":0.17329153,"about_ca_system_score_codex":0.00026367872,"about_ca_system_score_gemma":0.0022599665,"threshold_uncertainty_score":0.66873324},"labels":[],"label_agreement":null},{"id":"W3030999222","doi":"10.1001/jamaoncol.2020.1271","title":"Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Metastases","year":2020,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":215,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Université de Sherbrooke","funders":"National Center for Advancing Translational Sciences; National Institute of General Medical Sciences","keywords":"Medicine; Radiosurgery; Interquartile range; Lung cancer; Radiation therapy; Brain metastasis; Internal medicine; Prophylactic cranial irradiation; Oncology; Cohort; Retrospective cohort study; Cancer; Metastasis; Conventional PCI","score_opus":0.09586448013135285,"score_gpt":0.42618148420825736,"score_spread":0.3303170040769045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3030999222","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24557509,0.034004845,0.003082583,0.7101889,0.00048297175,0.0046427194,0.000932708,0.00009288054,0.0009972929],"genre_scores_gemma":[0.91080827,0.003017512,0.009882783,0.061408833,0.0055783144,0.0058667245,0.0007765747,0.0002197363,0.002441268],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99751824,0.00053293083,0.00047105542,0.00041330638,0.0006454981,0.000418981],"domain_scores_gemma":[0.9958144,0.002590252,0.00025630998,0.00025011934,0.00087942457,0.00020948655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028217633,0.00020148208,0.00084928935,0.00014310238,0.00008395426,0.000011970469,0.00015170325,0.00016080304,0.0008393807],"category_scores_gemma":[0.004848471,0.0001708646,0.00022304567,0.00032716035,0.00013423458,0.00007746834,0.0000625632,0.00024449878,0.000004691682],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032107003,0.00033942354,0.007380934,0.0014474477,0.0011612448,0.000032227006,0.0023340564,0.0010332379,0.022894375,0.00002783545,0.855301,0.10483748],"study_design_scores_gemma":[0.019762186,0.0038978711,0.003889667,0.00018400417,0.0010697771,0.000012132986,0.00025450694,0.05200739,0.012900832,0.00006061726,0.90573555,0.00022543588],"about_ca_topic_score_codex":0.00018714939,"about_ca_topic_score_gemma":0.00038229986,"teacher_disagreement_score":0.6652332,"about_ca_system_score_codex":0.0010514456,"about_ca_system_score_gemma":0.0016808683,"threshold_uncertainty_score":0.91906303},"labels":[],"label_agreement":null},{"id":"W3031395200","doi":"10.1016/j.ccell.2020.04.016","title":"MAX Functions as a Tumor Suppressor and Rewires Metabolism in Small Cell Lung Cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Cell","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Quest University Canada","funders":"National Institute of General Medical Sciences; National Cancer Institute; National Institutes of Health; University of Virginia","keywords":"Biology; Carcinogenesis; Cancer research; Suppressor; Derepression; Serine; Tumor suppressor gene; Phenotype; Cancer; Gene; Context (archaeology); Lung cancer; Genetics; Gene expression; Medicine; Internal medicine; Psychological repression","score_opus":0.02688124904498969,"score_gpt":0.3181522215302106,"score_spread":0.29127097248522094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031395200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78897876,0.17387564,0.000022223643,0.011898099,0.00043956225,0.0011848349,0.0001788348,0.000103976774,0.023318052],"genre_scores_gemma":[0.97094357,0.0115918955,0.00015085001,0.004457951,0.0008577205,0.0009985893,0.000011870948,0.000067281646,0.010920242],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99837416,0.000053850184,0.00025623958,0.0005411597,0.0002647796,0.0005098307],"domain_scores_gemma":[0.9991137,0.0000717933,0.00007215383,0.00024365138,0.00012286232,0.0003758443],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000096994656,0.00023728039,0.00047968508,0.00007454289,0.00009787639,0.000034504832,0.00013246237,0.00006111879,0.0020484119],"category_scores_gemma":[0.00007275608,0.00020406116,0.000078746496,0.00033613382,0.00012397661,0.000113634,0.00018521636,0.00039100897,0.000030149677],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040612286,0.0006648582,0.28102168,0.0117841875,0.00089332514,0.0011543469,0.028667532,0.0005134759,0.25737843,0.00017419815,0.40506226,0.008624497],"study_design_scores_gemma":[0.014964724,0.00059599127,0.09504645,0.00079539086,0.001356795,0.000021398759,0.004712277,0.0028712512,0.14184229,0.00007742021,0.7366205,0.001095543],"about_ca_topic_score_codex":0.009478621,"about_ca_topic_score_gemma":0.0023944427,"teacher_disagreement_score":0.33155823,"about_ca_system_score_codex":0.00033484946,"about_ca_system_score_gemma":0.00055857387,"threshold_uncertainty_score":0.9988639},"labels":[],"label_agreement":null},{"id":"W3031935808","doi":"10.1200/jco.2020.38.15_suppl.e21101","title":"Extensive small cell lung cancer (SCLC) chemotherapy: A population kinetics assessment.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Internal medicine; Chemotherapy; Etoposide; Population; Oncology; Nuclear medicine; Urology","score_opus":0.16877054844918138,"score_gpt":0.5475295781569021,"score_spread":0.3787590297077207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031935808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8427701,0.002887992,0.0012825178,0.14651397,0.0011423252,0.00048081865,0.000005556646,0.000019831663,0.004896894],"genre_scores_gemma":[0.96199584,0.0051362845,0.00864228,0.02025005,0.0036210783,0.0000075490534,0.0000024092321,0.000026937905,0.00031759572],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972609,0.00028987625,0.0015280526,0.00019813802,0.0004732988,0.00024970103],"domain_scores_gemma":[0.9962243,0.0010414188,0.0012253675,0.00012600845,0.00089228014,0.00049061904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010623477,0.00013078627,0.0012854344,0.000063225125,0.000034249246,0.000010050262,0.00015217837,0.00022506148,0.00027554994],"category_scores_gemma":[0.0022959264,0.00009215147,0.00036772672,0.00017091523,0.0001157931,0.00006202486,0.00007456759,0.0011878045,0.0000051825305],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005784069,0.0015800319,0.7734298,0.00041355065,0.0013328117,0.0010192492,0.0006693359,0.00019122966,0.0046046614,0.00004751302,0.08301922,0.12790854],"study_design_scores_gemma":[0.011531054,0.012992541,0.87144226,0.00014924539,0.00063757424,0.000046486497,0.00019178582,0.0016198828,0.0002577807,0.000088733155,0.10091578,0.00012685331],"about_ca_topic_score_codex":0.00005318325,"about_ca_topic_score_gemma":0.000035078334,"teacher_disagreement_score":0.12778169,"about_ca_system_score_codex":0.0003822434,"about_ca_system_score_gemma":0.0014848191,"threshold_uncertainty_score":0.51604855},"labels":[],"label_agreement":null},{"id":"W3032096744","doi":"10.1200/jco.2020.38.15_suppl.9001","title":"KEYNOTE-604: Pembrolizumab (pembro) or placebo plus etoposide and platinum (EP) as first-line therapy for extensive-stage (ES) small-cell lung cancer (SCLC).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"William Osler Health System; University of Toronto","funders":"","keywords":"Medicine; Placebo; Carboplatin; Internal medicine; Population; Etoposide; Interim analysis; Pembrolizumab; Clinical endpoint; Oncology; Clinical trial; Cisplatin; Chemotherapy; Cancer; Pathology; Immunotherapy","score_opus":0.2029837320610601,"score_gpt":0.5117943962480638,"score_spread":0.30881066418700365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3032096744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87866193,0.011837988,0.0009703418,0.103458084,0.0011422524,0.002116637,0.000054579446,0.00004087274,0.0017172914],"genre_scores_gemma":[0.8927283,0.05645387,0.0062584076,0.03236153,0.0065886034,0.00016510344,0.000007761635,0.00012169783,0.005314699],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955638,0.00037106374,0.0023238927,0.0005090287,0.0006125796,0.0006196362],"domain_scores_gemma":[0.98795897,0.008020091,0.0015699108,0.0002555331,0.001180105,0.001015414],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0020133047,0.00034957004,0.0025344475,0.00012738636,0.0001760433,0.000031573683,0.000322066,0.00047989638,0.0005191393],"category_scores_gemma":[0.010123159,0.00022373373,0.00056699925,0.00021073481,0.00040797278,0.00013707663,0.00021132053,0.0016840218,0.00001058231],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6868974,0.002295306,0.0444676,0.0026397903,0.005063762,0.0060244515,0.0049735145,0.0010725857,0.0030611341,0.00018194705,0.1304716,0.112850904],"study_design_scores_gemma":[0.20680428,0.090516604,0.033596482,0.0007501755,0.0015803359,0.00058740604,0.0011066033,0.011930772,0.0021097565,0.00023018854,0.65010875,0.00067864935],"about_ca_topic_score_codex":0.00012186006,"about_ca_topic_score_gemma":0.00033949668,"teacher_disagreement_score":0.51963717,"about_ca_system_score_codex":0.0004490904,"about_ca_system_score_gemma":0.005405172,"threshold_uncertainty_score":0.998215},"labels":[],"label_agreement":null},{"id":"W3032296787","doi":"10.1200/jco.2020.38.15_suppl.e21107","title":"Is there a role for hypofractionated thoracic radiotherapy in limited-stage small cell lung cancer? a propensity score matched analysis.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Cancer Care Ontario; University of Toronto; London Health Sciences Centre","funders":"","keywords":"Medicine; Propensity score matching; Chemoradiotherapy; Radiation therapy; Internal medicine; Lung cancer; Proportional hazards model; Performance status; Retrospective cohort study; Gemcitabine; Regimen; Stage (stratigraphy); Surgery; Oncology; Cancer","score_opus":0.26795590326361335,"score_gpt":0.5248756010756432,"score_spread":0.2569196978120299,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3032296787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.922062,0.00765041,0.0008075964,0.06787385,0.00020495962,0.0008746386,0.000022458247,0.000015788368,0.00048832776],"genre_scores_gemma":[0.97528404,0.0073748957,0.003474342,0.011909765,0.0011262029,0.000049209273,0.00000429352,0.000031289273,0.0007459554],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967257,0.00047619327,0.0017283773,0.00032475847,0.00040434682,0.00034066488],"domain_scores_gemma":[0.99554425,0.0016923124,0.0013524265,0.0001835038,0.00079146744,0.00043605306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024644078,0.00017546192,0.0023193348,0.0002308603,0.00005222819,0.000015939913,0.00023657433,0.00030997253,0.00028974513],"category_scores_gemma":[0.0020601344,0.000120379926,0.00080617366,0.00079597376,0.0001355647,0.00012881347,0.000063983636,0.0013563914,0.0000029808314],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020550456,0.0011592637,0.9379677,0.0003768973,0.0045259274,0.00050078036,0.0010235797,0.00047843234,0.0017065196,0.000006336222,0.0066662314,0.025037851],"study_design_scores_gemma":[0.014327423,0.009412397,0.8593696,0.00018299984,0.0027047205,0.00002166114,0.00056093873,0.022461297,0.0008222313,0.00005448091,0.08986831,0.00021395997],"about_ca_topic_score_codex":0.00021662665,"about_ca_topic_score_gemma":0.0004546736,"teacher_disagreement_score":0.08320208,"about_ca_system_score_codex":0.0005418097,"about_ca_system_score_gemma":0.0025171717,"threshold_uncertainty_score":0.5892921},"labels":[],"label_agreement":null},{"id":"W3034776875","doi":"10.1016/j.canlet.2020.06.002","title":"ASCL1 promotes tumor progression through cell-autonomous signaling and immune modulation in a subset of lung adenocarcinoma","year":2020,"lang":"en","type":"article","venue":"Cancer Letters","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Japan Society for the Promotion of Science; Cancerfonden; Takeda Science Foundation","keywords":"Biology; Cancer research; Immune system; Adenocarcinoma; CCL20; Carcinogenesis; Chemokine; Pathology; Immunology; Chemokine receptor; Cancer; Medicine","score_opus":0.028117049274614864,"score_gpt":0.3251756978793353,"score_spread":0.2970586486047204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034776875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9689113,0.012197271,0.00013118028,0.017744204,0.000047665286,0.0008481913,0.000010741456,0.000033972814,0.000075499534],"genre_scores_gemma":[0.99761236,0.00013148168,0.0006399318,0.0012884175,0.0001443729,0.00014017621,0.000010738753,0.000024079698,0.000008461848],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99881333,0.00004554429,0.00028673658,0.00031064803,0.00028089862,0.00026281778],"domain_scores_gemma":[0.9995787,0.00003987224,0.00011686594,0.00013495826,0.000054090073,0.00007548957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000111125366,0.00014258108,0.00034988398,0.00006119742,0.000044168617,0.00001257127,0.000073771174,0.00003203458,0.00002948693],"category_scores_gemma":[0.000054371256,0.000121621655,0.000046963407,0.00026386412,0.00012967324,0.00013482064,0.00008031289,0.00021439204,0.0000013368716],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040009242,0.000044407465,0.34645367,0.0018134543,0.000069355825,0.0000996972,0.007209227,0.00024257919,0.64124846,0.0000073188885,0.0007953934,0.0016163787],"study_design_scores_gemma":[0.005327949,0.00059080974,0.5111353,0.0017755547,0.00014910649,0.00001304638,0.00046875502,0.012950769,0.4668482,0.00003126233,0.0003473248,0.00036196812],"about_ca_topic_score_codex":0.00024004595,"about_ca_topic_score_gemma":0.000007024307,"teacher_disagreement_score":0.17440026,"about_ca_system_score_codex":0.00020083097,"about_ca_system_score_gemma":0.000112498405,"threshold_uncertainty_score":0.49595872},"labels":[],"label_agreement":null},{"id":"W3035309353","doi":"10.1158/1557-3265.aacrahns19-ia02","title":"Abstract IA02: Utilizing patient-derived xenografts for prognostication and biomarker discovery","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Oncology; Head and neck squamous-cell carcinoma; Internal medicine; Biomarker; Hazard ratio; Radiation therapy; Cohort; Cancer; Precision medicine; Personalized medicine; Bioinformatics; Head and neck cancer; Pathology; Biology; Confidence interval","score_opus":0.4849151068034955,"score_gpt":0.5792740164811869,"score_spread":0.09435890967769145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035309353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94923526,0.005443335,0.00012634,0.040781453,0.0002035964,0.0030057316,0.000099952515,0.0000740163,0.0010303162],"genre_scores_gemma":[0.99318427,0.0036514367,0.0004071644,0.0009228558,0.00077122875,0.0009068025,0.000030172165,0.0000414679,0.00008462843],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99703586,0.00017207128,0.00056718657,0.0007078575,0.0008432687,0.00067376904],"domain_scores_gemma":[0.9960313,0.002323829,0.000084003594,0.00029257283,0.00069833297,0.0005699725],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0014888551,0.00015572175,0.00043174854,0.000101131875,0.00025960576,0.000112108704,0.00016437145,0.00012788735,0.00008624694],"category_scores_gemma":[0.008466089,0.00012162919,0.00014754331,0.00043889252,0.0008424864,0.00021092879,0.00033690906,0.0007070367,0.000023239829],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0143745765,0.0007578254,0.25633514,0.0036942007,0.0009634045,0.00009606825,0.0018096409,0.0000014909468,0.06730869,0.00035345368,0.09533289,0.5589726],"study_design_scores_gemma":[0.0071582333,0.0044074613,0.8691749,0.00088776066,0.00015159367,0.0000047448257,0.0018338648,0.00090001384,0.010437223,0.00042375794,0.104213245,0.0004072113],"about_ca_topic_score_codex":0.00013583171,"about_ca_topic_score_gemma":0.000039529456,"teacher_disagreement_score":0.61283976,"about_ca_system_score_codex":0.00013794981,"about_ca_system_score_gemma":0.00060393795,"threshold_uncertainty_score":0.99988604},"labels":[],"label_agreement":null},{"id":"W3035392729","doi":"10.1158/2326-6074.tumimm18-b15","title":"Abstract B15: The oral Chk1 inhibitor, SRA737, synergizes with immune checkpoint blockade in small-cell lung cancer (SCLC)","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Positive Living Society of British Columbia","funders":"","keywords":"Immune checkpoint; Cancer research; Immunotherapy; Cancer; CHEK1; Immune system; In vivo; Blockade; Medicine; Lung cancer; T cell; Cancer immunotherapy; Immunology; Biology; Cell cycle checkpoint; Cell cycle; Oncology; Internal medicine; Receptor","score_opus":0.0738198577910945,"score_gpt":0.3948078948909215,"score_spread":0.320988037099827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035392729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81040347,0.119832955,0.0000037919008,0.06452083,0.00024390087,0.0020127874,0.000035362213,0.00010116718,0.0028457146],"genre_scores_gemma":[0.9716261,0.022057775,0.000056816018,0.000517656,0.00067638763,0.0024277715,0.000015572808,0.000110701345,0.002511196],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9949153,0.00047026257,0.00069981883,0.0009816253,0.0010373304,0.0018956591],"domain_scores_gemma":[0.9973003,0.00053972675,0.00015380657,0.00090059213,0.00080212706,0.00030342644],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016064115,0.0004538519,0.0009431737,0.0003818244,0.0004990415,0.00008983086,0.0009597874,0.0002842224,0.0010555116],"category_scores_gemma":[0.0005186725,0.00028938882,0.00017390086,0.0019159323,0.0019617819,0.00015683437,0.00090362405,0.0038643277,0.00008823563],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01832417,0.00086011516,0.16216306,0.0029407602,0.0034850214,0.0016690519,0.014994239,0.0004236551,0.75455755,0.00009955605,0.016763872,0.023718977],"study_design_scores_gemma":[0.021141792,0.003129724,0.43215832,0.0025709074,0.00032114782,0.00007806376,0.008928006,0.0007406541,0.47588742,0.0000747309,0.05386019,0.0011090407],"about_ca_topic_score_codex":0.012364846,"about_ca_topic_score_gemma":0.003187593,"teacher_disagreement_score":0.2786701,"about_ca_system_score_codex":0.0014306804,"about_ca_system_score_gemma":0.0027826412,"threshold_uncertainty_score":0.99995583},"labels":[],"label_agreement":null},{"id":"W3035570024","doi":"10.1016/j.ijrobp.2020.06.008","title":"Is There a Role for Hypofractionated Thoracic Radiation Therapy in Limited-Stage Small Cell Lung Cancer? A Propensity Score Matched Analysis","year":2020,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto; London Health Sciences Centre","funders":"","keywords":"Propensity score matching; Stage (stratigraphy); Lung cancer; Radiation therapy; Oncology; Medicine; Internal medicine; Lung cancer screening; Radiology; Biology","score_opus":0.07094110663707079,"score_gpt":0.3963725409874519,"score_spread":0.32543143435038113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035570024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9659445,0.0044183102,0.0067436304,0.020952344,0.00045481685,0.0010146655,0.00021661991,0.000043122025,0.00021195757],"genre_scores_gemma":[0.98773074,0.0060114507,0.0009436971,0.0034717096,0.0014238842,0.00011176133,0.00016071106,0.00003583691,0.00011022823],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979259,0.00026266184,0.000764209,0.0003639161,0.0003836991,0.00029965347],"domain_scores_gemma":[0.9967502,0.0004197089,0.0011100344,0.00014763905,0.0013982194,0.00017422486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058897276,0.00024052836,0.00078429334,0.00036088002,0.000088384906,0.000041312258,0.00035617338,0.00022550288,0.00012443056],"category_scores_gemma":[0.0003609014,0.00020177744,0.00040875227,0.0007817527,0.00010023993,0.0003441545,0.00006337854,0.0006149194,0.0000066811313],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029751305,0.00042346385,0.9011856,0.000056597437,0.0033439659,0.000031772717,0.0021609315,0.0029174278,0.008944382,0.00017795133,0.0009874717,0.076795354],"study_design_scores_gemma":[0.019720327,0.0034024816,0.7755218,0.00015310073,0.0014916878,0.000025457675,0.00064251665,0.12841338,0.02738424,0.00148015,0.0412052,0.00055964204],"about_ca_topic_score_codex":0.0001943377,"about_ca_topic_score_gemma":0.000050743616,"teacher_disagreement_score":0.12566374,"about_ca_system_score_codex":0.0014240353,"about_ca_system_score_gemma":0.0010812113,"threshold_uncertainty_score":0.82282454},"labels":[],"label_agreement":null},{"id":"W3036504375","doi":"10.1016/j.clon.2020.05.017","title":"Patient-derived Xenograft Models of Small Cell Lung Cancer for Therapeutic Development","year":2020,"lang":"en","type":"article","venue":"Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"Terry Fox Foundation; Canada Foundation for Innovation; Canadian Institutes of Health Research; Cancer Research Society; Lung Cancer Research Foundation; AstraZeneca; Memorial Sloan-Kettering Cancer Center; Pfizer","keywords":"Medicine; Lung cancer; Cancer; Internal medicine; Oncology; Scopus; Incidence (geometry); Breast cancer; Prostate cancer; Gynecology; MEDLINE","score_opus":0.2502004934547571,"score_gpt":0.4873475968305229,"score_spread":0.23714710337576583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036504375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9499916,0.007865099,0.008508889,0.027233616,0.00056945806,0.0027649407,0.00002752331,0.00007545399,0.0029634445],"genre_scores_gemma":[0.9793046,0.0013048926,0.010814641,0.0076378365,0.00029609707,0.00045399292,0.000010773444,0.000027949143,0.00014922164],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99828094,0.00011192255,0.00077241624,0.00033292072,0.00017464378,0.0003271641],"domain_scores_gemma":[0.99814785,0.00091457315,0.0002155541,0.00015394996,0.00030045665,0.0002675939],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003279109,0.00012785933,0.0007562502,0.00003125445,0.000050166956,0.000002672511,0.00012482217,0.00016755685,0.00007214319],"category_scores_gemma":[0.0002921287,0.00009742285,0.00018428483,0.00010991758,0.00021643392,0.000023765615,0.00015081716,0.0002846146,0.0000062342992],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012425803,0.0034000296,0.10926813,0.0037317385,0.0033506202,0.00008364008,0.016151402,0.0004941459,0.019551028,0.00028564318,0.03852536,0.7927325],"study_design_scores_gemma":[0.040317737,0.036090363,0.05572283,0.00047976503,0.0019190399,0.0000057954903,0.0021592616,0.042275194,0.048341412,0.0008570686,0.77088886,0.00094268034],"about_ca_topic_score_codex":0.000019962741,"about_ca_topic_score_gemma":0.000042473683,"teacher_disagreement_score":0.79178977,"about_ca_system_score_codex":0.00018739082,"about_ca_system_score_gemma":0.0015597704,"threshold_uncertainty_score":0.39727888},"labels":[],"label_agreement":null},{"id":"W3042800031","doi":"10.3389/fonc.2020.01146","title":"Current Management and Progress in Radiotherapy for Small Cell Lung Cancer","year":2020,"lang":"en","type":"review","venue":"Frontiers in Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Radiation therapy; Current (fluid); Medicine; Lung cancer; Oncology; Medical physics; Radiology; Physics","score_opus":0.049356620976664566,"score_gpt":0.4536308554047787,"score_spread":0.40427423442811417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042800031","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000045692623,0.9896942,0.00038536167,0.00091578584,0.0016170694,0.006978477,0.00003951099,0.000021039405,0.00034400803],"genre_scores_gemma":[8.063396e-7,0.9786758,0.0127541665,0.00010454993,0.00036640224,0.0076535027,0.000033847708,0.00005736321,0.00035356174],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99807435,0.00016597171,0.0004907159,0.00060481793,0.00015287676,0.00051124167],"domain_scores_gemma":[0.9993708,0.00010137887,0.0001735392,0.00019471702,0.000032394488,0.0001271365],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030225224,0.0003272614,0.0023516081,0.00047626861,0.00002906697,0.000010555133,0.00019999665,0.00022115558,0.00001050867],"category_scores_gemma":[0.000021316899,0.00026462585,0.00016415409,0.00035798273,0.00017350608,0.000018974866,0.00014326457,0.00060112035,6.1453187e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016140076,0.00013396151,0.009798346,0.0756826,0.00035200967,0.00017062931,0.00029038393,2.5718418e-7,7.690942e-9,0.000011186503,0.080466904,0.8329323],"study_design_scores_gemma":[0.0031818135,0.00040703354,0.00024622996,0.0074587837,0.0006562231,0.0000058040946,0.00006288451,0.00015609135,9.5154896e-8,0.000016420236,0.9876038,0.00020486422],"about_ca_topic_score_codex":0.000014894878,"about_ca_topic_score_gemma":0.000058747606,"teacher_disagreement_score":0.90713686,"about_ca_system_score_codex":0.0035171378,"about_ca_system_score_gemma":0.00076394615,"threshold_uncertainty_score":0.99998057},"labels":[],"label_agreement":null},{"id":"W3046905571","doi":"10.1183/13993003.00320-2020","title":"Radiotherapy in the era of immunotherapy: teaching an old dog new tricks","year":2020,"lang":"en","type":"article","venue":"European Respiratory Journal","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Abscopal effect; Immunotherapy; Medicine; Radiation therapy; Ablative case; Vaccination; Immune system; Immunology; Cancer research; Oncology; Internal medicine","score_opus":0.05702394213249148,"score_gpt":0.36812345674914543,"score_spread":0.31109951461665397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046905571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94884175,0.018834021,0.0010514475,0.019650571,0.00014783867,0.0004957094,0.0000030489832,0.0000486542,0.01092694],"genre_scores_gemma":[0.9629867,0.0013838472,0.0012503443,0.030686975,0.0033587902,0.0000024684534,8.963882e-7,0.000093305986,0.00023668422],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99686265,0.0015637671,0.000484959,0.00019617472,0.0006056845,0.0002867755],"domain_scores_gemma":[0.9990867,0.00009713495,0.0001835363,0.00031876788,0.00006506252,0.0002488429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026474376,0.00015732992,0.00031945753,0.000114083174,0.00016808635,0.000074357326,0.0004750002,0.000023969988,0.00016805457],"category_scores_gemma":[0.0002972416,0.000096974545,0.00013427978,0.00026583005,0.00008636467,0.00016661419,0.000038459188,0.0017505323,0.000013930196],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023493278,0.00043432377,0.11510743,0.0001018306,0.0005104616,0.0025128447,0.0678169,0.00008775329,0.10942763,0.00021566563,0.059876904,0.64155895],"study_design_scores_gemma":[0.011119134,0.005179342,0.2736251,0.00039748746,0.00004113537,0.00029674056,0.0022252786,0.00006633557,0.00074154703,0.00004367223,0.70600224,0.00026201268],"about_ca_topic_score_codex":0.000023485603,"about_ca_topic_score_gemma":0.000002267389,"teacher_disagreement_score":0.6461253,"about_ca_system_score_codex":0.000101815785,"about_ca_system_score_gemma":0.00027438847,"threshold_uncertainty_score":0.7605289},"labels":[],"label_agreement":null},{"id":"W3047400464","doi":"10.1016/j.annonc.2020.07.001","title":"The FDA approval of pembrolizumab for patients with TMB &gt;10 mut/Mb: was it a wise decision? No","year":2020,"lang":"en","type":"letter","venue":"Annals of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Arnold Ventures; Roche; Takeda Pharmaceuticals U.S.A.; Pfizer","keywords":"Medicine; Pembrolizumab; Crizotinib; Nivolumab; Ipilimumab; Oncology; Family medicine; Internal medicine; Lung cancer; Cancer; Immunotherapy","score_opus":0.07303249655138225,"score_gpt":0.4114210955109136,"score_spread":0.33838859895953133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047400464","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007659433,0.0012150495,0.000042232718,0.97757274,0.00052723876,0.0032710242,0.0004804257,0.00002903545,0.009202817],"genre_scores_gemma":[0.024843171,0.0046160133,0.0048276205,0.9345333,0.0076046158,0.0020581416,0.0011379377,0.00035460296,0.02002459],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968442,0.00016214339,0.00072621315,0.0005306717,0.0010525006,0.00068432733],"domain_scores_gemma":[0.9933837,0.002688852,0.0006189229,0.0006603695,0.0025167381,0.0001313967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000386605,0.00035316104,0.0014328107,0.00016326852,0.00013477265,0.000010714925,0.0005407305,0.00045256366,0.00012991435],"category_scores_gemma":[0.002678256,0.00020450214,0.00034173834,0.00023135563,0.0008168601,0.000046598503,0.00029691568,0.00097942,0.00004660973],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011523173,0.00026967633,0.00045559029,0.0009298414,0.0011279739,0.00017524001,0.00024651602,7.6033496e-7,0.000009645928,0.000012593233,0.9648827,0.020366326],"study_design_scores_gemma":[0.006013174,0.021342026,0.0009016781,0.00036728615,0.0002648929,0.000009785106,0.00004885038,0.0000147772525,0.000066694556,0.00028085842,0.9705162,0.00017375973],"about_ca_topic_score_codex":0.000046645513,"about_ca_topic_score_gemma":0.000044834178,"teacher_disagreement_score":0.043039437,"about_ca_system_score_codex":0.00013577145,"about_ca_system_score_gemma":0.0012555799,"threshold_uncertainty_score":0.83393556},"labels":[],"label_agreement":null},{"id":"W3047504968","doi":"10.1093/noajnl/vdaa073.005","title":"13. MANAGEMENT OF BRAIN METASTASES FROM SMALL CELL LUNG CANCER USING SRS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology Advances","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Radiosurgery; Conventional PCI; Salvage therapy; Prophylactic cranial irradiation; Lung cancer; Surgery; Progression-free survival; Overall survival; Internal medicine; Radiation therapy; Chemotherapy","score_opus":0.05111721896652023,"score_gpt":0.39034540519912575,"score_spread":0.33922818623260553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047504968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93043154,0.04579392,0.0009082288,0.016376102,0.00060588104,0.0011773555,0.00019044003,0.00010477312,0.0044117323],"genre_scores_gemma":[0.95363706,0.015485384,0.018094188,0.011552669,0.0006888089,0.00023336949,0.000031252588,0.00007729035,0.00019998598],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99832636,0.00016372727,0.00033508844,0.00048822045,0.00031386837,0.00037272193],"domain_scores_gemma":[0.9987795,0.00052622485,0.00018889399,0.00022648189,0.000100827456,0.00017810437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000120148834,0.00020248734,0.000597748,0.000070159986,0.00008614317,0.0000065714603,0.00020040057,0.000055774624,0.00025378095],"category_scores_gemma":[0.00015039381,0.00017345767,0.00010499377,0.00031106424,0.00024082635,0.00011267988,0.00026346266,0.0002770413,0.0000071281684],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004375969,0.00083673256,0.21369945,0.0066674473,0.0027083824,0.0038181432,0.0037162143,0.006336617,0.62931937,0.00021876955,0.030295543,0.09800735],"study_design_scores_gemma":[0.01460497,0.0035817905,0.018394362,0.00079252623,0.0033324833,0.000028672854,0.0048466097,0.005914044,0.27788386,0.00036532816,0.66941476,0.00084059173],"about_ca_topic_score_codex":0.00024064598,"about_ca_topic_score_gemma":0.00013164245,"teacher_disagreement_score":0.6391192,"about_ca_system_score_codex":0.0001663853,"about_ca_system_score_gemma":0.0001904564,"threshold_uncertainty_score":0.7073398},"labels":[],"label_agreement":null},{"id":"W3049272730","doi":"10.1111/crj.13266","title":"Comparison of oral versus intravenous etoposide in the management of small‐cell lung cancer; A real‐world, population‐based study","year":2020,"lang":"en","type":"article","venue":"The Clinical Respiratory Journal","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; University of Calgary; University of Alberta","funders":"","keywords":"Etoposide; Carboplatin; Medicine; Chemotherapy; Internal medicine; Population; Dosing; Lung cancer; Surgery; Cisplatin; Gastroenterology","score_opus":0.2842594416249,"score_gpt":0.5312428508591285,"score_spread":0.24698340923422846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049272730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925553,0.0013272112,0.00003974203,0.0038259996,0.00020630812,0.0011498824,0.0000047267913,0.000009554572,0.00088122813],"genre_scores_gemma":[0.99839747,0.00020122484,0.00022545092,0.0008546739,0.00024966407,0.000032200558,8.504671e-7,0.000016037991,0.000022436654],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99626803,0.0010476657,0.001345509,0.00020659831,0.00086134876,0.00027082599],"domain_scores_gemma":[0.997731,0.0010020563,0.000546678,0.00038253568,0.00018107901,0.00015666994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034310033,0.00014432245,0.00067678676,0.000097843025,0.00013081187,0.000019072626,0.0005255168,0.00004319259,0.00006219424],"category_scores_gemma":[0.00036202685,0.00007957529,0.00019309128,0.00056751794,0.00014986204,0.000031707335,0.0001444636,0.0010642428,0.000002270181],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051702256,0.0011504027,0.98120797,0.00028218876,0.0005078322,0.00012058598,0.0019794456,0.0008228358,0.000035745266,0.000047925452,0.0011948659,0.00748],"study_design_scores_gemma":[0.00913805,0.00405476,0.9797557,0.00028592115,0.00066917663,6.904355e-7,0.004280042,0.00076682575,0.000093088354,0.000023249679,0.00084621017,0.00008629719],"about_ca_topic_score_codex":0.0003187718,"about_ca_topic_score_gemma":0.000969193,"teacher_disagreement_score":0.007393703,"about_ca_system_score_codex":0.0001828321,"about_ca_system_score_gemma":0.00034621244,"threshold_uncertainty_score":0.46236646},"labels":[],"label_agreement":null},{"id":"W3080927742","doi":"10.1007/s11136-020-02615-1","title":"The impact of symptoms and comorbidity on health utility scores and health-related quality of life in small cell lung cancer using real world data","year":2020,"lang":"en","type":"article","venue":"Quality of Life Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Comorbidity; Medicine; Internal medicine; Quality of life (healthcare); Lung cancer; Disease; Cohort; Observational study; Physical therapy","score_opus":0.6519851450697941,"score_gpt":0.6026794382328372,"score_spread":0.0493057068369569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3080927742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95847964,0.016097879,0.0000067014807,0.023019062,0.000022153747,0.0015053971,0.0006918244,0.00001473581,0.00016262764],"genre_scores_gemma":[0.98737013,0.012234749,0.000077873665,0.00016264776,0.00006620369,0.000013732916,0.00003364632,0.000020531776,0.000020481926],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99021786,0.0047939685,0.0019148674,0.000687487,0.0015595743,0.0008262487],"domain_scores_gemma":[0.9928207,0.003783942,0.00082129706,0.0011424432,0.00055375806,0.00087786384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.026254538,0.0002121419,0.0016308922,0.000250545,0.00027075174,0.000024359762,0.00048809403,0.00007277068,0.00002164042],"category_scores_gemma":[0.005672449,0.00014912528,0.00009772376,0.0011904548,0.0018805867,0.00009771963,0.0010225244,0.0010961337,3.4109652e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039089434,0.0003298106,0.97861344,0.0075548203,0.00027960143,0.0000012807523,0.0032698687,0.000019482333,0.00041311525,0.00016739036,0.0026387405,0.002803509],"study_design_scores_gemma":[0.0025395127,0.0010561232,0.98988914,0.00069500797,0.000009414642,2.2736103e-7,0.0011639263,0.0043325787,0.00010722428,0.00009071015,0.00001698799,0.00009916931],"about_ca_topic_score_codex":0.647707,"about_ca_topic_score_gemma":0.07260363,"teacher_disagreement_score":0.57510334,"about_ca_system_score_codex":0.00056894077,"about_ca_system_score_gemma":0.0053202542,"threshold_uncertainty_score":0.94431895},"labels":[],"label_agreement":null},{"id":"W3081216235","doi":"10.7759/cureus.10011","title":"Case of Complete Remission from Palliative Radiation in Extensive Stage Small Cell Lung Cancer With Large Brain Metastasis Nine Years After Diagnosis: Cure Is Possible","year":2020,"lang":"en","type":"article","venue":"Cureus","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Regional Hospital","funders":"","keywords":"Medicine; Radiation therapy; Stage (stratigraphy); Asymptomatic; Lung cancer; Brain metastasis; Metastasis; Radiology; Chemotherapy; Palliative chemotherapy; Craniotomy; Prophylactic cranial irradiation; Palliative care; Cancer; Oncology; Surgery; Internal medicine","score_opus":0.04692756101348458,"score_gpt":0.3506770689578603,"score_spread":0.3037495079443757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081216235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9649992,0.024590224,0.00015436238,0.00706698,0.00004208625,0.0009102225,0.0021148461,0.000026554444,0.00009551204],"genre_scores_gemma":[0.9932615,0.00282913,0.000987952,0.0021475458,0.00013304595,0.0002970376,0.00007195871,0.000038007656,0.00023381392],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985513,0.00010564015,0.0002747844,0.00042237798,0.00032370997,0.00032215327],"domain_scores_gemma":[0.9989499,0.00019703203,0.00015753404,0.0002575657,0.000227064,0.00021093576],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001294096,0.00019573436,0.0004876425,0.00007398531,0.000040638977,0.000013682159,0.00008875489,0.00006855304,0.0010123388],"category_scores_gemma":[0.00020517714,0.00015498059,0.00007126718,0.00039492117,0.00006607455,0.00010118182,0.00011477571,0.00028930636,0.00000540674],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019025037,0.0002962119,0.9113106,0.0009295265,0.0007344701,0.0067995507,0.03760825,0.00010860205,0.0037933479,0.000009207032,0.035100166,0.0014075388],"study_design_scores_gemma":[0.02365838,0.002594894,0.86524135,0.0032623354,0.0015727492,0.000028997189,0.014079518,0.008963046,0.04997121,0.00004159697,0.02950955,0.0010763898],"about_ca_topic_score_codex":0.004739106,"about_ca_topic_score_gemma":0.0025282372,"teacher_disagreement_score":0.046177864,"about_ca_system_score_codex":0.00026729706,"about_ca_system_score_gemma":0.00020828203,"threshold_uncertainty_score":0.9999009},"labels":[],"label_agreement":null},{"id":"W3081953801","doi":"10.1634/theoncologist.2020-0193","title":"Prolonging Survival: The Role of Immune Checkpoint Inhibitors in the Treatment of Extensive-Stage Small Cell Lung Cancer","year":2020,"lang":"en","type":"review","venue":"The Oncologist","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; McMaster University; Trillium Health Centre; Juravinski Cancer Centre; Hôpital du Sacré-Cœur de Montréal; University of Ottawa; Ottawa Hospital; Princess Margaret Cancer Centre; Université de Montréal; William Osler Health System; University of Toronto; University of British Columbia","funders":"Pfizer Canada; Merck Canada; AstraZeneca Canada","keywords":"Medicine; Oncology; Tremelimumab; Lung cancer; Chemotherapy; Internal medicine; Durvalumab; Ipilimumab; Clinical trial; Immunotherapy; Radiation therapy; Maintenance therapy; Cancer; Stage (stratigraphy); Intensive care medicine; Nivolumab","score_opus":0.08041116675697593,"score_gpt":0.41151793173614376,"score_spread":0.3311067649791678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081953801","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011829392,0.9868995,7.095136e-7,0.002659098,0.00019750746,0.005315306,0.00008244396,0.00002065964,0.003641858],"genre_scores_gemma":[0.0064212405,0.9908865,0.000016380394,0.000047321533,0.00035416908,0.0015719826,0.000017806147,0.000047320907,0.0006372733],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969484,0.0008120915,0.0009619638,0.00035907532,0.0004945208,0.0004239032],"domain_scores_gemma":[0.99675816,0.0013177855,0.00083132606,0.00088803936,0.00015665308,0.000048029855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013688327,0.00042176963,0.0022395318,0.00008978189,0.000124781,0.000014676552,0.0006848615,0.00014655662,0.000029972878],"category_scores_gemma":[0.000297506,0.00015475703,0.00071863737,0.0006243269,0.000725682,0.000015903392,0.00024820108,0.00064080843,0.0000048564402],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004449196,0.001190292,0.001333886,0.02700494,0.0019604298,0.00024243549,0.0190607,0.0000348388,0.00021094532,0.00011094033,0.00052579626,0.94787985],"study_design_scores_gemma":[0.00090781366,0.0011857023,0.00044092856,0.004599987,0.0020285281,0.000009411166,0.004313806,0.000036496785,0.00046936126,0.000010336034,0.9858372,0.00016041286],"about_ca_topic_score_codex":0.005150838,"about_ca_topic_score_gemma":0.0009895732,"teacher_disagreement_score":0.98531145,"about_ca_system_score_codex":0.0011278103,"about_ca_system_score_gemma":0.0011239847,"threshold_uncertainty_score":0.77865607},"labels":[],"label_agreement":null},{"id":"W3083480767","doi":"10.1016/j.ctro.2020.08.005","title":"Stereotactic radiosurgery (SRS) – A new normal for small cell lung cancer?","year":2020,"lang":"en","type":"review","venue":"Clinical and Translational Radiation Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Radiosurgery; Medicine; Lung cancer; Radiation therapy; Oncology; Lung; Cancer; Small Cell Lung Carcinoma; Internal medicine; Radiology; Small-cell carcinoma","score_opus":0.1589078002729063,"score_gpt":0.5039253287010861,"score_spread":0.3450175284281798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083480767","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000020582534,0.9865265,0.00074031675,0.008535284,0.0008011626,0.0023555607,0.0002591713,0.00004243365,0.00071901927],"genre_scores_gemma":[0.00006433801,0.9928808,0.0010495172,0.00075046363,0.0033604393,0.00045496158,0.0004222397,0.000048457925,0.000968782],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972577,0.00027563472,0.0012685882,0.000613702,0.00024470757,0.0003396746],"domain_scores_gemma":[0.99352556,0.005254687,0.00041601804,0.00014578593,0.00012838407,0.00052954856],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00058644963,0.00032405573,0.0022921285,0.00015308235,0.00011653432,0.00002144133,0.00010931408,0.00052369776,0.00017585064],"category_scores_gemma":[0.00048600344,0.00026317584,0.0007659612,0.00023346567,0.00017471708,0.00007055863,0.00002979637,0.0007227245,0.000016609682],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035214346,0.0001269043,0.0034883646,0.0106066875,0.0009163635,0.000030589625,0.00009085383,0.0000015951493,7.2378505e-8,0.0001609313,0.010161409,0.9740641],"study_design_scores_gemma":[0.0037365723,0.00058121467,0.0018088579,0.001035533,0.0029928384,0.00003777619,0.0000037774955,0.0003751052,1.5050158e-7,0.00008224058,0.9891216,0.00022430818],"about_ca_topic_score_codex":0.000025983545,"about_ca_topic_score_gemma":0.000034413162,"teacher_disagreement_score":0.9789602,"about_ca_system_score_codex":0.00016731356,"about_ca_system_score_gemma":0.0064183455,"threshold_uncertainty_score":0.99998206},"labels":[],"label_agreement":null},{"id":"W3084355783","doi":"10.1016/j.jtho.2020.08.022","title":"Phase 1/2 Trial of Pembrolizumab and Concurrent Chemoradiation Therapy for Limited-Stage SCLC","year":2020,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Genentech; National Institutes of Health; Innovent Biologics; Jounce Therapeutics; Jazz Pharmaceuticals; Varian Medical Systems; Sierra Oncology; F. Hoffmann-La Roche; Novartis; National Cancer Institute; Johnson and Johnson; AbbVie; MedImmune; Merck; GlaxoSmithKline; Spectrum Pharmaceuticals; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb; AstraZeneca; Boehringer Ingelheim","keywords":"Medicine; Pembrolizumab; Common Terminology Criteria for Adverse Events; Internal medicine; Neutropenia; Oncology; Pneumonitis; Chemoradiotherapy; Radiation therapy; Progression-free survival; Surgery; Chemotherapy; Cancer; Immunotherapy","score_opus":0.11394025076929282,"score_gpt":0.5265962188109286,"score_spread":0.41265596804163573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3084355783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9682306,0.004062353,0.0007523131,0.02516142,0.000458896,0.0009525289,0.000027531316,0.000007842872,0.00034651143],"genre_scores_gemma":[0.99431896,0.0027089892,0.00093078124,0.00072917587,0.0011851233,0.000019406334,0.0000045584948,0.000012977252,0.00009003929],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99884385,0.000108521504,0.0005011724,0.000114648814,0.00027228004,0.0001595303],"domain_scores_gemma":[0.9984228,0.00033476038,0.0005563417,0.00007399906,0.00042152277,0.00019060436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058383937,0.000095203606,0.00065362256,0.00009027251,0.00003625074,0.000007402107,0.000081314276,0.00007909102,0.000037149824],"category_scores_gemma":[0.00092284963,0.00006887132,0.00014198151,0.00012624601,0.00012371005,0.000079295474,0.00002903603,0.00024990542,7.330869e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.35286382,0.0012587575,0.00017795902,0.0004156317,0.00044335925,0.000060485338,0.0013388045,0.0000039986285,0.016014833,0.000048727205,0.010241654,0.61713195],"study_design_scores_gemma":[0.4222257,0.15192217,0.00094663544,0.00016362926,0.0005374862,0.00016869213,0.00086092367,0.0017404818,0.029869977,0.00010189957,0.39129663,0.00016577197],"about_ca_topic_score_codex":0.0000018707134,"about_ca_topic_score_gemma":9.592416e-7,"teacher_disagreement_score":0.6169662,"about_ca_system_score_codex":0.00016468279,"about_ca_system_score_gemma":0.0006056464,"threshold_uncertainty_score":0.2808491},"labels":[],"label_agreement":null},{"id":"W3087964189","doi":"10.1016/j.annonc.2020.08.1544","title":"1782MO Health-related quality of life (HRQoL) in KEYNOTE-604: Pembrolizumab (pembro) or placebo added to etoposide and platinum (EP) as first-line therapy for ES-SCLC","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"William Osler Health System; University of Toronto","funders":"","keywords":"Medicine; Placebo; Discontinuation; Quality of life (healthcare); Nausea; Clinical trial; Clinical endpoint; Pembrolizumab; Internal medicine; Cancer; Alternative medicine","score_opus":0.28409615093826407,"score_gpt":0.5052354451313433,"score_spread":0.22113929419307926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087964189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8065711,0.0033203538,0.0000522034,0.1863721,0.00007370506,0.0024818603,0.000112465365,0.000036413167,0.0009798023],"genre_scores_gemma":[0.9799604,0.0038948208,0.00073167996,0.01469564,0.00013093775,0.00024793146,0.0000299,0.00003555301,0.00027314326],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99691135,0.00037869057,0.0012782866,0.00047659784,0.00037825518,0.00057685183],"domain_scores_gemma":[0.9962684,0.0020470035,0.00047091465,0.0002889056,0.00042613765,0.00049865677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014319834,0.00024205763,0.0016544948,0.00020370477,0.00007620099,0.0000054974926,0.00018775633,0.00021659925,0.0001814634],"category_scores_gemma":[0.005644383,0.00019101899,0.00014155646,0.00047770323,0.00023848761,0.00006477005,0.00015653874,0.0003376032,0.0000083325485],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.59563744,0.0030775666,0.035342097,0.0070490204,0.002609754,0.00016387829,0.041599154,0.00047944195,0.012947958,0.0018816121,0.16350377,0.13570829],"study_design_scores_gemma":[0.18272328,0.23496681,0.31409344,0.0015394351,0.00015399186,0.000087158674,0.004387699,0.0017621594,0.03522507,0.0030833124,0.22062822,0.0013494216],"about_ca_topic_score_codex":0.0020934,"about_ca_topic_score_gemma":0.0019354266,"teacher_disagreement_score":0.4129142,"about_ca_system_score_codex":0.000121535486,"about_ca_system_score_gemma":0.0015027047,"threshold_uncertainty_score":0.77895284},"labels":[],"label_agreement":null},{"id":"W3089280807","doi":"10.1016/j.annonc.2020.08.1546","title":"1785P Phase Ib expansion study of adavosertib plus olaparib in patients with extensive-stage or relapsed small cell lung cancer","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Neutropenia; Regimen; Gastroenterology; Febrile neutropenia; Olaparib; Phases of clinical research; Lung cancer; Oncology; Toxicity","score_opus":0.1250206933812882,"score_gpt":0.44095299222944834,"score_spread":0.3159322988481601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3089280807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99385023,0.00085966825,0.000008427562,0.0025411537,0.00007711236,0.0020223355,0.000046177556,0.000019443207,0.0005754649],"genre_scores_gemma":[0.997503,0.0004159678,0.00010560829,0.0014264365,0.000049581213,0.00012776679,0.000015323758,0.000029245417,0.00032710258],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979899,0.00018566096,0.0005540351,0.00040485302,0.00046473063,0.00040083568],"domain_scores_gemma":[0.99813306,0.00020608344,0.00031546043,0.00029458012,0.00085040636,0.00020042597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022510032,0.00019887953,0.00097549555,0.00015844239,0.00003971624,0.0000028052784,0.0001655752,0.00010016195,0.00014264465],"category_scores_gemma":[0.00039872545,0.00013767632,0.00005581637,0.000464202,0.00014188314,0.00007434647,0.0001712176,0.00032887544,0.0000022642157],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.122629985,0.018333646,0.76607484,0.0023366443,0.0010450335,0.0011689364,0.043284103,0.000669399,0.00799901,0.00000721483,0.01708333,0.019367894],"study_design_scores_gemma":[0.1740636,0.22423898,0.5504735,0.0008712089,0.00057707366,0.0000025960633,0.016304798,0.0012385524,0.022103425,0.000004369293,0.009548144,0.0005737078],"about_ca_topic_score_codex":0.0013266717,"about_ca_topic_score_gemma":0.0017497789,"teacher_disagreement_score":0.21560127,"about_ca_system_score_codex":0.00016580983,"about_ca_system_score_gemma":0.0009622043,"threshold_uncertainty_score":0.5614278},"labels":[],"label_agreement":null},{"id":"W3089522740","doi":"10.1016/j.jtho.2020.09.013","title":"American Radium Society Appropriate Use Criteria on Radiation Therapy for Extensive-Stage SCLC","year":2020,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"Takeda Pharmaceutical Company; Varian Medical Systems; Genentech; RefleXion Medical; AstraZeneca","keywords":"Medicine; Radiation therapy; Prophylactic cranial irradiation; Chemoimmunotherapy; Medical physics; Clinical trial; Randomized controlled trial; Oncology; Radiology; Surgery; Internal medicine; Immunotherapy; Cancer","score_opus":0.09826513809280533,"score_gpt":0.49856045829038376,"score_spread":0.4002953201975784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3089522740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88974327,0.0010350713,0.0027256191,0.10471383,0.00063376134,0.0008998669,0.00003297282,0.000030899188,0.00018468882],"genre_scores_gemma":[0.94551194,0.004006669,0.021774774,0.025019543,0.003041765,0.000041763702,0.000010429954,0.00005552747,0.00053756114],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984918,0.00019804889,0.0004393246,0.0002063971,0.0003604302,0.0003040052],"domain_scores_gemma":[0.9980082,0.00044972412,0.00050106266,0.00014709696,0.0006258202,0.00026808752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006429296,0.00015362776,0.0007220032,0.000069803355,0.00009697491,0.000030239999,0.00013802468,0.00008147787,0.000049849346],"category_scores_gemma":[0.0009917581,0.000109920875,0.00034261274,0.00022383248,0.00020816016,0.0001536161,0.000036448153,0.0004583332,0.0000070870938],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03361372,0.0005554677,0.002166332,0.00029926418,0.0013254676,0.0002601882,0.00600316,0.00008709986,0.050398696,0.000037953254,0.1389148,0.7663379],"study_design_scores_gemma":[0.0074779154,0.04140462,0.04402847,0.0001436109,0.0003748477,0.00016883688,0.002700228,0.0035485516,0.018124925,0.00011569666,0.8816057,0.00030663778],"about_ca_topic_score_codex":0.000015575684,"about_ca_topic_score_gemma":0.0000019308534,"teacher_disagreement_score":0.7660312,"about_ca_system_score_codex":0.00048707562,"about_ca_system_score_gemma":0.00052854256,"threshold_uncertainty_score":0.4482443},"labels":[],"label_agreement":null},{"id":"W3092781265","doi":"10.1186/s13019-020-01353-2","title":"Elevated preoperative CEA is associated with subclinical nodal involvement and worse survival in stage I non-small cell lung cancer: a systematic review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"Journal of Cardiothoracic Surgery","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"University of Alberta","keywords":"Medicine; Stage (stratigraphy); Lung cancer; Internal medicine; Oncology; Cardiothoracic surgery; Adenocarcinoma; Subclinical infection; Meta-analysis; Lymph node; Disease; Cancer; Surgery","score_opus":0.12651755555120447,"score_gpt":0.42197121808523586,"score_spread":0.2954536625340314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092781265","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00048056582,0.99468505,0.00003487093,0.0006611557,0.00008422248,0.003720426,0.0002860239,0.000012893104,0.000034806297],"genre_scores_gemma":[0.0010191235,0.99738365,0.00005634506,0.00040229238,0.00011645944,0.00042223063,0.00003275086,0.00008586977,0.0004812781],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9903838,0.0032544106,0.0035206655,0.000700387,0.001593554,0.0005471989],"domain_scores_gemma":[0.99039114,0.0042554475,0.0031952492,0.00051280705,0.001095232,0.0005501348],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.009225217,0.000847699,0.027859777,0.00096459984,0.0000793761,0.00010888643,0.00021395925,0.00028092402,0.00008870984],"category_scores_gemma":[0.0024702668,0.00048326017,0.004175269,0.0025831454,0.00016282688,0.00016442516,0.00019277622,0.0016647889,0.0000011641472],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001010479,0.00009113615,0.005142281,0.6490617,0.3425888,0.0017096477,0.00028559603,0.000002591349,1.4312688e-7,1.376702e-7,0.00060477585,0.00041214554],"study_design_scores_gemma":[0.0004760136,0.0001930115,0.00022122667,0.15312253,0.8420524,0.000086181935,0.0001444575,0.000022911581,0.0000013001167,1.8574102e-7,0.0032568702,0.00042294222],"about_ca_topic_score_codex":0.00009532031,"about_ca_topic_score_gemma":0.00012222734,"teacher_disagreement_score":0.49946356,"about_ca_system_score_codex":0.00095505605,"about_ca_system_score_gemma":0.0026593902,"threshold_uncertainty_score":0.9997619},"labels":[],"label_agreement":null},{"id":"W3093884247","doi":"10.1016/j.ijrobp.2020.07.1248","title":"Pattern of Practice and Comparison of Thoracic Radiotherapy for the Radical Treatment of Limited-Stage Small Cell Lung Cancer","year":2020,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Spinal Cord Injury BC; BC Cancer Agency","funders":"","keywords":"Radiation therapy; Stage (stratigraphy); Lung cancer; Medicine; Lung; Oncology; Radiology; Internal medicine; Biology","score_opus":0.059302165904571595,"score_gpt":0.45394378073849234,"score_spread":0.39464161483392074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093884247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8709319,0.033068605,0.060018554,0.033640604,0.000767578,0.0010928059,0.00032696553,0.000011840409,0.00014111318],"genre_scores_gemma":[0.9816674,0.013609279,0.0030367533,0.0006153929,0.0009855226,0.000027915179,0.000016541508,0.000017222612,0.000023997825],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.998575,0.0001896058,0.00069356227,0.00014305496,0.00026530083,0.00013349425],"domain_scores_gemma":[0.9954699,0.001989807,0.0014477704,0.00009744379,0.0009100177,0.00008500855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034081496,0.000131565,0.0006350666,0.00007436289,0.000036191617,0.00000591196,0.00020758167,0.000099371515,0.000024469691],"category_scores_gemma":[0.00036941937,0.000087557186,0.00018776918,0.00010881664,0.00030538053,0.00008930177,0.000033236523,0.00020369704,2.2059545e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044713244,0.0012410897,0.6243979,0.00023289266,0.0039472748,0.00000942455,0.009296085,0.0016816531,0.02261395,0.00038060662,0.0013822247,0.3303456],"study_design_scores_gemma":[0.05254743,0.04701433,0.11877751,0.0007026711,0.0048865257,0.00013307376,0.005558091,0.18330064,0.27353385,0.000456799,0.31243646,0.00065259123],"about_ca_topic_score_codex":0.00010305332,"about_ca_topic_score_gemma":0.0000092464925,"teacher_disagreement_score":0.50562036,"about_ca_system_score_codex":0.0004140995,"about_ca_system_score_gemma":0.0005267677,"threshold_uncertainty_score":0.35704783},"labels":[],"label_agreement":null},{"id":"W3093993098","doi":"10.1016/j.ijrobp.2020.07.1305","title":"Limited-Stage Small Cell Lung Cancer: Outcomes Associated with Prophylactic Cranial Irradiation Over a 20-year Period at a Single Institution","year":2020,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Western University; Kingston General Hospital; Princess Margaret Cancer Centre; McMaster University; Queen's University","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Conventional PCI; Surgery; Stage (stratigraphy); Proportional hazards model; Retrospective cohort study; Univariate analysis; Chemotherapy; Lung cancer; Internal medicine; Radiation therapy; Multivariate analysis","score_opus":0.03235396831466503,"score_gpt":0.3413911407597562,"score_spread":0.30903717244509116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093993098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9813958,0.0006629099,0.0018649538,0.013221185,0.0010894876,0.0006203934,0.00018371553,0.00007254905,0.0008889992],"genre_scores_gemma":[0.9951291,0.00031192752,0.0006299337,0.001754317,0.0017021892,0.000038227077,0.00012360391,0.000039954448,0.0002707095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99789256,0.00022774059,0.0006448005,0.0003200501,0.0005895914,0.0003252682],"domain_scores_gemma":[0.9970587,0.000277616,0.0011921269,0.00012374588,0.0011143707,0.0002334724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000315033,0.0002652235,0.0006305387,0.00016797814,0.00015416757,0.000049140846,0.00028351572,0.00021976084,0.00013561908],"category_scores_gemma":[0.0009076624,0.00020995837,0.00022074512,0.0003128685,0.0002261148,0.00034901616,0.00010262449,0.00062951277,0.000016502072],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024587708,0.00066951464,0.97123766,0.000067280234,0.0014598029,0.00014718018,0.0020746607,0.0018299803,0.01328064,0.00044051203,0.0013499391,0.0049840817],"study_design_scores_gemma":[0.05083769,0.012002013,0.8599576,0.0004003808,0.0016228621,0.00014136973,0.00051810325,0.024749313,0.005737809,0.0003363612,0.04274219,0.00095435],"about_ca_topic_score_codex":0.000051001753,"about_ca_topic_score_gemma":0.00007759391,"teacher_disagreement_score":0.111280076,"about_ca_system_score_codex":0.0040344736,"about_ca_system_score_gemma":0.0013897835,"threshold_uncertainty_score":0.9997889},"labels":[],"label_agreement":null},{"id":"W3094020491","doi":"10.1016/j.ijrobp.2020.07.2113","title":"Identifying Novel Epigenetic Radiosensitizers in Small Cell Lung Cancer Using a Custom EpiDrug CRISPR Screen","year":2020,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Institute of Cancer Research; Ontario Institute for Cancer Research; University of Toronto; University Health Network","funders":"","keywords":"Clonogenic assay; Medicine; Cancer research; CRISPR; Lung cancer; Epigenetics; Cancer; Radiation therapy; Gene knockdown; Oncology; Cell; Biology; Gene; Internal medicine; Genetics","score_opus":0.06677782092248206,"score_gpt":0.4060167710226977,"score_spread":0.3392389501002156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094020491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8927022,0.005268881,0.0844269,0.014593573,0.0018682114,0.00056572235,0.00008577415,0.000040846164,0.00044784218],"genre_scores_gemma":[0.98322016,0.0020581053,0.009084027,0.0025680528,0.0029628659,0.000011943648,0.000024854146,0.00004262593,0.00002738451],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9978504,0.00021638641,0.000853484,0.00032421027,0.0003785325,0.00037698873],"domain_scores_gemma":[0.9976472,0.000361551,0.0008284068,0.00012277113,0.0007932171,0.0002468361],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005686164,0.0002319822,0.0006678599,0.00026290744,0.00007775559,0.000034451306,0.00038162142,0.00017601222,0.000049267277],"category_scores_gemma":[0.00049299886,0.00021781429,0.00024343262,0.00034273195,0.00016006787,0.000226548,0.00014688582,0.0008010792,0.000009493046],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010791009,0.00043255277,0.8389668,0.00012284773,0.0013427278,0.00034575904,0.0043920693,0.011388248,0.11622073,0.0008376104,0.0015938688,0.023277683],"study_design_scores_gemma":[0.078481324,0.003919222,0.28312114,0.0021457039,0.002131828,0.001020338,0.0033922454,0.4877281,0.09769502,0.0037106783,0.034572832,0.0020815993],"about_ca_topic_score_codex":0.00030008485,"about_ca_topic_score_gemma":0.000036581514,"teacher_disagreement_score":0.5558457,"about_ca_system_score_codex":0.0020310627,"about_ca_system_score_gemma":0.0012637198,"threshold_uncertainty_score":0.8882209},"labels":[],"label_agreement":null},{"id":"W3094035833","doi":"10.1016/j.ijrobp.2020.07.1318","title":"Role of Prophylactic Cranial Radiation in Extensive Stage Small Cell Lung Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","year":2020,"lang":"en","type":"review","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Meta-analysis; Hazard ratio; Randomized controlled trial; Confidence interval; Conventional PCI; Odds ratio; Cochrane Library; Oncology; Internal medicine; Study heterogeneity; Lung cancer; Random effects model; Relative risk; Surgery; Myocardial infarction","score_opus":0.06882513134694297,"score_gpt":0.4376369998979601,"score_spread":0.36881186855101716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094035833","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000078136625,0.98830634,0.00040492232,0.0010447841,0.00031914184,0.009268045,0.0005094881,0.000008529325,0.00006059098],"genre_scores_gemma":[0.0034763,0.9941855,0.00028441634,0.00028766182,0.00046680868,0.001095817,0.0001074208,0.00003810399,0.000057968446],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98416734,0.0074922475,0.0069971764,0.00039603788,0.00071492896,0.00023226102],"domain_scores_gemma":[0.96881497,0.010480271,0.017878335,0.00025347387,0.002432809,0.00014013035],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.009597356,0.00052773615,0.040721174,0.0010857041,0.000029501758,0.000021574853,0.00044694988,0.00033685696,0.00011145374],"category_scores_gemma":[0.017890088,0.00030964587,0.007320895,0.0008161602,0.00027537256,0.00013321206,0.00010003487,0.0007791634,0.0000013963878],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014701084,0.00045380715,0.00018937726,0.24399446,0.71968937,0.000053305946,0.00067465124,0.00013299915,0.000048827387,0.00065204856,0.00007694567,0.019333133],"study_design_scores_gemma":[0.07375425,0.0004830176,0.00000961011,0.010742128,0.91099477,0.000024782194,0.000050844534,0.000992638,0.000015513553,0.0001595716,0.002563587,0.00020928192],"about_ca_topic_score_codex":0.000093251474,"about_ca_topic_score_gemma":0.000012934762,"teacher_disagreement_score":0.23325233,"about_ca_system_score_codex":0.0011854453,"about_ca_system_score_gemma":0.002600302,"threshold_uncertainty_score":0.99993557},"labels":[],"label_agreement":null},{"id":"W3096564526","doi":"10.1016/j.cllc.2020.10.018","title":"Deep and Durable Response to Nivolumab and Temozolomide in Small-Cell Lung Cancer Associated With an Early Decrease in Myeloid-Derived Suppressor Cells","year":2020,"lang":"en","type":"article","venue":"Clinical Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Ohio State University Press; Bristol-Myers Squibb Canada; Bristol-Myers Squibb","keywords":"Nivolumab; Medicine; Temozolomide; Lung cancer; Oncology; Biomarker; Myeloid; Clinical trial; Cancer research; Internal medicine; Cancer; Immunotherapy; Chemotherapy; Biology","score_opus":0.03676326828345943,"score_gpt":0.3743898209165638,"score_spread":0.33762655263310437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096564526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9825195,0.005672636,0.000017027523,0.00958595,0.00010117749,0.0018658265,0.00006844604,0.00006551144,0.00010394634],"genre_scores_gemma":[0.99201596,0.0023872452,0.00039885225,0.0037093398,0.00016990381,0.0005428233,0.00000804636,0.00007356913,0.0006942519],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996523,0.00063279545,0.0007183187,0.0010151414,0.0003583242,0.0007524023],"domain_scores_gemma":[0.99675065,0.0013019354,0.00015455222,0.0003393201,0.00020320273,0.0012503418],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011122605,0.0003325358,0.0009811062,0.00015673028,0.000096962605,0.00006469195,0.00019499563,0.00022721352,0.00013736142],"category_scores_gemma":[0.0024858708,0.00028041875,0.00006402868,0.0006285774,0.0003036334,0.00017562837,0.00024895644,0.0008324965,0.0000030030617],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02834299,0.00029144285,0.94931495,0.0003552911,0.00023309232,0.0004100221,0.0027015437,0.00017855472,0.015245091,0.0000012696004,0.0018743387,0.0010514006],"study_design_scores_gemma":[0.015038523,0.0020592122,0.9663466,0.0011080428,0.00027920792,0.000002059236,0.00038478267,0.010933556,0.003084644,0.000006484132,0.0003145004,0.00044236716],"about_ca_topic_score_codex":0.0043866592,"about_ca_topic_score_gemma":0.02021563,"teacher_disagreement_score":0.017031658,"about_ca_system_score_codex":0.00063243374,"about_ca_system_score_gemma":0.0009608315,"threshold_uncertainty_score":0.9999648},"labels":[],"label_agreement":null},{"id":"W3096676736","doi":"10.1016/j.jtho.2020.10.020","title":"American Radium Society Appropriate Use Criteria: Radiation Therapy for Limited-Stage SCLC 2020","year":2020,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"Takeda Pharmaceuticals U.S.A.; RefleXion Medical; American Radium Society; Varian Medical Systems; GlaxoSmithKline; Genentech; Philips; Aptitude Health; Australian Carbon Innovation; Bristol-Myers Squibb; AstraZeneca; Boehringer Ingelheim","keywords":"Medicine; Radium; Stage (stratigraphy); Radiation therapy; Radiation oncology; Medical physics; Oncology; Internal medicine; Radiochemistry","score_opus":0.0771952621113736,"score_gpt":0.47788536030754053,"score_spread":0.4006900981961669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096676736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82420766,0.002998555,0.0054984917,0.16503352,0.0007991422,0.001139689,0.000054842636,0.000049593546,0.00021850066],"genre_scores_gemma":[0.91281456,0.012799123,0.04725532,0.020240828,0.005786743,0.00007032905,0.00002436156,0.000085036154,0.0009236958],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99827844,0.00022127372,0.0005476458,0.00022198557,0.0003799563,0.000350677],"domain_scores_gemma":[0.99794835,0.00043209613,0.0005807635,0.00015358032,0.00055020035,0.0003349982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077513274,0.00016886645,0.0008075903,0.00006133253,0.00010514529,0.000041448937,0.00017967942,0.00010538028,0.000071168106],"category_scores_gemma":[0.0009492996,0.00012521454,0.00040046702,0.0003535373,0.00023333546,0.0002344723,0.000058698493,0.0005358941,0.000006479999],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020888025,0.0005281841,0.0060232375,0.0004333793,0.0018353405,0.00028183346,0.0064097876,0.000057015364,0.040064353,0.000017687795,0.24628268,0.67717844],"study_design_scores_gemma":[0.0051768334,0.01893508,0.023612263,0.000077550205,0.0004037256,0.00019489849,0.0019204972,0.0036385993,0.007219105,0.000060233826,0.93852377,0.00023746972],"about_ca_topic_score_codex":0.00001990912,"about_ca_topic_score_gemma":0.0000038245325,"teacher_disagreement_score":0.6922411,"about_ca_system_score_codex":0.00049799937,"about_ca_system_score_gemma":0.00070484396,"threshold_uncertainty_score":0.5106101},"labels":[],"label_agreement":null},{"id":"W3103821276","doi":"10.1101/2020.11.12.368522","title":"Extracellular signal-regulated kinase mediates chromatin rewiring and lineage transformation in lung cancer","year":2020,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Alberta Children's Hospital; University of Calgary; BC Cancer Agency","funders":"Canadian Institutes of Health Research; Alberta Innovates; Japanese Respiratory Society; Terry Fox Research Institute; Michael Smith Health Research BC; British Columbia Lung Association; Government of Canada; Alberta Health Services; Eli Lilly and Company","keywords":"MAPK/ERK pathway; Cancer research; Chromatin; Biology; Neuroendocrine differentiation; KRAS; Lineage (genetic); Kinase; Downregulation and upregulation; Cell biology; Cancer; Genetics; Mutation; Gene","score_opus":0.018637511071564652,"score_gpt":0.27873149613732234,"score_spread":0.2600939850657577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3103821276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9536015,0.04008743,0.0004866288,0.0028885785,0.00027480605,0.0021220078,0.00017293573,0.00035721165,0.000008894289],"genre_scores_gemma":[0.99277747,0.0046778554,0.0011649803,0.00012421349,0.00049110904,0.00062262645,0.000001998128,0.00013254036,0.000007234175],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967476,0.00015062168,0.0008027189,0.000948129,0.000689321,0.0006616059],"domain_scores_gemma":[0.9982207,0.00010461627,0.0002896216,0.0005856532,0.000361923,0.00043749576],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00071357866,0.0005905144,0.000988052,0.0004368415,0.00012690724,0.00012969217,0.00024960507,0.0004475618,0.00008494077],"category_scores_gemma":[0.00029588985,0.0005894625,0.00012439654,0.00071313715,0.00018048269,0.0002205587,0.0003373573,0.0013105123,0.000010000303],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020037036,0.000110795205,0.022491554,0.007994436,0.00042373844,0.00039838103,0.00032812814,0.00017745761,0.96751785,0.00007921724,0.0002639932,0.000014104847],"study_design_scores_gemma":[0.0036219095,0.00015159725,0.24778168,0.0065358747,0.0005557169,6.623214e-8,0.00002746444,0.03836771,0.7005468,0.000001986606,0.0013639464,0.0010452174],"about_ca_topic_score_codex":0.00037702225,"about_ca_topic_score_gemma":0.000027820655,"teacher_disagreement_score":0.266971,"about_ca_system_score_codex":0.0008069706,"about_ca_system_score_gemma":0.00083729735,"threshold_uncertainty_score":0.99965566},"labels":[],"label_agreement":null},{"id":"W3105254545","doi":"10.1158/1078-0432.ccr-20-2845","title":"AMG 757, a Half-Life Extended, DLL3-Targeted Bispecific T-Cell Engager, Shows High Potency and Sensitivity in Preclinical Models of Small-Cell Lung Cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":238,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Digital Payment Technologies (Canada)","funders":"Amgen","keywords":"Cancer research; Medicine; Cell; Lung cancer; Ligand (biochemistry); Small molecule; T cell; Oncology; Internal medicine; Receptor; Chemistry; Immunology; Immune system","score_opus":0.307856614907692,"score_gpt":0.5039285427276453,"score_spread":0.1960719278199533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3105254545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.939313,0.034239903,0.00018183806,0.020768305,0.0003396539,0.0028230925,0.00023393729,0.00009549858,0.002004766],"genre_scores_gemma":[0.9560607,0.039254457,0.0006836053,0.0011252426,0.0011124257,0.0005331397,0.000019359351,0.00010697693,0.0011040777],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98992854,0.0026544046,0.0019193218,0.0018539152,0.0020893512,0.0015544413],"domain_scores_gemma":[0.9906326,0.0051140497,0.0002903727,0.0009389529,0.0013605412,0.0016634637],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.008414973,0.00047240694,0.001931319,0.00036356924,0.00025039772,0.00006347625,0.00042819127,0.0005300268,0.0005858615],"category_scores_gemma":[0.005570857,0.0004057207,0.00037241267,0.0015162727,0.0016836927,0.00021959093,0.001215853,0.0049802037,0.000022833927],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03532979,0.007590272,0.7524678,0.014770391,0.0016653356,0.0032488618,0.006367546,0.0026548847,0.048446115,0.0006205225,0.068659425,0.058179066],"study_design_scores_gemma":[0.0637829,0.010733522,0.658531,0.004376822,0.0010609574,0.000029448245,0.0039660498,0.2149931,0.025728453,0.0020675866,0.011887179,0.0028429742],"about_ca_topic_score_codex":0.0100149065,"about_ca_topic_score_gemma":0.003776318,"teacher_disagreement_score":0.21233822,"about_ca_system_score_codex":0.0005223888,"about_ca_system_score_gemma":0.0036020502,"threshold_uncertainty_score":0.9998395},"labels":[],"label_agreement":null},{"id":"W3106497006","doi":"10.3389/fonc.2020.01783","title":"Editorial: Update on the Biology, Management, and Treatment of Small Cell Lung Cancer","year":2020,"lang":"en","type":"editorial","venue":"Frontiers in Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Lung cancer; Biology; Cancer; Medicine; Cancer research; Bioinformatics; Computational biology; Intensive care medicine; Oncology; Internal medicine","score_opus":0.01813735911018518,"score_gpt":0.3552819961654386,"score_spread":0.33714463705525344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3106497006","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013507534,0.016922086,0.000019022504,0.005132379,0.9706385,0.0016092141,0.00028806448,0.000024365396,0.005231257],"genre_scores_gemma":[0.000082806386,0.06752335,0.0008395295,0.0001702374,0.9285651,0.0008139548,0.00014895397,0.00004618744,0.0018098813],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99804175,0.00025463203,0.0003725185,0.00057706714,0.00032683386,0.00042722086],"domain_scores_gemma":[0.99852556,0.0006430882,0.00023923976,0.0003599298,0.00012546925,0.00010671977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028612182,0.00033296246,0.0011594228,0.00023974087,0.00006138353,0.000008230875,0.00025247564,0.0007060391,0.000029289522],"category_scores_gemma":[0.00024778183,0.00021216153,0.00010981866,0.00020230906,0.00043321206,0.000013356736,0.00019532842,0.00070655363,0.0000036178458],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015268024,0.00021349819,0.005459655,0.000499067,0.0008990514,0.00006527736,0.0003982161,0.000001717353,0.000007904678,0.000037118476,0.9848134,0.006078308],"study_design_scores_gemma":[0.004179026,0.0026853206,0.00013321369,0.00013596113,0.0005613773,2.293296e-7,0.00021831656,0.000025794337,0.000041845877,0.000118621785,0.99175435,0.00014591163],"about_ca_topic_score_codex":0.0004797975,"about_ca_topic_score_gemma":0.00018435979,"teacher_disagreement_score":0.050601263,"about_ca_system_score_codex":0.0020237018,"about_ca_system_score_gemma":0.000726395,"threshold_uncertainty_score":0.8651696},"labels":[],"label_agreement":null},{"id":"W3107273701","doi":"10.1016/j.jtcvs.2020.10.148","title":"Predictors of survival following surgical resection of limited-stage small cell lung cancer","year":2020,"lang":"en","type":"article","venue":"Journal of Thoracic and Cardiovascular Surgery","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University Health Network","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center; McGill University","keywords":"Medicine; Hazard ratio; Conventional PCI; Proportional hazards model; Univariate analysis; Confidence interval; Surgery; Internal medicine; Stage (stratigraphy); Lung cancer; Oncology; Cancer; Multivariate analysis","score_opus":0.04058821291245301,"score_gpt":0.3299596399808089,"score_spread":0.2893714270683559,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107273701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89326215,0.104738586,0.0003628754,0.000293615,0.00066393084,0.00016701105,0.0000128580405,0.000009580489,0.00048940984],"genre_scores_gemma":[0.98068666,0.018346464,0.00007536939,0.00001864806,0.0007257748,0.000004565717,0.0000019761299,0.000024323046,0.00011619717],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973791,0.00034196413,0.0006886554,0.00019404362,0.0011563268,0.00023991254],"domain_scores_gemma":[0.9983885,0.00038486227,0.00031746965,0.0002141398,0.00042785174,0.00026712858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026203578,0.00015586756,0.0014200434,0.00021332095,0.00004936764,0.000011036122,0.00008571431,0.00009616906,0.000021690652],"category_scores_gemma":[0.00049779844,0.000119644435,0.002046184,0.00043702772,0.00009542916,0.00011722497,0.00008684553,0.00038280842,2.1425983e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031012753,0.00012016913,0.9575978,0.0051678726,0.014155934,0.001687321,0.0010245248,0.00072078174,0.0026311227,0.0000026140026,0.002056052,0.011734546],"study_design_scores_gemma":[0.016106937,0.0053278767,0.533075,0.014388878,0.040069684,0.0012011862,0.010967579,0.0024605952,0.22962976,0.000023769087,0.14461091,0.0021378433],"about_ca_topic_score_codex":0.00010100216,"about_ca_topic_score_gemma":0.0000033561462,"teacher_disagreement_score":0.4245228,"about_ca_system_score_codex":0.00006843479,"about_ca_system_score_gemma":0.00036535223,"threshold_uncertainty_score":0.48789585},"labels":[],"label_agreement":null},{"id":"W3116330208","doi":"10.1111/cts.12928","title":"Effects of Rovalpituzumab Tesirine on Ventricular Repolarization in Patients With Small‐Cell Lung Cancer","year":2020,"lang":"en","type":"article","venue":"Clinical and Translational Science","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"AbbVie","keywords":"QT interval; Medicine; QRS complex; Proarrhythmia; Cardiology; Internal medicine; Confidence interval; Prolongation; Lung cancer; Heart rate; Repolarization; Blood pressure","score_opus":0.026305087981786986,"score_gpt":0.34854388861810387,"score_spread":0.3222388006363169,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3116330208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967201,0.00038056468,0.0003201064,0.0019256053,0.000027849139,0.00044963084,0.0000041946846,0.0000064598858,0.00016551954],"genre_scores_gemma":[0.99918365,0.000060271697,0.00043884368,0.00025457417,0.000036434765,0.00000786221,0.0000037571087,0.000003209793,0.000011365429],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99894994,0.000025701043,0.00021307234,0.00025033372,0.00044345256,0.00011748679],"domain_scores_gemma":[0.9994272,0.00022216977,0.000048673606,0.000051858053,0.00012995265,0.0001201456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022638177,0.000057134534,0.00016313807,0.000045139583,0.00004363949,0.0000061037745,0.000054868837,0.000022850383,0.0000072012176],"category_scores_gemma":[0.00032253706,0.00003775274,0.000024197803,0.0004928257,0.0003331728,0.00006185006,0.000017177297,0.00012370221,6.4769046e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040324163,0.0001969016,0.9963903,0.00021052339,0.000011568306,0.000008872429,0.00008596267,0.000090229165,0.00014791127,0.00013418506,0.0000064237447,0.0023139056],"study_design_scores_gemma":[0.0033293786,0.0006088678,0.9930502,0.00014163025,0.00003151793,1.6979968e-7,0.0000017574653,0.0016244312,0.0010863802,0.000032114393,0.000050232018,0.00004332041],"about_ca_topic_score_codex":0.00001998956,"about_ca_topic_score_gemma":0.0000037184057,"teacher_disagreement_score":0.0033400753,"about_ca_system_score_codex":0.000015246988,"about_ca_system_score_gemma":0.00022132421,"threshold_uncertainty_score":0.15395121},"labels":[],"label_agreement":null},{"id":"W3118711697","doi":"10.1200/jco.20.01055","title":"Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133)","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":824,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"F. Hoffmann-La Roche","keywords":"Atezolizumab; Medicine; Internal medicine; Lung cancer; Hazard ratio; Placebo; Carboplatin; Oncology; Etoposide; Interim analysis; Gastroenterology; Surgery; Clinical trial; Cancer; Chemotherapy; Pembrolizumab; Immunotherapy; Confidence interval; Pathology; Cisplatin","score_opus":0.05157558275665592,"score_gpt":0.4224178008924977,"score_spread":0.3708422181358418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3118711697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947345,0.0026860002,0.000032264383,0.0012924712,0.00011983904,0.00027594226,0.00005363185,0.000007258554,0.0007980717],"genre_scores_gemma":[0.99422807,0.003843591,0.000767523,0.00043021224,0.000113837435,0.000005144765,0.000029768127,0.00002479482,0.0005570564],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967782,0.00047852704,0.0014453728,0.00036367626,0.0006044324,0.00032980164],"domain_scores_gemma":[0.9942303,0.0013200599,0.0013816742,0.0002422147,0.0023884145,0.000437363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091323495,0.00022600683,0.002457977,0.00026061898,0.000058191323,0.000016024187,0.00009039621,0.00021906571,0.00013821684],"category_scores_gemma":[0.0008104297,0.00013839596,0.0002205681,0.00060275564,0.0004495656,0.000087174165,0.0001239003,0.00075767195,2.0153969e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014489717,0.0007126959,0.9722599,0.00014318892,0.008307744,0.0012469045,0.0001962541,0.00013842604,0.00025289628,0.000013406912,0.00039075024,0.0018481635],"study_design_scores_gemma":[0.018020738,0.0068854876,0.9658987,0.00017750674,0.006972529,0.000026797086,0.00024432133,0.00057345995,0.0002598549,0.000004509907,0.0007911802,0.00014491766],"about_ca_topic_score_codex":0.00056883733,"about_ca_topic_score_gemma":0.002309302,"teacher_disagreement_score":0.0063611553,"about_ca_system_score_codex":0.00021558336,"about_ca_system_score_gemma":0.0014361901,"threshold_uncertainty_score":0.56436235},"labels":[],"label_agreement":null},{"id":"W3118763175","doi":"10.3390/curroncol28010036","title":"Real World Analysis of Small Cell Lung Cancer Patients: Prognostic Factors and Treatment Outcomes","year":2021,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Lung cancer; Oncology; Internal medicine; Cancer; Intensive care medicine; Bioinformatics","score_opus":0.1051696614156578,"score_gpt":0.4555679916574566,"score_spread":0.3503983302417988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3118763175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99277365,0.00479805,0.0000045289025,0.00041228108,0.00035449458,0.00046017105,0.000096944044,0.00001759496,0.0010823131],"genre_scores_gemma":[0.9931221,0.005672118,0.00007011422,0.000021218531,0.000044808785,0.00015052457,0.0001443199,0.00001071595,0.00076405465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99889153,0.000089697984,0.00027133393,0.00029848202,0.00018742782,0.00026150513],"domain_scores_gemma":[0.9988908,0.00038432915,0.000115144896,0.00017804108,0.0002973076,0.00013436082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000054601325,0.00015777371,0.00078510225,0.00029596628,0.000044307257,0.000005455432,0.00004311383,0.000040344683,0.00016186784],"category_scores_gemma":[0.00015227433,0.00010497298,0.00016471813,0.0006141455,0.00010819454,0.000020362657,0.00009631993,0.00011273751,8.5144836e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049840106,0.0013219822,0.98465824,0.00021129161,0.0022207878,0.000014714048,0.0011440873,0.0000043525356,0.000045489258,0.000012746542,0.00039826732,0.009918218],"study_design_scores_gemma":[0.0019541387,0.00053571735,0.98577106,0.000050656126,0.0047582057,1.5976205e-7,0.00019423781,0.00015784531,0.00043685338,0.000002162527,0.006058509,0.00008044706],"about_ca_topic_score_codex":0.00059926294,"about_ca_topic_score_gemma":0.0074705016,"teacher_disagreement_score":0.009837771,"about_ca_system_score_codex":0.0008735986,"about_ca_system_score_gemma":0.00043772825,"threshold_uncertainty_score":0.42806742},"labels":[],"label_agreement":null},{"id":"W3126845260","doi":"10.1016/j.lungcan.2021.01.025","title":"Safety of G-CSF with concurrent chemo-radiotherapy in limited-stage small cell lung cancer - Secondary analysis of the randomised phase 3 CONVERT trial","year":2021,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Canadian Cancer Society Research Institute; National Institute for Health and Care Research; Cancer Research UK","keywords":"Medicine; Neutropenia; Internal medicine; Regimen; Incidence (geometry); Febrile neutropenia; Granulocyte colony-stimulating factor; Gastroenterology; Randomized controlled trial; Radiation therapy; Lung cancer; Chemotherapy; Surgery; Oncology","score_opus":0.01929891310890295,"score_gpt":0.36019842857951406,"score_spread":0.3408995154706111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126845260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94377536,0.048537012,0.00017991629,0.0015645116,0.000566116,0.0027455548,0.0006809172,0.000021151156,0.0019294759],"genre_scores_gemma":[0.98072207,0.013005395,0.00007836732,0.0006508095,0.00026155481,0.00068902393,0.000064678585,0.000050587598,0.00447753],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99751806,0.0002264101,0.00070839777,0.00047978226,0.0006476099,0.00041976565],"domain_scores_gemma":[0.998084,0.000318731,0.00039316056,0.00061071565,0.00046390182,0.00012950404],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004165567,0.00027817782,0.0014069718,0.00024111924,0.00006536509,0.000013488875,0.00022195028,0.000098815595,0.002747197],"category_scores_gemma":[0.00009844604,0.00018181879,0.00044144932,0.001786138,0.00029088164,0.000065332584,0.00008749346,0.00045464025,1.7372061e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.46554333,0.0028400098,0.37656277,0.0071864217,0.03586258,0.00018395808,0.013993928,0.0041820286,0.069482684,0.0000642368,0.0112377945,0.012860261],"study_design_scores_gemma":[0.8056142,0.00061071815,0.022510394,0.0015084473,0.00826824,0.0000024746832,0.00070958043,0.026498161,0.12127092,0.0000011588154,0.012521936,0.0004838058],"about_ca_topic_score_codex":0.0019482492,"about_ca_topic_score_gemma":0.005051947,"teacher_disagreement_score":0.3540524,"about_ca_system_score_codex":0.0010063222,"about_ca_system_score_gemma":0.0025795652,"threshold_uncertainty_score":0.9981644},"labels":[],"label_agreement":null},{"id":"W3127599355","doi":"10.1016/j.annonc.2021.01.075","title":"Combined small-cell lung carcinoma revealed to be an intratumoural metastasis by genetic analysis","year":2021,"lang":"en","type":"letter","venue":"Annals of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University and Génome Québec Innovation Centre; McGill Genome Centre; McGill University Health Centre; McGill University","funders":"Canadian Institutes of Health Research; Pfizer Canada; Amgen Canada; Bristol-Myers Squibb Canada; National Institutes of Health; Merck Canada; Canada Foundation for Innovation; Advanced Accelerator Applications; Clovis Oncology; Fondation de l'Hôpital Général de Montréal; McMaster University; GlaxoSmithKline; Cancer Research Society; American Surgical Association Foundation; Leon Lowenstein Foundation; March of Dimes Foundation; F. Hoffmann-La Roche; Roche; Samsung; Genentech; Merck; California Institute for Regenerative Medicine; Fonds de Recherche du Québec - Santé; L'Oreal USA; AstraZeneca; Prostate Cancer Foundation; Amgen","keywords":"Medicine; Adenocarcinoma; Carcinoma; Small-cell carcinoma; Large cell; Lung; Pathology; Small Cell Lung Carcinoma; Metastasis; Oncology; Internal medicine; Cancer","score_opus":0.1112573168191713,"score_gpt":0.406147336166251,"score_spread":0.2948900193470797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127599355","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31259662,0.0048421193,0.000030054956,0.6797144,0.00018569759,0.0008877716,0.0003539776,0.00004882178,0.0013405341],"genre_scores_gemma":[0.15233879,0.0017476354,0.0021623226,0.83280456,0.0013681606,0.00034628672,0.0022555143,0.00015650467,0.0068202345],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955204,0.0008913379,0.00087937235,0.0009557141,0.0007510201,0.0010021633],"domain_scores_gemma":[0.9964098,0.00042040134,0.00040697257,0.0011185487,0.0012474792,0.00039685305],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00059488736,0.00050327607,0.0027611295,0.0008839049,0.000076030454,0.000028905555,0.0005219381,0.0007092757,0.00040479543],"category_scores_gemma":[0.00033085313,0.00045806033,0.0006901462,0.0014298287,0.00023734636,0.00004375845,0.00036653265,0.00153613,0.000009208273],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032623767,0.00036056203,0.008243309,0.00084887835,0.005964399,0.0031092502,0.0005123909,0.0000049482983,0.0020844697,0.000002269182,0.977237,0.0013062743],"study_design_scores_gemma":[0.0035040053,0.01411612,0.026391694,0.00013222604,0.013914344,0.00007217577,0.00048557637,0.00010431346,0.009366347,0.000037993235,0.9310207,0.00085454696],"about_ca_topic_score_codex":0.0013008092,"about_ca_topic_score_gemma":0.0005158519,"teacher_disagreement_score":0.16025785,"about_ca_system_score_codex":0.000300282,"about_ca_system_score_gemma":0.0011033453,"threshold_uncertainty_score":0.9997871},"labels":[],"label_agreement":null},{"id":"W3128084713","doi":"10.1016/j.actbio.2021.02.001","title":"Co-delivery of etoposide and cisplatin in dual-drug loaded nanoparticles synergistically improves chemoradiotherapy in non-small cell lung cancer models","year":2021,"lang":"en","type":"article","venue":"Acta Biomaterialia","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of General Medical Sciences; National Cancer Institute; National Institutes of Health; Canadian Mennonite University","keywords":"Etoposide; Cisplatin; Prodrug; Chemoradiotherapy; Drug delivery; Chemotherapy; Regimen; Pharmacology; Combination chemotherapy; Doxorubicin; Combination therapy; Medicine; Cancer research; Materials science; Nanotechnology; Internal medicine","score_opus":0.01600420946452221,"score_gpt":0.3072976037732291,"score_spread":0.29129339430870693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128084713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961064,0.0019969202,0.00000437098,0.0010259656,0.00017609222,0.00043966188,0.00006223044,0.000020182084,0.00016818456],"genre_scores_gemma":[0.99736917,0.0014406469,0.00056652847,0.00014136622,0.00007391901,0.000087414264,0.000017360902,0.000029476183,0.00027412898],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99848145,0.00007809084,0.00044860196,0.0003705184,0.00023758302,0.00038372475],"domain_scores_gemma":[0.9993619,0.0000778436,0.000090047346,0.0002536657,0.0001094557,0.00010710066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023073604,0.0001930991,0.000576631,0.00013099764,0.000030060779,0.000040012947,0.00006808301,0.00008631716,0.00007635908],"category_scores_gemma":[0.000045280565,0.00016855566,0.000039371727,0.0002529865,0.00016056141,0.00011384896,0.0000832284,0.00008442349,0.000001108965],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005698814,0.00017187497,0.009774727,0.0010624862,0.00007055916,0.00026464448,0.0017540331,0.000006914348,0.9853511,0.00002059376,0.000761454,0.00019172402],"study_design_scores_gemma":[0.00338088,0.00008051541,0.034749582,0.0004582753,0.000043140248,0.000011979884,0.00024182243,0.0016881711,0.9590875,0.00005712308,0.00003916351,0.00016186819],"about_ca_topic_score_codex":0.0033310289,"about_ca_topic_score_gemma":0.00061745034,"teacher_disagreement_score":0.02626363,"about_ca_system_score_codex":0.00018133613,"about_ca_system_score_gemma":0.00027683526,"threshold_uncertainty_score":0.6873501},"labels":[],"label_agreement":null},{"id":"W3132559292","doi":"10.1016/j.jtho.2021.02.009","title":"Efficacy and Safety of Rovalpituzumab Tesirine Compared With Topotecan as Second-Line Therapy in DLL3-High SCLC: Results From the Phase 3 TAHOE Study","year":2021,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":258,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal","funders":"Merck Sharp and Dohme; Ono Pharmaceutical; PharmaMar; Shionogi; Astellas Pharma; Daiichi-Sankyo; Cancer Research UK; Les Laboratories Pierre Fabre; Regeneron Pharmaceuticals; Amgen; Boehringer Ingelheim; Taiho Pharmaceutical; F. Hoffmann-La Roche; Chugai Pharmaceutical; Roche; Novartis; AbbVie; Merck; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Topotecan; Second line; Oncology; Internal medicine; Phase (matter); First line; Chemotherapy","score_opus":0.0525605755118861,"score_gpt":0.4658585770188332,"score_spread":0.4132980015069471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132559292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826578,0.0026087055,0.000016057156,0.013231127,0.00015764823,0.00070511183,0.000057262074,0.0000069987923,0.00055932073],"genre_scores_gemma":[0.9968764,0.001094153,0.0009373005,0.00041213314,0.00035673566,0.000008017928,0.000013957701,0.000018494646,0.00028280923],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9972834,0.0006778593,0.00096113683,0.00026941215,0.00054228544,0.00026589233],"domain_scores_gemma":[0.9965735,0.0015746191,0.00062165956,0.0003979636,0.0006810997,0.00015115648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015614392,0.00018365683,0.0011015479,0.0001513829,0.00008508181,0.000016370403,0.0002134657,0.00007917306,0.0001922984],"category_scores_gemma":[0.000979495,0.00010421059,0.000073479336,0.00043183693,0.00028233996,0.00008308174,0.00013489972,0.00078751193,0.0000016694617],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.52331597,0.016417196,0.031990185,0.00015890981,0.005002263,0.012499391,0.02163609,0.00026781904,0.02436025,0.000026923406,0.003938362,0.3603866],"study_design_scores_gemma":[0.16721794,0.07160321,0.6943872,0.0010640085,0.0007847008,0.0019271377,0.016109822,0.00013593832,0.02164434,0.00032630062,0.024468487,0.00033093744],"about_ca_topic_score_codex":0.0004088638,"about_ca_topic_score_gemma":0.0015792612,"teacher_disagreement_score":0.662397,"about_ca_system_score_codex":0.00043337737,"about_ca_system_score_gemma":0.0015215356,"threshold_uncertainty_score":0.42495844},"labels":[],"label_agreement":null},{"id":"W3135737422","doi":"10.3390/curroncol28020106","title":"Comparative Efficacy and Safety of Immunotherapeutic Regimens with PD-1/PD-L1 Inhibitors for Previously Untreated Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis","year":2021,"lang":"en","type":"review","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Atezolizumab; Etoposide; Pembrolizumab; Internal medicine; Oncology; Irinotecan; Durvalumab; Lung cancer; Adverse effect; Cancer; Chemotherapy; Immunotherapy; Colorectal cancer","score_opus":0.26187099327505464,"score_gpt":0.4974725700530229,"score_spread":0.23560157677796828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135737422","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000015497442,0.98069423,0.00011080045,0.00022742437,0.00011282981,0.018510187,0.00023805209,0.00002738602,0.000063578016],"genre_scores_gemma":[0.00003346974,0.99345,0.00021084187,0.000107712505,0.00009426267,0.005076203,0.00029418472,0.00006380015,0.0006695669],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9944328,0.0017506239,0.0018351704,0.0009973001,0.00035049653,0.0006335912],"domain_scores_gemma":[0.99322194,0.002614167,0.0020580145,0.00082535273,0.001056637,0.0002238909],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0012454232,0.0008413995,0.02120577,0.0002956997,0.00015795673,0.000023341527,0.00020366762,0.00022737334,0.00006906354],"category_scores_gemma":[0.00021224101,0.0004935773,0.0015462306,0.0013652003,0.00043371023,0.000034739143,0.00022002158,0.0006326357,0.0000010006141],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018737606,0.00020776616,0.000024397043,0.7844165,0.20981847,0.000021273592,0.00046450685,0.000008285864,2.2214817e-7,0.00001760588,0.00092734804,0.0039062514],"study_design_scores_gemma":[0.0015408406,0.00075388374,0.0000072104,0.16178325,0.6604095,0.00003445495,0.000078249206,0.000026753427,7.069811e-7,5.418601e-7,0.1750696,0.0002949837],"about_ca_topic_score_codex":0.000053602696,"about_ca_topic_score_gemma":0.00017744761,"teacher_disagreement_score":0.6226332,"about_ca_system_score_codex":0.00076712656,"about_ca_system_score_gemma":0.0014087509,"threshold_uncertainty_score":0.99975157},"labels":[],"label_agreement":null},{"id":"W3156560386","doi":"10.1158/1557-3265.radsci21-po-086","title":"Abstract PO-086: Selective radiosensitization in preclinical models of HPV-negative squamous cell carcinoma","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Radioresistance; Cancer research; Clonogenic assay; Cell cycle; Radiosensitivity; Medicine; Cancer; Viability assay; Flow cytometry; Radiation therapy; Cell culture; Oncology; Pharmacology; Biology; Immunology; Internal medicine","score_opus":0.25444523328433466,"score_gpt":0.5329115100054382,"score_spread":0.2784662767211036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3156560386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9616677,0.005845373,0.000049077258,0.002722855,0.0002753277,0.0012766359,0.00007197391,0.00003209173,0.028058933],"genre_scores_gemma":[0.99461585,0.0026373302,0.00039462876,0.00021890066,0.000657013,0.00019896448,0.000024450295,0.000053412023,0.0011994323],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99367106,0.0013434881,0.0013178813,0.0008961499,0.0017317146,0.0010397289],"domain_scores_gemma":[0.9886868,0.0070866793,0.00018469495,0.00066923414,0.0028652872,0.0005073162],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.005077474,0.00022790661,0.0010430855,0.00032490262,0.00012488799,0.000025998657,0.00024284708,0.00034602798,0.00044935098],"category_scores_gemma":[0.01061,0.0002055665,0.00029728387,0.0017087482,0.0009800686,0.00021791783,0.00040099325,0.0025155854,0.0000304667],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0117543,0.007041513,0.89083743,0.003009607,0.00044868005,0.0013705532,0.005535138,0.001299116,0.005505873,0.0005189194,0.03437301,0.038305838],"study_design_scores_gemma":[0.007546195,0.001357265,0.9345992,0.00024253732,0.00006427323,0.000012643293,0.0013409429,0.001765735,0.050593995,0.0018877921,0.0003304294,0.00025894324],"about_ca_topic_score_codex":0.0018023251,"about_ca_topic_score_gemma":0.0008796267,"teacher_disagreement_score":0.04508812,"about_ca_system_score_codex":0.0009585643,"about_ca_system_score_gemma":0.004058363,"threshold_uncertainty_score":0.99978566},"labels":[],"label_agreement":null},{"id":"W3159120388","doi":"10.1158/1078-0432.ccr-20-4259","title":"Veliparib in Combination with Carboplatin and Etoposide in Patients with Treatment-Naïve Extensive-Stage Small Cell Lung Cancer: A Phase 2 Randomized Study","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre","funders":"","keywords":"Veliparib; Medicine; Carboplatin; Internal medicine; Hazard ratio; Etoposide; Placebo; Oncology; Lung cancer; Chemotherapy; Clinical endpoint; Surgery; Confidence interval; Clinical trial; Pathology; Cisplatin; Biology","score_opus":0.11156764103209474,"score_gpt":0.509988089102433,"score_spread":0.3984204480703383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3159120388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858175,0.0052617006,0.0000059297568,0.0016406385,0.000072878654,0.0066491016,0.000050999526,0.000021602935,0.00047964885],"genre_scores_gemma":[0.9912095,0.0040043625,0.00011453521,0.00011749382,0.00008658539,0.0029171533,0.00003994296,0.000051114475,0.001459322],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9943473,0.0018403681,0.00081188505,0.0009990735,0.001206944,0.0007944386],"domain_scores_gemma":[0.9950894,0.002478661,0.00014366252,0.0005113344,0.0014339024,0.0003429985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027152298,0.00029618337,0.0014957208,0.00038323703,0.00014191015,0.00006720112,0.00013196921,0.0001212577,0.0001157459],"category_scores_gemma":[0.0013566855,0.00019632264,0.00008416266,0.0011701012,0.0006845252,0.00010820387,0.00021139534,0.0011391385,0.000002104914],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14762661,0.006149598,0.8355177,0.00025572843,0.00040595292,0.00079317915,0.0021202713,0.00003453331,0.000031912394,0.0000094466905,0.00010402196,0.0069510494],"study_design_scores_gemma":[0.5311423,0.0064454223,0.45846206,0.0006289083,0.00020173716,0.0000010749633,0.001617204,0.00083329255,0.00032378535,0.000011983095,0.00013470522,0.00019754026],"about_ca_topic_score_codex":0.014017739,"about_ca_topic_score_gemma":0.03874834,"teacher_disagreement_score":0.3835157,"about_ca_system_score_codex":0.0013186805,"about_ca_system_score_gemma":0.002323743,"threshold_uncertainty_score":0.992548},"labels":[],"label_agreement":null},{"id":"W3159700540","doi":"10.1200/jco.21.00411","title":"Reply to S. Sundar et al and S. Höcht et al","year":2021,"lang":"fr","type":"letter","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Humanities; Philosophy","score_opus":0.20017974508941583,"score_gpt":0.5752673338191591,"score_spread":0.37508758872974324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3159700540","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011824199,0.019265646,0.00012336747,0.94689804,0.013860502,0.0004894637,0.000058537244,0.000011573545,0.007468669],"genre_scores_gemma":[0.0012366321,0.05133439,0.0050677834,0.9239214,0.01148944,0.00001566976,0.000019659825,0.00008136108,0.006833672],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98601973,0.0048598764,0.005196624,0.0008893035,0.0019071639,0.0011272862],"domain_scores_gemma":[0.97276604,0.020284751,0.0027400127,0.000641332,0.002063928,0.0015039442],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.020703858,0.00054307637,0.0054622926,0.00036872257,0.00012252932,0.00008395765,0.0005539551,0.0011659074,0.0012061005],"category_scores_gemma":[0.05326574,0.00041200488,0.00120878,0.00033458072,0.0013854816,0.00021217196,0.0010019211,0.014546966,0.00015909983],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031185898,0.0007654294,0.016072923,0.00020799483,0.0028049666,0.031028429,0.00037331347,0.0000053343097,0.000050041475,0.00011069721,0.8932667,0.05219559],"study_design_scores_gemma":[0.007574719,0.021366043,0.04912501,0.0018512432,0.00081379904,0.0028328642,0.00020440052,0.000009700101,0.000009591037,0.0001420268,0.9157606,0.00031004284],"about_ca_topic_score_codex":0.00025765144,"about_ca_topic_score_gemma":0.00027913752,"teacher_disagreement_score":0.05188555,"about_ca_system_score_codex":0.0010705207,"about_ca_system_score_gemma":0.013879729,"threshold_uncertainty_score":0.99983317},"labels":[],"label_agreement":null},{"id":"W3161006899","doi":"10.3390/curroncol28030179","title":"Cancer Testis Antigen, NOL4, Is an Immunogenic Antigen Specifically Expressed in Small-Cell Lung Cancer","year":2021,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Pusan National University","keywords":"Antigen; Lung cancer; Immunoscreening; Western blot; Cancer; Cancer research; Immunohistochemistry; Adenocarcinoma; Biology; Medicine; Pathology; Molecular biology; Immunology; Complementary DNA; cDNA library; Gene; Internal medicine","score_opus":0.16747805379984537,"score_gpt":0.46897064528481913,"score_spread":0.30149259148497376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3161006899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85587287,0.13536927,0.00006373319,0.0042453357,0.0016897556,0.00077456736,0.00014968416,0.00007165895,0.0017631049],"genre_scores_gemma":[0.7822109,0.21115904,0.00082420127,0.0010080726,0.0016444984,0.0010041335,0.00013485912,0.0001060974,0.001908198],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970222,0.0002449611,0.00055843836,0.0008757398,0.00038778,0.0009108551],"domain_scores_gemma":[0.99811405,0.00016911994,0.00014935085,0.0006681863,0.00058948825,0.00030978018],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029232007,0.0003262276,0.0008293124,0.00021060815,0.00013213335,0.000034146407,0.0003273781,0.00019983853,0.002454958],"category_scores_gemma":[0.00017797122,0.00030372525,0.00015458265,0.00068766647,0.0002304741,0.00011002132,0.00032946814,0.00079086516,0.00004697981],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036743804,0.0017185304,0.7574956,0.0006227389,0.00026628273,0.00064986415,0.0030664816,0.000016979906,0.14018118,0.000021083735,0.030924406,0.06466944],"study_design_scores_gemma":[0.0066142776,0.0005290293,0.5011012,0.00079255627,0.00019369066,0.00003767604,0.00069396535,0.0006687655,0.056303743,0.00005318676,0.4324884,0.00052350224],"about_ca_topic_score_codex":0.0010621413,"about_ca_topic_score_gemma":0.0036926067,"teacher_disagreement_score":0.401564,"about_ca_system_score_codex":0.0014970365,"about_ca_system_score_gemma":0.0030672913,"threshold_uncertainty_score":0.99994147},"labels":[],"label_agreement":null},{"id":"W3163369172","doi":"10.1016/j.ijrobp.2021.04.049","title":"Cost-Effectiveness of Prophylactic Cranial Irradiation Versus MRI Surveillance for Extensive-Stage Small Cell Lung Cancer","year":2021,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Association of Radiation Oncology","keywords":"Medicine; Conventional PCI; Prophylactic cranial irradiation; Context (archaeology); Lung cancer; Cost effectiveness; Quality-adjusted life year; Internal medicine; Radiology; Emergency medicine; Surgery","score_opus":0.055964621398963736,"score_gpt":0.41735329848306696,"score_spread":0.3613886770841032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163369172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9357867,0.00548025,0.04325126,0.003962888,0.008417661,0.001864496,0.0005463887,0.00003790095,0.0006524496],"genre_scores_gemma":[0.9930285,0.0019394882,0.002294362,0.00020768993,0.0021243743,0.0001284011,0.00013391969,0.000034304572,0.00010891768],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979857,0.0004460503,0.0006366427,0.0002904841,0.0003651368,0.00027594116],"domain_scores_gemma":[0.9925161,0.0019458958,0.0010273191,0.00016451145,0.004229721,0.0001164799],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008856935,0.00019545412,0.00066979014,0.0001449374,0.0000774346,0.000020361678,0.00023946277,0.0001782525,0.000046300087],"category_scores_gemma":[0.0014240551,0.00017815198,0.00028752082,0.00022485139,0.00017277176,0.00018194881,0.00006963005,0.0003893129,0.000002929091],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024878554,0.0017457872,0.73157626,0.0012329064,0.004446378,0.00022076964,0.0013237478,0.011224002,0.13164307,0.0048933574,0.001763904,0.08505126],"study_design_scores_gemma":[0.107048824,0.009636021,0.6344598,0.0007631454,0.0014012267,0.00019998153,0.0007436413,0.025723191,0.15989514,0.0035584653,0.05556116,0.001009426],"about_ca_topic_score_codex":0.000052135034,"about_ca_topic_score_gemma":0.000034439647,"teacher_disagreement_score":0.09711648,"about_ca_system_score_codex":0.0018015878,"about_ca_system_score_gemma":0.0022637083,"threshold_uncertainty_score":0.7264827},"labels":[],"label_agreement":null},{"id":"W3166305108","doi":"10.7554/elife.66524","title":"Extracellular signal-regulated kinase mediates chromatin rewiring and lineage transformation in lung cancer","year":2021,"lang":"en","type":"article","venue":"eLife","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Alberta Children's Hospital; University of Calgary; BC Cancer Agency","funders":"Canadian Institutes of Health Research; Alberta Innovates; Japanese Respiratory Society; Michael Smith Health Research BC; Terry Fox Research Institute; National Cancer Institute; British Columbia Lung Association; Canada Research Chairs; Alberta Health Services","keywords":"MAPK/ERK pathway; Cancer research; Biology; Chromatin; Neuroendocrine differentiation; KRAS; Cell biology; Kinase; Cancer; Genetics; Gene","score_opus":0.017026245887767934,"score_gpt":0.329726321255545,"score_spread":0.3127000753677771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3166305108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9395213,0.056481022,0.000121145684,0.0030906594,0.000056896348,0.00032818058,0.000010078595,0.00004773591,0.00034299123],"genre_scores_gemma":[0.99476784,0.003921201,0.00026875857,0.00013380576,0.00015585573,0.00007316405,0.00003589177,0.000017162267,0.00062633835],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99886405,0.000055864024,0.00026502626,0.00019870841,0.00036637177,0.000249989],"domain_scores_gemma":[0.9995205,0.00007693112,0.000036833877,0.00012729848,0.0001281523,0.000110284556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003046343,0.00011228464,0.00024964125,0.00009713812,0.000059627546,0.000021496535,0.000034837507,0.000058394635,0.00022403072],"category_scores_gemma":[0.00015374768,0.00009934127,0.000033346438,0.00029582612,0.00005224999,0.00012599496,0.00003474353,0.00019956953,0.00000498139],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028987572,0.00023222234,0.111779146,0.0035959163,0.00036456587,0.0011309814,0.015024,0.00043310598,0.8455287,0.00016227434,0.0033875874,0.018071583],"study_design_scores_gemma":[0.00483669,0.000106322914,0.15183674,0.0018043289,0.0001350662,0.000033319087,0.0010256106,0.039758112,0.7949442,0.000014672028,0.005212737,0.00029217458],"about_ca_topic_score_codex":0.00020184032,"about_ca_topic_score_gemma":0.00032340927,"teacher_disagreement_score":0.055246532,"about_ca_system_score_codex":0.00016346987,"about_ca_system_score_gemma":0.00017482378,"threshold_uncertainty_score":0.40510193},"labels":[],"label_agreement":null},{"id":"W3167778695","doi":"10.1200/jco.2021.39.15_suppl.e20575","title":"Real-world treatment patterns, clinical outcomes, and health care resource utilization in extensive-stage small cell lung cancer in Canada.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"AstraZeneca (Canada); University of Calgary","funders":"","keywords":"Medicine; Etoposide; Radiation therapy; Carboplatin; Medical record; Population; Chemotherapy; Internal medicine; Stage (stratigraphy); Retrospective cohort study; Cohort; Lung cancer; Disease; Oncology; Cisplatin","score_opus":0.2390552102471624,"score_gpt":0.5576946155708685,"score_spread":0.31863940532370616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3167778695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95121825,0.010490718,0.0000075639646,0.036126427,0.0006952107,0.00042469543,0.000035904905,0.000004030265,0.0009972254],"genre_scores_gemma":[0.92675674,0.06411613,0.00041010242,0.006952615,0.00049588905,0.000015386895,0.000012269613,0.000022829608,0.0012180626],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9947329,0.0011864728,0.0029273676,0.0003487818,0.00039779374,0.0004066876],"domain_scores_gemma":[0.99526143,0.002457777,0.0010718491,0.0002284497,0.0004657588,0.00051475374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002329095,0.0001710762,0.0021769372,0.00016780104,0.00003786825,0.000007423835,0.00009607574,0.0001617628,0.00007056493],"category_scores_gemma":[0.001574685,0.00012413281,0.00020881146,0.00024818908,0.000089500274,0.00003939876,0.000107439184,0.0010847775,3.7014306e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00081056677,0.0005062582,0.9093581,0.00019603904,0.00016429734,0.0034883493,0.0003888356,0.000049549013,8.6926093e-7,0.000005785485,0.0031636623,0.08186773],"study_design_scores_gemma":[0.010694591,0.0022028978,0.939048,0.00036325894,0.000101731726,0.000018611181,0.0020265325,0.00011234773,0.0000096426265,0.0000026546284,0.04533568,0.00008403476],"about_ca_topic_score_codex":0.6250309,"about_ca_topic_score_gemma":0.9939252,"teacher_disagreement_score":0.36889437,"about_ca_system_score_codex":0.005636226,"about_ca_system_score_gemma":0.03090895,"threshold_uncertainty_score":0.998181},"labels":[],"label_agreement":null},{"id":"W3169994688","doi":"10.1038/sj.bjc.6601930","title":"Oral Presentations 4","year":2004,"lang":"fr","type":"article","venue":"British Journal of Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine","score_opus":0.03377068451095193,"score_gpt":0.41469568713158056,"score_spread":0.3809250026206286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169994688","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07691005,0.875582,0.0006577031,0.034382652,0.0063173347,0.00029552475,0.00011638623,0.00001131378,0.005727062],"genre_scores_gemma":[0.5845487,0.37227547,0.0019839474,0.0011144142,0.009653257,0.000032400676,0.0000030994438,0.00006083852,0.030327847],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978821,0.000082340266,0.00053123577,0.0001390686,0.0008413445,0.0005238801],"domain_scores_gemma":[0.9982712,0.00006894319,0.00025683042,0.000103875645,0.0009222547,0.00037688896],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004253145,0.00012678612,0.00043171243,0.000111448346,0.00015120815,0.000105691,0.00018511976,0.00008079924,0.002064825],"category_scores_gemma":[0.00047597164,0.0001440733,0.00022494818,0.0003217705,0.00039395597,0.0004140149,0.00006083759,0.0007178743,0.00005353012],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003167886,0.0005539987,0.019376671,0.00067862717,0.0019342194,0.010307318,0.0010875566,0.0028285661,0.00044914038,0.0008296819,0.23047815,0.73115927],"study_design_scores_gemma":[0.01021754,0.0007776332,0.18813197,0.011150836,0.0008963454,0.009722003,0.00095841376,0.000013820244,0.0015253538,0.0024866008,0.7738647,0.00025477004],"about_ca_topic_score_codex":0.008863702,"about_ca_topic_score_gemma":0.0057681203,"teacher_disagreement_score":0.7309045,"about_ca_system_score_codex":0.0009698124,"about_ca_system_score_gemma":0.0020850615,"threshold_uncertainty_score":0.9988474},"labels":[],"label_agreement":null},{"id":"W3170470860","doi":"10.3390/cancers13122895","title":"A Comparison of Hypofractionated and Twice-Daily Thoracic Irradiation in Limited-Stage Small-Cell Lung Cancer: An Overlap-Weighted Analysis","year":2021,"lang":"en","type":"article","venue":"Cancers","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Toronto; Princess Margaret Cancer Centre; Queen's University","funders":"Terry Fox Foundation","keywords":"Medicine; Radiation therapy; Esophagitis; Retrospective cohort study; Hazard ratio; Internal medicine; Stage (stratigraphy); Toxicity; Pneumonitis; Lung cancer; Oncology; Proportional hazards model; Odds ratio; Gastroenterology; Urology; Lung; Confidence interval; Disease","score_opus":0.04622970254268941,"score_gpt":0.4091437960928496,"score_spread":0.3629140935501602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170470860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800724,0.017626403,0.00008166642,0.00052502274,0.00010271453,0.0003591736,0.000077186814,0.000038604852,0.0011168793],"genre_scores_gemma":[0.99464154,0.0036515105,0.0003487399,0.00020872893,0.000070364986,0.000095938085,0.00014121598,0.000021638236,0.0008203404],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983418,0.00013538689,0.00038537526,0.00044076063,0.00038982235,0.00030685973],"domain_scores_gemma":[0.9988031,0.0001354913,0.00019870381,0.0003182322,0.00036744642,0.00017703838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020180098,0.00017060901,0.0006467295,0.00047279362,0.00007478842,0.000023889657,0.000073844414,0.000099131896,0.00019660122],"category_scores_gemma":[0.00009814498,0.00016879005,0.000094228475,0.0021407648,0.00009953306,0.00019830457,0.00004971195,0.0003136147,0.0000010152899],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056131417,0.00012377913,0.9690369,0.0006663275,0.0010884292,0.00004986471,0.0022276677,0.005296496,0.015446529,0.00002402674,0.00050871726,0.004969976],"study_design_scores_gemma":[0.0023788004,0.00025638216,0.7817976,0.0002288905,0.0016119231,0.0000023430005,0.0046129986,0.18812542,0.017946662,0.0000080657,0.0027638297,0.0002671202],"about_ca_topic_score_codex":0.0069155134,"about_ca_topic_score_gemma":0.008337985,"teacher_disagreement_score":0.1872393,"about_ca_system_score_codex":0.0022777852,"about_ca_system_score_gemma":0.0012861448,"threshold_uncertainty_score":0.9996975},"labels":[],"label_agreement":null},{"id":"W3170771486","doi":"10.1200/jco.2021.39.15_suppl.e20592","title":"Incidence of pneumonitis among limited-stage small cell lung cancer patients exposed to concurrent chemoradiation: A systematic literature review and meta-analysis.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Randomized controlled trial; Pneumonitis; Systematic review; Internal medicine; Observational study; Lung cancer; Meta-analysis; Oncology; MEDLINE; Lung","score_opus":0.15368868871070734,"score_gpt":0.4874924618875805,"score_spread":0.33380377317687315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170771486","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38749364,0.5997576,0.00005953241,0.010707299,0.00034130467,0.0013016583,0.000065970635,0.0000055844357,0.00026736292],"genre_scores_gemma":[0.87613875,0.117198855,0.00066959223,0.0047389334,0.00017276035,0.00008836211,0.00000847194,0.000014088369,0.00097017444],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9947763,0.0010794941,0.0030142132,0.0002738786,0.00064438645,0.00021173996],"domain_scores_gemma":[0.9914778,0.002132249,0.0025597026,0.00027814915,0.0030935754,0.0004585437],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.002869719,0.00017748825,0.0055376976,0.00019336464,0.000033447643,0.000019089453,0.0001679625,0.0001659725,0.00017417404],"category_scores_gemma":[0.009093293,0.00011198975,0.0012619698,0.0008804704,0.00012011625,0.00010830756,0.00015192425,0.0007495926,0.0000012623573],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054817565,0.0029596852,0.52714294,0.25028107,0.20135447,0.002618931,0.0019390569,0.000077041215,0.00021065258,0.00002689394,0.011234931,0.0016061717],"study_design_scores_gemma":[0.005376993,0.005499959,0.2698079,0.014185227,0.7022533,0.000075646276,0.00018295704,0.000170234,0.00045425238,0.0000056986696,0.001714873,0.00027296878],"about_ca_topic_score_codex":0.000012914495,"about_ca_topic_score_gemma":0.00014934855,"teacher_disagreement_score":0.5008988,"about_ca_system_score_codex":0.00022009062,"about_ca_system_score_gemma":0.0010704149,"threshold_uncertainty_score":0.9992535},"labels":[],"label_agreement":null},{"id":"W3171042793","doi":"10.1016/j.ctarc.2021.100405","title":"Safety, pharmacokinetics, and efficacy of budigalimab with rovalpituzumab tesirine in patients with small cell lung cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cilag; Takeda Oncology; Chugai Pharmaceutical; Genentech; Aptitude Health; Sierra Oncology; Sociedad Española de Oncología Médica; PharmaMar; European Society for Medical Oncology; Oryzon Genomics; Astellas Pharma; Eisai; MacroGenics; Mersana Therapeutics; Agios Pharmaceuticals; BeiGene; Clovis Oncology; Loxo Oncology; Astex Pharmaceuticals; Les Laboratories Pierre Fabre; Pfizer; Incyte; Taiho Pharmaceutical; Regeneron Pharmaceuticals; Array BioPharma; Daiichi Sankyo Europe; Servier; Gilead Sciences; Glenmark Pharmaceuticals; AbbVie; Exelixis; Sanofi; Bristol-Myers Squibb; Ignyta; Eli Lilly and Company; EUSA Pharma; AstraZeneca; Argenx; American Society of Clinical Oncology; GlaxoSmithKline; Amgen; LAM Therapeutics; Celgene","keywords":"Tolerability; Medicine; Internal medicine; Adverse effect; Lung cancer; Oncology; Pharmacokinetics; Pleural effusion; Clinical trial; Gastroenterology","score_opus":0.06452351404831635,"score_gpt":0.41405822557187255,"score_spread":0.3495347115235562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171042793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.924476,0.06449292,0.000004274679,0.0073552695,0.0000119451415,0.0013530308,0.00010945433,0.0000146246075,0.002182429],"genre_scores_gemma":[0.8775381,0.11986033,0.00085516623,0.000027583494,0.000022705566,0.00048323907,0.00007706212,0.000024298977,0.0011115527],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985398,0.0001926417,0.00020973069,0.00031284598,0.00037851525,0.0003664435],"domain_scores_gemma":[0.99772656,0.0004020361,0.000055263215,0.0007897028,0.0008565847,0.00016983741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018564968,0.00016303532,0.00035672027,0.00018910549,0.00025296616,0.00002597848,0.00016727098,0.000036514335,0.000053535605],"category_scores_gemma":[0.000044825665,0.00010634024,0.000025360485,0.00061680475,0.0007104309,0.000056624154,0.00037431763,0.00031498767,4.8501306e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015569038,0.001653207,0.9725138,0.00039036904,0.00060831587,0.000014968862,0.0016126486,0.000024899342,0.00048285187,0.0000599922,0.00020961878,0.020872425],"study_design_scores_gemma":[0.028196884,0.001658206,0.95357656,0.0010965664,0.00039959874,0.0000035426306,0.00052695157,0.00026007945,0.005527779,0.000010759734,0.008552388,0.00019066875],"about_ca_topic_score_codex":0.0024058614,"about_ca_topic_score_gemma":0.0033972673,"teacher_disagreement_score":0.05536741,"about_ca_system_score_codex":0.00067122444,"about_ca_system_score_gemma":0.00096595276,"threshold_uncertainty_score":0.4336429},"labels":[],"label_agreement":null},{"id":"W3172939869","doi":"10.1200/jco.2021.39.15_suppl.8563","title":"Analysis of homologous recombination DNA repair gene mutation status in patients with metastatic small cell lung cancer treated with cediranib and olaparib on NCI 9881 study.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Institutes of Health","keywords":"Olaparib; Medicine; PARP inhibitor; Cancer research; Internal medicine; Oncology; Poly ADP ribose polymerase; Biology; Gene; Polymerase","score_opus":0.06330536481527846,"score_gpt":0.44215222228506307,"score_spread":0.37884685746978464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172939869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981626,0.0005561996,0.000029830126,0.00044146448,0.00009229988,0.0005265209,0.00001491359,0.000006731714,0.00016938653],"genre_scores_gemma":[0.99771845,0.0006086659,0.0013296644,0.00016823306,0.000034739638,0.000019375626,0.000020216949,0.000014295887,0.000086345106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99658406,0.00088719313,0.0014446264,0.0002838703,0.0005648795,0.00023537762],"domain_scores_gemma":[0.9952563,0.0015703326,0.0012911404,0.00017790389,0.0015084286,0.00019587133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016792269,0.0001441361,0.0016979525,0.0004701505,0.000033731103,0.000006428389,0.000056924568,0.00009631999,0.000040585066],"category_scores_gemma":[0.0015782684,0.00009012056,0.00016929428,0.0009366862,0.0001410591,0.000076501754,0.000034702025,0.0005535809,2.46587e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010565599,0.0058370885,0.96809787,0.00010448932,0.00589369,0.0012097039,0.00069736486,0.0006083397,0.000028991444,0.0000015990904,0.00006587821,0.0068893647],"study_design_scores_gemma":[0.023881389,0.0342348,0.9336508,0.00012065858,0.006613896,0.00001173083,0.00064362556,0.00053539954,0.0001934313,0.000005690052,0.00002940583,0.000079153346],"about_ca_topic_score_codex":0.00037917728,"about_ca_topic_score_gemma":0.003121303,"teacher_disagreement_score":0.03444707,"about_ca_system_score_codex":0.00051713525,"about_ca_system_score_gemma":0.0014467586,"threshold_uncertainty_score":0.36750096},"labels":[],"label_agreement":null},{"id":"W3176870208","doi":"10.1016/j.radonc.2021.06.026","title":"Stereotactic radiosurgery for brain metastases from small cell lung cancer without prior whole-brain radiotherapy: A meta-analysis","year":2021,"lang":"en","type":"review","venue":"Radiotherapy and Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital; Queen's University; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Radiosurgery; Whole brain radiotherapy; Lung cancer; Radiation therapy; Meta-analysis; Internal medicine; Randomized controlled trial; Cochrane Library; Oncology; Hazard ratio; Brain metastasis; Surgery; Cancer; Confidence interval; Metastasis","score_opus":0.12300602840642384,"score_gpt":0.45126397480220803,"score_spread":0.3282579463957842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3176870208","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009699777,0.9788079,0.0032699548,0.010389359,0.0003955106,0.0048687886,0.0020313326,0.000093482224,0.000046623634],"genre_scores_gemma":[0.000004106717,0.9689764,0.0099254,0.0065049636,0.0012791555,0.0046202275,0.00061936927,0.00026528945,0.007805101],"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","domain_scores_codex":[0.9925898,0.0024551658,0.0014809481,0.0018527672,0.00053092954,0.0010903983],"domain_scores_gemma":[0.9880335,0.008952977,0.0010560765,0.0011814911,0.00026307657,0.0005128994],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0020720938,0.0012669299,0.01548229,0.0010112862,0.00030451617,0.00014704694,0.00040334562,0.0007871965,0.0018965908],"category_scores_gemma":[0.0003457928,0.0008908402,0.0059621353,0.0012348857,0.000387101,0.00011843487,0.00009761438,0.0009648077,0.0000021499059],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042938866,0.0003657888,0.00022256454,0.010318968,0.5345047,0.00029855483,0.00077354297,0.0000051699913,0.00003978609,0.000017689097,0.03819087,0.41483295],"study_design_scores_gemma":[0.0028229984,0.00054262765,0.000012555838,0.00053387997,0.30944633,0.00008179788,0.000045708373,0.00010925467,0.0000059977747,0.000004618145,0.6858501,0.0005441255],"about_ca_topic_score_codex":0.0007391879,"about_ca_topic_score_gemma":0.0010575289,"teacher_disagreement_score":0.64765924,"about_ca_system_score_codex":0.0028175258,"about_ca_system_score_gemma":0.0035015282,"threshold_uncertainty_score":0.99935424},"labels":[],"label_agreement":null},{"id":"W3179417079","doi":"10.1158/1538-7445.am2021-1412","title":"Abstract 1412: Whole exome sequencing reveals PI3K-ATK pathway alterations are frequent in relapsed small cell-lung cancer after chemoradiation","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Exome sequencing; Lung cancer; Copy-number variation; Cancer; Oncology; Primary tumor; Medicine; Chemotherapy; Exome; Internal medicine; Cancer research; Biology; Gene; Mutation; Genetics; Genome; Metastasis","score_opus":0.08756969921773325,"score_gpt":0.40525648446732193,"score_spread":0.3176867852495887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3179417079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9494287,0.034295287,0.000020013234,0.011466664,0.0003103984,0.0014560198,0.00026172673,0.00006562654,0.0026955823],"genre_scores_gemma":[0.98148745,0.004153711,0.00020696364,0.0005946526,0.00084523886,0.003773013,0.00007691047,0.00008636343,0.008775679],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9953318,0.0003375208,0.00062571495,0.00094755075,0.0014555082,0.0013018816],"domain_scores_gemma":[0.9968417,0.00032058812,0.00013387718,0.000804785,0.0014701876,0.0004288403],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001542381,0.00030545142,0.0006060392,0.000538399,0.00032120178,0.00016769233,0.00025932773,0.00019979228,0.0014871892],"category_scores_gemma":[0.0007307723,0.00029114564,0.00014760513,0.001567337,0.00021069696,0.0002285056,0.00025924915,0.001608026,0.00008518587],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005504025,0.00033863293,0.1854625,0.00400285,0.00025027373,0.002823057,0.005455479,0.0009851917,0.7786334,0.000055731554,0.018066084,0.003376392],"study_design_scores_gemma":[0.008416824,0.00028711816,0.558314,0.008491548,0.00012678142,0.000037146896,0.004485471,0.0009521765,0.40179235,0.00047177493,0.015579761,0.0010450486],"about_ca_topic_score_codex":0.0038585071,"about_ca_topic_score_gemma":0.009238935,"teacher_disagreement_score":0.37684104,"about_ca_system_score_codex":0.006748592,"about_ca_system_score_gemma":0.004503379,"threshold_uncertainty_score":0.99995404},"labels":[],"label_agreement":null},{"id":"W3180501931","doi":"10.1158/1538-7445.am2021-2874","title":"Abstract 2874: Understanding small cell lung cancer metastasis using circulating tumor cell (CTC)-derived tumor explant (CDX) models","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Pathology; Metastasis; Medicine; Tropism; Parenchyma; Lung; Brain metastasis; Primary tumor; Cancer; Ex vivo; Lung cancer; Cancer research; Biology; In vivo; Internal medicine; Immunology","score_opus":0.3469073019242359,"score_gpt":0.45201999508232604,"score_spread":0.10511269315809013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180501931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94568247,0.037926976,0.001411921,0.0014132989,0.00043462144,0.0016536354,0.00027446364,0.00014118664,0.011061407],"genre_scores_gemma":[0.9922102,0.0037171615,0.0013258043,0.00030343857,0.00073204725,0.0006066246,0.000032815224,0.0001916487,0.00088022713],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99278706,0.00041951667,0.00073586364,0.0013763928,0.0024033585,0.0022778246],"domain_scores_gemma":[0.99610114,0.0006543311,0.00021949691,0.000930765,0.0013261576,0.0007680815],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017402645,0.0005207907,0.0009985635,0.000619028,0.0010200873,0.00032489307,0.0004878951,0.00012147932,0.0014450317],"category_scores_gemma":[0.00030151833,0.00048848847,0.00031875525,0.0016389538,0.00041967302,0.00042449444,0.00078705774,0.0018437976,0.000021854925],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005513042,0.0003176424,0.0054391893,0.006033578,0.00071419217,0.0043043895,0.0032049306,0.009133893,0.9652456,0.0003103316,0.004144315,0.0006006549],"study_design_scores_gemma":[0.007665924,0.0002506859,0.002076816,0.005508446,0.00078836683,0.00023605551,0.03130304,0.048543796,0.8991987,0.0011537726,0.0017316684,0.0015427433],"about_ca_topic_score_codex":0.006656926,"about_ca_topic_score_gemma":0.001293451,"teacher_disagreement_score":0.06604689,"about_ca_system_score_codex":0.0070243008,"about_ca_system_score_gemma":0.0053967717,"threshold_uncertainty_score":0.99995786},"labels":[],"label_agreement":null},{"id":"W3180586825","doi":"10.1016/j.ctro.2021.06.009","title":"Limited-stage small cell lung cancer: Outcomes associated with prophylactic cranial irradiation over a 20-year period at the Princess Margaret Cancer Centre","year":2021,"lang":"en","type":"article","venue":"Clinical and Translational Radiation Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; McMaster University; University of Toronto; Princess Margaret Cancer Centre; Queen's University","funders":"Canada Foundation for Innovation; Princess Margaret Cancer Foundation; Canadian Institutes of Health Research; International Association for the Study of Lung Cancer; Cancer Research Society; Memorial Sloan-Kettering Cancer Center; National Cancer Institute; National Institutes of Health; Conquer Cancer Foundation","keywords":"Medicine; Conventional PCI; Prophylactic cranial irradiation; Cumulative incidence; Internal medicine; Proportional hazards model; Retrospective cohort study; Incidence (geometry); Lung cancer; Cohort; Population; Exact test; Stage (stratigraphy); Surgery; Oncology; Myocardial infarction","score_opus":0.03946288059495504,"score_gpt":0.3970333386417983,"score_spread":0.35757045804684323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180586825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92629766,0.0038686441,0.00004327029,0.06683535,0.000379234,0.0008981795,0.00031779349,0.000040084848,0.0013197616],"genre_scores_gemma":[0.98835236,0.0021419055,0.00012373096,0.0016224846,0.00039954632,0.00016530948,0.00028400432,0.000026236412,0.0068844184],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979448,0.00037615912,0.00048618222,0.00044571015,0.00044462053,0.0003025798],"domain_scores_gemma":[0.9977853,0.0013017505,0.00023051946,0.00015678788,0.0003489049,0.00017679067],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00041904222,0.00018227242,0.00047898918,0.00005090701,0.00029357767,0.00003240097,0.000070557246,0.00020719394,0.0011218216],"category_scores_gemma":[0.0003821288,0.000119225,0.00013001994,0.0002634273,0.00030863448,0.000093011964,0.000036723213,0.00043790956,0.0000057802877],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090401585,0.00033800033,0.9899273,0.00012291822,0.00047278163,0.00005019028,0.00074405654,0.00029255488,0.000045327568,0.0001751793,0.00085513346,0.006072576],"study_design_scores_gemma":[0.007605238,0.00025061227,0.9617562,0.00004675968,0.00041192083,0.000004842375,0.000092022965,0.0028148557,0.000025534508,0.000037485366,0.026811618,0.00014288917],"about_ca_topic_score_codex":0.00012720982,"about_ca_topic_score_gemma":0.006757981,"teacher_disagreement_score":0.06521287,"about_ca_system_score_codex":0.00035248685,"about_ca_system_score_gemma":0.0017255386,"threshold_uncertainty_score":0.99979126},"labels":[],"label_agreement":null},{"id":"W3183328865","doi":"10.1016/j.lungcan.2021.07.007","title":"Stereotactic ablative radiotherapy in T1-2N0M0 small cell lung cancer: A systematic review and meta-analysis","year":2021,"lang":"en","type":"review","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; London Health Sciences Centre; University of Toronto","funders":"","keywords":"Medicine; SABR volatility model; Meta-analysis; Confidence interval; Radiation therapy; Internal medicine; Lung cancer; Observational study; Systematic review; Surgery; Oncology; MEDLINE","score_opus":0.09116733073286165,"score_gpt":0.45274710486949943,"score_spread":0.3615797741366378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3183328865","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000019005633,0.98689616,0.000026304951,0.0009753446,0.00012431019,0.011185535,0.0003445065,0.000051316496,0.00039461913],"genre_scores_gemma":[0.000006809941,0.9714981,0.00012752712,0.0012381375,0.00013804725,0.015967509,0.000064311476,0.00015791999,0.010801656],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99354476,0.0014694405,0.0018371361,0.0014208967,0.00088352413,0.00084423943],"domain_scores_gemma":[0.99586123,0.00086221535,0.0011750521,0.0013617,0.00041848578,0.00032134395],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001212838,0.0011282545,0.020358426,0.000801509,0.00011279872,0.000103213766,0.00039933855,0.00029836883,0.0021295599],"category_scores_gemma":[0.00025555378,0.00073413114,0.0032954395,0.0033158709,0.00012590605,0.00012022935,0.00021375457,0.0011923616,0.000004532061],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000069709804,0.000043721633,0.00011190674,0.6872714,0.30973318,0.00013379942,0.0003463564,0.0000028830234,1.09978245e-7,0.0000040945642,0.0015849344,0.0007606314],"study_design_scores_gemma":[0.00044358795,0.000038930288,0.000007072205,0.20238355,0.7523504,0.000026689,0.000033402906,0.00006858387,4.976898e-7,3.9642904e-7,0.044140246,0.00050665083],"about_ca_topic_score_codex":0.0025970482,"about_ca_topic_score_gemma":0.0023686702,"teacher_disagreement_score":0.48488787,"about_ca_system_score_codex":0.0037106154,"about_ca_system_score_gemma":0.002018897,"threshold_uncertainty_score":0.999511},"labels":[],"label_agreement":null},{"id":"W3183701786","doi":"10.3390/curroncol28040243","title":"Patterns of Relapse in Small Cell Lung Cancer: Competing Risks of Thoracic versus CNS Relapse","year":2021,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Radiation therapy; Internal medicine; Retrospective cohort study; Lung cancer; Oncology; Cancer; Disease; Stage (stratigraphy); Cohort; Multivariate analysis; Central nervous system","score_opus":0.20441430667409827,"score_gpt":0.5097476292177541,"score_spread":0.3053333225436558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3183701786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9670662,0.027296301,0.0000519083,0.000777411,0.0015282877,0.00040001783,0.000060182098,0.000018449115,0.002801228],"genre_scores_gemma":[0.98836523,0.01090592,0.00024615787,0.00002132338,0.00017009724,0.0000854818,0.00003305468,0.00002070939,0.00015199561],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981893,0.0003037989,0.0005320347,0.0003367996,0.0002483124,0.00038979086],"domain_scores_gemma":[0.9983369,0.0006077732,0.00026148604,0.00031668931,0.00036619243,0.00011094874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043963437,0.00015372918,0.0007066924,0.00017394821,0.000035289242,0.0000028525253,0.00014195696,0.00011414808,0.00018976528],"category_scores_gemma":[0.00054220314,0.00014447344,0.00011986296,0.00035366142,0.00011819616,0.00003062685,0.0002915855,0.000639906,0.0000043503974],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012218116,0.0009714741,0.9492065,0.0038146668,0.00015153298,0.00020231483,0.0027349582,0.00005192568,0.0033122099,0.00009884169,0.0008745426,0.037359264],"study_design_scores_gemma":[0.03887301,0.0053093773,0.73503363,0.011295268,0.0020674577,0.000067270616,0.016101634,0.0029500162,0.11737939,0.00011113889,0.06977731,0.0010345284],"about_ca_topic_score_codex":0.0006470927,"about_ca_topic_score_gemma":0.0022840905,"teacher_disagreement_score":0.21417286,"about_ca_system_score_codex":0.00071060593,"about_ca_system_score_gemma":0.0009612499,"threshold_uncertainty_score":0.58914554},"labels":[],"label_agreement":null},{"id":"W3184397245","doi":"10.1136/thoraxjnl-2020-216555","title":"International differences in lung cancer survival by sex, histological type and stage at diagnosis: an ICBP SURVMARK-2 Study","year":2021,"lang":"en","type":"article","venue":"Thorax","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Simon Fraser University; Nova Scotia Health Authority; CancerCare Manitoba; Saskatchewan Cancer Agency; Cancer Care Ontario; Alberta Health Services","funders":"Cancer Council Victoria; Public Health England; Odense Universitetshospital; Cancer Research UK; Canadian Association of Thoracic Surgeons; University of Twente; Cancer Council NSW; McMaster University; World Health Organization","keywords":"Medicine; Stage (stratigraphy); Lung cancer; Demography; Cancer; Relative survival; Cancer registry; Epidemiology; Internal medicine","score_opus":0.09615459167668594,"score_gpt":0.43238538497101914,"score_spread":0.3362307932943332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3184397245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901932,0.005887502,0.0000022604543,0.0014761165,0.00032175062,0.0003016112,0.00006002476,0.000028801793,0.0017287167],"genre_scores_gemma":[0.9888968,0.0032249342,0.000023984097,0.00010036547,0.000104119186,0.000144352,0.000040387033,0.0000106675125,0.007454428],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985769,0.00023040648,0.00016969533,0.00036684825,0.00042918124,0.00022701107],"domain_scores_gemma":[0.9993378,0.00019396035,0.000036271736,0.00016914294,0.00014930188,0.00011351255],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034407683,0.00012379784,0.00033684142,0.000053887277,0.000066300054,0.00002645972,0.00010235462,0.00004609018,0.0011618224],"category_scores_gemma":[0.00034511148,0.0000951788,0.000018083876,0.00019812616,0.00009791601,0.00006912735,0.000270298,0.0002158052,0.000002603081],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022606715,0.00046218952,0.9908833,0.000043229713,0.00015432177,0.00029876272,0.0011175947,4.842595e-7,0.00045123775,0.000011409425,0.004110312,0.0022410916],"study_design_scores_gemma":[0.0011985947,0.00034352223,0.99100155,0.00005229499,0.00004618513,0.0000042632546,0.0018626926,0.00013867892,0.00030129787,0.000006590354,0.0049284664,0.0001158738],"about_ca_topic_score_codex":0.0012046765,"about_ca_topic_score_gemma":0.00589734,"teacher_disagreement_score":0.005725711,"about_ca_system_score_codex":0.00037580758,"about_ca_system_score_gemma":0.00013432668,"threshold_uncertainty_score":0.99975127},"labels":[],"label_agreement":null},{"id":"W3188488521","doi":"10.6004/jnccn.2020.7796","title":"Cost-Effectiveness Analysis of Durvalumab Plus Chemotherapy in the First-Line Treatment of Extensive-Stage Small Cell Lung Cancer","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"Xiangya Hospital, Central South University; Central South University; National Natural Science Foundation of China","keywords":"Durvalumab; Medicine; Etoposide; Oncology; Chemotherapy; Lung cancer; Cost-effectiveness analysis; Internal medicine; Cost effectiveness; Stage (stratigraphy); Cancer; Immunotherapy","score_opus":0.1077639222556304,"score_gpt":0.4199083928252948,"score_spread":0.3121444705696644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3188488521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.917766,0.07312397,0.00015186326,0.0068105143,0.00053715974,0.0011872973,0.00014866248,0.0000037243906,0.00027083087],"genre_scores_gemma":[0.9819421,0.015411249,0.00011253707,0.0015013193,0.00065316015,0.00011519305,0.000007929053,0.000019392037,0.00023707775],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9974191,0.00038395918,0.0006416184,0.00020627158,0.0010920316,0.0002569791],"domain_scores_gemma":[0.9930056,0.0013608165,0.00077231927,0.00024231781,0.004561151,0.000057838013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003966047,0.00020462935,0.001016309,0.00021960659,0.00011018864,0.000012210912,0.00025771483,0.00006374373,0.00012193189],"category_scores_gemma":[0.00013244183,0.000116672774,0.00062624144,0.0019092568,0.00016363339,0.00004868999,0.00005502431,0.00028338324,1.635451e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028725283,0.00051493244,0.1415136,0.00041560797,0.0076868734,0.00005830424,0.0020227658,0.8388548,0.0020142014,0.000059593905,0.002660153,0.0013266257],"study_design_scores_gemma":[0.010010502,0.0005164151,0.94867307,0.0011073769,0.002926059,0.000026103518,0.00059477484,0.012851782,0.008809582,0.00011396373,0.014203111,0.00016726348],"about_ca_topic_score_codex":0.0003647015,"about_ca_topic_score_gemma":0.0008310743,"teacher_disagreement_score":0.826003,"about_ca_system_score_codex":0.0018495927,"about_ca_system_score_gemma":0.0013329681,"threshold_uncertainty_score":0.48366207},"labels":[],"label_agreement":null},{"id":"W3193645271","doi":"10.37766/inplasy2021.8.0049","title":"The impact of timing of concurrent chemoradiation in limited stage SCLC undergoing platinum-based chemotherapy","year":2021,"lang":"en","type":"report","venue":"","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Stage (stratigraphy); Chemotherapy; Oncology; Medicine; Internal medicine; Lung cancer; Biology","score_opus":0.10012407493386774,"score_gpt":0.4446843719408798,"score_spread":0.3445602970070121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193645271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73556495,0.0507782,0.0010107873,0.0032438682,0.0011392963,0.00672619,0.00040008422,0.00016791058,0.20096874],"genre_scores_gemma":[0.98184633,0.0126132425,0.00020556366,0.000026197036,0.00016513128,0.000047330046,0.00022678402,0.000057337613,0.0048121028],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99730605,0.00008018508,0.00076652237,0.0002966622,0.0012174104,0.00033316863],"domain_scores_gemma":[0.99687046,0.0010557817,0.0006184124,0.00046319695,0.000916584,0.00007554247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010318026,0.00026188933,0.0009521119,0.00021477525,0.000047119738,0.000017178107,0.00012551738,0.00016377919,0.0003238077],"category_scores_gemma":[0.002013276,0.0001623606,0.0003428692,0.0005273232,0.00016072083,0.000033644697,0.000061679595,0.0004525519,7.3859013e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028591908,0.0022621972,0.53772616,0.032225076,0.01047663,0.0002956307,0.00375534,0.0037388555,0.02875107,0.00010475072,0.10962557,0.2681795],"study_design_scores_gemma":[0.03808916,0.00508942,0.7126123,0.029850563,0.00079410354,0.000050211245,0.0043673613,0.048026808,0.14118525,0.00004382763,0.018207325,0.0016836931],"about_ca_topic_score_codex":0.0026552824,"about_ca_topic_score_gemma":0.00071847875,"teacher_disagreement_score":0.2664958,"about_ca_system_score_codex":0.0019361583,"about_ca_system_score_gemma":0.009191418,"threshold_uncertainty_score":0.99642557},"labels":[],"label_agreement":null},{"id":"W3194861611","doi":"10.3390/curroncol28040270","title":"Real-World Treatment Patterns, Clinical Outcomes, and Health Care Resource Utilization in Extensive-Stage Small Cell Lung Cancer in Canada","year":2021,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"AstraZeneca (Canada); University of Calgary","funders":"Canadian Institutes of Health Research; AstraZeneca Canada","keywords":"Medicine; Radiation therapy; Lung cancer; Chemotherapy; Stage (stratigraphy); Population; Internal medicine; Medical record; Cohort; Disease; Chemotherapy regimen; Oncology","score_opus":0.2412574352327262,"score_gpt":0.5305801339327255,"score_spread":0.2893226986999993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194861611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9500704,0.039202817,0.000004963125,0.008255718,0.0006942633,0.0009123231,0.0001341415,0.000013573726,0.0007118174],"genre_scores_gemma":[0.9390168,0.058392998,0.000046055215,0.0010909246,0.00015860748,0.00021242515,0.00019591,0.000023916604,0.0008623486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99796367,0.00037468865,0.00054625893,0.00047432183,0.00019475976,0.00044629083],"domain_scores_gemma":[0.99900556,0.0002685463,0.00012533678,0.00024223777,0.0001409195,0.000217405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002395299,0.00016909602,0.0007488175,0.00013059062,0.000046439254,0.000005728533,0.000053398086,0.000054047585,0.00006255148],"category_scores_gemma":[0.00009454058,0.00014279208,0.000047298647,0.00024310689,0.00004785305,0.000017170058,0.00011920195,0.0003558828,5.333683e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00008410249,0.00023182409,0.9049605,0.0005854484,0.000033847242,0.0004000527,0.0011946559,0.00001671728,0.0000010751766,0.000007943634,0.0029341623,0.089549676],"study_design_scores_gemma":[0.004155935,0.00026602508,0.8906531,0.00028040563,0.000034081975,0.0000022833647,0.002690094,0.00019571195,0.000020368865,6.5598135e-7,0.10160874,0.000092616196],"about_ca_topic_score_codex":0.83759123,"about_ca_topic_score_gemma":0.9983847,"teacher_disagreement_score":0.16079351,"about_ca_system_score_codex":0.011107737,"about_ca_system_score_gemma":0.009734215,"threshold_uncertainty_score":0.99587965},"labels":[],"label_agreement":null},{"id":"W3203387497","doi":"10.1016/j.cllc.2021.09.006","title":"Longitudinal Assessment of Health Utility Scores, Symptoms and Toxicities in Patients with Small Cell Lung Cancer Using Real World Data","year":2021,"lang":"en","type":"article","venue":"Clinical Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Disease; Lung cancer; Depression (economics); Anxiety; Performance status; Medical record; Cohort; Cancer; Pathological; Chemotherapy; Psychiatry","score_opus":0.17221650362404584,"score_gpt":0.5071352465686404,"score_spread":0.33491874294459456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203387497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842635,0.012472729,0.00011051709,0.0010214386,0.0003158599,0.0009499187,0.00043841702,0.000021926993,0.00040569162],"genre_scores_gemma":[0.9908512,0.006218909,0.0018279032,0.00037325936,0.00021602432,0.000065161315,0.0001085406,0.000035184803,0.00030380773],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965589,0.00033597744,0.0009938414,0.0009004591,0.0006488041,0.0005619966],"domain_scores_gemma":[0.99763596,0.00043169237,0.00038776742,0.00088448357,0.0004026276,0.00025745638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012454591,0.0002424011,0.0011207367,0.000117295334,0.000106530155,0.000027762002,0.00022135848,0.00006721408,0.00012302583],"category_scores_gemma":[0.00016455972,0.00019186943,0.00006722646,0.00053313904,0.00057270343,0.00014045346,0.0006727832,0.000617534,1.3270018e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005106226,0.00048603845,0.9865489,0.0017044266,0.0003544029,0.000021736418,0.00010159793,0.00003144054,0.0000045168963,0.000014413075,0.0013538791,0.008868024],"study_design_scores_gemma":[0.0040947697,0.00034709665,0.9868103,0.0022920375,0.00026027564,5.9865556e-7,0.0000672471,0.0056881364,0.000023578443,0.000004426387,0.00023779261,0.0001737014],"about_ca_topic_score_codex":0.010829166,"about_ca_topic_score_gemma":0.03795623,"teacher_disagreement_score":0.027127067,"about_ca_system_score_codex":0.0009193894,"about_ca_system_score_gemma":0.0038006778,"threshold_uncertainty_score":0.9957578},"labels":[],"label_agreement":null},{"id":"W3205715890","doi":"10.1038/s41388-021-02070-3","title":"Lineage-restricted neoplasia driven by Myc defaults to small cell lung cancer when combined with loss of p53 and Rb in the airway epithelium","year":2021,"lang":"en","type":"article","venue":"Oncogene","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"Cancer Council Victoria; Victorian Cancer Agency","keywords":"Biology; Cancer research; Phenotype; Small Cell Lung Carcinoma; Neuroendocrine cell; Cell; Pathology; Carcinoma; Immunology; Gene; Immunohistochemistry; Small-cell carcinoma; Genetics","score_opus":0.01177826060905788,"score_gpt":0.29109471281683386,"score_spread":0.27931645220777596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3205715890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98373926,0.006724459,0.000060998853,0.0070777168,0.000053846437,0.0008202015,0.000109209046,0.000018679702,0.0013956508],"genre_scores_gemma":[0.993577,0.0018963118,0.0007885863,0.0007428087,0.000103791084,0.00018120153,0.000043289383,0.00003219821,0.0026348284],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99846095,0.0001349857,0.00027692257,0.0003428408,0.00043062645,0.0003537057],"domain_scores_gemma":[0.99885464,0.00025247055,0.00008498084,0.00037065905,0.0002839604,0.00015327413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019185615,0.00018768711,0.00050009927,0.00009097476,0.00006146828,0.000019736884,0.00016038818,0.00006566392,0.00006343672],"category_scores_gemma":[0.00015169579,0.00011736614,0.000049268296,0.0005217562,0.00010465623,0.00003262318,0.0001418774,0.00024057087,0.000003866369],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002537279,0.0010386419,0.6839966,0.0014188169,0.00077726296,0.0012787179,0.01426439,0.00025405298,0.23890129,0.000021535996,0.05121707,0.004294339],"study_design_scores_gemma":[0.023288202,0.0050225025,0.24139091,0.0019400164,0.0010769357,0.00012368147,0.0038286592,0.0012587494,0.6933931,0.00002359231,0.027805286,0.0008483517],"about_ca_topic_score_codex":0.0011779182,"about_ca_topic_score_gemma":0.0040472783,"teacher_disagreement_score":0.45449182,"about_ca_system_score_codex":0.00015227307,"about_ca_system_score_gemma":0.00047137833,"threshold_uncertainty_score":0.47860524},"labels":[],"label_agreement":null},{"id":"W3205820819","doi":"10.3390/curroncol28050347","title":"Immunotherapy in Extensive-Stage Small Cell Lung Cancer","year":2021,"lang":"en","type":"review","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Immunotherapy; Disease; Lung cancer; Thriving; Intensive care medicine; Stage (stratigraphy); Oncology; Cancer; Internal medicine; Psychotherapist","score_opus":0.2726057617974544,"score_gpt":0.555082684203195,"score_spread":0.28247692240574057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3205820819","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000053467276,0.99202234,0.000011429738,0.00027430273,0.0025551054,0.0022894563,0.000087151595,0.00004103056,0.002665724],"genre_scores_gemma":[0.0000016689206,0.99340624,0.00007389813,0.00012696887,0.0007547373,0.0017734274,0.00016842483,0.00008894762,0.0036057206],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969118,0.00050105754,0.0007756823,0.0007647097,0.00030612195,0.00074060704],"domain_scores_gemma":[0.99813676,0.000438133,0.00033629668,0.0006016146,0.00032264338,0.00016457771],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039624487,0.0005135079,0.0036803363,0.00040962172,0.000058516158,0.000016689937,0.0002917822,0.00039170615,0.00087635097],"category_scores_gemma":[0.0001809623,0.00040158723,0.00058527075,0.00059982634,0.00017008776,0.000026854492,0.00030599686,0.0017287444,0.0000473315],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003146659,0.0004554171,0.00062032946,0.045370053,0.00034122664,0.0005366313,0.00027198336,3.984253e-7,0.0000021273147,0.00002140676,0.013913098,0.93843585],"study_design_scores_gemma":[0.0017072815,0.00019582036,0.00008313391,0.025481433,0.000640848,0.000033350196,0.000073833064,0.0000074519953,0.0000019598863,0.0000015181888,0.9714697,0.00030367207],"about_ca_topic_score_codex":0.00014177077,"about_ca_topic_score_gemma":0.00025919484,"teacher_disagreement_score":0.9575566,"about_ca_system_score_codex":0.0035250178,"about_ca_system_score_gemma":0.005062597,"threshold_uncertainty_score":0.9998436},"labels":[],"label_agreement":null},{"id":"W3206067573","doi":"10.3892/mco.2021.2423","title":"Standard therapy‑resistant small cell lung cancer showing dynamic transition of neuroendocrine fate during the cancer trajectory: A case report","year":2021,"lang":"en","type":"article","venue":"Molecular and Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Japan Society for the Promotion of Science; School of Medicine, New York University; York University","keywords":"Biology; Neuroendocrine differentiation; Cancer research; Carboplatin; Lung cancer; Oncology; Cancer; Internal medicine; Medicine; Chemotherapy; Prostate cancer; Genetics","score_opus":0.038663195797604945,"score_gpt":0.4214544604542036,"score_spread":0.38279126465659863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206067573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97183114,0.018799389,0.00024614396,0.008079155,0.00023023417,0.00048549133,0.000050346513,0.000029036246,0.00024905655],"genre_scores_gemma":[0.98773044,0.01082933,0.00011628889,0.00086771406,0.00008150796,0.00011278113,0.0000068285735,0.000033804554,0.00022130703],"study_design_codex":"case_report","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979445,0.0003905876,0.00062405376,0.00046351214,0.00025592497,0.00032142256],"domain_scores_gemma":[0.9988557,0.00026759348,0.00015969858,0.00033085648,0.00024164113,0.0001445071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045949523,0.00015896463,0.0006527188,0.000040373863,0.00012697563,0.000011736432,0.0000693451,0.0000714223,0.00007252067],"category_scores_gemma":[0.00020133925,0.00011012716,0.00025613405,0.00017589376,0.0002697127,0.000022883118,0.000084295985,0.00048600117,1.9253164e-7],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068739178,0.00077995734,0.030910414,0.0012985413,0.0020790342,0.67915094,0.0012207266,0.00022821,0.252383,0.00001679519,0.00021972293,0.024838718],"study_design_scores_gemma":[0.07898977,0.015869005,0.33612773,0.0019769957,0.008102606,0.08996874,0.006341067,0.0060347067,0.42229527,0.00016225332,0.032213695,0.0019181643],"about_ca_topic_score_codex":0.0006500388,"about_ca_topic_score_gemma":0.0034387077,"teacher_disagreement_score":0.5891822,"about_ca_system_score_codex":0.00024526523,"about_ca_system_score_gemma":0.0009017114,"threshold_uncertainty_score":0.44908553},"labels":[],"label_agreement":null},{"id":"W3206589224","doi":"10.2196/29017","title":"An Automated Line-of-Therapy Algorithm for Adults With Metastatic Non–Small Cell Lung Cancer: Validation Study Using Blinded Manual Chart Review","year":2021,"lang":"en","type":"article","venue":"JMIR Medical Informatics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Cohort; Algorithm; Medicine; Chart; Retrospective cohort study; Electronic health record; Machine learning; Computer science; Surgery; Statistics; Internal medicine; Health care; Mathematics","score_opus":0.0547978510910148,"score_gpt":0.4502776543505282,"score_spread":0.3954798032595134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206589224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9617043,0.006572602,0.020847805,0.00065270864,0.00017758358,0.009604879,0.000115678005,0.00022158248,0.0001028364],"genre_scores_gemma":[0.5061168,0.05886415,0.41136792,0.009890001,0.0013833367,0.009485818,0.0020311335,0.0003374815,0.00052331615],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9968634,0.00010105647,0.0010333012,0.00019715175,0.0013994615,0.00040560155],"domain_scores_gemma":[0.99757916,0.00014306726,0.00039000186,0.00042981986,0.0010911006,0.0003668408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082444283,0.00025376497,0.0008711399,0.00012989706,0.00010160096,0.000027924965,0.00019237131,0.00008362361,0.00013977636],"category_scores_gemma":[0.00014708881,0.00017709169,0.00010019755,0.00057694357,0.00010043842,0.00024117196,0.00007168791,0.00031662383,0.0000025078873],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027264373,0.012020838,0.012037297,0.15408586,0.005656418,0.000591418,0.10129282,0.00021067982,0.00057400565,0.000014304686,0.016771616,0.6940183],"study_design_scores_gemma":[0.02100956,0.004081616,0.0007049154,0.013026785,0.0010210683,0.00008115216,0.012942718,0.93919754,0.0066834795,0.0000034581408,0.00085320225,0.00039451],"about_ca_topic_score_codex":0.00006528531,"about_ca_topic_score_gemma":0.000033391614,"teacher_disagreement_score":0.93898684,"about_ca_system_score_codex":0.00016873708,"about_ca_system_score_gemma":0.0015329598,"threshold_uncertainty_score":0.72215897},"labels":[],"label_agreement":null},{"id":"W3206694174","doi":"10.1097/coc.0000000000000867","title":"Treatment and Prevention of Brain Metastases in Small Cell Lung Cancer","year":2021,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Research Institute in Oncology and Hematology; University of Manitoba","funders":"","keywords":"Radiation therapy; Prophylactic cranial irradiation; Brain metastasis; Neurocognitive; Lung cancer; Radiosurgery; Central nervous system; Conventional PCI; Chemotherapy","score_opus":0.11089184346273195,"score_gpt":0.5429156578752207,"score_spread":0.4320238144124887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206694174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97865844,0.0065447865,0.00007518471,0.013729413,0.00014173282,0.00013899342,0.0000060880548,0.000001839118,0.00070353143],"genre_scores_gemma":[0.97819424,0.015306871,0.0051826504,0.0005705948,0.0002163481,0.000010588735,0.0000013596685,0.0000085068605,0.0005088376],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9978098,0.00073771103,0.0010116617,0.00014572221,0.00013140435,0.00016366065],"domain_scores_gemma":[0.99656075,0.0021100263,0.0007758014,0.00010511959,0.00027798352,0.00017033606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010232534,0.00008335475,0.0012400951,0.00009552939,0.000012541172,0.0000025133022,0.000049144444,0.000043053868,0.00007398663],"category_scores_gemma":[0.0013834222,0.000058028767,0.00021376123,0.00021284416,0.00041061844,0.000031058014,0.000047956066,0.00028032277,4.0039254e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016769258,0.0012628947,0.4238491,0.000075717,0.00065697095,0.0006875561,0.00034165208,0.000012465624,0.00094266335,0.000019751918,0.00079906697,0.5696752],"study_design_scores_gemma":[0.027729815,0.0737419,0.8251795,0.0006620437,0.0018107464,0.00061575504,0.0041376157,0.000113385315,0.004949282,0.000293891,0.06055806,0.00020801827],"about_ca_topic_score_codex":0.00031376645,"about_ca_topic_score_gemma":0.0007230186,"teacher_disagreement_score":0.5694672,"about_ca_system_score_codex":0.00023087938,"about_ca_system_score_gemma":0.0021857691,"threshold_uncertainty_score":0.38774607},"labels":[],"label_agreement":null},{"id":"W3209942576","doi":"10.1016/j.ijrobp.2021.07.1310","title":"A Comparison of Hypofractionated and Twice Daily Thoracic Irradiation in Limited-Stage Small Cell Lung Cancer: An Overlap Weighted Analysis","year":2021,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University Health Network; University of Toronto; Kingston General Hospital; Princess Margaret Cancer Centre; Cancer Care South East; Queen's University","funders":"","keywords":"Medicine; Retrospective cohort study; Radiation therapy; Confounding; Hazard ratio; Proportional hazards model; Propensity score matching; Cohort; Lung cancer; Internal medicine; Stage (stratigraphy); Oncology; Confidence interval","score_opus":0.04100072426225624,"score_gpt":0.43078195673265235,"score_spread":0.3897812324703961,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209942576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98895514,0.0048206514,0.002673352,0.0022382406,0.0005848782,0.00021696815,0.00011456677,0.000019625923,0.00037660342],"genre_scores_gemma":[0.9928025,0.0036167454,0.0022441568,0.0003729116,0.0005738234,0.000017204069,0.0002539105,0.0000200961,0.000098671204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99763435,0.00045080401,0.00095314614,0.00030919805,0.00042198173,0.00023052949],"domain_scores_gemma":[0.9960756,0.00058725156,0.0012780664,0.00017320809,0.0017371586,0.00014873163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060274685,0.00018957065,0.0008273095,0.00059824775,0.00006237459,0.000028291692,0.00021204966,0.00021129508,0.000081906015],"category_scores_gemma":[0.0003503638,0.00017951877,0.0001988991,0.0009152484,0.00014480145,0.00042618238,0.000075913376,0.0006154091,0.000001662706],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079183996,0.0008690226,0.9453571,0.000058256934,0.0020655177,0.000056008295,0.0011830233,0.0029797622,0.01597817,0.00062109326,0.00016248353,0.029877719],"study_design_scores_gemma":[0.0059004053,0.0010687243,0.86746806,0.00011704909,0.0013017907,0.000039356266,0.000977383,0.10509321,0.01206968,0.0005269938,0.005204411,0.00023290783],"about_ca_topic_score_codex":0.00026611966,"about_ca_topic_score_gemma":0.00024054137,"teacher_disagreement_score":0.10211345,"about_ca_system_score_codex":0.0012227459,"about_ca_system_score_gemma":0.001051497,"threshold_uncertainty_score":0.7320563},"labels":[],"label_agreement":null},{"id":"W3211244077","doi":"10.1016/j.jtocrr.2021.100249","title":"A Real-World Evaluation of Atezolizumab Plus Platinum-Etoposide Chemotherapy in Patients With Extensive-Stage SCLC in Canada","year":2021,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; Kingston Health Sciences Centre; University of Calgary","funders":"","keywords":"Atezolizumab; Medicine; Etoposide; Hazard ratio; Oncology; Internal medicine; Chemotherapy; Carboplatin; Confidence interval; Cisplatin; Cancer; Pembrolizumab; Immunotherapy","score_opus":0.12703755635832875,"score_gpt":0.4785684825184646,"score_spread":0.35153092616013587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211244077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927102,0.00040722903,3.467625e-7,0.0018503352,0.00007058772,0.0011459845,0.0000065812883,0.0000052602213,0.0038035233],"genre_scores_gemma":[0.9975024,0.0008347522,0.00011692164,0.00010121866,0.000057286652,0.00007377245,0.000022068345,0.000017810107,0.0012737574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9941136,0.0005989898,0.00097446475,0.00056275685,0.0032747078,0.00047546788],"domain_scores_gemma":[0.99548775,0.00071353366,0.00017211505,0.00047799316,0.0029091763,0.0002394197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058900514,0.0001259502,0.0006400151,0.00018194635,0.00005674696,0.000014100924,0.000054442036,0.000068547546,0.0001251036],"category_scores_gemma":[0.005502391,0.000088204826,0.000045984387,0.0008605919,0.00034134387,0.000063405896,0.00015428904,0.0007275033,5.9194326e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015012299,0.00027693372,0.9813895,0.00017654191,0.00007795737,0.002243264,0.00016217107,0.0000327259,0.000033617387,0.00001041841,0.00106162,0.013033992],"study_design_scores_gemma":[0.006937295,0.00042585772,0.9897969,0.0005984284,0.000017834192,0.000012162074,0.0003348527,0.0005169248,0.00033177668,0.00016383357,0.00077368977,0.000090444766],"about_ca_topic_score_codex":0.6084371,"about_ca_topic_score_gemma":0.91091675,"teacher_disagreement_score":0.3024796,"about_ca_system_score_codex":0.0014749059,"about_ca_system_score_gemma":0.01336999,"threshold_uncertainty_score":0.99222326},"labels":[],"label_agreement":null},{"id":"W34930244","doi":"10.1186/s12935-021-02357-1","title":"Montreal Neurological Institute モントリオール留学記","year":2003,"lang":"en","type":"article","venue":"Toho Igakkai Zasshi","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Fundamental Research Funds for the Central Universities; National Key Research and Development Program of China; National Natural Science Foundation of China","keywords":"Medicine; Audiology","score_opus":0.03716610681098388,"score_gpt":0.34068772616028337,"score_spread":0.3035216193492995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W34930244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6978405,0.0013024404,0.00011412057,0.0069720196,0.0005510368,0.00067537714,0.000009893375,0.00029632455,0.2922383],"genre_scores_gemma":[0.98998195,0.0002855815,0.00054312847,0.0019190009,0.00024665112,0.0000669269,0.0000095379355,0.000024537214,0.0069226734],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99824035,0.0000882561,0.00022136529,0.0004076547,0.0004959993,0.0005463568],"domain_scores_gemma":[0.99905086,0.00007751709,0.0000415303,0.00044197313,0.00010479568,0.00028330577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002882684,0.00019502155,0.00036350364,0.00008904387,0.00013862751,0.000026448619,0.00013952368,0.00010344868,0.00044743164],"category_scores_gemma":[0.0008199847,0.00014479189,0.000117767195,0.00026745597,0.00026261064,0.00012235196,0.000087297354,0.00041834786,0.0003594884],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020695452,0.0018156302,0.547234,0.0005167515,0.0010941074,0.005747438,0.0016176606,0.00011231951,0.0067694136,0.043443065,0.33250058,0.057079475],"study_design_scores_gemma":[0.0037888451,0.0012690447,0.47320735,0.000056231776,0.00014276408,0.00031218876,0.000078443096,0.000100694095,0.0012545722,0.0019872934,0.517459,0.00034355622],"about_ca_topic_score_codex":0.00017439057,"about_ca_topic_score_gemma":0.00017003693,"teacher_disagreement_score":0.29214147,"about_ca_system_score_codex":0.00009494894,"about_ca_system_score_gemma":0.00018626676,"threshold_uncertainty_score":0.5904442},"labels":[],"label_agreement":null},{"id":"W4200122615","doi":"10.1016/j.annonc.2021.10.132","title":"114TiP KEYNOTE-B99: Phase II study of pembrolizumab plus investigational agents combined with chemotherapy as first-line therapy for extensive-stage small cell lung cancer (ES-SCLC)","year":2021,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Pembrolizumab; Chemotherapy; Oncology; Lung cancer; Internal medicine; Phases of clinical research; Stage (stratigraphy); Cancer; Immunotherapy","score_opus":0.1475345320760051,"score_gpt":0.46159411766718694,"score_spread":0.31405958559118186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200122615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9769284,0.0031402274,0.000057644258,0.016265959,0.00012850948,0.0026896487,0.0001334845,0.0000267786,0.0006293249],"genre_scores_gemma":[0.9860033,0.004654491,0.0004487699,0.0052627344,0.00017720333,0.000612038,0.00008343542,0.000056160672,0.002701878],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99776953,0.00014379638,0.0005769078,0.0005042236,0.00053259067,0.00047293174],"domain_scores_gemma":[0.9963109,0.00042025145,0.00042277222,0.00044424087,0.00219252,0.00020930934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035748884,0.0002877415,0.0010872255,0.00016376405,0.00017909003,0.0000074925806,0.00020246103,0.00012841531,0.0004050804],"category_scores_gemma":[0.0002517999,0.00022859727,0.00015704113,0.00037119337,0.000322691,0.00006563263,0.000116197145,0.00023919577,0.0000012824255],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.35462567,0.1063509,0.09793883,0.0073425733,0.022069052,0.0023958683,0.07739294,0.006593454,0.10958186,0.0010721823,0.1488443,0.06579235],"study_design_scores_gemma":[0.31740004,0.2808219,0.048043683,0.0006593653,0.00065128447,0.000048992708,0.004396981,0.0034922822,0.2502949,0.00040443923,0.093004175,0.0007819855],"about_ca_topic_score_codex":0.00048445663,"about_ca_topic_score_gemma":0.0007046879,"teacher_disagreement_score":0.17447099,"about_ca_system_score_codex":0.00019191489,"about_ca_system_score_gemma":0.0025275892,"threshold_uncertainty_score":0.9321927},"labels":[],"label_agreement":null},{"id":"W4200232423","doi":"10.1186/s12962-021-00329-w","title":"First-line pembrolizumab plus chemotherapy for extensive-stage small-cell lung cancer: a United States-based cost-effectiveness analysis","year":2021,"lang":"en","type":"article","venue":"Cost Effectiveness and Resource Allocation","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"Natural Science Foundation of Hunan Province; National Natural Science Foundation of China","keywords":"Medicine; Pembrolizumab; Lung cancer; Oncology; Public health; Health services research; Chemotherapy; Health administration; Health economics; Quality of Life Research; Stage (stratigraphy); Internal medicine; Cost effectiveness; Cancer; Immunotherapy; Pathology","score_opus":0.03294104266757879,"score_gpt":0.35881668465723265,"score_spread":0.32587564198965385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200232423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85568434,0.007456278,0.12874027,0.0016889173,0.000082327504,0.005983848,0.00019376374,0.00010740681,0.000062871],"genre_scores_gemma":[0.9899118,0.0024733145,0.00014629717,0.0006564853,0.00013513106,0.004791382,0.00139539,0.00008236294,0.00040782298],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9973883,0.000551745,0.00030804006,0.0008415891,0.00038227218,0.00052803394],"domain_scores_gemma":[0.9956197,0.0019864729,0.0001718686,0.00051819923,0.0014567794,0.00024693974],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008806554,0.00038483765,0.00090767886,0.00049078045,0.00045451423,0.0000833595,0.00011681812,0.00016005035,0.00003554754],"category_scores_gemma":[0.00034594606,0.00033530383,0.00028530907,0.0018235598,0.00017593565,0.00006578819,0.000077472374,0.00026535886,0.0000012248167],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030173758,0.0014619231,0.11847241,0.02257343,0.008606455,0.00020261931,0.0021871806,0.7484507,0.020347446,0.00013887418,0.00035037068,0.04703486],"study_design_scores_gemma":[0.033321943,0.00087969966,0.31539416,0.0015054289,0.0034882834,0.000010039313,0.0005781677,0.54861486,0.06383158,0.00002526339,0.03169558,0.00065498153],"about_ca_topic_score_codex":0.0010791254,"about_ca_topic_score_gemma":0.00046778418,"teacher_disagreement_score":0.1998358,"about_ca_system_score_codex":0.0012064133,"about_ca_system_score_gemma":0.00053645036,"threshold_uncertainty_score":0.9999099},"labels":[],"label_agreement":null},{"id":"W4200374965","doi":"10.3390/radiation1040026","title":"Limited-Stage Small-Cell Lung Cancer: Current Progress and the Next Frontier","year":2021,"lang":"en","type":"article","venue":"Radiation","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Weill Cornell Medical College; Canada Foundation for Innovation; Canadian Institutes of Health Research; International Association for the Study of Lung Cancer; Cancer Research Society; Memorial Sloan-Kettering Cancer Center; American Society of Clinical Oncology; National Cancer Institute; Ontario Institute for Cancer Research; Conquer Cancer Foundation","keywords":"Prophylactic cranial irradiation; Medicine; Conventional PCI; Oncology; Radiation therapy; Stage (stratigraphy); Clinical trial; Lung cancer; Internal medicine; Radiology","score_opus":0.03125763640342262,"score_gpt":0.34713092787304717,"score_spread":0.31587329146962456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200374965","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44856924,0.53094035,0.00020185218,0.016779013,0.0006307413,0.0011308884,0.000022666634,0.000056276476,0.0016689879],"genre_scores_gemma":[0.92800945,0.06480527,0.0002288133,0.00042412203,0.00076073164,0.00042739752,0.000055455715,0.000024464647,0.005264301],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992247,0.000076678065,0.000116540075,0.00018184833,0.00022180645,0.00017842925],"domain_scores_gemma":[0.99951446,0.00007074084,0.00005141298,0.00017523428,0.00012148965,0.00006667863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017242171,0.00008104277,0.00016160241,0.000036117213,0.00010792271,0.00005242021,0.000040288804,0.000027279797,0.000059156377],"category_scores_gemma":[0.000098985496,0.000053492528,0.000040808904,0.00015861726,0.00009705498,0.00006773787,0.00005678331,0.00016385697,0.00000424808],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003561632,0.00017315084,0.45790178,0.0014293675,0.00033360868,0.000038386697,0.0045292,0.00003067786,0.0003648053,0.0007858417,0.04339632,0.4906607],"study_design_scores_gemma":[0.015015761,0.0001068665,0.37913957,0.0004767572,0.0006960104,0.00001274849,0.0010133983,0.04100981,0.005280693,0.00008925834,0.55683535,0.00032375907],"about_ca_topic_score_codex":0.0000735236,"about_ca_topic_score_gemma":0.000050206312,"teacher_disagreement_score":0.51343906,"about_ca_system_score_codex":0.00017288362,"about_ca_system_score_gemma":0.00021335258,"threshold_uncertainty_score":0.21813619},"labels":[],"label_agreement":null},{"id":"W4200625024","doi":"10.51731/cjht.2021.145","title":"Durvalumab (Imfinzi)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Durvalumab; Reimbursement; Carboplatin; Medicine; Etoposide; Authorization; Cisplatin; Intensive care medicine; Political science; Cancer; Surgery; Chemotherapy; Internal medicine; Law; Computer science; Computer security","score_opus":0.0508276305137164,"score_gpt":0.36922993545455696,"score_spread":0.31840230494084054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200625024","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.129577,0.43787163,0.0001518958,0.42816922,0.00068952166,0.00028568725,0.000021015509,0.00014430036,0.0030897022],"genre_scores_gemma":[0.9940083,0.0032383874,0.0011503141,0.0010931226,0.000025140465,0.0000041241146,0.0000016043632,0.00001296204,0.00046605253],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998651,0.00004938348,0.00041374387,0.0001205293,0.00025369247,0.00051163207],"domain_scores_gemma":[0.9987924,0.000049515347,0.00017593293,0.0002805528,0.000544695,0.00015690888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053716183,0.00009260227,0.00042686425,0.00043457694,0.00021017063,0.000023490213,0.00017484932,0.00008779616,0.000081304264],"category_scores_gemma":[0.0023703743,0.00007518045,0.000090983194,0.00046718115,0.0002591462,0.00006465328,0.00003411743,0.00056743296,0.000014312878],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003747986,0.000041520292,0.039409745,0.000590928,0.0002861063,0.0057580476,0.00057416566,0.0000042953766,0.0002607797,0.0021186345,0.10997295,0.84094536],"study_design_scores_gemma":[0.0013418383,0.0008433672,0.05655726,0.00084574067,0.000033645785,0.0037034797,0.008353382,0.0000043042505,0.003604748,0.0035460985,0.92102385,0.00014227441],"about_ca_topic_score_codex":0.0018385928,"about_ca_topic_score_gemma":0.005019839,"teacher_disagreement_score":0.86443126,"about_ca_system_score_codex":0.00089971017,"about_ca_system_score_gemma":0.012903446,"threshold_uncertainty_score":0.9926925},"labels":[],"label_agreement":null},{"id":"W4205889660","doi":"10.1016/j.jtocrr.2022.100283","title":"Brief Report: Medical Assistance in Dying in Patients With Lung Cancer","year":2022,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Lung cancer; Cancer; Internal medicine; Referral; Population; Systemic therapy; Cancer registry; Oncology; Breast cancer; Family medicine","score_opus":0.07544225536086939,"score_gpt":0.5058288438690641,"score_spread":0.4303865885081947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205889660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850642,0.0021115397,0.000002044452,0.0089315465,0.00023006575,0.0010721337,0.000004366062,0.000022914026,0.002561185],"genre_scores_gemma":[0.9961101,0.00067300536,0.000048345843,0.00030880971,0.00016506793,0.00057692867,0.000015452495,0.000024805933,0.0020775183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9917285,0.00061715365,0.0012073616,0.0008713389,0.0048306296,0.00074503385],"domain_scores_gemma":[0.99754477,0.0007531829,0.00018001707,0.00052419526,0.0005035315,0.0004943142],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.014135068,0.00013874451,0.00060353096,0.00031034378,0.00026280808,0.00003211315,0.00012769362,0.00010818185,0.00048771768],"category_scores_gemma":[0.008581064,0.00009732312,0.000062012754,0.0010048117,0.0007189625,0.000086940745,0.0008050758,0.0026455503,6.572813e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011360482,0.0007053637,0.94668984,0.00017568299,0.000067157394,0.037749782,0.00015031513,0.0000056938134,0.0000016979851,0.000012274395,0.0066694967,0.006636642],"study_design_scores_gemma":[0.0029434592,0.0006008358,0.9726916,0.00045370712,0.000010849238,0.00024421373,0.00012228992,0.00019253851,0.0000025185816,0.000089444,0.022530315,0.00011823115],"about_ca_topic_score_codex":0.0024124838,"about_ca_topic_score_gemma":0.0019143721,"teacher_disagreement_score":0.037505567,"about_ca_system_score_codex":0.00062217587,"about_ca_system_score_gemma":0.0020957952,"threshold_uncertainty_score":0.9997701},"labels":[],"label_agreement":null},{"id":"W4210807771","doi":"10.1016/j.radonc.2022.01.032","title":"Once daily (OD) versus twice-daily (BID) chemoradiation for limited stage small cell lung cancer (LS-SCLC): A meta-analysis of randomized clinical trials","year":2022,"lang":"en","type":"review","venue":"Radiotherapy and Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Kingston General Hospital","funders":"","keywords":"Medicine; Meta-analysis; Prophylactic cranial irradiation; Randomized controlled trial; Radiation therapy; Internal medicine; Conventional PCI; Relative risk; Lung cancer; Oncology; Stage (stratigraphy); Clinical trial; Confidence interval","score_opus":0.4193608039850481,"score_gpt":0.5603529967973521,"score_spread":0.14099219281230396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210807771","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005159841,0.9871901,0.0008485894,0.0009470936,0.0007701327,0.008767613,0.0008996245,0.000044314853,0.0004809322],"genre_scores_gemma":[0.000008691711,0.9861227,0.0022865369,0.0005485915,0.0007725224,0.006861303,0.00044494547,0.00009899951,0.0028556942],"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","domain_scores_codex":[0.9851656,0.00910043,0.0035847463,0.0010446726,0.000541618,0.00056294474],"domain_scores_gemma":[0.9472731,0.04821298,0.0033032806,0.0006963271,0.00024941436,0.00026494774],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.022721367,0.0006633947,0.026021644,0.00093869603,0.00017090522,0.000030477791,0.0003583258,0.00067900534,0.0022552088],"category_scores_gemma":[0.005562654,0.00044703748,0.009584989,0.0011971464,0.00045401134,0.000055202243,0.00009963591,0.00091588666,7.344001e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1022212,0.0003713946,0.000014675304,0.010102993,0.50928307,0.000025639645,0.00055242196,0.000020395015,0.000007162421,0.00006140969,0.0033409304,0.37399873],"study_design_scores_gemma":[0.086992264,0.0010358996,0.0000019742795,0.000087078544,0.36626416,0.000001970532,0.000045237924,0.0006600187,0.0000017070644,0.0000011746228,0.5447099,0.0001985853],"about_ca_topic_score_codex":0.00044262828,"about_ca_topic_score_gemma":0.00040107727,"teacher_disagreement_score":0.541369,"about_ca_system_score_codex":0.0018907159,"about_ca_system_score_gemma":0.002685607,"threshold_uncertainty_score":0.9997981},"labels":[],"label_agreement":null},{"id":"W4213348369","doi":"10.1158/1078-0432.ccr-21-0344","title":"Targeting the Ubiquitin–Proteasome System Using the UBA1 Inhibitor TAK-243 is a Potential Therapeutic Strategy for Small-Cell Lung Cancer","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Princess Margaret Cancer Centre; University of Toronto","funders":"Canadian Institutes of Health Research; International Association for the Study of Lung Cancer; Weill Cornell Medical College; Canada Foundation for Innovation; National Center for Advancing Translational Sciences; Temerty Faculty of Medicine, University of Toronto; Ontario Institute for Cancer Research; Lung Cancer Research Foundation; National Cancer Institute; University of Toronto; Memorial Sloan-Kettering Cancer Center; American Society of Clinical Oncology; Cancer Research Society; National Institutes of Health; Conquer Cancer Foundation","keywords":"Lung cancer; Cancer; Gene; Therapeutic approach; Cell culture; Targeted therapy","score_opus":0.27928867953338987,"score_gpt":0.5313512002930797,"score_spread":0.2520625207596898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213348369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7968825,0.118904546,0.001076012,0.05781335,0.0031772787,0.01972089,0.0010814333,0.00024548275,0.0010984748],"genre_scores_gemma":[0.9783406,0.0018294841,0.00008934122,0.0017108549,0.0049313433,0.00949768,0.000017797038,0.00013671334,0.0034461373],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9912789,0.0023208947,0.0010787011,0.0010497025,0.0025551359,0.0017166899],"domain_scores_gemma":[0.994657,0.002407104,0.0002997274,0.00097301585,0.0013192026,0.00034396874],"candidate_categories":["sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.011659,0.0003465353,0.00074672815,0.00017383858,0.0034840342,0.00022633011,0.0011870237,0.00016143502,0.0009863853],"category_scores_gemma":[0.0006048675,0.00020411881,0.00051370834,0.0011368799,0.0010429241,0.00009253652,0.0014467853,0.0034157294,0.0000098632545],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039195303,0.004035157,0.11804515,0.02502589,0.011417294,0.0009747541,0.017065683,0.030123072,0.106699936,0.0033239971,0.5432755,0.10081828],"study_design_scores_gemma":[0.03544613,0.010058734,0.007993625,0.003183864,0.0035943883,0.00018669575,0.100309156,0.45803806,0.015866924,0.0010733731,0.3616059,0.002643156],"about_ca_topic_score_codex":0.0038366609,"about_ca_topic_score_gemma":0.00014666349,"teacher_disagreement_score":0.42791498,"about_ca_system_score_codex":0.0021692605,"about_ca_system_score_gemma":0.004055696,"threshold_uncertainty_score":0.99992687},"labels":[],"label_agreement":null},{"id":"W4214922303","doi":"10.1016/j.jncc.2022.02.003","title":"Radiotherapy for small cell lung cancer in current clinical practice guidelines","year":2022,"lang":"en","type":"review","venue":"Journal of the National Cancer Center","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Guideline; Medicine; Radiation therapy; Prophylactic cranial irradiation; Stage (stratigraphy); Conventional PCI; Lung cancer; Medical physics; Radiology; Oncology; Internal medicine; Pathology","score_opus":0.37240348404292484,"score_gpt":0.6262446593367588,"score_spread":0.25384117529383393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214922303","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000035195667,0.9758033,0.000035661018,0.016283574,0.0056089233,0.0015930746,0.0004271926,0.0000040340783,0.00024073469],"genre_scores_gemma":[9.805683e-7,0.9878866,0.001056534,0.0027071075,0.00670791,0.00053578,0.000010419826,0.000058158003,0.0010365079],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954071,0.0004427425,0.0019708425,0.00028715585,0.0015865144,0.00030566187],"domain_scores_gemma":[0.99395734,0.0012653389,0.0019931288,0.00016902007,0.002495967,0.00011920264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033790583,0.0002898026,0.0014681744,0.00031175764,0.000104658335,0.000029216446,0.00056695106,0.00011465918,0.00047697534],"category_scores_gemma":[0.0036640214,0.00016673765,0.0013692956,0.00039891643,0.00006441646,0.000116304385,0.00016992813,0.00167497,6.639818e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0005480485,0.00043761174,0.0011951618,0.008779381,0.0014026077,0.000010381592,0.00006825476,0.00007481424,2.5747323e-7,0.000012084909,0.3184973,0.6689741],"study_design_scores_gemma":[0.0028024695,0.00013087864,0.00011876796,0.0106439125,0.0011430446,0.00009796153,0.00001447212,0.000071115144,3.4951321e-7,0.00001519194,0.9848182,0.00014364299],"about_ca_topic_score_codex":0.00002983791,"about_ca_topic_score_gemma":0.000041071533,"teacher_disagreement_score":0.66883045,"about_ca_system_score_codex":0.004967472,"about_ca_system_score_gemma":0.0065915016,"threshold_uncertainty_score":0.9990402},"labels":[],"label_agreement":null},{"id":"W4220732082","doi":"10.1093/neuonc/noac072","title":"Effectiveness and safety of pneumocystis pneumonia prophylaxis for patients receiving temozolomide chemoradiotherapy","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Western University","funders":"Ontario Ministry of Health and Long-Term Care; Canadian Cancer Society; Canadian Centre for Applied Research in Cancer Control","keywords":"Medicine; Temozolomide; Chemoradiotherapy; Internal medicine; Population; Cohort; Retrospective cohort study; Neutropenia; Oncology; Surgery; Cancer; Radiation therapy; Chemotherapy","score_opus":0.014494316526808593,"score_gpt":0.32554737051981536,"score_spread":0.31105305399300676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220732082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946207,0.00043132174,0.000041749965,0.0012740633,0.00043198717,0.0025533072,0.00007486929,0.00004054292,0.00053145754],"genre_scores_gemma":[0.9979724,0.00033721887,0.0003685886,0.0002650807,0.000075729055,0.0008928405,0.00001292644,0.00004093001,0.000034249842],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982218,0.0004148491,0.000300068,0.00041716167,0.00031377177,0.00033235986],"domain_scores_gemma":[0.9976245,0.0017006835,0.0001596521,0.0002476503,0.00018283742,0.00008463779],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005778459,0.00015688677,0.00068291376,0.00014022522,0.00024564183,0.0000048681436,0.00013166277,0.00006588533,0.00003306655],"category_scores_gemma":[0.00094719103,0.0001419842,0.00008646418,0.00024565883,0.00019815395,0.00004188409,0.00022982279,0.00033989726,8.6660515e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0084299445,0.00057369313,0.13853185,0.0010385639,0.00018060708,0.000050555576,0.0007811197,0.00001947861,0.6968829,0.000049165767,0.0006629231,0.15279922],"study_design_scores_gemma":[0.02271647,0.056860138,0.6981022,0.000108882254,0.00015511492,0.00022561726,0.0002736261,0.0002080031,0.050520245,0.00024942518,0.17022125,0.00035904054],"about_ca_topic_score_codex":0.000039425595,"about_ca_topic_score_gemma":0.0000076286897,"teacher_disagreement_score":0.64636266,"about_ca_system_score_codex":0.0007554662,"about_ca_system_score_gemma":0.00029275598,"threshold_uncertainty_score":0.57899475},"labels":[],"label_agreement":null},{"id":"W4220777831","doi":"10.21203/rs.3.rs-1375680/v1","title":"Similar Programmed Death Ligand 1 (PD-L1) expression profile in patients with mild COPD and lung cancer","year":2022,"lang":"en","type":"preprint","venue":"Research Square","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"COPD; Lung cancer; Medicine; Bronchoalveolar lavage; Lung; Pathology; Parenchyma; Immunohistochemistry; Biomarker; Internal medicine; Immunology; Biology","score_opus":0.05457109385535603,"score_gpt":0.4371590814133415,"score_spread":0.38258798755798545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220777831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96811014,0.015862977,0.000003265164,0.0020334402,0.0001229949,0.01192035,0.00049249455,0.00010261136,0.0013517486],"genre_scores_gemma":[0.9793324,0.004018163,0.0005440677,0.00006792754,0.00023996488,0.012785031,0.0006872822,0.00014580715,0.0021793982],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99259734,0.00058458,0.0004221536,0.0013137003,0.0036829568,0.0013992436],"domain_scores_gemma":[0.99704415,0.00031898014,0.0001259475,0.00095271744,0.0010520269,0.0005061797],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.001471205,0.00045774097,0.00085589936,0.0008150619,0.00045331818,0.00013963728,0.00040267038,0.00027290147,0.0005462617],"category_scores_gemma":[0.0006204076,0.00033798473,0.00009553202,0.00080383953,0.00037235417,0.00011260171,0.003489795,0.0037555106,0.0000041516764],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003880163,0.0006910882,0.96690214,0.009447547,0.0002687178,0.00018226594,0.0017324997,0.000041834548,0.00008838474,0.000008855355,0.014093594,0.0026629413],"study_design_scores_gemma":[0.007847185,0.0020846426,0.96695787,0.010597508,0.00009371279,0.0000018449508,0.0010324372,0.00043705554,0.0013438334,0.00006214422,0.0090087075,0.0005330826],"about_ca_topic_score_codex":0.0019067232,"about_ca_topic_score_gemma":0.00037428126,"teacher_disagreement_score":0.011844814,"about_ca_system_score_codex":0.0020585614,"about_ca_system_score_gemma":0.0017632722,"threshold_uncertainty_score":0.9999072},"labels":[],"label_agreement":null},{"id":"W4220915836","doi":"10.1016/j.ijrobp.2022.03.020","title":"Graded Prognostic Assessment (GPA) for Patients With Lung Cancer and Brain Metastases: Initial Report of the Small Cell Lung Cancer GPA and Update of the Non-Small Cell Lung Cancer GPA Including the Effect of Programmed Death Ligand 1 and Other Prognostic Factors","year":2022,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute; National Institutes of Health; National Center for Advancing Translational Sciences; University of Minnesota","keywords":"Medicine; Lung cancer; Internal medicine; Adenocarcinoma; Oncology; Anaplastic lymphoma kinase; Brain metastasis; Lung; Epidermal growth factor receptor; Cancer; Population; Metastasis","score_opus":0.02320506572987794,"score_gpt":0.37326191633565264,"score_spread":0.3500568506057747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220915836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910586,0.0022519252,0.00033501853,0.0019503119,0.0006242787,0.0030120187,0.00074308587,0.0000059447184,0.000018814346],"genre_scores_gemma":[0.9981769,0.0003804573,0.00027950061,0.00022658838,0.00024086447,0.00060753484,0.000037003756,0.000033281187,0.000017900793],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99775857,0.0004560641,0.0007080615,0.000283319,0.00052441383,0.00026957577],"domain_scores_gemma":[0.9955432,0.001562843,0.0019591744,0.00016480946,0.00069051684,0.000079490484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010368171,0.0002502109,0.0006346543,0.00010988935,0.00024143759,0.000021766507,0.00032553417,0.000076677716,0.000009349596],"category_scores_gemma":[0.0004161192,0.00013097776,0.00014889787,0.00022079634,0.00041606993,0.00009306971,0.00033351686,0.00049811334,6.453966e-9],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007019104,0.0002566753,0.99059933,0.0004329145,0.0015971925,0.000006458278,0.0014303913,0.0005440446,0.0014581617,0.00005722087,0.00025096565,0.002664754],"study_design_scores_gemma":[0.016007544,0.0037847692,0.951289,0.0007149526,0.0030720027,0.000054919496,0.000391222,0.0048263487,0.017992442,0.00015615643,0.0014399283,0.00027068894],"about_ca_topic_score_codex":0.00047343055,"about_ca_topic_score_gemma":0.00014719447,"teacher_disagreement_score":0.039310288,"about_ca_system_score_codex":0.00065652543,"about_ca_system_score_gemma":0.0011697983,"threshold_uncertainty_score":0.5341118},"labels":[],"label_agreement":null},{"id":"W4221131077","doi":"10.1016/j.lungcan.2022.03.003","title":"Randomized phase 3 study of the anti-disialoganglioside antibody dinutuximab and irinotecan vs irinotecan or topotecan for second-line treatment of small cell lung cancer","year":2022,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"United Therapeutics Corporation","keywords":"Irinotecan; Topotecan; Medicine; Tolerability; Internal medicine; Clinical endpoint; Oncology; Lung cancer; Randomized controlled trial; Chemotherapy; Cancer; Adverse effect; Colorectal cancer","score_opus":0.032677582691871036,"score_gpt":0.39410300744961657,"score_spread":0.36142542475774553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221131077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9732829,0.013736107,0.000065526416,0.0014295587,0.0006059198,0.009573987,0.0010587018,0.00004444187,0.00020290239],"genre_scores_gemma":[0.98998547,0.0017309657,0.000073929354,0.0001737691,0.0002994715,0.004509821,0.000026235786,0.000076164004,0.0031241863],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9969347,0.0003406995,0.0008042318,0.00066404865,0.0006637274,0.00059260015],"domain_scores_gemma":[0.99780464,0.0004929677,0.00051862485,0.00071997184,0.00029797017,0.00016583786],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005338402,0.00042052873,0.0018311926,0.00024312832,0.0004122495,0.00001889783,0.00031793147,0.000067065805,0.0006472266],"category_scores_gemma":[0.00012012393,0.000263915,0.00036352183,0.00059360114,0.00034113112,0.000058571262,0.0003550519,0.0002784633,1.0224571e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6317653,0.026007425,0.16271584,0.0105741555,0.013138425,0.00027835826,0.050806496,0.0032204045,0.077971295,0.00011121961,0.0066639087,0.016747156],"study_design_scores_gemma":[0.86732405,0.015410961,0.008309178,0.00049748854,0.0060693626,0.000027334598,0.0042364546,0.0087162675,0.083262205,0.000026862139,0.005433198,0.0006866227],"about_ca_topic_score_codex":0.008114841,"about_ca_topic_score_gemma":0.005460285,"teacher_disagreement_score":0.23555875,"about_ca_system_score_codex":0.0011352669,"about_ca_system_score_gemma":0.001034108,"threshold_uncertainty_score":0.9999813},"labels":[],"label_agreement":null},{"id":"W4224983146","doi":"10.1016/s1470-2045(22)00155-3","title":"Sodium thiosulfate for prevention of cisplatin-induced hearing loss: updated survival from ACCL0431","year":2022,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute","keywords":"Cohort; Chemotherapy; Quality of life (healthcare); Hearing loss; Childhood cancer; Cisplatin; Cancer; Scopus","score_opus":0.16263474852385781,"score_gpt":0.4396365639109289,"score_spread":0.27700181538707114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224983146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9772165,0.00022956514,0.00011087716,0.016277958,0.0006083562,0.0010115912,0.000111291585,0.00005704243,0.0043768073],"genre_scores_gemma":[0.9969471,0.00006542018,0.00052686874,0.00048481385,0.00063599594,0.00032271392,0.00012370409,0.000019888972,0.00087350834],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99849486,0.00036314482,0.00026659618,0.00022051435,0.0003062848,0.00034860606],"domain_scores_gemma":[0.99880636,0.0005022777,0.00016880542,0.0003698404,0.00011121255,0.00004149532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012059705,0.000101127946,0.0005877632,0.000053029456,0.00021947383,0.0000054605516,0.00026051342,0.000050895076,0.0003326941],"category_scores_gemma":[0.0002194241,0.000073436684,0.000094264884,0.00017732593,0.0000905358,0.000032506083,0.00038367588,0.00038259933,0.000007775643],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.047985803,0.0020063359,0.099978425,0.0009240642,0.0050480627,0.00021449852,0.014111976,0.00033023526,0.6393807,0.008416123,0.1272898,0.05431396],"study_design_scores_gemma":[0.055547867,0.01629354,0.39123416,0.00021793303,0.0013481148,0.00012314897,0.0064459303,0.0025719998,0.07837031,0.022412524,0.4247024,0.0007320476],"about_ca_topic_score_codex":0.0004048721,"about_ca_topic_score_gemma":0.00022022825,"teacher_disagreement_score":0.5610104,"about_ca_system_score_codex":0.0003334223,"about_ca_system_score_gemma":0.00026322991,"threshold_uncertainty_score":0.3642767},"labels":[],"label_agreement":null},{"id":"W4232987386","doi":"10.1200/jco.2004.22.14_suppl.4545","title":"Genitourinary (GU) small cell carcinoma (SCC): A retrospective review of treatment and survival patterns at the Ottawa Regional Cancer Center (ORCC)","year":2004,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"","keywords":"Medicine; Cancer; Genitourinary system; Center (category theory); Retrospective cohort study; Oncology; Carcinoma; Internal medicine; Gynecology; General surgery","score_opus":0.24924841216649174,"score_gpt":0.5285793021020718,"score_spread":0.2793308899355801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232987386","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021559969,0.98538125,0.00000177571,0.008340102,0.001131727,0.0014093956,0.00015192608,0.0000045712222,0.0014232796],"genre_scores_gemma":[0.00048870634,0.9940396,0.00009668668,0.000778904,0.0026913162,0.000093902985,0.00001834115,0.000052641033,0.0017399113],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9928159,0.0017208754,0.0038693948,0.0004825005,0.00066550024,0.0004458281],"domain_scores_gemma":[0.9903958,0.0031635542,0.0046141692,0.00049805787,0.0008718459,0.00045658447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033669632,0.0004959845,0.0075562177,0.00014783186,0.000090153866,0.000006667348,0.00036499582,0.0005102237,0.00032055314],"category_scores_gemma":[0.0011647742,0.00024045487,0.0024084495,0.00019358334,0.00065084593,0.000040181272,0.0003407698,0.0018236439,0.000008968806],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0017479573,0.0028843915,0.09916898,0.16272883,0.005822257,0.0027253067,0.00018059216,4.688108e-7,5.920725e-7,0.000020489013,0.027850585,0.69686955],"study_design_scores_gemma":[0.004775036,0.01484529,0.019530362,0.067435175,0.005453264,0.0010898215,0.000025907468,1.4252043e-7,8.131172e-7,0.000011567943,0.8866651,0.00016749317],"about_ca_topic_score_codex":0.00050514215,"about_ca_topic_score_gemma":0.0007098594,"teacher_disagreement_score":0.85881454,"about_ca_system_score_codex":0.004663402,"about_ca_system_score_gemma":0.008809813,"threshold_uncertainty_score":0.99915755},"labels":[],"label_agreement":null},{"id":"W4237148214","doi":"10.21037/tcr.2017.04.14","title":"Targeting angiogenesis in small cell lung cancer","year":2017,"lang":"en","type":"article","venue":"Translational Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Research Society","funders":"","keywords":"Angiogenesis; Lung cancer; Medicine; Cancer research; Cancer; Oncology; Internal medicine","score_opus":0.1453075354616456,"score_gpt":0.48705733587026795,"score_spread":0.34174980040862235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237148214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9108648,0.045431376,0.00008190048,0.02769486,0.00021565607,0.001675063,0.00014957521,0.00004718333,0.013839616],"genre_scores_gemma":[0.98933583,0.005312644,0.00040964177,0.00008686514,0.0006545605,0.0009706799,0.000019677682,0.000045700937,0.0031644148],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99702466,0.00013617799,0.0002938379,0.0005043587,0.001187643,0.00085333764],"domain_scores_gemma":[0.99841785,0.00023643977,0.00006276394,0.00045766734,0.00061262614,0.00021261885],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014210282,0.0001698727,0.0003185056,0.00038144368,0.00077413674,0.00010460259,0.00042601582,0.000098517754,0.0011986494],"category_scores_gemma":[0.00018418061,0.00015307248,0.00011057947,0.00034427384,0.00035008957,0.00019337561,0.00012231799,0.0006445845,0.000024227205],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075475685,0.0001279049,0.9626219,0.00081912446,0.00013751049,0.0000919981,0.0011846586,0.0006608946,0.020515291,0.00020154554,0.0057347617,0.0071496507],"study_design_scores_gemma":[0.0043835584,0.00010543166,0.9683197,0.0006735725,0.000063155276,0.0000026241005,0.00017663941,0.004325719,0.010690438,0.00040337665,0.01054214,0.0003136349],"about_ca_topic_score_codex":0.015478293,"about_ca_topic_score_gemma":0.0063399593,"teacher_disagreement_score":0.07847105,"about_ca_system_score_codex":0.0005571817,"about_ca_system_score_gemma":0.0014399135,"threshold_uncertainty_score":0.9997144},"labels":[],"label_agreement":null},{"id":"W4239651622","doi":"10.1136/ijgc-00009577-200505001-00007","title":"Combination therapy with gemcitabine and carboplatin in recurrent ovarian cancer","year":2005,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Carboplatin; Medicine; Gemcitabine; Ovarian cancer; Internal medicine; Oncology; Hazard ratio; Regimen; Chemotherapy; Cancer; Surgery; Confidence interval; Cisplatin","score_opus":0.03470059525404154,"score_gpt":0.38610234289378614,"score_spread":0.35140174763974463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239651622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95325667,0.0059448536,0.000029875631,0.039508935,0.0003277768,0.00021459462,0.000008912321,0.000007234981,0.0007011356],"genre_scores_gemma":[0.98728716,0.0105223665,0.00047169102,0.0009799363,0.00048114377,0.00005233452,0.0000018302584,0.00000840073,0.00019515521],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871045,0.00004537679,0.00032462904,0.00013972221,0.0006156418,0.00016418166],"domain_scores_gemma":[0.99885994,0.00015368697,0.00019223038,0.000050058155,0.00064765423,0.000096415955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028651624,0.00010835982,0.00026904678,0.00018342517,0.00002575226,0.000024969335,0.0001267105,0.000051764415,0.0007335642],"category_scores_gemma":[0.00018207834,0.00006597956,0.000044222863,0.00012522597,0.00010060624,0.00015395609,0.00004170982,0.00034050352,0.0000012328469],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004736369,0.00074356905,0.54945964,0.00002138278,0.0005964424,0.00029602,0.00064911763,0.00040397,0.0016819198,0.0006165488,0.0014578267,0.4393372],"study_design_scores_gemma":[0.008204634,0.0013992941,0.9706469,0.00024471225,0.00002600793,0.00008784031,0.00006375743,0.00040081821,0.0007176824,0.00020024346,0.017909024,0.000099067365],"about_ca_topic_score_codex":0.00016571658,"about_ca_topic_score_gemma":0.0010555786,"teacher_disagreement_score":0.4392381,"about_ca_system_score_codex":0.0008523168,"about_ca_system_score_gemma":0.00025304765,"threshold_uncertainty_score":0.8032014},"labels":[],"label_agreement":null},{"id":"W4240718667","doi":"10.1158/1538-7445.sabcs18-2699","title":"Abstract 2699: Targeting an ubiquitin-activating enzyme in small-cell lung cancer (SCLC)","year":2019,"lang":"en","type":"article","venue":"Experimental and Molecular Therapeutics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Etoposide; Cancer research; Lung cancer; Cisplatin; Cancer; Cell culture; Medicine; Viability assay; Chemotherapy; Cancer cell; Cell; Biology; Oncology; Internal medicine; Genetics","score_opus":0.02517772543423411,"score_gpt":0.3542647523675444,"score_spread":0.32908702693331027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240718667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.967117,0.028917512,0.000030219586,0.00027639815,0.00009794619,0.0005871929,0.0000038465387,0.00003705255,0.0029328244],"genre_scores_gemma":[0.9975818,0.0003264829,0.00049686927,0.0012222225,0.00007733932,0.00007382389,0.00001287007,0.000044694458,0.00016391677],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99880135,0.000042274467,0.00020818779,0.00034063647,0.00022303773,0.00038453267],"domain_scores_gemma":[0.99957615,0.000027208771,0.000060493567,0.00018410405,0.000038554117,0.00011347504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014287699,0.00019750347,0.00025212296,0.00007113424,0.000069701135,0.000035677585,0.00008289995,0.000068382324,0.00013683237],"category_scores_gemma":[0.0000048218367,0.00017299425,0.000050941464,0.00010483736,0.00005761203,0.000088324894,0.00010120208,0.00026171075,0.0000048410225],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014043493,0.00021046861,0.014621325,0.00012834763,0.00008681076,0.00006986049,0.0030896766,0.000016057313,0.9796922,0.000048476104,0.00001610534,0.0018801874],"study_design_scores_gemma":[0.0019467447,0.0002939091,0.0049156887,0.0001765187,0.000020328736,0.0000073510123,0.0037188446,0.00094700174,0.9864254,0.0000100757225,0.0013175791,0.00022058336],"about_ca_topic_score_codex":0.00034104675,"about_ca_topic_score_gemma":0.000010835233,"teacher_disagreement_score":0.030464774,"about_ca_system_score_codex":0.00018260794,"about_ca_system_score_gemma":0.00007944416,"threshold_uncertainty_score":0.70545006},"labels":[],"label_agreement":null},{"id":"W4241797950","doi":"10.1007/978-3-540-47648-1_2076","title":"Extrapulmonary Small Cell Cancer","year":2008,"lang":"en","type":"book-chapter","venue":"","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Cancer; Medicine; Cancer research; Internal medicine","score_opus":0.06504446233578648,"score_gpt":0.32109718882963434,"score_spread":0.25605272649384786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241797950","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000067175286,0.04503102,0.000007949083,0.0013327168,0.00021233103,0.00065340725,0.000044540444,0.00013436662,0.9525165],"genre_scores_gemma":[0.00063849275,0.0818875,0.00028721822,0.0008636889,0.00082841946,0.000068476285,0.000032333977,0.00010128006,0.91529256],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99836767,0.000005543272,0.00025299715,0.00046895494,0.0005368452,0.0003680126],"domain_scores_gemma":[0.9989709,0.00005477315,0.00007646287,0.0004686473,0.00020094174,0.00022826073],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00005327277,0.00036098843,0.00059696386,0.00016801557,0.000086238135,0.0000069784187,0.00013922437,0.00026275282,0.0077763447],"category_scores_gemma":[0.0000093032995,0.00027590888,0.0002444479,0.000025027186,0.0002174595,0.000021855449,0.00015983806,0.000655236,0.00061081373],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026304054,0.00007376891,0.0006751096,0.0011738839,0.00063632976,0.0025746552,0.00022465552,9.800644e-7,0.00022919288,0.0014513537,0.9695202,0.023176821],"study_design_scores_gemma":[0.0006098501,0.0001923089,0.00039951983,0.00042344636,0.00016663638,0.00008168186,0.000010263222,0.0000043423784,0.000279414,0.00019569551,0.99734104,0.0002957983],"about_ca_topic_score_codex":0.00034612897,"about_ca_topic_score_gemma":0.00017144105,"teacher_disagreement_score":0.037223905,"about_ca_system_score_codex":0.00037320366,"about_ca_system_score_gemma":0.0005942363,"threshold_uncertainty_score":0.9999693},"labels":[],"label_agreement":null},{"id":"W4242351383","doi":"10.4081/mrm.2013.577","title":"CD24+/CD38- as new prognostic marker for non-small cell lung cancer","year":2013,"lang":"en","type":"article","venue":"Multidisciplinary Respiratory Medicine","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute","keywords":"CD24; Medicine; Lung cancer; Biomarker; Oncology; CD38; Cancer research; Cancer; Internal medicine; Pathology; Breast cancer; Biology; Stem cell; CD34","score_opus":0.04814623829855125,"score_gpt":0.3798468214217289,"score_spread":0.33170058312317763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242351383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9263595,0.019559588,0.00070350955,0.027348943,0.0011939026,0.011007341,0.000032530133,0.00028989275,0.013504807],"genre_scores_gemma":[0.8726709,0.0012493687,0.0054072575,0.008088994,0.010761995,0.011233245,0.00012434919,0.00049921166,0.089964695],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99616843,0.000095689466,0.0007829957,0.0009543163,0.0008628387,0.0011357106],"domain_scores_gemma":[0.9962304,0.0006497025,0.00023294793,0.00085063337,0.00068211596,0.0013541545],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00067887455,0.0005793293,0.0009952141,0.00036101823,0.0004001224,0.00003078958,0.000378355,0.00021801949,0.0021958493],"category_scores_gemma":[0.0012466654,0.00041210832,0.00021759652,0.00052552513,0.00044352483,0.00021445754,0.00038492607,0.00057190895,0.00026080094],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010570677,0.00034612973,0.45664027,0.0028759178,0.00040018052,0.00016466311,0.0029186003,0.000018197234,0.04234712,0.000017788876,0.4848336,0.008380452],"study_design_scores_gemma":[0.030848693,0.0086538335,0.82173693,0.00498384,0.001572893,0.000055720626,0.0030633525,0.006854506,0.006397841,0.00038814667,0.11409187,0.0013523436],"about_ca_topic_score_codex":0.0009938106,"about_ca_topic_score_gemma":0.00010626962,"teacher_disagreement_score":0.37074172,"about_ca_system_score_codex":0.0004898741,"about_ca_system_score_gemma":0.0015864109,"threshold_uncertainty_score":0.99983305},"labels":[],"label_agreement":null},{"id":"W4242644534","doi":"10.1007/bf02665359","title":"Pharmacokinetics of etoposide in cancer patients treated with high-dose etoposide and with dexrazoxane (ICRF-187) as a rescue agent","year":2004,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Etoposide; Pharmacokinetics; Dexrazoxane; Pharmacology; Medicine; Toxicity; Chemotherapy; Cancer; Internal medicine; Breast cancer","score_opus":0.018015198205579865,"score_gpt":0.35429900040109963,"score_spread":0.3362838021955198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242644534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871398,0.006988019,0.000004350547,0.004334137,0.00009186822,0.0011929892,0.00004790372,0.00002868639,0.00017223536],"genre_scores_gemma":[0.9608284,0.03497353,0.00015095455,0.0032018982,0.00013195223,0.0003974891,0.000011174994,0.00004782579,0.00025676648],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984842,0.00005786155,0.0002798243,0.0004582216,0.0002739062,0.00044599595],"domain_scores_gemma":[0.9992819,0.000057286306,0.00011256805,0.00013024223,0.00020008693,0.00021794882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000956723,0.00029707773,0.00058018434,0.00016968943,0.00006955545,0.000009082842,0.00008649522,0.00009214877,0.00029808446],"category_scores_gemma":[0.000005768838,0.0002100233,0.000028583465,0.00037121194,0.0005093074,0.00007486994,0.000043474167,0.00031978008,7.881355e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030287065,0.0012641241,0.6024142,0.0011650202,0.0020109979,0.00033246411,0.0043954994,0.0006977391,0.33970806,0.000043433913,0.0012859771,0.016395407],"study_design_scores_gemma":[0.054191727,0.003939911,0.22489665,0.00056192616,0.0004963488,0.000041943124,0.000100698635,0.000041411822,0.71210605,0.000050735216,0.0032248457,0.00034777255],"about_ca_topic_score_codex":0.0065851547,"about_ca_topic_score_gemma":0.0013721179,"teacher_disagreement_score":0.37751755,"about_ca_system_score_codex":0.00039799872,"about_ca_system_score_gemma":0.00040367644,"threshold_uncertainty_score":0.9954828},"labels":[],"label_agreement":null},{"id":"W4242720353","doi":"10.1200/jco.2006.10.4729","title":"In Reply","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine","score_opus":0.2537950998688346,"score_gpt":0.6361347659901684,"score_spread":0.3823396661213338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242720353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8822616,0.0010461524,0.00012746472,0.06980266,0.0015852462,0.0001293037,2.441643e-7,0.000004626159,0.045042753],"genre_scores_gemma":[0.97799486,0.0009849065,0.0032815875,0.01392324,0.0024702528,6.802151e-7,9.530037e-8,0.000007311792,0.0013370567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99735874,0.00014442595,0.0018411073,0.000090302325,0.0003449738,0.00022042972],"domain_scores_gemma":[0.9956818,0.002975733,0.0006135285,0.000116113966,0.00033966565,0.0002731444],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.011753106,0.000050963197,0.00088724366,0.00015961999,0.000011467769,0.0000017639977,0.00009388294,0.00013626128,0.00012448314],"category_scores_gemma":[0.014916431,0.000033086882,0.00022187558,0.00015808166,0.00017371323,0.00006773332,0.00004566909,0.001097404,0.000024885647],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011760565,0.0017408945,0.6055884,0.000042560878,0.00031278186,0.013357511,0.0002237722,0.0000018081275,0.0002816692,0.00029610185,0.12740035,0.23899357],"study_design_scores_gemma":[0.0045142886,0.006389709,0.5270732,0.000047084948,0.000033101456,0.00031577333,0.00009548202,0.0000025377074,0.0000786021,0.0004385999,0.46098706,0.000024537627],"about_ca_topic_score_codex":0.000027290082,"about_ca_topic_score_gemma":0.00010638188,"teacher_disagreement_score":0.3335867,"about_ca_system_score_codex":0.00025606868,"about_ca_system_score_gemma":0.0011977345,"threshold_uncertainty_score":0.9933813},"labels":[],"label_agreement":null},{"id":"W4243006526","doi":"10.21037/tcr.2016.11.51","title":"Combination chemotherapy for relapsed small-cell lung cancer—perspective on mechanisms of chemoresistance","year":2016,"lang":"en","type":"article","venue":"Translational Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Research Society","funders":"","keywords":"Etoposide; Medicine; Topotecan; Chemotherapy; Oncology; Cisplatin; Irinotecan; Regimen; Internal medicine; Combination chemotherapy; Lung cancer; Vinca; Cancer; Cancer research; Pharmacology; Colorectal cancer","score_opus":0.07202568808614888,"score_gpt":0.44274057648487847,"score_spread":0.37071488839872957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243006526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45953104,0.023048617,0.06137338,0.39351594,0.00075780565,0.018272154,0.00276257,0.0002966148,0.040441882],"genre_scores_gemma":[0.98981786,0.002079273,0.001120994,0.00020135022,0.00021124464,0.0018120555,0.000013682114,0.00005922146,0.0046842964],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99705213,0.00010460375,0.00030647655,0.0005162229,0.0014777976,0.00054273976],"domain_scores_gemma":[0.9964365,0.0008819572,0.00008798605,0.00029313093,0.002158502,0.00014197429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096945965,0.00018429123,0.00036677724,0.00033432955,0.00020491677,0.000013028356,0.00021747187,0.00010577794,0.00071309245],"category_scores_gemma":[0.00015951542,0.0001322061,0.00015230477,0.00054365967,0.00030487493,0.000094132396,0.000019713449,0.00027566965,0.0000054110415],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025242252,0.001141134,0.006235951,0.0023053351,0.0009660229,0.000008923597,0.0029452264,0.00008157687,0.6883123,0.23324023,0.012399013,0.027122045],"study_design_scores_gemma":[0.026539115,0.0018810122,0.043656502,0.0017002326,0.00011165135,0.0000014052104,0.00038801297,0.0006984002,0.86587507,0.056767393,0.0020071333,0.00037407942],"about_ca_topic_score_codex":0.0005558595,"about_ca_topic_score_gemma":0.00036989507,"teacher_disagreement_score":0.53028685,"about_ca_system_score_codex":0.0013869248,"about_ca_system_score_gemma":0.0013194636,"threshold_uncertainty_score":0.7807862},"labels":[],"label_agreement":null},{"id":"W4243150102","doi":"10.1158/1538-7445.am2019-lb-148","title":"Abstract LB-148: Combination treatment of the CHK1 inhibitor, SRA737, and low dose gemcitabine demonstrates profound synergy with anti-PDL1 inducing durable tumor regressions and modulating the immune microenvironment in small cell lung cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"Gemcitabine; Cancer research; Immune system; Immune checkpoint; Cytotoxic T cell; Tumor microenvironment; Regimen; Lung cancer; Medicine; Blockade; Immunotherapy; Cancer; Pharmacology; Immunology; Biology; Oncology; Internal medicine; Receptor","score_opus":0.02671144682847327,"score_gpt":0.3339614798496113,"score_spread":0.307250033021138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243150102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97076964,0.023277914,4.5000112e-7,0.002891288,0.00007156986,0.0026596377,0.00002092834,0.000009950621,0.00029863865],"genre_scores_gemma":[0.9920857,0.0061882753,0.000031267988,0.000020512884,0.00006490034,0.0006918663,0.0000049306173,0.000038114507,0.00087444286],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977172,0.00018771514,0.00035332868,0.00049274287,0.00062524516,0.0006237531],"domain_scores_gemma":[0.9987246,0.00033981656,0.00016082454,0.00048116155,0.00018045744,0.00011314653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069612876,0.00023439691,0.00043133943,0.0001770954,0.00038916548,0.00006157081,0.00016364225,0.00006417913,0.00007441529],"category_scores_gemma":[0.00006566351,0.000121587305,0.00004400311,0.0004982146,0.00060043205,0.00012967567,0.00024329504,0.00055042346,0.0000011772906],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035290245,0.0003124275,0.5359415,0.0010976788,0.00013452931,0.00002448592,0.0019355601,0.00050181017,0.45699066,0.000022515454,0.0000547307,0.0026312314],"study_design_scores_gemma":[0.0044278633,0.00049615046,0.79016525,0.0031635254,0.00005125578,0.000012036231,0.0019518764,0.0012522482,0.19824506,0.000021375683,0.00006725749,0.00014610618],"about_ca_topic_score_codex":0.008752522,"about_ca_topic_score_gemma":0.0017185824,"teacher_disagreement_score":0.2587456,"about_ca_system_score_codex":0.001031366,"about_ca_system_score_gemma":0.0005831208,"threshold_uncertainty_score":0.9978483},"labels":[],"label_agreement":null},{"id":"W4245722524","doi":"10.1007/978-1-4419-0461-4_34","title":"CD45 (PTPRC)","year":2012,"lang":"en","type":"book-chapter","venue":"","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Computer science","score_opus":0.061976767561712345,"score_gpt":0.35397590537197987,"score_spread":0.29199913781026754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245722524","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000070048,0.011505631,0.000015203809,0.0017314402,0.00018283402,0.0004120747,0.000013379932,0.00011129267,0.98602116],"genre_scores_gemma":[0.0018815609,0.003330614,0.00018482325,0.0006852922,0.0012105288,0.000016001411,0.000028353854,0.00006215551,0.9926007],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99883217,0.0000031686345,0.00015662769,0.00021595942,0.00049090316,0.00030117683],"domain_scores_gemma":[0.9991806,0.000044047516,0.00004204688,0.00040177256,0.00012511393,0.00020642555],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000107730644,0.00021423721,0.00041578477,0.00010954143,0.00003923998,0.000007274374,0.00007733446,0.00013663695,0.015142053],"category_scores_gemma":[0.00003389492,0.00014989564,0.00014661951,0.000009405571,0.00012342609,0.000029271392,0.00015278795,0.00041811177,0.00373263],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011420491,0.00003195729,0.00026649932,0.0005812915,0.0009978581,0.0001684136,0.00008959722,1.9505757e-8,0.00007509992,0.17113946,0.7748709,0.051664747],"study_design_scores_gemma":[0.00036693586,0.00011577593,0.0001447605,0.00020696774,0.00017390633,0.000037674858,0.000004662948,6.098235e-7,0.00009126158,0.0021319033,0.9965724,0.00015315632],"about_ca_topic_score_codex":0.000025939093,"about_ca_topic_score_gemma":0.000013595167,"teacher_disagreement_score":0.22170153,"about_ca_system_score_codex":0.0002142892,"about_ca_system_score_gemma":0.00013200994,"threshold_uncertainty_score":0.9970431},"labels":[],"label_agreement":null},{"id":"W4247533665","doi":"10.1002/cncy.21674","title":"Issue Information","year":2016,"lang":"en","type":"paratext","venue":"Cancer Cytopathology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Citation; Medicine; Information retrieval; Library science; World Wide Web; Internet privacy; Computer science","score_opus":0.020997665551220325,"score_gpt":0.3825721909814346,"score_spread":0.36157452543021423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247533665","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009629519,0.03624412,0.0007136713,0.02336838,0.01821501,0.0017305803,0.0015023754,0.00014604737,0.9171169],"genre_scores_gemma":[0.0033671353,0.044071395,0.00016275626,0.006545862,0.007124972,0.001443706,0.00050638424,0.000080043224,0.9366977],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982466,0.00007506402,0.00039433688,0.0003459049,0.00035667772,0.00058142265],"domain_scores_gemma":[0.99859124,0.00006143532,0.0002177098,0.0005404655,0.0004204784,0.00016865868],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00017229943,0.0003273065,0.00081982237,0.00032684964,0.000088812594,0.000020355252,0.00020195633,0.0004564728,0.020501956],"category_scores_gemma":[0.00016380807,0.00022364876,0.00014088549,0.00016735696,0.0003258584,0.00018092596,0.00020338425,0.0005467478,0.060619578],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020410345,0.000012669561,0.00034952402,0.0008684686,0.00010449657,0.00004909739,0.00027064432,9.589012e-7,0.00041310777,0.000031426905,0.9573939,0.040301606],"study_design_scores_gemma":[0.0012448641,0.0002634272,0.0010399946,0.0005635955,0.00010283196,0.000102745675,0.000035961475,0.0000011123175,0.00097454706,0.000026137117,0.9954146,0.00023019523],"about_ca_topic_score_codex":0.000082841936,"about_ca_topic_score_gemma":0.000012788599,"teacher_disagreement_score":0.04011762,"about_ca_system_score_codex":0.00083114626,"about_ca_system_score_gemma":0.0010319185,"threshold_uncertainty_score":0.9803934},"labels":[],"label_agreement":null},{"id":"W4252421162","doi":"10.1016/j.jtho.2016.11.254","title":"OA05.06 Compliance and Outcome of Elderly Patients Treated in the Concurrent Once-Daily versus Twice-Daily RadioTherapy (CONVERT) Trial","year":2017,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Medicine; Radiation therapy; Neutropenia; Etoposide; Randomized controlled trial; Chemotherapy; Surgery; Internal medicine","score_opus":0.15799874968648267,"score_gpt":0.52929168415816,"score_spread":0.3712929344716773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252421162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98802626,0.0020617528,0.0000163149,0.0068153464,0.0012714325,0.0007463909,0.000012348956,0.000005005314,0.0010451737],"genre_scores_gemma":[0.99785954,0.0010814404,0.00020367063,0.0002348097,0.00042248997,0.000016051265,0.0000023035514,0.000014785431,0.00016491137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976513,0.00042592222,0.0008457926,0.00018785379,0.0005738285,0.0003153379],"domain_scores_gemma":[0.99714094,0.00071221386,0.0011994668,0.00038808983,0.0004259223,0.00013334783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012967924,0.00018372493,0.0010311683,0.00017479414,0.00015520248,0.000036717574,0.0004824659,0.00013344252,0.00003688815],"category_scores_gemma":[0.0010146429,0.00011178724,0.00017068256,0.00010209638,0.0005646216,0.00018115644,0.00007745852,0.00064668374,0.0000037651828],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17138484,0.0014155104,0.5660008,0.00028498875,0.0007402397,0.0003498595,0.0024800973,0.0000018011611,0.0003941152,0.00003210736,0.005953099,0.25096253],"study_design_scores_gemma":[0.14393046,0.039916344,0.7787064,0.00045952364,0.00043604124,0.00010668625,0.0006912853,0.00007865602,0.00021556269,0.00004742927,0.03521686,0.00019477405],"about_ca_topic_score_codex":0.00018915224,"about_ca_topic_score_gemma":0.0002035808,"teacher_disagreement_score":0.25076774,"about_ca_system_score_codex":0.00053228205,"about_ca_system_score_gemma":0.00028190773,"threshold_uncertainty_score":0.45585513},"labels":[],"label_agreement":null},{"id":"W4254008234","doi":"10.3410/f.2998962.2676060","title":"Faculty Opinions recommendation of Signaling via Alk5 controls the ontogeny of lung Clara cells.","year":2010,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Ontogeny; Lung; Biology; Cell biology; Internal medicine; Medicine; Endocrinology","score_opus":0.03222470841982423,"score_gpt":0.3895250820406881,"score_spread":0.35730037362086386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254008234","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000015547885,0.004208343,0.00005162818,0.21550576,0.00093468366,0.002865535,0.7763526,0.000025505664,0.000054421485],"genre_scores_gemma":[0.00005650512,0.0011887639,0.00054038817,0.0042551532,0.0006461056,0.00044557755,0.992139,0.000038573377,0.0006899362],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9932712,0.00064645364,0.002240525,0.0007004386,0.0026239927,0.0005173897],"domain_scores_gemma":[0.981826,0.00054209423,0.0023328634,0.0022208944,0.0127147725,0.00036334997],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.003010325,0.0006113198,0.0017158914,0.00040867276,0.00031724642,0.00008122944,0.0018431362,0.00085122196,0.000650512],"category_scores_gemma":[0.012097545,0.0003231755,0.0010405733,0.0020330867,0.00096233847,0.00023355945,0.0007111211,0.0024890937,0.000023815353],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006812729,0.0004263546,0.000016110005,0.014508829,0.00067886186,4.6396002e-7,0.00019163365,1.3024405e-7,0.00016338711,0.00007549334,0.98252,0.001350633],"study_design_scores_gemma":[0.0014336202,0.0002435471,0.0009214308,0.0133881355,0.0007528644,0.000030002311,0.000041256764,0.000021202248,0.00036328813,0.00001822367,0.98252165,0.0002647763],"about_ca_topic_score_codex":0.00026416723,"about_ca_topic_score_gemma":0.0000236346,"teacher_disagreement_score":0.21578644,"about_ca_system_score_codex":0.00020705389,"about_ca_system_score_gemma":0.0010795551,"threshold_uncertainty_score":0.99992204},"labels":[],"label_agreement":null},{"id":"W4256129842","doi":"10.1158/1538-7445.sabcs18-3925","title":"Abstract 3925: A screen for epigenetic radiosensitizers in small cell lung cancer","year":2019,"lang":"en","type":"article","venue":"Experimental and Molecular Therapeutics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Epigenetics; Cancer; Lung cancer; Computer science; Computational biology; Chemistry; Biology; Medicine; Oncology; Biochemistry; Genetics","score_opus":0.022115013067051548,"score_gpt":0.3432664170486949,"score_spread":0.3211514039816434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256129842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94973135,0.047047224,0.00009861403,0.00049382774,0.000081833736,0.0012249149,0.000012736757,0.000016959406,0.0012925616],"genre_scores_gemma":[0.9966873,0.00071831455,0.0006065468,0.0014239136,0.000039076975,0.0001219911,0.000010360701,0.00003333577,0.00035915777],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991502,0.00001703371,0.00013960613,0.00025715973,0.00013788581,0.00029810722],"domain_scores_gemma":[0.99966824,0.000028471537,0.000030370304,0.00015774873,0.000031455173,0.00008371712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000076668206,0.00014922737,0.00023004097,0.000063246065,0.000035410903,0.00001581504,0.00005274248,0.000054948567,0.0000380369],"category_scores_gemma":[0.00000210484,0.00012973296,0.000070881346,0.000066553126,0.00005990967,0.000019975574,0.00004548529,0.000108988206,0.0000035495718],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003303304,0.00012530081,0.011426262,0.0001682405,0.0001481845,0.00003316841,0.0010853225,0.00001178591,0.98493016,0.000040882547,0.000053027223,0.0016473416],"study_design_scores_gemma":[0.004620343,0.0004310299,0.012825729,0.00013498758,0.000054675813,0.000007179095,0.0009784333,0.00067958,0.97737914,0.0000268848,0.0026537378,0.00020826817],"about_ca_topic_score_codex":0.00019350855,"about_ca_topic_score_gemma":0.000015007447,"teacher_disagreement_score":0.046955973,"about_ca_system_score_codex":0.00013731707,"about_ca_system_score_gemma":0.00007047518,"threshold_uncertainty_score":0.5290356},"labels":[],"label_agreement":null},{"id":"W4280651783","doi":"10.1101/2022.05.12.491321","title":"Cell-free Tumor Methylome Analysis of Small Cell Lung Cancer Patients Identifies Subgroups with Prognostic Associations","year":2022,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Canada Research Chairs; Ontario Institute for Cancer Research; St Mary's Hospital Centre; Toronto General Hospital; University of Toronto","funders":"Weill Cornell Medical College; Ontario Institute for Cancer Research; Canadian Institutes of Health Research; Cancer Research Society; National Cancer Institute; University of Toronto; Memorial Sloan-Kettering Cancer Center; Daiichi-Sankyo; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company","keywords":"DNA methylation; Methylation; Biology; Epigenetics; Cancer research; Differentially methylated regions; Lung cancer; Epigenomics; Cancer; Oncology; Genetics; Gene; Medicine; Gene expression","score_opus":0.014444489863605373,"score_gpt":0.26740885967778694,"score_spread":0.2529643698141816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280651783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873751,0.0055413744,0.00012775749,0.00019570511,0.00050446007,0.002467056,0.0035349834,0.00020669689,0.00004685889],"genre_scores_gemma":[0.9954708,0.0005781387,0.0013744554,0.00009908727,0.00015290701,0.0020816138,0.000011518285,0.00016020428,0.00007125618],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951474,0.00028997182,0.0009025875,0.0012206463,0.001643922,0.0007954586],"domain_scores_gemma":[0.9942259,0.00033951135,0.0011923137,0.0018323188,0.0020791509,0.0003307604],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008588265,0.00064072915,0.0016473022,0.0013219751,0.00030944357,0.00012062897,0.0008496229,0.0002125356,0.00028214641],"category_scores_gemma":[0.0008522073,0.0006006052,0.00045232766,0.0031370653,0.0002023701,0.00011181603,0.00159899,0.0012131736,0.0000042997267],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000119608725,0.0008969091,0.96010405,0.0029984498,0.0067509143,0.000072419054,0.00012361117,0.0005698973,0.027066788,0.000016211436,0.00128092,2.0185382e-7],"study_design_scores_gemma":[0.0017450558,0.00022610008,0.94419193,0.00038689497,0.012702442,2.1583604e-9,0.000028086182,0.0004425593,0.039476484,5.1672293e-7,0.00020395566,0.0005959927],"about_ca_topic_score_codex":0.0013552405,"about_ca_topic_score_gemma":0.0001574442,"teacher_disagreement_score":0.015912158,"about_ca_system_score_codex":0.0018790201,"about_ca_system_score_gemma":0.0019246514,"threshold_uncertainty_score":0.9996445},"labels":[],"label_agreement":null},{"id":"W4281653962","doi":"10.1200/jco.2022.40.16_suppl.7551","title":"Initial safety run-in results of the phase III POLARGO trial: Polatuzumab vedotin plus rituximab, gemcitabine, and oxaliplatin in patients (pts) with relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL).","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Oxaliplatin; Internal medicine; Tolerability; Gemcitabine; Neutropenia; Diffuse large B-cell lymphoma; Rituximab; Clinical endpoint; Adverse effect; Gastroenterology; Phases of clinical research; Oncology; Surgery; Lymphoma; Clinical trial; Chemotherapy; Cancer; Colorectal cancer","score_opus":0.05272054963104936,"score_gpt":0.428999063772115,"score_spread":0.3762785141410656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281653962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926678,0.00070354296,0.0000051270686,0.002936155,0.0010238241,0.001072358,0.00013008123,0.000006823755,0.0014543057],"genre_scores_gemma":[0.997909,0.0004283884,0.00018200013,0.00080449303,0.0004081612,0.00002055318,0.000013541225,0.000031894087,0.00020196503],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9921636,0.0020368965,0.003732977,0.0003659086,0.0011968014,0.00050383515],"domain_scores_gemma":[0.9926516,0.003697855,0.0025899436,0.00039730413,0.00036042643,0.00030290746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0062258444,0.00023668907,0.0021642689,0.00035517555,0.00015384154,0.000008303412,0.00037719536,0.0002563012,0.000042019987],"category_scores_gemma":[0.0071679973,0.0001502193,0.0003180056,0.0005238964,0.0004314575,0.000156857,0.0005288769,0.0022027828,0.000001425231],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8389443,0.0746349,0.06509681,0.000085461106,0.00029150423,0.0007355252,0.0015833689,0.000014093381,0.000043990272,0.000042504602,0.0025113614,0.01601617],"study_design_scores_gemma":[0.73133457,0.03914619,0.20170212,0.00014637606,0.00015507205,0.000039248145,0.0005996951,0.00010821421,0.000016161537,0.00004002356,0.026592558,0.00011980297],"about_ca_topic_score_codex":0.00034201206,"about_ca_topic_score_gemma":0.0006924275,"teacher_disagreement_score":0.13660531,"about_ca_system_score_codex":0.0013926238,"about_ca_system_score_gemma":0.0040152934,"threshold_uncertainty_score":0.95701176},"labels":[],"label_agreement":null},{"id":"W4281893891","doi":"10.1016/s1470-2045(22)00271-6","title":"Stereotactic radiosurgery versus whole brain radiotherapy in patients with intracranial metastatic disease and small-cell lung cancer: a systematic review and meta-analysis","year":2022,"lang":"en","type":"review","venue":"The Lancet Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre; Ontario Institute for Cancer Research; University of Toronto","funders":"Canadian Institutes of Health Research; American Association of Neurological Surgeons; University of Toronto; AstraZeneca; Congress of Neurological Surgeons; Pfizer","keywords":"Medicine; Radiosurgery; Meta-analysis; Oncology; Hazard ratio; Radiation therapy; Internal medicine; Lung cancer; Confidence interval","score_opus":0.1196381221426109,"score_gpt":0.4222014629856351,"score_spread":0.3025633408430242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281893891","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013570694,0.9854595,0.0000041692456,0.0057948916,0.0000720952,0.008133279,0.00034439427,0.000023466966,0.000032493204],"genre_scores_gemma":[0.0000377184,0.9915793,0.00009346602,0.0018718854,0.00008035959,0.005855757,0.00010563034,0.00006303234,0.00031285387],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9937723,0.003618261,0.0009177196,0.00064622815,0.00050428434,0.00054118456],"domain_scores_gemma":[0.99401116,0.0040112077,0.0008058507,0.0008836574,0.00006935367,0.00021875452],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002505461,0.00055246695,0.012814684,0.0003698338,0.00013308728,0.000036632468,0.00031612563,0.00006016846,0.00036109408],"category_scores_gemma":[0.000566731,0.0002780737,0.0006981483,0.0011037026,0.00022473557,0.000057317713,0.00019025768,0.00082715903,0.0000015201116],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008036574,0.00017714695,0.00035583533,0.77674466,0.21682183,0.00030018936,0.00017815511,0.0000015295258,8.121978e-9,0.0000042840534,0.0011171883,0.003495537],"study_design_scores_gemma":[0.003985085,0.00058973226,0.00014849992,0.009185387,0.8799496,0.000030837906,0.00002620519,0.000021201386,2.1631708e-9,0.0000016045572,0.10577401,0.00028781957],"about_ca_topic_score_codex":0.00012849458,"about_ca_topic_score_gemma":0.00026093138,"teacher_disagreement_score":0.76755923,"about_ca_system_score_codex":0.0011180583,"about_ca_system_score_gemma":0.00088259333,"threshold_uncertainty_score":0.99996716},"labels":[],"label_agreement":null},{"id":"W4282920681","doi":"10.21037/tlcr-22-320","title":"The efficacy of anlotinib as third-line treatment for non-small cell lung cancer by EGFR mutation status: a subgroup analysis of the ALTER0303 randomized phase 3 study","year":2022,"lang":"en","type":"article","venue":"Translational Lung Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Lung cancer; Subgroup analysis; Oncology; Internal medicine; Randomized controlled trial; Mutation; Genetics; Meta-analysis; Gene; Biology","score_opus":0.05746112818263294,"score_gpt":0.4689900606799801,"score_spread":0.4115289324973472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282920681","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9594907,0.018244246,0.0004074833,0.0048275907,0.00015406279,0.014137221,0.0023551402,0.000020301084,0.0003632507],"genre_scores_gemma":[0.9849792,0.0016495816,0.000059650087,0.000040414106,0.00012000329,0.010743138,0.00028511483,0.0000465587,0.0020763483],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9938955,0.001282538,0.0009063367,0.0005719705,0.0026166115,0.00072708394],"domain_scores_gemma":[0.9926814,0.005183187,0.00031670305,0.000576082,0.0010841872,0.00015847424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038138244,0.00026955517,0.001043638,0.0004883515,0.0010289564,0.000036269408,0.00043751783,0.00004675635,0.0004340069],"category_scores_gemma":[0.00029771784,0.00016039763,0.00069607975,0.0024308802,0.0005098562,0.000068792244,0.00011409863,0.00049297145,4.60128e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.62773716,0.013483745,0.124645546,0.0019808405,0.052075796,0.000027370736,0.07136375,0.06379993,0.022372905,0.0006619474,0.007788984,0.014062001],"study_design_scores_gemma":[0.6905229,0.0067276224,0.031486053,0.00028820417,0.018527443,0.000002761842,0.0074614123,0.22059622,0.019298136,0.0001896143,0.0043421146,0.0005574757],"about_ca_topic_score_codex":0.013528762,"about_ca_topic_score_gemma":0.003264342,"teacher_disagreement_score":0.15679629,"about_ca_system_score_codex":0.0012431303,"about_ca_system_score_gemma":0.0024687105,"threshold_uncertainty_score":0.99304026},"labels":[],"label_agreement":null},{"id":"W4282937497","doi":"10.1158/1538-7445.am2022-ct572","title":"Abstract CT572: Phase 1b dose-escalation and dose-expansion study evaluating trastuzumab deruxtecan (T-DXd) in combination with durvalumab and cisplatin, carboplatin, or pemetrexed in advanced or metastatic, HER2-overexpressing, nonsquamous non-small cell lung cancer (NSCLC): DESTINY-Lung03","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nuvo Pharmaceuticals (Canada)","funders":"","keywords":"Medicine; Carboplatin; Pemetrexed; Internal medicine; Oncology; Trastuzumab; Tolerability; Durvalumab; Lapatinib; Cancer; Lung cancer; Chemotherapy; Cisplatin; Nivolumab; Breast cancer; Immunotherapy; Adverse effect","score_opus":0.0972688980441431,"score_gpt":0.4678346401220942,"score_spread":0.3705657420779511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282937497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849795,0.0052956203,0.000057497855,0.00040526257,0.00010387823,0.008754194,0.000106556115,0.000060485916,0.00023700848],"genre_scores_gemma":[0.99021214,0.000935613,0.0014399433,0.000050316023,0.00007482236,0.006576986,0.000051837356,0.0001384804,0.00051984726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99235004,0.001158603,0.0009749005,0.0014164606,0.0028112964,0.001288704],"domain_scores_gemma":[0.99640274,0.0015379346,0.00034365625,0.0005713032,0.0007612181,0.00038314748],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0043631154,0.0005440151,0.0010277919,0.0012993029,0.00087490736,0.00015783505,0.0003041365,0.00009589353,0.0004908875],"category_scores_gemma":[0.0009499247,0.00042894454,0.00005229169,0.0025705013,0.000354191,0.00044297663,0.0005361713,0.0019288006,0.0000011974113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07165383,0.01174888,0.40154552,0.0053130346,0.0005802676,0.0022876258,0.045265198,0.010665103,0.12255553,0.000006693798,0.00054924114,0.32782906],"study_design_scores_gemma":[0.14053726,0.021733133,0.72767687,0.003220845,0.0004225286,0.000080198,0.035963938,0.063612714,0.0055655614,0.000049814083,0.000059231068,0.0010778945],"about_ca_topic_score_codex":0.014016018,"about_ca_topic_score_gemma":0.029589709,"teacher_disagreement_score":0.32675117,"about_ca_system_score_codex":0.003291398,"about_ca_system_score_gemma":0.0032952772,"threshold_uncertainty_score":0.99981624},"labels":[],"label_agreement":null},{"id":"W4282971362","doi":"10.1158/1538-7445.am2022-5731","title":"Abstract 5731: Structure-based development of a novel MYC inhibitor for neuroendocrine prostate cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"LNCaP; Prostate cancer; Cancer research; In silico; Cancer; Drug discovery; Biology; Chemistry; Gene; Computational biology; Bioinformatics; Genetics","score_opus":0.1123499322314152,"score_gpt":0.45688991081849545,"score_spread":0.34453997858708024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282971362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853201,0.0032061285,0.00005154054,0.0058524464,0.0003881303,0.0036053162,0.0013435351,0.000051160347,0.00018163437],"genre_scores_gemma":[0.9886357,0.00015155642,0.0013462974,0.00025186816,0.00033238294,0.007467681,0.00007567789,0.00008076816,0.0016580789],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9956593,0.00007582734,0.00050266576,0.0006095501,0.00210579,0.0010468544],"domain_scores_gemma":[0.9978721,0.00030242436,0.00012512422,0.0004323361,0.0010059703,0.00026203314],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00079915056,0.00022117149,0.00046633874,0.00049497146,0.00067604164,0.000027750957,0.00035863052,0.000025194202,0.0013756199],"category_scores_gemma":[0.00033589161,0.00019298425,0.00011217349,0.0009289593,0.00031102085,0.000067336354,0.00047441755,0.0009193774,0.0000020133857],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008718983,0.0008090928,0.011205882,0.004695917,0.0005239492,0.00009496465,0.0021875743,0.0018917938,0.8832787,0.00009591954,0.041484132,0.04501305],"study_design_scores_gemma":[0.0133961,0.0013090668,0.026306111,0.00053615804,0.000059719663,0.000014292209,0.00095257023,0.00058680907,0.6390399,0.00008106178,0.31730688,0.0004113791],"about_ca_topic_score_codex":0.0007986493,"about_ca_topic_score_gemma":0.00065239304,"teacher_disagreement_score":0.27582273,"about_ca_system_score_codex":0.0019258544,"about_ca_system_score_gemma":0.0058464645,"threshold_uncertainty_score":0.9997895},"labels":[],"label_agreement":null},{"id":"W4282979011","doi":"10.1158/1538-7445.am2022-324","title":"Abstract 324: Discovery of novel functional TROP2 antibodies for treatment of epithelial cancers","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Biotechnology Research Institute","funders":"","keywords":"Cancer research; In vivo; Cancer; Metastasis; Antibody; Intracellular; Cancer cell; Downregulation and upregulation; Extracellular; Antibody-drug conjugate; Biology; Immunology; Cell biology; Monoclonal antibody; Genetics","score_opus":0.17824344595736766,"score_gpt":0.46742746372008676,"score_spread":0.28918401776271907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282979011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98669755,0.004958488,0.00010221522,0.0018860858,0.00030108256,0.0016787478,0.0030278452,0.000013840888,0.0013341265],"genre_scores_gemma":[0.9921872,0.0020041377,0.00015526428,0.00003557301,0.00046611158,0.0023173732,0.00008874576,0.00002927728,0.0027163206],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970513,0.00007142886,0.00032350054,0.00036150616,0.0016597765,0.00053246226],"domain_scores_gemma":[0.99839485,0.00051504304,0.00009911214,0.00034171322,0.0005651306,0.00008415448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073274085,0.00014507536,0.00049255375,0.00036736674,0.00030338147,0.000013642572,0.00018981358,0.000033284297,0.00041114702],"category_scores_gemma":[0.00015820772,0.000115481314,0.0002278826,0.0004675921,0.0004696971,0.00009925056,0.00011560227,0.0001958442,0.0000012560579],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016027533,0.002681945,0.018894505,0.0023138046,0.0016045535,0.00004020582,0.00407444,0.0013062874,0.9107788,0.0016239999,0.029321263,0.0113326525],"study_design_scores_gemma":[0.038523726,0.025448993,0.26716986,0.0006576285,0.00046707547,0.0000480388,0.018994123,0.000335169,0.46403414,0.0005639194,0.1830569,0.00070042606],"about_ca_topic_score_codex":0.0046808133,"about_ca_topic_score_gemma":0.00023640378,"teacher_disagreement_score":0.44674468,"about_ca_system_score_codex":0.0021170042,"about_ca_system_score_gemma":0.0023472256,"threshold_uncertainty_score":0.7076021},"labels":[],"label_agreement":null},{"id":"W4283453063","doi":"10.1016/j.jtho.2022.05.016","title":"Brief Report: Exploratory Analysis of Maintenance Therapy in Patients With Extensive-Stage SCLC Treated First Line With Atezolizumab Plus Carboplatin and Etoposide","year":2022,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Janssen Pharmaceuticals; Chugai Pharmaceutical; Merck Sharp and Dohme; Genentech; Eisai; G1 Therapeutics; Puma Biotechnology; Yuhan; BeiGene; Mirati Therapeutics; Clovis Oncology; Jazz Pharmaceuticals; Regeneron Pharmaceuticals; F. Hoffmann-La Roche; Takeda Pharmaceutical Company; AbbVie; Teva Pharmaceutical Industries; Boehringer Ingelheim Japan; Merck KGaA; Daiichi Sankyo Europe; National Cancer Institute; Bayer; Gilead Sciences; Roche; Novartis; Mesothelioma Applied Research Foundation; GlaxoSmithKline; Canadian Asian Studies Association; AstraZeneca; Ono Pharmaceutical; U.S. Department of Defense; Eli Lilly and Company; Bristol-Myers Squibb; Kyowa Hakko Kirin; Sanofi; Amgen; Boehringer Ingelheim; Pfizer","keywords":"Atezolizumab; Medicine; Placebo; Maintenance therapy; Hazard ratio; Internal medicine; Oncology; Carboplatin; Population; Chemotherapy; Cancer; Confidence interval; Immunotherapy; Pembrolizumab; Pathology; Cisplatin","score_opus":0.025664155582500087,"score_gpt":0.377302734165158,"score_spread":0.35163857858265796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283453063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963266,0.0013049826,0.00005381338,0.0015757092,0.00005256557,0.0004210827,0.000027549266,0.000007257467,0.0002303981],"genre_scores_gemma":[0.9982288,0.00059993594,0.0005410364,0.00021104648,0.000036237932,0.00003105658,0.00001623053,0.000022747005,0.00031294598],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99781245,0.000266988,0.0007091488,0.00025381602,0.00067830656,0.00027930245],"domain_scores_gemma":[0.99742496,0.00019872678,0.0010640041,0.0002773844,0.00090009585,0.00013483105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077457615,0.00017422922,0.0011962687,0.000654767,0.00010172248,0.0000069062144,0.000114202856,0.00005372422,0.00006629497],"category_scores_gemma":[0.00020516287,0.00011124056,0.00009816038,0.0012423511,0.00025477065,0.0000909308,0.00009986519,0.0005522243,1.218234e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.059857897,0.0009049418,0.8910445,0.00012043732,0.0041482574,0.00982878,0.0033597627,0.006079557,0.00024158775,0.000004352982,0.000389253,0.024020696],"study_design_scores_gemma":[0.010299074,0.025510548,0.95627064,0.00024901025,0.0012368241,0.00053362065,0.0020024853,0.00044971617,0.00036040862,0.000010349531,0.002910782,0.00016651888],"about_ca_topic_score_codex":0.00023625213,"about_ca_topic_score_gemma":0.00080034183,"teacher_disagreement_score":0.06522618,"about_ca_system_score_codex":0.0010819125,"about_ca_system_score_gemma":0.00074857194,"threshold_uncertainty_score":0.45362583},"labels":[],"label_agreement":null},{"id":"W4283713334","doi":"10.1200/op.22.00345","title":"Reply to M.Z. Farooq et al","year":2022,"lang":"en","type":"letter","venue":"JCO Oncology Practice","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Chemistry","score_opus":0.07133152843313753,"score_gpt":0.4879265315011695,"score_spread":0.416595003068032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283713334","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000024879067,0.0007000098,0.000013741854,0.7947564,0.0014320754,0.001185582,0.000049967817,0.00014060561,0.20169671],"genre_scores_gemma":[0.000012669241,0.0009604827,0.0033759554,0.94028217,0.0025191202,0.0009455025,0.00023519994,0.00010261004,0.05156631],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951125,0.0014183493,0.00044804494,0.00094961235,0.0012918166,0.00077967625],"domain_scores_gemma":[0.99255013,0.0053585772,0.0003932044,0.0010740136,0.00043585093,0.00018823678],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0022809575,0.00035576877,0.0009404598,0.00036522606,0.0002462464,0.00003764258,0.0004113683,0.00042349385,0.0026182374],"category_scores_gemma":[0.013017197,0.00032620574,0.00018156497,0.00044381435,0.00015338225,0.00021274544,0.0010793405,0.008625076,0.0010417862],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014950446,0.00020598833,0.0000629071,0.00012110857,0.0008578074,0.018631885,0.00063598144,0.000001582172,0.000032558353,0.000029676114,0.975184,0.0027414623],"study_design_scores_gemma":[0.0012286997,0.0045491518,0.00013525374,0.000045646204,0.00055375136,0.0020912134,0.0004491161,0.0000013811238,0.000007770134,0.000018921031,0.9906397,0.00027942535],"about_ca_topic_score_codex":0.0010067833,"about_ca_topic_score_gemma":0.00003309212,"teacher_disagreement_score":0.15013039,"about_ca_system_score_codex":0.0028468487,"about_ca_system_score_gemma":0.002410768,"threshold_uncertainty_score":0.999919},"labels":[],"label_agreement":null},{"id":"W4284959841","doi":"10.1007/s40471-022-00295-8","title":"Considerations of Biomarker Application for Cancer Continuum in the Era of Precision Medicine","year":2022,"lang":"en","type":"article","venue":"Current Epidemiology Reports","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Public Health Ontario; University of Toronto","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Precision medicine; Biomarker; Medicine; Computational biology; Internal medicine; Oncology; Biology; Pathology; Genetics","score_opus":0.17609164285120027,"score_gpt":0.49943965261987233,"score_spread":0.32334800976867206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4284959841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8166402,0.08205018,0.0047082305,0.086123794,0.001889044,0.007677598,0.00012435977,0.000034065968,0.0007525326],"genre_scores_gemma":[0.99591273,0.0007559954,0.00018702925,0.00032359504,0.00009322576,0.0026057772,0.00008363686,0.0000071060017,0.000030896754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977917,0.00045531342,0.0010584608,0.00028013866,0.00022124761,0.00019310397],"domain_scores_gemma":[0.99508953,0.0035310765,0.0006822871,0.00040749036,0.00025553443,0.000034053475],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.005403669,0.000088932145,0.00062453526,0.00010579968,0.00009784909,4.1991254e-7,0.00006550936,0.00003323983,0.000119346274],"category_scores_gemma":[0.008570232,0.000055744265,0.00008805504,0.00022933293,0.00035187634,0.000019455727,0.00007979577,0.00027230856,1.323522e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027399175,0.0002889511,0.8145246,0.00037318977,0.00012976083,0.00001358789,0.0012406867,0.00010276937,0.0041193613,0.0016303974,0.14110862,0.036194123],"study_design_scores_gemma":[0.0021751095,0.00079490145,0.78356904,0.00044172123,0.00027904182,0.00034783757,0.0006635628,0.0012546275,0.0006729656,0.032252666,0.17740588,0.00014266507],"about_ca_topic_score_codex":0.00040154764,"about_ca_topic_score_gemma":0.0001265037,"teacher_disagreement_score":0.17927255,"about_ca_system_score_codex":0.000097839766,"about_ca_system_score_gemma":0.00023487497,"threshold_uncertainty_score":0.999781},"labels":[],"label_agreement":null},{"id":"W4286295221","doi":"10.1200/jco.2022.40.16_suppl.e20602","title":"Population kinetics assessment of limited small cell lung cancer (L-SCLC).","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Population; Internal medicine; Survival analysis; Area under the curve; Proportional hazards model; Progression-free survival; Nuclear medicine; Oncology; Overall survival","score_opus":0.1782929049983703,"score_gpt":0.5676061630957456,"score_spread":0.3893132580973753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286295221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98099166,0.0020257595,0.00016238281,0.010681537,0.0015901086,0.0003003217,0.000011830763,0.000006541446,0.0042298767],"genre_scores_gemma":[0.99164677,0.0016462,0.0042630346,0.0010585042,0.00079636526,0.000017308175,0.0000046546857,0.000014962018,0.0005521988],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964147,0.0006183718,0.0019064277,0.0001391306,0.00071570044,0.00020566102],"domain_scores_gemma":[0.9957334,0.0015209469,0.0017926281,0.00016336402,0.0005826232,0.0002070845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029310442,0.00009167038,0.0011668133,0.00016292611,0.000056170666,0.0000031700731,0.00017823598,0.00010910933,0.0005091517],"category_scores_gemma":[0.0013116766,0.00006997089,0.00034106584,0.0002207743,0.00009722389,0.00003414005,0.00021035712,0.0012770068,4.9534367e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017006997,0.0023904804,0.95283574,0.00019099124,0.0005521988,0.00024028386,0.00012176698,0.0012330718,0.0014363222,0.00006663833,0.01388805,0.025343781],"study_design_scores_gemma":[0.006089033,0.013826835,0.9344984,0.000066129345,0.000563142,0.00004674938,0.00018691322,0.0015746483,0.000094115574,0.00007151554,0.042914104,0.00006839619],"about_ca_topic_score_codex":0.00015063988,"about_ca_topic_score_gemma":0.0000803916,"teacher_disagreement_score":0.029026054,"about_ca_system_score_codex":0.00080356945,"about_ca_system_score_gemma":0.0019616163,"threshold_uncertainty_score":0.55748546},"labels":[],"label_agreement":null},{"id":"W4286296236","doi":"10.1200/jco.2022.40.16_suppl.8570","title":"Stereotactic radiosurgery (SRS) versus whole brain radiation therapy (WBRT) in patients with small cell lung cancer (SCLC) and intracranial metastatic disease (IMD): A systematic review and meta-analysis.","year":2022,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Radiosurgery; Meta-analysis; Hazard ratio; Internal medicine; Confidence interval; Oncology; Radiation therapy","score_opus":0.24485543690621728,"score_gpt":0.5107754946513745,"score_spread":0.26592005774515726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286296236","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007742194,0.9914428,0.000006088332,0.0033252786,0.0002665798,0.0040772366,0.0000874174,0.0000054678308,0.000014940434],"genre_scores_gemma":[0.00024798562,0.99711025,0.00013806987,0.001618176,0.00014582575,0.0004990405,0.000032933996,0.000048928752,0.00015879024],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98778546,0.0057670376,0.0046237623,0.00051717693,0.0009376528,0.00036892918],"domain_scores_gemma":[0.9778428,0.014912654,0.005863513,0.00042951788,0.00032669786,0.00062478974],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.008492271,0.0004984641,0.018084208,0.00066938746,0.000072527306,0.000034632303,0.00024167109,0.00014771003,0.00029317223],"category_scores_gemma":[0.0071001076,0.00026791438,0.0022933176,0.00092213415,0.00018723133,0.00015736114,0.00012225006,0.0018281993,0.0000012246661],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038094714,0.0015260978,0.0034221164,0.5942401,0.32058096,0.001363096,0.00009179184,0.000003974563,4.8351607e-9,0.0000015314357,0.0014595473,0.0735013],"study_design_scores_gemma":[0.008885003,0.0039433334,0.0028092887,0.010565014,0.85193586,0.000039683946,0.00001814312,0.00001364853,2.3294684e-9,0.000002414302,0.121522814,0.00026479905],"about_ca_topic_score_codex":0.000031375144,"about_ca_topic_score_gemma":0.000071477116,"teacher_disagreement_score":0.5836751,"about_ca_system_score_codex":0.00082741026,"about_ca_system_score_gemma":0.0036468965,"threshold_uncertainty_score":0.9999773},"labels":[],"label_agreement":null},{"id":"W4288081531","doi":"10.21037/tlcr-22-489","title":"The extent of mediastinal lymph node dissection correlates with survival of small cell lung cancer patients after resection: a propensity score-matched cohort study analysis","year":2022,"lang":"en","type":"article","venue":"Translational Lung Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"","keywords":"Medicine; Propensity score matching; Dissection (medical); Lymphadenectomy; Proportional hazards model; Lymph node; Lung cancer; Surveillance, Epidemiology, and End Results; Survival analysis; Surgery; Confounding; Mediastinal lymph node; Surgical oncology; Cancer registry; Cancer; Radiology; Internal medicine; Metastasis","score_opus":0.04560001679536454,"score_gpt":0.3675098791055545,"score_spread":0.32190986231019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4288081531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904843,0.003930079,0.00012998679,0.0007758263,0.00021288574,0.0038205255,0.00029160143,0.000021371488,0.00033345196],"genre_scores_gemma":[0.9944159,0.00041044952,0.000031336753,0.000009277657,0.00011738321,0.004218974,0.00008325528,0.0000401333,0.0006732856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9928426,0.0008678147,0.0006416624,0.0006424213,0.0044061625,0.0005993525],"domain_scores_gemma":[0.99614763,0.0006697854,0.00022011838,0.00047532478,0.0023185657,0.00016854338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002735021,0.0002400539,0.0006731703,0.0005457662,0.0008407525,0.000033062577,0.00032247265,0.00004985005,0.00065777457],"category_scores_gemma":[0.000087807624,0.00016436695,0.00020030067,0.002916089,0.00049399555,0.00010739063,0.00020739582,0.0008100776,6.405899e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015956903,0.0011049898,0.96573603,0.00058778934,0.003627544,0.00001876505,0.0028332865,0.009525553,0.00027377313,0.000011142772,0.00012371557,0.0002004878],"study_design_scores_gemma":[0.003231348,0.0008819334,0.98807967,0.00015667772,0.0015305128,0.000001505905,0.0008113869,0.0047168136,0.00039914896,0.000009130882,0.00002433392,0.0001575624],"about_ca_topic_score_codex":0.010101786,"about_ca_topic_score_gemma":0.012425525,"teacher_disagreement_score":0.022343595,"about_ca_system_score_codex":0.0010964861,"about_ca_system_score_gemma":0.0015228179,"threshold_uncertainty_score":0.99649},"labels":[],"label_agreement":null},{"id":"W4288905840","doi":"10.1016/j.semcancer.2022.07.008","title":"Novel therapeutic combinations with PARP inhibitors for small cell lung cancer: A bench-to-bedside review","year":2022,"lang":"en","type":"review","venue":"Seminars in Cancer Biology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; University Health Network; University of Toronto; Princess Margaret Cancer Centre","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Medicine; Cancer research; Lung cancer; Oncology","score_opus":0.09554822133260871,"score_gpt":0.45139660855054026,"score_spread":0.35584838721793155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4288905840","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000010239576,0.98479885,0.000066821136,0.0029789472,0.00076850934,0.009689463,0.0010414496,0.000054088105,0.00059163873],"genre_scores_gemma":[0.000008771949,0.95494604,0.0005523123,0.002231499,0.00031162286,0.040021207,0.00047857402,0.0001384495,0.00131152],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964209,0.00023951348,0.00091770786,0.0011294126,0.0003235189,0.0009689033],"domain_scores_gemma":[0.9974237,0.0009597919,0.0004869343,0.00070074724,0.00020941619,0.0002194036],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007780939,0.0007023086,0.0031418542,0.000554462,0.0002034537,0.0000130322105,0.0005473351,0.00028395507,0.00038213978],"category_scores_gemma":[0.00019198135,0.0005121225,0.00044023112,0.0015115843,0.0002452579,0.000030493044,0.00036518995,0.0010612692,0.000003965782],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009525262,0.00031058997,0.0007219951,0.12226583,0.000786724,0.00002061517,0.0002309987,0.000004578837,0.000014533357,0.000095222436,0.02262866,0.852825],"study_design_scores_gemma":[0.0013264031,0.0010340706,0.0000136333,0.0892306,0.002304946,0.000038370843,0.000050175866,0.000006021997,0.0000092757955,0.000021038419,0.90547514,0.00049030146],"about_ca_topic_score_codex":0.001348648,"about_ca_topic_score_gemma":0.0017901056,"teacher_disagreement_score":0.8828465,"about_ca_system_score_codex":0.003287045,"about_ca_system_score_gemma":0.0035322525,"threshold_uncertainty_score":0.99973303},"labels":[],"label_agreement":null},{"id":"W4289261182","doi":"10.1101/2022.07.31.22277301","title":"The Blood Proteome of Imminent Lung Cancer Diagnosis","year":2022,"lang":"en","type":"preprint","venue":"medRxiv","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Public Health Ontario; University of Toronto","funders":"National Cancer Institute; Cancer Research UK; Institut National Du Cancer; Fondation ARC pour la Recherche sur le Cancer; Centre International de Recherche sur le Cancer; World Health Organization","keywords":"Lung cancer; Cancer; Medicine; Internal medicine; Metastasis; Oncology; Biomarker; Odds ratio; Lung; Chemokine; Pathology; Immunology; Inflammation; Biology","score_opus":0.02904364612096589,"score_gpt":0.3775979276224786,"score_spread":0.34855428150151274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289261182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92625755,0.051309586,0.0000045834954,0.016513836,0.0009278488,0.003159966,0.00020661141,0.000061153776,0.0015588759],"genre_scores_gemma":[0.9061293,0.050031293,0.00010861185,0.00015026411,0.0006461329,0.035945557,0.000030129973,0.000078452984,0.0068802414],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99742424,0.00014459342,0.0004299172,0.0004701697,0.0011110983,0.00041996237],"domain_scores_gemma":[0.99809647,0.00030784923,0.00025591528,0.0009791693,0.00024348359,0.00011712507],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000774607,0.00025281176,0.0005796475,0.00011495667,0.00022517248,0.00002145104,0.0005222406,0.00008670995,0.0010971051],"category_scores_gemma":[0.00063778536,0.00015923697,0.0002621139,0.0002402578,0.0002442984,0.000016187805,0.0021129171,0.0010880544,0.000003165501],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001822233,0.00025416736,0.9766753,0.003033085,0.0021977331,0.00009663977,0.00085112127,0.0000535097,0.00087121385,0.0000737354,0.01415865,0.0015526671],"study_design_scores_gemma":[0.002855248,0.00064718095,0.752846,0.002455306,0.0025434168,0.000013794792,0.00041238542,0.00022203596,0.035323743,0.00029747302,0.20177585,0.0006076001],"about_ca_topic_score_codex":0.0013482906,"about_ca_topic_score_gemma":0.00015907967,"teacher_disagreement_score":0.22382928,"about_ca_system_score_codex":0.00035190163,"about_ca_system_score_gemma":0.00065922213,"threshold_uncertainty_score":0.999816},"labels":[],"label_agreement":null},{"id":"W4292185501","doi":"10.1158/2767-9764.crc-21-0135","title":"Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Institute of General Medical Sciences; Canadian Institutes of Health Research; Physicians' Services Incorporated Foundation; National Institute of Dental and Craniofacial Research; Free To Breathe; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill; North Carolina Biotechnology Center; Lung Cancer Research Foundation; National Cancer Institute; National Institutes of Health; Yale University","keywords":"Immunohistochemistry; Tissue microarray; Head and neck squamous-cell carcinoma; Immunostaining; Medicine; Cancer; Head and neck cancer; Cancer research; Pathology; Oncology; Immune system; HPV infection; Biomarker; Biology; Internal medicine; Cervical cancer; Immunology","score_opus":0.13157024526347763,"score_gpt":0.4713348231637256,"score_spread":0.33976457790024794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292185501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8600319,0.118025735,0.0000015064145,0.017441379,0.00004623962,0.002082133,0.000093855444,0.000044997716,0.0022322303],"genre_scores_gemma":[0.9431035,0.04359208,0.00021600678,0.00024846647,0.00002920578,0.011938638,0.000021131249,0.00004059045,0.0008104103],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967718,0.0008907705,0.00030886027,0.0004946439,0.00086143444,0.0006724972],"domain_scores_gemma":[0.99501026,0.0030325935,0.00006482762,0.0012719714,0.00030422115,0.0003161489],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011758915,0.00017556167,0.00033494132,0.00055749156,0.0010937606,0.000060849587,0.00059706386,0.000040014762,0.00046413267],"category_scores_gemma":[0.0022452387,0.00016469185,0.000037394228,0.0011904514,0.00092966645,0.0001306649,0.0035632318,0.0013844246,0.000010244963],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010584163,0.0014491124,0.9028795,0.0012206265,0.00017024892,0.0002766438,0.005631291,0.000036302154,0.032883324,0.00065925956,0.018420579,0.0353147],"study_design_scores_gemma":[0.0042819353,0.0009091194,0.8907805,0.0019366739,0.00006919602,0.00008419301,0.0038991347,0.0011246958,0.0011437489,0.00063767977,0.09476171,0.00037142754],"about_ca_topic_score_codex":0.007841412,"about_ca_topic_score_gemma":0.002911479,"teacher_disagreement_score":0.083071545,"about_ca_system_score_codex":0.0009884516,"about_ca_system_score_gemma":0.0011110475,"threshold_uncertainty_score":0.99876547},"labels":[],"label_agreement":null},{"id":"W4293778660","doi":"10.3892/ol.2022.13454","title":"Long‑term survival in a patient with extensive‑stage small cell lung cancer treated with multiple courses of salvage stereotactic radiation after whole brain radiotherapy: A case report","year":2022,"lang":"en","type":"article","venue":"Oncology Letters","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"London Health Sciences Centre","keywords":"Medicine; Radiation therapy; Radiosurgery; Lung cancer; Prophylactic cranial irradiation; Stereotactic radiation therapy; Stage (stratigraphy); Salvage therapy; Cancer; Radiology; Surgery; Oncology; Chemotherapy; Internal medicine","score_opus":0.014298012171305031,"score_gpt":0.3152644065497084,"score_spread":0.30096639437840333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293778660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866566,0.0011969769,0.0000707138,0.010159886,0.000115821924,0.0016083557,0.0000903019,0.00003264389,0.0000686705],"genre_scores_gemma":[0.99445564,0.000036654317,0.00021817748,0.003347934,0.00006709978,0.0012276997,0.000049885857,0.000054230644,0.0005426709],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99793917,0.00039066563,0.000359983,0.00047118127,0.00040580606,0.00043318162],"domain_scores_gemma":[0.9987309,0.0003387485,0.0003333444,0.00036993652,0.00011952819,0.000107557586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030727117,0.00023200396,0.0005982182,0.000277084,0.0001026649,0.000009729828,0.0000737731,0.000050382747,0.00014214992],"category_scores_gemma":[0.00004875385,0.00018083939,0.000059766633,0.00036731054,0.00022450213,0.000075428594,0.00006821616,0.00042133834,4.4735316e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005563623,0.00040327088,0.6991726,0.00020126131,0.00039088418,0.2770183,0.0042122756,0.00055702095,0.010180124,1.2010172e-7,0.001284994,0.0010155025],"study_design_scores_gemma":[0.027325545,0.008409073,0.9267282,0.00030090837,0.0006011118,0.022412492,0.003592948,0.0007327568,0.0028028616,1.2749774e-7,0.0064798645,0.0006140955],"about_ca_topic_score_codex":0.0039712354,"about_ca_topic_score_gemma":0.0075453953,"teacher_disagreement_score":0.25460583,"about_ca_system_score_codex":0.0019292826,"about_ca_system_score_gemma":0.000521974,"threshold_uncertainty_score":0.7374416},"labels":[],"label_agreement":null},{"id":"W4294934458","doi":"10.1016/j.jtho.2022.07.995","title":"EP14.05-020 Population-based Outcomes for Patients with Extensive-Stage Small-cell Lung Cancer from the Canadian SCLC Database (CASCADE)","year":2022,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cancer Care Ontario; Cancer Care South East; Northeast Cancer Centre; Queen Elizabeth II Health Sciences Centre; CancerCare Manitoba","funders":"","keywords":"Medicine; Stage (stratigraphy); Oncology; Internal medicine; Population; Cascade; Lung cancer; Cancer; Database; Environmental health","score_opus":0.04046655758585513,"score_gpt":0.4247877452949683,"score_spread":0.38432118770911317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294934458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9615572,0.001429052,0.00013645632,0.03313701,0.0009031562,0.0013176735,0.0013832127,0.000010648065,0.00012559192],"genre_scores_gemma":[0.98884785,0.000035830413,0.0028707623,0.00670702,0.0003678284,0.00017849088,0.00021440128,0.000042560132,0.0007352599],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997833,0.00029606634,0.00050564663,0.00023550814,0.0006843093,0.0004454823],"domain_scores_gemma":[0.99695164,0.0010153316,0.0006065764,0.00032021967,0.0007658014,0.00034044776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073618424,0.00018530326,0.0006299586,0.0002336941,0.0006527139,0.000025084992,0.0003338613,0.00006587401,0.0006020811],"category_scores_gemma":[0.0005894254,0.00011220518,0.00015689468,0.0002408175,0.00008703393,0.000084305284,0.000108139946,0.0007738462,0.000001576059],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029561133,0.000299185,0.9637478,0.00011025607,0.0004947326,0.0002510854,0.0005423486,0.0009663156,0.000043387678,0.0000065791505,0.024250802,0.0063314014],"study_design_scores_gemma":[0.0056317993,0.0028814902,0.8885324,0.0001562404,0.0012002158,0.000018805882,0.0011864965,0.0013023652,0.00011465859,0.000024736797,0.09872183,0.00022896641],"about_ca_topic_score_codex":0.09255526,"about_ca_topic_score_gemma":0.2620847,"teacher_disagreement_score":0.16952944,"about_ca_system_score_codex":0.0032698738,"about_ca_system_score_gemma":0.0040182127,"threshold_uncertainty_score":0.9134875},"labels":[],"label_agreement":null},{"id":"W4294940201","doi":"10.1016/j.jtho.2022.07.954","title":"EP14.01-019 Identifying Circulating DNA Methylation Patterns in Small Cell Lung Cancer Patients","year":2022,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; DNA methylation; Lung cancer; DNA; Methylation; Cancer; Cancer research; Computational biology; Oncology; Internal medicine; Genetics; Gene; Gene expression; Biology","score_opus":0.05116896901006629,"score_gpt":0.46292772861565523,"score_spread":0.41175875960558894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294940201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99376726,0.0021796045,0.00023542177,0.0016840334,0.001083294,0.0004025191,0.000012928128,0.000010109078,0.00062483473],"genre_scores_gemma":[0.9982696,0.00024057807,0.000509236,0.00033273557,0.00032137695,0.000051388673,0.000007787829,0.000026545616,0.0002407464],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99758404,0.00053604646,0.0007392219,0.00019647893,0.00058302126,0.00036120886],"domain_scores_gemma":[0.9984386,0.00027094778,0.0007475729,0.00013419423,0.00028664852,0.00012203926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015700847,0.00013208383,0.00054692087,0.0005122261,0.00016387482,0.000015824167,0.00018806856,0.00006759473,0.0003786395],"category_scores_gemma":[0.00026211358,0.00011957126,0.00014717525,0.00037702968,0.000030642717,0.00013889778,0.00026981242,0.0009944018,0.0000019319714],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076964684,0.0005184507,0.927536,0.0005540233,0.00019487081,0.0005976006,0.0038457222,0.0010816654,0.0078292955,0.0000022961406,0.0010087756,0.056061655],"study_design_scores_gemma":[0.003849364,0.0020294718,0.9799814,0.00048848573,0.0004959236,0.00018843892,0.0035362677,0.0015603394,0.003531941,0.00014267968,0.0039516184,0.00024402673],"about_ca_topic_score_codex":0.0002460819,"about_ca_topic_score_gemma":0.00024539395,"teacher_disagreement_score":0.05581763,"about_ca_system_score_codex":0.0026390126,"about_ca_system_score_gemma":0.00060213817,"threshold_uncertainty_score":0.6900926},"labels":[],"label_agreement":null},{"id":"W4294940874","doi":"10.1016/j.jtho.2022.07.974","title":"EP14.04-001 Treatment and Outcomes of Patients with Limited-Stage Small-cell Lung Cancer in the Canadian SCLC Database (CASCADE)","year":2022,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cancer Care Ontario; Cancer Care South East; Northeast Cancer Centre; CancerCare Manitoba; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Stage (stratigraphy); Oncology; Cascade; Internal medicine; Cancer; Lung cancer; Database","score_opus":0.0379800896193987,"score_gpt":0.4213255832223028,"score_spread":0.3833454936029041,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294940874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98696595,0.002893455,0.0000013269236,0.008243676,0.00016336427,0.00059830066,0.00026340265,0.00000244014,0.00086805923],"genre_scores_gemma":[0.99738556,0.00057899975,0.00023902506,0.0007098586,0.000061396844,0.0000640199,0.000016463207,0.00001544236,0.0009292583],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983416,0.0003542501,0.0004066605,0.00014638642,0.00043234587,0.0003187179],"domain_scores_gemma":[0.9987297,0.00030093186,0.00036898997,0.00020660697,0.00019584547,0.00019793391],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078313425,0.0001377989,0.0005720568,0.00039249993,0.00016956394,0.000009811404,0.00018805546,0.000043832326,0.00023251443],"category_scores_gemma":[0.000099127166,0.00007565774,0.000058411388,0.00027477226,0.00012670667,0.000065500666,0.00009657504,0.0005303412,3.9890995e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016667593,0.0009779634,0.97104055,0.00014200706,0.00041174545,0.00069881626,0.0027913887,0.00009734086,0.00004582926,0.0000073565716,0.0017401439,0.02038013],"study_design_scores_gemma":[0.006250999,0.007524089,0.9187404,0.0001001238,0.00073833106,0.00010234461,0.0034302117,0.00010421115,0.00015449211,0.0000055427668,0.06271513,0.0001341433],"about_ca_topic_score_codex":0.038493052,"about_ca_topic_score_gemma":0.28099874,"teacher_disagreement_score":0.24250568,"about_ca_system_score_codex":0.0024663927,"about_ca_system_score_gemma":0.00196733,"threshold_uncertainty_score":0.9679097},"labels":[],"label_agreement":null},{"id":"W4294942898","doi":"10.1016/j.jtho.2022.07.411","title":"EP03.01-016 The Canadian Small Cell Lung Cancer Database (CASCADE): Results from a Multi-Institutional Real-World Evidence Collaboration","year":2022,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cancer Care Ontario; CancerCare Manitoba; Queen Elizabeth II Health Sciences Centre; Cancer Care South East; Northeast Cancer Centre","funders":"","keywords":"Medicine; Cascade; Database; Lung cancer; Oncology","score_opus":0.08650866978257099,"score_gpt":0.47472910042043553,"score_spread":0.38822043063786454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294942898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.699655,0.029232908,0.0003331318,0.25092345,0.0054718805,0.0024169507,0.003652225,0.000046574638,0.008267894],"genre_scores_gemma":[0.985408,0.003198253,0.003851681,0.002370362,0.0013764129,0.00013753414,0.000081118094,0.000023740822,0.0035529106],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968699,0.00076520897,0.00074962736,0.00030390275,0.0008689695,0.000442366],"domain_scores_gemma":[0.9967232,0.0010092199,0.0006916468,0.00037988115,0.0007760987,0.0004199723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025657176,0.00018434471,0.0005070909,0.00043547308,0.0009867068,0.000045275097,0.0004682134,0.000076975106,0.00046961848],"category_scores_gemma":[0.0012365459,0.0001226002,0.0001243503,0.00083392905,0.00025069682,0.00024503472,0.00025408345,0.0013439025,0.0000092900855],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.034317918,0.0013824401,0.076314405,0.00054847787,0.0021459355,0.012850144,0.015308899,0.013166779,0.01600356,0.00028284386,0.79659176,0.03108684],"study_design_scores_gemma":[0.0075907954,0.0023650534,0.114267066,0.0013252549,0.0019462346,0.00072392594,0.0050352234,0.010381916,0.003676487,0.000071682574,0.8520986,0.0005177873],"about_ca_topic_score_codex":0.26979864,"about_ca_topic_score_gemma":0.8359297,"teacher_disagreement_score":0.56613106,"about_ca_system_score_codex":0.008932278,"about_ca_system_score_gemma":0.018282898,"threshold_uncertainty_score":0.9948723},"labels":[],"label_agreement":null},{"id":"W4294958749","doi":"10.1136/jitc-2022-004913","title":"Nemvaleukin alfa, a novel engineered IL-2 fusion protein, drives antitumor immunity and inhibits tumor growth in small cell lung cancer","year":2022,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Foundation Medicine; Pfizer; G1 Therapeutics; York University; NYU Grossman School of Medicine; Genentech; AstraZeneca; Bristol-Myers Squibb","keywords":"Immune system; CD8; Cancer research; Medicine; Immunotherapy; Immunology; Cytotoxic T cell; Chemotherapy; Tumor microenvironment; Cisplatin; Biology; Internal medicine","score_opus":0.01763794552398114,"score_gpt":0.3215746549365428,"score_spread":0.3039367094125617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294958749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91248447,0.082924046,0.00019190315,0.0018804895,0.00037091257,0.001833108,0.00023306774,0.000019146297,0.00006288748],"genre_scores_gemma":[0.9764324,0.01918903,0.0010926368,0.00038913198,0.00025290198,0.0013171786,0.000008238118,0.00008339961,0.0012351176],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99797636,0.00009082979,0.0006129405,0.00027857145,0.00052831095,0.00051296764],"domain_scores_gemma":[0.9988025,0.00009631979,0.0003858985,0.00021776767,0.0003790403,0.00011850807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080786465,0.00027017525,0.0006523636,0.00043210253,0.00042850742,0.00003701777,0.0002587829,0.000045219982,0.0002880739],"category_scores_gemma":[0.00007882145,0.00023197809,0.00018996294,0.00047748434,0.00013143195,0.00016077302,0.00016892106,0.00087315496,1.5523784e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044573643,0.000470034,0.021128142,0.0010723346,0.00042375308,0.000024885872,0.0030583635,0.00023600964,0.96258044,0.0000470072,0.0010312311,0.0054704193],"study_design_scores_gemma":[0.062936254,0.0053281602,0.18938346,0.0044059926,0.00040112398,0.00041732242,0.0034905649,0.003400292,0.68161243,0.00043328365,0.04684684,0.0013442462],"about_ca_topic_score_codex":0.0021834665,"about_ca_topic_score_gemma":0.00031196148,"teacher_disagreement_score":0.280968,"about_ca_system_score_codex":0.0008897514,"about_ca_system_score_gemma":0.0008761881,"threshold_uncertainty_score":0.9459792},"labels":[],"label_agreement":null},{"id":"W4295836988","doi":"10.1016/j.annonc.2022.07.1641","title":"1547P Predictors of short-, medium-, and long-term survival with limited stage small cell lung cancer in the real-world","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; AstraZeneca (Canada); University of Manitoba; CancerCare Manitoba","funders":"Daiichi Sankyo Europe; Shionogi; Astellas Pharma; Ono Pharmaceutical; Eisai; Chugai Pharmaceutical; Celltrion; Kissei; Taiho Pharmaceutical; Daiichi-Sankyo; Amgen; Pfizer; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Kyowa Hakko Kirin","keywords":"Medicine; Prophylactic cranial irradiation; Internal medicine; Cohort; Proportional hazards model; Survival analysis; Radiation therapy; Cancer; Retrospective cohort study; Oncology; Stage (stratigraphy); Surgery; Conventional PCI; Myocardial infarction","score_opus":0.09098211067852403,"score_gpt":0.42048352447356657,"score_spread":0.32950141379504255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295836988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815543,0.002472378,0.0000016511589,0.006125965,0.00012982046,0.00074241625,0.000113976195,0.000011607779,0.008847831],"genre_scores_gemma":[0.9933793,0.0047353925,0.000016183303,0.00042474794,0.00009281961,0.00021940398,0.000018127806,0.000017550004,0.0010964855],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998245,0.00034621233,0.0003302491,0.00024230174,0.00049782125,0.00033842397],"domain_scores_gemma":[0.99878204,0.0005334039,0.00014543196,0.00027343226,0.00018488517,0.00008080227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010242371,0.0001302347,0.00053859886,0.000244263,0.000068866735,0.0000033217877,0.00021292805,0.000042991192,0.0001858603],"category_scores_gemma":[0.000066413006,0.000085869186,0.000047864156,0.00048739216,0.00036311932,0.00003284707,0.00023755645,0.00039974894,1.3679528e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013859279,0.00039707654,0.9892826,0.0004923733,0.0002758284,0.0002396113,0.0033650247,0.000055859724,0.00093786203,0.000042473057,0.0020995487,0.0014258215],"study_design_scores_gemma":[0.001725257,0.0040193303,0.98616344,0.000080397556,0.00012231589,0.000006940104,0.0013437555,0.00003512855,0.001447074,0.000004757167,0.0049674315,0.00008415998],"about_ca_topic_score_codex":0.001883344,"about_ca_topic_score_gemma":0.022614397,"teacher_disagreement_score":0.020731052,"about_ca_system_score_codex":0.00012985307,"about_ca_system_score_gemma":0.00065272447,"threshold_uncertainty_score":0.99522036},"labels":[],"label_agreement":null},{"id":"W4295837114","doi":"10.1016/j.annonc.2022.07.1631","title":"1536P Synthetic control arm (SCA) analysis of lurbinectedin compared to the standard of care (SoC) among patients with small cell lung cancer (SCLC) previously treated with platinum-based chemotherapy","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Calgary","funders":"","keywords":"Medicine; Hazard ratio; Chemotherapy; Oncology; Internal medicine; Population; Proportional hazards model; Confidence interval","score_opus":0.02381458618281122,"score_gpt":0.3388116935326948,"score_spread":0.31499710734988356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295837114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927333,0.0012051371,0.000086259766,0.0023000904,0.000023644649,0.002232303,0.00081957085,0.000019913181,0.0005797645],"genre_scores_gemma":[0.9985802,0.00008612663,0.00014707712,0.0005142675,0.000017114193,0.00047208494,0.00007998639,0.000032417887,0.000070734364],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977061,0.00029494945,0.0004969158,0.0003434646,0.00076453725,0.0003940122],"domain_scores_gemma":[0.9969178,0.00041264648,0.00057249377,0.00046453957,0.0015066154,0.00012594889],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035850675,0.00022503563,0.0014673325,0.0003938604,0.000106863874,0.0000039965994,0.0002647088,0.000053086937,0.00030953268],"category_scores_gemma":[0.00007379864,0.00013701172,0.0001873353,0.0013248884,0.0003294851,0.000021284317,0.00006406524,0.0002291852,1.5103598e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026607784,0.0008786224,0.9329778,0.00046285096,0.005544306,0.000015948757,0.0058853296,0.022255514,0.0003640257,0.0000022612473,0.0022539361,0.0027516088],"study_design_scores_gemma":[0.028903376,0.056168918,0.8770704,0.00051085494,0.0067662913,0.0000012247127,0.0034610103,0.003231244,0.01924593,0.000001314666,0.004272714,0.00036669613],"about_ca_topic_score_codex":0.0023490228,"about_ca_topic_score_gemma":0.005195163,"teacher_disagreement_score":0.055907387,"about_ca_system_score_codex":0.00037305927,"about_ca_system_score_gemma":0.0007896243,"threshold_uncertainty_score":0.5587176},"labels":[],"label_agreement":null},{"id":"W4296099256","doi":"10.3389/fonc.2022.1002385","title":"Real-world eligibility for platinum doublet plus immune checkpoint inhibitors in extensive-stage small-cell lung cancer","year":2022,"lang":"en","type":"article","venue":"Frontiers in Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"AstraZeneca","keywords":"Stage (stratigraphy); Lung cancer; Platinum; Oncology; Immune checkpoint; Medicine; Cancer research; PD-L1; Cancer; Internal medicine; Immune system; Immunology; Immunotherapy; Biology","score_opus":0.03261963511411389,"score_gpt":0.3869636982292617,"score_spread":0.35434406311514777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296099256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.949881,0.01376197,0.00028734872,0.009433587,0.0051606405,0.0060871975,0.00021369407,0.00010310674,0.015071447],"genre_scores_gemma":[0.95510674,0.002030379,0.009443198,0.0011691718,0.00062666624,0.008795159,0.00015132608,0.000119988006,0.022557367],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969334,0.00027289803,0.0008311364,0.00071795715,0.00036932982,0.0008752991],"domain_scores_gemma":[0.998701,0.0002889128,0.00024652813,0.00048045313,0.00014421102,0.00013894522],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015726129,0.0002657136,0.0010988107,0.0006538263,0.00018989359,0.0000095565565,0.00027739088,0.0001290659,0.00021784185],"category_scores_gemma":[0.0003169833,0.00026662106,0.00017983328,0.0007988771,0.00024265435,0.00006080457,0.0005343978,0.0010175525,0.0000014714149],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012233401,0.0010206888,0.704911,0.0015762339,0.0002970285,0.0007882712,0.008921327,0.0049956455,0.0064343256,0.00010956146,0.25155306,0.007159475],"study_design_scores_gemma":[0.07216831,0.0048922095,0.21625087,0.00043937526,0.00041476727,0.000029476823,0.024358317,0.03295449,0.015582318,0.0012132068,0.6302073,0.0014893839],"about_ca_topic_score_codex":0.009897259,"about_ca_topic_score_gemma":0.009533243,"teacher_disagreement_score":0.4886601,"about_ca_system_score_codex":0.012311544,"about_ca_system_score_gemma":0.0017886253,"threshold_uncertainty_score":0.9999786},"labels":[],"label_agreement":null},{"id":"W4297253552","doi":"10.4049/jimmunol.2100901","title":"Negative Cross-Talk between TLR2/4-Independent AMPKα1 and TLR2/4-Dependent JNK Regulates <i>S. pneumoniae</i>–Induced Mucosal Innate Immune Response","year":2022,"lang":"en","type":"article","venue":"The Journal of Immunology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Institutes of Health; Ministry of Education, Culture, Sports, Science and Technology; National Institute on Deafness and Other Communication Disorders; Japan Society for the Promotion of Science; Georgia Research Alliance","keywords":"TLR2; Innate immune system; AMPK; Protein kinase A; Cell biology; Mucin; Immune system; Signal transduction; Biology; Pneumolysin; Downregulation and upregulation; Kinase; Streptococcus pneumoniae; Immunology; Chemistry; Microbiology","score_opus":0.023511746423171703,"score_gpt":0.32991962030180927,"score_spread":0.30640787387863755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297253552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9734625,0.009838887,0.000009035111,0.015336706,0.0005501249,0.0005352134,0.000035805595,0.000033495606,0.00019820788],"genre_scores_gemma":[0.99646735,0.0013962922,0.000049641883,0.00023438156,0.00021298285,0.000028453363,0.000004106903,0.000053641696,0.0015531615],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99509734,0.0018184818,0.0010299548,0.0002882159,0.0010774282,0.0006885898],"domain_scores_gemma":[0.9962806,0.0015821664,0.00085454946,0.0006021167,0.0005258694,0.00015470485],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.005095596,0.00032912212,0.00094443007,0.00044004302,0.0008509418,0.000053550946,0.0007343358,0.00012857451,0.00022123901],"category_scores_gemma":[0.0011533482,0.00022465794,0.0002083275,0.00040889203,0.00076102035,0.00021203385,0.0013628827,0.0023719433,0.000012976926],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030490482,0.00026757352,0.015436724,0.000059101036,0.0032620477,0.00096346677,0.007882455,0.000060450533,0.9357256,0.000071613154,0.0004919881,0.0052884803],"study_design_scores_gemma":[0.009735824,0.008385168,0.83435124,0.00013514378,0.00055173266,0.00862294,0.006721938,0.000017343067,0.12621328,0.0012199016,0.0036897734,0.00035571677],"about_ca_topic_score_codex":0.00037420687,"about_ca_topic_score_gemma":0.000021767999,"teacher_disagreement_score":0.81891453,"about_ca_system_score_codex":0.0007772446,"about_ca_system_score_gemma":0.00059725303,"threshold_uncertainty_score":0.9999296},"labels":[],"label_agreement":null},{"id":"W4297830820","doi":"10.30683/1927-7229.2022.11.04","title":"Clinical Features of de Novo Lung Neuroendocrine Tumor after Liver Transplantation for Hepatocellular Carcinoma","year":2022,"lang":"en","type":"article","venue":"Journal of Analytical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Hepatocellular carcinoma; Lung; Liver transplantation; Internal medicine; Etoposide; Carcinoma; Gastroenterology; Pathological; Chemotherapy; Transplantation; Radiology","score_opus":0.03791791447402312,"score_gpt":0.40468108486019,"score_spread":0.3667631703861669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297830820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915348,0.0014166973,0.00059620384,0.0054868488,0.00023085193,0.0003037394,0.000029646926,0.0000042662496,0.0003969393],"genre_scores_gemma":[0.9963736,0.00050379004,0.0012383731,0.0011098381,0.00041147502,0.000024797842,0.0000035189237,0.000014393724,0.0003202055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981601,0.00026704578,0.0007186659,0.00014375377,0.0004266313,0.00028376174],"domain_scores_gemma":[0.99827087,0.0008244146,0.0002678059,0.00010982952,0.00031906128,0.00020799355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085362815,0.000097004704,0.0006735268,0.0001955413,0.00005607955,0.000003909752,0.00013374355,0.000025283041,0.0002506059],"category_scores_gemma":[0.00050438114,0.000075293254,0.00041841224,0.00015548948,0.00017773338,0.000042091313,0.000061326486,0.00067225005,6.689818e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.047828887,0.00171422,0.85150194,0.0011701125,0.001056293,0.06715306,0.0005112144,0.00007448684,0.0011179346,0.00053434947,0.023509206,0.003828273],"study_design_scores_gemma":[0.01175461,0.023620639,0.88412666,0.00008009853,0.0028927932,0.027665036,0.00033976414,0.009061075,0.0010293581,0.00019803765,0.03907143,0.00016050908],"about_ca_topic_score_codex":0.000018837798,"about_ca_topic_score_gemma":0.000010315934,"teacher_disagreement_score":0.03948802,"about_ca_system_score_codex":0.0004016804,"about_ca_system_score_gemma":0.0007760217,"threshold_uncertainty_score":0.307037},"labels":[],"label_agreement":null},{"id":"W4297973571","doi":"10.3390/curroncol29100565","title":"External Validation of the Graded Prognostic Assessment in Patients with Brain Metastases from Small Cell Lung Cancer","year":2022,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Lung cancer; Oncology; Brain metastasis; Lung; Internal medicine; Pathology; Cancer; Metastasis","score_opus":0.07784989185794236,"score_gpt":0.4295213568732286,"score_spread":0.35167146501528623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297973571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99493885,0.0017755842,0.00004975684,0.0011348197,0.0005393102,0.0013237438,0.00014815448,0.00000892967,0.000080823294],"genre_scores_gemma":[0.9988085,0.000043253105,0.00015623009,0.00007836473,0.00005408932,0.0007277021,0.00008176658,0.000011088244,0.00003897935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984423,0.0004265586,0.00022911106,0.000220328,0.0004737371,0.00020799859],"domain_scores_gemma":[0.9992134,0.0002738679,0.00017850622,0.00018058762,0.000108896864,0.000044760785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025121588,0.00010094862,0.00027695848,0.000084976484,0.0000799919,0.0000042784254,0.000150844,0.000017177146,0.00025917735],"category_scores_gemma":[0.0000948655,0.00006492278,0.000045118075,0.00024620738,0.00008510518,0.00002697002,0.00026836703,0.00041082568,4.642235e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025870698,0.0012608436,0.9920612,0.00013160624,0.000072921626,0.0000052070823,0.00060228584,0.00015797043,0.00027609852,0.000014569546,0.0013148084,0.003843786],"study_design_scores_gemma":[0.005248217,0.0009658748,0.98929316,0.0001429264,0.000200306,6.012734e-7,0.00020991254,0.00015084409,0.00089553744,0.000043787764,0.0027792016,0.00006960769],"about_ca_topic_score_codex":0.00035793413,"about_ca_topic_score_gemma":0.0001795375,"teacher_disagreement_score":0.00498951,"about_ca_system_score_codex":0.0009919832,"about_ca_system_score_gemma":0.00071829854,"threshold_uncertainty_score":0.28378102},"labels":[],"label_agreement":null},{"id":"W4300573232","doi":"","title":"Lung cancer.","year":2009,"lang":"en","type":"review","venue":"PubMed","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Erlotinib; Lung cancer; Chemotherapy; Oncology; Radiation therapy; Systematic review; Cochrane Library; Cancer; Intensive care medicine; Gefitinib; Internal medicine; MEDLINE; Randomized controlled trial; Epidermal growth factor receptor","score_opus":0.11321257530201834,"score_gpt":0.44533948901758486,"score_spread":0.3321269137155665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4300573232","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[1.6882319e-7,0.9728241,9.069835e-7,0.00063917146,0.00028924324,0.0043268222,0.00003426922,0.00010539003,0.021779913],"genre_scores_gemma":[0.0000013968619,0.96444756,0.000014962413,0.00017875088,0.0011456426,0.017561322,0.000031278665,0.000048427617,0.016570667],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980656,0.000060099646,0.00033558143,0.00039496354,0.0004622493,0.00068151933],"domain_scores_gemma":[0.9990001,0.000082611834,0.00012857583,0.00043018963,0.00007826588,0.00028026098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002784208,0.0003099589,0.0018015584,0.00019478388,0.000056394107,0.000024031078,0.00019177275,0.0001652903,0.00006864403],"category_scores_gemma":[0.0002392076,0.00021031997,0.00043308566,0.00040698916,0.00006422856,0.00003378549,0.0000976136,0.000537601,0.000028744576],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000062917443,0.000021287493,0.000020145126,0.027986454,0.0005147651,0.000057411224,0.0000067501005,1.2114723e-8,1.0850688e-9,0.000011852624,0.06754368,0.90383136],"study_design_scores_gemma":[0.00024871182,0.000013213436,0.0009640005,0.006785142,0.0019392661,0.000029688705,0.0000010729017,3.1613524e-7,1.1986494e-7,0.0000045096363,0.9898371,0.00017686415],"about_ca_topic_score_codex":0.000054286542,"about_ca_topic_score_gemma":0.000011815125,"teacher_disagreement_score":0.9222934,"about_ca_system_score_codex":0.0011344933,"about_ca_system_score_gemma":0.0004832845,"threshold_uncertainty_score":0.85765994},"labels":[],"label_agreement":null},{"id":"W4302037882","doi":"","title":"Lung cancer.","year":2010,"lang":"en","type":"review","venue":"PubMed","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Erlotinib; Lung cancer; Cochrane Library; Radiation therapy; Systematic review; Oncology; MEDLINE; Chemotherapy; Intensive care medicine; Gefitinib; Cancer; Psychological intervention; Internal medicine; Surgery; Randomized controlled trial; Epidermal growth factor receptor","score_opus":0.09964664190625337,"score_gpt":0.4412358088684417,"score_spread":0.34158916696218833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4302037882","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[5.957625e-7,0.9772817,7.064563e-7,0.00046244063,0.000834614,0.004418139,0.000056272183,0.00009622316,0.016849304],"genre_scores_gemma":[0.0000013292449,0.9472968,0.0000193795,0.00008585012,0.0015443197,0.03450861,0.000031175434,0.000069047965,0.016443506],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99815,0.000046054305,0.00031435784,0.00039205476,0.00044141017,0.0006561057],"domain_scores_gemma":[0.998833,0.00011500534,0.0001346713,0.0005128348,0.00009458895,0.00030992547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032567754,0.00030058282,0.0016366262,0.0001803292,0.000063547166,0.000025875948,0.00021814137,0.00026743155,0.00012738527],"category_scores_gemma":[0.00038726564,0.00019992441,0.00041025612,0.00032313302,0.0001132472,0.000033045002,0.00017191826,0.001117013,0.000038901166],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000049250334,0.000017136883,0.000055117504,0.03411084,0.00043797024,0.000036386722,0.000007685454,2.4499898e-9,7.984038e-9,0.000014032926,0.02960083,0.9357151],"study_design_scores_gemma":[0.00022597714,0.0000063010325,0.0005754542,0.0038210324,0.0017424424,0.00003268623,0.000001005899,2.6695304e-7,3.3777374e-7,0.0000025659317,0.9934192,0.0001727507],"about_ca_topic_score_codex":0.00008075041,"about_ca_topic_score_gemma":0.00004353471,"teacher_disagreement_score":0.9638184,"about_ca_system_score_codex":0.0005872423,"about_ca_system_score_gemma":0.0005732713,"threshold_uncertainty_score":0.8152681},"labels":[],"label_agreement":null},{"id":"W4306247391","doi":"10.1016/s2213-2600(22)00309-5","title":"Combination lurbinectedin and doxorubicin versus physician's choice of chemotherapy in patients with relapsed small-cell lung cancer (ATLANTIS): a multicentre, randomised, open-label, phase 3 trial","year":2022,"lang":"en","type":"article","venue":"The Lancet Respiratory Medicine","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Regional Municipality of Durham; Lakeridge Health","funders":"Chugai Pharmaceutical; Genentech; Ipsen; Jazz Pharmaceuticals; Daiichi Sankyo Europe; Sanofi; GlaxoSmithKline; Servier; Amgen; Pfizer; PharmaMar; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Internal medicine; Clinical endpoint; Chemotherapy; Population; Febrile neutropenia; Oncology; Doxorubicin; Topotecan; Vincristine; Anthracycline; Clinical trial; Surgery; Cyclophosphamide; Cancer; Neutropenia; Breast cancer","score_opus":0.0657955502563836,"score_gpt":0.3892918764154446,"score_spread":0.323496326159061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306247391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985546,0.0034522172,0.0000035278324,0.003316657,0.00042802983,0.0059300433,0.000037196183,0.000031601423,0.0012547491],"genre_scores_gemma":[0.9955657,0.00043981982,0.00002644296,0.002102522,0.0006036481,0.0009386576,0.00004652032,0.000046393594,0.00023027274],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99736863,0.0004492195,0.0004928445,0.00040669471,0.00085410086,0.00042851156],"domain_scores_gemma":[0.998098,0.00069846836,0.00038195125,0.00049383653,0.0002180823,0.00010966775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012467476,0.00025990885,0.0010618035,0.00018652667,0.00020599736,0.000013232139,0.00040220266,0.000043471886,0.00012779824],"category_scores_gemma":[0.00037715363,0.00016003507,0.00002832191,0.00072528765,0.00030293933,0.00009852791,0.00023180302,0.00059111667,5.1155007e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.929752,0.003010796,0.039310087,0.00046143946,0.00048444344,0.000027141408,0.0022294472,0.000021318192,0.005644782,0.000049531187,0.014520343,0.0044886624],"study_design_scores_gemma":[0.9544728,0.0109952735,0.02518866,0.0004006765,0.00032331492,3.9244532e-7,0.00034597702,0.0004311722,0.00082563434,0.0000050257977,0.006835998,0.00017507785],"about_ca_topic_score_codex":0.0009420719,"about_ca_topic_score_gemma":0.0002292334,"teacher_disagreement_score":0.024720788,"about_ca_system_score_codex":0.00036162089,"about_ca_system_score_gemma":0.00025226627,"threshold_uncertainty_score":0.65260404},"labels":[],"label_agreement":null},{"id":"W4306655086","doi":"10.1016/j.radonc.2022.09.017","title":"In reply to Li et al. Letter to the editor. “Once daily (OD) versus twice-daily (BID) chemoradiation for limited stage small cell lung cancer (LS-SCLC): A meta-analysis of randomized clinical trials.”","year":2022,"lang":"en","type":"letter","venue":"Radiotherapy and Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital","funders":"","keywords":"Meta-analysis; Medicine; Oncology; Stage (stratigraphy); Randomized controlled trial; Lung cancer; Internal medicine; Biology","score_opus":0.1580808550286847,"score_gpt":0.48006860970875204,"score_spread":0.32198775468006735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306655086","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010530573,0.0212451,0.0014054179,0.9627981,0.00464114,0.008015386,0.00064742286,0.000030939413,0.00016340404],"genre_scores_gemma":[0.00009265196,0.010323949,0.0021083131,0.9584679,0.015563064,0.008091158,0.00025263173,0.00010215527,0.004998204],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9873407,0.0077250865,0.0023007274,0.0011735923,0.0007818473,0.0006780773],"domain_scores_gemma":[0.9672669,0.030111128,0.0012307583,0.0009021826,0.00030972806,0.00017927804],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.022618832,0.0005351954,0.0082969405,0.0009896526,0.00013565354,0.000047011938,0.00047397753,0.00058374583,0.001112491],"category_scores_gemma":[0.0051704133,0.00034840117,0.002731641,0.0011332538,0.00026733868,0.00006862998,0.00014796847,0.0021106668,0.0000014396029],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13903156,0.0001154142,0.000056819346,0.00018028707,0.07952659,0.00006214948,0.001909836,0.00029974373,0.00014135343,0.0000033387603,0.77801955,0.0006533694],"study_design_scores_gemma":[0.09393591,0.001952297,0.000038852304,0.000016395954,0.063012354,0.0000012032802,0.00007984934,0.0011386963,0.000031040978,0.0000013240114,0.83952373,0.00026836872],"about_ca_topic_score_codex":0.002041805,"about_ca_topic_score_gemma":0.0017038946,"teacher_disagreement_score":0.06150418,"about_ca_system_score_codex":0.0015638421,"about_ca_system_score_gemma":0.0009830625,"threshold_uncertainty_score":0.9998968},"labels":[],"label_agreement":null},{"id":"W4307101139","doi":"10.14740/wjon1494","title":"Precise Therapeutic Benefits and Underlying Mechanisms of Anlotinib Combined With Checkpoint Immunotherapy in Advanced Non-Small-Cell Lung Cancer","year":2022,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Gannan Medical University; Beijing Medical and Health Foundation","keywords":"Medicine; Immunotherapy; Lung cancer; Oncology; Cancer research; Cancer; Internal medicine","score_opus":0.037985730280862134,"score_gpt":0.3591037669550723,"score_spread":0.32111803667421013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307101139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97223127,0.021903733,0.00028127842,0.0037028797,0.00023485521,0.00078330823,0.0000058448913,0.0000065212657,0.0008503038],"genre_scores_gemma":[0.99358016,0.0034971253,0.002043709,0.0003858014,0.000029507424,0.00009702324,8.588473e-7,0.000029860134,0.00033597872],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984652,0.00015348103,0.00053011405,0.00017051712,0.00038332093,0.0002974094],"domain_scores_gemma":[0.9988036,0.00023882087,0.000517387,0.00014696733,0.00020333407,0.00008989987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007674639,0.00015094703,0.0007201361,0.00044522935,0.000098899865,0.0000058457817,0.00016278443,0.000031886888,0.00018438634],"category_scores_gemma":[0.00001599972,0.000114729344,0.00007342656,0.00046303292,0.000092872986,0.00006263548,0.00010594744,0.00064238574,1.4077662e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.058708794,0.003407405,0.21152668,0.0010874044,0.0025975173,0.0009551382,0.014431691,0.0102243,0.37929222,0.0012601234,0.00040369082,0.31610504],"study_design_scores_gemma":[0.18206789,0.10511783,0.5826545,0.0038635791,0.0013876962,0.0017403116,0.016419632,0.0027204405,0.08651451,0.0033468888,0.012923128,0.0012436301],"about_ca_topic_score_codex":0.00008812063,"about_ca_topic_score_gemma":0.0007940111,"teacher_disagreement_score":0.37112778,"about_ca_system_score_codex":0.00079763203,"about_ca_system_score_gemma":0.0008256919,"threshold_uncertainty_score":0.46785268},"labels":[],"label_agreement":null},{"id":"W4307657760","doi":"10.3390/curroncol29100631","title":"The Impact of Chemosensitivity on the Outcome of Brain Metastases in Small-Cell Lung Cancer: A Retrospective Analysis","year":2022,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Oncology; Retrospective cohort study; Lung cancer; Cancer; Internal medicine; Pathology; Cancer research; Bioinformatics; Biology","score_opus":0.11488748989150868,"score_gpt":0.4945503053120081,"score_spread":0.3796628154204994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307657760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98910683,0.0036243512,0.000008353873,0.0054316777,0.00014551923,0.0006920604,0.0002458172,0.000007280497,0.0007381354],"genre_scores_gemma":[0.99914354,0.00041433497,0.0000053046997,0.000058775502,0.00003897632,0.00022817409,0.000010675227,0.000008109858,0.000092109025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998059,0.00073929224,0.00034538718,0.0002293627,0.0003363891,0.00029058207],"domain_scores_gemma":[0.9973515,0.0017911872,0.0002750402,0.00036811968,0.00016783041,0.0000462836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017708621,0.0001267615,0.00071717944,0.00021897304,0.00014632478,0.0000032417565,0.00018425223,0.00002312989,0.0001714805],"category_scores_gemma":[0.00092098577,0.0000661531,0.00037180912,0.001239773,0.00027790444,0.0000124509415,0.00029081453,0.00057936436,4.794616e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006359371,0.0007770606,0.9852026,0.00007306533,0.0016509241,0.000016223416,0.0011974437,0.0004995058,0.00090331945,0.00020651985,0.0055303113,0.0033070846],"study_design_scores_gemma":[0.0018657312,0.0017396145,0.9887608,0.00002635577,0.00088207686,0.0000032875187,0.0013281753,0.0022913066,0.0015159184,0.00009113786,0.0014087032,0.00008685986],"about_ca_topic_score_codex":0.0021844674,"about_ca_topic_score_gemma":0.0021483854,"teacher_disagreement_score":0.010036736,"about_ca_system_score_codex":0.002195743,"about_ca_system_score_gemma":0.000479808,"threshold_uncertainty_score":0.5741791},"labels":[],"label_agreement":null},{"id":"W4308326586","doi":"10.1016/j.isci.2022.105487","title":"Cell-free DNA methylation-defined prognostic subgroups in small-cell lung cancer identified by leukocyte methylation subtraction","year":2022,"lang":"en","type":"article","venue":"iScience","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Princess Margaret Cancer Centre; Canada Research Chairs; St Mary's Hospital Centre; University of Toronto","funders":"Memorial Sloan-Kettering Cancer Center; University of Toronto; Canada Foundation for Innovation; National Cancer Institute; National Institutes of Health; Ontario Institute for Cancer Research; Canadian Institutes of Health Research; Cancer Research Society","keywords":"DNA methylation; Methylation; Biology; Methylated DNA immunoprecipitation; Differentially methylated regions; Epigenomics; Cancer research; Epigenetics; Lung cancer; Molecular biology; DNA; Genetics; Oncology; Gene; Medicine; Gene expression","score_opus":0.027333121702545444,"score_gpt":0.3252409477923015,"score_spread":0.2979078260897561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308326586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824711,0.0099024335,0.0013127284,0.0024581526,0.0005326269,0.0012881276,0.00003480882,0.00008339961,0.0019165972],"genre_scores_gemma":[0.9950204,0.0003378202,0.0003372942,0.00016399017,0.000070275404,0.00077580917,0.00003812975,0.000023218297,0.0032330833],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99729973,0.0002016097,0.0003707265,0.0006120415,0.0010066233,0.00050925894],"domain_scores_gemma":[0.99875385,0.00034320535,0.00018429982,0.00043728977,0.00015417671,0.00012720471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013642746,0.00017826614,0.0002678319,0.0003323241,0.00046086864,0.00006434973,0.00037943828,0.000045677585,0.000295302],"category_scores_gemma":[0.00053316256,0.0001722959,0.000067880006,0.0015389201,0.00013488371,0.0003364063,0.00034157178,0.0004726155,0.000012072466],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003052183,0.00047688972,0.1818611,0.0004257004,0.000039681436,0.00005710934,0.0031440286,0.0025915226,0.79100406,0.00008543926,0.016184486,0.0038247819],"study_design_scores_gemma":[0.00962614,0.00093512103,0.4613206,0.00021617817,0.00041204641,0.000028658342,0.0025882283,0.044306524,0.47041494,0.0012786215,0.0078050494,0.001067894],"about_ca_topic_score_codex":0.0022400878,"about_ca_topic_score_gemma":0.000693212,"teacher_disagreement_score":0.32058913,"about_ca_system_score_codex":0.0012582458,"about_ca_system_score_gemma":0.0005176615,"threshold_uncertainty_score":0.70260227},"labels":[],"label_agreement":null},{"id":"W4308653809","doi":"10.1158/0008-5472.can-22-1433","title":"Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Institute of General Medical Sciences; National Cancer Institute; Canadian Institutes of Health Research; Genentech; National Institutes of Health; University of California, San Francisco; Scheme for Promotion of Academic and Research Collaboration; Astellas Pharma; Clovis Oncology; U.S. Department of Defense; Sanofi; Celgene; Prostate Cancer Foundation; AstraZeneca; Amgen; Pfizer; Advanced Accelerator Applications","keywords":"Prostate cancer; Medicine; Immunotherapy; Cancer; Cancer research; T cell; Immunology; Internal medicine; Immune system","score_opus":0.053846302946261894,"score_gpt":0.41391753279444676,"score_spread":0.36007122984818485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308653809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93425184,0.05739909,0.00000106453,0.0063662212,0.000111973044,0.0011125593,0.00005978356,0.000024527506,0.00067291193],"genre_scores_gemma":[0.9823396,0.012968054,0.0000505906,0.00024667662,0.000086313245,0.0016846111,0.0000075343773,0.00005572492,0.0025608852],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970871,0.00037544192,0.00033408942,0.00047654746,0.00085168146,0.00087509106],"domain_scores_gemma":[0.99897987,0.00022078141,0.000070474765,0.0003045541,0.0002976004,0.00012674974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011336925,0.00015480314,0.00036891695,0.00051444944,0.00030700947,0.00002632015,0.00024126844,0.0000073650763,0.00073908264],"category_scores_gemma":[0.00012201348,0.00014422313,0.00004990874,0.0010353419,0.00036041683,0.000071978735,0.0008121859,0.0011569447,0.0000021663195],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023310399,0.00031493278,0.5570263,0.0022061574,0.0001439518,0.0014485853,0.004728756,0.00029402087,0.4030983,0.00006200209,0.0045480565,0.023797864],"study_design_scores_gemma":[0.049254682,0.004837661,0.34617844,0.0030658839,0.00032087587,0.0008961374,0.047007162,0.009309249,0.30257374,0.0018879059,0.23247653,0.0021917422],"about_ca_topic_score_codex":0.008964457,"about_ca_topic_score_gemma":0.00041080674,"teacher_disagreement_score":0.22792847,"about_ca_system_score_codex":0.00082071306,"about_ca_system_score_gemma":0.00085182884,"threshold_uncertainty_score":0.99763495},"labels":[],"label_agreement":null},{"id":"W4309680566","doi":"10.3390/curroncol29120709","title":"Chemo-Immunotherapy in First Line Extensive Stage Small Cell Lung Cancer (ES-SCLC): A Systematic Review and Meta-Analysis","year":2022,"lang":"en","type":"review","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Meta-analysis; Immunotherapy; Lung cancer; Oncology; Stage (stratigraphy); Internal medicine; Cancer research; Cancer; Biology","score_opus":0.33216281371612116,"score_gpt":0.5244035456527203,"score_spread":0.19224073193659913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309680566","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000020836471,0.9870341,0.000014920819,0.0009283855,0.00024964145,0.011105345,0.0004079392,0.000037627073,0.00021998181],"genre_scores_gemma":[0.0000020156137,0.9798348,0.000040839306,0.0005606264,0.00009386403,0.017203864,0.00022616309,0.00008486377,0.0019529474],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.994391,0.0014256792,0.0018989607,0.0010590184,0.0005628547,0.00066249026],"domain_scores_gemma":[0.99574214,0.0013745865,0.001318793,0.0010946022,0.00027140812,0.00019844844],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018240979,0.000823997,0.018034717,0.00084270095,0.00013768139,0.000022679102,0.0004600026,0.00022297497,0.0036583617],"category_scores_gemma":[0.0005915617,0.000537321,0.0026954308,0.0019189145,0.00016485932,0.000038110466,0.0005099092,0.0015989761,0.000014276769],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017541408,0.00030207896,0.000020681968,0.883467,0.10240562,0.00013697417,0.00022546432,0.0000015207723,4.3747416e-8,0.0000045142096,0.0014277998,0.011990754],"study_design_scores_gemma":[0.00046321345,0.0001403725,0.0000021876306,0.027606487,0.44868532,0.000019331064,0.000027154076,0.000009689509,5.643837e-8,5.6126544e-7,0.5228144,0.00023123925],"about_ca_topic_score_codex":0.00018321662,"about_ca_topic_score_gemma":0.0007019044,"teacher_disagreement_score":0.85586053,"about_ca_system_score_codex":0.0029017592,"about_ca_system_score_gemma":0.0013532438,"threshold_uncertainty_score":0.9997078},"labels":[],"label_agreement":null},{"id":"W4310753331","doi":"10.1016/j.annonc.2022.10.396","title":"358P Intracranial metastatic disease (IMD) burden and management of patients with small cell lung cancer (SCLC): A population-based analysis of 8705 patients","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Cancer Care Ontario; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; Health Sciences Centre; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Oncology; Internal medicine; Disease; Lung cancer; Population; Disease burden","score_opus":0.03618631874369391,"score_gpt":0.37250374823269977,"score_spread":0.3363174294890059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310753331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965345,0.0007139701,0.000033688095,0.0010361699,0.00004044521,0.0009084155,0.00058511354,0.000005739568,0.00014193535],"genre_scores_gemma":[0.99847627,0.00024006245,0.0005538375,0.00018727592,0.000012189898,0.0001912441,0.0002618647,0.000013142333,0.00006409191],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983935,0.00015529759,0.00042265287,0.00024235681,0.0005691231,0.00021707897],"domain_scores_gemma":[0.998692,0.00013325988,0.00039653995,0.00022458893,0.00043424458,0.00011940589],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022723903,0.00012316399,0.00065029156,0.0004016948,0.000060815422,0.0000020183195,0.00010670436,0.000015638485,0.00021972919],"category_scores_gemma":[0.000042537515,0.000100741556,0.000110677356,0.00065082766,0.000109686975,0.00003053796,0.00015280022,0.0000951945,1.2092565e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003669465,0.0011567039,0.97492206,0.0015412576,0.004211919,0.000031140135,0.00041744238,0.004089795,0.00000926873,0.000019498968,0.00034115053,0.009590303],"study_design_scores_gemma":[0.0045468207,0.0022419603,0.98547894,0.00007031218,0.004819751,5.262612e-8,0.00016756725,0.001986845,0.00003439008,0.00001352482,0.0005536483,0.00008616279],"about_ca_topic_score_codex":0.0013544918,"about_ca_topic_score_gemma":0.00027023838,"teacher_disagreement_score":0.010556909,"about_ca_system_score_codex":0.00012730928,"about_ca_system_score_gemma":0.00019421129,"threshold_uncertainty_score":0.41081214},"labels":[],"label_agreement":null},{"id":"W4310754084","doi":"10.1016/j.annonc.2022.10.395","title":"357P Molecular stratification of small cell lung carcinoma subtypes by immunoexpression of ASCL1, NEUROD1, POU2F3 and YAP1 with clinicopathological correlation","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"YAP1; Medicine; Lung; Correlation; Cancer research; Pathology; Internal medicine; Biology; Genetics; Gene; Transcription factor","score_opus":0.052204182496479,"score_gpt":0.3770225237112079,"score_spread":0.3248183412147289,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310754084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99154484,0.004415283,0.00020381094,0.0015372917,0.000044040713,0.00045547646,0.000036591533,0.000008192956,0.0017544511],"genre_scores_gemma":[0.99863046,0.0005510368,0.000445059,0.00015195672,0.000010268892,0.000043501437,0.00004569012,0.000010374782,0.00011164462],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99862176,0.00032518865,0.00040435014,0.0002285336,0.00026641585,0.00015375315],"domain_scores_gemma":[0.99879616,0.00024930874,0.00039589754,0.00023045753,0.00027946357,0.000048733298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055140303,0.000093540235,0.00042175132,0.00009383563,0.00005337482,0.000001661244,0.00009822052,0.00007062126,0.00004780133],"category_scores_gemma":[0.0001580279,0.00007457325,0.00005235869,0.00015270134,0.00024764892,0.00003140349,0.00013667392,0.00023668133,3.1454513e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036062826,0.0010865605,0.28510454,0.0004437065,0.00007177903,0.00006747075,0.0009223608,0.00025117822,0.6969238,0.00024550848,0.0048819124,0.0063948845],"study_design_scores_gemma":[0.005102522,0.035066277,0.63374984,0.000110178036,0.00026710427,0.000078582954,0.0014923859,0.0016482238,0.3187142,0.00026434366,0.00329769,0.00020863065],"about_ca_topic_score_codex":0.00010511232,"about_ca_topic_score_gemma":0.0000038519174,"teacher_disagreement_score":0.3782096,"about_ca_system_score_codex":0.000029146164,"about_ca_system_score_gemma":0.00021603836,"threshold_uncertainty_score":0.30410087},"labels":[],"label_agreement":null},{"id":"W4311150526","doi":"10.51731/cjht.2022.523","title":"Atezolizumab (Tecentriq)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Atezolizumab; Carboplatin; Medicine; Intensive care medicine; Family medicine; Political science; Cancer; Surgery; Internal medicine; Chemotherapy; Health care; Law","score_opus":0.037319562789226685,"score_gpt":0.3405334726099894,"score_spread":0.3032139098207627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311150526","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18205239,0.38084117,0.00009027114,0.43310532,0.0010370858,0.00075927394,0.000053476415,0.00022688389,0.0018341405],"genre_scores_gemma":[0.9974727,0.0011118392,0.00024920443,0.0008801564,0.000013066772,0.000017343184,0.0000017087175,0.000013128821,0.00024086169],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985017,0.00006349743,0.00040029347,0.00010824283,0.00036146506,0.000564777],"domain_scores_gemma":[0.99919575,0.000035949866,0.0002385458,0.00022993443,0.00016696617,0.00013286546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072822446,0.000088408,0.0003656064,0.00080464187,0.00061164616,0.000013307186,0.0003150338,0.00003740889,0.00020026753],"category_scores_gemma":[0.000663876,0.00007487671,0.00007964046,0.00053035974,0.00021110653,0.00004781265,0.000083151295,0.00085190294,0.0000063048274],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011221694,0.000042429234,0.027022148,0.00022921443,0.00017615574,0.0018993942,0.0007669364,0.000029541252,0.000042391013,0.001392342,0.14394163,0.8243456],"study_design_scores_gemma":[0.00093457976,0.0015063743,0.007832944,0.00008685425,0.000013464803,0.0016962722,0.007264,0.000008369918,0.00016634782,0.001388051,0.97902375,0.000079000376],"about_ca_topic_score_codex":0.0047818082,"about_ca_topic_score_gemma":0.0009712979,"teacher_disagreement_score":0.8350821,"about_ca_system_score_codex":0.0024241062,"about_ca_system_score_gemma":0.007282041,"threshold_uncertainty_score":0.99834573},"labels":[],"label_agreement":null},{"id":"W4311980609","doi":"10.3390/curroncol29120765","title":"Real World Patient Eligibility for Second Line Lurbinectedin Based Treatment in Small Cell Lung Cancer: Understanding Epidemiology and Estimating Health Care Utilization","year":2022,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"AstraZeneca Canada","keywords":"Medicine; Retrospective cohort study; Population; Internal medicine; Radiation therapy; Lung cancer; Conventional PCI; Cancer; Surgery","score_opus":0.34319917607191924,"score_gpt":0.5363135905518455,"score_spread":0.19311441447992622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311980609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93813056,0.039688185,0.0056360043,0.0080241775,0.0017645793,0.0057686274,0.0004370671,0.00009212743,0.00045865044],"genre_scores_gemma":[0.99207777,0.00095696014,0.0034413878,0.0003702763,0.00018494613,0.002491446,0.00041242555,0.000025614938,0.000039156886],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.997685,0.00056196906,0.00057230704,0.00052896456,0.000109454355,0.00054231944],"domain_scores_gemma":[0.99805325,0.0012449421,0.00026610075,0.00017619401,0.000093668896,0.0001658491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000775973,0.00018541215,0.0007264415,0.0002864494,0.00031351758,0.000003947316,0.000054939246,0.00004394385,0.00008738422],"category_scores_gemma":[0.00031739604,0.00016728151,0.000068112466,0.00030265903,0.0000790576,0.000021704838,0.00011924586,0.00030234273,1.3379342e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016908225,0.0011033303,0.8668714,0.004414668,0.000092770104,0.00001662241,0.010881862,0.0041603046,0.000071816314,0.00035949575,0.005599476,0.10473743],"study_design_scores_gemma":[0.03749428,0.03224034,0.060248617,0.0009295068,0.0004878763,0.000018814657,0.018969297,0.7480667,0.0005752801,0.0012230079,0.098857895,0.00088833907],"about_ca_topic_score_codex":0.0012033023,"about_ca_topic_score_gemma":0.01910654,"teacher_disagreement_score":0.8066228,"about_ca_system_score_codex":0.015332483,"about_ca_system_score_gemma":0.0016629598,"threshold_uncertainty_score":0.99879223},"labels":[],"label_agreement":null},{"id":"W4312186829","doi":"10.3390/curroncol30010008","title":"Stereotactic Body Radiotherapy (SBRT) in Very Limited-Stage Small Cell Lung Cancer (VLS-SCLC)","year":2022,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Cohort; Radiation therapy; Radiosurgery; Retrospective cohort study; Oncology; Stage (stratigraphy); Internal medicine; Lung cancer; Overall survival","score_opus":0.09737665455314672,"score_gpt":0.44644402928962457,"score_spread":0.34906737473647786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312186829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89867646,0.08842547,0.000029606768,0.003744524,0.0031212613,0.0015134352,0.000085680884,0.00009384304,0.00430973],"genre_scores_gemma":[0.9659919,0.022905532,0.00013087898,0.0014246203,0.00095325656,0.0024124724,0.00008601867,0.0000949038,0.006000388],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975331,0.00042927987,0.0003915978,0.00050977955,0.00043241063,0.0007038536],"domain_scores_gemma":[0.998817,0.0003754966,0.00015413556,0.0003819676,0.00009230556,0.00017908118],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005305554,0.00023491564,0.00065275776,0.00039283518,0.00017628665,0.000014031998,0.00026687677,0.000071210874,0.0018832656],"category_scores_gemma":[0.000103800994,0.00022118208,0.00013060916,0.0005681291,0.000120854216,0.00006180392,0.00033936673,0.0011706802,0.000012416042],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002036302,0.0030581728,0.8532803,0.0014190243,0.00043845605,0.000873351,0.0050012,0.00020112745,0.0040990626,0.00008185728,0.09526074,0.03425042],"study_design_scores_gemma":[0.0071283616,0.0016344261,0.07009934,0.000091987495,0.00013338927,0.000032308966,0.00054616394,0.002322017,0.00020265166,0.000010097958,0.917531,0.00026821307],"about_ca_topic_score_codex":0.00028019515,"about_ca_topic_score_gemma":0.00027079988,"teacher_disagreement_score":0.8222703,"about_ca_system_score_codex":0.005366356,"about_ca_system_score_gemma":0.0011889269,"threshold_uncertainty_score":0.99902916},"labels":[],"label_agreement":null},{"id":"W4315853248","doi":"10.51731/cjht.2023.538","title":"Lurbinectedin (Zepzelca)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Quality of life (healthcare); Disease; Lung cancer; Oncology; Intensive care medicine; Clinical trial; Cancer; Overall survival; Internal medicine; Stage (stratigraphy); Surgery","score_opus":0.06750447713632651,"score_gpt":0.38564942484924675,"score_spread":0.31814494771292023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4315853248","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34305996,0.09505163,0.000057875353,0.5573166,0.0010158581,0.00061514374,0.000030426945,0.00080142816,0.0020511092],"genre_scores_gemma":[0.996274,0.0024776803,0.00024246928,0.00045524476,0.000030734594,0.000008494837,0.0000023097766,0.000016156659,0.00049290614],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998564,0.00002908773,0.00039251865,0.00010980821,0.0002665523,0.0006380291],"domain_scores_gemma":[0.99911046,0.000068246125,0.00016913019,0.00022245377,0.00027030878,0.00015938036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007856586,0.00009679397,0.0003881731,0.0013491913,0.00021805888,0.000017686572,0.00023291375,0.00008969151,0.000030296764],"category_scores_gemma":[0.0021640495,0.00007457288,0.000074707765,0.0011552658,0.0002645718,0.00006510487,0.000034236462,0.00053609593,0.000058284357],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034500288,0.000012787399,0.04556524,0.00043112796,0.00016325417,0.0017662232,0.0005522494,0.000008229302,0.00017351599,0.00088011235,0.45169333,0.49871942],"study_design_scores_gemma":[0.0011867903,0.0014088459,0.15619339,0.00079293805,0.000023902106,0.0007774017,0.0071937772,0.000026486368,0.00074369734,0.003490168,0.82800704,0.0001555942],"about_ca_topic_score_codex":0.0026467922,"about_ca_topic_score_gemma":0.00237787,"teacher_disagreement_score":0.65321404,"about_ca_system_score_codex":0.00069101946,"about_ca_system_score_gemma":0.00460657,"threshold_uncertainty_score":0.8171858},"labels":[],"label_agreement":null},{"id":"W4320914516","doi":"10.6004/jnccn.2022.7089","title":"Small Cell Lung Cancer in Light/Never Smokers – A Role for Molecular Testing?","year":2023,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Lung cancer; Chemotherapy; Oncology; Disease; Cancer; Internal medicine; Incidence (geometry); Cancer research","score_opus":0.06197872644611645,"score_gpt":0.37007329462359173,"score_spread":0.30809456817747527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320914516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8498585,0.085037634,0.0001321395,0.054273877,0.0038642713,0.0028539721,0.00013782221,0.000070318594,0.0037714436],"genre_scores_gemma":[0.9825959,0.0016986419,0.0012557869,0.008066009,0.00397822,0.00037726364,0.0000045303327,0.00008059985,0.0019430494],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9980019,0.00008439272,0.00043561365,0.00019077308,0.00086542097,0.00042193878],"domain_scores_gemma":[0.99615854,0.00061376306,0.00035359082,0.00011102305,0.0026530637,0.000110031564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003450488,0.00016861632,0.00039329962,0.0002014501,0.00014388368,0.00002219384,0.0002776043,0.00006727328,0.00002965415],"category_scores_gemma":[0.00042358492,0.00011791349,0.00023800253,0.0012105075,0.00006246344,0.000083463994,0.00011668011,0.0004638744,0.0000019703584],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011927444,0.000092477836,0.12840825,0.0005426728,0.0009817102,0.00007075741,0.00055655406,0.47758934,0.027730713,0.00020099002,0.36117187,0.0014618994],"study_design_scores_gemma":[0.01491439,0.00074929255,0.59869313,0.0063136555,0.00093306124,0.00010916164,0.0006731727,0.059233386,0.011956618,0.00879323,0.2968146,0.0008163208],"about_ca_topic_score_codex":0.00007441809,"about_ca_topic_score_gemma":0.000051057188,"teacher_disagreement_score":0.47028488,"about_ca_system_score_codex":0.0010030048,"about_ca_system_score_gemma":0.0011092632,"threshold_uncertainty_score":0.48083726},"labels":[],"label_agreement":null},{"id":"W4321370565","doi":"10.1097/01.cot.0000920704.38427.0f","title":"Avasopasem for Radiotherapy-Induced Oral Mucositis in Head &amp; Neck Cancer","year":2023,"lang":"en","type":"article","venue":"Oncology Times","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Mucositis; Medicine; Radiation therapy; Head and neck cancer; Placebo; Cancer; Randomized controlled trial; Internal medicine; Surgery; Oncology; Alternative medicine; Pathology","score_opus":0.09215289734530328,"score_gpt":0.4705246043207524,"score_spread":0.3783717069754491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321370565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.931451,0.0031726137,0.00002886107,0.053065896,0.0005995554,0.0015753574,0.000055371514,0.00024421467,0.009807104],"genre_scores_gemma":[0.77067715,0.007743598,0.008093632,0.007726617,0.0021827305,0.0057539064,0.00025120217,0.00020768409,0.1973635],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99868536,0.00007498221,0.00020679229,0.00031112344,0.00018091315,0.00054083735],"domain_scores_gemma":[0.9992167,0.0003235318,0.000044985103,0.00021300786,0.00009081444,0.000110971305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036453304,0.00014099643,0.00050406257,0.00023441324,0.00008533759,0.000008498372,0.000103817714,0.00013757333,0.0006428949],"category_scores_gemma":[0.00019504037,0.00012010743,0.00008886018,0.00043902118,0.00010369368,0.000048945938,0.00005695596,0.00021701583,0.000154587],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012548682,0.00022352657,0.055408683,0.00020817341,0.0004377498,0.0002225147,0.0017896206,0.000024164216,0.02063632,0.00013837976,0.8127196,0.106936425],"study_design_scores_gemma":[0.0071530156,0.0014995039,0.081227876,0.00015230497,0.00006165721,0.000027122029,0.00015200641,0.00049143063,0.0017336844,0.00021381526,0.9071032,0.0001844091],"about_ca_topic_score_codex":0.0010800259,"about_ca_topic_score_gemma":0.0055936305,"teacher_disagreement_score":0.1875564,"about_ca_system_score_codex":0.0008665722,"about_ca_system_score_gemma":0.0005943564,"threshold_uncertainty_score":0.70392483},"labels":[],"label_agreement":null},{"id":"W4322772055","doi":"10.1158/1538-7445.sabcs22-ot1-03-05","title":"Abstract OT1-03-05: TROPION-Breast02: Phase 3, open-label, randomized study of first-line datopotamab deruxtecan versus chemotherapy in patients with locally recurrent inoperable or metastatic TNBC who are not candidates for anti-PD-(L)1 therapy","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Oncology; Phases of clinical research; Metastatic breast cancer; Neutropenia; Chemotherapy; Cancer; Breast cancer","score_opus":0.18287316189759106,"score_gpt":0.49214510451055715,"score_spread":0.3092719426129661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322772055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9790996,0.0011370595,0.000015606172,0.0027759227,0.00017567152,0.016248807,0.00045600918,0.000052694882,0.000038650523],"genre_scores_gemma":[0.9844224,0.0077804746,0.00009565318,0.0000941119,0.00010922691,0.0067687966,0.00016017673,0.000120117686,0.0004490697],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99461097,0.0005066231,0.0008583984,0.00093889737,0.0018672846,0.0012178583],"domain_scores_gemma":[0.99491155,0.0020327487,0.00026584638,0.00082223094,0.0016523177,0.00031528543],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002748697,0.0004381086,0.0019818924,0.0007952006,0.00033034114,0.00013896088,0.00077151984,0.00007876279,0.00032799365],"category_scores_gemma":[0.0012758621,0.00027364132,0.00008888442,0.0022308528,0.00050919154,0.0002837525,0.0003126168,0.0007133142,0.000011383988],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9260356,0.00984041,0.018076427,0.0011176758,0.0022970096,0.00013874708,0.0034586913,0.00012581944,0.0004104289,0.0000060823913,0.0056088967,0.03288424],"study_design_scores_gemma":[0.94498545,0.02082995,0.02222211,0.0018187851,0.00013628966,0.0000011167776,0.0031091117,0.0009415801,0.0035807427,0.000026444714,0.0019518732,0.00039653166],"about_ca_topic_score_codex":0.0064363787,"about_ca_topic_score_gemma":0.011489662,"teacher_disagreement_score":0.03248771,"about_ca_system_score_codex":0.00085619546,"about_ca_system_score_gemma":0.0014004709,"threshold_uncertainty_score":0.99997157},"labels":[],"label_agreement":null},{"id":"W4323664765","doi":"10.1016/j.lungcan.2023.03.002","title":"Use of radiation therapy among patients with Extensive-stage Small-cell lung cancer receiving Immunotherapy: Canadian consensus recommendations","year":2023,"lang":"en","type":"review","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; Surrey Memorial Hospital; Sunnybrook Health Science Centre; Surrey Place Centre; Centre Hospitalier de l’Université de Montréal; McGill University Health Centre; McGill University; University Health Network; Health Sciences Centre; St. John’s Health Sciences Centre; BC Cancer Agency; Princess Margaret Cancer Centre","funders":"AstraZeneca Canada; AstraZeneca","keywords":"Medicine; Radiation therapy; Lung cancer; Immunotherapy; Oncology; Stage (stratigraphy); Intensive care medicine; Consensus conference; Internal medicine; Cancer","score_opus":0.0804489223633583,"score_gpt":0.39027321538339904,"score_spread":0.3098242930200408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323664765","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0068768677,0.9830237,0.0000053237977,0.00055210455,0.00089743984,0.005842522,0.0024929796,0.00010940546,0.00019964247],"genre_scores_gemma":[0.00021450354,0.99076974,0.00009170769,0.00030398145,0.0002802654,0.0023616834,0.0006706436,0.00030867357,0.0049987794],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964821,0.00030086638,0.00091073784,0.00079779554,0.0006202268,0.00088829093],"domain_scores_gemma":[0.9963547,0.00061063614,0.00090130337,0.0008219622,0.0009274868,0.0003839304],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003032968,0.0006998093,0.0020338371,0.00081678206,0.00030722868,0.00007848311,0.00026443478,0.00032691812,0.00045780806],"category_scores_gemma":[0.00016930177,0.0005411789,0.00036771497,0.0012624876,0.00022482392,0.00013601297,0.00007345793,0.000821551,0.000006816382],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002051064,0.00010536564,0.096775666,0.02108012,0.005353594,0.000043084397,0.0009547382,0.00006263258,0.0000059268577,0.000004893465,0.044052888,0.831356],"study_design_scores_gemma":[0.0025423386,0.00016939655,0.024683101,0.037783895,0.0017515089,0.0000016879877,0.000054750457,0.00013329087,0.000027653254,6.115431e-7,0.9321093,0.0007424649],"about_ca_topic_score_codex":0.26343778,"about_ca_topic_score_gemma":0.20456366,"teacher_disagreement_score":0.8880564,"about_ca_system_score_codex":0.0040905173,"about_ca_system_score_gemma":0.0053953133,"threshold_uncertainty_score":0.9997326},"labels":[],"label_agreement":null},{"id":"W4327947028","doi":"10.3390/curroncol30030265","title":"Exon-18-EGFR Mutated Transformed Small-Cell Lung Cancer: A Case Report and Literature Review","year":2023,"lang":"en","type":"review","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Exon; Adenocarcinoma; Lung cancer; Medicine; Point mutation; Cancer research; Mutation; Phenotype; Epidermal growth factor receptor; Malignant transformation; Transformation (genetics); Mutant; Gene; Cancer; Pathology; Genetics; Biology; Internal medicine","score_opus":0.2670269450661654,"score_gpt":0.5538121025375843,"score_spread":0.28678515747141886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4327947028","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000022552706,0.98827004,0.0000052912133,0.0010374893,0.0017930827,0.0070194243,0.00036548235,0.00020166769,0.0012849622],"genre_scores_gemma":[7.3187e-7,0.99126774,0.00004077251,0.00013231533,0.0007990984,0.0041863816,0.0010208549,0.00013278735,0.0024192915],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956753,0.00046725906,0.0014537505,0.0011291392,0.00041717812,0.0008573672],"domain_scores_gemma":[0.99717885,0.0005388506,0.0006187322,0.0006873106,0.00047526494,0.0005009916],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010548205,0.00078210444,0.0046855947,0.0004349141,0.00016565107,0.00003522608,0.000218861,0.0005407169,0.00017679881],"category_scores_gemma":[0.0006207743,0.0005546776,0.00066087156,0.0013719194,0.00025453203,0.000057767746,0.00024032572,0.0021794797,0.00003385333],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016677204,0.00009363841,0.000011462541,0.3681483,0.00044845513,0.14775719,0.00019172617,8.300885e-9,9.011457e-8,0.000001707358,0.045507275,0.43782347],"study_design_scores_gemma":[0.0008408416,0.0002148882,0.0000016690528,0.24042685,0.0055024903,0.10009618,0.000022116395,0.0000038463777,2.1822882e-7,0.000002290069,0.65259826,0.000290328],"about_ca_topic_score_codex":0.0000651185,"about_ca_topic_score_gemma":0.00024709784,"teacher_disagreement_score":0.607091,"about_ca_system_score_codex":0.0017118704,"about_ca_system_score_gemma":0.0036093753,"threshold_uncertainty_score":0.9996905},"labels":[],"label_agreement":null},{"id":"W4361953683","doi":"10.1158/1078-0432.c.6530028.v1","title":"Data from AMG 757, a Half-Life Extended, DLL3-Targeted Bispecific T-Cell Engager, Shows High Potency and Sensitivity in Preclinical Models of Small-Cell Lung Cancer","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Phoenix Technologies (Canada)","funders":"Amgen","keywords":"Medicine; Tolerability; Cancer research; T cell; Lung cancer; Cell; Internal medicine; Chemistry; Immunology; Adverse effect; Immune system","score_opus":0.21373206253175525,"score_gpt":0.4117611795012103,"score_spread":0.19802911696945502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361953683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93778014,0.03451797,0.0036185805,0.0048140655,0.001400319,0.0048519,0.00955166,0.00041756986,0.0030478034],"genre_scores_gemma":[0.95282924,0.032548886,0.006361393,0.0002450595,0.00063864345,0.00032473353,0.0018379908,0.0001707154,0.005043357],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9928857,0.0008158481,0.0014806013,0.0026707929,0.001217651,0.0009293902],"domain_scores_gemma":[0.99313104,0.002129477,0.0004723151,0.0032405278,0.00046589758,0.00056073547],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0027885064,0.0007823182,0.0023367538,0.00047895283,0.00011304769,0.00007021385,0.00067195547,0.00074084883,0.00038766884],"category_scores_gemma":[0.001237548,0.00067326095,0.00022914994,0.0004251706,0.00042505245,0.00019090739,0.007390531,0.003375572,0.000018805918],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018254476,0.015509395,0.38212764,0.060982853,0.015285013,0.011500781,0.013717311,0.035682674,0.09880874,0.00054370303,0.32791167,0.019675748],"study_design_scores_gemma":[0.017568974,0.000516241,0.23700365,0.0061050714,0.002576123,0.000014215689,0.002084098,0.7185269,0.007800162,0.004408583,0.00087280385,0.0025231754],"about_ca_topic_score_codex":0.09298605,"about_ca_topic_score_gemma":0.043187745,"teacher_disagreement_score":0.6828442,"about_ca_system_score_codex":0.0004587745,"about_ca_system_score_gemma":0.002151892,"threshold_uncertainty_score":0.99957186},"labels":[],"label_agreement":null},{"id":"W4361958509","doi":"10.1158/1078-0432.c.6530718.v1","title":"Data from Veliparib in Combination with Carboplatin and Etoposide in Patients with Treatment-Naïve Extensive-Stage Small Cell Lung Cancer: A Phase 2 Randomized Study","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Veliparib; Medicine; Carboplatin; Internal medicine; Hazard ratio; Etoposide; Placebo; Lung cancer; Clinical endpoint; PARP inhibitor; Chemotherapy; Oncology; Surgery; Confidence interval; Clinical trial; Cisplatin; Biology; Pathology","score_opus":0.06618949606572638,"score_gpt":0.3835364755736122,"score_spread":0.3173469795078858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361958509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98135895,0.0014343081,0.000071943934,0.00042810154,0.00010626258,0.0148703065,0.0013925761,0.00008288456,0.00025465153],"genre_scores_gemma":[0.99105173,0.0011974903,0.0005930205,0.000049402264,0.000043020056,0.0025713015,0.0031516466,0.00008640458,0.0012559701],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9964138,0.00041127196,0.0006365427,0.0013837818,0.00070693373,0.00044765536],"domain_scores_gemma":[0.99730664,0.00073354883,0.0003014704,0.0011921347,0.00031093124,0.00015526364],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005892581,0.00055771373,0.001995043,0.00048459464,0.00005955436,0.00007120202,0.00025971586,0.00013723502,0.000041586834],"category_scores_gemma":[0.00024881444,0.00035249043,0.000044150052,0.00033254054,0.00016712831,0.000105505285,0.0010193317,0.0006547003,0.0000019404724],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13436435,0.0041748807,0.8516068,0.00045010832,0.001737122,0.00049152813,0.005949248,0.00023748745,0.000011367794,0.0000018893403,0.00018173772,0.0007934877],"study_design_scores_gemma":[0.66836774,0.0021284607,0.3120237,0.001281787,0.0012853644,2.7906376e-7,0.0022411896,0.012190644,0.00007096008,0.000016931139,0.000013233505,0.0003796814],"about_ca_topic_score_codex":0.13831465,"about_ca_topic_score_gemma":0.15566719,"teacher_disagreement_score":0.5395831,"about_ca_system_score_codex":0.0010414054,"about_ca_system_score_gemma":0.00076338695,"threshold_uncertainty_score":0.9998927},"labels":[],"label_agreement":null},{"id":"W4361959346","doi":"10.1158/1078-0432.c.6530028","title":"Data from AMG 757, a Half-Life Extended, DLL3-Targeted Bispecific T-Cell Engager, Shows High Potency and Sensitivity in Preclinical Models of Small-Cell Lung Cancer","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Phoenix Technologies (Canada)","funders":"Amgen","keywords":"Medicine; Tolerability; Cancer research; T cell; Lung cancer; Cell; Internal medicine; Chemistry; Immunology; Adverse effect; Immune system","score_opus":0.21373206253175525,"score_gpt":0.4117611795012103,"score_spread":0.19802911696945502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361959346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93778014,0.03451797,0.0036185805,0.0048140655,0.001400319,0.0048519,0.00955166,0.00041756986,0.0030478034],"genre_scores_gemma":[0.95282924,0.032548886,0.006361393,0.0002450595,0.00063864345,0.00032473353,0.0018379908,0.0001707154,0.005043357],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9928857,0.0008158481,0.0014806013,0.0026707929,0.001217651,0.0009293902],"domain_scores_gemma":[0.99313104,0.002129477,0.0004723151,0.0032405278,0.00046589758,0.00056073547],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0027885064,0.0007823182,0.0023367538,0.00047895283,0.00011304769,0.00007021385,0.00067195547,0.00074084883,0.00038766884],"category_scores_gemma":[0.001237548,0.00067326095,0.00022914994,0.0004251706,0.00042505245,0.00019090739,0.007390531,0.003375572,0.000018805918],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018254476,0.015509395,0.38212764,0.060982853,0.015285013,0.011500781,0.013717311,0.035682674,0.09880874,0.00054370303,0.32791167,0.019675748],"study_design_scores_gemma":[0.017568974,0.000516241,0.23700365,0.0061050714,0.002576123,0.000014215689,0.002084098,0.7185269,0.007800162,0.004408583,0.00087280385,0.0025231754],"about_ca_topic_score_codex":0.09298605,"about_ca_topic_score_gemma":0.043187745,"teacher_disagreement_score":0.6828442,"about_ca_system_score_codex":0.0004587745,"about_ca_system_score_gemma":0.002151892,"threshold_uncertainty_score":0.99957186},"labels":[],"label_agreement":null},{"id":"W4362452239","doi":"10.7759/cureus.37015","title":"Prevalence of Thyroid Transcription Factor-1 (TTF-1)-Negative Small Cell Carcinoma and Napsin A Positivity in Small Cell Carcinoma in a Cross-Sectional Study of Lung Core Biopsies","year":2023,"lang":"en","type":"article","venue":"Cureus","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"","keywords":"Medicine; Small-cell carcinoma; Pathology; Small Cell Lung Carcinoma; Carcinoma; Biopsy; Immunostaining; Lung; Thyroid Transcription Factor 1; Thyroid; Lung cancer; Immunohistochemistry; Oncology; Cancer; Internal medicine; Adenocarcinoma","score_opus":0.06283292988453881,"score_gpt":0.3359408671562166,"score_spread":0.2731079372716778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362452239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951242,0.002401097,0.0000030489603,0.00003553968,0.000104953,0.0016748911,0.00023634947,0.000028047016,0.00039187752],"genre_scores_gemma":[0.9991206,0.00022989168,0.00003880204,0.000007437831,0.00003805101,0.0001247523,0.000012204031,0.000024041372,0.00040423035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99799055,0.00017445024,0.0005175401,0.00052154524,0.00040348253,0.00039244222],"domain_scores_gemma":[0.9988772,0.00032039013,0.00015275531,0.00029915664,0.00025294532,0.00009752849],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004773859,0.00023660198,0.00050092116,0.0003789214,0.00006543461,0.000015741232,0.0001793912,0.00011620355,0.000021875656],"category_scores_gemma":[0.00017378437,0.00021768364,0.00007965274,0.00067864574,0.0002816625,0.00011941193,0.0001673859,0.00036971943,0.0000016476725],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072158204,0.00080060144,0.8859674,0.002483565,0.00003358334,0.00009168255,0.020122917,0.00003188825,0.08969249,0.0000046161076,0.000021790704,0.000027887078],"study_design_scores_gemma":[0.0051766234,0.0018748333,0.96051806,0.00012419409,0.00005169562,0.0000064981587,0.0032565286,0.00046166164,0.028339602,0.000035111094,0.0000011364785,0.00015407837],"about_ca_topic_score_codex":0.007162385,"about_ca_topic_score_gemma":0.0052589965,"teacher_disagreement_score":0.07455064,"about_ca_system_score_codex":0.0003491446,"about_ca_system_score_gemma":0.00020664925,"threshold_uncertainty_score":0.999449},"labels":[],"label_agreement":null},{"id":"W4362544178","doi":"10.1158/1538-7445.am2023-3434","title":"Abstract 3434: Selective glucocorticoid receptor modulation reveals a new role for CLEC10A in patients with solid tumors","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Glucocorticoid receptor; Medicine; Internal medicine; Oncology; Glucocorticoid; Confounding; Bioinformatics; Pharmacology; Biology","score_opus":0.059963316763689066,"score_gpt":0.4351800655281019,"score_spread":0.37521674876441286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362544178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925141,0.0002617343,0.000014672715,0.0020352642,0.00008010203,0.0042568287,0.00006364866,0.00008397615,0.00068970816],"genre_scores_gemma":[0.9935971,0.00017822308,0.00012111196,0.00006594832,0.00032183016,0.0015504688,0.00010168577,0.00007191522,0.0039917026],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965603,0.00008634182,0.00033550922,0.0005899316,0.0013464354,0.0010814768],"domain_scores_gemma":[0.99788433,0.00035875879,0.00007394306,0.0003569996,0.0010496011,0.00027639052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009668392,0.0001793209,0.00043516292,0.00064981927,0.0001662885,0.0000444534,0.00018190718,0.000087189575,0.00015293914],"category_scores_gemma":[0.00088743516,0.00014578021,0.00006410884,0.0020692414,0.00013172932,0.00018430967,0.000120870405,0.0006004289,0.0001605059],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010877717,0.00033009358,0.82068646,0.0011316247,0.00036325693,0.00002104319,0.002932476,0.0010775574,0.044268012,0.00008527861,0.082089074,0.036137402],"study_design_scores_gemma":[0.005518548,0.0012963585,0.9830303,0.0007373713,0.000012828855,3.629983e-7,0.0003827931,0.00037905315,0.0061154314,0.0006720244,0.0016754587,0.00017943933],"about_ca_topic_score_codex":0.0014157773,"about_ca_topic_score_gemma":0.00044273215,"teacher_disagreement_score":0.16234386,"about_ca_system_score_codex":0.0016423545,"about_ca_system_score_gemma":0.0015332479,"threshold_uncertainty_score":0.59447443},"labels":[],"label_agreement":null},{"id":"W4362587019","doi":"10.1016/s1556-0864(23)00423-9","title":"169P Phase I dose escalation trial combining olaparib and thoracic radiation therapy in extensive-stage small cell lung cancer","year":2023,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"PharmaMar; Castle Biosciences; Daiichi Sankyo Europe; Exelixis; ViewRay; Novocure; Elekta; Varian Medical Systems; Pfizer; Eli Lilly and Company; AstraZeneca; Accuray; LUNGevity Foundation; MedImmune; Mesothelioma Applied Research Foundation","keywords":"Medicine; Olaparib; Atezolizumab; Internal medicine; Oncology; Dysgeusia; Lung cancer; Adverse effect; Radiation therapy; Urology; Cancer; Gastroenterology; Nivolumab; Immunotherapy","score_opus":0.07487591896206015,"score_gpt":0.50855599154978,"score_spread":0.4336800725877199,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362587019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98638463,0.0061185914,0.000073039744,0.005144874,0.00092201703,0.0009203047,0.000008493908,0.000027033011,0.00040099662],"genre_scores_gemma":[0.9854091,0.012367697,0.00032850562,0.00033666138,0.000769076,0.00005804333,0.000010463821,0.000028556042,0.0006919105],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9978498,0.00046251013,0.0006950481,0.00022529518,0.0003926551,0.0003746597],"domain_scores_gemma":[0.998141,0.0005794945,0.0005877678,0.00014742558,0.00036090804,0.0001834186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021005906,0.0001702316,0.00072439486,0.00065398385,0.000104396524,0.000029717303,0.00010697371,0.00017401869,0.00006658629],"category_scores_gemma":[0.00047797372,0.00013522618,0.000111559864,0.00060628075,0.000102528385,0.00019849565,0.00006502087,0.00070123025,0.000004623061],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15205327,0.0011514365,0.034163237,0.00045248712,0.00037368704,0.0014072036,0.005962276,0.0003825821,0.022943437,0.000013004316,0.0046171625,0.7764802],"study_design_scores_gemma":[0.4341041,0.05211706,0.3801237,0.0020548229,0.0015142229,0.0005281356,0.0075738495,0.03866141,0.023203539,0.0006369672,0.058315,0.001167155],"about_ca_topic_score_codex":0.00007839344,"about_ca_topic_score_gemma":0.00007626551,"teacher_disagreement_score":0.7753131,"about_ca_system_score_codex":0.0007301938,"about_ca_system_score_gemma":0.00079756085,"threshold_uncertainty_score":0.55143636},"labels":[],"label_agreement":null},{"id":"W4362588741","doi":"10.1016/s1556-0864(23)00424-0","title":"170P Preliminary results from LUMINANCE: A phase IIIb, single-arm study of 1L durvalumab (D) + platinum-etoposide (EP) for patients with extensive-stage SCLC (ES-SCLC)","year":2023,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Symphogen; GlaxoSmithKline; Daiichi-Sankyo; Amgen; Pfizer; AstraZeneca; Daiichi Sankyo Europe; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Durvalumab; Etoposide; Internal medicine; Phases of clinical research; Oncology; Chemotherapy; Cancer; Nivolumab","score_opus":0.06322569750506297,"score_gpt":0.45745489743307094,"score_spread":0.394229199928008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362588741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942628,0.0004271935,0.000071642935,0.0015737796,0.0006487197,0.0022137705,0.00038961766,0.000040225113,0.00037226622],"genre_scores_gemma":[0.9946352,0.00014325399,0.0033005432,0.0001242876,0.0005125378,0.000079504105,0.00007204344,0.000064208245,0.0010684173],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99594915,0.00035596555,0.0014574567,0.0004817034,0.0011477064,0.0006080088],"domain_scores_gemma":[0.99353,0.0018304107,0.0017255713,0.0005182477,0.0021189307,0.00027685263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013774812,0.0003278341,0.0014854758,0.00046031576,0.00019261373,0.000019383446,0.00033600998,0.00017567177,0.000034269906],"category_scores_gemma":[0.0031783644,0.00023787367,0.00021933012,0.00065853156,0.00029728448,0.00023179493,0.00023406687,0.0006511461,0.000008747964],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6172427,0.047474347,0.038504753,0.0012318426,0.0045164735,0.0070609385,0.029645473,0.00047946375,0.009351549,0.000007958653,0.04422413,0.20026036],"study_design_scores_gemma":[0.10814382,0.51848054,0.31899607,0.0028746221,0.0028482436,0.00022549198,0.02475178,0.00087026024,0.006490413,0.00018965549,0.015478934,0.0006501751],"about_ca_topic_score_codex":0.00009425232,"about_ca_topic_score_gemma":0.00011491566,"teacher_disagreement_score":0.5090989,"about_ca_system_score_codex":0.00071608333,"about_ca_system_score_gemma":0.00082010106,"threshold_uncertainty_score":0.97002065},"labels":[],"label_agreement":null},{"id":"W4365512763","doi":"10.1158/1538-7445.am2023-ct058","title":"Abstract CT058: TROPION-PanTumor03: Phase 2, multicenter study of datopotamab deruxtecan (Dato-DXd) as monotherapy and in combination with anticancer agents in patients (pts) with advanced/metastatic solid tumors","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Nivolumab; Prostate cancer; Internal medicine; Combination therapy; Cancer; Oncology; Bevacizumab; Phases of clinical research; Immunotherapy; Chemotherapy","score_opus":0.07314861898670705,"score_gpt":0.47179241001322003,"score_spread":0.398643791026513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365512763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99491805,0.0003196741,0.000003388307,0.0005170444,0.000037968628,0.004049962,0.00004571084,0.000033483946,0.00007471384],"genre_scores_gemma":[0.9970233,0.0015210077,0.000046624828,0.00004834615,0.000021314387,0.0011138315,0.00003582884,0.000071098,0.00011863437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99586326,0.00024312818,0.0005293476,0.0007058594,0.0017760635,0.00088231673],"domain_scores_gemma":[0.998292,0.0002854579,0.0001427026,0.00047323355,0.0005834716,0.00022311257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074384187,0.0002739722,0.0006850185,0.0011338269,0.00012899005,0.000042297812,0.00023272689,0.00003827399,0.00010323044],"category_scores_gemma":[0.00025406064,0.000202547,0.000026428032,0.0019992406,0.0003660051,0.00029929003,0.00015541141,0.0006544282,0.000011985284],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018807149,0.0064131473,0.9426793,0.001037114,0.00032592737,0.00074022403,0.006542027,0.00029845227,0.0021984298,0.0000079117835,0.0002406086,0.020709751],"study_design_scores_gemma":[0.06343371,0.0083118,0.91551024,0.0018260432,0.000033369928,0.0000027551507,0.006625632,0.000603696,0.0032859852,0.000051464107,0.000079670004,0.00023566803],"about_ca_topic_score_codex":0.002985856,"about_ca_topic_score_gemma":0.004024584,"teacher_disagreement_score":0.044626556,"about_ca_system_score_codex":0.00074251846,"about_ca_system_score_gemma":0.0006286066,"threshold_uncertainty_score":0.8259627},"labels":[],"label_agreement":null},{"id":"W4366334545","doi":"10.46747/cfp.6904e74","title":"Cours accéléré sur le cancer du poumon","year":2023,"lang":"fr","type":"article","venue":"Canadian Family Physician","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Gynecology","score_opus":0.044833204727703815,"score_gpt":0.3144413035088692,"score_spread":0.2696080987811654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366334545","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26325688,0.16579632,0.0000063485754,0.20467368,0.014808309,0.002121656,0.0031874548,0.0004652679,0.34568408],"genre_scores_gemma":[0.78109056,0.020830296,0.000015081276,0.11992961,0.011420085,0.0004265287,0.00025975038,0.00029278352,0.06573532],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957275,0.00012259925,0.0003298957,0.0006911353,0.00065975945,0.002469129],"domain_scores_gemma":[0.9969384,0.00016655235,0.00008913577,0.0006630228,0.000410426,0.0017324507],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00036599083,0.0004534931,0.0006829205,0.00054629357,0.00057121384,0.0001020523,0.00044960502,0.00020384656,0.00005595097],"category_scores_gemma":[0.00008577071,0.00051045057,0.00023811038,0.0019162939,0.0005730467,0.0002982031,0.0001261092,0.0006394875,0.003509295],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028350754,0.000063763786,0.0048277224,0.00038025607,0.00052874227,0.0010483655,0.0006514611,0.00016305203,0.0015167168,0.0017809353,0.87381595,0.11519469],"study_design_scores_gemma":[0.001468424,0.00014134082,0.14418928,0.0011460435,0.00019098901,0.0000014812446,0.0042297863,0.0011162435,0.0003307136,0.00032678165,0.8463508,0.00050813565],"about_ca_topic_score_codex":0.5900629,"about_ca_topic_score_gemma":0.3425944,"teacher_disagreement_score":0.51783365,"about_ca_system_score_codex":0.0037740797,"about_ca_system_score_gemma":0.011137279,"threshold_uncertainty_score":0.9997347},"labels":[],"label_agreement":null},{"id":"W4366998885","doi":"10.1186/s13046-023-02678-1","title":"MYC drives platinum resistant SCLC that is overcome by the dual PI3K-HDAC inhibitor fimepinostat","year":2023,"lang":"en","type":"article","venue":"Journal of Experimental & Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"Cancer Council Victoria; State Government of Victoria; Australian Government; National Imaging Facility; Marshfield Clinic Research Foundation; Victorian Cancer Agency","keywords":"Cancer research; Platinum; Dual (grammatical number); Apoptosis; PI3K/AKT/mTOR pathway; Chemistry; Medicine; Biochemistry","score_opus":0.26930834829172673,"score_gpt":0.5712986221216317,"score_spread":0.301990273829905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366998885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93607956,0.026863761,0.0000013700749,0.03318823,0.0010103242,0.0008773757,0.00013433823,0.000042306998,0.0018027357],"genre_scores_gemma":[0.97861177,0.010482788,0.00006210438,0.001320505,0.0024203395,0.00012311997,0.000010250787,0.00007488846,0.00689423],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9915051,0.00089756737,0.0014098748,0.00056263077,0.0044391137,0.00118573],"domain_scores_gemma":[0.9944119,0.003001781,0.0004009101,0.00063017337,0.0008162149,0.000739047],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0062132687,0.00030878262,0.0009193025,0.0003847135,0.0006145527,0.00016901424,0.0006549321,0.00019635151,0.0012850618],"category_scores_gemma":[0.0017164727,0.00018860197,0.0005140909,0.0010970157,0.0016478956,0.00033550375,0.0009236242,0.002735572,0.00017486745],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063141487,0.0006249592,0.031374052,0.00011448133,0.0008024817,0.00047006801,0.0023189338,0.0000013049314,0.1425571,0.000050004706,0.81267506,0.0026974003],"study_design_scores_gemma":[0.017570604,0.01826165,0.12812394,0.0025750971,0.00022527584,0.00021557503,0.027323877,0.00009606353,0.42967907,0.00056840223,0.37462577,0.00073467946],"about_ca_topic_score_codex":0.0004223595,"about_ca_topic_score_gemma":0.000039371054,"teacher_disagreement_score":0.4380493,"about_ca_system_score_codex":0.0010852503,"about_ca_system_score_gemma":0.0012032724,"threshold_uncertainty_score":0.9996279},"labels":[],"label_agreement":null},{"id":"W4368341244","doi":"10.1093/jnci/djad073","title":"Comparison of first-line radiosurgery for small-cell and non-small cell lung cancer brain metastases (CROSS-FIRE)","year":2023,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Université de Sherbrooke","funders":"National Center for Advancing Translational Sciences","keywords":"Medicine; Hazard ratio; Oncology; Internal medicine; Brain metastasis; Retrospective cohort study; Lung cancer; Radiosurgery; Proportional hazards model; Anaplastic lymphoma kinase; Confidence interval; Cancer; Metastasis; Radiation therapy","score_opus":0.11825364100405085,"score_gpt":0.4429461179180069,"score_spread":0.3246924769139561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4368341244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9714103,0.013236099,0.00029533965,0.011486085,0.0019384606,0.0007675141,0.0005646524,0.000015109043,0.00028647736],"genre_scores_gemma":[0.9913844,0.003859505,0.0005869186,0.00064784725,0.0014664524,0.000118689415,0.000015874724,0.00002992843,0.0018904186],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976798,0.00004752476,0.0007611169,0.00020870552,0.0009820829,0.00032073774],"domain_scores_gemma":[0.996802,0.00068084436,0.00070349145,0.00013772317,0.0015226816,0.00015326598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012084638,0.00019956636,0.0006570081,0.00026202793,0.00027494263,0.000036430123,0.0002830766,0.000072475224,0.000035954174],"category_scores_gemma":[0.0008179024,0.00013538903,0.00030860494,0.0005586321,0.00025986118,0.00019060688,0.00014649925,0.0003650762,0.0000010056032],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019738912,0.00043534566,0.6381318,0.0041913,0.0015266541,0.00003063904,0.0014294472,0.047994707,0.011931138,0.00008917203,0.28935772,0.0029081833],"study_design_scores_gemma":[0.028582342,0.0012938031,0.42380008,0.004657345,0.0024218052,0.0001373159,0.00049108913,0.038236815,0.18420683,0.00082100724,0.31437346,0.0009781144],"about_ca_topic_score_codex":0.00035725825,"about_ca_topic_score_gemma":0.0007894346,"teacher_disagreement_score":0.21433175,"about_ca_system_score_codex":0.00062632735,"about_ca_system_score_gemma":0.001625241,"threshold_uncertainty_score":0.5521004},"labels":[],"label_agreement":null},{"id":"W4379340377","doi":"10.1200/jco.2023.41.16_suppl.8503","title":"Exploratory biomarker analysis of the phase 3 KEYNOTE-604 study of pembrolizumab plus etoposide for extensive-stage SCLC.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"William Osler Health System; University of Toronto","funders":"","keywords":"Medicine; Pembrolizumab; Oncology; Internal medicine; Cancer research; Cancer; Immunotherapy","score_opus":0.39782845581144777,"score_gpt":0.6052007752304426,"score_spread":0.2073723194189948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379340377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99278,0.0004302927,0.00011882556,0.0047009173,0.0007897564,0.00082057534,0.000040597562,0.000009944175,0.00030903541],"genre_scores_gemma":[0.9978484,0.00054471235,0.00018681273,0.00052463484,0.00031666056,0.000028041966,0.0000027868398,0.000019942981,0.0005280271],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99485236,0.00083781267,0.002865058,0.00024428076,0.00089088466,0.00030962515],"domain_scores_gemma":[0.988925,0.0059212404,0.0023950366,0.00049211987,0.00202496,0.00024168107],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0058024153,0.00015312951,0.0026984185,0.0005157594,0.00007566591,0.000004596357,0.00037116223,0.00019387738,0.00006475961],"category_scores_gemma":[0.014897692,0.000088005945,0.0013022382,0.0015117561,0.0005242266,0.0000826837,0.00025133826,0.0006301601,0.0000029522614],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18300794,0.032809086,0.3857148,0.001185368,0.104071036,0.0028177176,0.011655224,0.0027388625,0.016574526,0.00017848975,0.117830314,0.14141664],"study_design_scores_gemma":[0.076601684,0.0476495,0.8240867,0.00020769835,0.013637347,0.00002296631,0.011903855,0.004475902,0.000789327,0.00013964188,0.020309707,0.00017563792],"about_ca_topic_score_codex":0.000044574295,"about_ca_topic_score_gemma":0.00021178476,"teacher_disagreement_score":0.43837193,"about_ca_system_score_codex":0.0002495694,"about_ca_system_score_gemma":0.002415312,"threshold_uncertainty_score":0.9934002},"labels":[],"label_agreement":null},{"id":"W4379341468","doi":"10.1200/jco.2023.41.16_suppl.e20636","title":"Prophylactic cranial irradiation in small cell lung cancer patients in the era of magnetic resonance imaging: A systematic review and meta-analysis.","year":2023,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Conventional PCI; Prophylactic cranial irradiation; Hazard ratio; Internal medicine; Meta-analysis; Retrospective cohort study; Lung cancer; Oncology; Magnetic resonance imaging; Surgery; Radiology; Confidence interval; Myocardial infarction","score_opus":0.23733862060632313,"score_gpt":0.540150651919288,"score_spread":0.30281203131296486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379341468","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013098326,0.99301475,7.1793835e-7,0.0027498698,0.00013746762,0.0038767282,0.000021367629,0.0000023680989,0.000065728986],"genre_scores_gemma":[0.0007822834,0.9976182,0.00008214467,0.00081954384,0.00012728863,0.00041394957,0.0000036470128,0.000024901185,0.00012804318],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9878635,0.0044913907,0.006370136,0.000321482,0.0006756122,0.00027789018],"domain_scores_gemma":[0.9872053,0.0064890548,0.0052427384,0.00036337055,0.00057201344,0.00012749305],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.011627051,0.00029193528,0.0154868355,0.00047135004,0.00002103685,0.000011753341,0.0003956567,0.00023770193,0.000041701514],"category_scores_gemma":[0.010638293,0.00013961594,0.0022414196,0.0014375884,0.00017373964,0.000060055998,0.00010186053,0.0022652908,0.0000029038154],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012971992,0.000803443,0.0040419814,0.95343083,0.013481409,0.00034506095,0.0001679403,0.0000011088599,1.1104812e-8,0.0000030723606,0.0004669466,0.02712849],"study_design_scores_gemma":[0.0022167885,0.002153386,0.016763303,0.06270133,0.9041354,0.000036242967,0.000027648124,0.00003187557,7.3838105e-9,0.000018144421,0.011760765,0.00015510558],"about_ca_topic_score_codex":0.00022175218,"about_ca_topic_score_gemma":0.0006901363,"teacher_disagreement_score":0.8907295,"about_ca_system_score_codex":0.00046954027,"about_ca_system_score_gemma":0.0024845263,"threshold_uncertainty_score":0.9991293},"labels":[],"label_agreement":null},{"id":"W4379341601","doi":"10.1200/jco.2023.41.16_suppl.8596","title":"Brain metastasis burden and management in small cell lung cancer: An analysis of 8705 patients.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; University Health Network; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Radiosurgery; Hazard ratio; Brain metastasis; Confidence interval; Lung cancer; Internal medicine; Radiation therapy; Incidence (geometry); Chemotherapy; Population; Oncology; Cancer; Metastasis; Surgery","score_opus":0.1354225464933262,"score_gpt":0.5332530314402404,"score_spread":0.3978304849469142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379341601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98698145,0.000964481,0.000016376438,0.010632149,0.00021351724,0.0002642632,0.000013527861,0.00000579398,0.0009084448],"genre_scores_gemma":[0.9826712,0.014826542,0.0010928544,0.00068082183,0.00027791914,0.000014621708,0.00000705503,0.000012148431,0.00041683295],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970852,0.000462441,0.0016224051,0.0002000298,0.00038447542,0.00024540763],"domain_scores_gemma":[0.9968886,0.0015195563,0.00082513463,0.0001730841,0.00033699517,0.00025667562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040939874,0.00009900591,0.001578926,0.00084072707,0.00002192761,0.0000050227372,0.00015641189,0.000114989,0.00007097768],"category_scores_gemma":[0.0012389186,0.000071430004,0.00032114814,0.0010160895,0.0001557186,0.00006478992,0.00016977513,0.00045489438,0.000001395435],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013938663,0.0005718364,0.81026363,0.00023706756,0.005019278,0.00039661545,0.00047857853,0.0004494541,0.000024661875,0.000029534507,0.0044730376,0.17666245],"study_design_scores_gemma":[0.006447448,0.003959392,0.9690324,0.00007705991,0.0039791963,0.0000015416523,0.000595619,0.0020906662,0.000016977374,0.000045739806,0.013690395,0.0000635353],"about_ca_topic_score_codex":0.00038064204,"about_ca_topic_score_gemma":0.0013319895,"teacher_disagreement_score":0.1765989,"about_ca_system_score_codex":0.00022294025,"about_ca_system_score_gemma":0.00034709155,"threshold_uncertainty_score":0.2912831},"labels":[],"label_agreement":null},{"id":"W4379341825","doi":"10.1200/jco.2023.41.16_suppl.tps8611","title":"Randomized phase 3 study of tarlatamab, a DLL3-targeting bispecific T-cell engager (BiTE),compared to standard of care in patients with relapsed small cell lung cancer (DeLLphi-304).","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Amgen","keywords":"Topotecan; Medicine; Refractory (planetary science); Internal medicine; Discontinuation; Oncology; Chemotherapy; Lung cancer; Cancer; Malignancy","score_opus":0.08975948839399366,"score_gpt":0.4811738018165464,"score_spread":0.39141431342255273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379341825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933936,0.001874845,0.000026885707,0.00073090056,0.00068401755,0.0027284385,0.00004835307,0.000014020311,0.00049896503],"genre_scores_gemma":[0.99737424,0.0009075171,0.001045836,0.00011763293,0.00030238894,0.0000667885,0.000010377139,0.00004258648,0.00013262211],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9917106,0.0020927822,0.004083272,0.00038436984,0.0012409256,0.00048804094],"domain_scores_gemma":[0.98876816,0.0057578194,0.0024749658,0.00033605847,0.0022433915,0.00041958713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008313868,0.00026181887,0.004595212,0.0005676135,0.00006194049,0.00000789084,0.0003214071,0.00020210986,0.000103836675],"category_scores_gemma":[0.0058225337,0.00017045047,0.000455223,0.0009062198,0.0002611074,0.000080235346,0.00019962921,0.0015542129,0.0000032275811],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.64273375,0.005627542,0.3321461,0.0005684929,0.0008313057,0.0004052279,0.009208512,0.00091854663,0.00028836072,8.363341e-7,0.0046139546,0.0026573644],"study_design_scores_gemma":[0.86915606,0.05605631,0.059057064,0.0008316616,0.0011060038,0.0000014618652,0.010275121,0.00018611965,0.00070011494,0.000006193688,0.0024156177,0.00020827983],"about_ca_topic_score_codex":0.00019550671,"about_ca_topic_score_gemma":0.0004913763,"teacher_disagreement_score":0.27308905,"about_ca_system_score_codex":0.0005547925,"about_ca_system_score_gemma":0.0021612966,"threshold_uncertainty_score":0.69705373},"labels":[],"label_agreement":null},{"id":"W4379377976","doi":"10.1080/0284186x.2023.2216339","title":"FOLFIRI in advanced platinum-resistant/refractory small-cell lung cancer: a retrospective study","year":2023,"lang":"en","type":"article","venue":"Acta Oncologica","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Janssen Biotech; Eisai; Mylan; Ipsen; Astellas Pharma Canada; Takeda Pharmaceutical Company; Gilead Sciences; Roche; Novartis; GlaxoSmithKline Australia; Meso Scale Diagnostics; Sanofi; Merck; British Microcirculation Society; Amgen; Pfizer; Bayer; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Internal medicine; Irinotecan; FOLFIRI; Population; Regimen; Clinical endpoint; Response Evaluation Criteria in Solid Tumors; Topotecan; Refractory (planetary science); Surgery; Lung cancer; Retrospective cohort study; Chemotherapy regimen; Oncology; Progressive disease; Cancer; Chemotherapy; Colorectal cancer; Clinical trial","score_opus":0.03943207050000615,"score_gpt":0.385076322317816,"score_spread":0.3456442518178099,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379377976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9759207,0.0011908448,8.959484e-7,0.0020180822,0.00023098041,0.0026268207,0.000031884898,0.00031331574,0.017666502],"genre_scores_gemma":[0.9925768,0.0014709411,0.00014913212,0.00023215063,0.00017003027,0.0012341158,0.000012213294,0.000038045175,0.0041166237],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99742424,0.00016213047,0.0003941836,0.00068381894,0.00059673697,0.00073890784],"domain_scores_gemma":[0.99861634,0.0004208568,0.00015044659,0.00046244185,0.00017981714,0.00017011157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061491365,0.00027274265,0.0007263692,0.0002930013,0.00018159299,0.000022741486,0.00027053125,0.00012956504,0.000276022],"category_scores_gemma":[0.00084389513,0.00021115431,0.00008569782,0.0013058378,0.00010784328,0.00010452698,0.0003638077,0.00065988256,0.00005045654],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019611767,0.0015939277,0.93521816,0.00019235023,0.0002988004,0.0016353936,0.005021658,0.000025040901,0.029457582,0.00001469486,0.02053132,0.004049902],"study_design_scores_gemma":[0.0059923567,0.0042667594,0.97740006,0.00014686272,0.000105278516,0.0000021205663,0.0037833601,0.00009218976,0.0003144004,0.00008106011,0.0075763105,0.000239209],"about_ca_topic_score_codex":0.0005710262,"about_ca_topic_score_gemma":0.0028826962,"teacher_disagreement_score":0.04218194,"about_ca_system_score_codex":0.0022870721,"about_ca_system_score_gemma":0.0004999281,"threshold_uncertainty_score":0.8610623},"labels":[],"label_agreement":null},{"id":"W4380422654","doi":"10.1007/s41030-023-00229-9","title":"Symptoms and Experiences with Small Cell Lung Cancer: A Mixed Methods Study of Patients and Caregivers","year":2023,"lang":"en","type":"article","venue":"Pulmonary Therapy","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Amgen","keywords":"Lung cancer; Medicine; Intensive care medicine; Oncology","score_opus":0.02504368870819661,"score_gpt":0.36270935911924335,"score_spread":0.3376656704110467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380422654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99146694,0.0070773195,0.000005506486,0.00013819341,0.00007122504,0.0009889939,0.000007517288,0.000040919313,0.00020336166],"genre_scores_gemma":[0.99573725,0.0032945585,0.0001926345,0.000029396666,0.000024174802,0.00044386004,0.00000388498,0.000018246126,0.0002560026],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99897486,0.00012380056,0.0001251766,0.00028823348,0.00027146566,0.00021645072],"domain_scores_gemma":[0.999466,0.00012879586,0.000057248795,0.00015282705,0.00010085412,0.000094259616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018918831,0.0001349309,0.00029497227,0.00011875906,0.00009639233,0.000009607945,0.00007031148,0.00002509577,0.000015850306],"category_scores_gemma":[0.000010926459,0.00008926787,0.00001881798,0.00032641913,0.00016815783,0.000052091502,0.00008056201,0.00008345736,1.9670446e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010578649,0.0003362361,0.8189378,0.00017440808,0.00026652534,0.000042635023,0.101609975,0.0000019920747,0.00065174996,5.754785e-7,0.00019218278,0.07672808],"study_design_scores_gemma":[0.004743826,0.003981584,0.7930689,0.000092435956,0.00008303281,0.0000034174684,0.1949263,0.00028161905,0.0020278506,0.000005011332,0.00060926756,0.00017678601],"about_ca_topic_score_codex":0.00066767953,"about_ca_topic_score_gemma":0.000045440796,"teacher_disagreement_score":0.09331633,"about_ca_system_score_codex":0.000039436385,"about_ca_system_score_gemma":0.000052286843,"threshold_uncertainty_score":0.3640238},"labels":[],"label_agreement":null},{"id":"W4382023243","doi":"10.3390/curroncol30070449","title":"Management of Very Early Small Cell Lung Cancer: A Canadian Survey Study","year":2023,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Ottawa Hospital Research Institute","keywords":"Medicine; Radiation therapy; Chemoradiotherapy; Lung cancer; Lesion; Stage (stratigraphy); Internal medicine; Surgery; Family medicine","score_opus":0.17913059590505878,"score_gpt":0.4761600256705797,"score_spread":0.29702942976552094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382023243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98845357,0.003732255,0.0000026303896,0.00053566165,0.001303156,0.001521761,0.000091570604,0.00005084733,0.0043085366],"genre_scores_gemma":[0.99491197,0.002933771,0.000013957482,0.000024939976,0.00010963636,0.00040102433,0.00004034485,0.00002074176,0.0015436083],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99838394,0.00019977288,0.00026461188,0.00031337864,0.00028646452,0.0005518584],"domain_scores_gemma":[0.99900454,0.00014075854,0.00006999316,0.00030102886,0.00020911254,0.0002745722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007610764,0.00013601659,0.0004212528,0.00035269337,0.00007926803,0.000006439714,0.00018599337,0.000049302347,0.00009829939],"category_scores_gemma":[0.000051001545,0.00012226273,0.000058451587,0.00072234066,0.00008578213,0.000021278438,0.00020604406,0.0002535295,0.000064056185],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013706488,0.00041798418,0.9470897,0.0006896246,0.00036392466,0.00033526402,0.0016121414,0.000006585979,0.000011371443,0.000011143909,0.028851924,0.020473309],"study_design_scores_gemma":[0.002259951,0.00083090266,0.96869296,0.00013157971,0.00019378537,9.242348e-7,0.0010354216,0.000077912824,0.00002502804,0.0000046836667,0.026650328,0.00009650859],"about_ca_topic_score_codex":0.15494658,"about_ca_topic_score_gemma":0.33630884,"teacher_disagreement_score":0.18136226,"about_ca_system_score_codex":0.0011300533,"about_ca_system_score_gemma":0.00095191324,"threshold_uncertainty_score":0.8506807},"labels":[],"label_agreement":null},{"id":"W4382983283","doi":"10.3390/curroncol30070465","title":"Canadian Consensus Recommendations on the Management of Extensive-Stage Small-Cell Lung Cancer","year":2023,"lang":"en","type":"review","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"William Osler Health System; University of British Columbia; Surrey Place Centre; McMaster University; University of Manitoba; Juravinski Cancer Centre; University of Alberta; University of Ottawa; Centre Hospitalier de l’Université de Montréal; University Health Network; CancerCare Manitoba; Ottawa Hospital; Princess Margaret Cancer Centre; University of Toronto","funders":"Jazz Pharmaceuticals; F. Hoffmann-La Roche; AstraZeneca","keywords":"Medicine; Consensus conference; Intensive care medicine; Randomized controlled trial; Lung cancer; Stage (stratigraphy); MEDLINE; Systemic therapy; Neuroendocrine tumors; Radiation therapy; Oncology; Cancer; Pathology; Internal medicine","score_opus":0.4128847573331576,"score_gpt":0.5497326315138387,"score_spread":0.13684787418068106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382983283","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000021399284,0.97333467,0.0000014786428,0.008528263,0.0021965273,0.0036022482,0.000746465,0.000037651054,0.011531275],"genre_scores_gemma":[0.000004378194,0.98839074,0.000044060376,0.00016646231,0.00023750273,0.0017840097,0.0001914525,0.00005949721,0.009121869],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99776804,0.0003264988,0.0006048748,0.0004590473,0.00026010154,0.0005814383],"domain_scores_gemma":[0.99761575,0.00088516675,0.000357981,0.0006010842,0.00028415403,0.0002558691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005159464,0.0003389161,0.0014559559,0.0004291793,0.00017418535,0.000009204769,0.00031846942,0.0001668132,0.0005299076],"category_scores_gemma":[0.00012124923,0.00021763046,0.00032255735,0.0005786382,0.00018776683,0.0000058335227,0.00023525921,0.00087875815,0.00015180242],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013981648,0.00011760499,0.000034438046,0.049593106,0.0014107085,0.00017873896,0.00012307578,8.575354e-7,5.0241987e-8,0.00075788534,0.22559355,0.722176],"study_design_scores_gemma":[0.00046729282,0.00014531722,0.000030562624,0.023268813,0.0022848714,0.0000065903087,0.00032887617,0.0000129141035,4.1903647e-7,0.000008555652,0.9732868,0.00015899756],"about_ca_topic_score_codex":0.008538985,"about_ca_topic_score_gemma":0.036893748,"teacher_disagreement_score":0.74769324,"about_ca_system_score_codex":0.0036585624,"about_ca_system_score_gemma":0.0033957767,"threshold_uncertainty_score":0.99806327},"labels":[],"label_agreement":null},{"id":"W4385685238","doi":"10.4049/jimmunol.210.supp.233.15","title":"Using lung-on-a-chip to characterize HIF-1α-dependent inflammatory responses during acute <i>Streptococcus pneumoniae</i> infection","year":2023,"lang":"en","type":"article","venue":"The Journal of Immunology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Immune system; Biology; Streptococcus pneumoniae; Western blot; Gene knockdown; Immunology; Hypoxia-inducible factors; Cytokine; Lung; Gene; Microbiology; Medicine","score_opus":0.04108608355596852,"score_gpt":0.35426107446247745,"score_spread":0.3131749909065089,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385685238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927907,0.00041039436,0.00001600435,0.0054628686,0.0007163234,0.0004347906,0.000008430503,0.000062502084,0.000097962366],"genre_scores_gemma":[0.99608433,0.002367156,0.000014190082,0.000294404,0.00041015528,0.000017272274,0.0000012046482,0.000033987126,0.00077728333],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980884,0.0003809027,0.00050390133,0.00014028656,0.00043721194,0.0004492812],"domain_scores_gemma":[0.9986188,0.0003293898,0.0003221578,0.0003708774,0.0002575246,0.00010125445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011261344,0.00017992865,0.00042498973,0.00058282283,0.00029153933,0.000021017337,0.00022940205,0.0000750394,0.000039665796],"category_scores_gemma":[0.0005212312,0.000118156495,0.0001328339,0.00044585668,0.00014457924,0.00012465997,0.00027529013,0.0007647839,0.000108540495],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004914011,0.000044789896,0.023672527,0.00005334962,0.0010829282,0.0005100408,0.0011682279,0.00010049041,0.9673708,0.000007591204,0.00041509402,0.00066016166],"study_design_scores_gemma":[0.0021350903,0.0013988246,0.86073774,0.00043238682,0.00028813604,0.001963879,0.00027973784,0.000023042872,0.13127002,0.00004060929,0.0012870034,0.00014354671],"about_ca_topic_score_codex":0.000033169494,"about_ca_topic_score_gemma":0.000008992991,"teacher_disagreement_score":0.8370652,"about_ca_system_score_codex":0.00052847934,"about_ca_system_score_gemma":0.00024691396,"threshold_uncertainty_score":0.48182818},"labels":[],"label_agreement":null},{"id":"W4386137644","doi":"10.1177/17588359231192399","title":"The role of thoracic consolidative radiotherapy in the setting of immunotherapy in extensive stage small cell lung cancer","year":2023,"lang":"en","type":"review","venue":"Therapeutic Advances in Medical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Durvalumab; Atezolizumab; Chemoimmunotherapy; Oncology; Radiation therapy; Immunotherapy; Lung cancer; Internal medicine; Chemotherapy; Prophylactic cranial irradiation; Pembrolizumab; Clinical trial; Cancer","score_opus":0.05325617056729078,"score_gpt":0.5120078415180879,"score_spread":0.4587516709507971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386137644","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000515605,0.9935106,0.000048821068,0.0013237365,0.00026224795,0.0033355912,0.000035259,0.00001672768,0.00095141],"genre_scores_gemma":[0.00067300507,0.9967161,0.0001361076,0.00055740954,0.00016468193,0.0015401421,0.000011494759,0.000076571036,0.00012450799],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9930871,0.0028816562,0.0017451562,0.00051568146,0.0009771906,0.00079318555],"domain_scores_gemma":[0.98601687,0.0121320505,0.0009837778,0.0006171393,0.00016898382,0.00008118166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004842172,0.00046376535,0.0032722796,0.00044216999,0.000072280796,0.000007172864,0.001056525,0.00048121886,0.00010959148],"category_scores_gemma":[0.0006292872,0.00024267536,0.0002941896,0.0015690365,0.0014659545,0.000057920322,0.00015288635,0.0021993378,0.0000021259507],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057766825,0.00026411487,0.0012687651,0.007833201,0.00039871383,0.00015537742,0.0057515395,0.000014524446,0.0000132398145,0.00022002797,0.000013915324,0.9834889],"study_design_scores_gemma":[0.0023309698,0.0008002187,0.00032812767,0.021857077,0.00024369266,0.000031427615,0.007221212,0.00030878664,0.000032302087,0.000727561,0.965844,0.00027463547],"about_ca_topic_score_codex":0.00044581605,"about_ca_topic_score_gemma":0.0030690788,"teacher_disagreement_score":0.98321426,"about_ca_system_score_codex":0.0011363574,"about_ca_system_score_gemma":0.003210095,"threshold_uncertainty_score":0.98960143},"labels":[],"label_agreement":null},{"id":"W4386346584","doi":"10.1007/s11523-023-00995-1","title":"Comparative Effectiveness of Lurbinectedin for the Treatment of Relapsed Small Cell Lung Cancer in the Post-Platinum Setting: A Real-World Canadian Synthetic Control Arm Analysis","year":2023,"lang":"en","type":"article","venue":"Targeted Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; CancerCare Manitoba; University of Calgary","funders":"Jazz Pharmaceuticals Canada","keywords":"Medicine; Hazard ratio; Confidence interval; Proportional hazards model; Population; Internal medicine; Oncology; Chemotherapy; Surgery; Environmental health","score_opus":0.027790270941448557,"score_gpt":0.3760701408180536,"score_spread":0.3482798698766051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386346584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831791,0.0023760856,0.00003676093,0.00611405,0.00016080392,0.0053638876,0.00070553354,0.000029823974,0.0020339866],"genre_scores_gemma":[0.99703056,0.00032685915,0.00004617685,0.00009604316,0.00005442079,0.0020665482,0.00009442216,0.000015834616,0.00026915653],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979017,0.0007349748,0.00038602905,0.00028375574,0.00020474847,0.00048883713],"domain_scores_gemma":[0.990859,0.0081276335,0.00020101776,0.00032734536,0.00039154856,0.00009347211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010994952,0.00018637859,0.0010707455,0.0006916682,0.00012210906,0.0000043421023,0.00018213643,0.000085022075,0.000065893255],"category_scores_gemma":[0.00025836533,0.000103229344,0.00023981881,0.0019378819,0.00022361978,0.000014203105,0.000016462536,0.0001737029,0.0000018644625],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014057249,0.0022651076,0.81991184,0.0018694088,0.022324566,0.00029334423,0.06476423,0.025309378,0.041077558,0.00048128245,0.004253585,0.0033924226],"study_design_scores_gemma":[0.010290834,0.0049491203,0.9336466,0.00014447405,0.005787261,0.000002221441,0.0035569903,0.032042094,0.00747028,0.00004725725,0.0019029455,0.00015988485],"about_ca_topic_score_codex":0.25698242,"about_ca_topic_score_gemma":0.6812501,"teacher_disagreement_score":0.42426765,"about_ca_system_score_codex":0.0014350673,"about_ca_system_score_gemma":0.0013876597,"threshold_uncertainty_score":0.7479654},"labels":[],"label_agreement":null},{"id":"W4386391777","doi":"10.1007/s10143-023-02129-7","title":"Whole-tumor histogram analysis of multi-parametric MRI for differentiating brain metastases histological subtypes in lung cancers: relationship with the Ki-67 proliferation index","year":2023,"lang":"en","type":"article","venue":"Neurosurgical Review","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"National Natural Science Foundation of China","keywords":"Medicine; Kurtosis; Effective diffusion coefficient; Lung cancer; Percentile; Nuclear medicine; Skewness; Coefficient of variation; Adenocarcinoma; Standard deviation; Ki-67; Histogram; Radiology; Pathology; Cancer; Internal medicine; Magnetic resonance imaging; Immunohistochemistry; Mathematics; Statistics","score_opus":0.07793797974727316,"score_gpt":0.3945653936290378,"score_spread":0.31662741388176463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386391777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7379943,0.17774116,0.0070440904,0.06438758,0.00018223544,0.011919633,0.00023651902,0.00031463173,0.00017982247],"genre_scores_gemma":[0.9914735,0.0058082915,0.00025902645,0.00091802655,0.000028830389,0.0010885694,0.000125851,0.00002064069,0.00027726442],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99759406,0.00047769878,0.00058773794,0.0004252577,0.00057205115,0.00034322002],"domain_scores_gemma":[0.9961754,0.002904799,0.0002834409,0.00033842048,0.00020038869,0.000097518416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012285917,0.00019175354,0.0009772291,0.00050982874,0.00013106104,0.00002093254,0.00014889598,0.00004501099,0.00003699648],"category_scores_gemma":[0.0068114437,0.000104802544,0.00030583,0.005199698,0.00018799044,0.00006463248,0.00006671486,0.00035329876,0.0000036140286],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005752443,0.0003115478,0.9728234,0.0071849157,0.0008891519,0.00010468806,0.00016882195,0.0017941119,0.00011114384,0.00035506018,0.0090776505,0.006604267],"study_design_scores_gemma":[0.0016592589,0.00043877662,0.92819804,0.0013327606,0.002606431,0.000009108886,0.00003252033,0.03922219,0.000013884248,0.000011020826,0.026306339,0.00016964991],"about_ca_topic_score_codex":0.00007700225,"about_ca_topic_score_gemma":0.0003523984,"teacher_disagreement_score":0.25347915,"about_ca_system_score_codex":0.000301937,"about_ca_system_score_gemma":0.0001549314,"threshold_uncertainty_score":0.8154427},"labels":[],"label_agreement":null},{"id":"W4386570892","doi":"10.1016/j.jtocrr.2023.100572","title":"Patient-Reported Health-Related Quality of Life in KEYNOTE-604: Pembrolizumab or Placebo Added to Etoposide and Platinum as First-Line Therapy for Extensive-Stage SCLC","year":2023,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"William Osler Health System; University of Toronto","funders":"Daiichi Sankyo Europe; National Cancer Institute; Chugai Pharmaceutical; Merck Sharp and Dohme; Genentech; Oryzon Genomics; BeiGene; Merck KGaA; Gilead Sciences; GlaxoSmithKline; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Pembrolizumab; Medicine; Placebo; Internal medicine; Lung cancer; Quality of life (healthcare); Hazard ratio; Confidence interval; Etoposide; Oncology; Chemotherapy; Surgery; Cancer; Pathology; Immunotherapy; Nursing","score_opus":0.3304689780494397,"score_gpt":0.5523388797000741,"score_spread":0.22186990165063442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386570892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96941686,0.0015630077,0.000007510103,0.023386361,0.0001789534,0.004967786,0.000039853607,0.000081436185,0.00035825532],"genre_scores_gemma":[0.98804915,0.0061097336,0.00019432054,0.00072592404,0.0001380365,0.0005180137,0.000047912967,0.00004573489,0.004171183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9923856,0.0007601757,0.0031143716,0.0010265338,0.0017589967,0.00095430866],"domain_scores_gemma":[0.98994005,0.0061202226,0.00059859024,0.0007271388,0.0015467546,0.0010672393],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.014696706,0.0002480171,0.0014860311,0.00042279952,0.00029966075,0.000035676527,0.0000917074,0.0002589514,0.00008831003],"category_scores_gemma":[0.06873883,0.00016514855,0.00017466162,0.0011662035,0.0007503187,0.00008073738,0.00044729243,0.0009255249,0.00000687068],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12533867,0.0019458133,0.71250457,0.0037454031,0.0012191229,0.006545985,0.0053763855,0.00006545038,0.0011147034,0.0001061823,0.057223015,0.08481473],"study_design_scores_gemma":[0.01976062,0.014483881,0.94160795,0.0011443476,0.000023073933,0.00016408622,0.0015371551,0.00054792577,0.0004693606,0.0018788484,0.018022748,0.00035999357],"about_ca_topic_score_codex":0.0045666182,"about_ca_topic_score_gemma":0.0014598215,"teacher_disagreement_score":0.22910342,"about_ca_system_score_codex":0.00013432807,"about_ca_system_score_gemma":0.001973254,"threshold_uncertainty_score":0.9391056},"labels":[],"label_agreement":null},{"id":"W4386600587","doi":"10.1016/j.ccell.2023.08.007","title":"Unfolding the secrets of small cell lung cancer progression: Novel approaches and insights through rapid autopsies","year":2023,"lang":"en","type":"article","venue":"Cancer Cell","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cancer Moonshot; National Cancer Institute; National Research, Development and Innovation Office; University of Texas MD Anderson Cancer Center; National Institutes of Health; International Association for the Study of Lung Cancer; Hungarian-American Enterprise Scholarship Fund; Fru Berta Kamprads Stiftelse; Sierra Oncology; Innovációs és Technológiai Minisztérium; Magyar Tudományos Akadémia; BeiGene; Magyar Tüdőgyógyász Társaság; Cancer Prevention and Research Institute of Texas; Austrian Science Fund; Moonshot Research and Development Program; AstraZeneca; Bristol-Myers Squibb","keywords":"Biology; Lung cancer; Cancer; Cancer research; Cell; Computational biology; Medicine; Pathology; Genetics","score_opus":0.09589570687595671,"score_gpt":0.3582686172030531,"score_spread":0.26237291032709636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386600587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7583649,0.21745093,0.00005618666,0.0031203537,0.00048620274,0.0015424337,0.000051385192,0.00016388389,0.018763708],"genre_scores_gemma":[0.96063167,0.0339521,0.00044232619,0.00023709964,0.0003531084,0.00077537977,0.00001279166,0.000053141008,0.0035423692],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99831814,0.000046963607,0.00028108852,0.00042836493,0.00045630062,0.00046917572],"domain_scores_gemma":[0.99902165,0.00018938139,0.0001545947,0.00038052004,0.00014101098,0.00011286082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021927455,0.00024294392,0.00042989748,0.000054474676,0.00023673134,0.000029469908,0.00020234517,0.000093819755,0.00012873467],"category_scores_gemma":[0.0000336165,0.00014721938,0.000090111665,0.0005333962,0.0003727356,0.00012396279,0.0003115922,0.00028244313,0.0000031294917],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018771745,0.0011027321,0.17414904,0.043674197,0.0028761753,0.00024552832,0.26652065,0.0016490552,0.3021271,0.0021682992,0.1326171,0.07099296],"study_design_scores_gemma":[0.011108669,0.00083907077,0.05308234,0.0045456234,0.0014309657,0.000022158569,0.026724815,0.019327736,0.7192965,0.00038480991,0.16193701,0.0013003079],"about_ca_topic_score_codex":0.0006263147,"about_ca_topic_score_gemma":0.00024147506,"teacher_disagreement_score":0.41716942,"about_ca_system_score_codex":0.00024197462,"about_ca_system_score_gemma":0.00043169523,"threshold_uncertainty_score":0.6003432},"labels":[],"label_agreement":null},{"id":"W4386784419","doi":"10.1158/1557-3265.aacrahns23-po-016","title":"Abstract PO-016: SSTR2 use and molecular profile in EBV-positive nasopharyngeal carcinoma: A single institution experience","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Somatostatin receptor 2; Immunohistochemistry; Medicine; Nasopharyngeal carcinoma; Malignancy; Microsatellite instability; Internal medicine; Oncology; Biopsy; Pathology; Cancer research; Somatostatin receptor; Receptor; Biology; Radiation therapy; Microsatellite; Gene; Genetics","score_opus":0.2902034492759341,"score_gpt":0.5352508114987602,"score_spread":0.24504736222282608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386784419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99095297,0.0018631894,0.0000042892393,0.0037189922,0.00018700588,0.0013912045,0.000062528925,0.000080394755,0.0017394216],"genre_scores_gemma":[0.9963462,0.001617983,0.00007345707,0.00023795955,0.00029243104,0.000753614,0.000030418365,0.00003381315,0.0006141292],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959957,0.00034980098,0.00057681097,0.0008442447,0.0012548686,0.0009785863],"domain_scores_gemma":[0.997247,0.0012047032,0.000059461217,0.00044392314,0.0005951293,0.0004497819],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021882036,0.00019181431,0.0005000492,0.0004324372,0.00021956365,0.000101662634,0.00021881159,0.00018627978,0.00013205188],"category_scores_gemma":[0.0040893364,0.0001652208,0.00010342195,0.0014604575,0.0015132971,0.0003373395,0.0005539355,0.0014045173,0.000107192056],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00367438,0.00080948224,0.9160891,0.0006776949,0.00015563694,0.0047396137,0.002836822,0.000014110793,0.033074494,0.00030477365,0.0101814205,0.02744246],"study_design_scores_gemma":[0.0028283752,0.00090572966,0.9812729,0.000514263,0.00001498249,0.0000104906185,0.0007535883,0.00019622674,0.011665475,0.00011052991,0.0015490165,0.00017845647],"about_ca_topic_score_codex":0.0037594165,"about_ca_topic_score_gemma":0.00052082125,"teacher_disagreement_score":0.06518376,"about_ca_system_score_codex":0.0006851137,"about_ca_system_score_gemma":0.0009798881,"threshold_uncertainty_score":0.6737509},"labels":[],"label_agreement":null},{"id":"W4386848086","doi":"10.3389/fonc.2023.1191855","title":"Real-world predictors of survival in patients with extensive-stage small-cell lung cancer in Manitoba, Canada: a retrospective cohort study","year":2023,"lang":"en","type":"article","venue":"Frontiers in Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; AstraZeneca (Canada); University of Manitoba; CancerCare Manitoba","funders":"Manitoba Medical Service Foundation","keywords":"Medicine; Cohort; Internal medicine; Retrospective cohort study; Cancer registry; Lung cancer; Proportional hazards model; Oncology; Radiation therapy; Cancer; Prophylactic cranial irradiation; Chemotherapy; Survival analysis; Stage (stratigraphy); Performance status; Surgery; Conventional PCI","score_opus":0.01587972647602231,"score_gpt":0.30716899989587293,"score_spread":0.2912892734198506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386848086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916076,0.00017363671,0.000002734427,0.0002466236,0.0013723507,0.003375384,0.00010476176,0.00002504081,0.0030918398],"genre_scores_gemma":[0.99729526,0.0003822226,0.000096235985,0.00004413659,0.00006806288,0.0005946309,0.000027303102,0.000036747562,0.0014554263],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973951,0.0002784142,0.00049554283,0.0005310047,0.000672344,0.00062762207],"domain_scores_gemma":[0.9989842,0.00013899716,0.00016455,0.00031129582,0.00029419377,0.000106769614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065724604,0.00021351977,0.0011339596,0.0008286328,0.000034159824,0.0000031662998,0.00017805473,0.00008757897,0.000022649183],"category_scores_gemma":[0.00022297764,0.0001861848,0.000028870292,0.0016921848,0.00017148315,0.000044481276,0.00016998491,0.0005629642,4.7989283e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016953402,0.00062077807,0.9796724,0.00014067513,0.00029871828,0.00078022736,0.001837744,0.00022857347,0.0000039988,0.0000025639497,0.014539973,0.00017903408],"study_design_scores_gemma":[0.008443058,0.001213433,0.9825675,0.00014019963,0.00007880947,1.561292e-7,0.006874412,0.00024162364,0.000013022174,0.0000045640886,0.00027772514,0.00014550307],"about_ca_topic_score_codex":0.80346966,"about_ca_topic_score_gemma":0.99229974,"teacher_disagreement_score":0.18883009,"about_ca_system_score_codex":0.01125927,"about_ca_system_score_gemma":0.0024503786,"threshold_uncertainty_score":0.9925363},"labels":[],"label_agreement":null},{"id":"W4387206412","doi":"10.1016/j.ijrobp.2023.06.779","title":"Survival Outcomes of Extensive Stage Small Cell Lung Cancer Patients Treated with Consolidative Thoracic Radiotherapy at a Tertiary Cancer Center","year":2023,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Lung cancer; Radiation therapy; Pneumonitis; Chemoradiotherapy; Tolerability; Chemotherapy; Survival rate; Radiology; Surgery; Internal medicine; Lung; Adverse effect","score_opus":0.028754974698601592,"score_gpt":0.39726293108172067,"score_spread":0.36850795638311906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387206412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935584,0.0010323819,0.0003274756,0.002440723,0.0010874607,0.00055260205,0.0007296501,0.00003753565,0.00023376704],"genre_scores_gemma":[0.99164796,0.0053979526,0.00030250824,0.0008275438,0.00065478514,0.000078495344,0.00018713746,0.00005027583,0.0008533634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99793553,0.0002890088,0.00065867096,0.00028046,0.0004999823,0.00033635172],"domain_scores_gemma":[0.9958353,0.00055659685,0.0011605691,0.00014943819,0.0021580912,0.00014001415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031115278,0.0002606162,0.00079766737,0.0002824437,0.00007874312,0.00001294537,0.0002854337,0.00013923133,0.0001462946],"category_scores_gemma":[0.00014611708,0.00018378589,0.00024506802,0.00029355136,0.00032431012,0.00016972059,0.00010405744,0.00037516007,0.0000064021083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020211178,0.00046506384,0.9784331,0.000053326716,0.0035496044,0.00006878112,0.0012491463,0.00040981724,0.0032619764,0.000054269145,0.0019825327,0.008451307],"study_design_scores_gemma":[0.01352657,0.0015117931,0.967425,0.00022730685,0.00034895443,0.000013590406,0.00020265064,0.0010764642,0.010505093,0.0000497561,0.0048790565,0.00023377022],"about_ca_topic_score_codex":0.00022498344,"about_ca_topic_score_gemma":0.00008910977,"teacher_disagreement_score":0.011505452,"about_ca_system_score_codex":0.0018580364,"about_ca_system_score_gemma":0.0007643084,"threshold_uncertainty_score":0.7494571},"labels":[],"label_agreement":null},{"id":"W4387207571","doi":"10.1016/j.ijrobp.2023.06.738","title":"A Survey Study of Practice Patterns in Management of Very Early Small Cell Lung Cancer in Canada","year":2023,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Radiation therapy; Lung cancer; Chemoradiotherapy; Stage (stratigraphy); Lesion; Chemotherapy; Demographics; Adjuvant chemotherapy; Cancer; Internal medicine; Surgery; Family medicine; Radiology","score_opus":0.035320653426812156,"score_gpt":0.3908238424059557,"score_spread":0.3555031889791435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387207571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968664,0.0004424604,0.000079738194,0.0009730685,0.00088456646,0.0004408043,0.00010790123,0.0000048824086,0.00020014672],"genre_scores_gemma":[0.99719024,0.002352672,0.000080080325,0.00010296038,0.00016606633,0.000032019838,0.00002064676,0.000014593943,0.000040696596],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978575,0.00045123446,0.0008239154,0.00017443125,0.00047715983,0.0002157613],"domain_scores_gemma":[0.9972359,0.00090036535,0.0008848698,0.00012356999,0.0007961191,0.00005917191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012262773,0.00012144961,0.0004894331,0.0003164222,0.000015263056,0.0000049107066,0.00030292777,0.000060025533,0.000020994203],"category_scores_gemma":[0.00029015783,0.00011130934,0.000059111324,0.00047907748,0.000045064484,0.0001326405,0.00013059912,0.0003935596,0.0000013292708],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007067432,0.00069447595,0.98061776,0.00008606126,0.00085969997,0.00031828257,0.0017372632,0.0032843393,0.00017206954,0.000044749428,0.0004020631,0.011076507],"study_design_scores_gemma":[0.0063845217,0.0007708156,0.98902255,0.0002018875,0.00008940374,0.000005386475,0.002055203,0.0009013765,0.0002341839,0.000048535134,0.00021181944,0.000074332274],"about_ca_topic_score_codex":0.42388687,"about_ca_topic_score_gemma":0.34664115,"teacher_disagreement_score":0.07724573,"about_ca_system_score_codex":0.0025796324,"about_ca_system_score_gemma":0.0018677554,"threshold_uncertainty_score":0.6745649},"labels":[],"label_agreement":null},{"id":"W4387207935","doi":"10.1016/j.ijrobp.2023.06.380","title":"The Effect of PARP Inhibitor Radiosensitization on the mRNA Translational Regulation of T Cell Chemokines","year":2023,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; McGill University; University Health Network","funders":"","keywords":"Cancer research; Olaparib; Chemokine; CXCL10; CCL5; PARP inhibitor; Medicine; Immunotherapy; Molecular biology; T cell; Biology; Immunology; Poly ADP ribose polymerase; Immune system; Gene; IL-2 receptor","score_opus":0.017688799030240253,"score_gpt":0.34276262769586285,"score_spread":0.3250738286656226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387207935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98108745,0.0003456933,0.0008270572,0.014815427,0.0015250796,0.00047922842,0.000048911978,0.00002543943,0.00084573566],"genre_scores_gemma":[0.9971986,0.00075824937,0.000114321294,0.0001305695,0.0015946203,0.000014967177,0.0000720628,0.000018766494,0.00009788984],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979452,0.00040145856,0.0007139065,0.00014140311,0.00062646845,0.00017155691],"domain_scores_gemma":[0.9948172,0.0030652164,0.00100247,0.0001599539,0.00090572954,0.00004940446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015325611,0.00014664746,0.0003896337,0.000171827,0.000121678,0.000012506096,0.00026382576,0.00012340817,0.000019439307],"category_scores_gemma":[0.0009969781,0.00008433275,0.00024233379,0.0003815387,0.00035608222,0.0001135952,0.00003866255,0.00032509046,0.000010774716],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0072939964,0.00046904053,0.35536975,0.0001780609,0.002653863,0.000025756239,0.0023667985,0.010958342,0.35565856,0.02685386,0.021458268,0.21671371],"study_design_scores_gemma":[0.011616637,0.005594369,0.24771816,0.00031629906,0.00035756407,0.00007284781,0.00020935106,0.014126642,0.6905149,0.011250078,0.017994894,0.00022822653],"about_ca_topic_score_codex":0.000006537053,"about_ca_topic_score_gemma":0.0000021647593,"teacher_disagreement_score":0.3348564,"about_ca_system_score_codex":0.00026742983,"about_ca_system_score_gemma":0.0003126597,"threshold_uncertainty_score":0.34389895},"labels":[],"label_agreement":null},{"id":"W4387517250","doi":"10.1200/jco.23.01435","title":"Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) Guideline","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Hamilton Health Sciences; Windsor Regional Hospital; Western University; Juravinski Cancer Centre","funders":"Hamilton Health Sciences; Brown University; American Society of Clinical Oncology; University of California","keywords":"Medicine; Guideline; Lung cancer; Systemic therapy; Randomized controlled trial; Systematic review; Intensive care medicine; Radiation therapy; Cancer; Evidence-based medicine; Oncology; MEDLINE; Quality of life (healthcare); Family medicine; Disease; Internal medicine; Alternative medicine; Pathology; Nursing; Breast cancer","score_opus":0.22785546923338496,"score_gpt":0.5706298294869827,"score_spread":0.34277436025359775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387517250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8776369,0.052972272,0.00018215836,0.059751295,0.005763509,0.0021935543,0.00005212414,0.000053871285,0.0013942934],"genre_scores_gemma":[0.7170854,0.19482131,0.008772266,0.029667322,0.01687616,0.00091803743,0.000077381796,0.00021723045,0.03156485],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945241,0.00033527598,0.0034335535,0.00036798554,0.0006553081,0.0006837769],"domain_scores_gemma":[0.9933441,0.0016882471,0.0020683326,0.00030125986,0.0019748358,0.0006232128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005103402,0.0002422159,0.0025506865,0.00022540097,0.0001719076,0.000015438989,0.00034190193,0.000335005,0.0003330248],"category_scores_gemma":[0.0009165072,0.00016668758,0.00081877684,0.00024489878,0.00015223623,0.000073979965,0.00011057638,0.0015778516,0.000009503831],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0072325203,0.00046167322,0.51847386,0.0007397365,0.0014845448,0.0002303597,0.0047317166,0.0002589453,0.00008903694,0.00001054342,0.34110904,0.12517802],"study_design_scores_gemma":[0.021203358,0.015368994,0.12548728,0.0009431882,0.00038770222,0.00008312979,0.0014121232,0.00013137655,0.000047458212,0.000041988256,0.8347101,0.00018328431],"about_ca_topic_score_codex":0.1853998,"about_ca_topic_score_gemma":0.653929,"teacher_disagreement_score":0.49360108,"about_ca_system_score_codex":0.0078047924,"about_ca_system_score_gemma":0.04469162,"threshold_uncertainty_score":0.99600405},"labels":[],"label_agreement":null},{"id":"W4387812459","doi":"10.1016/j.annonc.2023.09.1327","title":"2300P Clonal hematopoiesis of indeterminate potential (CHIP) in patients with advanced NSCLC treated with immune checkpoint blockers (ICB) as monotherapy: Analysis of the PREMIS study","year":2023,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cilag; Chugai Pharmaceutical; Genentech; Aptitude Health; Sierra Oncology; Eisai; Astellas Pharma; Basilea Pharmaceutica; Daiichi Sankyo Europe; Servier; AstraZeneca; Institut National Du Cancer; Pfizer; Incyte; BeiGene; Astex Pharmaceuticals; Les Laboratories Pierre Fabre; Ipsen; Jazz Pharmaceuticals; Bayer HealthCare; Exelixis; Sanofi; Amgen; American Association for Cancer Research; Eli Lilly and Company; Bristol-Myers Squibb; Agios Pharmaceuticals; Society for Immunotherapy of Cancer; PharmaMar; Celgene","keywords":"Medicine; Internal medicine; Oncology; Pembrolizumab; Lung cancer; Cancer; Immunotherapy","score_opus":0.02526084698264695,"score_gpt":0.366198722378926,"score_spread":0.340937875396279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387812459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972332,0.00012781245,0.00000130512,0.0011083226,0.000019420377,0.0011702208,0.00003598283,0.000016167705,0.00028754718],"genre_scores_gemma":[0.99947095,0.0001316182,0.00006084263,0.00005193451,0.000007320547,0.000096877164,0.000018911536,0.000021863038,0.00013971145],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978605,0.00021188625,0.0006318213,0.00030183792,0.00066135096,0.0003326074],"domain_scores_gemma":[0.99819976,0.00014502375,0.000516004,0.0004761911,0.0006031906,0.00005981594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047771502,0.0001897316,0.0011587655,0.0006128052,0.00004310508,0.000002380341,0.00022422352,0.00008058416,0.00004459895],"category_scores_gemma":[0.00013140633,0.00011157807,0.00019922071,0.00229502,0.00040386734,0.000051917435,0.00013645587,0.0001900511,0.0000010274273],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015156193,0.0023645235,0.9590853,0.00013799615,0.007313058,0.00005534019,0.0039371233,0.000582303,0.004258946,0.0000027416236,0.000060785667,0.007045732],"study_design_scores_gemma":[0.008552066,0.012893393,0.95102835,0.00016591127,0.00084124185,0.0000017445251,0.001978268,0.00011983913,0.024276394,0.0000127030635,0.000031443396,0.00009864134],"about_ca_topic_score_codex":0.0010694185,"about_ca_topic_score_gemma":0.00060027,"teacher_disagreement_score":0.020017447,"about_ca_system_score_codex":0.00008395796,"about_ca_system_score_gemma":0.00028584123,"threshold_uncertainty_score":0.45500216},"labels":[],"label_agreement":null},{"id":"W4387812581","doi":"10.1016/j.annonc.2023.09.1257","title":"2027P Immune checkpoint inhibitors in the treatment of small cell lung cancer: A systematic review and meta-analysis","year":2023,"lang":"en","type":"review","venue":"Annals of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; BC Cancer Agency; McMaster University; Western University","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Oncology; Lung cancer; Meta-analysis; Cochrane Library; Adverse effect; Chemotherapy; Clinical endpoint; Confidence interval; Randomized controlled trial; Subgroup analysis","score_opus":0.33720105477581636,"score_gpt":0.5258642158560765,"score_spread":0.1886631610802601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387812581","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000112532725,0.9888578,3.0488067e-7,0.003598133,0.000030692918,0.0070622275,0.00012424578,0.000012723195,0.00030264034],"genre_scores_gemma":[0.000019560626,0.9935691,0.000018412607,0.00020134222,0.000034882924,0.0051855044,0.000032232536,0.000039312516,0.0008997034],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99530286,0.0013147753,0.002254853,0.00040687434,0.0003730705,0.0003475856],"domain_scores_gemma":[0.9958889,0.0014015568,0.0015574642,0.00079506944,0.00028368007,0.000073352974],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0025505156,0.00042067285,0.01616506,0.000579505,0.000025295258,0.000005173394,0.00027408305,0.00019186756,0.00005424571],"category_scores_gemma":[0.0003529561,0.0001970038,0.0035073266,0.0016844941,0.00017805978,0.000016675825,0.0001093865,0.00025886294,0.00000419156],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008457134,0.00032106723,0.0000061807914,0.8235059,0.17049079,0.00006707153,0.00047728032,4.7036278e-7,2.2681657e-7,0.0000038870476,0.0007521062,0.004366562],"study_design_scores_gemma":[0.00029810725,0.0014947728,0.0000071972277,0.052735716,0.847236,0.000013254527,0.000120122786,0.0000017973533,0.0000072660355,0.0000037562427,0.09795689,0.0001251656],"about_ca_topic_score_codex":0.0018426221,"about_ca_topic_score_gemma":0.00085140025,"teacher_disagreement_score":0.7707702,"about_ca_system_score_codex":0.00029247743,"about_ca_system_score_gemma":0.00074061134,"threshold_uncertainty_score":0.998441},"labels":[],"label_agreement":null},{"id":"W4388045013","doi":"10.1016/j.jtho.2023.09.674","title":"P2.17-07 Real-world Safety and Dosing of Lurbinectedin-Treated Patients with Small Cell Lung Cancer: Jazz EMERGE 402 Preliminary Analysis","year":2023,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"Medicine; Dosing; Jazz; Lung cancer; Intensive care medicine; Internal medicine; Acoustics","score_opus":0.023414895978585516,"score_gpt":0.4081311427605147,"score_spread":0.38471624678192917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388045013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99246144,0.0016882803,0.000051767158,0.0021235452,0.00018859177,0.00043838966,0.00004074743,0.000030364867,0.0029768692],"genre_scores_gemma":[0.99060875,0.005228792,0.0010546268,0.00007658456,0.0002148471,0.000014150443,0.000030386564,0.000034476663,0.0027373768],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99765027,0.00023999515,0.0008321012,0.000268665,0.0005711136,0.00043784748],"domain_scores_gemma":[0.99720615,0.00041426055,0.00089864276,0.00023868102,0.000979146,0.00026309676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078088924,0.00022044902,0.0012366554,0.0012519355,0.00012434003,0.000010117421,0.00015916106,0.00011446438,0.00015438731],"category_scores_gemma":[0.00015293965,0.0001531963,0.00019594195,0.0022700694,0.00018713076,0.00011093566,0.00016744253,0.000511755,0.0000022479032],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013243402,0.00037917466,0.9596079,0.00063655875,0.0035273212,0.00042629952,0.00086669263,0.0005082324,0.0006793139,0.0000018917802,0.0064811185,0.013642095],"study_design_scores_gemma":[0.0025889506,0.0043704123,0.98133427,0.00051848515,0.006522468,0.000023601064,0.00027302327,0.0007796844,0.000947916,0.000006213019,0.0024812194,0.00015374129],"about_ca_topic_score_codex":0.00083893153,"about_ca_topic_score_gemma":0.0018790449,"teacher_disagreement_score":0.021726387,"about_ca_system_score_codex":0.00074381975,"about_ca_system_score_gemma":0.00050053856,"threshold_uncertainty_score":0.6247164},"labels":[],"label_agreement":null},{"id":"W4388086806","doi":"10.1016/j.jtho.2023.09.1368","title":"EP13.07-08 Canadian Consensus Recommendations: Use of Radiation Therapy among Patients with ES-SCLC receiving Immunotherapy","year":2023,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Conventional PCI; Radiation therapy; Immunotherapy; Magnetic resonance imaging; Oncology; Radiology; Internal medicine; Cancer","score_opus":0.05251884460915777,"score_gpt":0.4249657968331807,"score_spread":0.3724469522240229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388086806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98787004,0.0006128464,0.000029115596,0.010192741,0.0005664611,0.0004474172,0.00002893074,0.000016651067,0.0002358266],"genre_scores_gemma":[0.99222326,0.005045163,0.0017198705,0.0004653757,0.00016914202,0.000015003397,0.000024290935,0.00003246651,0.00030543984],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982603,0.00030112235,0.00058293226,0.00013611952,0.00038696584,0.0003325481],"domain_scores_gemma":[0.9973626,0.0007972846,0.0006391335,0.00020509269,0.0007815729,0.00021429455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009632094,0.00013307636,0.00052752526,0.0007283024,0.00012921459,0.000019584908,0.000121245306,0.00011077347,0.0002109038],"category_scores_gemma":[0.0006665881,0.000096588534,0.00010019619,0.0006198046,0.00017774687,0.00017762808,0.00002012987,0.00040169843,0.0000137731],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002174759,0.0001486491,0.4813075,0.000033431304,0.0006421336,0.00008498762,0.0012116625,0.000069268004,0.00018432805,0.0000046155787,0.026967527,0.48717114],"study_design_scores_gemma":[0.0026504907,0.0030036627,0.9074612,0.0003129577,0.00007049339,0.00004738619,0.00033708767,0.00006021172,0.0002996508,0.000044615215,0.08561379,0.000098434684],"about_ca_topic_score_codex":0.004695266,"about_ca_topic_score_gemma":0.008260102,"teacher_disagreement_score":0.4870727,"about_ca_system_score_codex":0.0009964608,"about_ca_system_score_gemma":0.001428882,"threshold_uncertainty_score":0.7097869},"labels":[],"label_agreement":null},{"id":"W4388557462","doi":"10.1016/s0167-8140(23)89310-0","title":"218 Management of Very Early Small Cell Lung Cancer: A Canadian Survey Study","year":2023,"lang":"en","type":"article","venue":"Radiotherapy and Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lung cancer; Medicine; Oncology; Cancer; Lung; Internal medicine","score_opus":0.04239821605233692,"score_gpt":0.3835605425912749,"score_spread":0.341162326538938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388557462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888651,0.0065681757,0.00000694329,0.0010592313,0.00021192837,0.0010540207,0.00003384705,0.000031820528,0.002168964],"genre_scores_gemma":[0.9781379,0.017591253,0.00013906103,0.0002972446,0.00009566085,0.00017731418,0.00000808981,0.000023585857,0.0035298602],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988946,0.00016538445,0.00017557546,0.00024145235,0.00015008755,0.0003729137],"domain_scores_gemma":[0.999368,0.00014448061,0.000043965098,0.00018768755,0.00006568015,0.00019018857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063638797,0.000110835404,0.00039030664,0.00023294214,0.000087557826,0.0000071142667,0.00009295336,0.00006363943,0.000086406355],"category_scores_gemma":[0.000009422833,0.00009510375,0.000029821427,0.00040546566,0.00009474923,0.000019568166,0.000037234255,0.00013488221,0.0000036872113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055136706,0.00021725144,0.9603095,0.0003253237,0.00095401274,0.0004894111,0.0038623852,0.0000069216994,0.00021831586,0.000020577818,0.008979532,0.02406539],"study_design_scores_gemma":[0.0043622977,0.0020790594,0.9782791,0.000046303703,0.000088533256,0.0000036910267,0.0007216619,0.00016236209,0.000042888336,0.000004574004,0.014120811,0.000088715795],"about_ca_topic_score_codex":0.2322093,"about_ca_topic_score_gemma":0.36665514,"teacher_disagreement_score":0.13444586,"about_ca_system_score_codex":0.00088290084,"about_ca_system_score_gemma":0.0004632824,"threshold_uncertainty_score":0.7729035},"labels":[],"label_agreement":null},{"id":"W4388577101","doi":"10.1016/s0167-8140(23)89980-7","title":"95 Use of Radiation Therapy Among Patients with Extensive-Stage Small-Cell Lung Cancer Receiving Immunotherapy: Canadian Consensus Recommendations","year":2023,"lang":"en","type":"article","venue":"Radiotherapy and Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Lung cancer; Radiation therapy; Immunotherapy; Oncology; Stage (stratigraphy); Intensive care medicine; Internal medicine; Cancer; Biology","score_opus":0.03621660484755423,"score_gpt":0.34397554471795266,"score_spread":0.30775893987039843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388577101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98572594,0.0072451187,0.000029485895,0.0051662493,0.00022658879,0.0012273581,0.000120201774,0.000056309866,0.00020271949],"genre_scores_gemma":[0.8373201,0.15435074,0.0014201016,0.0031598299,0.00020162064,0.00034743614,0.00016659776,0.000111509784,0.002922041],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865,0.00018235458,0.00027603618,0.00030044565,0.00016574109,0.00042543438],"domain_scores_gemma":[0.99865127,0.00047481386,0.00017170179,0.00024073846,0.00026705355,0.00019441101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025691336,0.00018399442,0.00045221785,0.00031409782,0.00022177951,0.000021365802,0.0000684912,0.0001315181,0.0002599737],"category_scores_gemma":[0.000057803358,0.00014695377,0.000052260428,0.00045970967,0.00025190154,0.00007948695,0.00001329757,0.00022007283,0.0000011377241],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000941834,0.00010761528,0.8557869,0.00007176995,0.00058815675,0.00002761259,0.003204909,0.000083640276,0.0016910973,0.000015877362,0.012692003,0.12478857],"study_design_scores_gemma":[0.0071833725,0.001118945,0.83682686,0.000103989,0.000040838953,0.0000033872402,0.0002358223,0.0010287806,0.00046305233,0.0000035761288,0.15281418,0.0001771989],"about_ca_topic_score_codex":0.053928357,"about_ca_topic_score_gemma":0.06156102,"teacher_disagreement_score":0.14840585,"about_ca_system_score_codex":0.0010202654,"about_ca_system_score_gemma":0.000827011,"threshold_uncertainty_score":0.95556307},"labels":[],"label_agreement":null},{"id":"W4388799926","doi":"10.14740/wjon1726","title":"Efficacy of First-Line Immunotherapy Combined With Chemotherapy in Extensive-Stage Small Cell Lung Cancer Patients With Different Brain Metastases Status: A Systematic Review and Meta-Analysis","year":2023,"lang":"en","type":"review","venue":"World Journal of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Brain metastasis; Immunotherapy; Chemotherapy; Internal medicine; Oncology; Hazard ratio; Lung cancer; Meta-analysis; Cochrane Library; Randomized controlled trial; Confidence interval; Cancer; Metastasis","score_opus":0.07540190027459537,"score_gpt":0.4124079862341873,"score_spread":0.3370060859595919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388799926","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00063451286,0.991396,0.00002197851,0.0015004152,0.000032085598,0.0061876858,0.00019992638,0.000009960862,0.000017429686],"genre_scores_gemma":[0.00021646998,0.9970821,0.00020334213,0.000568716,0.00002554389,0.0005656218,0.000046668774,0.00010289692,0.0011886437],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9944815,0.0012299056,0.0025470464,0.00043926548,0.00079068926,0.0005116125],"domain_scores_gemma":[0.99145794,0.002718818,0.0040994217,0.00055747066,0.00094090006,0.00022542225],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0014030503,0.00071402977,0.018289449,0.0016404879,0.000053046744,0.000018055756,0.00031203675,0.000105360414,0.00025476897],"category_scores_gemma":[0.00032333142,0.00033375339,0.0015461221,0.002201101,0.00022592742,0.000053644642,0.00008684303,0.0008638726,5.9047204e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015398284,0.0011274915,0.0010009332,0.6833534,0.3099997,0.00023712924,0.00025814545,0.0000148049785,1.8749327e-7,0.0000024228232,0.0003785986,0.0020872953],"study_design_scores_gemma":[0.011988111,0.0057736244,0.0008532485,0.1332122,0.818606,0.000026947244,0.000051159346,0.0000044435205,0.0000012706715,0.0000011552239,0.029111354,0.00037048984],"about_ca_topic_score_codex":0.00015307823,"about_ca_topic_score_gemma":0.0034869562,"teacher_disagreement_score":0.5501413,"about_ca_system_score_codex":0.00096325256,"about_ca_system_score_gemma":0.0008880635,"threshold_uncertainty_score":0.9999114},"labels":[],"label_agreement":null},{"id":"W4389227682","doi":"10.1158/2326-6074.tumimm23-b028","title":"Abstract B028: WEE1 inhibition enhances the antitumor immune response to PD-L1 blockade by the concomitant activation of STING and STAT1 pathways in small cell lung cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Wee1; Cancer research; Immune checkpoint; Cell cycle checkpoint; Blockade; Immunotherapy; Cell cycle; Medicine; Biology; Immunology; Immune system; Cancer; Cyclin-dependent kinase 1; Internal medicine","score_opus":0.07118017525727223,"score_gpt":0.4046953547627054,"score_spread":0.3335151795054332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.957073,0.019246314,0.0000052132555,0.021328526,0.0001399383,0.0017897388,0.00010513205,0.00004242336,0.00026976573],"genre_scores_gemma":[0.9878576,0.009351233,0.00001148396,0.000108782064,0.00009755159,0.0014387895,0.000015341808,0.00003571254,0.00108353],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99672127,0.00076626375,0.00051532564,0.00047936125,0.0006066802,0.0009110773],"domain_scores_gemma":[0.9959851,0.0027302871,0.00015323803,0.00050574343,0.00054374133,0.00008190808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045817476,0.00020463293,0.00044400393,0.00047135787,0.00049285666,0.00004594089,0.00033560334,0.000127809,0.00008805184],"category_scores_gemma":[0.0014926307,0.00013048353,0.000056884215,0.0016397991,0.0010234375,0.000113936185,0.00050841586,0.001282441,0.000012186281],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004981936,0.00006507736,0.00791556,0.00032635653,0.00015874453,0.00003274244,0.0067628953,0.00004033915,0.9730589,0.000018739434,0.002754024,0.003884714],"study_design_scores_gemma":[0.0018335555,0.00041660146,0.34839466,0.0009014665,0.000021814349,0.0000048886454,0.007266309,0.00014066325,0.6391489,0.00005784271,0.0016836841,0.00012961411],"about_ca_topic_score_codex":0.0066858134,"about_ca_topic_score_gemma":0.0007237814,"teacher_disagreement_score":0.3404791,"about_ca_system_score_codex":0.0009993522,"about_ca_system_score_gemma":0.0014705854,"threshold_uncertainty_score":0.9999288},"labels":[],"label_agreement":null},{"id":"W4389227733","doi":"10.1158/2326-6074.tumimm23-b027","title":"Abstract B027: ATR inhibition upregulates PD-L1 and potentiates the antitumor immune response to chemoimmunotherapy in small-cell lung cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer research; Blockade; Lung cancer; Immune system; Medicine; Immunology; Chemoimmunotherapy; Immunotherapy; Biology; Pharmacology; Oncology; Internal medicine; Receptor","score_opus":0.05111201229879783,"score_gpt":0.4114197291463439,"score_spread":0.36030771684754603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8763567,0.08229943,0.0000014650636,0.038843937,0.00024725543,0.0018835356,0.000039195842,0.00011211033,0.00021633871],"genre_scores_gemma":[0.9521362,0.03940428,0.00002366663,0.00025956778,0.00017076469,0.0020682784,0.000021100379,0.000078512414,0.0058376086],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9961663,0.0005443718,0.00050864724,0.0007330289,0.00060621195,0.0014414368],"domain_scores_gemma":[0.99744976,0.00096945814,0.000086176646,0.00079264,0.0005622749,0.00013968557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037907218,0.0003080513,0.0005817152,0.0010231207,0.0005977257,0.00010381367,0.00042535868,0.00021465478,0.00036376162],"category_scores_gemma":[0.0005351852,0.00023036177,0.00010948058,0.0023708986,0.0010497995,0.00014301602,0.00070840016,0.0014295814,0.000113032],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010592639,0.00012392316,0.054479785,0.0004151072,0.00044623954,0.00023471353,0.0034951363,0.000081479906,0.9179082,0.000021516264,0.0057672975,0.006433968],"study_design_scores_gemma":[0.0035418537,0.0003706447,0.8865933,0.000870888,0.000031013722,0.000021727972,0.0022362492,0.00018668086,0.102158785,0.00010879642,0.0036424971,0.00023755354],"about_ca_topic_score_codex":0.0061707688,"about_ca_topic_score_gemma":0.0006838071,"teacher_disagreement_score":0.8321135,"about_ca_system_score_codex":0.00093891163,"about_ca_system_score_gemma":0.0009583689,"threshold_uncertainty_score":0.939388},"labels":[],"label_agreement":null},{"id":"W4389243260","doi":"10.1182/blood-2023-180567","title":"Targeting CDK9 in KMT2A-Rearranged Infant Leukemia: Evidence for Activity and Drug Synergy with Enitociclib","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Propidium iodide; Cancer research; Leukemia; Biology; Apoptosis; Programmed cell death; Immunology; Biochemistry","score_opus":0.040844396706024015,"score_gpt":0.35252926437032056,"score_spread":0.31168486766429654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954639,0.0014873578,0.00002001179,0.0018629737,0.000033344437,0.00079947815,0.000008627721,0.00010168065,0.000222629],"genre_scores_gemma":[0.9976391,0.00079767784,0.00038185157,0.000056129287,0.00016682896,0.00040662795,0.0000053067074,0.000024568859,0.00052190287],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881166,0.000051403455,0.00012981801,0.00031432352,0.00030325298,0.00038951097],"domain_scores_gemma":[0.99889,0.0007121675,0.00004376732,0.00017501597,0.000083094004,0.00009598711],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005724099,0.00012703333,0.00029153083,0.00013418385,0.000100888356,0.000020459116,0.00006829472,0.000043622254,0.0000049073556],"category_scores_gemma":[0.0012111356,0.00009391716,0.00003204206,0.00040920073,0.000097934775,0.00013665539,0.000109119195,0.00022382494,0.0000049434148],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034246568,0.00034460114,0.7120047,0.0028887994,0.00068393233,0.0006503614,0.0053161383,0.00006642717,0.2581412,0.0000678044,0.008415901,0.007995493],"study_design_scores_gemma":[0.026355289,0.0018178982,0.85723656,0.004122752,0.0005425434,0.00007541701,0.0021742966,0.0017981987,0.101144575,0.00018665254,0.0038487846,0.00069704803],"about_ca_topic_score_codex":0.0011424127,"about_ca_topic_score_gemma":0.00086259004,"teacher_disagreement_score":0.15699661,"about_ca_system_score_codex":0.00011330184,"about_ca_system_score_gemma":0.00024699018,"threshold_uncertainty_score":0.38298306},"labels":[],"label_agreement":null},{"id":"W4389392859","doi":"10.3389/fonc.2023.1191920","title":"Real-world predictors of survival in patients with limited-stage small-cell lung cancer in Manitoba, Canada","year":2023,"lang":"en","type":"article","venue":"Frontiers in Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; AstraZeneca (Canada); University of Manitoba; CancerCare Manitoba","funders":"AstraZeneca Canada; AstraZeneca","keywords":"Medicine; Cohort; Internal medicine; Proportional hazards model; Radiation therapy; Lung cancer; Retrospective cohort study; Cancer registry; Stage (stratigraphy); Survival analysis; Cancer; Oncology; Chemotherapy; Performance status; Hazard ratio; Surgery; Confidence interval","score_opus":0.018975249284334448,"score_gpt":0.30184871221770915,"score_spread":0.2828734629333747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389392859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900873,0.0003285496,0.000003633338,0.00064078503,0.0015139463,0.001021326,0.000104432555,0.000022896644,0.0062771523],"genre_scores_gemma":[0.9946605,0.0011234763,0.0002826232,0.00010406685,0.00009189683,0.00027038506,0.00006249177,0.000039561895,0.003365005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980478,0.00016957865,0.00041592823,0.000335843,0.0004285531,0.0006022709],"domain_scores_gemma":[0.9992672,0.00016829303,0.000117086565,0.00023481323,0.00010511503,0.00010748667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035862712,0.00016764506,0.0007038186,0.0007952203,0.000022542636,0.0000025833895,0.00017480172,0.00009768958,0.000028304556],"category_scores_gemma":[0.00011630778,0.00014652169,0.000025202664,0.0014611706,0.00013937171,0.000039130762,0.00012902866,0.00044671964,6.3028125e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010731008,0.00018872831,0.953363,0.00032655604,0.00009441238,0.0003433378,0.00068729545,0.00050755485,0.0000077320365,0.000004201066,0.042421978,0.0009821177],"study_design_scores_gemma":[0.0059720343,0.0004147747,0.9848142,0.0002140617,0.000030374049,1.2161678e-7,0.0016584854,0.0005476095,0.00004694799,0.0000041559233,0.00617696,0.0001202675],"about_ca_topic_score_codex":0.74695265,"about_ca_topic_score_gemma":0.99175626,"teacher_disagreement_score":0.24480358,"about_ca_system_score_codex":0.005312747,"about_ca_system_score_gemma":0.002502127,"threshold_uncertainty_score":0.99850565},"labels":[],"label_agreement":null},{"id":"W4389480655","doi":"10.1016/j.iotech.2023.100692","title":"LBA2 First-line (1L) durvalumab (D) + platinum-etoposide (EP) for patients (pts) with extensive-stage SCLC (ES-SCLC): Primary results from the phase IIIb LUMINANCE study","year":2023,"lang":"en","type":"article","venue":"Immuno-Oncology Technology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Symphogen; Astellas Pharma; Gilead Sciences; Daiichi-Sankyo; Amgen; Pfizer; AstraZeneca; Daiichi Sankyo Europe; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Durvalumab; Internal medicine; Neutropenia; Gastroenterology; Etoposide; Cancer; Chemotherapy; Immunotherapy; Pembrolizumab","score_opus":0.032707548856386964,"score_gpt":0.3655740603058458,"score_spread":0.3328665114494589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389480655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9694259,0.001539929,0.00010970466,0.018765852,0.0006614402,0.006933155,0.000986919,0.0009387322,0.00063833315],"genre_scores_gemma":[0.989993,0.0012126926,0.0013843937,0.00080390525,0.00027670155,0.002945234,0.0007750448,0.00013632324,0.0024727504],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99533457,0.00021286431,0.0010941239,0.0013326522,0.00069743086,0.0013283788],"domain_scores_gemma":[0.993718,0.0025326167,0.00060467276,0.0019964173,0.0010294064,0.00011884997],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010139317,0.00060026255,0.0014364887,0.0004714144,0.00090659084,0.000029871419,0.00097158446,0.0005695614,0.000041312647],"category_scores_gemma":[0.0042388258,0.00041371866,0.00016806142,0.0017036416,0.0017076109,0.00015371622,0.0010487156,0.0011325612,0.0001251026],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12016451,0.021354057,0.28777644,0.00073612307,0.009339417,0.0060652373,0.017616883,0.0001650356,0.02358657,0.00064366224,0.15604195,0.3565101],"study_design_scores_gemma":[0.20952213,0.08438363,0.31387997,0.00095873233,0.0014108345,0.00016876133,0.013842349,0.00069930987,0.006390626,0.001124041,0.3661595,0.0014601243],"about_ca_topic_score_codex":0.0004993032,"about_ca_topic_score_gemma":0.0016075599,"teacher_disagreement_score":0.35504997,"about_ca_system_score_codex":0.0011286214,"about_ca_system_score_gemma":0.00074711704,"threshold_uncertainty_score":0.99983144},"labels":[],"label_agreement":null},{"id":"W4389789420","doi":"10.1016/j.ijrobp.2023.12.011","title":"CRISPR Screen of Druggable Targets in Small Cell Lung Cancer Identified ATM Inhibitor (AZD1390) as a Radiosensitizer","year":2023,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Radiosensitizer; Radiosensitivity; Clonogenic assay; Cancer research; Radioresistance; Viability assay; DNA damage; Biology; Cell culture; Medicine; Radiation therapy; Internal medicine; Genetics; DNA","score_opus":0.02469730288463872,"score_gpt":0.38191726990410485,"score_spread":0.3572199670194661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389789420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844949,0.0028142573,0.00064747245,0.006772744,0.0028674232,0.0005338362,0.00012460446,0.000050725037,0.0016940382],"genre_scores_gemma":[0.99128515,0.0039326125,0.00069068704,0.0006454048,0.0023968557,0.000037366106,0.00008409403,0.000040532595,0.0008873266],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976093,0.000255476,0.0009583822,0.00029063286,0.0004814114,0.0004047753],"domain_scores_gemma":[0.9969285,0.00055300805,0.0009015688,0.00017438908,0.0012816977,0.00016079398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010252348,0.00021659954,0.0007507616,0.000511412,0.000061152976,0.000020723977,0.00036447222,0.00021374277,0.0001211205],"category_scores_gemma":[0.00064988347,0.00019408047,0.0002623083,0.0005315777,0.00022463105,0.00023042802,0.00016370657,0.00062522886,0.00005416927],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026929674,0.00094530906,0.7377408,0.0002277808,0.0025798457,0.00084352907,0.00594176,0.002675613,0.12534052,0.0027782214,0.073672265,0.044561364],"study_design_scores_gemma":[0.07161925,0.005695813,0.3627758,0.002419317,0.0014322405,0.0006126598,0.0034352213,0.026565928,0.39745596,0.024145776,0.10216412,0.0016779273],"about_ca_topic_score_codex":0.0005074613,"about_ca_topic_score_gemma":0.00009352211,"teacher_disagreement_score":0.374965,"about_ca_system_score_codex":0.0013801197,"about_ca_system_score_gemma":0.0015198573,"threshold_uncertainty_score":0.79143715},"labels":[],"label_agreement":null},{"id":"W4389839591","doi":"10.1016/j.jtocrr.2023.100623","title":"Brief Report: Comprehensive Clinicogenomic Profiling of Small Cell Transformation From EGFR-Mutant NSCLC Informs Potential Therapeutic Targets","year":2023,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Genentech; National Institutes of Health; Mirati Therapeutics; Regeneron Pharmaceuticals; Daiichi Sankyo Europe; Sanofi; GlaxoSmithKline; Eli Lilly and Company; AstraZeneca; Damon Runyon Cancer Research Foundation; LUNGevity Foundation; Computer Modelling Group; Amgen; Cancer Prevention and Research Institute of Texas; University of Texas MD Anderson Cancer Center; V Foundation for Cancer Research","keywords":"Profiling (computer programming); Mutant; Transformation (genetics); Cancer research; Oncology; Computational biology; Medicine; Biology; Computer science; Gene; Genetics","score_opus":0.1404393992648889,"score_gpt":0.44822864770405335,"score_spread":0.30778924843916444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389839591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99039716,0.0024104936,0.000145153,0.0020939736,0.00050042255,0.001887195,0.000036138845,0.000110783345,0.0024186864],"genre_scores_gemma":[0.9928075,0.005084452,0.0004076535,0.00013676028,0.00047875982,0.00008768442,0.00022297,0.000037546022,0.0007366739],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99406177,0.00032230868,0.002370684,0.0007163702,0.0017688605,0.0007600188],"domain_scores_gemma":[0.99567443,0.0011972747,0.00046554935,0.0007058134,0.001502558,0.00045440227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0066237017,0.00022463546,0.0008926088,0.0003237271,0.00027043032,0.000053214073,0.00014328954,0.00028280343,0.000062985935],"category_scores_gemma":[0.001966058,0.00015607725,0.00034906753,0.0005948001,0.0009856006,0.00014513246,0.00033169912,0.0012173973,0.000033615237],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008994841,0.0022807096,0.50596106,0.0049742176,0.003070487,0.04556911,0.005856164,0.00013570131,0.198232,0.00018140856,0.007191608,0.21755272],"study_design_scores_gemma":[0.010053993,0.0049876226,0.8477963,0.0010945437,0.00050307333,0.0015670501,0.0056945905,0.00440617,0.06526286,0.010165238,0.04761342,0.00085508934],"about_ca_topic_score_codex":0.0005057165,"about_ca_topic_score_gemma":0.000034568737,"teacher_disagreement_score":0.3418353,"about_ca_system_score_codex":0.000093429364,"about_ca_system_score_gemma":0.0010387237,"threshold_uncertainty_score":0.6364646},"labels":[],"label_agreement":null},{"id":"W4390521315","doi":"10.1016/j.eclinm.2023.102396","title":"Re-examining prophylactic cranial irradiation in small cell lung cancer: a systematic review and meta-analysis","year":2024,"lang":"en","type":"review","venue":"EClinicalMedicine","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Canada Research Chairs; Princess Margaret Cancer Centre; Sunnybrook Health Science Centre; Health Sciences Centre; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Meta-analysis; Prophylactic cranial irradiation; Lung cancer; Pooled analysis; Pathology; Internal medicine","score_opus":0.24139725108261756,"score_gpt":0.5048452527919505,"score_spread":0.2634480017093329,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390521315","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000019723586,0.9856261,0.000008710988,0.0038293956,0.000172709,0.009753918,0.000070928145,0.00008020349,0.0004560501],"genre_scores_gemma":[0.00011812204,0.98936844,0.00012567747,0.0013125624,0.00041093334,0.004430612,0.000097598386,0.00010811639,0.0040279217],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9927971,0.001034765,0.003491037,0.0013016725,0.00081004744,0.00056540966],"domain_scores_gemma":[0.99493724,0.0022562635,0.0010941763,0.001137948,0.00020395342,0.00037042785],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.004748239,0.00083681685,0.019798689,0.001069998,0.00006299057,0.0000441968,0.0003088881,0.00035993868,0.00046568655],"category_scores_gemma":[0.0041795275,0.0004572276,0.002116227,0.003006847,0.00018753433,0.000058193775,0.00025913457,0.0018806829,0.000057102014],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010555004,0.00006875133,0.000041594558,0.89040333,0.10646674,0.0002849493,0.00010897332,2.3645114e-7,2.272388e-8,0.0000024195215,0.001278023,0.0013344324],"study_design_scores_gemma":[0.00044850228,0.00027338712,0.000015831545,0.2137563,0.7759002,0.000019833884,0.00002829966,0.00005464052,1.2621352e-8,0.000004377311,0.009228012,0.00027059493],"about_ca_topic_score_codex":0.00026169923,"about_ca_topic_score_gemma":0.0003499777,"teacher_disagreement_score":0.676647,"about_ca_system_score_codex":0.0006674285,"about_ca_system_score_gemma":0.0009807384,"threshold_uncertainty_score":0.9997879},"labels":[],"label_agreement":null},{"id":"W4390757470","doi":"10.1158/1538-7445.dnarepair24-ia003","title":"Abstract IA003: Molecular and imaging biomarkers of PARP inhibitors for small cell lung cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Lung cancer; Medicine; Context (archaeology); PARP inhibitor; Cancer; Cancer research; Liquid biopsy; Positron emission tomography; Biomarker; Oncology; Poly ADP ribose polymerase; Bioinformatics; Pathology; Internal medicine; Nuclear medicine; DNA; Biology; Genetics","score_opus":0.04924374847328876,"score_gpt":0.4434771862253096,"score_spread":0.39423343775202085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390757470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7810196,0.20807691,0.00009183548,0.005992132,0.0003429956,0.0018421261,0.0001623305,0.000064883876,0.0024071445],"genre_scores_gemma":[0.9905693,0.0064678118,0.00020608256,0.0000734437,0.00035366532,0.0012885068,0.0000097854445,0.00007611686,0.00095530995],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974685,0.000062092855,0.00030137302,0.0005865135,0.000784924,0.000796635],"domain_scores_gemma":[0.9983686,0.0004266048,0.000037659418,0.00030447083,0.0005915627,0.00027105957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001234391,0.00018960182,0.0003449993,0.0005057359,0.0001427373,0.00008512328,0.00016679152,0.000071164985,0.00018530255],"category_scores_gemma":[0.00021191739,0.00015763733,0.00013144527,0.00070123456,0.0005148272,0.00010188769,0.00021137277,0.0005146466,0.0000037254877],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007385455,0.000084169624,0.034877475,0.018607382,0.0008855522,0.00027979692,0.001347525,0.000019467454,0.7954581,0.00018482532,0.09746369,0.050053496],"study_design_scores_gemma":[0.003489387,0.00035320886,0.013076582,0.006524201,0.00034189416,0.000013988703,0.0015321681,0.0026084564,0.913618,0.0004370615,0.057501018,0.00050399086],"about_ca_topic_score_codex":0.002862808,"about_ca_topic_score_gemma":0.00018046661,"teacher_disagreement_score":0.20954964,"about_ca_system_score_codex":0.00066115387,"about_ca_system_score_gemma":0.0013391742,"threshold_uncertainty_score":0.6428264},"labels":[],"label_agreement":null},{"id":"W4390978892","doi":"10.1080/1120009x.2024.2302736","title":"Review of real-world experience with lurbinectedin in relapsed/refractory small cell lung cancer","year":2024,"lang":"en","type":"review","venue":"Journal of Chemotherapy","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"American Society of Hematology","keywords":"Food and drug administration; Medicine; Refractory (planetary science); Clinical trial; Lung cancer; Drug approval; Intensive care medicine; Family medicine; Drug; Oncology; Internal medicine; Medical emergency; Pharmacology","score_opus":0.04827015999822119,"score_gpt":0.42860374637497983,"score_spread":0.3803335863767586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390978892","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018463827,0.9955427,0.0000023669675,0.00073354633,0.0002795603,0.0011546029,0.000013139088,0.000014102188,0.0020753585],"genre_scores_gemma":[0.000017156166,0.9955383,0.00029495487,0.0004990149,0.00059769186,0.0001207475,0.000003289283,0.000120531855,0.0028083078],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99671763,0.00014190187,0.0016150328,0.00033693248,0.0008156947,0.0003728029],"domain_scores_gemma":[0.99725115,0.00020169621,0.0014309989,0.00043755423,0.00048906484,0.00018955124],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007746543,0.00049229426,0.003683631,0.00075427437,0.00001950762,0.000015090005,0.00039136116,0.00014860735,0.0003228431],"category_scores_gemma":[0.00009376933,0.00027702525,0.00066785706,0.0014400652,0.00014853044,0.00007021194,0.000051422518,0.0015910486,0.0000031716058],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028993087,0.0002601647,0.0005551407,0.6451918,0.0011446712,0.00047809246,0.00079336466,3.0913216e-7,0.00003201306,0.0000036908561,0.05500084,0.29625],"study_design_scores_gemma":[0.0008560154,0.00033234272,0.000035176345,0.4262411,0.00103638,0.0000885361,0.00001693644,8.162939e-7,0.00004077617,0.0000019736283,0.5712008,0.00014916553],"about_ca_topic_score_codex":0.00013577743,"about_ca_topic_score_gemma":0.0001130418,"teacher_disagreement_score":0.51619995,"about_ca_system_score_codex":0.0013060656,"about_ca_system_score_gemma":0.0027748083,"threshold_uncertainty_score":0.9999682},"labels":[],"label_agreement":null},{"id":"W4391041972","doi":"10.14740/wjon1765","title":"Treatment Patterns and Survival Outcomes in Patients With Stage T1-2N0M0 Small Cell Lung Cancer Undergoing Surgery: A Retrospective Cohort Study","year":2024,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Hazard ratio; Surgery; Chemoradiotherapy; Radiation therapy; Chemotherapy; Retrospective cohort study; Confidence interval; Proportional hazards model; Stage (stratigraphy); Internal medicine","score_opus":0.024039291431935863,"score_gpt":0.35889634482448024,"score_spread":0.3348570533925444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391041972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99510974,0.0013897805,0.000010855364,0.0013544366,0.00053866254,0.0009070153,0.000022196067,0.000013711392,0.00065359386],"genre_scores_gemma":[0.99675924,0.0012614478,0.00003873114,0.000049444658,0.00012439971,0.000057483354,0.0000019295385,0.000028561404,0.001678754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99829805,0.0002125219,0.0004382834,0.00026715046,0.00045401996,0.00032999553],"domain_scores_gemma":[0.9983695,0.0009782069,0.00018773964,0.00012472297,0.00020124187,0.00013854622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005869176,0.00019738529,0.0010527672,0.00056947605,0.000053692347,0.000029516072,0.000057125086,0.000035397043,0.000073107956],"category_scores_gemma":[0.000096181306,0.000121108176,0.0000907799,0.00031871058,0.00006444645,0.00008521901,0.000059628015,0.00040085363,9.1707216e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000913699,0.0011036418,0.99104375,0.00019189685,0.0015949819,0.0017959693,0.0017393662,0.000009598828,0.0000031482653,0.000005011291,0.00020688146,0.0013920723],"study_design_scores_gemma":[0.0058095977,0.0050810254,0.9868245,0.00035046748,0.0004467265,0.0000120320965,0.0008427231,0.000012871509,0.000010212375,0.0000034469226,0.0005017554,0.00010464662],"about_ca_topic_score_codex":0.001488111,"about_ca_topic_score_gemma":0.06520633,"teacher_disagreement_score":0.063718215,"about_ca_system_score_codex":0.0038597796,"about_ca_system_score_gemma":0.0012539361,"threshold_uncertainty_score":0.99996424},"labels":[],"label_agreement":null},{"id":"W4391219445","doi":"10.1016/j.ccell.2024.01.001","title":"Tumor- and circulating-free DNA methylation identifies clinically relevant small cell lung cancer subtypes","year":2024,"lang":"en","type":"article","venue":"Cancer Cell","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Horizon 2020; Daiichi Sankyo Europe; National Cancer Institute; HORIZON EUROPE Framework Programme; University of Texas MD Anderson Cancer Center; EMD Serono; Foundation Medicine; Sierra Oncology; Sociedad Española de Oncología Médica; Birla Institute of Scientific Research; PharmaMar; European Society for Medical Oncology; Rexanna's Foundation; BeiGene; Mirati Therapeutics; Pfizer; Innovent Biologics; Medical Research Council; Les Laboratories Pierre Fabre; Jazz Pharmaceuticals; Francis Crick Institute; National Institutes of Health; Regeneron Pharmaceuticals; Cancer Moonshot; Albert Einstein Cancer Center; Genentech; Cancer Prevention and Research Institute of Texas; Moonshot Research and Development Program; Sanofi; GlaxoSmithKline; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Wellcome Trust; Cancer Research UK; Spectrum Pharmaceuticals; Amgen; Agence Nationale de la Recherche; LUNGevity Foundation","keywords":"Subtyping; DNA methylation; Epigenetics; Biology; Lung cancer; Malignancy; Cancer research; Methylation; Oncology; Gene; Medicine; Gene expression; Genetics","score_opus":0.03025156051891841,"score_gpt":0.36322397436800746,"score_spread":0.33297241384908904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391219445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7636243,0.22187471,0.00015143822,0.0025797263,0.0012911612,0.0008282099,0.00008299314,0.00022753829,0.009339925],"genre_scores_gemma":[0.96568304,0.022170397,0.00036209793,0.00045150486,0.0009616243,0.00031369133,0.000014612359,0.00008087103,0.009962135],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978035,0.000075990276,0.0004960221,0.0006870245,0.00046487732,0.00047256082],"domain_scores_gemma":[0.9985797,0.0003760216,0.000111898196,0.00048560847,0.00023022854,0.00021658333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053795235,0.00026153147,0.00044640686,0.00011077976,0.00014579401,0.00012914915,0.00018424772,0.00009826553,0.0004892531],"category_scores_gemma":[0.00021362741,0.00021724463,0.00013937164,0.0002910019,0.00018342386,0.00017270421,0.00025137057,0.00043377277,0.000023134615],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011794283,0.0003608102,0.28029925,0.03825891,0.0018834196,0.001146177,0.0140825445,0.00036368708,0.43084368,0.00039268556,0.17934132,0.051848076],"study_design_scores_gemma":[0.015804201,0.0019061537,0.28428668,0.013425215,0.007141408,0.00011922911,0.0045083053,0.040015433,0.45072874,0.0047919457,0.17351224,0.0037604375],"about_ca_topic_score_codex":0.0018896819,"about_ca_topic_score_gemma":0.0011608142,"teacher_disagreement_score":0.20205876,"about_ca_system_score_codex":0.0006011117,"about_ca_system_score_gemma":0.0006732566,"threshold_uncertainty_score":0.8858979},"labels":[],"label_agreement":null},{"id":"W4392282412","doi":"10.1101/2024.02.28.582577","title":"A Lung Cancer Mouse Model Database","year":2024,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"University of Texas Southwestern Medical Center","keywords":"Lung cancer; Database; Computer science; Medicine; Internal medicine","score_opus":0.02869371616307937,"score_gpt":0.320126543131461,"score_spread":0.29143282696838163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392282412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92336476,0.056405414,0.001259119,0.005274064,0.0021567433,0.0036374475,0.005798066,0.0019722437,0.0001321414],"genre_scores_gemma":[0.9830372,0.0069314493,0.0048790076,0.00074576365,0.001458674,0.0020989673,0.0000014655277,0.00039743166,0.00045008323],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99566966,0.00007270968,0.00057196914,0.001630849,0.0010701382,0.0009846991],"domain_scores_gemma":[0.9961411,0.000054570457,0.00019176924,0.0022052205,0.00078210817,0.0006252777],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00060931366,0.0007790554,0.0010029088,0.00052332797,0.00016266825,0.00022173388,0.0005376841,0.00045174418,0.00012382012],"category_scores_gemma":[0.00034565423,0.0007240834,0.00029384872,0.0005996411,0.00023214704,0.00011969805,0.0028073266,0.0023886398,0.00013887302],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027150195,0.00030764713,0.005887813,0.01611507,0.0025765134,0.0006387737,0.00005657677,0.0007740985,0.91421396,0.0009791987,0.0581758,0.000003033045],"study_design_scores_gemma":[0.0038506188,0.00018653,0.007331855,0.014319692,0.004618118,7.876529e-8,0.000012041997,0.20713018,0.7439041,0.000015910171,0.015140709,0.0034901479],"about_ca_topic_score_codex":0.00043009428,"about_ca_topic_score_gemma":0.000018008048,"teacher_disagreement_score":0.20635608,"about_ca_system_score_codex":0.001736071,"about_ca_system_score_gemma":0.004008783,"threshold_uncertainty_score":0.9999129},"labels":[],"label_agreement":null},{"id":"W4392987004","doi":"10.3390/curroncol31030122","title":"Population Survival Kinetics Derived from Clinical Trials of Potentially Curable Lung Cancers","year":2024,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Adjuvant; Oncology; Internal medicine; Lung cancer; Population; Chemoradiotherapy; Chemotherapy; Osimertinib; Cancer; Adenocarcinoma","score_opus":0.38898023172426777,"score_gpt":0.5979591709863932,"score_spread":0.2089789392621254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392987004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.919497,0.054450903,0.0029644861,0.0029031963,0.016910512,0.0012007689,0.0002313879,0.0001317562,0.001709999],"genre_scores_gemma":[0.99146223,0.005776195,0.0005220149,0.000035163208,0.001779718,0.00004922579,0.00023180952,0.000022783448,0.000120884644],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99704504,0.0008161049,0.0011134857,0.00036830836,0.00038020284,0.00027683165],"domain_scores_gemma":[0.9973317,0.0018623112,0.00021931449,0.00022928548,0.00021069942,0.00014669682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023468146,0.0001395273,0.0010990445,0.00012793252,0.00003425496,0.0000146030325,0.000107676424,0.00014621628,0.00038011873],"category_scores_gemma":[0.0031070474,0.00010926659,0.00028987115,0.00020672254,0.00017641015,0.00005206327,0.000105398336,0.00042955196,0.000018992643],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016060912,0.00058286905,0.35593247,0.0010945855,0.0015629528,0.000089457906,0.000515859,0.000057220084,0.010412341,0.00031983742,0.037894946,0.58993137],"study_design_scores_gemma":[0.008987236,0.002450888,0.6308089,0.0017128495,0.0026596927,0.000012640831,0.00036701397,0.0093528265,0.00221759,0.0011442208,0.33987752,0.00040863652],"about_ca_topic_score_codex":0.0007656824,"about_ca_topic_score_gemma":0.0004067754,"teacher_disagreement_score":0.5895227,"about_ca_system_score_codex":0.00074181077,"about_ca_system_score_gemma":0.0007708461,"threshold_uncertainty_score":0.44557622},"labels":[],"label_agreement":null},{"id":"W4393089268","doi":"10.1158/1538-7445.am2024-7335","title":"Abstract 7335: Characterizing germline variants in patients with small cell lung cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; Toronto General Hospital; Western University","funders":"","keywords":"Germline; Cancer; Lung cancer; Medicine; Oncology; Internal medicine; Biology; Cancer research; Genetics; Gene","score_opus":0.06340972096898669,"score_gpt":0.4157031245460039,"score_spread":0.3522934035770172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393089268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9786176,0.013053438,0.0000073876627,0.0031503201,0.00034959416,0.0016603288,0.00014679227,0.00009774849,0.00291676],"genre_scores_gemma":[0.9912442,0.003075665,0.0000743887,0.00017406554,0.0006417898,0.0011187798,0.00004113897,0.00010460798,0.0035253435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996078,0.00010162464,0.00034997778,0.00079126045,0.0014322962,0.0012468462],"domain_scores_gemma":[0.99832165,0.00023324134,0.000040339095,0.00045840637,0.00062169775,0.0003246563],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001023268,0.00026470065,0.00044325122,0.0006877594,0.00016398384,0.00015687155,0.00028166527,0.00011582004,0.0014409206],"category_scores_gemma":[0.00011032495,0.00019592338,0.00006964002,0.0014202608,0.00022824726,0.00024668095,0.00024349379,0.0015842658,0.000075749755],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028947724,0.00065314997,0.88638955,0.009046762,0.00060188305,0.0011717761,0.0026995083,0.000037474158,0.041006226,0.000054639557,0.021251539,0.03419271],"study_design_scores_gemma":[0.0030856924,0.00032426685,0.9721655,0.0043974877,0.00005253033,0.0000019586444,0.000099677876,0.00019650791,0.0049663554,0.00001379315,0.01441389,0.00028233283],"about_ca_topic_score_codex":0.003404202,"about_ca_topic_score_gemma":0.0010726114,"teacher_disagreement_score":0.08577595,"about_ca_system_score_codex":0.0019384276,"about_ca_system_score_gemma":0.0018908508,"threshold_uncertainty_score":0.9994719},"labels":[],"label_agreement":null},{"id":"W4393092556","doi":"10.1158/1538-7445.am2024-675","title":"Abstract 675: Targeting Bcl-2/Bcl-xl for small cell lung cancer treatment with LP-118","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Lung cancer; Cancer; Cancer research; Oncology; Internal medicine","score_opus":0.10506868197426737,"score_gpt":0.47593163215635753,"score_spread":0.37086295018209015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393092556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.63435197,0.3187346,0.0002072892,0.021135332,0.0009794487,0.008318992,0.00070570345,0.00046890439,0.01509777],"genre_scores_gemma":[0.90281826,0.037569925,0.00058440113,0.00015042593,0.002675959,0.010942469,0.00006813215,0.00022534197,0.044965107],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.995486,0.00009585936,0.0003777038,0.0010573659,0.0012923499,0.0016906967],"domain_scores_gemma":[0.9972608,0.000762216,0.000052268595,0.00053484435,0.0008817238,0.00050811074],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011763407,0.00039589236,0.0005869253,0.0004632528,0.0004949214,0.00022508965,0.00030388695,0.00013788862,0.001027878],"category_scores_gemma":[0.00012585208,0.00026533223,0.00020891489,0.00091265084,0.00036688164,0.00016123593,0.00016464648,0.00086670154,0.00007028205],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070700394,0.001072556,0.03658239,0.030933378,0.004805227,0.001955079,0.011437225,0.00041910063,0.18698156,0.00037376047,0.52229285,0.19607686],"study_design_scores_gemma":[0.0072091883,0.0033184062,0.0045075826,0.0049765795,0.0005184406,0.000017672548,0.002024083,0.0021393455,0.09261324,0.00011622665,0.881774,0.0007852032],"about_ca_topic_score_codex":0.0066137975,"about_ca_topic_score_gemma":0.0020796668,"teacher_disagreement_score":0.35948122,"about_ca_system_score_codex":0.0043111774,"about_ca_system_score_gemma":0.0039170543,"threshold_uncertainty_score":0.9999799},"labels":[],"label_agreement":null},{"id":"W4393092679","doi":"10.1158/1538-7445.am2024-6465","title":"Abstract 6465: A population-based analysis of brain metastasis burden and management in 8705 small cell lung cancer patients","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; Princess Margaret Cancer Centre; Sunnybrook Health Science Centre; Health Sciences Centre; Queen's University; University of Toronto","funders":"","keywords":"Medicine; Brain metastasis; Lung cancer; Cancer; Metastasis; Oncology; Internal medicine; Population; Pathology; Environmental health","score_opus":0.06127359750672997,"score_gpt":0.44992459586566036,"score_spread":0.3886509983589304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393092679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.975219,0.017897636,0.00001308497,0.0041237245,0.00007468306,0.0013470998,0.00023027774,0.000029630404,0.0010648696],"genre_scores_gemma":[0.9937381,0.003883883,0.00010678753,0.00007044313,0.000093661,0.000858614,0.00007743541,0.000034945348,0.0011361144],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99708563,0.00014254845,0.000395605,0.0005877226,0.0011981147,0.00059036346],"domain_scores_gemma":[0.9986242,0.00045725523,0.00004800383,0.00034066488,0.00034806033,0.00018178573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001176998,0.00017436505,0.00050270115,0.0022063793,0.00008648251,0.000064584376,0.0001748755,0.00006410228,0.0006207654],"category_scores_gemma":[0.00012311919,0.00014657773,0.00014076925,0.0033837052,0.00013681538,0.00008203895,0.0001847539,0.00045746076,0.000003960771],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005874634,0.00021668822,0.9167584,0.010945568,0.005248561,0.00017238042,0.0016389263,0.0028959897,0.0020313777,0.000104216255,0.0076502925,0.05175012],"study_design_scores_gemma":[0.0017557285,0.00013437305,0.98178643,0.0012163285,0.0010858601,1.099883e-7,0.00029296862,0.008689243,0.0013327813,0.000031051364,0.0034917037,0.000183404],"about_ca_topic_score_codex":0.027386699,"about_ca_topic_score_gemma":0.007081338,"teacher_disagreement_score":0.06502803,"about_ca_system_score_codex":0.0012543559,"about_ca_system_score_gemma":0.0003833797,"threshold_uncertainty_score":0.97909003},"labels":[],"label_agreement":null},{"id":"W4393096830","doi":"10.1158/1538-7445.am2024-6028","title":"Abstract 6028: Preferential tumor-to-normal tissue biodistribution and single-dose efficacy with ABD147, a DLL3-targeted engineered antibody-based radiotherapeutic, in preclinical small cell lung cancer models","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"iCo Therapeutics (Canada)","funders":"","keywords":"Biodistribution; Medicine; Cancer; Pathology; Radioimmunotherapy; Lung cancer; Cancer research; Antibody; Monoclonal antibody; Internal medicine; Biology; In vivo; Immunology","score_opus":0.10323605793788523,"score_gpt":0.4506887193218676,"score_spread":0.34745266138398234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393096830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95779735,0.033796646,0.0014294008,0.0027975098,0.0002257101,0.0030839029,0.00039244303,0.00018135096,0.00029567728],"genre_scores_gemma":[0.99559695,0.0017073296,0.00049259776,0.00010592094,0.0004946467,0.0009990748,0.00012779058,0.000104907704,0.000370767],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9955509,0.00022232781,0.0005280899,0.0010889864,0.0012443326,0.0013653868],"domain_scores_gemma":[0.99783444,0.0005325656,0.000050359722,0.0005021027,0.00048105454,0.00059949094],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001208302,0.00039722136,0.00065458036,0.0007751966,0.00017532306,0.00023703689,0.00029867873,0.00018368784,0.0003533897],"category_scores_gemma":[0.00016149468,0.00031910505,0.00009007876,0.0014920761,0.0004031047,0.00021078507,0.00017147436,0.0015495693,0.000016964788],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014200033,0.001530575,0.022049477,0.009715792,0.0009600052,0.0011158068,0.0027229385,0.010678515,0.90160275,0.00008786179,0.0034068658,0.031929415],"study_design_scores_gemma":[0.029212447,0.006267001,0.1820139,0.014731866,0.0006600465,0.00005869483,0.00041874408,0.119078144,0.62319916,0.00008149933,0.022179702,0.0020987794],"about_ca_topic_score_codex":0.002399639,"about_ca_topic_score_gemma":0.0010101948,"teacher_disagreement_score":0.27840355,"about_ca_system_score_codex":0.0016747726,"about_ca_system_score_gemma":0.0023999584,"threshold_uncertainty_score":0.9999261},"labels":[],"label_agreement":null},{"id":"W4393465895","doi":"10.5281/zenodo.7235988","title":"Processed counts data of cfMeDIP-seq profiles of small cell lung cancer patients","year":2022,"lang":"en","type":"dataset","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Lung cancer; RNA-Seq; Computational biology; Biology; Medicine; Oncology; Transcriptome; Genetics; Gene","score_opus":0.053081263262401486,"score_gpt":0.31797597246758064,"score_spread":0.26489470920517916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393465895","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000521988,0.0010491237,0.000007711546,0.00013702795,0.00015915136,0.0012365706,0.9884923,0.00009354176,0.0083025545],"genre_scores_gemma":[0.0011190412,0.0023320713,0.0000351345,0.000049954895,0.0001271938,5.426531e-7,0.9946582,0.000666576,0.0010112874],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99753267,0.00018703498,0.00039779165,0.00051575014,0.0010447354,0.00032201537],"domain_scores_gemma":[0.99718624,0.000035869012,0.0003507905,0.0010801225,0.0012149371,0.00013201621],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005225938,0.0001923212,0.0004032383,0.00032073644,0.0004560006,0.00007156768,0.0017234961,0.000086464235,0.102459915],"category_scores_gemma":[0.001036043,0.00018228873,0.00004859935,0.0005852581,0.0002360099,0.000108213455,0.0039434507,0.00051610474,0.00033285192],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016117311,0.0004028751,0.000035041758,0.0051377127,0.00018896764,0.000009162698,0.00015558237,0.0000022129625,0.00013598235,0.0000044036397,0.99137795,0.002388943],"study_design_scores_gemma":[0.000874832,0.00038661418,0.00023603602,0.00024278938,0.00017076427,0.000004340217,0.00008867831,0.000035711764,0.00024116198,0.0000021669418,0.997575,0.00014191311],"about_ca_topic_score_codex":0.00015309235,"about_ca_topic_score_gemma":0.0000017433018,"teacher_disagreement_score":0.10212706,"about_ca_system_score_codex":0.00029068743,"about_ca_system_score_gemma":0.000085215375,"threshold_uncertainty_score":0.89836055},"labels":[],"label_agreement":null},{"id":"W4393538845","doi":"10.5281/zenodo.8286762","title":"Processed counts data of cfMeDIP-seq profiles of small cell lung cancer patients","year":2022,"lang":"en","type":"dataset","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Lung cancer; Computational biology; Medicine; Oncology; Biology","score_opus":0.053081263262401486,"score_gpt":0.31797597246758064,"score_spread":0.26489470920517916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393538845","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000521988,0.0010491237,0.000007711546,0.00013702795,0.00015915136,0.0012365706,0.9884923,0.00009354176,0.0083025545],"genre_scores_gemma":[0.0011190412,0.0023320713,0.0000351345,0.000049954895,0.0001271938,5.426531e-7,0.9946582,0.000666576,0.0010112874],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99753267,0.00018703498,0.00039779165,0.00051575014,0.0010447354,0.00032201537],"domain_scores_gemma":[0.99718624,0.000035869012,0.0003507905,0.0010801225,0.0012149371,0.00013201621],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005225938,0.0001923212,0.0004032383,0.00032073644,0.0004560006,0.00007156768,0.0017234961,0.000086464235,0.102459915],"category_scores_gemma":[0.001036043,0.00018228873,0.00004859935,0.0005852581,0.0002360099,0.000108213455,0.0039434507,0.00051610474,0.00033285192],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016117311,0.0004028751,0.000035041758,0.0051377127,0.00018896764,0.000009162698,0.00015558237,0.0000022129625,0.00013598235,0.0000044036397,0.99137795,0.002388943],"study_design_scores_gemma":[0.000874832,0.00038661418,0.00023603602,0.00024278938,0.00017076427,0.000004340217,0.00008867831,0.000035711764,0.00024116198,0.0000021669418,0.997575,0.00014191311],"about_ca_topic_score_codex":0.00015309235,"about_ca_topic_score_gemma":0.0000017433018,"teacher_disagreement_score":0.10212706,"about_ca_system_score_codex":0.00029068743,"about_ca_system_score_gemma":0.000085215375,"threshold_uncertainty_score":0.89836055},"labels":[],"label_agreement":null},{"id":"W4393931655","doi":"10.1002/mp.16993","title":"In reply to Masjedi et al","year":2024,"lang":"en","type":"editorial","venue":"Medical Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia, Okanagan Campus; Kelowna General Hospital; University of British Columbia","funders":"","keywords":"Philosophy","score_opus":0.019733729945420247,"score_gpt":0.4170086054486865,"score_spread":0.39727487550326623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393931655","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003844344,0.0010886141,0.00013038449,0.1838855,0.8065604,0.0005715388,0.00011091248,0.00011590602,0.0074983127],"genre_scores_gemma":[0.0001803409,0.0011874601,0.000052971485,0.046030097,0.94208604,0.00013688607,0.00022288176,0.00010978153,0.009993546],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9937969,0.00006649246,0.00039078674,0.0007210739,0.0044606715,0.0005641112],"domain_scores_gemma":[0.99780196,0.0008501049,0.000041304505,0.00053615985,0.00019879937,0.00057165243],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001056248,0.00031754363,0.00081323914,0.00013707118,0.000026140566,0.00003348742,0.00031941305,0.00036899382,0.0002533794],"category_scores_gemma":[0.007960014,0.00024683736,0.00016565196,0.0005632135,0.00017800559,0.00005228769,0.0006217432,0.0036865876,0.0010608841],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013306965,0.00012442668,0.000019163866,0.00069841754,0.0001432243,0.0014634819,0.00043114944,2.2036114e-7,0.000005060344,0.00005997998,0.993172,0.0037498283],"study_design_scores_gemma":[0.0008623976,0.00033351735,0.000016108192,0.0022616184,0.000063209794,0.0000028140673,0.000015971378,0.000010328316,0.000049483147,0.0011582519,0.9950212,0.00020508868],"about_ca_topic_score_codex":0.000450746,"about_ca_topic_score_gemma":0.000085718115,"teacher_disagreement_score":0.1378554,"about_ca_system_score_codex":0.0006173592,"about_ca_system_score_gemma":0.0026670936,"threshold_uncertainty_score":0.9999984},"labels":[],"label_agreement":null},{"id":"W4393988374","doi":"10.1158/1538-7445.am2024-ct256","title":"Abstract CT256: Results from KEYNOTE-B98: A phase 1b/2 study of pembrolizumab plus investigational agents in patients with anti-PD-(L)1-refractory extensive-stage small-cell lung cancer (ES-SCLC)","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pembrolizumab; Refractory (planetary science); Medicine; Stage (stratigraphy); Oncology; Cancer; Internal medicine; Investigational Drugs; Phases of clinical research; Lung cancer; Chemotherapy; Clinical trial; Immunotherapy; Biology","score_opus":0.12428141881778623,"score_gpt":0.44922300988849573,"score_spread":0.3249415910707095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393988374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98512995,0.006764291,0.0000035139997,0.00088712206,0.00033157502,0.0040226723,0.0021236783,0.000081132865,0.00065607333],"genre_scores_gemma":[0.9952787,0.0012649376,0.000041627907,0.00012656639,0.00040317723,0.0010225667,0.0002933265,0.00012776977,0.0014413333],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9927597,0.00036991166,0.00093751115,0.0014179928,0.0033157163,0.0011991406],"domain_scores_gemma":[0.9957492,0.0008551419,0.00019967984,0.0009357861,0.0017218096,0.0005383786],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011661863,0.00047135548,0.00091113884,0.0010846135,0.00023817157,0.00012662745,0.0005299433,0.00017533869,0.0005856526],"category_scores_gemma":[0.00068247,0.00037444252,0.00011600068,0.0017675066,0.00053674093,0.0003463655,0.00043536013,0.0019137973,0.00003014404],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07471714,0.019576475,0.7321466,0.0086128805,0.0047362316,0.0044225235,0.04811533,0.003189825,0.023869501,0.00004219468,0.070199706,0.0103716],"study_design_scores_gemma":[0.07858862,0.002997254,0.9006752,0.0043433704,0.00023384999,0.0000010818227,0.0032568804,0.0016021499,0.004753449,0.0000212785,0.0029682748,0.0005586426],"about_ca_topic_score_codex":0.035502724,"about_ca_topic_score_gemma":0.004339909,"teacher_disagreement_score":0.16852856,"about_ca_system_score_codex":0.003128356,"about_ca_system_score_gemma":0.0047707064,"threshold_uncertainty_score":0.9998708},"labels":[],"label_agreement":null},{"id":"W4393988846","doi":"10.1158/1538-7445.am2024-ct253","title":"Abstract CT253: Results from KEYNOTE-B99: Phase 2 study of first-line (1L) pembrolizumab (pembro) plus investigational agents and chemotherapy (chemo) for extensive-stage small-cell lung cancer (ES-SCLC)","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre","funders":"","keywords":"Pembrolizumab; Medicine; Investigational Drugs; Chemotherapy; Cancer; Oncology; Stage (stratigraphy); Lung cancer; Internal medicine; Clinical trial; Immunotherapy; Biology","score_opus":0.16508682338391562,"score_gpt":0.4784425243929593,"score_spread":0.3133557010090437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393988846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9664893,0.017261138,0.00005060895,0.0075353165,0.00033966498,0.004988292,0.0028745166,0.00009979124,0.00036134332],"genre_scores_gemma":[0.9819529,0.009267235,0.00020401363,0.00032796292,0.0010636573,0.0021978298,0.00021529706,0.00014677031,0.0046243113],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9947455,0.0001492877,0.00085173524,0.0013761005,0.0018357363,0.001041629],"domain_scores_gemma":[0.995336,0.001602126,0.00016757907,0.00078155287,0.001568121,0.0005445989],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014109861,0.00045157177,0.0008706787,0.0005633315,0.00041014637,0.00015350452,0.0004251716,0.00019096861,0.0006093323],"category_scores_gemma":[0.00086281897,0.0003848267,0.00016865456,0.0009167089,0.0006135133,0.00020701984,0.00033109012,0.0010779772,0.000009202373],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12669091,0.008538365,0.04387761,0.03371822,0.011686998,0.0019036024,0.08346304,0.0033684701,0.23595148,0.00017302987,0.39965,0.050978266],"study_design_scores_gemma":[0.33854795,0.0121724205,0.17270222,0.013689661,0.0017536189,0.000025718115,0.016013913,0.094457835,0.21234465,0.00095134607,0.13444777,0.002892903],"about_ca_topic_score_codex":0.018200727,"about_ca_topic_score_gemma":0.0032722966,"teacher_disagreement_score":0.26520225,"about_ca_system_score_codex":0.0016413037,"about_ca_system_score_gemma":0.0024243044,"threshold_uncertainty_score":0.99986035},"labels":[],"label_agreement":null},{"id":"W4394878299","doi":"10.1016/j.lungcan.2024.107733","title":"172 Stage and Survival of Screen Detected Small Cell Lung Cancer from the SUMMIT Study","year":2024,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Summit; Medicine; Stage (stratigraphy); Lung cancer; Oncology; Internal medicine; Cartography","score_opus":0.028990671029437663,"score_gpt":0.36243275310084566,"score_spread":0.333442082071408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394878299","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8753208,0.11886697,0.000057281883,0.001652732,0.0006239833,0.0015935516,0.0006925554,0.00010751117,0.0010846481],"genre_scores_gemma":[0.9880759,0.0045768972,0.000045574703,0.0001464028,0.00067403796,0.00040604034,0.00001343435,0.00006273648,0.00599899],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979517,0.00014065648,0.0003104496,0.000537021,0.0006297707,0.00043042467],"domain_scores_gemma":[0.9986489,0.00047360233,0.000070238595,0.0004734589,0.00019316998,0.00014062674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036750507,0.00025500383,0.00047446068,0.00008793427,0.00013043203,0.00006532959,0.00022441638,0.00007125714,0.0007016214],"category_scores_gemma":[0.00007341807,0.0001637333,0.00009278133,0.00044484952,0.00017976384,0.00007532392,0.00027193263,0.00047335256,0.0000035409698],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038583376,0.000097132346,0.9713852,0.0010603683,0.0017240128,0.000091549715,0.004594421,0.00002886934,0.0035875496,0.00002005214,0.013059995,0.003965052],"study_design_scores_gemma":[0.0040489207,0.0004476863,0.96078813,0.0016883055,0.0022744446,8.90766e-7,0.004590035,0.0052133324,0.006025269,0.00001662654,0.014471533,0.00043484272],"about_ca_topic_score_codex":0.0512693,"about_ca_topic_score_gemma":0.04595522,"teacher_disagreement_score":0.11429007,"about_ca_system_score_codex":0.00040934217,"about_ca_system_score_gemma":0.00054282905,"threshold_uncertainty_score":0.9714536},"labels":[],"label_agreement":null},{"id":"W4396769086","doi":"10.1016/j.lungcan.2024.107819","title":"Natural history of SCLC patients treated in third-line and beyond: A retrospective real world study","year":2024,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Amgen","keywords":"Medicine; Natural history; Retrospective cohort study; Real world evidence; Natural (archaeology); Internal medicine; Archaeology; History","score_opus":0.015157342278014005,"score_gpt":0.35070606231962614,"score_spread":0.3355487200416121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396769086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9509573,0.029910825,2.509416e-7,0.0005041886,0.00071396626,0.001444386,0.00003854097,0.00006143927,0.016369134],"genre_scores_gemma":[0.9779339,0.0008315454,0.000016201731,0.00009784657,0.000111407906,0.00021820229,0.000009280017,0.000025419704,0.020756224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869144,0.000051095238,0.00024179321,0.00038661348,0.00039319767,0.00023587927],"domain_scores_gemma":[0.99947155,0.000059295297,0.00004600981,0.00019213528,0.0001636382,0.000067357665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019074911,0.0001479459,0.0004173953,0.00030648097,0.000023307572,0.000013877761,0.00009217077,0.00003179046,0.00008190275],"category_scores_gemma":[0.000065017324,0.00011304336,0.00003935049,0.0004943239,0.0001276305,0.00012376966,0.00016840875,0.00035782208,0.0000013279852],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007020875,0.0002861059,0.9623972,0.00035479444,0.0003909687,0.00007759943,0.006757646,7.778186e-7,0.00017776607,0.00008278592,0.026021983,0.0027502906],"study_design_scores_gemma":[0.0030888712,0.0006479396,0.9924068,0.00057526847,0.00017949595,6.616928e-7,0.00022183637,0.00044617202,0.000096133204,0.000032217293,0.0021864052,0.00011819937],"about_ca_topic_score_codex":0.011582856,"about_ca_topic_score_gemma":0.020079555,"teacher_disagreement_score":0.030009605,"about_ca_system_score_codex":0.0043409565,"about_ca_system_score_gemma":0.00033679637,"threshold_uncertainty_score":0.9994812},"labels":[],"label_agreement":null},{"id":"W4396817571","doi":"10.2139/ssrn.4819356","title":"Real World Outcomes of Prophylactic Cranial Irradiation Utilization and Efficacy for Patients with Extensive-Stage Small Cell Lung Cancer Treated with Consolidative Thoracic Radiotherapy","year":2024,"lang":"en","type":"preprint","venue":"SSRN Electronic Journal","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Prophylactic cranial irradiation; Radiation therapy; Stage (stratigraphy); Medicine; Lung cancer; Radiology; Oncology; Internal medicine; Biology","score_opus":0.022701520062784895,"score_gpt":0.3613556800085309,"score_spread":0.338654159945746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396817571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834851,0.010610826,0.0011445497,0.0005475439,0.000115287585,0.0038077391,0.00013115861,0.000043700893,0.00011407077],"genre_scores_gemma":[0.98071647,0.01576564,0.0004709612,0.00002881914,0.00020255124,0.00023676582,0.00009682979,0.00011070251,0.0023712425],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99727625,0.00013033,0.00042373445,0.00051717163,0.0005338993,0.0011185951],"domain_scores_gemma":[0.9978873,0.00018263303,0.000572426,0.0002329161,0.0010012018,0.00012352782],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004611847,0.00041931786,0.0008388093,0.0004589358,0.0001491377,0.0000703253,0.00011605139,0.00012104659,0.0000119366205],"category_scores_gemma":[0.000072434676,0.00026445708,0.00011985582,0.00030835884,0.00017330523,0.000073322015,0.00006995967,0.0019504755,2.5815197e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027437769,0.0009208192,0.925667,0.005702227,0.009926832,0.000032438107,0.0034362122,0.0006420186,0.00040372703,0.0008349029,0.0000793191,0.024916744],"study_design_scores_gemma":[0.03667654,0.016394362,0.92044127,0.0043456107,0.008674906,0.00005741051,0.0016495797,0.005803965,0.0016195567,0.002669172,0.00022667537,0.0014409346],"about_ca_topic_score_codex":0.000557826,"about_ca_topic_score_gemma":0.0019954043,"teacher_disagreement_score":0.023475809,"about_ca_system_score_codex":0.0029525373,"about_ca_system_score_gemma":0.005954748,"threshold_uncertainty_score":0.99998075},"labels":[],"label_agreement":null},{"id":"W4399280225","doi":"10.1200/jco.2024.42.16_suppl.e23266","title":"Real-world safety and healthcare resource utilization (HCRU) of lurbinectedin (lurbi) in patients (pts) with small cell lung cancer (SCLC): Jazz EMERGE 402 updated analysis.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"Jazz Pharmaceuticals","keywords":"Medicine; Standard of care; Oncology; Lung cancer; Health care; Healthcare system; Internal medicine; Intensive care medicine","score_opus":0.10058853251565913,"score_gpt":0.4898858693503855,"score_spread":0.3892973368347264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399280225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9790805,0.0046660556,0.000100847705,0.012615857,0.00038725688,0.00052050216,0.000035784473,0.000018676728,0.0025745193],"genre_scores_gemma":[0.9858256,0.011799906,0.0006380465,0.00048582707,0.00036277642,0.000008266209,0.000035229765,0.000028284303,0.00081604504],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955246,0.0006715002,0.0025000158,0.00035037487,0.00060736266,0.0003461908],"domain_scores_gemma":[0.99635744,0.001114314,0.0010488048,0.00020901588,0.0009129933,0.0003574296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002599934,0.00018644436,0.0019092383,0.00081109593,0.000045009758,0.000010119296,0.0001424478,0.00023036033,0.00012547559],"category_scores_gemma":[0.00082806003,0.0001237919,0.00026074523,0.0018635753,0.00023148296,0.000097183416,0.00010896344,0.0012377533,9.858172e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00904289,0.0006788855,0.9584203,0.00060041744,0.0018831441,0.00021605972,0.00047914268,0.00022336257,0.000017607388,0.000050526338,0.0068777734,0.021509925],"study_design_scores_gemma":[0.0071418937,0.0060499595,0.9398206,0.000705893,0.0018761468,0.0000053279514,0.00014210671,0.0023195725,0.00004260128,0.000014550251,0.041764412,0.00011693906],"about_ca_topic_score_codex":0.0015321001,"about_ca_topic_score_gemma":0.017771693,"teacher_disagreement_score":0.034886636,"about_ca_system_score_codex":0.0006591228,"about_ca_system_score_gemma":0.0017955218,"threshold_uncertainty_score":0.9917022},"labels":[],"label_agreement":null},{"id":"W4399325908","doi":"10.1200/jco.2024.42.16_suppl.e15030","title":"Circulating tumor cells enumeration and characterization in patients with lung cancer treated with immunotherapy.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Cancer Care Ontario; Western University","funders":"Academic Medical Organization of Southwestern Ontario","keywords":"Medicine; Lung cancer; Immunotherapy; Enumeration; Cancer immunotherapy; Cancer research; Cancer; Tumor cells; Oncology; Internal medicine","score_opus":0.04006512856295487,"score_gpt":0.4478770831718037,"score_spread":0.40781195460884884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399325908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969829,0.00072733546,0.00008320018,0.0016297033,0.00018075436,0.00027836597,0.0000057788843,0.000007166111,0.00010483749],"genre_scores_gemma":[0.99834406,0.00067394023,0.0002512097,0.00034649955,0.00028743542,0.0000096402,0.000006555319,0.000014841895,0.000065806846],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863887,0.00014210012,0.0007059078,0.0001288204,0.00025841902,0.00012588235],"domain_scores_gemma":[0.9988777,0.00035882564,0.00035008692,0.00005471364,0.00027685854,0.000081817954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007044595,0.000080752616,0.00055288785,0.00011934057,0.000024590874,0.000018232091,0.000029947238,0.00006636486,0.000036013447],"category_scores_gemma":[0.00013904282,0.000045315635,0.00004262129,0.00017551752,0.00008598845,0.00016175435,0.00001132334,0.0004597989,5.741927e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003704395,0.0002797158,0.93040717,0.00010519132,0.0003947029,0.0003390651,0.00029168744,0.000016819167,0.0019001812,0.0000048183983,0.00005988152,0.062496364],"study_design_scores_gemma":[0.0059728655,0.0056123696,0.98474306,0.0007006725,0.00013136092,0.000031660464,0.000021201986,0.000883733,0.00012205355,0.00000305286,0.0017245848,0.000053371623],"about_ca_topic_score_codex":0.000035608882,"about_ca_topic_score_gemma":0.00003880999,"teacher_disagreement_score":0.062442992,"about_ca_system_score_codex":0.00024151067,"about_ca_system_score_gemma":0.0007302766,"threshold_uncertainty_score":0.1997623},"labels":[],"label_agreement":null},{"id":"W4399374116","doi":"10.1200/jco.2024.42.17_suppl.lba5","title":"ADRIATIC: Durvalumab (D) as consolidation treatment (tx) for patients (pts) with limited-stage small-cell lung cancer (LS-SCLC).","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Medicine; Durvalumab; Oncology; Internal medicine; Stage (stratigraphy); Lung cancer; Cancer; Immunotherapy; Pembrolizumab","score_opus":0.13536777185527651,"score_gpt":0.522701672356838,"score_spread":0.38733390050156147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399374116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97031164,0.004535393,0.0003559676,0.015881512,0.0021525195,0.0015722675,0.000060463633,0.00003405117,0.005096162],"genre_scores_gemma":[0.9750426,0.008731205,0.0032891927,0.0013874515,0.0022257164,0.00018272677,0.000021941341,0.000057904585,0.009061283],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969888,0.00027531091,0.0015542057,0.0003057732,0.00050912524,0.00036678993],"domain_scores_gemma":[0.993855,0.0037277378,0.0007943726,0.00019354916,0.0010398071,0.00038951353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014055992,0.00020742601,0.0012540291,0.00018244036,0.00007666477,0.000032634995,0.00012964447,0.00023849381,0.00025675388],"category_scores_gemma":[0.0022947686,0.00012142913,0.0004298954,0.00017565442,0.00018382855,0.00012618357,0.000048568883,0.0006007661,0.000022540793],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040239133,0.011425479,0.42263183,0.002278068,0.010610644,0.0020468165,0.002243946,0.000166069,0.0002172224,0.0005796896,0.08319858,0.4243625],"study_design_scores_gemma":[0.049097028,0.12255969,0.07281111,0.0013257286,0.004484434,0.00009474827,0.0004624756,0.0029838688,0.00060889416,0.00012420848,0.7451223,0.00032551136],"about_ca_topic_score_codex":0.000110544825,"about_ca_topic_score_gemma":0.00025198315,"teacher_disagreement_score":0.6619237,"about_ca_system_score_codex":0.0013677836,"about_ca_system_score_gemma":0.0053497306,"threshold_uncertainty_score":0.9490192},"labels":[],"label_agreement":null},{"id":"W4399505409","doi":"10.1158/1538-8514.synthleth24-pr006","title":"Abstract PR006: DNA repair inhibition via targeting ATR activates cGAS/STING signaling, promotes anti-tumor immunity, and is a synthetic lethal strategy to augment immunotherapy response in preclinical models and clinical samples of small cell lung cancer","year":2024,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer research; Blockade; Immunotherapy; Immune checkpoint; Tumor microenvironment; Biology; Immune system; Immunology; Medicine; Receptor","score_opus":0.08230421986962153,"score_gpt":0.4102955688589184,"score_spread":0.3279913489892968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399505409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9405562,0.05482363,0.0012543916,0.0016456508,0.000098190445,0.0014406968,0.00006707167,0.00009308617,0.000021066591],"genre_scores_gemma":[0.9920438,0.0052585686,0.0017425634,0.0005124824,0.00009298538,0.00022208775,0.000006929548,0.000095243755,0.000025331989],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967875,0.00048023922,0.0009811708,0.0007437653,0.00047381513,0.00053352094],"domain_scores_gemma":[0.9981341,0.0009260354,0.00020550202,0.0003617036,0.00020936636,0.000163297],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002211318,0.00037185752,0.0007335773,0.00024128299,0.00011717484,0.00008394298,0.00012765072,0.00017435577,0.000039780807],"category_scores_gemma":[0.00013132575,0.00032490585,0.00020802359,0.0003541196,0.0002891864,0.00012139256,0.00019073478,0.0007721049,5.470339e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035380179,0.00037420428,0.024226172,0.0020721548,0.0011094708,0.00020063853,0.0040244255,0.0011605044,0.9484078,0.000011192633,0.000024800891,0.014850574],"study_design_scores_gemma":[0.0048165717,0.0036595867,0.06268258,0.009789327,0.0009603772,0.0000452075,0.0012800886,0.06390379,0.85065156,0.0008011381,0.00039621073,0.0010135635],"about_ca_topic_score_codex":0.0014899599,"about_ca_topic_score_gemma":0.00008322308,"teacher_disagreement_score":0.09775629,"about_ca_system_score_codex":0.0003325206,"about_ca_system_score_gemma":0.0006475765,"threshold_uncertainty_score":0.9999203},"labels":[],"label_agreement":null},{"id":"W4399670437","doi":"10.1200/jco.2024.42.16_suppl.e20123","title":"Treatment of relapsed small cell lung cancer in the real-world: A comparison of platinum-etoposide rechallenge and cyclophosphamide-doxorubicin-vincristine (CAV) chemotherapy.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Etoposide; Vincristine; Doxorubicin; Cyclophosphamide; Chemotherapy; Oncology; Internal medicine","score_opus":0.13541354670541178,"score_gpt":0.5286251097895158,"score_spread":0.39321156308410404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399670437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92946905,0.043339733,0.000016642487,0.020028658,0.0005212542,0.00057788496,0.00001160564,0.000008255741,0.006026888],"genre_scores_gemma":[0.9275086,0.07009994,0.0011073578,0.00019274678,0.0004920792,0.000019292225,0.000001076131,0.000020651165,0.0005582476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99611455,0.0005147078,0.0024618865,0.0002310243,0.00042405553,0.0002537796],"domain_scores_gemma":[0.9922259,0.006069279,0.0010615562,0.00022558036,0.00026921724,0.0001484536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002472346,0.00018011154,0.0020168794,0.00023524906,0.00002797879,0.000006621206,0.00016482505,0.00019460444,0.00006873719],"category_scores_gemma":[0.0007041272,0.00009976103,0.00032434778,0.0003427185,0.00033231513,0.000042035335,0.000045827175,0.0008300116,7.7359323e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010638864,0.0040034316,0.7586802,0.0012312758,0.0015115214,0.0010881597,0.008757553,0.00005478854,0.0021178967,0.00024597667,0.0058428776,0.20582743],"study_design_scores_gemma":[0.028301097,0.047852274,0.845815,0.0024743788,0.0018624294,0.00013364358,0.0027011784,0.0022058277,0.0054516494,0.00059111393,0.06235707,0.0002543484],"about_ca_topic_score_codex":0.0010782538,"about_ca_topic_score_gemma":0.0028098768,"teacher_disagreement_score":0.20557308,"about_ca_system_score_codex":0.0004945602,"about_ca_system_score_gemma":0.0015222445,"threshold_uncertainty_score":0.40681368},"labels":[],"label_agreement":null},{"id":"W4399670554","doi":"10.1200/jco.2024.42.16_suppl.e20111","title":"Real world outcomes in extensive stage small cell lung cancer (ES-SCLC) treated with consolidative thoracic radiation (cTRT) and chemoimmunotherapy (CIT): A population level study.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Calgary","funders":"","keywords":"Chemoimmunotherapy; Medicine; Lung cancer; Stage (stratigraphy); Oncology; Radiation therapy; Population; Internal medicine; Radiology; Chemotherapy; Surgery; Cyclophosphamide","score_opus":0.16477889486802624,"score_gpt":0.5439998163855461,"score_spread":0.37922092151751985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399670554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99014443,0.002808415,0.00003522495,0.0053169834,0.000281899,0.0009436486,0.000018712726,0.000018049772,0.00043261773],"genre_scores_gemma":[0.99139094,0.0050029694,0.0005539189,0.00036274912,0.00036694144,0.000039980398,0.0000050922245,0.00002943017,0.0022479824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970456,0.0005938049,0.0014168263,0.00029465236,0.0003890152,0.0002601263],"domain_scores_gemma":[0.9961516,0.0023887055,0.00072159857,0.00014192503,0.00042768035,0.00016846345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021149663,0.00019458197,0.0014987803,0.00041693807,0.000048196,0.000030226305,0.00008447352,0.00014343178,0.000055951285],"category_scores_gemma":[0.0006484842,0.000119628916,0.0001471016,0.00040390997,0.00016732122,0.00017062438,0.00004108911,0.0010529277,0.0000012207722],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073818653,0.0008370694,0.9417608,0.0001324325,0.0011892639,0.0011244257,0.0017259571,0.00004695264,0.00016935956,0.000013711529,0.0003880191,0.04523015],"study_design_scores_gemma":[0.008708724,0.0068433904,0.98032576,0.00036668347,0.00046462435,0.000023134859,0.00097257044,0.0006294927,0.00008611018,0.000021296626,0.001440983,0.00011723488],"about_ca_topic_score_codex":0.0023095428,"about_ca_topic_score_gemma":0.004268954,"teacher_disagreement_score":0.045112915,"about_ca_system_score_codex":0.00086243526,"about_ca_system_score_gemma":0.0014020603,"threshold_uncertainty_score":0.48783255},"labels":[],"label_agreement":null},{"id":"W4399705795","doi":"10.1016/j.jtocrr.2024.100696","title":"Brief Report: Real-World Eligibility for Clinical Trials in Patients With Extensive-Stage SCLC at a Tertiary Care Center","year":2024,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Kingston Health Sciences Centre; Queen's University","funders":"","keywords":"Center (category theory); Tertiary care; Stage (stratigraphy); Medicine; Lung cancer; Cancer; Clinical trial; Oncology; Internal medicine; Family medicine","score_opus":0.2734519420320826,"score_gpt":0.6070180270986795,"score_spread":0.33356608506659685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399705795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830275,0.0026907409,0.000008883304,0.0049977372,0.00080150645,0.0054863296,0.0001028093,0.00009994284,0.0027845476],"genre_scores_gemma":[0.98159075,0.003372033,0.0002985513,0.00034479905,0.0010914295,0.00048836216,0.00020590116,0.00006828593,0.012539872],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98835766,0.0022139174,0.0042458186,0.0019781648,0.0022255697,0.0009788669],"domain_scores_gemma":[0.9837795,0.010917179,0.00042091077,0.0013491401,0.002634048,0.00089923094],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.0534175,0.00029367252,0.0018505469,0.00032831327,0.0002414683,0.00012652545,0.000120431054,0.0002897941,0.0000843251],"category_scores_gemma":[0.06718991,0.00017205378,0.00062917237,0.0005715832,0.0015491392,0.00015088469,0.0006962047,0.0016687255,0.000009227088],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045311283,0.0006881769,0.9088591,0.0014351482,0.0003430271,0.01280438,0.0001482223,1.6783513e-7,0.0000053170947,0.00001532667,0.05074304,0.020427013],"study_design_scores_gemma":[0.0038930487,0.0015682608,0.83713347,0.0011899249,0.00008569286,0.00008419221,0.00009755193,0.000028125867,0.000026726586,0.00020167467,0.15551849,0.0001728471],"about_ca_topic_score_codex":0.00066166965,"about_ca_topic_score_gemma":0.001787226,"teacher_disagreement_score":0.10477545,"about_ca_system_score_codex":0.0005015071,"about_ca_system_score_gemma":0.0014478792,"threshold_uncertainty_score":0.9747059},"labels":[],"label_agreement":null},{"id":"W4399781814","doi":"10.3390/curroncol31060254","title":"Durable Objective Response to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation: A Molecular-Directed Strategy","year":2024,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Conquer Cancer Foundation","keywords":"Medicine; Cancer research; Etoposide; Disease; Mutation; Cancer; Suppressor; Chemotherapy; Gene; Oncology; Genetics; Biology; Internal medicine","score_opus":0.06926260446440863,"score_gpt":0.43661754399225333,"score_spread":0.3673549395278447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399781814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9721674,0.013753118,0.000164788,0.006322413,0.00063034124,0.001418906,0.000033867338,0.00023456843,0.005274597],"genre_scores_gemma":[0.9961004,0.0003789797,0.0003237235,0.00018126096,0.00018156243,0.0011900758,0.00002029399,0.000043858716,0.001579811],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980958,0.0003017445,0.00025792836,0.0005597591,0.00026168086,0.0005230858],"domain_scores_gemma":[0.99884796,0.0003855839,0.00003903822,0.00020276239,0.00031459655,0.00021007204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003644109,0.00022036044,0.00042097614,0.00047577394,0.00004685321,0.00003111374,0.00010070809,0.000097222284,0.0002637289],"category_scores_gemma":[0.00028071154,0.00017140764,0.000052894342,0.0013028639,0.000112571346,0.000051232422,0.000077843535,0.00059332943,0.000073408446],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09115625,0.006145902,0.056799058,0.007021209,0.0034249101,0.04157514,0.057739396,0.006502157,0.32218993,0.0010089583,0.15648893,0.24994817],"study_design_scores_gemma":[0.031113276,0.032971255,0.40785182,0.0067653856,0.0015710104,0.00095044024,0.010143863,0.011753687,0.07372669,0.0007819471,0.41999674,0.0023739066],"about_ca_topic_score_codex":0.00043105558,"about_ca_topic_score_gemma":0.002568912,"teacher_disagreement_score":0.35105276,"about_ca_system_score_codex":0.0016738377,"about_ca_system_score_gemma":0.0025540167,"threshold_uncertainty_score":0.69898003},"labels":[],"label_agreement":null},{"id":"W4400103914","doi":"10.3390/curroncol31070271","title":"Durable Response to Atezolizumab in Extensive-Stage Small-Cell Lung Cancer Leading to 60 Months Overall Survival: A Case Report","year":2024,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Atezolizumab; Medicine; Stage (stratigraphy); Lung cancer; Oncology; Lung; Cancer; Overall survival; Internal medicine; Cancer research; Immunotherapy; Nivolumab; Biology","score_opus":0.12771728508599753,"score_gpt":0.48482095162714567,"score_spread":0.3571036665411481,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400103914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9611952,0.01652764,0.0001541897,0.013501135,0.0032963825,0.0021094,0.00006224949,0.00016720527,0.002986644],"genre_scores_gemma":[0.9724564,0.0011585926,0.00026810815,0.0005660224,0.0005689679,0.0013550629,0.000016027396,0.000089686924,0.023521144],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968178,0.0003375483,0.00059769157,0.0009144538,0.0004019884,0.00093047076],"domain_scores_gemma":[0.99784005,0.0007012291,0.00007320545,0.0005351428,0.00034747418,0.00050290406],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014275836,0.0003073889,0.00078951765,0.0006762959,0.00010799553,0.000048323604,0.00015593588,0.00012875636,0.00022497747],"category_scores_gemma":[0.0016617848,0.0002749501,0.00012783696,0.00079153525,0.00007561614,0.00008825365,0.00039399884,0.00071959716,0.00013550547],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009494636,0.0006611558,0.027433833,0.0029327264,0.00030495034,0.762136,0.013397582,0.0009309755,0.02061456,0.00011804852,0.1427049,0.019270625],"study_design_scores_gemma":[0.0039109597,0.0016728841,0.014567149,0.0019970746,0.0002369886,0.0068364576,0.0016585944,0.002415188,0.0014811115,0.000018994779,0.9646253,0.0005792914],"about_ca_topic_score_codex":0.002506725,"about_ca_topic_score_gemma":0.005798794,"teacher_disagreement_score":0.8219204,"about_ca_system_score_codex":0.0042898133,"about_ca_system_score_gemma":0.0017945104,"threshold_uncertainty_score":0.99997026},"labels":[],"label_agreement":null},{"id":"W4400412031","doi":"10.1016/j.jtocrr.2024.100702","title":"Identifying Novel Germline Mutations and Copy Number Variations in Patients With SCLC","year":2024,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Toronto General Hospital; University of Toronto; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; St Mary's Hospital Centre; Western University","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; Canadian Institutes of Health Research; Weill Cornell Medical College; University of Toronto; Memorial Sloan-Kettering Cancer Center","keywords":"Germline; Germline mutation; Genetics; Biology; Copy-number variation; Mutation; Affect (linguistics); Oncology; Medicine; Gene; Genome; Psychology","score_opus":0.1449493709868936,"score_gpt":0.5350573537025527,"score_spread":0.3901079827156591,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400412031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907438,0.00068073894,0.00022855577,0.0045247213,0.00018006416,0.00084928476,0.000011503158,0.00004690232,0.0027344306],"genre_scores_gemma":[0.99597543,0.00048785325,0.001206089,0.000053284974,0.00017272522,0.00008463208,0.00002617084,0.00001873902,0.0019750637],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973777,0.00010819829,0.000568824,0.00051223976,0.0010848246,0.00034820492],"domain_scores_gemma":[0.99786496,0.0009703018,0.000042353866,0.00023284984,0.0006154465,0.0002740843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033816113,0.00009738729,0.00028350466,0.00021265885,0.00018472786,0.00013014046,0.000033401775,0.00008593704,0.000075525015],"category_scores_gemma":[0.0031008816,0.000062916784,0.00004194719,0.0006043784,0.00062638195,0.00015757309,0.00019576326,0.0008190308,0.000013561459],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001442868,0.00035473748,0.99155533,0.00030106504,0.00013519371,0.0007774185,0.000276887,4.3539683e-7,0.000017687069,0.00048120314,0.0017708361,0.004184941],"study_design_scores_gemma":[0.0012929307,0.0003192385,0.98843503,0.00060173473,0.000038038874,0.00008446437,0.00007894545,0.00022057253,0.000009543988,0.0014942313,0.0073440145,0.00008126897],"about_ca_topic_score_codex":0.00024671483,"about_ca_topic_score_gemma":0.00012845405,"teacher_disagreement_score":0.005573178,"about_ca_system_score_codex":0.00008139478,"about_ca_system_score_gemma":0.0004530851,"threshold_uncertainty_score":0.3712269},"labels":[],"label_agreement":null},{"id":"W4400452226","doi":"10.1016/j.jtho.2024.05.344","title":"PP01.119 Real-World Use of Lurbinectedin in Patients with Small Cell Lung Cancer: Jazz EMERGE 402 Updated Analysis","year":2024,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"Medicine; Jazz; Lung cancer; Internal medicine; Acoustics","score_opus":0.03104700443746073,"score_gpt":0.42867154048630385,"score_spread":0.3976245360488431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400452226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99358195,0.0019145401,0.00006606498,0.0025722126,0.000432107,0.0003828852,0.00004285696,0.000020266289,0.0009870919],"genre_scores_gemma":[0.99402755,0.0016975054,0.001966578,0.000111116984,0.00021013431,0.00001644783,0.000025261645,0.000033811888,0.0019116183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975032,0.0002706846,0.00092942663,0.0002717518,0.0006170589,0.00040785348],"domain_scores_gemma":[0.99785393,0.00029923918,0.00051992526,0.00025404323,0.00086534774,0.00020748324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070055196,0.0002095269,0.0011883661,0.0019576026,0.00003565728,0.00002120843,0.00018618508,0.00011615977,0.0003258471],"category_scores_gemma":[0.00014361733,0.00014219194,0.00024770395,0.0030712988,0.00012158475,0.00020147339,0.000103169106,0.0008112542,0.0000029488692],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048453016,0.0006618479,0.9605159,0.0006423912,0.0039331256,0.00080904807,0.00069939345,0.0006839357,0.0005051052,0.0000074919703,0.016845023,0.009851416],"study_design_scores_gemma":[0.0023781734,0.003282562,0.9639598,0.0009203082,0.0067348727,0.000018072518,0.00014158865,0.0016948808,0.0015156243,0.000012125127,0.019125897,0.00021605394],"about_ca_topic_score_codex":0.0017663077,"about_ca_topic_score_gemma":0.009856332,"teacher_disagreement_score":0.009635362,"about_ca_system_score_codex":0.0014432479,"about_ca_system_score_gemma":0.0010923839,"threshold_uncertainty_score":0.5798419},"labels":[],"label_agreement":null},{"id":"W4401094899","doi":"10.21037/jtd-24-278","title":"Pleural pro-gastrin releasing peptide is a potential diagnostic marker for malignant pleural effusion induced by small-cell lung cancer","year":2024,"lang":"en","type":"article","venue":"Journal of Thoracic Disease","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Inner Mongolia Medical University","keywords":"Medicine; Pleural effusion; Malignant pleural effusion; Pathology; Lung; Lung cancer; Cancer; Gastrin-releasing peptide; Gastrin; Pleural cavity; Oncology; Internal medicine; Radiology; Cancer research; Surgery; Bombesin; Secretion","score_opus":0.026747527689240568,"score_gpt":0.38138781588710413,"score_spread":0.3546402881978636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401094899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9562564,0.031505004,0.00059987576,0.009152378,0.0008760515,0.0012466934,0.000252112,0.000046449553,0.000065040076],"genre_scores_gemma":[0.9928979,0.0021779437,0.00048319876,0.00042960054,0.0011719059,0.00014160005,0.000020195434,0.000080701015,0.002596946],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9973152,0.00015665275,0.0006438459,0.0003752536,0.0009013622,0.00060766656],"domain_scores_gemma":[0.99786,0.00042883374,0.00025556877,0.00023855365,0.0004457849,0.00077123084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054090424,0.00030488017,0.00050561543,0.00029085763,0.00019809623,0.000175002,0.00021845478,0.00007312916,0.00017404201],"category_scores_gemma":[0.0011287505,0.00021993896,0.00050671556,0.00030281986,0.000074429605,0.00028184592,0.00015058657,0.0006417861,0.000008195939],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034720268,0.0020035084,0.11174009,0.038526278,0.003501122,0.012096549,0.002417184,0.0002117703,0.22711945,0.000019152225,0.47573966,0.091904975],"study_design_scores_gemma":[0.028597064,0.009438312,0.58086884,0.12126018,0.035386857,0.002089045,0.0039828904,0.101742536,0.067920476,0.0012154814,0.042995475,0.0045028403],"about_ca_topic_score_codex":0.00006581993,"about_ca_topic_score_gemma":0.000005008395,"teacher_disagreement_score":0.46912876,"about_ca_system_score_codex":0.0005868493,"about_ca_system_score_gemma":0.0011135563,"threshold_uncertainty_score":0.89688504},"labels":[],"label_agreement":null},{"id":"W4402183332","doi":"10.1200/op.24.00394","title":"Impact of an Etoposide Chemotherapy Shortage on Patients With Extensive-Stage Small-Cell Lung Cancer: Results of a Natural Experiment","year":2024,"lang":"en","type":"article","venue":"JCO Oncology Practice","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Oakville-Trafalgar Memorial Hospital; University of British Columbia; London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Etoposide; Hazard ratio; Internal medicine; Lung cancer; Irinotecan; Confidence interval; Proportional hazards model; Chemotherapy; Odds ratio; Surgery; Oncology; Cancer","score_opus":0.023182339556315146,"score_gpt":0.4419740678812649,"score_spread":0.41879172832494976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402183332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851855,0.003099654,0.000006693643,0.0025791817,0.00025123125,0.0012354694,0.0001061701,0.00004947972,0.0074866116],"genre_scores_gemma":[0.9958074,0.0008665541,0.0012308118,0.0005898391,0.00012254686,0.00010255629,0.000037342525,0.000043076172,0.0011998917],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.998036,0.00022700433,0.00040078576,0.00045918647,0.00052608585,0.00035091036],"domain_scores_gemma":[0.99735796,0.0010595018,0.00031229624,0.00045506383,0.0006696501,0.00014554226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046026078,0.00023271653,0.000566048,0.00018425491,0.000052833002,0.000014312282,0.00013792193,0.00011621349,0.00007071283],"category_scores_gemma":[0.00052342983,0.0001528309,0.00011893252,0.0002960023,0.00019164859,0.00026018743,0.00006594755,0.00059108034,0.000003213328],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.396655,0.027723962,0.13464697,0.0046463707,0.018443609,0.005007181,0.06846221,0.0009572972,0.19940996,0.00041990302,0.050541606,0.09308593],"study_design_scores_gemma":[0.06318058,0.118141636,0.51740944,0.0027236869,0.002887757,0.00013286909,0.008228937,0.004218119,0.19196105,0.000012701701,0.08987807,0.0012251831],"about_ca_topic_score_codex":0.002154993,"about_ca_topic_score_gemma":0.00017046687,"teacher_disagreement_score":0.38276243,"about_ca_system_score_codex":0.0012376652,"about_ca_system_score_gemma":0.0012099566,"threshold_uncertainty_score":0.6232263},"labels":[],"label_agreement":null},{"id":"W4402565972","doi":"10.1016/j.annonc.2024.08.1889","title":"1798P Relapsed and refractory systemic therapy real-world outcomes in the Canadian small cell lung cancer database (CASCADE)","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital; CancerCare Manitoba; St. Michael's Hospital; Ottawa Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Systemic therapy; Refractory (planetary science); Lung cancer; Oncology; Internal medicine; Database; Cancer","score_opus":0.1196713710788802,"score_gpt":0.45891073948268385,"score_spread":0.33923936840380364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402565972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.866349,0.059875622,6.578022e-7,0.049326792,0.00034764182,0.0010074661,0.00012651217,0.000029347848,0.022936981],"genre_scores_gemma":[0.94705594,0.046826053,0.000025404406,0.0032872048,0.0001388938,0.00017912599,0.0000157765,0.00002186929,0.0024497283],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99847317,0.00024872308,0.00031703766,0.00029569023,0.00023657214,0.00042881307],"domain_scores_gemma":[0.9986248,0.00068766956,0.00006597106,0.00033856023,0.00012240255,0.00016058153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010854282,0.00015101329,0.0004819879,0.0004242482,0.00007808161,0.000018994137,0.00017774208,0.000106193685,0.000066607536],"category_scores_gemma":[0.000113238355,0.00009326484,0.00006730549,0.00034810268,0.00018599672,0.0000683592,0.000052635096,0.0005136916,0.00000572284],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008413531,0.000445755,0.6300592,0.0038761282,0.0012011745,0.003335807,0.017257532,0.000008627256,0.005615334,0.001726107,0.2904337,0.0451993],"study_design_scores_gemma":[0.0040024007,0.0022839904,0.39313218,0.0017409294,0.00021049335,0.0001038731,0.0020962534,0.00026493656,0.0016896313,0.00013604407,0.5939651,0.00037416114],"about_ca_topic_score_codex":0.41495737,"about_ca_topic_score_gemma":0.7701746,"teacher_disagreement_score":0.35521728,"about_ca_system_score_codex":0.00044258797,"about_ca_system_score_gemma":0.0019950164,"threshold_uncertainty_score":0.5889385},"labels":[],"label_agreement":null},{"id":"W4402566002","doi":"10.1016/j.annonc.2024.08.1884","title":"1793P Treatment and outcomes of limited disease small cell lung cancer (LD-SCLC) in the Canadian small cell lung cancer database (CASCADE)","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Jewish General Hospital; Western University; Capital District Health Authority; AstraZeneca (Canada); Ottawa Hospital; Princess Margaret Cancer Centre; BC Cancer Agency; CancerCare Manitoba","funders":"","keywords":"Medicine; Lung cancer; Oncology; Disease; Internal medicine; Cascade","score_opus":0.10322854119174955,"score_gpt":0.43619415135617623,"score_spread":0.33296561016442666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402566002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84797454,0.10196992,0.0000027209337,0.043909956,0.00025671264,0.0013863266,0.0010049449,0.000020123636,0.0034747825],"genre_scores_gemma":[0.96346784,0.031315845,0.00006569688,0.0025021806,0.00014919034,0.0005302945,0.00005853212,0.000033979046,0.0018764387],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99803686,0.00021122335,0.00042663136,0.00044257447,0.0002495233,0.00063320546],"domain_scores_gemma":[0.99825156,0.00058713293,0.00010943223,0.00042864555,0.00019769558,0.00042554157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004786007,0.00026656035,0.00069386134,0.00040563117,0.0000886478,0.000019562074,0.0002151618,0.000118447024,0.00014514904],"category_scores_gemma":[0.00012201329,0.00017228957,0.00014345006,0.00038437016,0.00026221882,0.00006438608,0.000109619046,0.0003168539,0.000002374737],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076381024,0.0009284844,0.9087304,0.0046419348,0.0012548324,0.0017364495,0.00948307,0.00009928706,0.0012448914,0.00016079392,0.05235894,0.018597143],"study_design_scores_gemma":[0.0066621588,0.0026727878,0.78851295,0.0014834668,0.002300459,0.000016310574,0.0014464937,0.00461465,0.0065496275,0.000060400693,0.18509932,0.00058138894],"about_ca_topic_score_codex":0.42720956,"about_ca_topic_score_gemma":0.7209061,"teacher_disagreement_score":0.29369652,"about_ca_system_score_codex":0.00075394637,"about_ca_system_score_gemma":0.0039170566,"threshold_uncertainty_score":0.70257646},"labels":[],"label_agreement":null},{"id":"W4402616149","doi":"10.3390/cancers16183179","title":"Metabolomic Profiling of Pulmonary Neuroendocrine Neoplasms","year":2024,"lang":"en","type":"article","venue":"Cancers","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières; Centre hospitalier universitaire de Québec; University of Alberta; Université Laval; The Metabolomics Innovation Centre; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval; Institut de Valorisation des Données; MEDTEQ+; Mitacs","keywords":"Metabolomics; Profiling (computer programming); Computational biology; Medicine; Pathology; Bioinformatics; Biology; Computer science","score_opus":0.025177995786751423,"score_gpt":0.3437458890967281,"score_spread":0.3185678933099767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402616149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9107071,0.058597337,0.00009133156,0.0031162903,0.0014884055,0.0008362226,0.00006205567,0.00027560745,0.02482561],"genre_scores_gemma":[0.9946066,0.0022250856,0.00028070042,0.00013769622,0.00023754739,0.000072030096,0.000008434813,0.00002744497,0.0024044304],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99906516,0.000017188411,0.00016546415,0.00024171628,0.0002571232,0.00025334625],"domain_scores_gemma":[0.9995717,0.00006757346,0.000021174674,0.00019556154,0.00005816261,0.00008587254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007420705,0.00010261683,0.00025168073,0.00012734036,0.000027440778,0.00000921073,0.00007205014,0.000012735706,0.00010798458],"category_scores_gemma":[0.00008283672,0.000080347585,0.00009268307,0.00033260827,0.00013274982,0.00006508677,0.00005991977,0.00020196375,0.000027308763],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002351375,0.00007950843,0.028961044,0.012877303,0.0025668838,0.006328202,0.0011063361,0.0014725167,0.7249461,0.005218375,0.062202662,0.1518897],"study_design_scores_gemma":[0.0018971661,0.0008180719,0.010915324,0.0017304767,0.0008318548,0.0008869124,0.0009990698,0.032017887,0.69532406,0.0004928616,0.2535826,0.0005037567],"about_ca_topic_score_codex":0.00017032759,"about_ca_topic_score_gemma":0.0000063573552,"teacher_disagreement_score":0.19137992,"about_ca_system_score_codex":0.0005718287,"about_ca_system_score_gemma":0.00086823,"threshold_uncertainty_score":0.32764792},"labels":[],"label_agreement":null},{"id":"W4402906184","doi":"10.1016/j.ijrobp.2024.07.166","title":"Phase I Trial of Concurrent Talazoparib and Consolidative Thoracic Radiotherapy for Patients with Extensive-Stage Small Cell Lung Cancer","year":2024,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Stage (stratigraphy); Radiation therapy; Medicine; Lung cancer; Oncology; Radiology; Biology","score_opus":0.033374533425620634,"score_gpt":0.4356903169352997,"score_spread":0.40231578350967906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402906184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9680621,0.007441246,0.018317398,0.001724966,0.002355644,0.0013334485,0.0006475201,0.000019675661,0.00009801595],"genre_scores_gemma":[0.99242896,0.003988566,0.0014773672,0.00024803594,0.0015414696,0.000089810674,0.00010006679,0.000029628234,0.00009609257],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9986336,0.0001323441,0.00053971034,0.0002273083,0.0002761537,0.00019084183],"domain_scores_gemma":[0.99682444,0.00077700586,0.0006368421,0.0000815928,0.0015753763,0.000104733284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037088917,0.00017527699,0.0005469132,0.000172792,0.000048372098,0.000025531117,0.0001462931,0.000101068,0.000031311094],"category_scores_gemma":[0.00021591382,0.00012677538,0.00014503315,0.000119241435,0.0003209473,0.0001652436,0.000035316643,0.00032067174,5.880434e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11881515,0.0058208955,0.21307456,0.00075753574,0.01009281,0.0001029678,0.0056905034,0.00035593583,0.009819818,0.0067469506,0.0069579408,0.6217649],"study_design_scores_gemma":[0.6837054,0.07670156,0.013427978,0.0019251041,0.0026066357,0.00009256544,0.00072550145,0.032639123,0.02648008,0.0019639847,0.15877496,0.00095712906],"about_ca_topic_score_codex":0.000014419342,"about_ca_topic_score_gemma":0.0000037424923,"teacher_disagreement_score":0.6208078,"about_ca_system_score_codex":0.00070894224,"about_ca_system_score_gemma":0.001038898,"threshold_uncertainty_score":0.51697505},"labels":[],"label_agreement":null},{"id":"W4402908729","doi":"10.1016/j.ijrobp.2024.08.024","title":"Safety Profile of Durvalumab (D) as Consolidation Treatment (tx) in Limited-Stage Small-Cell Lung Cancer (LS-SCLC) in ADRIATIC: Focus on Pneumonitis and Immune-Mediated Adverse Events (imAEs)","year":2024,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Durvalumab; Pneumonitis; Medicine; Adverse effect; Stage (stratigraphy); Immune system; Oncology; Lung; Internal medicine; Immunology; Immunotherapy; Pembrolizumab; Biology","score_opus":0.022623903191408546,"score_gpt":0.3684291593653184,"score_spread":0.34580525617390984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402908729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98811483,0.0036476143,0.00015767418,0.00464443,0.0010328188,0.00081182644,0.0003062893,0.000023827879,0.0012606613],"genre_scores_gemma":[0.98833835,0.010381725,0.00026901686,0.00014052007,0.0003994062,0.00008658711,0.00013707667,0.00002860234,0.00021870674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99781466,0.00032047764,0.00096356205,0.00028795496,0.00034919154,0.00026414267],"domain_scores_gemma":[0.9978953,0.00084875367,0.0005998194,0.0001257732,0.0004317742,0.00009858229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056737656,0.00022635801,0.00060392707,0.00052504445,0.00003774977,0.0000109920875,0.00017199443,0.00018306622,0.0001048223],"category_scores_gemma":[0.00040616546,0.00018999814,0.00015114092,0.0003134867,0.0001401258,0.0002085464,0.00006724939,0.00048551057,0.0000149981],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043869237,0.0018879003,0.84324396,0.00026165202,0.0020307046,0.0005738146,0.0047043855,0.0017483273,0.018345352,0.004216395,0.00022597337,0.11837464],"study_design_scores_gemma":[0.052386,0.01049825,0.833467,0.0033467214,0.00070256996,0.00022374328,0.0013320704,0.046651933,0.038516235,0.0034865867,0.008668635,0.0007202211],"about_ca_topic_score_codex":0.00053713087,"about_ca_topic_score_gemma":0.0001650336,"teacher_disagreement_score":0.11765441,"about_ca_system_score_codex":0.003170048,"about_ca_system_score_gemma":0.0013674829,"threshold_uncertainty_score":0.82895654},"labels":[],"label_agreement":null},{"id":"W4403095475","doi":"10.1016/j.eclinm.2024.102871","title":"Brain metastasis burden and management in patients with small cell lung cancer in Canada: a retrospective, population-based cohort study","year":2024,"lang":"en","type":"article","venue":"EClinicalMedicine","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; Institute for Clinical Evaluative Sciences; Princess Margaret Cancer Centre; Sunnybrook Health Science Centre; Health Sciences Centre; Queen's University; University of Toronto","funders":"Ministry of Long-Term Care; Canadian Institutes of Health Research; Seagen; Institute for Clinical Evaluative Sciences; University of Oxford; Elekta; Bristol-Myers Squibb; Kementerian Kesihatan Malaysia; AstraZeneca; Congress of Neurological Surgeons; Cancer Care Ontario; Pfizer; Ministry of Health, Ontario","keywords":"Medicine; Retrospective cohort study; Brain metastasis; Lung cancer; Cohort; Cancer; Metastasis; Population; Oncology; General surgery; Internal medicine; Environmental health","score_opus":0.01739674314544606,"score_gpt":0.3429313140409801,"score_spread":0.32553457089553406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403095475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98552537,0.0019030642,0.000012902788,0.008480775,0.0001620592,0.0034263742,0.000035502973,0.000028941176,0.0004250198],"genre_scores_gemma":[0.9981486,0.0002201226,0.00015521389,0.0005181852,0.000123805,0.00040898516,0.000034584344,0.00003145636,0.0003590465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99755585,0.00010806929,0.00054062,0.00062348816,0.00081689766,0.0003550447],"domain_scores_gemma":[0.99900293,0.00038942366,0.000058827474,0.0002994708,0.00008601634,0.00016330686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008485115,0.0002051925,0.0006566228,0.00030207893,0.000035415465,0.0000130845,0.000086121734,0.00003344581,0.00008287886],"category_scores_gemma":[0.0002262272,0.00014318438,0.00002693849,0.0007302075,0.000057308218,0.000038842347,0.000082916005,0.00043294183,0.0000017159034],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042266463,0.00019019442,0.99301267,0.000578208,0.00040506877,0.0004940279,0.00016618666,0.00009253206,3.8863723e-7,0.0000056811245,0.0016402897,0.0029921075],"study_design_scores_gemma":[0.00830374,0.00072026404,0.98744035,0.0009987066,0.00036494096,3.526152e-7,0.00027385502,0.0014747741,8.1591924e-7,0.0000069197777,0.00027991092,0.00013537578],"about_ca_topic_score_codex":0.7919113,"about_ca_topic_score_gemma":0.8911691,"teacher_disagreement_score":0.099257745,"about_ca_system_score_codex":0.0022494006,"about_ca_system_score_gemma":0.0007293621,"threshold_uncertainty_score":0.5882104},"labels":[],"label_agreement":null},{"id":"W4403250115","doi":"10.1016/j.ygyno.2024.07.485","title":"Practice patterns in the treatment of small cell carcinoma of the cervix: Analysis of a Canadian multidisciplinary survey","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Multidisciplinary approach; Cervix; Gynecology; Carcinoma; Oncology; General surgery; Internal medicine; Cancer","score_opus":0.0803598955646283,"score_gpt":0.38781550183967584,"score_spread":0.30745560627504753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403250115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98487866,0.0020473865,0.0000021066226,0.0059656003,0.00017356111,0.0008392467,0.00025205425,0.000004740779,0.0058366586],"genre_scores_gemma":[0.99840087,0.0009651136,0.000094658666,0.00013454471,0.000020854037,0.00011547209,0.00003003498,0.000007341209,0.00023113655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977796,0.0010464168,0.0004162163,0.00024818775,0.00020473727,0.0003048044],"domain_scores_gemma":[0.99389035,0.005228004,0.0001654819,0.0004556127,0.00019578506,0.00006480019],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012595518,0.00012680331,0.0006545708,0.0007527132,0.0000459977,0.000003411408,0.00025634584,0.00012565387,0.00013642487],"category_scores_gemma":[0.00076687033,0.000062644365,0.00021983817,0.002223817,0.00022797573,0.000021410126,0.000085268846,0.0001829916,0.0000024575972],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015246046,0.0010700907,0.98419523,0.00019346022,0.00089759583,0.00030468102,0.009939436,0.00011616451,0.00017695395,0.000035132598,0.00030670874,0.0026120553],"study_design_scores_gemma":[0.000724713,0.0039393045,0.98495495,0.000017094628,0.0014633527,0.000007945767,0.004371772,0.00045527323,0.00038109886,0.000011496921,0.003624668,0.00004832729],"about_ca_topic_score_codex":0.423648,"about_ca_topic_score_gemma":0.89210945,"teacher_disagreement_score":0.46846148,"about_ca_system_score_codex":0.0009801926,"about_ca_system_score_gemma":0.001477134,"threshold_uncertainty_score":0.58019},"labels":[],"label_agreement":null},{"id":"W4403259921","doi":"10.1111/1759-7714.15463","title":"Prophylactic cranial irradiation in patients with resected small‐cell lung cancer: A systematic review and meta‐analysis","year":2024,"lang":"en","type":"review","venue":"Thoracic Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"West China Hospital, Sichuan University; Sichuan University","keywords":"Medicine; Conventional PCI; Prophylactic cranial irradiation; Hazard ratio; Meta-analysis; Internal medicine; Subgroup analysis; Oncology; Chemoradiotherapy; Lung cancer; Confidence interval; Surgery; Gastroenterology; Cancer; Myocardial infarction","score_opus":0.054745677474583754,"score_gpt":0.4321879469504419,"score_spread":0.3774422694758581,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403259921","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000034915814,0.9860674,0.0000029193784,0.00030340115,0.00007459507,0.012996517,0.00035058585,0.00007068002,0.00009895317],"genre_scores_gemma":[0.0002969912,0.98411894,0.00003820907,0.0001344954,0.00009653981,0.013058307,0.000116845586,0.000119900826,0.0020197553],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99591994,0.00061993237,0.0010895247,0.00095158553,0.0008946826,0.00052432297],"domain_scores_gemma":[0.9978767,0.0001650401,0.0006272982,0.0007331254,0.00039491983,0.00020289488],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00071471883,0.0007349587,0.008677717,0.00095314713,0.000077749166,0.00008302391,0.0002096632,0.00019246386,0.00025486556],"category_scores_gemma":[0.00015166511,0.0004091336,0.0008552084,0.0038435885,0.00009328293,0.00010080807,0.0001433446,0.0009256374,0.000016067348],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007555106,0.000062376785,0.00013973529,0.904665,0.091363005,0.000037861777,0.00012086802,0.0000013280063,2.357827e-8,8.446665e-7,0.00017162824,0.0033617637],"study_design_scores_gemma":[0.00028743205,0.0001206321,0.00009934369,0.20026231,0.7968061,0.0000035819664,0.000005873203,0.000018163608,1.0130236e-7,9.090501e-7,0.0020549316,0.000340651],"about_ca_topic_score_codex":0.0016936688,"about_ca_topic_score_gemma":0.0022161065,"teacher_disagreement_score":0.7054431,"about_ca_system_score_codex":0.0018381269,"about_ca_system_score_gemma":0.001463626,"threshold_uncertainty_score":0.999836},"labels":[],"label_agreement":null},{"id":"W4403302105","doi":"10.3390/cancers16203438","title":"Strategies to Target Chemoradiotherapy Resistance in Small Cell Lung Cancer","year":2024,"lang":"en","type":"review","venue":"Cancers","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; Weill Cornell Medical College; Canadian Institutes of Health Research; Cancer Research Society; Memorial Sloan-Kettering Cancer Center","keywords":"Chemoradiotherapy; Lung cancer; Medicine; Resistance (ecology); Oncology; Cancer; Internal medicine; Cancer research; Biology","score_opus":0.05217455957717654,"score_gpt":0.42742310539681266,"score_spread":0.3752485458196361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403302105","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000013532868,0.9754012,0.0000216378,0.00056455395,0.0008220135,0.0027148519,0.00020892767,0.00011513195,0.0201381],"genre_scores_gemma":[0.000008704937,0.9715785,0.0008534949,0.00032478545,0.00085573824,0.0030534386,0.000033329314,0.00018440808,0.023107642],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971589,0.000076193915,0.00058776693,0.0009633161,0.0003979132,0.00081593136],"domain_scores_gemma":[0.9987651,0.00008009207,0.00013226041,0.0006178517,0.000108,0.00029670922],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002651101,0.00065201346,0.0025204925,0.0005268391,0.00005479143,0.000102121005,0.00039150377,0.00024898638,0.00026208998],"category_scores_gemma":[0.00003305788,0.00050068425,0.0004057119,0.0014364462,0.00012361186,0.00006853431,0.00011353004,0.0010096969,0.000062886975],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00023946552,0.000032261138,0.000054919856,0.44129026,0.0015381371,0.0015163947,0.0029515938,0.00010755391,0.000011925036,0.0003708994,0.40471,0.14717658],"study_design_scores_gemma":[0.00042833664,0.0000583652,0.000004580275,0.05078029,0.0007241026,0.000006085164,0.00018407713,0.000011050168,0.000008422382,0.000041447274,0.9473147,0.00043855823],"about_ca_topic_score_codex":0.0012846161,"about_ca_topic_score_gemma":0.004233504,"teacher_disagreement_score":0.5426047,"about_ca_system_score_codex":0.016470391,"about_ca_system_score_gemma":0.013077845,"threshold_uncertainty_score":0.9997445},"labels":[],"label_agreement":null},{"id":"W4403419865","doi":"10.1016/j.jtho.2024.09.379","title":"P1.13A.10 Efficacy and Safety of Lurbinectedin for Small Cell Lung Cancer in a Real-World Setting: Jazz EMERGE 402 Study","year":2024,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec; Southlake Regional Health Center","funders":"","keywords":"Medicine; Jazz; Lung cancer; Oncology; Acoustics","score_opus":0.04138748019909001,"score_gpt":0.49237024254741807,"score_spread":0.45098276234832807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403419865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9755593,0.012685791,0.000051725012,0.0053467206,0.0007756651,0.0015702432,0.000029306688,0.000022286818,0.0039589843],"genre_scores_gemma":[0.99239945,0.002530547,0.0012790941,0.000050859027,0.0005744996,0.00006971952,0.0000018251787,0.00003735524,0.0030566177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99775016,0.0003002893,0.00094762706,0.00027154773,0.00034243806,0.0003879643],"domain_scores_gemma":[0.9976619,0.0012496222,0.00035995184,0.00016599458,0.0003881154,0.00017444944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023402264,0.00018919796,0.000949204,0.000695128,0.000055804885,0.000014502583,0.00014734197,0.00010174956,0.00015263601],"category_scores_gemma":[0.0007060518,0.00014018116,0.00014273201,0.00058478984,0.00009997925,0.000078086116,0.000112543166,0.0006863215,0.0000011365162],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049577214,0.006344879,0.5158027,0.014771683,0.0051808134,0.004409943,0.027155405,0.0003728737,0.022979422,0.00020882895,0.10004827,0.253148],"study_design_scores_gemma":[0.026250927,0.03039337,0.71891874,0.00736183,0.005729807,0.00049457524,0.008091978,0.0030082278,0.007625159,0.0003144469,0.1910182,0.00079275237],"about_ca_topic_score_codex":0.0002536333,"about_ca_topic_score_gemma":0.0033287934,"teacher_disagreement_score":0.25235525,"about_ca_system_score_codex":0.00091401,"about_ca_system_score_gemma":0.0013190489,"threshold_uncertainty_score":0.5716422},"labels":[],"label_agreement":null},{"id":"W4403420098","doi":"10.1016/j.jtho.2024.09.222","title":"MA17.03 30 Years of International Real World Outcomes in Patients with Limited Disease Small Cell Lung Cancer","year":2024,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Lunenfeld-Tanenbaum Research Institute; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Lung cancer; Disease; Lung disease; Intensive care medicine; Oncology; Internal medicine; Lung","score_opus":0.023121765768051753,"score_gpt":0.4367275228555888,"score_spread":0.41360575708753705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403420098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913227,0.001180301,0.000011038377,0.00375213,0.0007952439,0.00024426766,0.000033417735,0.000009533986,0.0026514004],"genre_scores_gemma":[0.9965711,0.00094557967,0.0006464995,0.00015481147,0.00021693925,0.000014161541,0.000005137679,0.000019967683,0.0014258078],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986406,0.00009259083,0.00043937197,0.00014118777,0.00048740287,0.00019887213],"domain_scores_gemma":[0.99892724,0.0002366051,0.00022375816,0.00011271337,0.0003385348,0.00016113713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034429604,0.0001037845,0.00045207003,0.0006135044,0.000012611065,0.00001194331,0.00015516207,0.000043989425,0.00021926561],"category_scores_gemma":[0.00014220821,0.0000724786,0.000105134735,0.00029336588,0.00009054571,0.00009032615,0.000081399114,0.00044653824,0.0000048243683],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033876637,0.0005020575,0.96209645,0.00035662972,0.00049690605,0.00089513254,0.00042375518,0.00006378556,0.00005074775,0.000008271616,0.0022296088,0.029489018],"study_design_scores_gemma":[0.001516971,0.0007486587,0.9889949,0.00072154193,0.00030807793,0.00000472728,0.00006270939,0.00023207263,0.00005335445,0.00001619858,0.007273428,0.000067352],"about_ca_topic_score_codex":0.000119822784,"about_ca_topic_score_gemma":0.00030794073,"teacher_disagreement_score":0.029421667,"about_ca_system_score_codex":0.0010276517,"about_ca_system_score_gemma":0.00092534715,"threshold_uncertainty_score":0.29555914},"labels":[],"label_agreement":null},{"id":"W4403464924","doi":"10.1016/j.jtho.2024.09.1286","title":"EP.13D.12 International Consortium Real-World Outcomes in Extensive Disease Small Cell Lung Cancer Compared to IMPOWER133 And CASPIAN","year":2024,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Medicine; Lung cancer; Disease; Internal medicine; Oncology; Intensive care medicine","score_opus":0.04067733677870837,"score_gpt":0.4912064786779988,"score_spread":0.45052914189929044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403464924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91408545,0.006118595,0.000063173,0.07324481,0.0022005432,0.00053404464,0.00005375055,0.00002052572,0.0036791232],"genre_scores_gemma":[0.9881122,0.0017331305,0.0009278996,0.0018364465,0.0005260647,0.00004223799,0.0000035142093,0.000025146443,0.0067933705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982954,0.00014583662,0.00060272525,0.0002533092,0.00037402948,0.00032866278],"domain_scores_gemma":[0.9984234,0.00038357405,0.00018845302,0.0001421622,0.00038568405,0.00047675337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005758452,0.00017061364,0.0006887043,0.0007493009,0.00004401864,0.000042864292,0.00016307773,0.00005725033,0.00019062532],"category_scores_gemma":[0.00036750454,0.00012785222,0.00012835607,0.0002418481,0.00013379248,0.000112569694,0.0001800072,0.00057392294,0.000007455678],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004949126,0.00037729042,0.9120856,0.0007534795,0.0008640845,0.013110228,0.0026381735,0.00013346913,0.0019292987,0.00007805865,0.04220797,0.0208732],"study_design_scores_gemma":[0.0015348152,0.0006345961,0.9319696,0.001034851,0.00053339376,0.00024764807,0.0007605198,0.0010167295,0.00025479234,0.0001363768,0.06168573,0.00019096198],"about_ca_topic_score_codex":0.00053170143,"about_ca_topic_score_gemma":0.004059654,"teacher_disagreement_score":0.074026756,"about_ca_system_score_codex":0.0016268608,"about_ca_system_score_gemma":0.0011980956,"threshold_uncertainty_score":0.52136624},"labels":[],"label_agreement":null},{"id":"W4403688538","doi":"10.3390/curroncol31110482","title":"Prognostic Factors for Patients with Small-Cell Lung Cancer Treated with Chemoimmunotherapy: A Retrospective Multicenter Study","year":2024,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Chemoimmunotherapy; Medicine; Multicenter study; Lung cancer; Retrospective cohort study; Oncology; Lung; Internal medicine; Cancer; Surgery; Immunotherapy; Randomized controlled trial","score_opus":0.05682987250388637,"score_gpt":0.4117551903969849,"score_spread":0.3549253178930985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403688538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873098,0.004499731,0.00011816055,0.0002081875,0.00042698238,0.0070552174,0.000076665536,0.00013764657,0.00016759985],"genre_scores_gemma":[0.9964199,0.00020424146,0.00010003909,0.000022800456,0.00013714579,0.0026588307,0.000058699818,0.00006529664,0.00033305085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843794,0.00005781766,0.00020419585,0.00054160156,0.00030291738,0.00045553324],"domain_scores_gemma":[0.9988806,0.00024578485,0.00007090394,0.00020888295,0.0004862072,0.00010757945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009916253,0.00027633266,0.0005036782,0.00014919763,0.00010272667,0.00003110501,0.00009638827,0.00005685088,0.0000672203],"category_scores_gemma":[0.000069756556,0.00015695835,0.00006692193,0.0003186667,0.00010863008,0.00006122565,0.0000483277,0.00034325768,0.0000035998985],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027580753,0.0035476014,0.98003244,0.0008271605,0.0011941012,0.000025593894,0.005763091,0.0000011965851,0.000044067605,0.0000022171146,0.000858226,0.0049462323],"study_design_scores_gemma":[0.01524292,0.014249343,0.9556543,0.00067650515,0.00113793,0.0000010484305,0.0011185077,0.00037081252,0.00019038138,0.0000016556568,0.0111226365,0.00023390986],"about_ca_topic_score_codex":0.0001133013,"about_ca_topic_score_gemma":0.00025023473,"teacher_disagreement_score":0.024378087,"about_ca_system_score_codex":0.0015530706,"about_ca_system_score_gemma":0.00044620477,"threshold_uncertainty_score":0.6400576},"labels":[],"label_agreement":null},{"id":"W4403812934","doi":"10.1093/eurheartj/ehae666.3038","title":"Treatment of Post-COVID-19 POTS by inhibiting FcRn: a phase 2 randomized, placebo controlled, double-blind, proof of concept study with efgartigimod","year":2024,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary","funders":"","keywords":"Medicine; Coronavirus disease 2019 (COVID-19); Placebo; Double blind; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Randomized controlled trial; Proof of concept; Internal medicine; Virology; Pharmacology; Pathology; Disease","score_opus":0.06484357411088452,"score_gpt":0.40801393386563733,"score_spread":0.3431703597547528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403812934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96743447,0.015122193,0.00055083464,0.0056178663,0.00015740357,0.007264264,0.000055606342,0.00007202545,0.003725316],"genre_scores_gemma":[0.9976079,0.00014903914,0.00014746262,0.00016631022,0.00042596806,0.00011347272,0.0000103088905,0.00006949558,0.0013100365],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99611074,0.0011885582,0.00096341927,0.0003646364,0.0009416725,0.000430953],"domain_scores_gemma":[0.99774426,0.00079418306,0.00030607719,0.00024471566,0.00040691477,0.0005038338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023727582,0.0003172987,0.0015875644,0.00033498104,0.00018899744,0.00009169962,0.00011010613,0.000026935657,0.00018741982],"category_scores_gemma":[0.00057244295,0.00018043429,0.00041215104,0.00030903582,0.00040137873,0.00013541947,0.000061817,0.00039877792,0.000011004808],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96583444,0.0027656301,0.0012039033,0.00032525888,0.0036771004,0.002717461,0.011728492,0.00009306754,0.004084908,0.000017039616,0.0046939207,0.002858764],"study_design_scores_gemma":[0.9586175,0.01981408,0.000025390393,0.0005993423,0.0010177423,0.001534744,0.00321214,0.00019782048,0.010531425,0.0000041442177,0.0042733327,0.00017234095],"about_ca_topic_score_codex":0.000075099764,"about_ca_topic_score_gemma":0.000009503214,"teacher_disagreement_score":0.030173415,"about_ca_system_score_codex":0.00032906246,"about_ca_system_score_gemma":0.0009233567,"threshold_uncertainty_score":0.7357897},"labels":[],"label_agreement":null},{"id":"W4404059690","doi":"10.3390/curroncol31110501","title":"Current Radiotherapy Management of Extensive-Stage Small-Cell Lung Cancer in the Immunotherapy Era: An Italian National Survey on Behalf of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)","year":2024,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Radiation therapy; Oncology; Clinical Oncology; Lung cancer; Internal medicine; Immunotherapy; Stage (stratigraphy); Radiation oncology; Family medicine; Cancer; Medical physics; Intensive care medicine","score_opus":0.14185551874276126,"score_gpt":0.5144830345141657,"score_spread":0.3726275157714044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404059690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9131732,0.075938046,0.0000644522,0.005444059,0.0024798468,0.0019804123,0.00034043594,0.000016792166,0.00056275335],"genre_scores_gemma":[0.9071707,0.091433965,0.00014029589,0.00029669103,0.0003365513,0.00021095856,0.0000515259,0.00003958234,0.0003197445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99597687,0.0016118635,0.0009155556,0.0004338505,0.0007336066,0.00032827206],"domain_scores_gemma":[0.99714124,0.0014970253,0.0004967955,0.00036031473,0.00043929138,0.000065331384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039055375,0.00022521055,0.0008145254,0.00022745044,0.00006223864,0.000012388017,0.0003449137,0.000175437,0.00009175441],"category_scores_gemma":[0.00015201743,0.00014109323,0.00022075642,0.00050099083,0.00041228445,0.000061364575,0.00006896142,0.0007242836,5.8187453e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017139015,0.0041172877,0.7091526,0.001435068,0.0016091713,0.00001820557,0.0054248646,0.00006634916,0.0009809851,0.0012253666,0.010302918,0.2639533],"study_design_scores_gemma":[0.0054390742,0.0024379864,0.9337378,0.00063628785,0.00016199917,0.0000031491277,0.0004632183,0.0012551893,0.00015194132,0.000060955124,0.055514008,0.00013839242],"about_ca_topic_score_codex":0.00037309516,"about_ca_topic_score_gemma":0.0013319465,"teacher_disagreement_score":0.2638149,"about_ca_system_score_codex":0.0019649253,"about_ca_system_score_gemma":0.00092252606,"threshold_uncertainty_score":0.5753615},"labels":[],"label_agreement":null},{"id":"W4404559853","doi":"10.1200/op-24-00840","title":"Systemic Therapy for Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update Clinical Insights","year":2024,"lang":"en","type":"article","venue":"JCO Oncology Practice","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Regional Hospital; Western University","funders":"","keywords":"Guideline; Lung cancer; Medicine; Systemic therapy; Intensive care medicine; Oncology; Medical physics; Clinical Oncology; Internal medicine; Cancer; Pathology; Breast cancer","score_opus":0.09883768673068831,"score_gpt":0.5222914815626931,"score_spread":0.4234537948320048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404559853","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05357265,0.23060298,0.012568356,0.62556654,0.0133101735,0.009998851,0.00016788318,0.00088134076,0.053331237],"genre_scores_gemma":[0.26143223,0.61246973,0.041098673,0.057453837,0.012405044,0.004642899,0.000750923,0.00029628642,0.009450408],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99704546,0.00072152354,0.0009549586,0.00063101645,0.00023557105,0.0004114808],"domain_scores_gemma":[0.99357396,0.0047964365,0.0003311952,0.0003493888,0.00076915993,0.00017983708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033895131,0.0002241084,0.00062638463,0.00017896671,0.00019566325,0.000054561842,0.00017012686,0.00028924664,0.00026811883],"category_scores_gemma":[0.0019978913,0.00017112751,0.0001935687,0.00028954813,0.00011681238,0.00034697246,0.0001104048,0.0008363471,0.00009704147],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039250213,0.00061363284,0.0008940337,0.0008117901,0.0013901046,0.00016976304,0.000673064,0.000008407625,0.0010628286,0.0003140589,0.66526365,0.32487366],"study_design_scores_gemma":[0.0042231577,0.002036441,0.0001621046,0.00020130594,0.00067631167,0.00014386937,0.0005213565,0.004273587,0.00041238125,0.000045624696,0.9871378,0.00016609445],"about_ca_topic_score_codex":0.00022114246,"about_ca_topic_score_gemma":0.00008958615,"teacher_disagreement_score":0.5681127,"about_ca_system_score_codex":0.0010752877,"about_ca_system_score_gemma":0.0019680918,"threshold_uncertainty_score":0.69783777},"labels":[],"label_agreement":null},{"id":"W4404595681","doi":"10.1038/s41590-024-02014-5","title":"A STAT3–STING–IFN axis controls the metastatic spread of small cell lung cancer","year":2024,"lang":"en","type":"article","venue":"Nature Immunology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"Cancer Council Victoria; Victorian Cancer Agency","keywords":"STAT3; STAT protein; Cancer research; Stimulator of interferon genes; Interferon; Biology; Immune system; Metastasis; Immunotherapy; Sting; Innate immune system; Signal transduction; Immunology; Medicine; Cancer; Cell biology","score_opus":0.014727437349149164,"score_gpt":0.3590550363570377,"score_spread":0.34432759900788856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404595681","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26896748,0.7057909,0.00017443323,0.016661284,0.0013736775,0.0013899668,0.00015218518,0.0001366906,0.005353428],"genre_scores_gemma":[0.9910956,0.0038128328,0.0003217244,0.00061479374,0.00017003132,0.00023646856,0.000011890873,0.00003482073,0.003701841],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985384,0.00014772892,0.00028865674,0.0003079866,0.00027824508,0.00043898766],"domain_scores_gemma":[0.9982691,0.0009457107,0.00007954022,0.0004062819,0.0002573097,0.000042049975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039019957,0.00018732625,0.00049356895,0.00015958857,0.00007672506,0.000019390276,0.0002418981,0.00017917009,0.00022205782],"category_scores_gemma":[0.00052615785,0.00010794176,0.0001469852,0.0003915308,0.0003501905,0.00004020772,0.00015091832,0.0015455532,0.000018112907],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054663657,0.0008106253,0.020258114,0.012576225,0.02680762,0.0018863848,0.018134555,0.000103622646,0.62724733,0.013244113,0.1612376,0.11222743],"study_design_scores_gemma":[0.01755462,0.0043726163,0.08582801,0.004859524,0.007088888,0.00060515944,0.0047468236,0.0061002416,0.15315376,0.0030364816,0.711387,0.0012668719],"about_ca_topic_score_codex":0.00076979696,"about_ca_topic_score_gemma":0.0002733938,"teacher_disagreement_score":0.72212815,"about_ca_system_score_codex":0.00020760577,"about_ca_system_score_gemma":0.00052737177,"threshold_uncertainty_score":0.6714746},"labels":[],"label_agreement":null},{"id":"W4404722329","doi":"10.3390/diagnostics14232660","title":"Novel Immunohistochemical Profiling of Small-Cell Lung Cancer: Correlations Between Tumor Subtypes and Immune Microenvironment","year":2024,"lang":"en","type":"article","venue":"Diagnostics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Immunohistochemistry; Tumor-infiltrating lymphocytes; Tumor microenvironment; CD8; Malignancy; Lung cancer; Immune system; Oncology; Cancer research; Immunotherapy; Biology; Medicine; Internal medicine; Immunology","score_opus":0.017461678260209675,"score_gpt":0.30987438428550007,"score_spread":0.2924127060252904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404722329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8766662,0.119717956,0.0011929058,0.0008567638,0.0001876256,0.000692313,0.0002358833,0.000045592962,0.00040474877],"genre_scores_gemma":[0.98882943,0.007253375,0.003153423,0.000039476217,0.00018269358,0.00011837804,0.00007263721,0.000033280336,0.00031732704],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99906826,0.000010958834,0.0002729168,0.00022736595,0.00020028143,0.0002202356],"domain_scores_gemma":[0.99891084,0.00072341156,0.00004790993,0.00018353273,0.00005348735,0.00008083367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011669587,0.00012976435,0.0002807096,0.00007825943,0.00006120877,0.000014702553,0.000067371824,0.00004637108,0.000026288979],"category_scores_gemma":[0.00030671046,0.00011495749,0.000058218215,0.00013353518,0.0001904406,0.000028061922,0.00014170952,0.000276931,0.0000062883832],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005499472,0.0002061395,0.6224053,0.0029282866,0.0004950251,0.000058319707,0.00095310906,0.000042487805,0.36903664,0.00027646564,0.002158412,0.0013848502],"study_design_scores_gemma":[0.0024503076,0.0004192194,0.44877893,0.0035894606,0.0021330423,0.000040916322,0.00040712586,0.0043909736,0.5334801,0.00008811314,0.003757889,0.0004639398],"about_ca_topic_score_codex":0.00019088793,"about_ca_topic_score_gemma":0.000003956853,"teacher_disagreement_score":0.17362635,"about_ca_system_score_codex":0.00023212757,"about_ca_system_score_gemma":0.00016696265,"threshold_uncertainty_score":0.46878305},"labels":[],"label_agreement":null},{"id":"W4404939528","doi":"","title":"Immune Checkpoint Inhibitors for the Treatment of Unresectable Stage III Non&ndash;Small Cell Lung Cancer: Emerging Mechanisms and Perspectives","year":2020,"lang":"en","type":"article","venue":"DOAJ (DOAJ: Directory of Open Access Journals)","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Stage (stratigraphy); Lung cancer; Immune system; Cancer research; Cancer; Medicine; Oncology; Immunology; Internal medicine; Biology","score_opus":0.19703219933805025,"score_gpt":0.5301286365175516,"score_spread":0.3330964371795013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404939528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7323811,0.25757492,0.0014199382,0.003721823,0.00029276888,0.0034024317,0.00014314684,0.00003064114,0.0010332346],"genre_scores_gemma":[0.8567436,0.14100336,0.00034691143,0.000088916095,0.00029601762,0.0004208043,0.000004977277,0.00006409447,0.0010313642],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99743396,0.00010470248,0.0007870481,0.0005168692,0.00065220974,0.00050523115],"domain_scores_gemma":[0.99763143,0.00046252058,0.0006752573,0.0003871634,0.0005358181,0.00030783948],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007727147,0.0003656792,0.0011521573,0.00031190473,0.00041088165,0.00026997487,0.000808082,0.000069339876,0.0016839422],"category_scores_gemma":[0.00022839574,0.00024363057,0.00033063552,0.00066357205,0.00021867789,0.00051325874,0.0006068582,0.00029017281,6.924957e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003436854,0.00077944243,0.088234805,0.0019983328,0.0028397967,0.000050119983,0.021282958,0.00046326153,0.86484355,0.0000869174,0.006345044,0.009638935],"study_design_scores_gemma":[0.0073246993,0.00053453137,0.08185342,0.0010181135,0.0009798537,0.000004934345,0.012450874,0.0025596116,0.88496584,0.00024015989,0.0076089823,0.00045896435],"about_ca_topic_score_codex":0.0055276453,"about_ca_topic_score_gemma":0.00017349422,"teacher_disagreement_score":0.12436247,"about_ca_system_score_codex":0.00045068457,"about_ca_system_score_gemma":0.00040448585,"threshold_uncertainty_score":0.99922866},"labels":[],"label_agreement":null},{"id":"W4404984759","doi":"10.1007/s00259-024-07011-2","title":"Preclinical safety and effectiveness of a long-acting somatostatin analogue [225Ac]Ac-EBTATE against small cell lung cancer and pancreatic neuroendocrine tumors","year":2024,"lang":"en","type":"article","venue":"European Journal of Nuclear Medicine and Molecular Imaging","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal University Hospital; Université Laval; University of Saskatchewan","funders":"","keywords":"Biodistribution; Medicine; Somatostatin receptor 2; Pharmacokinetics; Somatostatin receptor; Neuroendocrine tumors; Internal medicine; Radionuclide therapy; Somatostatin; Radioligand; Octreotide; Endocrinology; Pharmacology; Receptor; Biology; In vivo","score_opus":0.016936122211568046,"score_gpt":0.3281207674784843,"score_spread":0.31118464526691625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404984759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94906485,0.043754213,0.0005754317,0.0048941667,0.00011905326,0.0002788238,0.0000057804546,0.000024570028,0.0012831014],"genre_scores_gemma":[0.9873297,0.011205788,0.00037697292,0.00085141254,0.0001450419,0.0000010397493,0.0000025597358,0.00007452429,0.000012943682],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99793,0.0005731311,0.0006149234,0.0002933825,0.00031610965,0.00027249032],"domain_scores_gemma":[0.99874175,0.00045963892,0.00021963971,0.0001337011,0.00016345785,0.000281836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014600367,0.00021308297,0.0006431233,0.00026041872,0.00008429807,0.000039521354,0.000080768856,0.000008608931,0.000008270292],"category_scores_gemma":[0.0006302524,0.00015489657,0.00007860892,0.00018352219,0.00038031684,0.000106251384,0.00017075155,0.00053939666,4.948232e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047305785,0.0002187314,0.20099354,0.030334333,0.0023665817,0.121999666,0.01178273,0.000086366315,0.4426928,0.000106868065,0.002168606,0.18251923],"study_design_scores_gemma":[0.02994296,0.006370461,0.79491085,0.090210676,0.005613025,0.016194291,0.007899732,0.021284593,0.009350825,0.000060026883,0.017006276,0.0011562731],"about_ca_topic_score_codex":0.0000397113,"about_ca_topic_score_gemma":0.0000012176276,"teacher_disagreement_score":0.5939173,"about_ca_system_score_codex":0.000045394398,"about_ca_system_score_gemma":0.00008749952,"threshold_uncertainty_score":0.63164985},"labels":[],"label_agreement":null},{"id":"W4405333204","doi":"10.1007/s12022-024-09844-x","title":"Insights into Biologic Evolution of Grade 3 Neuroendocrine Tumors Reflect Classification Challenges","year":2024,"lang":"en","type":"editorial","venue":"Endocrine Pathology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Neuroendocrine tumors; Medicine; Biology; Computational biology; Pathology; Oncology","score_opus":0.046479539844225044,"score_gpt":0.380929945337969,"score_spread":0.33445040549374394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405333204","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018715605,0.19789243,0.000046223086,0.009893916,0.76436937,0.0018632659,0.00014919465,0.000649582,0.0064204223],"genre_scores_gemma":[0.42168498,0.06824428,0.00034632167,0.00004191305,0.5048577,0.00074823806,0.0008828181,0.00018938436,0.0030043588],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958018,0.0004783293,0.00087012426,0.0012728979,0.0008953229,0.00068154867],"domain_scores_gemma":[0.997137,0.00077752833,0.00037102398,0.0009782215,0.00057394133,0.00016226228],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002172629,0.00058810244,0.001445771,0.001038138,0.00009488424,0.000013169234,0.0003944286,0.00027817648,0.00003135318],"category_scores_gemma":[0.0036246937,0.00045692854,0.00030512793,0.00053575746,0.00063367694,0.00006964355,0.0005263091,0.0019816598,0.00015667334],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005376356,0.0003520761,0.00014344834,0.0050724093,0.00040533964,0.0060232896,0.00054932956,0.000001765964,0.03049936,0.0044255685,0.9486848,0.0033049553],"study_design_scores_gemma":[0.0015565862,0.0033446746,0.0025250518,0.0007011486,0.00042979213,0.00043326712,0.000295294,0.000039149814,0.002377435,0.0065699187,0.98131984,0.00040780896],"about_ca_topic_score_codex":0.00016001191,"about_ca_topic_score_gemma":0.00018072975,"teacher_disagreement_score":0.40296936,"about_ca_system_score_codex":0.00093183905,"about_ca_system_score_gemma":0.00078244705,"threshold_uncertainty_score":0.9997882},"labels":[],"label_agreement":null},{"id":"W4405740627","doi":"10.1093/neuonc/noae271","title":"Hippocampal avoidance prophylactic cranial irradiation (HA-PCI) for small-cell lung cancer better preserves white matter networks compared to conventional PCI","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"KWF Kankerbestrijding; Vlaamse regering; Vlaamse Liga Tegen Kanker; Fonds NutsOhra","keywords":"Conventional PCI; Prophylactic cranial irradiation; Hippocampal formation; Neurocognitive; White matter; Hippocampus; Medicine; Neuropsychology; Neuroscience; Cardiology; Internal medicine; Cognition; Psychology; Radiology; Magnetic resonance imaging","score_opus":0.029815567915925222,"score_gpt":0.35491882690403387,"score_spread":0.32510325898810866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405740627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85036093,0.006829117,0.006233015,0.11865244,0.0065295417,0.007576598,0.00022106242,0.00034109314,0.0032562292],"genre_scores_gemma":[0.9809607,0.00014388683,0.0012760207,0.009304821,0.003193489,0.0028809963,0.0000823862,0.00009865311,0.0020589994],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99747634,0.0002293911,0.00045575792,0.00072940305,0.00038374934,0.000725383],"domain_scores_gemma":[0.9983215,0.00073183514,0.00010461524,0.0003084004,0.00027196825,0.0002617278],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032671876,0.00028896655,0.0005589748,0.00020815432,0.00017791968,0.00009016949,0.00022154597,0.00015410842,0.00077643665],"category_scores_gemma":[0.00013581103,0.00025586772,0.00019019237,0.0003152629,0.00013853975,0.0001478232,0.00017021822,0.0006232006,0.00012241155],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004692327,0.00046368176,0.24745142,0.004074461,0.00056824525,0.00041026963,0.0016764016,0.0033627623,0.0412689,0.000062975574,0.68780106,0.008167471],"study_design_scores_gemma":[0.012386344,0.0040051728,0.17932059,0.0006076754,0.0012049216,0.00026926378,0.00016493688,0.12226855,0.0018232228,0.00029747214,0.6767208,0.00093106495],"about_ca_topic_score_codex":0.000086510176,"about_ca_topic_score_gemma":0.00027181153,"teacher_disagreement_score":0.13059984,"about_ca_system_score_codex":0.00083166885,"about_ca_system_score_gemma":0.00069312326,"threshold_uncertainty_score":0.99998933},"labels":[],"label_agreement":null},{"id":"W4406061941","doi":"10.1016/j.lungcan.2025.108080","title":"Assessing the feasibility and external validity of natural language processing-extracted data for advanced lung cancer patients","year":2025,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); University Health Network; Systems, Applications & Products in Data Processing (Canada); Princess Margaret Cancer Centre","funders":"Princess Margaret Cancer Foundation; F. Hoffmann-La Roche","keywords":"Medicine; Lung cancer; Intensive care medicine; Natural language processing; Medical physics; Oncology; Computer science","score_opus":0.060318550680282884,"score_gpt":0.48930471986458773,"score_spread":0.4289861691843049,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406061941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9102039,0.084753,0.00048598665,0.0016038824,0.000538203,0.0017913503,0.00038116908,0.000042607386,0.00019991903],"genre_scores_gemma":[0.9970297,0.0007677796,0.0005521806,0.00032673802,0.00018571911,0.00031743725,0.00007119414,0.000019884073,0.0007293359],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983646,0.000069648595,0.00030835462,0.0005007716,0.00041070647,0.00034590694],"domain_scores_gemma":[0.9984044,0.00026085906,0.00018406459,0.00059552136,0.00049080857,0.000064346736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000422873,0.00018212409,0.0003801832,0.00006267449,0.00023388612,0.00006956852,0.00031573218,0.00005809402,0.000028739798],"category_scores_gemma":[0.0007006282,0.00011848507,0.00005560672,0.00028561743,0.00021656347,0.00044274013,0.00033321508,0.00031369456,6.276658e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054690783,0.00014104813,0.90096164,0.004004566,0.0002499328,0.0000022703546,0.0007247851,0.000007969536,0.0058593396,0.000009175076,0.0051359693,0.08235639],"study_design_scores_gemma":[0.0040284735,0.000071977454,0.9661036,0.0025257003,0.00061331375,9.793739e-7,0.0003730268,0.021822453,0.0031057585,0.000023850645,0.0011542356,0.00017660994],"about_ca_topic_score_codex":0.0007290661,"about_ca_topic_score_gemma":0.00064984005,"teacher_disagreement_score":0.08682585,"about_ca_system_score_codex":0.0005356801,"about_ca_system_score_gemma":0.0006971786,"threshold_uncertainty_score":0.4831681},"labels":[],"label_agreement":null},{"id":"W4406135453","doi":"10.1016/j.ctro.2025.100917","title":"Real-world outcomes of prophylactic cranial irradiation utilization and efficacy for patients with extensive-stage small cell lung cancer treated with consolidative thoracic radiotherapy","year":2025,"lang":"en","type":"article","venue":"Clinical and Translational Radiation Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"National Center for Advancing Translational Sciences; Canadian Institutes of Health Research; Weill Cornell Medical College; Terry Fox Research Institute; Canada Foundation for Innovation; Princess Margaret Cancer Foundation; National Cancer Institute; National Institutes of Health; Memorial Sloan-Kettering Cancer Center","keywords":"Conventional PCI; Prophylactic cranial irradiation; Medicine; Cumulative incidence; Incidence (geometry); Proportional hazards model; Hazard ratio; Internal medicine; Randomized controlled trial; Radiation therapy; Radiology; Surgery; Oncology; Confidence interval; Myocardial infarction; Transplantation","score_opus":0.05676862559185449,"score_gpt":0.4621101044452192,"score_spread":0.40534147885336475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406135453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99046135,0.0008687409,0.0025515298,0.0030096637,0.00007051798,0.0024752624,0.00013885845,0.000022617123,0.00040146353],"genre_scores_gemma":[0.99512035,0.0015084085,0.0021813984,0.0002703886,0.000059543443,0.00017840712,0.00018846725,0.000015107156,0.0004779058],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987548,0.00015039052,0.00044791872,0.0003258884,0.00017099167,0.00015000755],"domain_scores_gemma":[0.9972455,0.0018081395,0.00023175078,0.00008884081,0.0005410651,0.00008470127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022433358,0.00014825613,0.00052464695,0.00018283866,0.00011399589,0.000010377469,0.00003054208,0.00010269212,0.000020414838],"category_scores_gemma":[0.00015335233,0.00010141046,0.000049504833,0.00026539815,0.00035833422,0.00008679739,0.0000057175957,0.00013577752,1.1937021e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008117657,0.00054374186,0.948473,0.0003276558,0.000449599,0.0000013862852,0.0003113741,0.000097664364,0.00002529847,0.00058472157,0.00003857862,0.04102935],"study_design_scores_gemma":[0.016147383,0.0018754133,0.97593784,0.00006605119,0.00046939013,3.2218102e-7,0.000026303103,0.00401018,0.000065174674,0.000056662095,0.0012490065,0.00009626247],"about_ca_topic_score_codex":0.00008195749,"about_ca_topic_score_gemma":0.00023578845,"teacher_disagreement_score":0.040933087,"about_ca_system_score_codex":0.0000837386,"about_ca_system_score_gemma":0.00061714253,"threshold_uncertainty_score":0.41353983},"labels":[],"label_agreement":null},{"id":"W4406400630","doi":"10.3390/cancers17020260","title":"Neuroendocrine Transformation as a Mechanism of Resistance to Targeted Lung Cancer Therapies: Emerging Mechanisms and Their Therapeutic Implications","year":2025,"lang":"en","type":"review","venue":"Cancers","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital Research Institute of Manitoba; University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"Canadian Institutes of Health Research; CancerCare Manitoba Foundation","keywords":"Lung cancer; Medicine; Mechanism (biology); Targeted therapy; Cancer; Oncology; Treatment of lung cancer; Bioinformatics; Internal medicine; Biology","score_opus":0.03350607489971705,"score_gpt":0.39180885245938524,"score_spread":0.3583027775596682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406400630","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000012948727,0.9873121,0.0041361484,0.003106438,0.00024717208,0.0037165284,0.00041171565,0.00008226361,0.0009747034],"genre_scores_gemma":[0.0013726864,0.9932824,0.00017003779,0.00063548837,0.000067819405,0.003107036,0.0000508811,0.00006564741,0.0012480286],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979487,0.00011801603,0.00062249345,0.00055018795,0.00029684362,0.00046377143],"domain_scores_gemma":[0.9985838,0.00020211814,0.00024945335,0.0005427086,0.00024690726,0.00017503109],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001659917,0.00047660124,0.0016106657,0.0004779575,0.00017858054,0.000023061066,0.00026650773,0.00008213793,0.00008484132],"category_scores_gemma":[0.00007406334,0.00035223595,0.00030082779,0.0010487904,0.00008604966,0.000085602165,0.000079697376,0.0003669138,0.0000017576688],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018065739,0.000021186182,0.0000021206079,0.08607122,0.0025321632,0.000007227482,0.0036177763,0.000012585975,0.0005624432,0.020944726,0.0017814259,0.8842665],"study_design_scores_gemma":[0.00087820453,0.00022689799,0.0000112349,0.03549052,0.0019112779,0.000019978948,0.0008476616,0.00005758428,0.0007369677,0.002415567,0.9569197,0.000484366],"about_ca_topic_score_codex":0.0002705096,"about_ca_topic_score_gemma":0.00023118922,"teacher_disagreement_score":0.9551383,"about_ca_system_score_codex":0.001890582,"about_ca_system_score_gemma":0.002826344,"threshold_uncertainty_score":0.99989295},"labels":[],"label_agreement":null},{"id":"W4406554841","doi":"10.1016/s1634-6939(18)75846-8","title":"10.1016/s1634-6939(18)75846-8","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.014862781422329267,"score_gpt":0.26855525853075324,"score_spread":0.25369247710842396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406554841","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00070310454,0.00045066333,2.896467e-7,0.002532589,0.0000015852017,0.00045231218,0.000014404228,0.0001614748,0.99568355],"genre_scores_gemma":[0.0003181055,0.000003843382,0.000104626626,0.00015028616,0.0003406174,0.00006657977,0.000012279735,0.000032714273,0.9989709],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99867636,0.000032295196,0.0001638887,0.00027375665,0.00042857914,0.00042511977],"domain_scores_gemma":[0.9991415,0.000060145187,0.000016427688,0.00039558907,0.00009622014,0.00029007994],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00017142194,0.00014897941,0.00027809342,0.00009552446,0.00008722468,0.000021065363,0.0001425735,0.00005060608,0.9985221],"category_scores_gemma":[0.00013699733,0.00012372616,0.0000759461,0.0002797117,0.000079219506,0.000057391055,0.00007380812,0.00019259375,0.9950216],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027374807,0.00005397906,0.0000014107558,0.000028163075,0.000068320725,0.000033861623,0.000029231793,0.000003865707,0.00009327246,2.3138918e-7,0.6972757,0.3021382],"study_design_scores_gemma":[0.00080520357,0.00050399813,0.0003285821,0.00007275985,0.00004637247,0.000021945378,0.0000025604406,0.000040697985,0.00024079354,0.0000048134466,0.9978005,0.00013172202],"about_ca_topic_score_codex":0.00006468694,"about_ca_topic_score_gemma":4.3391393e-7,"teacher_disagreement_score":0.30200648,"about_ca_system_score_codex":0.0001529118,"about_ca_system_score_gemma":0.0000925592,"threshold_uncertainty_score":0.5045406},"labels":[],"label_agreement":null},{"id":"W4406583287","doi":"10.1016/s1155-195x(20)30207-3","title":"10.1016/s1155-195x(20)30207-3","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Oncology","score_opus":0.010257737401582204,"score_gpt":0.2525233760039636,"score_spread":0.24226563860238137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406583287","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00078462256,0.0004387806,2.7730388e-7,0.0035598387,0.0000015279282,0.00045758195,0.00001740656,0.00016523858,0.9945747],"genre_scores_gemma":[0.0002812397,0.0000032177963,0.0000973308,0.00016188135,0.00034526453,0.00006624556,0.000016122012,0.00003254642,0.99899614],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986872,0.00003039211,0.000163752,0.0002741399,0.00042050783,0.00042402686],"domain_scores_gemma":[0.9991555,0.000060032722,0.00001646525,0.00039230677,0.000095555646,0.00028010964],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00016565058,0.00014685768,0.00027772487,0.00009451957,0.000087795044,0.000021156844,0.00014509555,0.0000489943,0.9975204],"category_scores_gemma":[0.00012705092,0.00012322556,0.00007499214,0.0002752641,0.000076076285,0.000060961414,0.0000754331,0.0001849895,0.9952975],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031003382,0.00005542198,0.0000014234678,0.000030271163,0.00007113445,0.000036674108,0.000037271468,0.0000050787985,0.00012668564,3.1046392e-7,0.66201735,0.33730838],"study_design_scores_gemma":[0.0007819668,0.0005055412,0.00024634908,0.00007267599,0.000046110927,0.00002200562,0.000002680022,0.00004053476,0.00023864766,0.0000049332066,0.99790734,0.00013122703],"about_ca_topic_score_codex":0.000052866188,"about_ca_topic_score_gemma":6.9225393e-7,"teacher_disagreement_score":0.33717716,"about_ca_system_score_codex":0.00015432156,"about_ca_system_score_gemma":0.00010019043,"threshold_uncertainty_score":0.5024993},"labels":[],"label_agreement":null},{"id":"W4406738245","doi":"10.1016/s1052-3359(25)00558-7","title":"Small-Cell Lung Cancer","year":2001,"lang":"en","type":"article","venue":"Chest Surgery Clinics of North America","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Medicine; Lung cancer; Cancer; Oncology; Internal medicine","score_opus":0.06512340970010452,"score_gpt":0.3656849645134011,"score_spread":0.3005615548132966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406738245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865847,0.0072018076,0.00009288194,0.002015884,0.00037846284,0.00035390336,0.000033673292,0.00007518517,0.0032634775],"genre_scores_gemma":[0.9485187,0.04672112,0.0004462078,0.001362309,0.00041326298,0.00010406121,0.000048173093,0.000050314782,0.0023358394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99803096,0.000051512798,0.00062756136,0.00036489943,0.00041898727,0.00050606887],"domain_scores_gemma":[0.99731517,0.0012214525,0.00031797108,0.0005209928,0.0003466603,0.000277744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030632512,0.00020400283,0.0008278818,0.00017055066,0.00007287673,0.000007968274,0.00014700131,0.000058926165,0.00028460438],"category_scores_gemma":[0.00075748604,0.0001777756,0.00032843807,0.0007187486,0.00033085077,0.000059077152,0.00011763411,0.00032590574,0.000041435513],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023244874,0.0002566642,0.89133066,0.0004347016,0.00018180745,0.00010402577,0.00012083627,0.000027157957,0.000024717812,3.3211626e-7,0.01950336,0.08778327],"study_design_scores_gemma":[0.00060011406,0.00014223655,0.7556282,0.00020263068,0.00020364723,0.000008768574,0.0000778675,0.00022787707,0.00020728116,0.0000043235827,0.24246544,0.000231599],"about_ca_topic_score_codex":0.00045380872,"about_ca_topic_score_gemma":0.00014515482,"teacher_disagreement_score":0.22296208,"about_ca_system_score_codex":0.00011777443,"about_ca_system_score_gemma":0.0007798391,"threshold_uncertainty_score":0.72494787},"labels":[],"label_agreement":null},{"id":"W4406787938","doi":"10.1016/j.jtho.2025.01.013","title":"The International Association for the Study of Lung Cancer Staging Project: The Database and Proposal for the Revision of the Staging of Pulmonary Neuroendocrine Carcinoma in the Forthcoming Ninth Edition of the TNM Classification for Lung Cancer","year":2025,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"International Association for the Study of Lung Cancer; Sanofi; AstraZeneca","keywords":"Medicine; Ninth; Neuroendocrine carcinoma; Lung cancer staging; Lung cancer; Oncology; General surgery; Carcinoma; Internal medicine","score_opus":0.04515490801387808,"score_gpt":0.4892663703647838,"score_spread":0.44411146235090576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406787938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.818698,0.0063066096,0.0015889723,0.16070539,0.0018248963,0.010521217,0.00027032223,0.0000036465692,0.00008095659],"genre_scores_gemma":[0.9969486,0.0015338723,0.00009787371,0.00021579956,0.00040137733,0.0006302492,0.0000038394696,0.000013849974,0.00015452578],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973908,0.00058828836,0.000891769,0.00017119144,0.0007225324,0.00023538971],"domain_scores_gemma":[0.99042964,0.006075024,0.0018993824,0.00040044743,0.0011812736,0.000014261084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048487713,0.00013420156,0.00039472253,0.00011862174,0.000553312,0.000025384144,0.00077256555,0.00003493864,0.0000021496592],"category_scores_gemma":[0.002378751,0.000046382243,0.00018919441,0.00039524658,0.00027613447,0.00013773417,0.00027078684,0.0004866378,3.4231158e-9],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009494308,0.0008602192,0.8231345,0.0025860323,0.0022111302,0.0000034480568,0.012559165,0.0010317647,0.009320285,0.0013704157,0.022473825,0.114954956],"study_design_scores_gemma":[0.0050818133,0.0014597244,0.7457052,0.0024624555,0.004171706,0.00003745501,0.0583719,0.16145973,0.007778577,0.0005398878,0.012784671,0.00014688143],"about_ca_topic_score_codex":0.0005382042,"about_ca_topic_score_gemma":0.0010788507,"teacher_disagreement_score":0.17825063,"about_ca_system_score_codex":0.0006728671,"about_ca_system_score_gemma":0.0012968669,"threshold_uncertainty_score":0.4255685},"labels":[],"label_agreement":null},{"id":"W4406809476","doi":"10.21037/tcr-24-1711","title":"On the precipice of a new generation of biomarkers for immunotherapy in small cell lung cancer","year":2025,"lang":"en","type":"letter","venue":"Translational Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Immunotherapy; Lung cancer; Medicine; Cancer; Cancer immunotherapy; Oncology; Cancer research; Immunology; Internal medicine","score_opus":0.18517779788675498,"score_gpt":0.4655473992923152,"score_spread":0.2803696014055602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406809476","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016418336,0.034144893,0.0004849867,0.9376268,0.0002939894,0.0068863113,0.0011888044,0.000013765,0.002942132],"genre_scores_gemma":[0.26216236,0.098893695,0.0067465124,0.35606074,0.02764796,0.050756775,0.004540449,0.0010487967,0.1921427],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966627,0.00031826177,0.0005707658,0.000479381,0.0014350953,0.00053379964],"domain_scores_gemma":[0.99614567,0.002255514,0.00014310771,0.00043399658,0.0009754136,0.000046284895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013017217,0.00024347045,0.0005635801,0.00076248293,0.000112324495,0.00001758128,0.0003904182,0.00033036066,0.0006220244],"category_scores_gemma":[0.000146864,0.00017710234,0.00023449694,0.0009203055,0.00027154616,0.000040829495,0.000032148826,0.0014591212,8.0435353e-7],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029579657,0.00009002031,0.0018012237,0.004034017,0.0008803392,0.0000050184226,0.0012113787,0.00042321644,0.009960026,0.00029221785,0.97232854,0.0060160398],"study_design_scores_gemma":[0.020993812,0.0019484645,0.013917473,0.011776837,0.00058723777,0.0000019315855,0.00018199866,0.008582942,0.10369055,0.004292548,0.8330893,0.000936925],"about_ca_topic_score_codex":0.01041097,"about_ca_topic_score_gemma":0.0028728542,"teacher_disagreement_score":0.58156604,"about_ca_system_score_codex":0.0006233356,"about_ca_system_score_gemma":0.005490312,"threshold_uncertainty_score":0.9961788},"labels":[],"label_agreement":null},{"id":"W4408065122","doi":"10.1016/j.lungcan.2025.108334","title":"225 Durvalumab (D) as consolidation therapy in limited-stage SCLC (LS-SCLC): Outcomes by prior concurrent chemoradiotherapy (cCRT) regimen and prophylactic cranial irradiation (PCI) use in the ADRIATIC trial","year":2025,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Durvalumab; Regimen; Oncology; Chemoradiotherapy; Conventional PCI; Internal medicine; Radiation therapy; Cancer; Immunotherapy","score_opus":0.03159646343939662,"score_gpt":0.39573207681587,"score_spread":0.3641356133764734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408065122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96941984,0.009463832,0.00002564602,0.014556226,0.0006074504,0.00545332,0.000037016933,0.000047355767,0.0003893374],"genre_scores_gemma":[0.9868101,0.006381015,0.00004380031,0.0025410368,0.00019361514,0.0014071959,0.00003254533,0.000032935804,0.0025577466],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99759525,0.00036929,0.00051304116,0.00049701316,0.0006002321,0.0004251611],"domain_scores_gemma":[0.9986192,0.0006008627,0.00018840203,0.0003962417,0.00012268127,0.00007263058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006779208,0.00028822178,0.00063559547,0.00024225542,0.00013114589,0.00014542643,0.00017530397,0.00012771769,0.00009997866],"category_scores_gemma":[0.0005926988,0.00020025176,0.00008183118,0.00063196925,0.00017343098,0.00028260695,0.000038186106,0.00045714653,0.0000027343478],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06056965,0.0017371725,0.8010295,0.0015798536,0.0012996031,0.00008574666,0.017678171,0.000053436055,0.006723846,0.0011847168,0.026586924,0.08147138],"study_design_scores_gemma":[0.23828743,0.0021272,0.7152907,0.0010169403,0.00029959265,0.000008474107,0.0010144586,0.0043075597,0.0012478492,0.00013353858,0.035589408,0.0006768376],"about_ca_topic_score_codex":0.0025803281,"about_ca_topic_score_gemma":0.0012101721,"teacher_disagreement_score":0.17771778,"about_ca_system_score_codex":0.0011415407,"about_ca_system_score_gemma":0.00079073897,"threshold_uncertainty_score":0.81660295},"labels":[],"label_agreement":null},{"id":"W4408144109","doi":"10.1016/j.jtho.2024.12.021","title":"Predictive Biomarker for SCLC Therapeutics: A Broken Promise or a Complex Disease With Missing Links","year":2025,"lang":"en","type":"editorial","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; University of Alberta","funders":"","keywords":"Medicine; Biomarker; Disease; Biomarker discovery; Oncology; Internal medicine; Proteomics; Gene; Genetics","score_opus":0.07089036606738772,"score_gpt":0.5033168943564978,"score_spread":0.4324265282891101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408144109","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012371887,0.020306032,0.010166847,0.07415873,0.8765535,0.0103717055,0.0023305162,0.00016257627,0.004712951],"genre_scores_gemma":[0.0023771147,0.0035164247,0.021871487,0.0014575437,0.95194274,0.00051694445,0.00027037077,0.00021014892,0.017837204],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99635106,0.00040084356,0.00094065187,0.00045347805,0.0012597849,0.000594196],"domain_scores_gemma":[0.9909472,0.0036260167,0.0012633818,0.0004042253,0.0032453574,0.00051383296],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0014007074,0.00045675886,0.0018725814,0.00063079136,0.00021270446,0.000065411514,0.0004363414,0.0009919812,0.00007139021],"category_scores_gemma":[0.0036607978,0.0002672649,0.00042720334,0.00033730207,0.0004894713,0.000119557735,0.00017027899,0.002482314,0.0000020330624],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15498425,0.0005810346,0.00014856647,0.0029055034,0.004489651,0.0011825574,0.0003960737,0.00000262791,0.000137272,8.426038e-7,0.771718,0.06345359],"study_design_scores_gemma":[0.005729765,0.011566403,0.0010971585,0.0048875157,0.006220151,0.00012005408,0.00022865576,0.00023668284,0.000034566714,0.00015676861,0.96947575,0.00024654763],"about_ca_topic_score_codex":0.00001301313,"about_ca_topic_score_gemma":0.000038587794,"teacher_disagreement_score":0.1977577,"about_ca_system_score_codex":0.0021880758,"about_ca_system_score_gemma":0.020145154,"threshold_uncertainty_score":0.99997795},"labels":[],"label_agreement":null},{"id":"W4408153935","doi":"10.1038/s41467-025-57257-z","title":"PARP inhibitor radiosensitization enhances anti-PD-L1 immunotherapy through stabilizing chemokine mRNA in small cell lung cancer","year":2025,"lang":"en","type":"article","venue":"Nature Communications","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of Toronto; Princess Margaret Cancer Centre; McGill University; University Health Network","funders":"National Center for Advancing Translational Sciences; Terry Fox Research Institute; National Cancer Institute; Foundation for the National Institutes of Health","keywords":"Chemokine; Immunotherapy; Lung cancer; Cancer research; PARP inhibitor; Poly ADP ribose polymerase; Medicine; Cancer immunotherapy; Immunology; Immune system; Biology; Oncology; DNA; Polymerase; Genetics","score_opus":0.020724234770475542,"score_gpt":0.377221889949697,"score_spread":0.3564976551792215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408153935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6604551,0.2797838,0.00026707718,0.040313646,0.0004893807,0.0017669045,0.000041321535,0.00017233564,0.016710455],"genre_scores_gemma":[0.9341633,0.059738595,0.0038551483,0.0012430634,0.00010425737,0.00025850913,0.00008937362,0.000026868152,0.00052090164],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985769,0.00017434002,0.00038548734,0.0003090913,0.00022713057,0.00032707772],"domain_scores_gemma":[0.9975692,0.0004020005,0.000116602394,0.0014789241,0.00039033944,0.000042911674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032641905,0.00020051008,0.00040297338,0.00021660565,0.0003099939,0.000039371604,0.0005276793,0.0002460854,0.000029069795],"category_scores_gemma":[0.00026416668,0.00018241799,0.0000906974,0.0011892058,0.00022391809,0.00015290645,0.0003110776,0.0013559698,0.0000026153068],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049020676,0.0014184073,0.3262823,0.00133356,0.00077295676,0.000014935611,0.010238963,0.00012806209,0.6194874,0.0055527035,0.025584737,0.0086958045],"study_design_scores_gemma":[0.009597422,0.00013883838,0.3251661,0.0039350474,0.00039091348,0.000009808378,0.002948117,0.0036772252,0.49293897,0.00074862386,0.15956321,0.0008857],"about_ca_topic_score_codex":0.0005111006,"about_ca_topic_score_gemma":0.002121424,"teacher_disagreement_score":0.2737082,"about_ca_system_score_codex":0.0006500326,"about_ca_system_score_gemma":0.0004702295,"threshold_uncertainty_score":0.743879},"labels":[],"label_agreement":null},{"id":"W4408387396","doi":"10.3390/curroncol32030163","title":"A Recurrent Small Cell Lung Carcinoma Harboring an EML4–ALK Fusion Mutation with Sustained Response to Ensartinib: A Case Report","year":2025,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Fusion gene; Cancer research; Mutation; Lung cancer; Gene; Oncology; Biology; Genetics","score_opus":0.06957705211892619,"score_gpt":0.44324317419409703,"score_spread":0.37366612207517086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408387396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885137,0.0017710292,0.0010516206,0.0039530043,0.0009178065,0.0020912339,0.000010607276,0.00013273198,0.0015582647],"genre_scores_gemma":[0.9968582,0.000042792137,0.0010113189,0.00014635449,0.00022769796,0.0005583967,0.000043693493,0.000029732719,0.0010818319],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973311,0.00046147688,0.00052654033,0.0007194127,0.00033876763,0.00062273926],"domain_scores_gemma":[0.99773073,0.00036163803,0.00017432467,0.00059797545,0.0007616411,0.00037370698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001274043,0.00026370943,0.00052664086,0.0005561742,0.0002459669,0.00002860172,0.00012253296,0.00010430442,0.000029316527],"category_scores_gemma":[0.0012398781,0.00021685631,0.00007633508,0.0007104986,0.00011039739,0.00007887853,0.00024078434,0.00049377535,0.000009533354],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07514948,0.004407995,0.22084858,0.0039132056,0.00034932597,0.43585473,0.023874938,0.00008122629,0.0152772805,0.00017744889,0.018278608,0.20178719],"study_design_scores_gemma":[0.04525209,0.04374991,0.26985478,0.0034806111,0.0026994438,0.05537881,0.035819583,0.009115543,0.022100197,0.00014338396,0.51030606,0.0020996141],"about_ca_topic_score_codex":0.00015032312,"about_ca_topic_score_gemma":0.0004766125,"teacher_disagreement_score":0.49202743,"about_ca_system_score_codex":0.0018526793,"about_ca_system_score_gemma":0.0020344392,"threshold_uncertainty_score":0.88431436},"labels":[],"label_agreement":null},{"id":"W4408431596","doi":"10.1186/s13195-025-01706-w","title":"Beyond expectations: investigating nilotinib’s potential in attenuating neurodegeneration in Alzheimer’s disease","year":2025,"lang":"en","type":"review","venue":"Alzheimer s Research & Therapy","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; St. Boniface Hospital","funders":"National Institute on Aging","keywords":"Neurodegeneration; Neurology; Disease; Medicine; Geriatric psychiatry; Psychopharmacology; Neuroscience; Nilotinib; Psychology; Psychiatry; Internal medicine","score_opus":0.2501518016237052,"score_gpt":0.4991603195452006,"score_spread":0.24900851792149542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408431596","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00048213266,0.9894673,0.00000577906,0.0019676867,0.00026755154,0.006886416,0.00005230609,0.000085007785,0.0007857911],"genre_scores_gemma":[0.0023248217,0.9909578,0.00048716585,0.0002508555,0.0006662752,0.004568118,0.00042372008,0.00015377242,0.00016748978],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9904169,0.0029221126,0.0015297601,0.0014749396,0.0021640018,0.0014922766],"domain_scores_gemma":[0.9957158,0.0017438224,0.0002734145,0.00112886,0.0006203364,0.0005177969],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.002642242,0.00072732975,0.0020342683,0.0029329113,0.00041345696,0.0002106228,0.00070100423,0.000315456,0.00009923387],"category_scores_gemma":[0.0022040687,0.0006262708,0.00046152293,0.003956101,0.0005198966,0.00032190958,0.00047674164,0.0028599775,0.00009225519],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020065019,0.00039626082,0.0010057858,0.0030543332,0.0014244799,0.0004341062,0.0010536487,0.00003391955,0.000030823812,0.00014987202,0.0026897348,0.9895264],"study_design_scores_gemma":[0.021969507,0.0033123018,0.011393573,0.18721023,0.008019058,0.00010441701,0.0042357068,0.0043780394,0.000344521,0.004694714,0.7485525,0.0057854396],"about_ca_topic_score_codex":0.00093240343,"about_ca_topic_score_gemma":0.00034858493,"teacher_disagreement_score":0.9837409,"about_ca_system_score_codex":0.00046608262,"about_ca_system_score_gemma":0.004981604,"threshold_uncertainty_score":0.9996189},"labels":[],"label_agreement":null},{"id":"W4408745550","doi":"10.1136/bmjopen-2024-093943","title":"Retrospective cohort study assessing clinical outcomes of patients with extensive-stage small cell lung cancer treated with and without consolidative thoracic radiotherapy at the Princess Margaret Cancer Centre","year":2025,"lang":"en","type":"article","venue":"BMJ Open","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Retrospective cohort study; Lung cancer; Internal medicine; Tolerability; Chemotherapy; Radiation therapy; Stage (stratigraphy); Regimen; Surgery; Oncology; Adverse effect","score_opus":0.05923953237721239,"score_gpt":0.49160016638802295,"score_spread":0.43236063401081054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408745550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97355616,0.00058594067,0.000030791627,0.0010192506,0.00006596082,0.022636125,0.0001465826,0.000022335,0.0019368478],"genre_scores_gemma":[0.9869208,0.0003347516,0.00025232346,0.0004188439,0.00002984116,0.0018851535,0.000018035307,0.00004178852,0.010098505],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973619,0.0004886309,0.00046543096,0.0006941303,0.00063770026,0.0003522203],"domain_scores_gemma":[0.9975063,0.0002780129,0.00045034438,0.0006223779,0.0010318835,0.00011107123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008694952,0.00031501302,0.0012373207,0.00007724562,0.00027938746,0.000107339794,0.0002948969,0.00006169027,0.00013360314],"category_scores_gemma":[0.00015673552,0.00015616677,0.000061708466,0.00039500848,0.0005919219,0.00016857943,0.00049691176,0.00033195407,3.45994e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064067245,0.00048672134,0.98591036,0.00024248104,0.0041734157,0.000024093799,0.0016152957,0.000012678788,0.0000079584615,0.0000042874076,0.0005539927,0.00056198856],"study_design_scores_gemma":[0.009192881,0.00063302653,0.9853209,0.0009227362,0.0010081162,6.31747e-7,0.0022963642,0.00007282173,0.00022442035,0.0000010108777,0.00012580362,0.0002012788],"about_ca_topic_score_codex":0.0054960214,"about_ca_topic_score_gemma":0.009910223,"teacher_disagreement_score":0.020750972,"about_ca_system_score_codex":0.0007751223,"about_ca_system_score_gemma":0.00091588515,"threshold_uncertainty_score":0.83083767},"labels":[],"label_agreement":null},{"id":"W4408929714","doi":"10.6004/jnccn.2024.7262","title":"HSR25-180: Real-World (rw) Characteristics, Treatment (tx) Patterns and Clinical Outcomes in Patients (pts) With Limited-Stage Small-Cell Lung Cancer (LS-SCLC) Who Received Chemoradiotherapy (CRT)","year":2025,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Medicine; Chemoradiotherapy; Stage (stratigraphy); Oncology; Internal medicine; Lung cancer; Cancer","score_opus":0.046397441055767874,"score_gpt":0.39264714849384935,"score_spread":0.3462497074380815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408929714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98478556,0.004032824,0.000016512984,0.008252477,0.0011271756,0.0010793624,0.00015248827,0.000013156823,0.0005404171],"genre_scores_gemma":[0.9489272,0.036808982,0.00024779252,0.0062120194,0.0015337812,0.00010535232,0.0000166055,0.000052496787,0.006095744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972727,0.00025600055,0.0009145628,0.00035093262,0.0008015858,0.00040427753],"domain_scores_gemma":[0.99610806,0.00081931613,0.0007718326,0.00022202403,0.0019136945,0.00016508452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027350037,0.000337568,0.0011149364,0.0002493766,0.00017714188,0.0000484862,0.0002545906,0.000095937234,0.00007121983],"category_scores_gemma":[0.0001223459,0.00020418894,0.00024951133,0.0005045024,0.00018496443,0.000090961934,0.000098229764,0.0006668114,4.884229e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025494338,0.00039081438,0.97960025,0.00016929932,0.0018063497,0.000018038472,0.00020952031,0.0009454455,0.000014716217,0.000019383608,0.011506689,0.00277005],"study_design_scores_gemma":[0.010019443,0.0005859272,0.9750351,0.0017258732,0.00034972254,0.0000022269726,0.000049270344,0.00060858886,0.000050669154,0.000020891486,0.011374884,0.00017746016],"about_ca_topic_score_codex":0.00058924255,"about_ca_topic_score_gemma":0.0019548929,"teacher_disagreement_score":0.03585836,"about_ca_system_score_codex":0.0025133153,"about_ca_system_score_gemma":0.0009933925,"threshold_uncertainty_score":0.83265835},"labels":[],"label_agreement":null},{"id":"W4408981555","doi":"10.1016/s1556-0864(25)00491-5","title":"299P: First-line (1L) durvalumab (D) + platinum-etoposide (EP) in extensive-stage SCLC (ES-SCLC): Final results and exploratory biomarker analyses from LUMINANCE","year":2025,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Durvalumab; Etoposide; Oncology; Biomarker; Stage (stratigraphy); Internal medicine; Cancer; Nivolumab; Chemotherapy","score_opus":0.12809308711444112,"score_gpt":0.5083823957932491,"score_spread":0.38028930867880795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408981555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9622663,0.017677946,0.0003051093,0.016448086,0.0007445481,0.00041541926,0.000083884086,0.000021737396,0.0020369282],"genre_scores_gemma":[0.9867748,0.005155589,0.004196937,0.0008666837,0.0003753433,0.000024893825,0.000015401703,0.000026315087,0.0025640272],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99668926,0.00047362235,0.0013172519,0.0004626309,0.0005580045,0.0004992521],"domain_scores_gemma":[0.9964034,0.0014470996,0.0007718656,0.0004081938,0.0007462729,0.00022314949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016384287,0.0003039686,0.0013371856,0.00070956553,0.00018120145,0.00003489294,0.00026165115,0.0002448695,0.00006255943],"category_scores_gemma":[0.0034264273,0.00024082964,0.00019243658,0.0007710986,0.0005220168,0.0002948718,0.00028340405,0.0009298907,0.000009343761],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12937206,0.0031844229,0.13482222,0.0022116045,0.0048371297,0.033227604,0.00739826,0.0007321423,0.077971354,0.00011153232,0.11582963,0.49030206],"study_design_scores_gemma":[0.015593232,0.004519731,0.8750621,0.004667902,0.0010764145,0.0004906822,0.00425074,0.0016586216,0.014191177,0.0009834835,0.076997966,0.0005079424],"about_ca_topic_score_codex":0.00029007837,"about_ca_topic_score_gemma":0.0015548139,"teacher_disagreement_score":0.7402399,"about_ca_system_score_codex":0.0009179626,"about_ca_system_score_gemma":0.0011365669,"threshold_uncertainty_score":0.98207474},"labels":[],"label_agreement":null},{"id":"W4408981570","doi":"10.1016/s1556-0864(25)00489-7","title":"297MO: Patterns of disease progression with durvalumab (D) after concurrent chemoradiotherapy (cCRT) in limited-stage small-cell lung cancer (LS-SCLC): Results from ADRIATIC","year":2025,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Durvalumab; Medicine; Oncology; Stage (stratigraphy); Chemoradiotherapy; Internal medicine; Disease; Cancer; Lung cancer; Immunotherapy","score_opus":0.022631747890215565,"score_gpt":0.4437401101460588,"score_spread":0.42110836225584325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408981570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97220755,0.016862305,0.00023599449,0.008703509,0.00055796094,0.000873915,0.00018697034,0.000012638813,0.00035914656],"genre_scores_gemma":[0.99332523,0.0036821668,0.001101143,0.0004412082,0.00030561906,0.00010753858,0.000014937963,0.00002841983,0.0009937459],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99733216,0.00037095352,0.0010014122,0.0003296946,0.0005713639,0.00039441502],"domain_scores_gemma":[0.99764985,0.00043370968,0.000853467,0.00034711405,0.00044821636,0.00026766324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071631663,0.00025029058,0.0010898123,0.00043792874,0.000040097613,0.000017338889,0.00024598115,0.00013391189,0.00014310652],"category_scores_gemma":[0.00027574316,0.00016714328,0.0001657118,0.00037666722,0.0001547902,0.00009368262,0.00011057737,0.0007233716,0.0000010186945],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09212701,0.0024559544,0.78872746,0.0031003484,0.0011246374,0.002582164,0.0030227795,0.00014238003,0.0027504794,0.0000056803538,0.0026987703,0.10126236],"study_design_scores_gemma":[0.028206695,0.005249263,0.91685,0.017811337,0.0017893672,0.000030012252,0.0011014877,0.0021265221,0.010295388,0.00003195972,0.016091645,0.0004163333],"about_ca_topic_score_codex":0.00025887002,"about_ca_topic_score_gemma":0.00067926134,"teacher_disagreement_score":0.12812255,"about_ca_system_score_codex":0.0013425275,"about_ca_system_score_gemma":0.002233568,"threshold_uncertainty_score":0.68159056},"labels":[],"label_agreement":null},{"id":"W4409625082","doi":"10.1158/1538-7445.am2025-541","title":"Abstract 541: PARP and autophagy inhibition synergy in small cell lung cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Autophagy; Lung cancer; Poly ADP ribose polymerase; Cancer research; Cancer; Biology; Medicine; Internal medicine; Apoptosis; Genetics; DNA","score_opus":0.05385608005567917,"score_gpt":0.4419410958944348,"score_spread":0.38808501583875565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409625082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93168926,0.045411784,0.000009213908,0.006508071,0.00017757683,0.0010354425,0.00003045321,0.000049973245,0.015088244],"genre_scores_gemma":[0.9715146,0.017026987,0.000035073597,0.00033005525,0.00022599155,0.0014544304,0.000009005736,0.000029745226,0.009374118],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9974598,0.00013502313,0.00031086194,0.0005994068,0.00059825025,0.0008966389],"domain_scores_gemma":[0.9986417,0.00032089115,0.000037471716,0.00035173056,0.00043228467,0.00021590161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010382439,0.00018748286,0.00038614043,0.00073102326,0.00020663772,0.00006779596,0.00014497762,0.00013887566,0.000528907],"category_scores_gemma":[0.0002520834,0.00016536763,0.000054280845,0.0011497117,0.00036157842,0.00010970637,0.00032266448,0.001037964,0.000011667273],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028075122,0.000812807,0.32864252,0.015308211,0.0006218602,0.0012982979,0.003584942,0.00027728055,0.38486117,0.0026596922,0.17284288,0.08628283],"study_design_scores_gemma":[0.008761253,0.00031238643,0.6950597,0.006284759,0.000098851175,0.0000074063996,0.001226088,0.00082897843,0.24588764,0.0011041962,0.039914716,0.0005140131],"about_ca_topic_score_codex":0.013803552,"about_ca_topic_score_gemma":0.0077811936,"teacher_disagreement_score":0.3664172,"about_ca_system_score_codex":0.0016286846,"about_ca_system_score_gemma":0.0016518637,"threshold_uncertainty_score":0.99276364},"labels":[],"label_agreement":null},{"id":"W4409633818","doi":"10.1158/1538-7445.am2025-2758","title":"Abstract 2758: Methylome plasticity as a biomarker of treatment response in small cell lung cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Princess Margaret Cancer Centre","funders":"","keywords":"Biomarker; Lung cancer; Cancer; Biology; DNA methylation; Medicine; Cancer research; Oncology; Internal medicine; Genetics; Gene expression; Gene","score_opus":0.10422788769621784,"score_gpt":0.49205316455889025,"score_spread":0.38782527686267243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409633818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96773565,0.017637957,0.000009837746,0.0037254912,0.000151932,0.0017757077,0.00010971287,0.000032159183,0.008821565],"genre_scores_gemma":[0.9793298,0.0064562564,0.00005731164,0.00009342294,0.00007850704,0.0019053674,0.0000043504615,0.00003494201,0.012040007],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9966055,0.00048444947,0.0005058636,0.0006490913,0.0007491786,0.0010059197],"domain_scores_gemma":[0.99647826,0.00198963,0.00007363486,0.0005085341,0.00069578015,0.0002541606],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019927244,0.00025922598,0.0006743774,0.0012987586,0.00014500493,0.000030425941,0.00030707108,0.00015355255,0.0012425503],"category_scores_gemma":[0.0011822917,0.00020459674,0.00014878021,0.0019370683,0.00049805635,0.000066432076,0.00027983647,0.00066488923,0.000024066876],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.04248256,0.0009838525,0.11187697,0.0033917925,0.0010517823,0.000430317,0.0024270557,0.00014415335,0.80790603,0.0001020323,0.01644564,0.012757804],"study_design_scores_gemma":[0.008696062,0.0014664932,0.5952336,0.0027095564,0.00015983614,0.0000028221566,0.0009851322,0.00041294898,0.37447163,0.00018110548,0.015391997,0.00028880563],"about_ca_topic_score_codex":0.033409875,"about_ca_topic_score_gemma":0.0047992226,"teacher_disagreement_score":0.48335662,"about_ca_system_score_codex":0.0055746185,"about_ca_system_score_gemma":0.0066493535,"threshold_uncertainty_score":0.99967045},"labels":[],"label_agreement":null},{"id":"W4409690046","doi":"10.1158/1538-7445.am2025-427","title":"Abstract 427: Genome-wide CRISPR knockout screen identifies novel determinant of PARP inhibitor resistance in small-cell lung cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Princess Margaret Cancer Centre","funders":"","keywords":"CRISPR; PARP inhibitor; Cancer; Biology; Genetics; Genome; Cancer research; Knockout mouse; Lung cancer; Poly ADP ribose polymerase; Computational biology; Medicine; Gene; Pathology","score_opus":0.06454410470683547,"score_gpt":0.4333816477657002,"score_spread":0.36883754305886474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409690046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9150788,0.06930298,0.00006308669,0.0037148905,0.0003247514,0.0022038368,0.00021286418,0.000045392237,0.009053347],"genre_scores_gemma":[0.9629656,0.00993877,0.00020219441,0.00017922158,0.00031230206,0.0015004445,0.000014216634,0.0000630771,0.024824178],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99534136,0.00016023102,0.000861533,0.0009203502,0.0013285008,0.0013880285],"domain_scores_gemma":[0.9965044,0.0007776249,0.00015800235,0.0009303274,0.0013587573,0.00027086854],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019767235,0.00033688612,0.0008593174,0.0011629332,0.00027618857,0.000084380496,0.00068879384,0.0001945895,0.0003652605],"category_scores_gemma":[0.000932229,0.00029999876,0.0001748967,0.0019331512,0.0007478428,0.00018242684,0.0006809335,0.0013456648,0.00001541848],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003983217,0.00084093114,0.3758613,0.015990464,0.0006633237,0.00038057566,0.003192273,0.00008751409,0.52981865,0.0001936178,0.06547999,0.0035081329],"study_design_scores_gemma":[0.004991529,0.00013726557,0.6910644,0.006787956,0.000115457144,0.0000011703847,0.0012190233,0.00004908345,0.2750427,0.00018572486,0.020008588,0.0003970593],"about_ca_topic_score_codex":0.0129074,"about_ca_topic_score_gemma":0.042891476,"teacher_disagreement_score":0.31520313,"about_ca_system_score_codex":0.0022056138,"about_ca_system_score_gemma":0.0031588448,"threshold_uncertainty_score":0.9999452},"labels":[],"label_agreement":null},{"id":"W4409690532","doi":"10.1158/1538-7445.am2025-2147","title":"Abstract 2147: Radiosensitization via ATM inhibition in small cell lung cancer leads to increased immunogenicity and tumor infiltration","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Immunogenicity; Medicine; Infiltration (HVAC); Cancer research; Lung cancer; Cancer; Oncology; Pathology; Immune system; Internal medicine; Immunology","score_opus":0.032968959835324746,"score_gpt":0.39751457076864183,"score_spread":0.36454561093331705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409690532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98542225,0.006367678,0.00015855694,0.004047341,0.00011972521,0.002092885,0.000037637743,0.000048869504,0.0017050538],"genre_scores_gemma":[0.9952536,0.0022365835,0.000093138195,0.0005594582,0.00020186158,0.000963372,0.000038070397,0.000029591418,0.0006243051],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9975583,0.00021651422,0.0003795612,0.0005630434,0.00060619874,0.00067639054],"domain_scores_gemma":[0.99840236,0.0002534297,0.000052544514,0.00033283196,0.00073870143,0.00022015205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012910796,0.00019638715,0.0003686915,0.0007949663,0.00025631877,0.00008101241,0.000092512535,0.000105234416,0.00012785364],"category_scores_gemma":[0.00041903433,0.00019036747,0.000049754788,0.0016017645,0.00020197475,0.00016576298,0.00018746649,0.00073593704,0.000011146384],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014577328,0.00013694844,0.16130306,0.001526146,0.0000776412,0.00010578889,0.0008806425,0.000222608,0.8248181,0.00006890167,0.005092037,0.0043103863],"study_design_scores_gemma":[0.0035125047,0.00019095952,0.53865,0.0017609068,0.000053303316,0.000008051281,0.00029975869,0.00093262736,0.4534441,0.00012622075,0.0007848898,0.00023667638],"about_ca_topic_score_codex":0.019505108,"about_ca_topic_score_gemma":0.008559728,"teacher_disagreement_score":0.37734693,"about_ca_system_score_codex":0.0022857026,"about_ca_system_score_gemma":0.0013868719,"threshold_uncertainty_score":0.98702407},"labels":[],"label_agreement":null},{"id":"W4409822191","doi":"10.1158/1538-7445.am2025-ct094","title":"Abstract CT094: Durvalumab (D) vs placebo (P) after concurrent chemoradiotherapy (cCRT) in limited-stage small-cell lung cancer (LS-SCLC): Outcomes by PD-L1 expression in ADRIATIC","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Durvalumab; Medicine; Oncology; Internal medicine; Stage (stratigraphy); Chemoradiotherapy; Placebo; Cancer; Pathology; Immunotherapy; Biology","score_opus":0.04740485122507896,"score_gpt":0.4421369264632889,"score_spread":0.3947320752382099,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409822191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92162585,0.061845355,0.000018035724,0.00916447,0.0005136695,0.0037656813,0.0002022269,0.00007879902,0.0027859376],"genre_scores_gemma":[0.95129097,0.020316754,0.00006850521,0.0008452338,0.00018665544,0.0069248574,0.000034374425,0.000102858896,0.020229788],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9941517,0.0004620376,0.00087111164,0.0011912198,0.0015159837,0.0018079609],"domain_scores_gemma":[0.997241,0.00091354654,0.00013042253,0.0009073471,0.00041938553,0.00038830686],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019275573,0.0005268767,0.0012130978,0.0012150668,0.00018884438,0.000130306,0.0006431382,0.00029890792,0.0021361813],"category_scores_gemma":[0.0005004543,0.00043912724,0.00019193966,0.0017456677,0.00043437455,0.00019549314,0.0004529551,0.002281477,0.000032609678],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008014832,0.0011319066,0.7944107,0.0061646183,0.00036042006,0.00042367095,0.0035713683,0.00012411702,0.08026955,0.000026005564,0.096356854,0.009145962],"study_design_scores_gemma":[0.03564249,0.00043457787,0.77710783,0.010130073,0.000089031244,0.0000021307123,0.0012610293,0.0014474872,0.09923765,0.000040142244,0.07359403,0.0010135205],"about_ca_topic_score_codex":0.007948315,"about_ca_topic_score_gemma":0.007421459,"teacher_disagreement_score":0.0415286,"about_ca_system_score_codex":0.0053079557,"about_ca_system_score_gemma":0.0023803439,"threshold_uncertainty_score":0.99980605},"labels":[],"label_agreement":null},{"id":"W4409912100","doi":"10.1016/j.xhgg.2025.100445","title":"Pathogenic germline variants in small cell lung cancer: A systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"Human Genetics and Genomics Advances","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Princess Margaret Cancer Centre; Canada Research Chairs; Ontario Institute for Cancer Research; St. Michael's Hospital; Western University","funders":"National Cancer Institute; National Institutes of Health; Terry Fox Research Institute; Memorial Sloan-Kettering Cancer Center; University of Toronto; Canada Foundation for Innovation; Princess Margaret Cancer Foundation; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Meta-analysis; Germline; Lung cancer; Biology; Cancer; Genetics; Medicine; Oncology; Internal medicine; Gene","score_opus":0.07090975319869,"score_gpt":0.41188827442225434,"score_spread":0.3409785212235643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409912100","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000019179946,0.99438673,0.000021435439,0.000082179824,0.000028538228,0.004902614,0.00038858748,0.000012026722,0.0001587042],"genre_scores_gemma":[0.000012077213,0.9952901,0.00050225656,0.00023327806,0.0000435396,0.0015866212,0.00007664337,0.000043434906,0.002212021],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9969395,0.00026614722,0.0013146723,0.00085685175,0.00020877128,0.00041408735],"domain_scores_gemma":[0.99816245,0.00023350754,0.0005889241,0.00071285083,0.00013639685,0.00016585474],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007047831,0.00060598296,0.009021105,0.0005479298,0.00013466492,0.000059886723,0.00025603888,0.0001428746,0.000054409364],"category_scores_gemma":[0.00006695665,0.00042211128,0.0010202122,0.00072224013,0.000104270744,0.000024791396,0.0003541222,0.00036562714,0.000001232661],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000019232616,0.000034034256,0.00002009129,0.95215774,0.0435282,0.00002952686,0.000053822583,0.000005371164,8.69092e-7,0.0000203035,0.000029586112,0.0041185413],"study_design_scores_gemma":[0.0002705317,0.000063790016,0.000017028291,0.050697014,0.9089178,0.0000126898,0.000014464539,0.000027059517,4.2250187e-7,0.00005201687,0.039532486,0.00039473185],"about_ca_topic_score_codex":0.0000429645,"about_ca_topic_score_gemma":0.0007405387,"teacher_disagreement_score":0.9014607,"about_ca_system_score_codex":0.00021666505,"about_ca_system_score_gemma":0.0003840919,"threshold_uncertainty_score":0.9998231},"labels":[],"label_agreement":null},{"id":"W4409931474","doi":"10.3390/curroncol32050258","title":"A Population Survival Kinetics Assessment of Extensive Small Cell Lung Cancer and Rationale for Maintenance Therapy","year":2025,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Lung cancer; Population; Cancer therapy; Oncology; Cancer; Bioinformatics; Intensive care medicine; Internal medicine; Biology; Environmental health","score_opus":0.12066166537994488,"score_gpt":0.5026773819871048,"score_spread":0.3820157166071599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409931474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9585762,0.02475479,0.006190562,0.00507508,0.0013815578,0.0023838594,0.00006400854,0.000017618362,0.0015563308],"genre_scores_gemma":[0.9887192,0.007843286,0.001782582,0.00018062165,0.00016281538,0.0005993218,0.000054726712,0.000009187303,0.00064822135],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99930125,0.000043048592,0.00019519417,0.00018682597,0.00011256194,0.00016108951],"domain_scores_gemma":[0.9989823,0.00028113768,0.00009131484,0.000100965444,0.0005089559,0.000035328365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001684867,0.000082598795,0.00030274564,0.000078998084,0.000041810457,0.0000038409544,0.000040723917,0.000042908858,0.000012637365],"category_scores_gemma":[0.000113458715,0.00006628682,0.00004222596,0.0000981304,0.00007783608,0.00001619681,0.000044722907,0.00010307614,8.410742e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062051474,0.0006068702,0.859604,0.0015040872,0.00020521243,0.0000021433702,0.00040565772,0.000045215525,0.00548735,0.0026155263,0.0111532835,0.11775015],"study_design_scores_gemma":[0.0066322763,0.00072352064,0.9312729,0.00027146214,0.0001376093,0.0000013172605,0.00024453492,0.004844806,0.0008828778,0.0006796845,0.054216642,0.00009235316],"about_ca_topic_score_codex":0.000055279586,"about_ca_topic_score_gemma":0.00016084028,"teacher_disagreement_score":0.1176578,"about_ca_system_score_codex":0.00036429445,"about_ca_system_score_gemma":0.00035067418,"threshold_uncertainty_score":0.2703098},"labels":[],"label_agreement":null},{"id":"W4409965915","doi":"10.3390/curroncol32050261","title":"ADCs and TCE in SCLC Therapy: The Beginning of a New Era?","year":2025,"lang":"en","type":"review","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Milestone; Drug development; Monoclonal antibody; Chemotherapy; Drug; Immunotherapy; Lung cancer; Intensive care medicine; Oncology; Cancer; Internal medicine; Antibody; Immunology; Pharmacology","score_opus":0.37186130948611357,"score_gpt":0.5912302124212313,"score_spread":0.21936890293511774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409965915","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000037165966,0.99447703,0.0000052860255,0.0013808149,0.0005422989,0.0014760711,0.0000097766215,0.000012627703,0.002058954],"genre_scores_gemma":[0.000012490833,0.99865884,0.00003874563,0.00006684379,0.00030427138,0.00020925762,0.000015114279,0.000014444316,0.00067999534],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99853283,0.0002662716,0.00043055273,0.00029854348,0.00019343571,0.00027835227],"domain_scores_gemma":[0.99843657,0.0009193941,0.00018893613,0.00030826667,0.0000739752,0.00007287848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045904628,0.00022533446,0.0017596148,0.00027355508,0.000039444636,0.000005970442,0.00020136044,0.00015722941,0.00003299212],"category_scores_gemma":[0.0005203799,0.00012536538,0.00016863097,0.00048400005,0.00025855663,0.000016672937,0.0002663312,0.0009166806,0.00000401513],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003646815,0.00008742157,0.00042742124,0.018436791,0.00016540432,0.000011489572,0.0004292162,3.2759054e-8,1.2589413e-7,0.000103348,0.018026812,0.96227545],"study_design_scores_gemma":[0.0010372626,0.00030741296,0.00024753594,0.025016412,0.00030064603,0.000020256826,0.00006163998,0.0000011947513,2.498364e-7,0.000056523128,0.9728713,0.00007956009],"about_ca_topic_score_codex":0.00006455644,"about_ca_topic_score_gemma":0.000051837524,"teacher_disagreement_score":0.96219593,"about_ca_system_score_codex":0.000361841,"about_ca_system_score_gemma":0.003277595,"threshold_uncertainty_score":0.58143127},"labels":[],"label_agreement":null},{"id":"W4410477751","doi":"10.3389/fonc.2025.1508563","title":"Diagnostic significance of the novel biomarker combination for early-stage non-small cell lung cancer detection: results of the blind clinical study","year":2025,"lang":"en","type":"article","venue":"Frontiers in Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alpha Cancer Technologies","funders":"","keywords":"Medicine; Stage (stratigraphy); Lung cancer; Biomarker; Clinical significance; Oncology; Internal medicine; Cancer; Prospective cohort study; Radiology","score_opus":0.0463737174783091,"score_gpt":0.41474014284698096,"score_spread":0.36836642536867187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410477751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9803223,0.00077558385,0.0044990443,0.0027911852,0.004289408,0.005899433,0.00009368891,0.000008254921,0.0013210865],"genre_scores_gemma":[0.9959019,0.00020902572,0.0004629483,0.00013352817,0.00006546953,0.00078355527,0.0000014734412,0.0000110384435,0.0024310756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825907,0.00028514842,0.00068286376,0.00031236067,0.00022852121,0.00023206491],"domain_scores_gemma":[0.9969969,0.001853482,0.00034546037,0.00043706544,0.0003348172,0.00003231751],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013305736,0.00011644907,0.0005136628,0.00013863694,0.00009373558,0.00000389792,0.00032203435,0.00014771378,0.0000027630967],"category_scores_gemma":[0.0031250666,0.00007322954,0.00013349182,0.0006953981,0.00044685294,0.000024173443,0.00020080987,0.0003449351,1.2205493e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003534347,0.0016613543,0.96995765,0.0003588217,0.00034039727,0.0000024313583,0.0010596772,0.00006329802,0.00092476007,0.00000859325,0.015567693,0.0065209838],"study_design_scores_gemma":[0.018525323,0.0012138102,0.96697724,0.0002057343,0.00028962665,2.3398604e-7,0.0013193556,0.0018142271,0.0046743713,0.000041712807,0.004873593,0.00006476569],"about_ca_topic_score_codex":0.0008742371,"about_ca_topic_score_gemma":0.0023098805,"teacher_disagreement_score":0.015579571,"about_ca_system_score_codex":0.00055226724,"about_ca_system_score_gemma":0.00093081675,"threshold_uncertainty_score":0.37412226},"labels":[],"label_agreement":null},{"id":"W4410820333","doi":"10.1200/jco.2025.43.16_suppl.8014","title":"Clinical and molecular characteristics of early progressors (EPs) and long-term progression-free survivors (LTPs) from the phase 3 ADRIATIC trial of consolidation durvalumab (D) vs placebo (P) after concurrent chemoradiotherapy (cCRT) in limited-stage small-cell lung cancer (LS-SCLC).","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Durvalumab; Medicine; Placebo; Chemoradiotherapy; Internal medicine; Oncology; Phases of clinical research; Clinical trial; Cancer; Pathology; Pembrolizumab; Immunotherapy; Alternative medicine","score_opus":0.06979469026144287,"score_gpt":0.5023767545804756,"score_spread":0.43258206431903273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410820333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98393273,0.008528806,0.00011536097,0.004567565,0.0011545424,0.0015679155,0.0000787656,0.0000060812404,0.000048253554],"genre_scores_gemma":[0.9851302,0.013094966,0.00062332966,0.000459458,0.00051511236,0.0000929213,0.000007332165,0.000021836498,0.00005484116],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99357134,0.0016383086,0.0035631994,0.00035416236,0.00057625776,0.0002967289],"domain_scores_gemma":[0.98993933,0.0063205226,0.0025126066,0.00038364937,0.0005934167,0.0002504928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052035,0.000237503,0.0024597538,0.00016873033,0.000037901384,0.000023181723,0.0003075377,0.00039734197,0.0000551735],"category_scores_gemma":[0.006393504,0.00015192255,0.00032143298,0.00022714768,0.001262092,0.0000773868,0.00022243947,0.0012432738,2.3654599e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14525765,0.0028524098,0.7646694,0.00046371616,0.0008957631,0.00024621724,0.00040103216,5.051765e-7,0.00016417394,0.00001419044,0.00018411558,0.084850825],"study_design_scores_gemma":[0.19048099,0.013331036,0.7915974,0.0018513642,0.0009960518,0.0000074069817,0.0000796093,0.0004582838,0.00029981445,0.000026749218,0.0007361363,0.00013512843],"about_ca_topic_score_codex":0.000099014076,"about_ca_topic_score_gemma":0.00026136,"teacher_disagreement_score":0.084715694,"about_ca_system_score_codex":0.00013279062,"about_ca_system_score_gemma":0.0021450724,"threshold_uncertainty_score":0.76540834},"labels":[],"label_agreement":null},{"id":"W4410823142","doi":"10.1200/jco.2025.43.16_suppl.e20126","title":"Survival outcomes for patients with extensive stage small cell lung cancer (ES-SCLC) treated with consolidative thoracic radiation therapy (cTRT) and chemoimmunotherapy (CIT): A population level study.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; University of Calgary","funders":"","keywords":"Medicine; Chemoimmunotherapy; Oncology; Radiation therapy; Lung cancer; Stage (stratigraphy); Population; Internal medicine; Chemotherapy; Radiology; Cyclophosphamide","score_opus":0.13281562938069374,"score_gpt":0.516175931575943,"score_spread":0.38336030219524925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410823142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99317753,0.0010237367,0.0003617235,0.0027162945,0.0002484254,0.0023164651,0.00004099362,0.000011171754,0.000103639046],"genre_scores_gemma":[0.99531245,0.0017659914,0.0010133515,0.0007847892,0.00016448794,0.00009605674,0.000014597574,0.000026363052,0.0008219148],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99748546,0.0004733939,0.0011182226,0.00028188174,0.00038613557,0.0002549277],"domain_scores_gemma":[0.9941925,0.0026099323,0.0012642035,0.00016972693,0.0016314812,0.00013217745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013767374,0.00021993532,0.0016023652,0.00019061149,0.00011402327,0.00002076837,0.000100654936,0.00015438747,0.000016456255],"category_scores_gemma":[0.0008131829,0.00012183662,0.00014752396,0.00021862854,0.00018320644,0.00012806494,0.000027821083,0.00050213037,1.8819192e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03653739,0.0019020876,0.9092886,0.00007192027,0.0024368586,0.00002771994,0.00058202335,0.000021082527,0.000026120733,0.000008197971,0.0002196207,0.048878387],"study_design_scores_gemma":[0.039208088,0.021085294,0.93676066,0.00014244484,0.00053072436,0.0000017421512,0.00065543415,0.00008644257,0.00007142385,0.000014346656,0.0013276975,0.00011568023],"about_ca_topic_score_codex":0.0003919654,"about_ca_topic_score_gemma":0.0003771521,"teacher_disagreement_score":0.04876271,"about_ca_system_score_codex":0.00041191885,"about_ca_system_score_gemma":0.0012632,"threshold_uncertainty_score":0.49683535},"labels":[],"label_agreement":null},{"id":"W4411059462","doi":"10.3390/curroncol32060332","title":"Quality of Life of Lung Cancer Patients with Immune-Related Endocrinopathies During Immunotherapy: A Prospective Study Based on the EORTC QLQ-C30 and QLQ-LC13 Questionnaires in Romania","year":2025,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Lung cancer; Prospective cohort study; Quality of life (healthcare); Cancer; Internal medicine; Adverse effect; Cohort; Oncology; Population; Immunotherapy; Nursing","score_opus":0.029085719694515365,"score_gpt":0.41454819175111085,"score_spread":0.3854624720565955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411059462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98762226,0.008402142,0.0000032804112,0.00077235774,0.00023209004,0.002616159,0.000019982848,0.000022248652,0.00030949942],"genre_scores_gemma":[0.99874264,0.00048943673,0.0000068995237,0.000028400718,0.000015800482,0.00067107816,0.0000037006803,0.00001257615,0.000029493223],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99796534,0.00051777926,0.00059966295,0.00030752327,0.00036166082,0.00024802546],"domain_scores_gemma":[0.99852836,0.00047042777,0.00029091488,0.00029660013,0.00037589655,0.000037785358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005186927,0.00018107757,0.0006850928,0.0002581925,0.00009944891,0.000005619683,0.0001230808,0.000047266294,0.000024112785],"category_scores_gemma":[0.00068153156,0.00011310887,0.000052627976,0.0004499473,0.00040813204,0.000043855835,0.00010967646,0.0004062708,2.466176e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046117995,0.002783445,0.98442715,0.0007232546,0.00046389658,0.0000045184547,0.0044389674,0.00001838789,0.0005099058,0.000333915,0.00003925026,0.0016455253],"study_design_scores_gemma":[0.011547939,0.0019086893,0.9836222,0.0012107835,0.00008015962,2.7804913e-7,0.0009902532,0.00011193613,0.00036355833,0.000041956944,0.00003395243,0.00008830751],"about_ca_topic_score_codex":0.0012042215,"about_ca_topic_score_gemma":0.0009637937,"teacher_disagreement_score":0.011120374,"about_ca_system_score_codex":0.0006309287,"about_ca_system_score_gemma":0.000616051,"threshold_uncertainty_score":0.46124458},"labels":[],"label_agreement":null},{"id":"W4411174277","doi":"10.1200/gdl.23.1011","title":"Systemic Therapy for SCLC: ASCO-OH (CCO) Guideline","year":2024,"lang":"en","type":"dataset","venue":"","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Guideline; Medicine; Internal medicine; Oncology; Pathology","score_opus":0.05174471415785745,"score_gpt":0.44499250608857166,"score_spread":0.39324779193071424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411174277","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00000799632,0.03302712,0.00004539448,0.0048907115,0.0011332743,0.0031052895,0.9567814,0.00017037851,0.00083842716],"genre_scores_gemma":[0.000009761002,0.020109622,0.00038595562,0.002284666,0.0027501653,0.001002751,0.9598899,0.00007451581,0.013492649],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99733627,0.00003646646,0.0006536609,0.0006804027,0.0007546389,0.00053858047],"domain_scores_gemma":[0.9980408,0.00020183112,0.00009640113,0.0010041134,0.00047940333,0.00017747552],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00068268937,0.00042643308,0.0009360869,0.00032024874,0.000083248204,0.00006881127,0.0003442718,0.00028553655,0.0011850176],"category_scores_gemma":[0.00037826903,0.00026842157,0.0003312742,0.00023869061,0.00009849003,0.000036830323,0.000219051,0.00055980816,0.0026625465],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030879054,0.000058817965,0.000003944373,0.004323751,0.0011360073,0.00007945815,0.00001456954,3.5919084e-7,0.000063869586,0.000020201715,0.99230057,0.0016896623],"study_design_scores_gemma":[0.0017470156,0.00069351646,0.0000028426994,0.001579604,0.00034199568,0.0000901005,0.00008491642,0.000022660666,0.00009423797,0.00006714555,0.9950197,0.00025627296],"about_ca_topic_score_codex":0.00061171566,"about_ca_topic_score_gemma":0.00019283235,"teacher_disagreement_score":0.012917498,"about_ca_system_score_codex":0.00043536245,"about_ca_system_score_gemma":0.00075144356,"threshold_uncertainty_score":0.9999768},"labels":[],"label_agreement":null},{"id":"W4411306851","doi":"10.14740/wjon2543","title":"Nomograms for Predicting Overall Survival and Cancer-Specific Survival of Small Cell Carcinoma of Ovary Patients: A Retrospective Cohort Study","year":2025,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Natural Science Foundation of Gansu Province","keywords":"Medicine; Nomogram; Retrospective cohort study; Oncology; Cohort; Cancer; Ovary; Internal medicine; Overall survival; Cancer survival; Survival analysis","score_opus":0.030380243542358337,"score_gpt":0.3452886023781528,"score_spread":0.31490835883579443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411306851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989718,0.0030053146,0.000103219856,0.00047182717,0.0011095097,0.0014438182,0.00004835369,0.0000057593275,0.004094163],"genre_scores_gemma":[0.9980677,0.0005932207,0.00048401466,0.00003036911,0.00025504804,0.000049080278,0.0000031457078,0.00001759366,0.00049984094],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99786544,0.00021331474,0.0008999964,0.00025087156,0.00046633463,0.00030405668],"domain_scores_gemma":[0.9966606,0.0006926219,0.00075285323,0.0001917409,0.0015920191,0.00011018285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013852573,0.00016971827,0.0012753517,0.00044453912,0.000075337295,0.0000066923826,0.00016612148,0.00006484489,0.000023711224],"category_scores_gemma":[0.00030425805,0.00013876126,0.00016794103,0.00039179894,0.00023263867,0.00005724866,0.00015951798,0.00043789565,8.631754e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036678752,0.0015368983,0.98624027,0.00033273787,0.0008115642,0.00003387488,0.00091880315,0.000008682275,0.00043045904,0.00009514368,0.0013943374,0.004529366],"study_design_scores_gemma":[0.01170988,0.00849294,0.97462964,0.00020131575,0.00045708808,0.000004536513,0.0012112993,0.00002255264,0.0003447849,0.0000878637,0.002758434,0.000079678044],"about_ca_topic_score_codex":0.0004670343,"about_ca_topic_score_gemma":0.0014994412,"teacher_disagreement_score":0.011610632,"about_ca_system_score_codex":0.00087426795,"about_ca_system_score_gemma":0.00066997856,"threshold_uncertainty_score":0.565852},"labels":[],"label_agreement":null},{"id":"W4411475146","doi":"10.70389/pjs.100084","title":"Outcomes of Clinical Trials on the Roles of Immune Checkpoint Inhibitors in the Management of Lung Cancers: A Comprehensive Review","year":2025,"lang":"en","type":"review","venue":"Premier journal of science.","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Medicine; Lung cancer; Oncology; Internal medicine; Clinical trial; Chemotherapy; Cancer; Radiation therapy; Immunotherapy; Adverse effect; Pembrolizumab; Treatment of lung cancer","score_opus":0.2463859360446617,"score_gpt":0.5542475828009386,"score_spread":0.30786164675627686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411475146","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00041515665,0.9924694,0.0000023518726,0.0022816611,0.0004602892,0.002827257,0.000018520397,0.0000015136972,0.0015238627],"genre_scores_gemma":[0.0010999173,0.99835,0.00014684531,0.00016921831,0.00010092077,0.00004893571,6.993565e-7,0.000008719091,0.00007471073],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9890177,0.001883041,0.006152539,0.00028446535,0.0023597921,0.00030242797],"domain_scores_gemma":[0.98671514,0.005567952,0.00585629,0.00075922377,0.0010160002,0.00008540005],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.044752326,0.00028856273,0.0059318226,0.000557076,0.00006474604,0.000013147749,0.0015437374,0.00008365318,0.000037870603],"category_scores_gemma":[0.008629371,0.00011287621,0.0019884096,0.0018335255,0.0018102758,0.000086209846,0.00043913923,0.0010443478,7.1958124e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021256605,0.0003413498,0.0007792783,0.2291851,0.003122184,0.000039933617,0.00089138333,0.0000038968014,0.000012461467,0.00029189824,0.0033814812,0.7617385],"study_design_scores_gemma":[0.001785224,0.00068324455,0.003691352,0.82120496,0.0060525043,0.00003240902,0.001912205,0.000003739266,0.00013172317,0.00010028578,0.16423713,0.00016521204],"about_ca_topic_score_codex":0.00003500316,"about_ca_topic_score_gemma":0.000003997584,"teacher_disagreement_score":0.76157326,"about_ca_system_score_codex":0.00047336073,"about_ca_system_score_gemma":0.0026614948,"threshold_uncertainty_score":0.99972135},"labels":[],"label_agreement":null},{"id":"W4411715496","doi":"10.6004/jnccn.2025.7029","title":"Association of Polypharmacy and Potentially Inappropriate Medications With Outcomes in Older Adults With DLBCL: A Population Study","year":2025,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; University Health Network; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Polypharmacy; Hazard ratio; Internal medicine; Population; Comorbidity; Proportional hazards model; Emergency medicine; Confidence interval; Environmental health","score_opus":0.015517056097077942,"score_gpt":0.3569374022833494,"score_spread":0.3414203461862715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411715496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838338,0.0018276288,0.000058395974,0.013047944,0.00020582636,0.0008946248,0.000007588093,0.0000046451764,0.00011955442],"genre_scores_gemma":[0.998434,0.00024194943,0.00027670615,0.00057866867,0.00016324519,0.000035423473,0.0000018981392,0.000008026604,0.00026008414],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99812394,0.00014102494,0.00040978892,0.000121512574,0.0010635476,0.00014020609],"domain_scores_gemma":[0.9968339,0.00028704517,0.0006025898,0.00007659255,0.0021580039,0.000041852603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032111406,0.0001061749,0.00037311204,0.00018969888,0.00009544894,0.000012256706,0.00010994575,0.00003232566,0.0000087482085],"category_scores_gemma":[0.00017015614,0.000059116734,0.00005158527,0.0006325205,0.000056584548,0.000099333694,0.00004989407,0.00031564277,8.694603e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015481138,0.00029338812,0.98990804,0.00008361696,0.0013986167,0.0000034848665,0.00057075644,0.0038245455,0.000030600655,0.00005140887,0.001604165,0.00068324636],"study_design_scores_gemma":[0.008159339,0.00023680578,0.9890726,0.0011134545,0.00035350185,0.000008642943,0.00044933427,0.00021161084,0.0000200734,0.00015712669,0.00016530625,0.00005220029],"about_ca_topic_score_codex":0.00022129896,"about_ca_topic_score_gemma":0.00047764572,"teacher_disagreement_score":0.014600206,"about_ca_system_score_codex":0.0005619124,"about_ca_system_score_gemma":0.00046584048,"threshold_uncertainty_score":0.24107105},"labels":[],"label_agreement":null},{"id":"W4412816997","doi":"10.3322/caac.70026","title":"Multidisciplinary assessment of patients with extensive stage small cell lung cancer: A geriatric tumor board","year":2025,"lang":"en","type":"article","venue":"CA A Cancer Journal for Clinicians","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Multidisciplinary approach; Lung cancer; Stage (stratigraphy); Cancer; Oncology; Geriatric oncology; Intensive care medicine; Internal medicine","score_opus":0.02501476209211731,"score_gpt":0.42295476984659197,"score_spread":0.3979400077544747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412816997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.978555,0.008582505,0.0019030889,0.0020144358,0.0015153014,0.002971465,0.0007171326,0.00003694225,0.0037041067],"genre_scores_gemma":[0.95176214,0.0056430744,0.0049039377,0.0009997498,0.00073182874,0.0010760588,0.000021979014,0.0001550737,0.034706138],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977703,0.000072762356,0.0007220424,0.00039885275,0.00047987612,0.00055615505],"domain_scores_gemma":[0.9971243,0.00030294625,0.0006157595,0.0003192698,0.0014071332,0.00023055448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003837755,0.00027457252,0.0008316771,0.00034835635,0.00028155677,0.000028001108,0.00021597456,0.00007254628,0.00023430842],"category_scores_gemma":[0.00015399356,0.00019983719,0.00029583508,0.00046791334,0.00015892407,0.00007792651,0.00012897662,0.0005598699,9.627912e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023628932,0.0005585986,0.9648448,0.0020572075,0.0011199141,0.00007912856,0.0004801812,0.00044987202,0.00023017153,0.000025147152,0.024929173,0.0028628765],"study_design_scores_gemma":[0.01878004,0.0025288695,0.94613147,0.0027652122,0.0018478667,0.0000044449607,0.0015395989,0.0018819309,0.0004984948,0.0000430009,0.023597028,0.00038204322],"about_ca_topic_score_codex":0.0003669769,"about_ca_topic_score_gemma":0.00075731665,"teacher_disagreement_score":0.03100203,"about_ca_system_score_codex":0.0010397474,"about_ca_system_score_gemma":0.0032024528,"threshold_uncertainty_score":0.8149124},"labels":[],"label_agreement":null},{"id":"W4413108138","doi":"10.1200/jco-25-00221","title":"Hippocampal Avoidance During Prophylactic Cranial Irradiation for Patients With Small Cell Lung Cancer: Randomized Phase II/III Trial NRG-CC003","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute","keywords":"Medicine; Prophylactic cranial irradiation; Conventional PCI; Internal medicine; Hazard ratio; Lung cancer; Randomized controlled trial; Surgery; Oncology; Urology; Confidence interval; Myocardial infarction","score_opus":0.052532914754491816,"score_gpt":0.46942480112778784,"score_spread":0.416891886373296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413108138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849744,0.0012383268,0.0009032572,0.00499175,0.003050475,0.0041617416,0.000011739353,0.000014953121,0.00065337395],"genre_scores_gemma":[0.99209577,0.00089575787,0.0024073056,0.0006083306,0.0025583617,0.00030907776,0.000004646048,0.000022845312,0.0010978862],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9955409,0.00072553125,0.0024846257,0.00030431643,0.0005363579,0.00040825538],"domain_scores_gemma":[0.9912108,0.004844015,0.002124181,0.00019214425,0.0013375191,0.00029132457],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0040540574,0.00021274427,0.0026981006,0.00022573076,0.00021691057,0.000018254035,0.00019401274,0.0002679739,0.000052119187],"category_scores_gemma":[0.01048334,0.00013433743,0.00066204695,0.00023362483,0.00031831075,0.0001412749,0.00007333066,0.0010615434,8.412327e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96126425,0.0049327076,0.008108072,0.00043916746,0.0011856384,0.000053285356,0.00021859362,0.000029113058,0.000082518454,0.000015525107,0.0019088768,0.021762228],"study_design_scores_gemma":[0.9530619,0.031674348,0.008146823,0.0002952491,0.0020025559,0.0000046218515,0.00003813378,0.00037276544,0.00009207692,0.00012718879,0.0040594526,0.00012490069],"about_ca_topic_score_codex":0.00003982552,"about_ca_topic_score_gemma":0.000056223602,"teacher_disagreement_score":0.02674164,"about_ca_system_score_codex":0.0007468427,"about_ca_system_score_gemma":0.0049120365,"threshold_uncertainty_score":0.9978518},"labels":[],"label_agreement":null},{"id":"W4413329353","doi":"10.3390/curroncol32080472","title":"Real-World Effectiveness and Safety of Immune Checkpoint Inhibitors Combined with Chemotherapy in Taiwanese Patients with Extensive-Stage Small Cell Lung Cancer","year":2025,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Taiwan University; Far Eastern Memorial Hospital; National Taiwan University Hospital Yunlin Branch; National Taiwan University Hospital","keywords":"Medicine; Lung cancer; Chemotherapy; Stage (stratigraphy); Oncology; Cancer; Internal medicine; Intensive care medicine; Cancer research; Biology","score_opus":0.02236862853258093,"score_gpt":0.3767170663839872,"score_spread":0.3543484378514063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413329353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923409,0.0029601213,0.000023889455,0.00056650944,0.00019413023,0.0023074658,0.0000139721515,0.000022735496,0.0015702457],"genre_scores_gemma":[0.99725443,0.0019211745,0.000065761466,0.000039785453,0.000029901134,0.00033977733,0.000021355845,0.000023800834,0.00030402103],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984888,0.00017608186,0.00038974662,0.00038531856,0.00021758072,0.00034251602],"domain_scores_gemma":[0.9987503,0.00026642147,0.0001910813,0.00025163422,0.0004578453,0.00008270934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034576622,0.00022983525,0.00082455465,0.0003029066,0.000055291788,0.0000049198898,0.00008539529,0.00006594209,0.000022896307],"category_scores_gemma":[0.000057772802,0.00015677726,0.00004734652,0.0005903056,0.0003725012,0.000041841733,0.000117218144,0.00036728667,3.2734383e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017922806,0.0011219622,0.9667528,0.0030483655,0.00021543136,0.000021752257,0.00076601515,0.000020911584,0.0010576034,0.000047403657,0.0001290339,0.008895882],"study_design_scores_gemma":[0.026311923,0.0021041832,0.9595203,0.0020792726,0.00011815922,5.6787536e-7,0.00018515189,0.00007116698,0.0073210946,0.000008652241,0.0021355157,0.00014404996],"about_ca_topic_score_codex":0.00095979875,"about_ca_topic_score_gemma":0.002048495,"teacher_disagreement_score":0.008751833,"about_ca_system_score_codex":0.001023039,"about_ca_system_score_gemma":0.000654796,"threshold_uncertainty_score":0.6393191},"labels":[],"label_agreement":null},{"id":"W4413382855","doi":"10.58931/cot.2025.2239","title":"Small-Cell Lung Cancer: Integration of Radiation and Immunotherapy for All Stages","year":2025,"lang":"en","type":"article","venue":"Canadian oncology today.","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Charles-Le Moyne","funders":"","keywords":"Immunotherapy; Lung cancer; Cancer; Medicine; Radiation therapy; Oncology; Cancer research; Internal medicine","score_opus":0.025115515050603034,"score_gpt":0.3782479123245323,"score_spread":0.35313239727392925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413382855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8067602,0.08449829,0.0015984224,0.07698238,0.001032477,0.00446659,0.00034038554,0.000054052176,0.024267225],"genre_scores_gemma":[0.97243094,0.011680221,0.00084320694,0.004717512,0.0001372753,0.0006216622,0.000075708376,0.00002181233,0.009471661],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99932665,0.000038508453,0.00017110878,0.00016652334,0.00005402365,0.0002432183],"domain_scores_gemma":[0.9993641,0.00016912831,0.000057207704,0.00013026217,0.00015186299,0.00012745317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021016975,0.00008711909,0.00026015384,0.000271972,0.00007415147,0.0000070072406,0.000060780883,0.00011196179,0.00005266319],"category_scores_gemma":[0.00011873806,0.000079929305,0.00003831639,0.00013193837,0.000102402366,0.000031529937,0.00001160318,0.000114466595,4.5488548e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006732643,0.00008622734,0.15731007,0.0007871922,0.0008531539,0.000018929231,0.0032887582,0.000012727802,0.032620497,0.002275824,0.18824475,0.6138286],"study_design_scores_gemma":[0.009390092,0.0015291414,0.17997049,0.000429374,0.00042795856,0.000005558492,0.0010772038,0.001146028,0.036143433,0.00045778265,0.769169,0.000253932],"about_ca_topic_score_codex":0.06419909,"about_ca_topic_score_gemma":0.2699619,"teacher_disagreement_score":0.6135747,"about_ca_system_score_codex":0.0014246607,"about_ca_system_score_gemma":0.0027098577,"threshold_uncertainty_score":0.9420325},"labels":[],"label_agreement":null},{"id":"W4413836422","doi":"10.1158/1078-0432.ccr-24-4342","title":"Phase I Dose-Escalation Trial Combining Olaparib and Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; AstraZeneca; AstraZeneca United States","keywords":"Medicine; Olaparib; Pneumonitis; Esophagitis; Internal medicine; PARP inhibitor; Radiation therapy; Adverse effect; Oncology; Gastroenterology; Urology; Surgery; Lung","score_opus":0.24740009084507647,"score_gpt":0.6157291510270154,"score_spread":0.36832906018193895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413836422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9470594,0.037042014,0.00011511983,0.009017634,0.00069785095,0.003530904,0.00003631414,0.000057750072,0.002443046],"genre_scores_gemma":[0.94575197,0.040737648,0.00024623467,0.00097411365,0.0009505015,0.001510409,0.000015498692,0.00005463661,0.009758992],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99504185,0.0011105543,0.0009754031,0.00096732494,0.0009291913,0.0009757019],"domain_scores_gemma":[0.99549794,0.002680317,0.00012351248,0.00057813706,0.0007490226,0.00037105536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056139217,0.00025733048,0.000953775,0.00059307157,0.00029545152,0.00010631296,0.0002865195,0.0002875585,0.0003332634],"category_scores_gemma":[0.0019069647,0.00021900069,0.00016462317,0.0013673801,0.00083765766,0.00012893512,0.00032646727,0.0022545182,0.000005391243],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24912624,0.0044181803,0.42327768,0.003051891,0.00078690157,0.00033824318,0.0017217795,0.00007726102,0.0059198933,0.00035840322,0.028132603,0.28279093],"study_design_scores_gemma":[0.6421677,0.011136361,0.22182874,0.0054834257,0.00041970256,0.0000040896134,0.0017393931,0.03153638,0.004648794,0.00055454747,0.07943371,0.0010471819],"about_ca_topic_score_codex":0.0026438008,"about_ca_topic_score_gemma":0.001248759,"teacher_disagreement_score":0.39304143,"about_ca_system_score_codex":0.0010538263,"about_ca_system_score_gemma":0.0022825722,"threshold_uncertainty_score":0.9794885},"labels":[],"label_agreement":null},{"id":"W4413956624","doi":"10.1158/1535-7163.mct-24-0861","title":"CRISPR Screen Identifies HDAC3 as a Novel Radiosensitizing Target in Small Cell Lung Cancer","year":2025,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University; Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute; Terry Fox Research Institute; Canada Foundation for Innovation; Deutsche Forschungsgemeinschaft; Clinical and Translational Science Center, Weill Cornell Medical College; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Radioresistance; Cancer research; Clonogenic assay; DNA repair; Olaparib; HDAC3; Gene knockdown; DNA damage; Radiosensitivity; Synthetic lethality; Biology; Radiosensitizer; Cell; Chemistry; Cell culture; Poly ADP ribose polymerase; Radiation therapy; Medicine; Histone; Genetics; DNA; Histone deacetylase; Internal medicine","score_opus":0.02859787776326449,"score_gpt":0.36494875402170607,"score_spread":0.33635087625844157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413956624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77558506,0.17957541,0.012144604,0.01716427,0.00095654506,0.0023079505,0.00010678789,0.00019127001,0.011968109],"genre_scores_gemma":[0.9735224,0.0070616654,0.0014339858,0.012355104,0.00016836342,0.00042888816,0.000018160155,0.000090059984,0.0049213227],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99772453,0.00008830943,0.0004044494,0.00058779813,0.0004586523,0.00073624327],"domain_scores_gemma":[0.99886477,0.000077674726,0.0000930847,0.00054112985,0.0003000538,0.00012327307],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028797885,0.00034933077,0.0005767051,0.00038971004,0.00013976492,0.00007548201,0.00025973772,0.00015475567,0.00008759341],"category_scores_gemma":[0.000040887793,0.00033402513,0.00018470443,0.0008454734,0.00016829,0.000069473404,0.00020288579,0.000573719,0.0000072567173],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078501506,0.00037782794,0.06747078,0.0015981941,0.0021666072,0.0006704618,0.002727058,0.001180516,0.9129815,0.000756947,0.0026667234,0.006618366],"study_design_scores_gemma":[0.009421165,0.0002012253,0.026148034,0.0025637003,0.0013886875,0.000022684331,0.0012270432,0.007682278,0.9040809,0.0008709808,0.045467436,0.0009258211],"about_ca_topic_score_codex":0.0057964376,"about_ca_topic_score_gemma":0.0014033274,"teacher_disagreement_score":0.1979374,"about_ca_system_score_codex":0.0010060619,"about_ca_system_score_gemma":0.001038148,"threshold_uncertainty_score":0.9999112},"labels":[],"label_agreement":null},{"id":"W4413974852","doi":"10.1101/2025.09.04.674147","title":"γδ T cells modulate anti-tumor immunity in small cell lung cancer","year":2025,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Institut National Du Cancer; National Health and Medical Research Council; State Government of Victoria; Bundesministerium für Bildung und Forschung; Cancer Council Victoria; Deutsche Forschungsgemeinschaft; Australian Government; Marshfield Clinic Research Foundation; Wellcome Trust; International Association for the Study of Lung Cancer","keywords":"Immunity; Lung cancer; Cancer research; Tumor cells; Cell mediated immunity; Medicine; Immunology; Immune system; Oncology","score_opus":0.017754942945400913,"score_gpt":0.28238433777502375,"score_spread":0.26462939482962283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413974852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9797569,0.014046167,0.00012358534,0.0005970076,0.0017065804,0.0026452488,0.0006122732,0.0003654386,0.00014683658],"genre_scores_gemma":[0.99113506,0.005208431,0.0014876316,0.00047740905,0.00044390434,0.000944338,6.2341866e-7,0.00013877738,0.00016384566],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9957279,0.00027448204,0.0008354051,0.0013870687,0.0005846228,0.001190515],"domain_scores_gemma":[0.9961074,0.00013799027,0.00038262032,0.0021208473,0.0008530433,0.00039808414],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0009507332,0.0008441355,0.0014745046,0.00081075,0.00019504463,0.00013337581,0.0008113493,0.0004988719,0.00010788323],"category_scores_gemma":[0.00024395836,0.00086268614,0.0002874043,0.0011360862,0.00021685327,0.00010207753,0.0018088542,0.0026107738,0.000033236913],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019522799,0.00060357957,0.15452982,0.010992103,0.00067634246,0.00063260994,0.0000716182,0.00079375505,0.82921106,0.000052068972,0.0022387842,0.000003052171],"study_design_scores_gemma":[0.002465494,0.00006907827,0.34740797,0.004879962,0.00048388378,1.40963055e-8,0.000009793565,0.0025188918,0.6379482,0.0000012517459,0.0032217684,0.0009936839],"about_ca_topic_score_codex":0.003382083,"about_ca_topic_score_gemma":0.00009631693,"teacher_disagreement_score":0.19287813,"about_ca_system_score_codex":0.0019993277,"about_ca_system_score_gemma":0.0035644306,"threshold_uncertainty_score":0.99969023},"labels":[],"label_agreement":null},{"id":"W4414377875","doi":"10.1016/j.jtcvs.2025.09.017","title":"TROPION-Lung12: A phase 3 study of adjuvant datopotamab deruxtecan and rilvegostomig in ctDNA-positive or high-risk pathology stage I non–small cell lung cancer","year":2025,"lang":"en","type":"article","venue":"Journal of Thoracic and Cardiovascular Surgery","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"National Cancer Institute; AstraZeneca","keywords":"Clinical endpoint; Stage (stratigraphy); Adenocarcinoma; Adjuvant; Lung cancer; Randomized controlled trial; Phases of clinical research; Adjuvant therapy","score_opus":0.015638285913113642,"score_gpt":0.3483685570031425,"score_spread":0.33273027109002884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414377875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9077185,0.0902601,0.0007633483,0.00014428042,0.0002876529,0.0007254189,0.00004964515,0.000006850972,0.000044232875],"genre_scores_gemma":[0.96621406,0.03319066,0.00015187981,0.000059173915,0.00013275688,0.000046469504,0.0000025925422,0.000023260754,0.0001791168],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971473,0.0007134061,0.00081618887,0.00037593342,0.0005796452,0.000367498],"domain_scores_gemma":[0.99809897,0.0005445741,0.00036364733,0.00040351835,0.00041004192,0.00017923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026762441,0.00026131974,0.0019347261,0.00073776284,0.000108656066,0.000025334346,0.00010710492,0.00011044334,0.000015354826],"category_scores_gemma":[0.00038450593,0.00018458751,0.0005009833,0.0005225554,0.00016429833,0.00012948478,0.00018487596,0.00060089515,1.8631175e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008252896,0.001541869,0.72821945,0.002328407,0.009335208,0.008682042,0.0039468496,0.00019513135,0.0007298218,0.0000018987153,0.0007370816,0.23602934],"study_design_scores_gemma":[0.021273954,0.0029407141,0.9345674,0.0036432396,0.010959957,0.00071142206,0.01585922,0.00036453208,0.0077827442,0.000029350625,0.0013087901,0.000558664],"about_ca_topic_score_codex":0.0012096935,"about_ca_topic_score_gemma":0.00027916845,"teacher_disagreement_score":0.23547068,"about_ca_system_score_codex":0.00019159648,"about_ca_system_score_gemma":0.0007465279,"threshold_uncertainty_score":0.752726},"labels":[],"label_agreement":null},{"id":"W4414422734","doi":"10.1016/j.euo.2025.07.007","title":"Genomic Predictors of Response to Metastasis-directed Therapy With or Without Androgen Deprivation Therapy","year":2025,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"McMaster University; Movember Foundation; National Cancer Institute; National Institutes of Health; Prostate Cancer Foundation; Foundation for the National Institutes of Health; U.S. Department of Defense","keywords":"Androgen deprivation therapy; Prostate cancer; Predictive testing; Personalized medicine; Personalization; Precision medicine; Androgen","score_opus":0.03536143272135039,"score_gpt":0.35896742767318646,"score_spread":0.32360599495183606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414422734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98222405,0.001482271,0.00024750273,0.0073991427,0.00017125836,0.0013110652,0.000012044513,0.00017482469,0.0069778357],"genre_scores_gemma":[0.99103445,0.0009115274,0.0013483368,0.00467759,0.00010186332,0.000087912085,0.000011353564,0.000049489394,0.0017774897],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967172,0.00186516,0.00038402982,0.00045792994,0.00019126177,0.000384418],"domain_scores_gemma":[0.99838233,0.0005760626,0.00013963495,0.0004975456,0.0002798952,0.00012454245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013673615,0.00021529691,0.00066775386,0.00047337532,0.00009530939,0.0000058556748,0.0002525063,0.00008257696,0.00012588638],"category_scores_gemma":[0.00055465446,0.00013849403,0.000062812265,0.0006081811,0.00040167943,0.00003167188,0.000142461,0.00027558426,0.000035621564],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.270816,0.0007583339,0.48844925,0.000040321123,0.0029965206,0.00047064197,0.0030186914,0.000053618718,0.17646284,0.000033478664,0.009669884,0.047230404],"study_design_scores_gemma":[0.009655622,0.016659463,0.6472668,0.000020798425,0.0001225046,0.000092736605,0.00010287265,0.000021178894,0.0064133443,0.000010080744,0.31951532,0.00011929672],"about_ca_topic_score_codex":0.000029804174,"about_ca_topic_score_gemma":0.0000793587,"teacher_disagreement_score":0.30984545,"about_ca_system_score_codex":0.00019378518,"about_ca_system_score_gemma":0.0008014808,"threshold_uncertainty_score":0.5647623},"labels":[],"label_agreement":null},{"id":"W4414492606","doi":"10.3390/curroncol32100536","title":"Bridging Knowledge Gaps in Small Cell Lung Cancer: Data, Challenges and Priorities","year":2025,"lang":"en","type":"review","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Immunotherapy; Limiting; Malignancy; Clinical trial; Biomarker; Lung cancer; Biomarker discovery; Acquired resistance; Immune system","score_opus":0.31855522871559755,"score_gpt":0.5447749419546917,"score_spread":0.22621971323909412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414492606","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000016024664,0.98743695,0.0000036673323,0.00045270892,0.0019072286,0.0019445071,0.00018506168,0.00005145728,0.008002383],"genre_scores_gemma":[0.000006454117,0.996758,0.000039648705,0.00001333848,0.0009916207,0.00081020297,0.00015828302,0.00003805944,0.0011843999],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972854,0.00040220082,0.0006061822,0.0009404107,0.0001504478,0.0006153203],"domain_scores_gemma":[0.9979122,0.0008862715,0.00019841635,0.0007234803,0.00012600656,0.00015356943],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006668072,0.00045353267,0.0028177032,0.0005979212,0.000070795715,0.000015983736,0.00047338972,0.00029708826,0.00002196214],"category_scores_gemma":[0.0003612878,0.0003757653,0.00013293081,0.0002740467,0.00023297177,0.000056832996,0.0016667694,0.0012821128,0.000009457196],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011747656,0.0001373289,0.0002605014,0.2553038,0.00013358811,0.000044013053,0.0005203366,1.4005383e-8,3.6844625e-8,0.00004803023,0.0073766923,0.7361639],"study_design_scores_gemma":[0.0009412047,0.00012121642,0.00013402611,0.07579127,0.0012480796,0.00002197098,0.00010650878,0.00003113944,2.0725061e-7,0.0000079442325,0.9213537,0.00024275163],"about_ca_topic_score_codex":0.00007789679,"about_ca_topic_score_gemma":0.0019504116,"teacher_disagreement_score":0.91397697,"about_ca_system_score_codex":0.0015416861,"about_ca_system_score_gemma":0.004626941,"threshold_uncertainty_score":0.9998694},"labels":[],"label_agreement":null},{"id":"W4414520286","doi":"10.3389/fphar.2025.1607255","title":"Efficacy and safety of anlotinib in the treatment of brain metastases from non-small cell lung cancer: a systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"Frontiers in Pharmacology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lung; Cell; Cell growth; Lung cancer; Clinical trial; Safety profile","score_opus":0.05666635317085317,"score_gpt":0.43167140022410183,"score_spread":0.37500504705324866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414520286","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000032138578,0.98709905,0.000046997353,0.0007271608,0.0001038929,0.010850087,0.0010737028,0.000004674451,0.000062272695],"genre_scores_gemma":[0.000037486585,0.99522406,0.00051660085,0.00036046957,0.000021010499,0.0034322564,0.000097025724,0.000017705599,0.00029335628],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99521554,0.0022037055,0.0014934135,0.0005460985,0.00024021103,0.0003010356],"domain_scores_gemma":[0.99605125,0.0026157305,0.0007408026,0.00044393135,0.00007807244,0.00007022399],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012144272,0.00046723435,0.013144053,0.00078313524,0.000030591033,0.000005332301,0.0002765661,0.00012615319,0.00009230213],"category_scores_gemma":[0.00017188604,0.00024986197,0.0010196641,0.001355148,0.00022906641,0.000021488746,0.0001042295,0.00028553556,1.8335346e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000935546,0.0003608261,0.00014850995,0.78764474,0.19929366,0.000048906157,0.0005658272,0.0000031784396,7.6325955e-7,8.7130826e-7,0.007614745,0.004224403],"study_design_scores_gemma":[0.0023345088,0.00024079306,0.00003112977,0.027459128,0.94596833,0.0000028030927,0.00010928928,0.0000270439,0.0000073189553,0.0000019164697,0.023670042,0.0001477066],"about_ca_topic_score_codex":0.0007046799,"about_ca_topic_score_gemma":0.00016304146,"teacher_disagreement_score":0.76018566,"about_ca_system_score_codex":0.0003554659,"about_ca_system_score_gemma":0.00045346806,"threshold_uncertainty_score":0.99999535},"labels":[],"label_agreement":null},{"id":"W4414557925","doi":"10.1016/j.ijrobp.2025.06.3722","title":"Multidisciplinary Team (MDT) Perceptions Towards the Treatment of Limited-Stage Small-Cell Lung Cancer (LS-SCLC): A US Physician Survey","year":2025,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Lung cancer; Multidisciplinary approach; Multidisciplinary team; Perception; MEDLINE; Lung disease","score_opus":0.04471187721567959,"score_gpt":0.4112612050795816,"score_spread":0.366549327863902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414557925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9766159,0.0038914955,0.0023459538,0.0063537923,0.0017450629,0.0007750197,0.00037704283,0.00003651797,0.007859228],"genre_scores_gemma":[0.9857018,0.008269717,0.000650646,0.00052191794,0.0012737759,0.000086643064,0.00008690193,0.00003463859,0.003373968],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981198,0.00038957855,0.000661732,0.00024903144,0.0003107271,0.00026914157],"domain_scores_gemma":[0.9971995,0.00062061904,0.00073191983,0.00024503528,0.0011074686,0.0000954781],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004931848,0.0002331344,0.00059642835,0.00024600336,0.00014252593,0.000019594887,0.00040349484,0.00015067913,0.000096475786],"category_scores_gemma":[0.00020082993,0.00015832855,0.00033443098,0.0003452239,0.0003633208,0.00010391091,0.00010747131,0.0003578873,0.000009798957],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083188736,0.0020669755,0.89630777,0.00004553475,0.0025621152,0.000019806508,0.002229414,0.0009791465,0.0057485057,0.0008165902,0.0052055856,0.083186656],"study_design_scores_gemma":[0.008725057,0.0023341114,0.93354905,0.00020156642,0.00056057016,0.000014752841,0.0006879474,0.0056746393,0.004170824,0.00035580478,0.04352955,0.00019613426],"about_ca_topic_score_codex":0.0006372422,"about_ca_topic_score_gemma":0.00030619703,"teacher_disagreement_score":0.08299053,"about_ca_system_score_codex":0.0020299593,"about_ca_system_score_gemma":0.0015303768,"threshold_uncertainty_score":0.6456451},"labels":[],"label_agreement":null},{"id":"W4414873690","doi":"10.3390/curroncol32100558","title":"Incidence of Hypothyroidism and Thyroid Function Monitoring After Immune Checkpoint Inhibitor Therapy Completion for Lung Cancer: A Nationwide Analysis of a Japanese Claims Database","year":2025,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Incidence (geometry); Thyroid; Bevacizumab; Adverse effect; Thyroid function; Thyroid cancer; Lung cancer; Cumulative incidence","score_opus":0.06824818010564082,"score_gpt":0.4450663110306363,"score_spread":0.3768181309249955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414873690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9296461,0.06683555,0.0011581082,0.0006920968,0.0006183223,0.00089718675,0.00010159424,0.000016036081,0.00003503265],"genre_scores_gemma":[0.9889385,0.009727573,0.00023032671,0.000022496499,0.00015774522,0.00080139976,0.0000665113,0.000008275028,0.000047156573],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986971,0.00008328317,0.00048592326,0.0002868739,0.0002539665,0.00019284127],"domain_scores_gemma":[0.9985566,0.00034631332,0.00022675587,0.0002359037,0.000583611,0.00005082071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000493901,0.00013121395,0.0006493501,0.00054175255,0.00006642278,0.0000056389217,0.00007215784,0.00006403714,0.00001736931],"category_scores_gemma":[0.00025973443,0.00011075376,0.00014933865,0.00073331664,0.00019610686,0.00009263005,0.00011367159,0.00016652839,1.5309719e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006794015,0.0007210365,0.6114749,0.0019744185,0.003214612,0.000002915071,0.0035904539,0.000056839188,0.34109008,0.00008014583,0.00065497437,0.030345617],"study_design_scores_gemma":[0.0060662236,0.0013200358,0.9530982,0.000867343,0.0026665244,0.0000017890887,0.0011055121,0.0066783456,0.025866223,0.000067255336,0.0021026393,0.00015993297],"about_ca_topic_score_codex":0.00035212308,"about_ca_topic_score_gemma":0.00017048042,"teacher_disagreement_score":0.3416233,"about_ca_system_score_codex":0.00037636305,"about_ca_system_score_gemma":0.00024786152,"threshold_uncertainty_score":0.45164073},"labels":[],"label_agreement":null},{"id":"W4415519091","doi":"10.1016/j.jtho.2025.09.967","title":"P3.13.31 Real-World Effectiveness and Safety of Lurbinectedin for Small Cell Lung Cancer (SCLC): Updates From Jazz EMERGE 402","year":2025,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec; Southlake Regional Health Center","funders":"","keywords":"Jazz; Lung cancer; MEDLINE; Small Cell Lung Carcinoma","score_opus":0.021141748485960583,"score_gpt":0.45212914127192616,"score_spread":0.4309873927859656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415519091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9712113,0.014227494,0.001077769,0.0064838785,0.0012788239,0.0010726429,0.00011287865,0.000016695736,0.0045185033],"genre_scores_gemma":[0.9842672,0.009358506,0.0032438138,0.00027536447,0.00068630854,0.00009888152,0.000012266543,0.000031301053,0.0020263987],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99810225,0.00029917175,0.00074064924,0.00025916315,0.00024858897,0.00035016082],"domain_scores_gemma":[0.99643457,0.0018493278,0.0005535876,0.00020245151,0.0008016801,0.00015836798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012587175,0.00020327233,0.0011807346,0.00043970565,0.00010155158,0.000009835752,0.00019671088,0.00014987239,0.00008609744],"category_scores_gemma":[0.00045708535,0.00015322979,0.00020074703,0.00041304983,0.00018316934,0.00008596373,0.00016399493,0.0004929819,6.9367314e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06692396,0.0012009287,0.60905844,0.008837553,0.0052977307,0.00031559763,0.0013559067,0.00017776666,0.09083074,0.00019673051,0.07437579,0.14142887],"study_design_scores_gemma":[0.010509905,0.004389582,0.8382198,0.0039150515,0.00370755,0.00003920318,0.0005487027,0.0008358882,0.07279522,0.001216479,0.06348638,0.00033618484],"about_ca_topic_score_codex":0.001167437,"about_ca_topic_score_gemma":0.0025279124,"teacher_disagreement_score":0.22916143,"about_ca_system_score_codex":0.0009099294,"about_ca_system_score_gemma":0.001187414,"threshold_uncertainty_score":0.62485296},"labels":[],"label_agreement":null},{"id":"W4415520521","doi":"10.1016/j.jtho.2025.09.700","title":"P2.10.06 Docetaxel in NSCLC: A Multi-Centre Real World Evidence Analysis in the Immunotherapy Era","year":2025,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Docetaxel; Immunotherapy; Lung cancer; Real world evidence; Standard of care; Second line; Chemotherapy; Nivolumab","score_opus":0.057748108346006,"score_gpt":0.5180295112931637,"score_spread":0.46028140294715764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415520521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86633927,0.019432997,0.00027483588,0.10672128,0.0003041998,0.00074320444,0.000003744754,0.000013412654,0.006167084],"genre_scores_gemma":[0.98333937,0.0061765793,0.0019912026,0.0015557891,0.00017016944,0.000021352958,0.0000013655894,0.0000097237435,0.006734428],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99710906,0.00094760564,0.0008447214,0.00020942045,0.00049369765,0.00039550808],"domain_scores_gemma":[0.9974943,0.0013680314,0.00037557987,0.00034589978,0.00034483479,0.00007138437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034620776,0.00016022156,0.000956823,0.0017127134,0.000062823194,0.000028144092,0.0004506526,0.00010124535,0.00020976426],"category_scores_gemma":[0.0009991986,0.00009818886,0.00031065027,0.0031296967,0.00016780068,0.0001590634,0.000087051674,0.0011217288,0.0000122104375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0114731975,0.0022466676,0.7811423,0.00026543566,0.003390215,0.0028623682,0.0072041634,0.00029503103,0.002435186,0.00008527613,0.020937378,0.1676628],"study_design_scores_gemma":[0.003519474,0.00070157147,0.96157366,0.0012251879,0.00094335165,0.00006803559,0.0024980102,0.00055271725,0.00017791284,0.00016184915,0.028455349,0.0001228652],"about_ca_topic_score_codex":0.000615823,"about_ca_topic_score_gemma":0.010486451,"teacher_disagreement_score":0.1804314,"about_ca_system_score_codex":0.0014390128,"about_ca_system_score_gemma":0.0011728343,"threshold_uncertainty_score":0.5851686},"labels":[],"label_agreement":null},{"id":"W4415537250","doi":"10.1007/s00253-025-13577-0","title":"Genetically encoded fluorescent probes to assist in the diagnosis of small cell lung cancer","year":2025,"lang":"en","type":"article","venue":"Applied Microbiology and Biotechnology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"123 Certification (Canada)","funders":"","keywords":"Peptide; Detection limit; Fluorescence; Enolase; Phage display; Lung cancer; Binding selectivity; Molecular probe","score_opus":0.0100182625724784,"score_gpt":0.28899144555107403,"score_spread":0.27897318297859564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415537250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.961141,0.006335923,0.00023129866,0.030196019,0.000056199922,0.0013090067,0.000018715591,0.000032322667,0.0006795541],"genre_scores_gemma":[0.9935872,0.002591213,0.001106088,0.0018874428,0.000015099428,0.00073612115,0.0000062124013,0.0000059382282,0.000064666536],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99903595,0.00003861002,0.00023085489,0.0003402894,0.000031140713,0.00032317618],"domain_scores_gemma":[0.99949247,0.00013464077,0.000038850685,0.0002699453,0.000039521492,0.000024577628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020385932,0.00013397959,0.0003488106,0.00024999655,0.000058876823,0.0000037306627,0.00022815874,0.00034479718,0.000013149565],"category_scores_gemma":[0.000052940028,0.00008519851,0.000031197585,0.0004179993,0.00056034775,0.0000035156756,0.00027420116,0.0003472789,0.0000023209861],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024227856,0.00021240047,0.08436999,0.0003409126,0.00011320863,0.00000924085,0.00024818126,0.000001929733,0.89549655,0.005640529,0.0032425656,0.010082224],"study_design_scores_gemma":[0.0012487146,0.00022523009,0.030687546,0.0001282681,0.000105442035,0.0000097573475,0.00030068328,0.000004983558,0.9570832,0.00028946705,0.009812759,0.00010394564],"about_ca_topic_score_codex":0.0001233892,"about_ca_topic_score_gemma":0.00045774446,"teacher_disagreement_score":0.06158666,"about_ca_system_score_codex":0.000065679706,"about_ca_system_score_gemma":0.000115334034,"threshold_uncertainty_score":0.34742945},"labels":[],"label_agreement":null},{"id":"W4415817108","doi":"10.1016/j.lungcan.2025.108812","title":"Systematic review and network meta-analysis: evaluation of systemic therapies for platinum refractory or resistant small cell lung cancer","year":2025,"lang":"en","type":"review","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Waterloo","funders":"","keywords":"Refractory (planetary science); Lung cancer; Platinum; Chemotherapy; Clinical trial","score_opus":0.15357206138554297,"score_gpt":0.4720203776983185,"score_spread":0.31844831631277554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415817108","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000014556248,0.97320765,0.000066808985,0.00019935405,0.00025376055,0.025126472,0.0008801341,0.000045737397,0.00021862364],"genre_scores_gemma":[0.00003678863,0.94524556,0.00013485012,0.0002187837,0.00025524964,0.045926753,0.00011407589,0.00008898758,0.007978963],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.993148,0.001584178,0.0023980357,0.0009753078,0.0012960386,0.00059840543],"domain_scores_gemma":[0.992786,0.001988283,0.0022992587,0.0012653178,0.0015170386,0.00014412755],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005052025,0.00083147746,0.014210646,0.0004551036,0.00016883103,0.000041996933,0.00037572763,0.00030650062,0.0004232526],"category_scores_gemma":[0.0008802533,0.0004682196,0.002721283,0.0017254999,0.00009951355,0.000080197555,0.0001580532,0.0004595732,7.668896e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006369257,0.00002155202,0.000010641561,0.7374313,0.25492832,0.0000023725029,0.00020332586,0.000028534929,4.7807913e-7,0.000010545157,0.005833631,0.0014656401],"study_design_scores_gemma":[0.0003825335,0.00005118619,0.0000014967266,0.4121821,0.57732207,0.000002446353,0.000055673394,0.00012958692,3.058864e-7,0.0000022213492,0.009635214,0.00023515588],"about_ca_topic_score_codex":0.00036921998,"about_ca_topic_score_gemma":0.0012614797,"teacher_disagreement_score":0.32524917,"about_ca_system_score_codex":0.0021620803,"about_ca_system_score_gemma":0.004086529,"threshold_uncertainty_score":0.99977696},"labels":[],"label_agreement":null},{"id":"W4415939802","doi":"10.1016/j.annonc.2025.08.3399","title":"2788P Real-world third-line treatment patterns and outcomes for recurrent or extensive stage small cell lung cancer (SCLC) in the Canadian small cell lung cancer database (CASCADE)","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Capital District Health Authority; London Health Sciences Centre; Western University; Atlantic School of Theology; Atlantic Cancer Research Institute; BC Cancer Agency; Princess Margaret Cancer Centre; University Health Network; Jewish General Hospital; Ottawa Regional Cancer Foundation; CancerCare Manitoba","funders":"","keywords":"Lung cancer; Small Cell Lung Carcinoma; Cancer; Small-cell carcinoma; Stage (stratigraphy)","score_opus":0.14396334498684643,"score_gpt":0.4763903635046531,"score_spread":0.33242701851780665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415939802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88614196,0.018168401,0.000028221308,0.07964442,0.0006622588,0.0054463507,0.0033666403,0.000027679307,0.00651407],"genre_scores_gemma":[0.86241144,0.088257015,0.00040141033,0.015074343,0.00035422284,0.0026721708,0.00022758638,0.00006429405,0.030537492],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997542,0.00022528095,0.00056466646,0.0005802223,0.0002275049,0.00086027995],"domain_scores_gemma":[0.9974224,0.0010804724,0.00022505884,0.00051648275,0.00048613822,0.00026946136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006443631,0.000350592,0.00097518263,0.00048969773,0.000170352,0.000022447472,0.00026778923,0.00014165844,0.00011281989],"category_scores_gemma":[0.0001943679,0.00021560008,0.00014612297,0.00036305963,0.00017372984,0.000055143886,0.00014610209,0.0003720258,0.0000010062957],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003090294,0.0011167043,0.86266375,0.004364646,0.0011888703,0.0006976592,0.007457796,0.00007465693,0.00029045128,0.00024714155,0.090403736,0.028404327],"study_design_scores_gemma":[0.018276941,0.0070235757,0.60105395,0.001964154,0.001783439,0.000008473432,0.0044811554,0.001864956,0.01159864,0.000054867964,0.3511492,0.00074064604],"about_ca_topic_score_codex":0.6753426,"about_ca_topic_score_gemma":0.98763466,"teacher_disagreement_score":0.31229204,"about_ca_system_score_codex":0.0014429562,"about_ca_system_score_gemma":0.004126548,"threshold_uncertainty_score":0.87919164},"labels":[],"label_agreement":null},{"id":"W4415942153","doi":"10.1016/j.annonc.2025.08.3374","title":"2763P Treatment patterns and outcomes of clinical stage I small cell lung cancer (SCLC) in the Canadian SCLC database (CASCADE)","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; London Health Sciences Centre; Queen Elizabeth II Health Sciences Centre; Ottawa Regional Cancer Foundation; CancerCare Manitoba; Princess Margaret Cancer Centre; BC Cancer Agency; University Health Network; University of Ottawa","funders":"","keywords":"Stage (stratigraphy); Radiation therapy; Small Cell Lung Carcinoma; Chemotherapy; Prophylactic cranial irradiation; Modalities; Stereotactic radiotherapy","score_opus":0.21553980894216113,"score_gpt":0.5431567617882272,"score_spread":0.3276169528460661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415942153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9546331,0.003386877,0.000002712316,0.033438377,0.00013625529,0.00069421023,0.00033167205,0.0000041397225,0.007372657],"genre_scores_gemma":[0.9859868,0.008516134,0.000059164595,0.0037510006,0.000048817346,0.00009814013,0.000017214084,0.0000070656833,0.0015156543],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847394,0.00025548594,0.0005368125,0.00023944429,0.0001600387,0.00033428264],"domain_scores_gemma":[0.9984192,0.0008323347,0.0001361836,0.00033594403,0.0001409045,0.00013539386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094724423,0.00012328084,0.0007329828,0.00020870658,0.000049890885,0.0000046774967,0.0001538747,0.00011158062,0.000066465494],"category_scores_gemma":[0.0003075296,0.000075524884,0.00009466126,0.00015653239,0.00024179039,0.000027248314,0.00009045426,0.00024062555,8.4377007e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018886133,0.00040723,0.9709046,0.00032142785,0.00032995795,0.0001253196,0.0011990167,0.000002445829,0.000040507646,0.00012479769,0.005629266,0.020726608],"study_design_scores_gemma":[0.002815292,0.0014328817,0.93765885,0.00013805396,0.00013723262,0.0000012975119,0.00092979474,0.000046130936,0.0012970174,0.0000120506875,0.055471387,0.000060009126],"about_ca_topic_score_codex":0.50091076,"about_ca_topic_score_gemma":0.8948456,"teacher_disagreement_score":0.39393482,"about_ca_system_score_codex":0.00019558653,"about_ca_system_score_gemma":0.002134429,"threshold_uncertainty_score":0.5024127},"labels":[],"label_agreement":null},{"id":"W4416019187","doi":"10.1016/j.ijgc.2025.102731","title":"PHASE 3 ROSELLA (GOG-3073, ENGOT-OV72) TRIAL OF RELACORILANT + NAB-PACLITAXEL VS NAB-PACLITAXEL IN PLATINUM-RESISTANT OVARIAN CANCER: PRIMARY RESULTS AND OUTCOMES IN OLDER PATIENTS","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Phase (matter); Phases of clinical research; Clinical trial; MEDLINE","score_opus":0.022602088258806528,"score_gpt":0.39534424490579323,"score_spread":0.3727421566469867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416019187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834457,0.002410132,0.000011137205,0.00925275,0.0017929474,0.00096202525,0.00040508935,0.000011036009,0.0017092051],"genre_scores_gemma":[0.99314195,0.0043734387,0.00027041038,0.0008875552,0.00029988308,0.00012453215,0.000018491712,0.00001612689,0.00086762774],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99586976,0.00022942535,0.0017688118,0.0004081543,0.0013009321,0.00042290823],"domain_scores_gemma":[0.9964376,0.0014641517,0.0007331616,0.00018956547,0.0010024162,0.0001731018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001238363,0.00028466494,0.0011256449,0.0006888421,0.000051943785,0.00003787233,0.00039957973,0.00020767549,0.00017101159],"category_scores_gemma":[0.004285829,0.0002017391,0.00019378534,0.00037895073,0.00024391571,0.00020090956,0.0002543268,0.0008206483,0.0000011222739],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23019834,0.005909383,0.7197424,0.00026731592,0.0012509424,0.0006764972,0.0011928679,0.000085974294,0.0016446277,0.000436106,0.005767409,0.032828115],"study_design_scores_gemma":[0.1732936,0.0036012507,0.8156157,0.00102074,0.00009105988,0.000005419697,0.00015666497,0.000051456107,0.0002852546,0.00047878415,0.005232097,0.00016793665],"about_ca_topic_score_codex":0.0010559944,"about_ca_topic_score_gemma":0.001338351,"teacher_disagreement_score":0.09587332,"about_ca_system_score_codex":0.0023089908,"about_ca_system_score_gemma":0.0010379967,"threshold_uncertainty_score":0.82266814},"labels":[],"label_agreement":null},{"id":"W4416345611","doi":"10.1016/j.lungcan.2025.108840","title":"Treatment and outcomes of limited stage small cell lung cancer in the Canadian small cell lung cancer database (CASCADE)","year":2025,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research; Western University; AstraZeneca (Canada); London Health Sciences Centre; Dalhousie University; University of Ottawa; McGill University; Princess Margaret Cancer Centre; University of Calgary; Jewish General Hospital; Occupational Cancer Research Centre; CancerCare Manitoba","funders":"Princess Margaret Cancer Foundation; AstraZeneca","keywords":"Immunotherapy; Small-cell carcinoma; Lung cancer; Overall survival; Stage (stratigraphy); Small Cell Lung Carcinoma","score_opus":0.028782662505763917,"score_gpt":0.3607694565274413,"score_spread":0.3319867940216774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416345611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8337967,0.13534658,0.000019008814,0.0138258375,0.0007193144,0.003871569,0.0023835811,0.000056298988,0.009981145],"genre_scores_gemma":[0.9295082,0.033111807,0.00013685024,0.0026610054,0.00023400539,0.0026926724,0.00007429101,0.000077477875,0.031503707],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99684435,0.00018479662,0.0005833313,0.00080563047,0.00047992187,0.0011019967],"domain_scores_gemma":[0.9979377,0.00035826306,0.00019160961,0.000880494,0.00025605,0.00037590324],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003704444,0.0005434937,0.00093726645,0.00056006864,0.00030465913,0.00007219169,0.00041336965,0.00018754674,0.00043010258],"category_scores_gemma":[0.00007440606,0.00037347645,0.0001693277,0.0008993579,0.00023812315,0.00011546132,0.00019246199,0.000597332,0.0000013918701],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026344712,0.00019714872,0.97331136,0.0031579353,0.0008826323,0.00015076014,0.004808792,0.00029520426,0.0013078711,0.00009354392,0.01342777,0.0021035431],"study_design_scores_gemma":[0.015435341,0.00034154803,0.87562054,0.0030333695,0.0037792553,0.000005573687,0.0026823487,0.012173404,0.015071206,0.000010296713,0.07074252,0.001104604],"about_ca_topic_score_codex":0.81089044,"about_ca_topic_score_gemma":0.93472254,"teacher_disagreement_score":0.123832084,"about_ca_system_score_codex":0.0048672827,"about_ca_system_score_gemma":0.0043879193,"threshold_uncertainty_score":0.99987173},"labels":[],"label_agreement":null},{"id":"W4416398904","doi":"10.1016/j.lungcan.2025.108844","title":"Tarlatamab population survival kinetics in extensive-stage small cell lung cancer: brief report","year":2025,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Population; Lung; Survival analysis; Duration (music); Cell","score_opus":0.021190006092245132,"score_gpt":0.37352279612439293,"score_spread":0.3523327900321478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416398904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92928773,0.03916447,0.0004086234,0.0058382163,0.0024615729,0.0021501342,0.00013027666,0.00017487686,0.02038411],"genre_scores_gemma":[0.9501811,0.0037158944,0.00029865623,0.0009729493,0.00052005897,0.0005443812,0.00010859571,0.00005956508,0.043598767],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99739593,0.000075379285,0.0005949801,0.00070411275,0.000571287,0.00065828883],"domain_scores_gemma":[0.99848765,0.00011324239,0.0001819979,0.0006497374,0.0004210618,0.0001462836],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003340041,0.0002998217,0.00063894485,0.00030185518,0.00010654886,0.000040200546,0.00017598242,0.00015045976,0.0002812235],"category_scores_gemma":[0.0002562809,0.00028483276,0.00012021163,0.00079617195,0.0000886651,0.00010138574,0.00020931434,0.0005015148,0.0000023303699],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032585277,0.0001133326,0.97532517,0.0016433032,0.00021408798,0.0005972498,0.00032628287,0.0009593595,0.0022529725,0.00010653216,0.01570874,0.0024271184],"study_design_scores_gemma":[0.0032328097,0.00005942345,0.95647603,0.0011859167,0.00034155592,0.000009537582,0.0001544545,0.004485565,0.0021898702,0.000027374792,0.031511307,0.00032617175],"about_ca_topic_score_codex":0.033854555,"about_ca_topic_score_gemma":0.018028684,"teacher_disagreement_score":0.035448574,"about_ca_system_score_codex":0.0022073097,"about_ca_system_score_gemma":0.00070106704,"threshold_uncertainty_score":0.99996036},"labels":[],"label_agreement":null},{"id":"W4416822418","doi":"10.1016/j.jlb.2025.100449","title":"Cancer in a drop: Liquid biopsy highlights from the World Conference on Lung Cancer (WCLC) 2025","year":2025,"lang":"en","type":"article","venue":"The Journal of Liquid Biopsy","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Institutes of Health","keywords":"Liquid biopsy; Lung cancer; Biopsy; Targeted therapy; Disease; Cancer; Malignancy; Minimal residual disease","score_opus":0.039971330608888155,"score_gpt":0.3780679746078897,"score_spread":0.3380966439990016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416822418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7654624,0.02489144,0.000052879437,0.20355041,0.0012530705,0.0006132649,0.00006040547,0.000023922046,0.0040922],"genre_scores_gemma":[0.97646034,0.011887309,0.00006601634,0.0027370034,0.0011603491,0.00006442191,0.000002118493,0.000026074866,0.0075963675],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9972828,0.0003402067,0.00073427527,0.00026258803,0.00084698637,0.00053312926],"domain_scores_gemma":[0.9977469,0.000736352,0.00038145046,0.0005636137,0.0004232507,0.0001484699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010566551,0.0003101671,0.0006689135,0.0003659019,0.00023157033,0.000043691485,0.0007369327,0.000093992916,0.00065262994],"category_scores_gemma":[0.00021004872,0.00014729556,0.00018575261,0.0011054722,0.0003902301,0.00011555441,0.00023418976,0.001121944,0.000013683559],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11954646,0.0013827094,0.05478475,0.0006941617,0.007556125,0.001391097,0.016183637,0.0004209426,0.4777059,0.009409783,0.3063596,0.00456486],"study_design_scores_gemma":[0.0253738,0.0075040455,0.45792222,0.04814879,0.005540846,0.000376311,0.005462722,0.0020801846,0.25480977,0.0019155911,0.1888488,0.002016937],"about_ca_topic_score_codex":0.004310939,"about_ca_topic_score_gemma":0.0047111954,"teacher_disagreement_score":0.40313748,"about_ca_system_score_codex":0.00082703115,"about_ca_system_score_gemma":0.0013687157,"threshold_uncertainty_score":0.714584},"labels":[],"label_agreement":null},{"id":"W4417168166","doi":"10.1097/coc.0000000000001265","title":"Immunotherapy in Extensive Stage Small-Cell Lung Cancer in First-Line and Second-Line Setting","year":2025,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; BC Cancer Agency; London Health Sciences Centre; McMaster University; Hamilton Health Sciences","funders":"","keywords":"Lung cancer; Immunotherapy; Stage (stratigraphy); Respiratory disease; MEDLINE; Neoplasm staging; Retrospective cohort study","score_opus":0.04850980863133062,"score_gpt":0.49210545852412857,"score_spread":0.4435956498927979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417168166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9577342,0.009574196,0.00012905496,0.030421851,0.00038244383,0.00034632444,0.000008763163,0.0000061460614,0.0013970144],"genre_scores_gemma":[0.9647587,0.02497483,0.0016973595,0.0070979465,0.00033682765,0.000022038346,8.219538e-7,0.00001843372,0.0010930706],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968555,0.0004882036,0.0017891981,0.00027443253,0.00020404889,0.000388626],"domain_scores_gemma":[0.9946415,0.003711657,0.000914287,0.00018115147,0.00037973138,0.0001717193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002704984,0.00016552446,0.0017082122,0.00037444505,0.00003856137,0.00000831265,0.00016652406,0.00011468782,0.00015557969],"category_scores_gemma":[0.001867417,0.00012764755,0.00016757252,0.00052186626,0.0006518727,0.000060242965,0.0001231044,0.0014693184,9.2198474e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049444316,0.0005653296,0.6190556,0.00015694015,0.00036709558,0.0009062875,0.00066624046,0.00016272698,0.00036542126,0.000013124944,0.00079150073,0.37200528],"study_design_scores_gemma":[0.022623744,0.01063643,0.9144817,0.0011196126,0.00015370862,0.00006683533,0.0025351148,0.0011170702,0.00025533355,0.00012415873,0.04668177,0.00020455077],"about_ca_topic_score_codex":0.00059765804,"about_ca_topic_score_gemma":0.0036934186,"teacher_disagreement_score":0.37180075,"about_ca_system_score_codex":0.00047251224,"about_ca_system_score_gemma":0.0018930542,"threshold_uncertainty_score":0.6383539},"labels":[],"label_agreement":null},{"id":"W4417407062","doi":"10.1016/j.lungcan.2025.108875","title":"Corrigendum to “Treatment and outcomes of limited stage small cell lung cancer in the Canadian small cell lung cancer database (CASCADE)” [Lung Cancer 210 (2025) 108840]","year":2025,"lang":"en","type":"erratum","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research; Western University; AstraZeneca (Canada); London Health Sciences Centre; Dalhousie University; University of Ottawa; McGill University; Princess Margaret Cancer Centre; University of Calgary; Jewish General Hospital; Occupational Cancer Research Centre; CancerCare Manitoba","funders":"","keywords":"Cancer; Lung cancer; Stage (stratigraphy); Cell; Small-cell carcinoma","score_opus":0.03818360186285828,"score_gpt":0.3594488226258624,"score_spread":0.3212652207630041,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417407062","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.050459046,0.77115524,0.000045959827,0.024492055,0.045647748,0.020970488,0.047166165,0.00027788477,0.03978542],"genre_scores_gemma":[0.01989698,0.20672485,0.00019370181,0.00742042,0.003242914,0.016283568,0.0013605581,0.0004911199,0.7443859],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9898021,0.0005128488,0.0017530603,0.0028080337,0.0017896838,0.003334266],"domain_scores_gemma":[0.9934653,0.0004631277,0.0008937765,0.002555329,0.0011023792,0.0015200698],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0008757085,0.0022048727,0.0034730416,0.0019264842,0.00078472466,0.00026663876,0.0016107088,0.0011641377,0.0025249575],"category_scores_gemma":[0.00022888208,0.0016803552,0.00061083946,0.0023511779,0.00044881608,0.00024065895,0.00086712296,0.0033919371,0.000006059233],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00043810086,0.00024416938,0.33752403,0.011775406,0.002612361,0.00042768902,0.005347894,0.0004079131,0.00019736767,0.000021617376,0.6394428,0.0015606359],"study_design_scores_gemma":[0.009308432,0.00045140038,0.11212971,0.015433428,0.00984486,0.0000079182655,0.0017761709,0.007834713,0.001628696,0.0000032805103,0.8386214,0.002960003],"about_ca_topic_score_codex":0.9196461,"about_ca_topic_score_gemma":0.9792813,"teacher_disagreement_score":0.70460045,"about_ca_system_score_codex":0.021151656,"about_ca_system_score_gemma":0.026096718,"threshold_uncertainty_score":0.99906915},"labels":[],"label_agreement":null},{"id":"W4417451585","doi":"10.1016/j.ejca.2025.116190","title":"Ambient air pollution and survival in SCLC/LCNEC: Analysis of a single centre retrospective cohort","year":2025,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Retrospective cohort study; Air pollution; Cohort; Pollution; Cohort study; Risk factor","score_opus":0.014090027745508923,"score_gpt":0.31947163993190025,"score_spread":0.3053816121863913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417451585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98140424,0.004825056,0.00010758968,0.0044835904,0.00020034054,0.00013613973,0.000016435792,0.0000048898023,0.008821713],"genre_scores_gemma":[0.9975661,0.001118583,0.000067562854,0.00017425818,0.00008733234,7.5245185e-7,9.408188e-7,0.0000087291555,0.0009757472],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986347,0.00022268776,0.00040100224,0.00013909813,0.0004410563,0.00016143499],"domain_scores_gemma":[0.99907684,0.000032403685,0.00021757947,0.00011912497,0.00047846505,0.00007556652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093445345,0.00008807003,0.0005056613,0.0006020916,0.000030097279,0.000008436136,0.000072239185,0.000012633725,0.00005222145],"category_scores_gemma":[0.00028211655,0.000068890986,0.00012558035,0.0010430086,0.00011963836,0.000059618378,0.00006545758,0.00020884718,5.3626957e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052325963,0.00010973704,0.98490715,0.00005609606,0.0024815155,0.00011593291,0.0007026661,0.00031557505,0.0052894484,0.000053815245,0.0016588215,0.0037859993],"study_design_scores_gemma":[0.0014805469,0.00023115196,0.9927338,0.00045641258,0.0010012105,0.000002237489,0.00033979822,0.000057182402,0.0011313503,0.000010043936,0.0025081786,0.000048116886],"about_ca_topic_score_codex":0.00014889782,"about_ca_topic_score_gemma":0.0005078792,"teacher_disagreement_score":0.016161848,"about_ca_system_score_codex":0.0006205283,"about_ca_system_score_gemma":0.0001515977,"threshold_uncertainty_score":0.2809293},"labels":[],"label_agreement":null},{"id":"W4417482148","doi":"10.1016/j.jval.2025.09.1376","title":"EPH247 The Incidence, Mortality, and Survival of Malignant Non-Small Cell Lung Cancer (NSCLC) in the United States: A Surveillance Epidemiology and End Results (SEER) 2000-2022 Database Analysis","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"","keywords":"Surveillance, Epidemiology, and End Results; Epidemiology; Lung cancer; Epidemiological surveillance; Cancer; Lung","score_opus":0.08724169503674144,"score_gpt":0.42320669820038004,"score_spread":0.3359650031636386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417482148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9603875,0.020991618,0.00010471508,0.016559208,0.000085481355,0.0011691632,0.00053143356,0.000008858249,0.00016202278],"genre_scores_gemma":[0.93376195,0.064173914,0.00009131041,0.0015791925,0.000039673836,0.00012588971,0.0001311326,0.000009167626,0.00008775211],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.994817,0.0027058348,0.0010046717,0.00052776776,0.0003497309,0.00059497915],"domain_scores_gemma":[0.9932031,0.005569676,0.0003000118,0.0006811094,0.00013590376,0.00011018521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014288037,0.00019045461,0.0008903853,0.0006205333,0.00013158518,0.000010687248,0.00025740126,0.000061838015,0.000007499572],"category_scores_gemma":[0.0017471523,0.0001116909,0.000054556294,0.002912012,0.00034900985,0.000038136382,0.00028611152,0.0005135084,1.9688717e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032579695,0.00007881077,0.98913646,0.0015129787,0.00023086272,0.000028856733,0.0039020244,0.0034309502,0.000013971197,0.0001602864,0.0010215627,0.00015742648],"study_design_scores_gemma":[0.0015522209,0.00013497144,0.9579537,0.0004968931,0.00013371362,0.000002064283,0.0013747262,0.03775838,0.0000116035935,0.00012699656,0.0003679406,0.00008679265],"about_ca_topic_score_codex":0.37707993,"about_ca_topic_score_gemma":0.093785256,"teacher_disagreement_score":0.28329468,"about_ca_system_score_codex":0.00032233086,"about_ca_system_score_gemma":0.0011471296,"threshold_uncertainty_score":0.9227508},"labels":[],"label_agreement":null},{"id":"W4417535783","doi":"10.1200/go-25-00638","title":"Durvalumab in Limited-Stage Small Cell Lung Cancer: Clinical Triumph and Toward Sustainable Value","year":2025,"lang":"en","type":"article","venue":"JCO Global Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Durvalumab; Value (mathematics); Lung; Immune system; Sustainable development","score_opus":0.038634724482300764,"score_gpt":0.45614707482075234,"score_spread":0.4175123503384516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417535783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7886842,0.020933399,0.00007839362,0.02594823,0.00075430784,0.0017641508,0.000041639425,0.00009669062,0.16169898],"genre_scores_gemma":[0.94461066,0.010797946,0.00068665424,0.0048931413,0.0003207717,0.00030306278,0.000011423624,0.000019257815,0.03835709],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99742097,0.00036579146,0.0005945986,0.00057316944,0.00022693811,0.000818506],"domain_scores_gemma":[0.99862576,0.00047652028,0.00010759813,0.00030398925,0.00025760665,0.00022851209],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011280358,0.00021205904,0.0008833001,0.00016477914,0.000089754576,0.000022865454,0.00019099007,0.00034287904,0.00006263572],"category_scores_gemma":[0.0010146882,0.00018678386,0.00011960308,0.00072390295,0.00033425796,0.00006085607,0.0005403176,0.0005714277,0.000008285106],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024255496,0.00075922185,0.90893036,0.0017165262,0.0003016507,0.0017610742,0.0003279658,0.00004391858,0.00003906945,0.008490331,0.0561903,0.019014018],"study_design_scores_gemma":[0.013672998,0.0016922073,0.4538148,0.0001911101,0.00032239748,0.00002011704,0.0020551633,0.0010804264,0.00007702614,0.00054728455,0.52630234,0.00022411495],"about_ca_topic_score_codex":0.0066091595,"about_ca_topic_score_gemma":0.0017595527,"teacher_disagreement_score":0.47011206,"about_ca_system_score_codex":0.003542016,"about_ca_system_score_gemma":0.0032685844,"threshold_uncertainty_score":0.9991116},"labels":[],"label_agreement":null},{"id":"W46269388","doi":"10.1593/neo.101524","title":"Optimization of Circulating Biomarkers of Obatoclax-Induced Cell Death in Patients with Small Cell Lung Cancer","year":2011,"lang":"en","type":"article","venue":"Neoplasia","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Xenon Pharmaceuticals (Canada)","funders":"Cancer Research UK; Moffitt Cancer Center","keywords":"Etoposide; Carboplatin; Lung cancer; Pharmacology; Medicine; Cisplatin; Oncology; Internal medicine; Apoptosis; Chemotherapy; Cancer research; Biology","score_opus":0.02953228557169934,"score_gpt":0.27724635827513283,"score_spread":0.24771407270343349,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W46269388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99101037,0.00018057597,0.00020485318,0.0000111584295,0.000048792903,0.0007449036,0.000010292575,0.0000142495055,0.0077747856],"genre_scores_gemma":[0.993632,0.00003269483,0.0061938586,0.000013711972,0.00001224111,0.00003862882,0.000010648471,0.000024846491,0.000041361844],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890757,0.000036721343,0.00028635236,0.00021196173,0.0003176299,0.00023974034],"domain_scores_gemma":[0.999236,0.000037586215,0.0001930609,0.00020934119,0.00025296168,0.000071063056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000107695574,0.00012943592,0.0003030513,0.00017572277,0.000024345154,0.0000024416972,0.000079618374,0.00006422351,0.000088009925],"category_scores_gemma":[0.000038063325,0.000104146384,0.000039080485,0.00033763255,0.000043234293,0.000058569116,0.000047127825,0.00011731563,7.3065837e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052005245,0.000223846,0.9934759,0.0007109001,0.00009046601,0.000006909082,0.001806845,0.0007274571,0.0020388751,0.000003109432,0.000034437104,0.00036121326],"study_design_scores_gemma":[0.0048110215,0.0005519483,0.95564246,0.0004921084,0.0001233328,6.616939e-7,0.00022624864,0.0035466885,0.034479015,0.000002094941,0.0000033230942,0.00012111828],"about_ca_topic_score_codex":0.0019477066,"about_ca_topic_score_gemma":0.00017108141,"teacher_disagreement_score":0.03783345,"about_ca_system_score_codex":0.00019590119,"about_ca_system_score_gemma":0.0002587056,"threshold_uncertainty_score":0.42469662},"labels":[],"label_agreement":null},{"id":"W6908707646","doi":"10.3205/23swdgu046","title":"Lebensqualität und Patienten-relevante Endpunkte unter Darolutamid-Therapie in der Phase-3-Studie ARASENS","year":2023,"lang":"de","type":"article","venue":"German Medical Science (German Research Foundation)","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Placebo; Long-term prediction; Term (time); Work (physics)","score_opus":0.1326690753293251,"score_gpt":0.5501395070951672,"score_spread":0.41747043176584214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6908707646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91337633,0.014918564,0.0001556386,0.059585147,0.0034941374,0.003979107,0.00014011092,0.0004078021,0.0039431453],"genre_scores_gemma":[0.9737547,0.016979156,0.00006091543,0.0017289278,0.0025366424,0.0005660376,0.00040999177,0.00012929384,0.003834323],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9699603,0.0019925917,0.0019752712,0.0025678545,0.017713169,0.0057908185],"domain_scores_gemma":[0.98902184,0.0034283604,0.00031441764,0.0018768681,0.0023533923,0.0030051027],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch","sts","insufficient_payload"],"category_scores_codex":[0.0289624,0.0007979509,0.001308267,0.0041675665,0.0028438985,0.0007294744,0.0026788348,0.00042962356,0.0047636353],"category_scores_gemma":[0.01461717,0.0006734254,0.00030356905,0.014092987,0.014026161,0.0014622472,0.002891733,0.0040309005,0.022236984],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036424487,0.008546152,0.05292331,0.0038848696,0.0050353836,0.017042289,0.05207442,0.000069941234,0.010181355,0.017682225,0.16361171,0.6653059],"study_design_scores_gemma":[0.023510119,0.0038332215,0.118552536,0.0050454903,0.00048821777,0.000051099792,0.0031537164,0.044336617,0.0011756057,0.0063190213,0.79149956,0.002034786],"about_ca_topic_score_codex":0.00093005714,"about_ca_topic_score_gemma":0.0011565121,"teacher_disagreement_score":0.6632711,"about_ca_system_score_codex":0.0036053099,"about_ca_system_score_gemma":0.007967683,"threshold_uncertainty_score":0.9998875},"labels":[],"label_agreement":null},{"id":"W6929858119","doi":"10.5061/dryad.cz8w9gj75","title":"Functional profiling and evolutionary analysis of a marine microalgal virus pangenome","year":2023,"lang":"en","type":"dataset","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Context (archaeology); Nucleofection; Identification (biology); Population; Proteogenomics","score_opus":0.04467216541675376,"score_gpt":0.28978101661942274,"score_spread":0.24510885120266898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6929858119","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017918355,0.00060623477,0.000037552,0.00040766914,0.00009516002,0.0007396516,0.99428844,0.0002968751,0.0017365715],"genre_scores_gemma":[0.00053754187,0.0020723983,0.000110825364,0.00005733211,0.0002288394,2.9951042e-7,0.99533224,0.00065165065,0.0010088538],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975601,0.0002113336,0.00040203295,0.0006026538,0.0008259419,0.00039792946],"domain_scores_gemma":[0.99796903,0.00006964982,0.00018711804,0.0005927265,0.0009703429,0.00021115817],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00064572715,0.00022998963,0.00055377954,0.0014651121,0.0009271883,0.00013649232,0.00041955148,0.0001362538,0.0072853467],"category_scores_gemma":[0.0010485115,0.00022586803,0.00015653457,0.0019994003,0.00037954948,0.00008407597,0.002775672,0.00051247195,0.0031296099],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033783872,0.00015088664,0.000032559954,0.0006932348,0.0026881825,0.00005127274,0.00006000044,0.000021025258,0.001496057,0.000030514095,0.9916026,0.0028358025],"study_design_scores_gemma":[0.0006331848,0.00035778258,0.018316796,0.000076078446,0.0012288371,0.00007208762,0.00009729097,0.00009788154,0.000055596964,0.000021809961,0.97885907,0.00018356636],"about_ca_topic_score_codex":0.00039308198,"about_ca_topic_score_gemma":0.000008958072,"teacher_disagreement_score":0.018284235,"about_ca_system_score_codex":0.00037372162,"about_ca_system_score_gemma":0.000026003343,"threshold_uncertainty_score":0.9976466},"labels":[],"label_agreement":null},{"id":"W6930519948","doi":"10.5281/zenodo.12360361","title":"Oedipus at colonus pdf","year":2024,"lang":"en","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ridiculous; Spectacle; Blame; Lament; Character (mathematics)","score_opus":0.03221269340577838,"score_gpt":0.2951358253615847,"score_spread":0.26292313195580636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930519948","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006494803,0.0030152618,0.000039258986,0.001423863,0.00035806381,0.001091925,0.0005013337,0.002025541,0.9914798],"genre_scores_gemma":[0.0011353766,0.0012716112,0.000097619144,0.0002057931,0.0009842518,2.0829978e-7,0.0019597444,0.013281991,0.9810634],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99737155,0.00017157863,0.0002554849,0.00075133686,0.00085850654,0.000591567],"domain_scores_gemma":[0.9984227,0.000018312308,0.00010683884,0.00075721875,0.00034899986,0.0003459479],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00041270276,0.00030552578,0.00042177684,0.0006341661,0.0007374497,0.0003666942,0.0006619874,0.0002109879,0.28714085],"category_scores_gemma":[0.00043773875,0.000284113,0.00013439846,0.0006170049,0.00038156976,0.000046500554,0.0026143007,0.00066002767,0.3922778],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001190504,0.00008034426,0.0000015420038,0.0010638987,0.00041594228,0.00020267536,0.0004410475,2.7474812e-7,0.0003979436,0.00022532346,0.98765695,0.009394977],"study_design_scores_gemma":[0.0007259366,0.00043737178,0.000037600974,0.0005592592,0.0001350597,0.00037269382,0.000112443966,0.000013058222,0.00008650399,0.000035914913,0.9972355,0.000248701],"about_ca_topic_score_codex":0.000106454885,"about_ca_topic_score_gemma":0.000006386407,"teacher_disagreement_score":0.10513697,"about_ca_system_score_codex":0.000841935,"about_ca_system_score_gemma":0.000013313962,"threshold_uncertainty_score":0.9999611},"labels":[],"label_agreement":null},{"id":"W6930662333","doi":"10.5281/zenodo.15785673","title":"Rhaphitelus maculatus Walker 1834","year":2025,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Holotype; Bark beetle; Genus; Subfamily; Scarabaeoidea; Braconidae","score_opus":0.027297863168135247,"score_gpt":0.3024273562868514,"score_spread":0.27512949311871615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930662333","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.033456594,0.0012749655,0.0017811634,0.010360242,0.0002486003,0.0012958952,0.0001193999,0.0015611517,0.949902],"genre_scores_gemma":[0.96771914,0.0005912689,0.00037143225,0.0011194483,0.0002486171,1.7777157e-7,0.0007578407,0.0012377383,0.027954355],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99812794,0.00016835218,0.00024444744,0.00045095384,0.00050803524,0.00050029124],"domain_scores_gemma":[0.99837077,0.00003201215,0.00004852711,0.0005844015,0.0007561713,0.00020809621],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00051148905,0.00015871318,0.00023734052,0.00041610637,0.0016234855,0.0003152091,0.00052436604,0.00006924064,0.010499866],"category_scores_gemma":[0.0010392945,0.00014865784,0.00008991777,0.0010009445,0.00027294422,0.00012258466,0.001331095,0.0003952915,0.005840294],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039514134,0.00024020248,0.00012640707,0.00038081824,0.00033879487,0.000097253454,0.0006652655,0.000011765169,0.0067879916,0.008141794,0.815715,0.16709954],"study_design_scores_gemma":[0.0012429756,0.0002267222,0.005726646,0.00012027367,0.00005057106,0.000091654,0.00020421247,0.00015997309,0.0008751388,0.00028055193,0.99089265,0.00012861931],"about_ca_topic_score_codex":0.000027884196,"about_ca_topic_score_gemma":3.860525e-7,"teacher_disagreement_score":0.9342625,"about_ca_system_score_codex":0.00038265507,"about_ca_system_score_gemma":0.000014904757,"threshold_uncertainty_score":0.9996763},"labels":[],"label_agreement":null},{"id":"W6931583484","doi":"10.5683/sp3/wfvdeq","title":"Obabigan Lake Ontario. 1:50,000. Map Sheet 053A12, ed. 1, 1977","year":2021,"lang":"en","type":"dataset","venue":"Borealis","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Georeference; General partnership; Raster graphics; Natural (archaeology); Aerial photography; Topographic map (neuroanatomy); Viewshed analysis; Digital mapping","score_opus":0.024693891053948893,"score_gpt":0.31795312737210857,"score_spread":0.2932592363181597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6931583484","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000015817555,0.003477425,0.0000011351576,0.0033495743,0.000857219,0.00079355354,0.9849414,0.000098743556,0.0064651235],"genre_scores_gemma":[0.0000024487124,0.0034725242,0.00015041945,0.0017628996,0.0017971363,0.00025585003,0.98109835,0.00006815795,0.011392211],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99594253,0.00011632045,0.00055932096,0.0009564351,0.0014635741,0.00096183515],"domain_scores_gemma":[0.9966319,0.00014131218,0.0001850463,0.0021200338,0.00040106624,0.00052062917],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003852247,0.00063794514,0.0012852977,0.00025072088,0.0001944925,0.000118646625,0.0005673192,0.00049244636,0.0051015387],"category_scores_gemma":[0.00047878711,0.00054408243,0.0003638881,0.00023960385,0.000276524,0.00008187074,0.00068455527,0.0014217921,0.00019561272],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015807537,0.00020916316,0.00060273346,0.0011362344,0.00085850595,0.0018102237,0.00013830789,5.267409e-7,0.0000038160592,0.000007666435,0.9946903,0.00038443718],"study_design_scores_gemma":[0.0012285877,0.00027112072,0.0045179254,0.00093191885,0.0006537651,0.00009230866,0.000071050184,3.6521553e-7,0.000022193886,0.000027898886,0.99169147,0.00049138407],"about_ca_topic_score_codex":0.6535377,"about_ca_topic_score_gemma":0.975074,"teacher_disagreement_score":0.32153633,"about_ca_system_score_codex":0.0010736982,"about_ca_system_score_gemma":0.0020350812,"threshold_uncertainty_score":0.9997011},"labels":[],"label_agreement":null},{"id":"W6931622709","doi":"10.5683/sp3/p7mhpo","title":"Entrance (East) Alberta. 1:50,000. Map Sheet 083F05, ed. 1, 1958","year":2022,"lang":"en","type":"dataset","venue":"Borealis","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Georeference; General partnership; Raster graphics; Natural (archaeology); Digital mapping; Aerial photography; Geographic information system; Government (linguistics)","score_opus":0.017784846497199233,"score_gpt":0.3155693224285967,"score_spread":0.29778447593139745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6931622709","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000004765384,0.007007313,0.0000015778023,0.0058122072,0.00063010084,0.0011768736,0.9809583,0.00008370761,0.004325142],"genre_scores_gemma":[0.000008826244,0.008207907,0.000041405947,0.0019142551,0.001320659,0.0008072323,0.9833635,0.00008666855,0.004249551],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.995585,0.0001722732,0.00054564467,0.0009547886,0.0017053903,0.0010368682],"domain_scores_gemma":[0.99700314,0.00026756298,0.00022288584,0.0018889494,0.00016126253,0.00045622254],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040015625,0.0005821322,0.0011021319,0.0003004195,0.00030211036,0.000063566265,0.00081255706,0.00026744656,0.03463409],"category_scores_gemma":[0.0005709488,0.0005447828,0.00033099507,0.00030352932,0.00028602636,0.000088431705,0.00071160786,0.0013551692,0.00015877173],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004197711,0.00021933074,0.0001039401,0.001344263,0.00067495677,0.00051997154,0.00015886387,0.0000030653034,0.000004774703,0.000028876086,0.99569803,0.0008241273],"study_design_scores_gemma":[0.0014034598,0.00037880018,0.00095449196,0.00029959806,0.00048878934,0.000070358255,0.0000969567,0.000002975992,0.0000094481875,0.000024874644,0.99579686,0.00047340046],"about_ca_topic_score_codex":0.2130008,"about_ca_topic_score_gemma":0.040865954,"teacher_disagreement_score":0.17213485,"about_ca_system_score_codex":0.00080081186,"about_ca_system_score_gemma":0.00062203803,"threshold_uncertainty_score":0.99970037},"labels":[],"label_agreement":null},{"id":"W6931623283","doi":"10.5281/zenodo.7503708","title":"Quedius pallipes Lucas 1849","year":2022,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Agriculture and Agri-Food Canada","funders":"","keywords":"Subspecies; Synonym (taxonomy); Variety (cybernetics); Type (biology); Taxonomy (biology)","score_opus":0.04239560790659652,"score_gpt":0.29245552730168334,"score_spread":0.2500599193950868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6931623283","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13465737,0.0022074676,0.0009903144,0.021007279,0.00060951663,0.0028815211,0.0008746615,0.0036440636,0.8331278],"genre_scores_gemma":[0.9855774,0.00028364896,0.00022154815,0.0007756701,0.00037520693,4.9283085e-7,0.0013523333,0.0016467819,0.009766884],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975343,0.0003581451,0.00022847121,0.00044136052,0.0009374963,0.0005002359],"domain_scores_gemma":[0.99864674,0.000031850526,0.000071422626,0.0005181414,0.0004799053,0.0002519171],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0008459518,0.00014329623,0.00021231822,0.00028776197,0.003841404,0.0002559198,0.00067700865,0.000029661547,0.04075716],"category_scores_gemma":[0.00076150656,0.0001452466,0.00008099101,0.00076863315,0.0002064943,0.00012123612,0.002571695,0.00056761777,0.0039204923],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004990717,0.00040059927,0.00008234877,0.00019500687,0.0002208874,0.00022691337,0.002438275,0.00006108047,0.0062288526,0.003744433,0.90274435,0.08315818],"study_design_scores_gemma":[0.001024463,0.00075481186,0.0017254475,0.000020043311,0.000029342324,0.00037458568,0.0010637635,0.00012506288,0.00033569793,0.00013891526,0.9942625,0.00014537602],"about_ca_topic_score_codex":0.000043173626,"about_ca_topic_score_gemma":3.9504556e-7,"teacher_disagreement_score":0.8509201,"about_ca_system_score_codex":0.00060814276,"about_ca_system_score_gemma":0.00001573862,"threshold_uncertainty_score":0.9974555},"labels":[],"label_agreement":null},{"id":"W6939892695","doi":"10.6084/m9.figshare.26703448","title":"Additional file 1 of Segmentation of patients with small cell lung cancer into responders and non-responders using the optimal cross-validation technique","year":2024,"lang":"en","type":"article","venue":"Figshare","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; University of Victoria","funders":"","keywords":"Segmentation; Lung cancer; Pattern recognition (psychology); Image segmentation; Computed tomography; Small-cell carcinoma","score_opus":0.031226824338127054,"score_gpt":0.35306310269138114,"score_spread":0.32183627835325407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6939892695","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03268791,0.00021379179,0.00003445782,0.000043252432,0.000010217141,0.0009186034,0.9659124,0.000017953915,0.00016142742],"genre_scores_gemma":[0.18545678,0.0000093877115,0.0063500074,0.000060890103,0.00008716612,0.0033126464,0.8039351,0.000047251746,0.00074074155],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9992293,0.000028678283,0.00014321807,0.00016662221,0.00031980866,0.000112381385],"domain_scores_gemma":[0.9989457,0.000515092,0.00008626046,0.00010494445,0.00031412704,0.000033877674],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000045514516,0.00009010344,0.00011570771,0.00011707723,0.0000699224,0.0000255221,0.000054280576,0.000041968637,0.54320496],"category_scores_gemma":[0.00037620214,0.0000607997,0.000031658685,0.00024697292,0.000051434392,0.00012221916,0.00006628275,0.000118756914,0.0000047971366],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039444075,0.000028257704,0.0007638612,0.0022704354,0.00010409656,0.0000043805544,0.00084626215,0.0002140919,0.0017919182,2.6249919e-7,0.9931608,0.00042118397],"study_design_scores_gemma":[0.00665133,0.002753365,0.3358197,0.09423415,0.00063741097,0.000018824843,0.003794739,0.022814127,0.3289808,0.000037842692,0.2030889,0.0011688425],"about_ca_topic_score_codex":0.000044792858,"about_ca_topic_score_gemma":0.000012585876,"teacher_disagreement_score":0.7900719,"about_ca_system_score_codex":0.00017102827,"about_ca_system_score_gemma":0.00040326596,"threshold_uncertainty_score":0.4572126},"labels":[],"label_agreement":null},{"id":"W6969153818","doi":"10.5281/zenodo.7462743","title":"Ligation Independent Cloning of transporter gene into BacMam vector","year":2022,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"Horizon 2020 Framework Programme","keywords":"Gene; Cloning (programming); Vector (molecular biology); clone (Java method); Transfection; Ligation; Molecular cloning","score_opus":0.02834462510341702,"score_gpt":0.27420402723037024,"score_spread":0.24585940212695323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6969153818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9322506,0.0009825837,0.0025246532,0.0052964836,0.0002774582,0.0019921148,0.00039319874,0.00091607816,0.055366833],"genre_scores_gemma":[0.99710655,0.00010458857,0.00026091508,0.00012090865,0.00011024634,3.184421e-7,0.0009931427,0.0006291062,0.0006742394],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979443,0.00022622857,0.00029613823,0.00034292744,0.00089259417,0.00029781274],"domain_scores_gemma":[0.9988655,0.000019834526,0.00010788184,0.0003803786,0.00047714554,0.0001493026],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00078880816,0.00011432622,0.00020996807,0.00027790072,0.0015832529,0.000076088596,0.00045357808,0.000031161522,0.012846758],"category_scores_gemma":[0.00027193283,0.000119030425,0.000075963915,0.00060346647,0.00014323993,0.00011580071,0.00085606123,0.00039623352,0.00037465358],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023632552,0.0013612604,0.00082359003,0.0012539782,0.0009178919,0.00027404653,0.02911145,0.00046469746,0.6159579,0.004032438,0.12760116,0.21583831],"study_design_scores_gemma":[0.0021997767,0.0016528486,0.021066893,0.00006391841,0.00007795495,0.00022354945,0.0017653984,0.00019630924,0.023504542,0.00015906245,0.948868,0.00022178995],"about_ca_topic_score_codex":0.00006205343,"about_ca_topic_score_gemma":6.63468e-7,"teacher_disagreement_score":0.8212668,"about_ca_system_score_codex":0.00046752288,"about_ca_system_score_gemma":0.000016127688,"threshold_uncertainty_score":0.9997165},"labels":[],"label_agreement":null},{"id":"W6981747667","doi":"","title":"Exploring Involvement of Community of Water Users in Collaborative Water Resource Governance and Management Regime for Lake Diefenbaker, Saskatchewan, Canada.","year":2022,"lang":"en","type":"dissertation","venue":"University Library (University of Saskatchewan)","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Collaborative governance; Corporate governance; Natural resource management; Incentive; Resource management (computing); Recreation; Resource (disambiguation); Natural resource; Ecosystem-based management; Water resources","score_opus":0.02263888034026521,"score_gpt":0.21772987577017416,"score_spread":0.19509099542990896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6981747667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99333435,0.00024728762,0.000003944479,0.00106102,0.00009322544,0.0013301952,0.0012545974,0.00002544294,0.002649946],"genre_scores_gemma":[0.9309017,0.001573143,0.0008161261,0.0000588807,0.000014825003,0.0000035529206,0.0029125423,0.000045298897,0.063673936],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.99809444,0.00022713566,0.0002834438,0.00036350102,0.00062934565,0.00040211662],"domain_scores_gemma":[0.99874747,0.00013752103,0.00030132994,0.0004915962,0.00018550002,0.00013658918],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026317468,0.00030374146,0.00089695666,0.00040594456,0.0003456403,0.000005811657,0.0005405977,0.000119217264,0.00027087412],"category_scores_gemma":[0.000007021605,0.00031972403,0.00015043931,0.00045535163,0.00029173875,0.0006429681,0.0008363427,0.0005305356,3.4804458e-7],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019257836,0.000821461,0.014134723,0.01845566,0.0030652885,0.00054959947,0.9232077,0.00013416636,0.0022737489,0.00014330802,0.015546294,0.002410197],"study_design_scores_gemma":[0.0035779786,0.0004295853,0.016860565,0.00069045124,0.00034835355,6.4559185e-7,0.8949218,0.0000046873906,0.012377532,0.00002935872,0.070486695,0.00027239224],"about_ca_topic_score_codex":0.23605622,"about_ca_topic_score_gemma":0.8791935,"teacher_disagreement_score":0.6431373,"about_ca_system_score_codex":0.00052311877,"about_ca_system_score_gemma":0.00089276675,"threshold_uncertainty_score":0.9999255},"labels":[],"label_agreement":null},{"id":"W6995929217","doi":"","title":"Political Wine in a Judicial Bottle: Justice Sotomayor's Surprising Concurrence in &lt;em&gt;Aurelius&lt;/em&gt;","year":2020,"lang":"en","type":"article","venue":"eYLS (Yale Law School)","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Economic Justice; Politics; Concurrence; Sovereignty; Constitution","score_opus":0.029318235660281716,"score_gpt":0.32170331994554424,"score_spread":0.29238508428526255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6995929217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92575985,0.008510947,0.00022923236,0.032303393,0.0010578724,0.002243468,0.00014739817,0.00042199125,0.029325824],"genre_scores_gemma":[0.9899917,0.0001942561,0.00061946677,0.0064364388,0.0022849026,0.00012311296,0.00003706516,0.00007579343,0.00023724872],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947977,0.00029292508,0.00088864716,0.0009698464,0.0013988134,0.0016520481],"domain_scores_gemma":[0.9973421,0.0005462204,0.00012359969,0.00054879574,0.0003036951,0.0011355788],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008495247,0.00047228916,0.0010745865,0.00023899552,0.00019185818,0.00012429676,0.00045689612,0.00025456987,0.00047060917],"category_scores_gemma":[0.004849135,0.00045856828,0.00016300972,0.0012781052,0.0004830668,0.00035368084,0.00047239408,0.0015718823,0.0005359587],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009435385,0.003402906,0.20212853,0.008841702,0.0012145658,0.017825425,0.016799424,0.00025326348,0.06644972,0.36693326,0.29690817,0.009807673],"study_design_scores_gemma":[0.05748646,0.0064310683,0.41472405,0.0095051,0.0018400236,0.0004977977,0.0108864475,0.008654084,0.011524504,0.008888495,0.4644212,0.0051407665],"about_ca_topic_score_codex":0.0016166752,"about_ca_topic_score_gemma":0.0044089574,"teacher_disagreement_score":0.35804474,"about_ca_system_score_codex":0.0008168178,"about_ca_system_score_gemma":0.0008361921,"threshold_uncertainty_score":0.9997866},"labels":[],"label_agreement":null},{"id":"W6995937880","doi":"","title":"Placebos in medicine: from conceptualizations in medical school to integration in clinical practice","year":2012,"lang":"en","type":"dissertation","venue":"eScholarship@McGill (McGill)","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Natural Sciences and Engineering Research Council of Canada; McGill University","keywords":"Psychosocial; Placebo; Clinical Practice; Medical practice; Clinical trial; Alternative medicine; Inclusion (mineral); Medical school","score_opus":0.055821790209035174,"score_gpt":0.42958685427694965,"score_spread":0.3737650640679145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6995937880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8820182,0.0030565893,0.0000029724508,0.0030065796,0.0026477387,0.00438268,0.0003984993,0.00017466079,0.10431206],"genre_scores_gemma":[0.9861487,0.0024213973,0.0009539665,0.003758804,0.00049563317,0.0010833989,0.0024285484,0.00018797765,0.00252158],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9895046,0.002290729,0.0029389241,0.0014140524,0.0027847434,0.0010669996],"domain_scores_gemma":[0.9918619,0.004385687,0.00057750737,0.0008680128,0.00080268225,0.0015042474],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0077678263,0.0007482821,0.0018761023,0.0015949075,0.00020713772,0.00003391036,0.00064223737,0.0015515487,0.002545904],"category_scores_gemma":[0.15477647,0.00068947184,0.0002005335,0.0022273157,0.00021564438,0.00097015494,0.0002335295,0.0058919135,0.0005334199],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020620493,0.007461978,0.08419263,0.001552468,0.0014404932,0.0045567816,0.0024356325,0.000055404602,0.01088805,0.05101791,0.0023033314,0.81347483],"study_design_scores_gemma":[0.028762594,0.0019279945,0.6952788,0.030457122,0.0009701683,0.000094179384,0.025985913,0.00023784986,0.003387385,0.004620914,0.20556143,0.0027156083],"about_ca_topic_score_codex":0.0101080155,"about_ca_topic_score_gemma":0.094594315,"teacher_disagreement_score":0.8107592,"about_ca_system_score_codex":0.0032317154,"about_ca_system_score_gemma":0.00086013146,"threshold_uncertainty_score":0.99974465},"labels":[],"label_agreement":null},{"id":"W6998430133","doi":"","title":"2014 Allen D Leman Conference Recent Research Reports","year":2014,"lang":"en","type":"article","venue":"University of Minnesota Digital Conservancy (University of Minnesota)","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Swine Health Board; Ontario Ministry of Agriculture, Food and Rural Affairs; Diamond V; Agricultural Adaptation Council; University of Minnesota","keywords":"Field (mathematics); Perspective (graphical); Agency (philosophy); Identification (biology)","score_opus":0.054854082283159473,"score_gpt":0.2884977654331173,"score_spread":0.23364368314995781,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6998430133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8676111,0.0008541127,0.0007512682,0.016655913,0.00016819642,0.0009872816,0.00014759805,0.00013021125,0.11269428],"genre_scores_gemma":[0.98262906,0.0030390255,0.0011631591,0.000040425082,0.000047861176,1.8762762e-7,0.00006799108,0.000028124065,0.012984136],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963292,0.00023654163,0.00032721861,0.00081184827,0.0015712762,0.00072393403],"domain_scores_gemma":[0.99430734,0.00042421973,0.0003900014,0.0010922384,0.0033237012,0.00046251292],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012357308,0.00030478122,0.0009150937,0.0006026373,0.0004889284,0.0000279207,0.0006824582,0.00022372368,0.0008674748],"category_scores_gemma":[0.0007659931,0.00038275562,0.00030731456,0.0006072203,0.002174498,0.00085068954,0.0009507889,0.00050552597,0.00013656021],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007904457,0.0031238415,0.21438956,0.004088184,0.0023342276,0.0058128596,0.020821381,0.00002417511,0.008549195,0.007293714,0.6642222,0.061436187],"study_design_scores_gemma":[0.00390788,0.0015095731,0.039399866,0.0008999196,0.00023618079,0.00017728365,0.0206666,0.00024313152,0.00043102758,0.00084943284,0.9311576,0.00052149483],"about_ca_topic_score_codex":0.0014669499,"about_ca_topic_score_gemma":0.0016329304,"teacher_disagreement_score":0.2669354,"about_ca_system_score_codex":0.00035776405,"about_ca_system_score_gemma":0.00079035363,"threshold_uncertainty_score":0.99986243},"labels":[],"label_agreement":null},{"id":"W7008610139","doi":"","title":"Challenges with Estimating Long-Term Overall Survival in Extensive Stage Small-Cell Lung Cancer: A Validation-Based Case Study","year":2024,"lang":"en","type":"article","venue":"DOAJ (DOAJ: Directory of Open Access Journals)","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Durvalumab; Survival analysis; Clinical trial; Covariate; Markov model; Lung cancer; Stage (stratigraphy); Overall survival","score_opus":0.32648579091045726,"score_gpt":0.592727764153825,"score_spread":0.26624197324336774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7008610139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.910137,0.08502999,0.00027649512,0.00056412903,0.00045775468,0.0024484303,0.000049643324,0.00007504816,0.0009615041],"genre_scores_gemma":[0.9885799,0.009786365,0.00032741996,0.00009536457,0.0002773693,0.00044165153,0.0000110357705,0.00010741604,0.00037345893],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99603575,0.00046066626,0.00083799555,0.0008312337,0.0012247695,0.00060958654],"domain_scores_gemma":[0.99689275,0.0010695611,0.00041361578,0.000594326,0.0007028028,0.00032691783],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019264941,0.00046557494,0.0011635245,0.0011489468,0.00022986867,0.000940024,0.0008354964,0.00007951413,0.0015827114],"category_scores_gemma":[0.00036903395,0.0003629093,0.00014067284,0.0009786044,0.00013981255,0.0010570535,0.00061807584,0.00085343275,0.0000036531803],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000742176,0.00087536254,0.9454775,0.0035301307,0.0009801119,0.03017378,0.0029586118,0.0029442776,0.0023798344,0.000006207038,0.0008201886,0.009111833],"study_design_scores_gemma":[0.0056396904,0.0002415625,0.96916115,0.008530024,0.0007860364,0.00030301235,0.0030870473,0.0070873396,0.004289064,0.00004619542,0.00008974003,0.00073915906],"about_ca_topic_score_codex":0.010208629,"about_ca_topic_score_gemma":0.0060537294,"teacher_disagreement_score":0.07844291,"about_ca_system_score_codex":0.0007036622,"about_ca_system_score_gemma":0.0011285152,"threshold_uncertainty_score":0.9998823},"labels":[],"label_agreement":null},{"id":"W7039851288","doi":"","title":"Northland Power, Air Canada, and More By The Motley Fool","year":2021,"lang":"en","type":"other","venue":"","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Motley; Moonlight; Thunder","score_opus":0.007905477337263949,"score_gpt":0.2920552218876832,"score_spread":0.28414974455041925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7039851288","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004961884,0.045079257,0.0000053601098,0.013506893,0.00016515965,0.00052532647,0.00016809063,0.000041921387,0.9400118],"genre_scores_gemma":[0.0028265854,0.0016905043,0.000030305744,0.0026116066,0.00018244308,0.000032616364,0.000067062516,0.00013666794,0.9924222],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989783,0.000018601377,0.000085712,0.00024498213,0.0004399509,0.0002324174],"domain_scores_gemma":[0.9994156,0.000049824328,0.00003197418,0.00033745673,0.000046015935,0.00011914876],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000046573685,0.00016794105,0.00030211374,0.0000327088,0.000047552156,0.000009603416,0.00008162872,0.000074590105,0.0041672345],"category_scores_gemma":[0.00005672926,0.00008963394,0.000030644267,0.000087282584,0.00011981991,0.0000042973447,0.000119375356,0.00023587284,0.0000035133874],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000824298,0.000008646122,0.005416575,0.00016566447,0.0003344768,0.00008770885,0.000052620217,1.8371086e-8,0.000008393477,0.00000890038,0.9933514,0.0005573808],"study_design_scores_gemma":[0.000464988,0.000037900005,0.0062910495,0.00019195084,0.000048719216,0.00002542773,0.00030589916,0.0000014947728,0.00002548995,0.0000016725942,0.9925032,0.000102195205],"about_ca_topic_score_codex":0.8704324,"about_ca_topic_score_gemma":0.9729465,"teacher_disagreement_score":0.10251412,"about_ca_system_score_codex":0.00012095389,"about_ca_system_score_gemma":0.0007111224,"threshold_uncertainty_score":0.9967431},"labels":[],"label_agreement":null},{"id":"W7071992068","doi":"","title":"Validation of 8th edition AJCC staging system of small cell lung cancer in a North American cohort","year":2024,"lang":"en","type":"dissertation","venue":"Mspace (University of Manitoba)","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Lung cancer; Cohort; Lung cancer staging; Proportional hazards model; AJCC staging system; Cancer; Staging system; Retrospective cohort study; TNM staging system","score_opus":0.011619996960912518,"score_gpt":0.2621523437341635,"score_spread":0.250532346773251,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7071992068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99506676,0.0007792665,0.00006980895,0.00015966686,0.00037082637,0.00086734863,0.00019447213,0.000030401307,0.0024614267],"genre_scores_gemma":[0.9968873,0.0013504467,0.00015243936,0.0000022457489,0.00009646463,0.0000050929266,0.0004394011,0.000028388795,0.0010381792],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859834,0.000070078444,0.00021003775,0.00032778797,0.0005833811,0.00021040397],"domain_scores_gemma":[0.9986747,0.00005321241,0.00051264267,0.000240971,0.0004554104,0.00006306859],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019611177,0.00018483412,0.00071817567,0.00066917075,0.00004933393,0.0000053745066,0.00016390758,0.00008370236,0.000008498607],"category_scores_gemma":[0.000015821082,0.00022075644,0.00014084837,0.00080078735,0.00012136132,0.00008454605,0.000055155742,0.00031795158,0.0000032532823],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053416553,0.000092193404,0.96775585,0.023374917,0.00050467165,0.00005955443,0.0034388623,0.00023368729,0.001982691,0.000018902292,0.0016292832,0.00037522518],"study_design_scores_gemma":[0.00073031976,0.00019551907,0.91100305,0.0032944044,0.0009965986,7.4327835e-7,0.07857619,0.0009768503,0.0039945603,0.0000010109273,0.00007223845,0.00015848997],"about_ca_topic_score_codex":0.038141567,"about_ca_topic_score_gemma":0.5009556,"teacher_disagreement_score":0.46281403,"about_ca_system_score_codex":0.00090529374,"about_ca_system_score_gemma":0.00039704805,"threshold_uncertainty_score":0.9682635},"labels":[],"label_agreement":null},{"id":"W7097137035","doi":"","title":"previously untreated patients with extensive small cell lung cancer: a study of the National Cancer Institute of Canada Clinical Trials Group","year":2013,"lang":"en","type":"article","venue":"","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Etoposide; Chemotherapy; Carboplatin; Regimen; Clinical trial; Lung cancer; Progressive disease; Cisplatin","score_opus":0.07551501458178837,"score_gpt":0.40603959854712984,"score_spread":0.33052458396534146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7097137035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99192107,0.00051237,0.0000027683068,0.0008258724,0.00032029982,0.005132758,0.00007239405,0.000010019597,0.0012024606],"genre_scores_gemma":[0.9969014,0.00018289247,0.000052159525,0.0004373972,0.00011286106,0.0005940881,0.0000065065333,0.000015029771,0.001697676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971764,0.00033087315,0.0008521012,0.0002885099,0.0010831945,0.00026892152],"domain_scores_gemma":[0.99621093,0.00043233836,0.0004840278,0.0002520257,0.0024832385,0.00013745135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072368025,0.00016573908,0.00082248996,0.00005202868,0.00007928556,0.000006790102,0.00017886166,0.000043787302,0.00029924672],"category_scores_gemma":[0.0011825843,0.00008019185,0.000085126056,0.00031619295,0.0001758666,0.000068856425,0.00012628072,0.00020147023,4.7542815e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054772943,0.00080170424,0.9628382,0.00021437979,0.0010678227,0.0000021070641,0.0004796221,0.00009098484,0.00005493141,0.000007569071,0.03305099,0.00084400136],"study_design_scores_gemma":[0.010836659,0.00095794885,0.98591214,0.0003121236,0.00046291333,3.0733426e-7,0.0004429982,0.00014129936,0.00030420153,0.0000037835662,0.00052311516,0.00010253302],"about_ca_topic_score_codex":0.82876873,"about_ca_topic_score_gemma":0.85735095,"teacher_disagreement_score":0.032527875,"about_ca_system_score_codex":0.0005590466,"about_ca_system_score_gemma":0.0035689317,"threshold_uncertainty_score":0.63311315},"labels":[],"label_agreement":null},{"id":"W7132914567","doi":"","title":"Role of the mTOR Pathway and Autophagy in Mediating PARP Inhibitor Sensitivity in Small Cell Lung Cancer","year":2022,"lang":"","type":"dissertation","venue":"TSpace","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Autophagy; Sensitization; PI3K/AKT/mTOR pathway; mTORC1; PARP inhibitor; Lung cancer; Synthetic lethality; Poly ADP ribose polymerase","score_opus":0.012489069735870151,"score_gpt":0.34395841611532074,"score_spread":0.3314693463794506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7132914567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9481561,0.04648104,5.1238385e-7,0.00065146404,0.0008306385,0.0020914387,0.00008755272,0.000016124086,0.0016851312],"genre_scores_gemma":[0.99130315,0.0038446065,0.00003103552,0.000064772066,0.00033934257,0.00054852944,0.000053983753,0.00007291625,0.0037416865],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99604064,0.0007808692,0.00071656925,0.0007755056,0.00090528367,0.0007811187],"domain_scores_gemma":[0.99772775,0.00083786924,0.00060364394,0.0004758551,0.0001994044,0.00015548452],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016016751,0.00048821387,0.001094168,0.00036262206,0.00021766777,0.000021140013,0.00019974158,0.0002626429,0.0002700005],"category_scores_gemma":[0.00097007793,0.00040939287,0.00014173878,0.0009829701,0.00018526708,0.00007060903,0.0005045152,0.0018407592,0.0000012155604],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007843763,0.00036390015,0.42114317,0.006310704,0.00017255601,0.00015381236,0.24279456,0.0003505921,0.32207972,0.000037580103,0.00012569837,0.0056833355],"study_design_scores_gemma":[0.004228112,0.00026011353,0.59355724,0.0034109664,0.00024001492,0.0000040997584,0.12933277,0.0066308496,0.2612553,0.000029802339,0.00048421125,0.0005665523],"about_ca_topic_score_codex":0.037045207,"about_ca_topic_score_gemma":0.08362697,"teacher_disagreement_score":0.17241406,"about_ca_system_score_codex":0.0014357958,"about_ca_system_score_gemma":0.0020762389,"threshold_uncertainty_score":0.9998358},"labels":[],"label_agreement":null},{"id":"W7135856747","doi":"","title":"Onkologi \"metronomisk\" chemotherapi:why less may be more","year":2010,"lang":"da","type":"article","venue":"Research at the University of Copenhagen (University of Copenhagen)","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Privy Council Office","funders":"","keywords":"Identification (biology); Set (abstract data type); Work (physics)","score_opus":0.07125759978039221,"score_gpt":0.3406673691142023,"score_spread":0.2694097693338101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7135856747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7249075,0.015830528,0.0003365353,0.027335223,0.00040188376,0.003374643,0.0007104397,0.00009115574,0.2270121],"genre_scores_gemma":[0.529461,0.0025105104,0.0005035365,0.00013859969,0.00011908675,4.4046843e-7,0.00006779254,0.00005066172,0.4671483],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99187887,0.0015110585,0.00045817636,0.0013191705,0.002904316,0.0019284188],"domain_scores_gemma":[0.9919406,0.0018442762,0.0005829659,0.0025439,0.0021222003,0.0009660171],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["sts","insufficient_payload"],"category_scores_codex":[0.0048037595,0.00064552197,0.0015908179,0.0007259565,0.003106478,0.00006946309,0.0042477604,0.00062807865,0.57119143],"category_scores_gemma":[0.0006379176,0.00066971465,0.0007759648,0.0021312186,0.009185493,0.000726652,0.0042954446,0.0028435937,0.049907375],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051020626,0.00060265575,0.00019708062,0.00082123646,0.0019860633,0.0006517414,0.0096495375,0.000023489882,0.03379549,0.00025353167,0.94127005,0.005647037],"study_design_scores_gemma":[0.0061923456,0.0011323242,0.024872854,0.0003256113,0.0005525425,0.00002503087,0.05730992,0.00024609338,0.009222293,0.0000065841855,0.8995801,0.00053426274],"about_ca_topic_score_codex":0.013753303,"about_ca_topic_score_gemma":0.009873577,"teacher_disagreement_score":0.5212841,"about_ca_system_score_codex":0.0014462912,"about_ca_system_score_gemma":0.0025163107,"threshold_uncertainty_score":0.99957544},"labels":[],"label_agreement":null},{"id":"W75391978","doi":"10.1155/2005/376404","title":"Does Sex Influence the Impact That Smoking, Treatment Interruption and Impaired Pulmonary Function Have on Outcomes in Limited Stage Small Cell Lung Cancer Treatment?","year":2005,"lang":"en","type":"article","venue":"Canadian Respiratory Journal","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Kingston Health Sciences Centre; Western University; BC Cancer Agency","funders":"","keywords":"Medicine; DLCO; Radiation therapy; Internal medicine; Lung cancer; Pulmonary function testing; Diffusing capacity; Chemotherapy; Stage (stratigraphy); Surgery; Gastroenterology; Lung; Lung function","score_opus":0.054517910325286315,"score_gpt":0.35356224820194493,"score_spread":0.29904433787665863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W75391978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922333,0.0037609627,0.0000016170811,0.0024520678,0.00013196457,0.00075685885,0.00008274127,0.000018982479,0.00056153344],"genre_scores_gemma":[0.9940463,0.0013029409,0.000004438046,0.0014246863,0.00031333778,0.00012865452,0.000004782946,0.000033127075,0.002741789],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830186,0.00018759747,0.0003040853,0.00030760007,0.00027559043,0.0006232489],"domain_scores_gemma":[0.9986736,0.00010705913,0.00014815475,0.00029337613,0.000089781424,0.0006880053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030958006,0.000325593,0.0003761423,0.0005692029,0.00037158802,0.00012414376,0.0001051157,0.000104207276,0.000177364],"category_scores_gemma":[0.00004872295,0.00015136455,0.00015006954,0.00014286122,0.000114187176,0.0002061307,0.00001985265,0.0004144655,0.0000034462853],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034853077,0.00010864756,0.96438813,0.0000218588,0.0003275795,0.0003882787,0.0015346478,0.00060713734,0.00043389972,0.000001147578,0.00029549727,0.031544637],"study_design_scores_gemma":[0.0026552083,0.0016147293,0.9770094,0.00018317705,0.00013601077,0.000039294682,0.0011773377,0.0004930284,0.00075824885,0.000005557727,0.015752045,0.0001759336],"about_ca_topic_score_codex":0.060441907,"about_ca_topic_score_gemma":0.3726953,"teacher_disagreement_score":0.3122534,"about_ca_system_score_codex":0.009521757,"about_ca_system_score_gemma":0.0014493514,"threshold_uncertainty_score":0.9942805},"labels":[],"label_agreement":null},{"id":"W79586950","doi":"","title":"Diagnostic value of tumor marker pro-gastrin-releasing peptide in patients with small cell lung cancer: a systematic review.","year":2011,"lang":"en","type":"review","venue":"PubMed","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Northern College","funders":"","keywords":"Medicine; Meta-analysis; Lung cancer; Receiver operating characteristic; Cochrane Library; MEDLINE; Internal medicine; Cancer; Tumor marker; Oncology; Systematic review; Pathological; Pathology","score_opus":0.03579943465697798,"score_gpt":0.3020399575085808,"score_spread":0.2662405228516028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W79586950","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004859711,0.9607865,0.000002118856,0.000020694426,0.000114933384,0.037516087,0.00007377322,0.00003369494,0.0009662109],"genre_scores_gemma":[0.000271431,0.9483479,0.000094009236,0.00006612494,0.000069288566,0.05039195,0.00004030888,0.00012276553,0.00059617055],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9955619,0.00057606335,0.0015281509,0.0006434525,0.0007735078,0.0009169196],"domain_scores_gemma":[0.9964666,0.0008087141,0.001227087,0.00084526825,0.0003647138,0.00028764663],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009450337,0.0006350427,0.005207475,0.00040067628,0.000039742965,0.000015676504,0.0003943816,0.00010768346,0.000019817082],"category_scores_gemma":[0.0034448488,0.00039623716,0.0003915528,0.00078289874,0.00011926781,0.00006771018,0.00022507997,0.0006660378,0.000008189513],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057068693,0.00023401919,0.027077002,0.92983484,0.000635523,0.000056207715,0.000045227946,1.3494417e-7,1.9592892e-9,0.0000025223474,0.0005548465,0.041502602],"study_design_scores_gemma":[0.0013165876,0.000115793526,0.056230422,0.92124635,0.010104442,0.000013998628,0.000007686479,9.0971577e-7,3.26371e-7,7.410992e-7,0.010607244,0.00035551205],"about_ca_topic_score_codex":0.00034416417,"about_ca_topic_score_gemma":0.000049213908,"teacher_disagreement_score":0.04114709,"about_ca_system_score_codex":0.0013231972,"about_ca_system_score_gemma":0.00074789056,"threshold_uncertainty_score":0.99984896},"labels":[],"label_agreement":null},{"id":"W851077011","doi":"10.1097/jto.0000000000000548","title":"Multitrial Evaluation of Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Extensive-Stage Small-Cell Lung Cancer","year":2015,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Cancer Institute","keywords":"Surrogate endpoint; Medicine; Hazard ratio; Progression-free survival; Internal medicine; Confidence interval; Proportional hazards model; Oncology; Lung cancer; Clinical endpoint; Randomized controlled trial; Overall survival","score_opus":0.13755274537181256,"score_gpt":0.5236198700037795,"score_spread":0.38606712463196696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W851077011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97799283,0.005824744,0.0002253712,0.0099321185,0.002618905,0.0021127055,0.00006541632,0.000011270128,0.001216621],"genre_scores_gemma":[0.9926916,0.00087809656,0.0039730924,0.00014360885,0.0014918719,0.00016220276,0.000013372911,0.00004405321,0.0006021216],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9955513,0.00086429797,0.0011022297,0.00028190823,0.0017259961,0.00047428376],"domain_scores_gemma":[0.9925045,0.0012112049,0.001130903,0.00033199115,0.004498362,0.00032303212],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.01122653,0.0002300311,0.0012098822,0.00041258318,0.00005799048,0.000013940808,0.00030478358,0.00021137286,0.00016023283],"category_scores_gemma":[0.009334052,0.00017232086,0.0002548654,0.00025822263,0.000163958,0.00016726047,0.0002210274,0.0005647795,0.0000020356345],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.31147522,0.0104587665,0.23009667,0.0069651366,0.0043019606,0.002778366,0.019044474,0.020755729,0.02617701,0.00023016978,0.03285134,0.33486518],"study_design_scores_gemma":[0.4246332,0.08392717,0.16901818,0.010910638,0.01324373,0.0009935342,0.01838726,0.12862319,0.06597743,0.010184395,0.071535975,0.002565292],"about_ca_topic_score_codex":0.0006510303,"about_ca_topic_score_gemma":0.003592091,"teacher_disagreement_score":0.3322999,"about_ca_system_score_codex":0.0021460499,"about_ca_system_score_gemma":0.00464625,"threshold_uncertainty_score":0.99901074},"labels":[],"label_agreement":null},{"id":"W96443023","doi":"10.1007/978-2-287-48618-0_11","title":"Les cancers bronchiques à petites cellules du sujet âgé","year":2007,"lang":"fr","type":"book-chapter","venue":"","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine","score_opus":0.09560753856126977,"score_gpt":0.37477642059574223,"score_spread":0.27916888203447243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W96443023","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013751815,0.076116756,0.00038548053,0.004171678,0.0015056083,0.0011829289,0.00018719058,0.00029092343,0.91478425],"genre_scores_gemma":[0.063835666,0.112005234,0.0020135522,0.001053836,0.008028216,0.000044104876,0.00015094127,0.00026939137,0.81259906],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950063,0.0000788497,0.0008758621,0.0010700441,0.0014535475,0.0015153695],"domain_scores_gemma":[0.9964013,0.0010810903,0.00027792857,0.0008074672,0.00074076233,0.0006914305],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0008827565,0.0010652196,0.0014364072,0.000528204,0.00045248956,0.00007889905,0.00048629718,0.00070007716,0.032319],"category_scores_gemma":[0.00041975587,0.0008844327,0.00052180473,0.00010490978,0.0023501876,0.00014342093,0.00049036485,0.0014720884,0.0016164114],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006430762,0.00012534797,0.029784169,0.0041990336,0.003369044,0.002265605,0.00121797,0.000020703212,0.0005875208,0.7847803,0.046897292,0.12610991],"study_design_scores_gemma":[0.0012528974,0.000905894,0.0042479723,0.004000486,0.0006019957,0.00009413755,0.0007408965,0.00007254578,0.0022099854,0.0011668333,0.9837516,0.0009547499],"about_ca_topic_score_codex":0.029489316,"about_ca_topic_score_gemma":0.02620869,"teacher_disagreement_score":0.9368543,"about_ca_system_score_codex":0.0041986755,"about_ca_system_score_gemma":0.0010265836,"threshold_uncertainty_score":0.999624},"labels":[],"label_agreement":null}]}